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Antibiotic prescribing – quality indicators
P1460
Is self-medication with antibiotics in Europe
driven by prescribed use?
L. Grigoryan, F.M. Haaijer-Ruskamp, J.G.M. Burgerhof,
J.E. Degener, R. Deschepper, D. Monnet, A. Di Matteo,
E.A. Scicluna, A. Bara, C. Sta˚lsby Lundborg, J. Birkin and the SAR
group
Objectives: The occurrence of self-medication with antibiotics
has been described in the US and Europe, a possible
contributing factor to increased antibiotic resistance. An
important reason for using self-medication can be past
experience with antibiotics prescribed by health professionals.
We investigated whether self-medication in Europe follows the
same pattern as prescribed use.
Methods: A population survey was conducted in: North and
West of Europe (DK, AT, NL, SE, BE, UK, IE and LU), South (IT,
MT, IL and ES) and East (SK, LT, CZ, HR, PL, RO and SL) with a
self-administered postal questionnaire. A total of 15548 people
completed the questionnaires. Using a multistage sampling
design, we selected in each country a random sample of 1000–
3000 adults equally distributed in urban and rural areas. The
analyses were done on the individual level using multivariate
logistic regression analysis. We tested possible interactions
between the factors found to be signiﬁcant.
Results: The use of prescribed antibiotics was independently
associated with self-medication in the previous 12 months. A
signiﬁcant interaction was found between prescribed use and
regions in Europe: the effect of prescribed use was the largest in
North and West (odds ratio 7.6 95% CI 4.2–13.6) and smaller in
South (OR 2.1, 1.2–3.7) and East (1.9, 1.3–2.7). When studying the
association between prescribed use and self-medication for a
speciﬁc symptom/disease or speciﬁc antibiotic strong associations
were found. For example, respondents who used prescribed
antibiotics for a throat symptom had 7.1 times (4.4–11.4) higher
probability for self-medication for a throat symptom. For the other
symptoms the odds ratios varied from6.4 to 7.7. Prescribeduse and
actual self-medication were both signiﬁcant predictors of intended
self-medication. We found a signiﬁcant interaction, indicating that
prescribed use increased the risk of intended self-medication in
those respondents who did not use actual self-medication.
Respondents who used prescribed antibiotics for a speciﬁc
symptom in the previous 12 months had 1.7–7.1 times higher
probability of intended self-medication for the same symptom.
Conclusion: Self-medication with antibiotics in Europe is
associated with prescribed use and may even be driven by it.
Routine prescribing of antibiotics for minor ailments such as
cold symptoms increases the risk of self-medication with
antibiotics for such ailments.
P1461
Adjustment of antibiotic treatment according to
the results of blood cultures leads to decreased
antibiotic use and costs
D. Berild, A. Mohseni, L.M. Diep, M. Jensenius,
S.H. Ringertz (Oslo, NO)
Objective: To investigate whether the results of blood cultures
led to changes in antibiotic use and costs in a university hospital
in Norway
Methods: Medical records from all patients with positive blood
cultures in 2001 were analysed retrospectively. Factors
predisposing to infections, results of blood cultures, antibiotic
use, and outcome were recorded.
Results: The antibiotic use in 226 episodes of true bacteraemia
were analysed. According to guidelines empirical antibiotic
treatment should be adjusted in 166 episodes. Antibiotic use was
adjusted in 146 (88%) of these 166 episodes, which led to a
narrowing of therapy in 118 (80%) episodes. Compared to
empirical therapy there was a 22% reduction in the number of
antibiotics. Adjustment of therapy was more often performed in
Gram-negative bacteraemia and polymicrobial cultures than in
Gram-positive bacteraemia. In bacteraemia caused by
ampicillin-resistant E. coli, ampicillin was mostly replaced by
ciproﬂoxacin. The cost for 7 days adjusted therapy was 19800
EUR (23%) less than for 7 days of empirical therapy.
Conclusion: Adjustment of antibiotic use according to results of
blood cultures led to improvement of antibiotic use and
decreased costs.
P1462
Impact of an active surveillance system on
antimicrobial use and resistance in a
neurosurgical intensive care unit
E. Meyer, J. Buttler, F. Schwab, E. Strehl, P. Gastmeier, H. Ruden,
K. de With, J. Zentner, F. Daschner (Freiburg, Berlin, Hannover,
DE)
Objective: To analyse the impact of SARI (Surveillance of
Antimicrobial Use and Antimicrobial Resistance in Intensive
Care Units) on antibiotic use, resistance, device associated
infection rates (NI) and costs in a neurosurgical university ICU.
Methods: Comparison of prospective unit and laboratory based
surveillance data of 40 German ICUs from 2000–2004 with the
study ICU. Antimicrobial consumption is calculated by WHO
deﬁned daily doses (DDD) per 1000 patient days (AD). NIs are
reported according to CDC deﬁnitions. Benchmarking data were
fed back to the study ICU and analysed there in a multidisci-
plinary team every three months between 2000 and 2003 and
every 6 months since 2004.
Results: In the study a total of 1,004 SARI isolates were
reported; this ﬁgure corresponds to 72.0 isolates/1000 pd.
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Resistance rates (RR) over a period of 5 years were generally
better than those reported for a total of 40 ICUs. The mean
MRSA RR was 22.1%, for all the SARI ICUs, whereas it was only
2.7% in the study ICU. By the end of 2003 duration of treatment
for pneumonia had been reduced to 5–7 days and written
guidelines on empiric antibiotic treatment and prophylaxis were
revised with respect to the resistance situation of the study ICU.
The signiﬁcant decrease between 2000 and 2004 in total
antimicrobial AD from 1,099 to 607 in the study ICU resulted
mainly from the reduced consumption of 2nd generation
cephalosporins, carbapenems and imidazoles. NI did not
change signiﬁcantly over time. Compared to the year 2000, the
costs for antibiotics were halved from €51,102 to 22,324, which
corresponds to €18.7/pd and €6.6/pd, respectively. The per-
centage of antibiotics in the total ICU budget for pharmaceuti-
cals decreased from 14.6% to 10.4%.
Conclusion: Surveillance and feedback of antibiotic use and
resistance can serve as a valuable quality control instrument and
can have an impact on antibiotic treatment. From 2000 to 2004,
antibiotic use was reduced by 45% and costs for antibiotics/pd
were cut by two third in the ICU study without any increase in
device associated nosocomial infection rates. The resistance
situation was generally better than in all SARI ICUs, but showed
heavy ﬂuctuations.
P1463
Similar illness burden but different antibiotic
prescription to children: a population-based
study
K. Hedin, M. Andre, A. Ha˚kansson, N. Rodhe, S. Mo¨lstad,
C. Petersson (Va¨xjo¨, Falun, Malmo¨, Linko¨ping, SE)
Objectives: Respiratory tract infections are the most common
reason for antibiotic prescription in Sweden as in other
countries. The prescription rates vary markedly in different
countries, counties and municipalities. The reasons for these
variations in prescription rates are not obvious. The aim of the
study was to ﬁnd possible explanations for different antibiotic
prescription rates in children. Therefore a prospective
population based log book study was conducted in four
municipalities which, according to ofﬁcial statistics, had high
and three municipalities which had low antibiotic prescription
rates.
Methods: During one month, parents recorded all infectious
symptoms, physician consultations and antibiotic treatments,
from 848 18-month-old children in a log book. The children’s
parents also answered a questionnaire about socioeconomic
factors and concern about infectious illness.
Results: Antibiotics were prescribed to 11.6% of the children
in the high prescription area and 4.7% in the low prescription
area (crude OR 2.67 (95% CI 1.45–4.93)). After multiple logistic
regression analyses taking account of socioeconomic factors,
concern about infectious illness, number of symptom days and
physician consultations, differences in antibiotic prescription
rates remained (adjusted OR 2.61 (95%CI 1.14–5.98)). The
variable that impacted most on antibiotic prescription rates
although it was not relevant to the geographical differences
was a high level of concern about infectious illness in the
family.
Conclusion: The differences in antibiotic prescription rates
could not be explained by socioeconomic factors, concern
about infectious illness, number of symptom days and
physician consultations. The differences may be attributable to
different prescription customs, in which case physicians´
prescription patterns are not always rational.
P1464
Decreasing outpatient antibiotic prescribing in
Germany, 1995–2004, does not include newer
macrolides, ﬂuoroquinolones and extended-
spectrum beta-lactams
W.V. Kern, K. de With, K. Nink, H. Schro¨der (Freiburg, Bonn,
DE)
Objective: The ESAC (European Surveillance of Antibiotic
Consumption, www.ua.ac.be/ESAC) project has shown that
outpatient antibiotic prescribing in Germany has been
comparatively low among European countries. We assessed
trends over time and regional variation of outpatient antibiotic
use in Germany, and wondered if the observable decreasing
trend included all drug classes to a similar extent.
Methods: Prescription data (compulsory health insurance
covering >90% of the population, sample of 0.4% until the
year 2000, all prescriptions thereafter) were analysed using the
ATC/WHO methodology and current DDD deﬁnitions. We
speciﬁcally deﬁned the following drug groups: ‘‘basic’’
penicillins (BPENs, oral penicillin or aminopenicillins),
extended-spectrum betalactams (ESBLs, oral cephalosporins,
staphylococcal penicillins, aminopenicillin/betalactamse
inhibitor combinations, parenteral cephalosporins and broad-
spectrum betalactams), newer macrolides (NMLs,
roxithromycin, clarithromycin, azithromycin) versus older
macrolides (OMLs). Quinolones (FQs), folate synthesis
inhibitors (T/Ss) and tetracyclines (TETs) were also assessed.
Data were expressed in yearly DDD/1000 persons covered by
the insurance (DDD/1000).
Findings: Outpatient prescribing in 1995 was 6140 DDD/1000
(corresponding to 16.8 DID = DDD/1000 and day) and
decreased to 5430 DDD/1000 in the year 2000 and to 4672
DDD/1000 in 2004. The decreasing trend over the last 4 years
was observed in all regions. The decrease was most signiﬁcant
for OMLs ()55%), T/Ss ()48%), TETs ()36%), and BPENs
()13%) while there was no decreasing use of ESBLs (±0%) and
increases in the rate of prescribing NMLs (+13%) and FQs
(+43%). TETs and BPENs, however remained the most
prescribed antibiotics in 2004. Regional variations in 2004
remained large for BPENs (>3-fold) with very low prescribing
rates in the Eastern region, but were small for T/Ss, NMLs and
FQs (<2-fold).
Conclusions: Over a decade we observed a 24% decreasing
outpatient antibiotic prescribing that included relevant
antibiotic drug classes except ESBLs, NMLs and FQs. The
relative increase was most signiﬁcant for FQs.
P1465
Severe community-acquired pneumonia admitted
to the intensive care unit: impact of antibiotic
therapy delay on hospital mortality
P.F. Laterre, T. Dugernier, X. Wittebole, C. Collienne,
M.N. France, R. Wunderink (Brussels, BE; Chicago, US)
Introduction: Severe community-acquired pneumonia (CAP)
admitted to the ICU remains associated with a high hospital
mortality. Time to antibiotic treatment has been considered to
inﬂuence patients (pts) outcome in severe infections. We
thought to determine if time from hospital admission to
antibiotherapy had an impact on hospital mortality in severe
CAP.
Materials and methods: All consecutive pts with CAP from 2
institutions, admitted to the ICU and treated with a combination
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antibiotic therapy were enrolled in the study. Pts were divided
in 4 Groups according to time to treatment (<2 h GI, 2–4 h GII,
4–8 h GIII and >8 h GIV). Baseline severity scores (APACHE II,
SOFA, PSI, CURB-65), microbiological documentation, and
hospital outcome were compared for all groups.
Results: 152 pts were included in the study. Microbiological
documentation was achieved in 80% of all pts, positive blood
cultures in 54/152 (35.5%), S. Pneumoniae in 64/152 (42%). Mean
age was 66 ± 13, APACHE II 25.8 ± 7.6, SOFA 8.8 ± 3.7, PSI
158 ± 40, CURB-65 3.2 ± 1, mechanical ventilation in 67.7% and
vasopressors use in 63.1%. Overall ICU and Hospital all-cause
mortality were 27.5% and 35.5%, respectively. Baseline severity
scores were comparable in all 4 Groups and their respective
Hospital mortality is provided in Table 1.
Conclusions: In severe CAP, treated with a combination
therapy, time to treatment seems to have an impact on
hospital all-cause mortality. Based on our results, antibiotic
treatment should be initiated within the ﬁrst 2 hours after
hospital admission.
P1466
Antibiotics cycling in the intensive care unit: next
stage – cefoperazone/sulbactam
D. Protsenko, S. Yakovlev, B. Gelfand, O. Romashov,
A. Yaroshetskiy, O. Ignatenko (Moscow, RU)
Purpose: The aim of investigation was a study of changing
antibiotic resistance of causative agents of VAP of the
emergency municipal hospital as a result of antibiotic cycling
of empirical treatment regimes.
Methods: The present study was based on the results of
research conducted from October 2003 till September 2005 in
the ICU department of the municipal emergency hospital.
Within the period from October 2003 till December 2004
(Period I) cefepime (4 g a day) as monotherapy and from
January 2005 till September 2005 (Period II) – cefoperazone/
sulbactam (8 g a day) as monotherapy were used as the
empirical antibacterial therapy of VAP. The rotation from
cefepime to cefoperazone/sulbactam was performed due to
our previous study demonstrated high frequency of ESBL
producers among Enterobacteriaceae. The samples from the
lower respiratory tract were obtained by mini-BAL. The
sensitivity of microorganisms to the antibiotics studied
(ceftazidime, cefepime, cefoperazone/sulbactam and
carbapenems) was determined by the disk diffusion method.
Results: The main pathogens of VAP were S. aureus (20%), P.
aeruginosa (19%), Enterobacteriaceae (23%) and this structure did
not changed during both periods. The antibiotic sensitivity of P.
aeruginosa and Enterobacteriaceae (K. pneumoniae and E. coli),
was studied separately. A high level of resistance of
Enterobacteriaceae to cefepime can be explained by the strains
prevailing in the given ICU, which produced extended spectrum
beta-lactamases (CTX-M). The resistance of Enterobacteriaceae
to cefepime was 57.5% in I period and 80.5% in II period, to
ceftazidime – 90.0 and 100%, meropenem – 0 and 0%, imipenem
– 5.1 and 2.1%, cefoperazone/sulbactam – 10.9 and 20.8%,
respectively. A change of cefepime for cefoperazone/sulbactam
was not followed by any decrease of Enterobacteriaceae
resistance level to cefepime during II period. The resistance
level of P. aeruginosa to cefepime was 20.5% in I period and
24.1% in II period, to ceftazidime – 22.5 and 33.0%, meropenem –
44.7 and 39.5%, imipenem – 50.1 and 39.5%, cefoperazone/
sulbactam – 16.9 and 12.5%, respectively.
Conclusion: The exclusion of cefepime for 9 months didn’t
improved the sensitivity of Enterobacteriaceae to this medication.
The level of resistance of P. aeruginosa and Enterobacteriaceae to
cefoperazone/sulbactam did not increased despite a wide use
of this antibiotic during 9 months.
P1467
Antibiotic consumption in German acute care
hospitals
M. Steib-Bauert, K. de With, E. Meyer, P. Straach,
W.V. Kern (Freiburg, Frankfurt, DE)
Objective: Outpatient antibiotic use in Germany differs
substantially between Eastern and Southern parts of the
country (relatively low use) and Western part (relatively high
use). There is no nationwide estimate of hospital antibiotic use
and its geographic variation if any. The aim of the present study
was to provide an estimate of recent hospital antibiotic use
density in Germany and to identify basic unit/hospital
characteristics associated with excess use.
Methods: Data on hospital consumption of systemic antibiotics
in Anatomical Therapeutic Chemical (ATC) class J01 were
obtained from a convenience sample of 145 acute care hospitals
in Germany that participated in an IMS survey in the year 2003
and had complete data (dispensed drugs and patient-days per
year) for at least one non-paediatric, non-psychiatric department
or ward. A total of 275 non-ICU surgical departments/wards,
229 non-ICU non-surgical (general medicine, oncology-
haematology, neurology/stroke) departments/wards, and 184
ICUs covering >16 million patient-days were analysed. Data
were expressed in DDD (WHO/ATC deﬁnition version 2001) or
‘‘prescribed/recommended daily doses’’ (PDD, better reﬂecting
[high] dosages given to hospitalized patients) per 100 patient
days (DDD/100 and PDD/100).
Findings: The weighted mean over all departments/wards incl.
ICUs was 49.8 DDD/100 (31.4 PDD/100). As expected, ICU
antibiotic use density was much higher than use in non-ICU
areas, and use in haematology-oncology was higher than in
other non-surgical departments/wards. In univariate analyses,
bed-size category and university afﬁliation (ICUs, surgical
wards), region (ICU, surgical and non-surgical wards) and
haematology-oncology as specialty (non-surgical wards) were
associated with use density, but these associations were only
partly conﬁrmed in multivariate logistic regression analyses of
factors associated with excess (‡75%) use density which showed
university afﬁliation and haematology-oncology to be
independently associated with high use.
Conclusions: Based on this hospital sample, antibiotic use in
German hospitals shows little, non-signiﬁcant regional variation
and appears to be similar to what has been described from other
European countries. Adjustment of the data at least for
university afﬁliation and haematology-oncology is important
in comparative analyses of hospital antibiotic consumption.
P1468
Impact of formulary change in medical intensive
care unit on outcome of infection and
antimicrobial resistance
V. Huang, J. Jinson, M. Zervos (Atlanta, Detroit, US)
Objective: Antimicrobial resistance in medical intensive care
unit patients (ICU) is an increasing problem worldwide. We
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
sought to evaluate a formulary change and impact it has on
infection and resistant.
Methods: Prospectively, all patients in a 20-bed ICU were
followed for a period of 4 months in Phase I (390 patients per
2379 patient days) and to collect baseline data after a decrease in
the use of piperacillin-tazobactam (PT) when substituted by
cefepime for a period of 4 months in Phase II (383 patients per
2260 patient days).
Results: Total infections in Phase I vs. Phase II were lower
respiratory tract (LRTI) 214 patients (55%) vs. 203 patients (53%);
urinary tract infection (UTI) 94 patients (24%) vs. 96 patients
(25%); and sepsis of undetermined aetiology 70 patients (18%)
vs. 65 patients (17%), respectively. There were no signiﬁcant
differences in death (22% vs. 19%), cure or improvement of
infection (53% vs. 56%), readmission to the unit (3.5% vs. 3.2%),
hospital risk of death (29.8% vs. 30.2%), mean length of ICU stay
(6.1 days vs. 5.9 days), or rates of nosocomial infection (6.3% vs.
5.1% for LRTI; 4.0% vs. 4.2% for UTI; 0.8% vs. 0.0% for soft tissue
infection; 0.8% vs. 1.0% for bacteremia; 2.1 vs. 1.0 per 1000
patient days for intravenous catheter infection) in Phase I and II
respectively. The cost of antimicrobial acquisition in Phase I and
II were $548 and $433 per patient respectively (p < 0.001). The
mean antimicrobial treatment costs per patient for PT were $145
vs. $100 and cefepime were $80 vs. $105 in Phase I and II
respectively (p < 0.01). The in vitro susceptibility and rate of
infection and colonization with Escherichia coli were unchanged
in both study periods. There were 68 vs. 39 Staphylococcus aureus
(p < 0.001); of these 94percnt vs. 87percnt were methicillin-
resistant S. aureus and 11 vs. 9 Enterococcus faecium (82% vs. 77%
vancomycin-resistant enterococci) in Phase I and II respectively.
There were 73% vs. 31% Pseudomonas aeruginosa and 70% vs. 4%
Klebsiella pneumoniae extended spectrum beta lactamases in
Phase I and II respectively.
Conclusion: The implementation of formulary substitution of
PT to cefepime in the medical ICU had resulted in a decrease in
the use of PT. In addition, there were decreased costs and less S.
aureus infections without adversely affecting the outcome of
infection or antimicrobial resistance.
P1469
Intravenous antibiotic use in Scottish hospitals;
evaluation of the Glasgow antimicrobial audit
tool
R.A. Seaton, D. Nathwani, P. Burton, E. Douglas (Glasgow,
Dundee, UK)
Introduction: There are few data on antibiotic prescribing
within Scottish hospitals and a coordinated multisite point
prevalence survey had not been performed before. There is
concern that antimicrobials are overused in hospitals.
Methods: Antibiotic use in acute medical and surgical units in
10 Scottish hospitals across 5 trusts, was investigated using a
point prevalence survey. Data were collected by pharmacists.
Appropriateness of the IV route of administration was deter-
mined by review of data by an infectious diseases physician
(IDP) and compared with a speciﬁcally designed computerised
algorithm. The IDP also judged the appropriateness of the
chosen IV agent against local guidelines. 3826 patients from 10
hospitals in 5 regions were surveyed on a single day. 1079
(28.3%) were receiving an antibiotic, 381 (35.3%) intravenously.
197 receiving oral antibiotics had received an IV previously.
Median duration of IV therapy was 4 days (IQR 2–7 days) and
time from IV to oral switch was 3.5 (2–6). The IDP judged
appropriate IV route in 84% patients compared with 84.8% by
the algorithm. The sensitivity of the algorithm was 93.4% and
speciﬁcity 60.7%. The positive predictive value was 92.6% and
the negative predictive value was 63.8%. The IDP judged IV
agents to have been chosen and administered appropriately in
80%. Most frequently prescribed IV agents were 3rd generation
cephalosporins (3GC) (28.3%), Co-amoxiclav (20.2%), Metroni-
dazole (19.2%), Glycopeptides (18.6%). Signiﬁcant regional
differences were seen for most antibiotic groups including
3GCs (49.2% (site 3) vs 24.4% (sites 1, 2, 4, 5), p < 0.001) and
Glycopeptides [31.8% (site 1) vs 9.3% (site 2, 3, 4, 5), p < 0.001].
It is possible to coordinate, collect and compare data from
Scottish hospitals. The GAAT gives a good estimate of the
appropriateness of IV therapy. Signiﬁcant differences in
prescribing patterns between similar patient groups across
different hospital sites were demonstrated. Such data may
usefully inform local and national audit and support prescrib-
ing initiatives.
P1470
Use of glycopeptides in 47 French hospitals
A.M. Rogues, C. Dumartin, H. Boulestreau, P. Parneix,
N. Marty, J.P. Gachie (Bordeaux, Toulouse, FR)
Objective: To describe consumption of glycopeptides for
systemic use in hospitals. Setting: 47 hospitals in south-
western France (31 were public hospitals and 16 were private
hospitals).
Method: Consumption of glycopeptides for systemic use
(deﬁned daily doses per 1,000 patient-days: DDJ per 1000 PD),
number of methicillin-resistant Staphylococcus aureus per 1000
patient-days (incidence of MRSA), number of central-line per
1000 patient-days and hospitals characteristics (size, length of
stay, number of beds: total and for each hospital areas) were
recorded from January 2002 through December 2002.
Associations between continuous variables were tested in
univariate analysis with the Spearman correlation test (r).
Multiple linear regression analysis was performed in a
backward stepwise approach.
Results: The median rate of total hospital glycopeptides use
was 4.11 (range 0.21 to 27.22) DDDs per 1,000 PD with higher
consumption in large public hospitals. Consumption was higher
in intensive care areas (median 46.51; range 7.19 to 134) than in
surgery areas (median 4.5; range 0.17 to 24.76) and in medicine
(median 4.26; range 0 to 41). Glycopeptides use correlated with
number of central line per 1,000 PD (r: 0.44; p: 0.03) and with size
of the various areas in the hospital (for intensive care, r: 0.50; for
medicine areas, r: 0.33 and for surgery areas, r: 0.42; p < 0.05).
Median incidence of MRSA was 0.87 per 1,000 PD. Incidence of
MRSA explained a small proportion of the variation in hospital
glycopeptides consumption (R2: 0.13). In a multivariate linear
regression model, incidence of MRSA and number of beds in
surgery areas were independent predictors of total
glycopeptides use in the hospital (R2 adjusted: 0.39). After
controlling for these factors, number of central-line per 1,000 PD
was no more associated with glycopeptides use.
Conclusion: In our hospitals, total glycopeptides use was not
heavily determined by incidence of MRSA. Although
glycopeptides use in surgery areas was not the highest, the
total number of surgery beds in the hospital explained a large
variation of the total hospital glycopeptides use. Therefore we
had to take it into account to interpret these consumption and to
decide further evaluation.
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Antibiotic management of acute lower respiratory
tract infections among Dutch elderly patients in
primary care
J. Bont, C. Birkhoff, T. Verheij, E. Hak on behalf of ESPRIT
Objectives: Acute lower respiratory tract infection (LRTI) can
cause various complications leading to morbidity as well as
mortality notably among elderly patients. Antibiotic treatment
of LRTI is common, despite Dutch clinical guidelines
recommending antibiotics only in case of pneumonia or high
risk of serious complications. We assessed the course of illness
and outcome of pneumonia, acute bronchitis and exacerbations
of COPD or asthma among Dutch elderly patients in primary
care and assessed whether GPs were inclined to prescribe
antibiotics more readily to patients with potential risk factors for
complications in acute bronchitis or exacerbations of COPD/
asthma.
Methods: We retrospectively analysed medical data from 3,166
episodes of LRTI among patients ‡65 years of age presenting in
primary care to describe the course of illness and outcome. The
relation between prescriptions of antibiotics and patients with
risk factors for a complicated course was assessed by means of
multivariate logistic regression. Risk factors for a complicated
course included heart failure, history of myocardial infarction,
angina pectoris, diabetes, history of stroke, dementia,
malignancy, and history of pneumonia or hospitalisation in
preceding year.
Results: One or more complications arose in 17% of episodes of
LRTI. Among these, 8% suffered from pulmonary complica-
tions, 5% had cardiovascular complications (heart failure,
myocardial infarction etc.), 5% had a protracted course and
0.6% had a diabetes event. In 6.9% of the patients complications
led to hospital admission and in 2.4% LRTI were fatal.
Antibiotics were more readily prescribed to patients aged
‡90 years, when heart failure was present and in patients with
diabetes. No signiﬁcant association was observed in patients
with other co-morbid conditions. Patients diagnosed with an
exacerbation of COPD or acute bronchitis with a history of
pneumonia or hospitalisation in the preceding year were not
more likely to receive antibiotics.
Conclusions: A considerable part of elderly patients with a
LRTI suffers from a severely complicated course in primary
care. Although GPs are inclined to prescribe more readily
antibiotics in the very old and those with heart failure or
diabetes, other potential risk factors are not taken into account.
P1472
Prospective evaluation of consultations
performed by infectious diseases trainees
O. Sipahi, M. Tasbakan, H. Pullukcu, B. Arda, T. Yamazhan,
S. Mizrakci, S. Senol, S. Atalay, D. Koseli, G. Arsu, S. Calik,
H. Sipahi, C. Buke, S. Ulusoy (Izmir, TR)
Objectives: In this study it was aimed to analyse the infectious
diseases (ID) trainees’ night/weekend shift consultation process
in terms of patient and consultant characteristics, types of
recommendations, and compliance with recommendations.
Methods: All consultations performed by ID trainees in night
shift and at the weekends between June 10th–August 10th 2004
were analysed in terms of consultation type [treatment
continuation (TC), consultation for surgical antibiotic
prophylaxis (PA), and consultation with or without a request
of a speciﬁc antibiotic (others)]. Appropriateness of
recommendations was assessed the day after the consultation
by infectious diseases specialists (IDS). Adherence to
recommendations was assessed 3 days after the consultation
by IDSs. Recommendations including antibiotics were
considered appropriate, if they were appropriate according to
national and international guidelines. Recommendations were
considered complied, if they were done in up to 72 hours after
the consultation (except the consultations in the emergency
medicine and the consultations in which antibiotics were started
by the counselling IDSs).
Results: Of 436 consultations 79 was for TC, 74 was for PA and
290 was for others. The clinic where ID consultations were
requested mostly was general surgery clinic (152/436, 34.9%). In
2% of all consultations trainees consulted the specialists. Overall
146 consultations (74 for SP, 69 for a clinical infectious disease
diagnosed clinically, 9 for an infectious disease diagnosed
microbiologically) were for requesting spesiﬁc antibiotic(s). PA
were approved in 68 of 74 consultations. Antibiotic was not
recommended in 14 of 290 other consultations. In six of 74
consultations for PA antibiotic was changed for a clinically
diagnosed infectious disease. In one of 79 consultations for TC
antibiotic was changed due to lack of response to the given
antibiotic, in others TC was approved. Inappropriate antibiotic
recommendation rate was 2.4% (8/32, 4 inappropriate choice, 3
inappropriate dosage, one antibiotic unnecessary). Overall
compliance to ID recommendations was 76.1% (476/608). Rate
of compliance to antibiotic recommendations was evaluated in
240 consultations and was found 98.2% (277/282) and was
higher than compliance to other (microbiology etc.)
recommendations (60.8%, 199/327, chi square p < 0.05).
Conclusion: Methodologies to improve the compliance to non-
treatment based recommendations and optimizing antibiotic
selection is necessary.
P1473
Study of the inﬂuence of online practice
guidelines on the appropriateness of antibiotic
prescribing in a university-afﬁliated psychiatric
hospital
J.F. Westphal, C. Nonnenmacher, D. Gregoire, M. Hittinger,
C. Oulerich, F. Jehl (Brumath, Strasbourg, FR)
Background: Problems with the dissemination of guidelines are
frequently cited as a major reason for failure to impact practice.
Reviews of the effectiveness of various methods of guideline
dissemination show that the most predictable impact is achieved
when the guideline is made accessible through computer-based
reminders that are integrated into the clinician’s workﬂow. We
report a time-series prospective investigation aimed at
comparing the appropriateness of antibiotic (AB) orders for
pneumonia at the treatment initiation level after vs. before
having embedded our current AB guidelines for pneumonia in
the computerized physician drug-order entry system of our
teaching psychiatric hospital comprising 410 adult beds.
Methods: In total, 160 consecutive AB orders for pneumonia
were evaluated by the pharmacy department, including 80
orders just before and 80 orders just after implementation of
online AB guidelines. Appropriateness of AB orders relative to
the guidelines was assessed according to 3 criteria: (1) the
choice of AB with respect to the mode of acquisition
(community- or hospital-acquired) of pneumonia or the
presence of clinical risk factors for involvement of gram-
negative bacilli, (2) the daily dosage, (3) the planned duration
of treatment. Data were extracted from the computerized
infection declaration system that recorded all AB-requiring
infections in our hospital.
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Results: The number of AB orders with at least 1 criterion of
inappropriateness tended to decrease, yet not signiﬁcantly
(p = 0.11), after vs. before implementation of online guidelines:
30/80 (36.5%) and 40/80 (50.0%), respectively. The number of
criteria of inappropriateness relative to all AB orders for
pneumonia was signiﬁcantly lower in the post-implementation
period: 43.8% vs. 65.0% before implementation (difference
21.2%, 95% CI 6.1–36.3, p < 0.01), with a trend to a decreased
number of orders containing more than 1 criterion of
inappropriateness. Analyzed separately, the numbers of
inappropriate orders for the choice of the AB, or the daily
dosage, or the planned duration of treatment decreased, yet
not signiﬁcantly (p > 0.1 for each criterion), in the post- vs. pre-
implementation period: 11 vs. 18, 12 vs.15, 12 vs.19,
respectively.
Conclusion: In this study, the moderate impact on AB
prescribing practices of online guidelines available at the time
of drug order shows that additional types of intervention are
needed to improve further the quality of AB prescribing.
P1474
Pilot implementation of multidisciplinary
antibiotic management teams in Belgian
hospitals: 2-year progress report, 2003–04
L. Sourdeau, M.J. Struelens, W.E. Peetermans, C. Suetens,
M. Costers for the Hospital Care Working Group of Belgium
Antibiotic Policy Coordination Committee
Objectives: To analyse the interventions undertaken by local
Antibiotic Managers (AMs) and multidisciplinary Antibiotic
Management Teams (AMTs) in Belgian hospitals during a 2-year
pilot project.
Methods: Since 2002, the Belgian government subsidized the
part-time activities of AMs in 36 hospitals with an operational
AMT. The activity of AMTs from these hospitals and their
impact on antibiotic usage were evaluated based on yearly
progress reports for 2003 and 2004.
Material: The pilot hospitals had a median capacity of 654
(range, 154 to 1597) beds; their regional distribution was
representative of population size; 18 were general hospitals, 8
teaching hospitals and 10 general hospitals with teaching beds.
Results: AMs were Internists (28), Microbiologists (13) and
Pharmacists (13). AMTs included a mean of 10 members who
met every 6 weeks on average. All hospitals irrespective of size
or afﬁliation had undertaken a wide range of antibiotic
management interventions in 2003, which increased in 2004;
These included (in 2003 and 2004, respectively): major review of
formulary (in 10 and 23 hospitals), development of clinical
guidelines (69 and 215 topics), restricted access to selected
antibiotics (carbapenems, glycopeptides, quinolones, new drugs;
in 25 and 33 hospitals). In 2003, antibiotic consumption
databases were established in 35 hospitals and antibacterial
susceptibility databases in 31 hospitals. In 2004, cross-analysis of
these databases was performed in 28 hospitals. In 2004,
prescribing assistance, antibiotic stop orders, treatment
streamlining and IV/PO therapy switch were implemented in
32, 21, 24 and 24 hospitals, respectively. In 2004, 26 hospitals
reported a better use of target antibiotics, 15 hospitals a decrease
in consumption of restricted antibiotics, 5 hospitals a decrease of
total antibiotic consumption, 2 hospitals a decrease in high
consumer departments.
Conclusion: All hospitals participating in the AMT pilot
scheme have developed multiple antibiotic policy
interventions and established monitoring and guidance of
antibiotic prescription. Preliminary data from some hospitals
indicated success in meeting self-deﬁned targets of appropriate
use and reducing the consumption of selected antimicrobial
agents. More systematic evaluation using standard quantitative
and qualitative indicators is planned.
P1475
Antibiotic prescribing practices at two linked
London teaching hospitals
P. Panesar, G. Scott, P. Wilson, C. Kibbler,
I. Balakrishnan (London, UK)
Objectives: To analyse and compare Microbiological isolates,
their antibiograms and antibiotic prescribing patterns between
two London teaching hospitals.
Methods: Patients admitted to hospital were identiﬁed
prospectively over 3 months. Those initiated on antibiotics on
admission were included in the study and followed throughout
their hospital stay.
Results: Five hundred and ﬁfty two patients were surveyed, of
which 194 (35%) were initiated on antibiotics. Over the course of
the study, a total of 402 patient antibiotics were prescribed
during in-patient stay, of which 49% were intravenous (Figure
1). Cefuroxime was the most commonly prescribed in-patient
antibiotic at UCLH and co-amoxiclav at RFH. On discharge, 53%
of patients were given an antibiotic. Amoxicillin was the most
frequently prescribed antibiotic on discharge at UCLH and
co-amoxiclav at RFH. The main indications for antibiotic use
were urinary tract infection (24% UCLH; 27% RFH), lower
respiratory tract infection (29% UCLH; 42% RFH), and skin and
soft tissue infection (24% UCLH; 21% RFH). Twenty-eight
percent of these patients were already taking an antibiotic
prior to admission - therapy was changed on admission in 19
patients (95%) at UCLH and 17 patients (65%) at RFH. Median
duration of total antibiotic course was 7 days at both hospitals,
and that of IV antibiotics was 3 days at UCLH and 3.5 days at
RFH. The most frequent specimens sent at UCLH were urine
(21% positive), blood (15% positive) and sputum (18% positive).
At RFH the specimens sent were MRSA swabs (35% positive),
urine (21% positive) and blood (20% positive). The predominant
organisms isolated at both hospitals were E. coli, Enterococcus
spp. and S. aureus. E. coli accounted for 50% of the total
organisms from urine at UCLH and 89% at RFH. Resistance
rates to E. coliwere: trimethoprim 57% and 40%, amoxicillin 50%
and 43% (UCLH and RFH respectively).
Conclusions: The study provides an insight into prescribing
habits at two teaching hospitals, and highlights differences in
resistance patterns and antibiotic use. The data derived may
help inform local audit and aid in the assessment of
prescribing initiatives. Further work is needed to establish
accurate resistance patterns in order to guide local antibiotic
policies.
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P1476
Comparison of different antibiotic consumption
measurement methods in large multidisciplinary
hospital
E. Pujate, I. Apine, U. Dumpis (Riga, LV)
Objectives: Antibiotic selection pressure is determined by the
total amount of antibiotics, number and density of patients
treated with antibiotics in the particular geographical area.
Several antibiotic consumption detection methods should be
combined in the hospital setting. Our objective was to evaluate
efﬁcacy of different approaches in large multidisciplinary
hospital.
Methods: Point prevalence studies were repeated annually at
2002–2004 in StradinsUniversityHospital (1000 beds) in Latvia. All
patients receiving antibiotics on the day of the survey were
identiﬁed and their medical records were reviewed. Data on
antibiotics, dose and route of administration were collected. In
addition, annual data on antibiotics dispensed to the departments
were collected frompharmacy. Total used grams for each antibiotic
were expressed into deﬁned daily doses (DDD-WHO). Bed days
(BD) and admission days (AD) were used as denominators.
Results: Table 1 Total use of antibiotics in Stradins University
Hospital 2002–2004.
The most commonly used antibiotic groups in the pharmacy
study were 1st generation cephalosporins (13.35 DDD/100 BD
in 2002, 11.6 in 2003, 10.8 in 2004) and penicillin’s with extended
spectrum (11.20, 11.98, 13.15) followed by ﬂuoroquinolones
(6.26, 8.13, 8.69) and metronidazole (4.42, 4.59, 5.61). There was
no signiﬁcant difference between distribution of different
antibiotics from prevalence and pharmacy studies if calculated
in DDDs. In contrast, distribution of antibiotics calculated per
patient in the prevalence study was quite different; 1st genera-
tion cephalosporins (8.71%, 8.63%, 5.84% in 2002, 2003, 2004
respectively) and ﬂuoroquinolones (3.05%, 6.69%, 5.63%) with
smaller proportion of extended spectrum penicillins (4.36%,
3.88%, 3.93%) and metronidazole (4.03%, 3.56%, 4.68%).
Conclusions: There were no differences in the distribution of
antibiotics calculated in DDDs per bed days and admissions.
Distribution of antibiotics in annual pharmacy studies and point
prevalence studies if calculated in DDDs were also similar. In
contrast, the prevalence data expressed as a proportion of
patients with selected antibiotics showed quite different
distribution. Studies using only DDDs may overestimate use
of certain antibiotic groups in our setting where WHO DDDs are
signiﬁcantly different from actual PDDs used.
P1477
A study of prescribing patterns and errors of
antibiotics in a Saudi hospital
M. Al-Jamal, M. Al-Barrak (Riyadh, SA)
Background: The term ‘‘prescribing patterns’’ has been used
extensively in studies to describe different aspects of the
prescribing process. Antibiotics as well as other drugs are
prescribed for the purpose of achieving deﬁnite therapeutic
outcomes that improve a patient’s quality of life while
minimizing risk. In the clinical literature, the incidence of
antibiotics prescribing errors ranges between 0.5% and 18.8%.
Objective: In this study we will address antibiotics prescribing
patterns and the incidence of prescribing errors in a tertiary
hospital and the potential relationship between them.
Methods: A prospective study of all prescriptions in a 3-month
period (June to August 2003) in a tertiary hospital has been
analysed. The hospital provides both primary and secondary
levels of care. Criteria used include frequency of selected
prescribed drugs, average number of items per prescription,
compliance to the hospital formulary, frequency of prescriptions
for antibiotics, generic prescribing and diagnosis. The
prescribing patterns and the incidence of prescribing errors
were performed.
Results: Total number of prescriptions for the 3-month study
was 24,404. Emergency Room (ER) and primary care have the
highest number of prescriptions (37.1%). The average number of
items per prescription is 2.1. The most prescribed drugs by
primary care (25.3% errors), emergency are antibiotics (28.2%),
medicine (3.7), ophthalmology (22.3), gynaecology (7.8), and
paediatrics (17.8). The prescription errors were 13.6% in primary
care and 22.3% in emergency department.
Discussions and conclusions: Over 24000 prescriptions were
included in this study. The incidence of prescribing errors was
18.8% the average number of items per prescription was 2.1.
Total Prescription errors are also related to frequency of
prescribing antibiotics. There was a relation between
prescribing of antibiotics and prescribing of trade names
(p < 0.01), and compliance to the hospital formulary
(p < 0.001). Several factors inﬂuence prescribing patterns and
variations in prescribing rates has been identiﬁed. These include
general physician behavior, differences in morbidity and
mortality patterns, social perception toward illness, and
physician clinical skills, experience and qualiﬁcation, as well
as physician continuing education and training. Special
antibiotic prescribing guidelines and restrictions should target
primary care and emergency department physicians.
P1478
Effect of a policy for restriction of selected classes
of antibiotics on antimicrobial drug cost and
resistance
M. Falagas, I. Bliziotis, A. Michalopoulos, G. Sermaides,
V. Papaioannou, D. Nikita, N. Choulis (Athens, GR)
Objectives: The introduction of a new policy for the restriction
of selected classes of antibiotics offers the opportunity to study
its effect on antimicrobial consumption and cost.
Methods: After the instructions of the National Organization of
Pharmaceutical Agents a new policy regarding the use of
antimicrobial agents was introduced in our hospital on July/01/
2003. Speciﬁcally, quinolones, 3rd and 4th generation cephalo-
sporins, carbapenems, monobactams, glycopeptides, oxazolidi-
nones, and streptogramins were considered as ‘‘restricted’’
antibiotics that could be used with the approval of one of the
Infectious Diseases specialists. We analysed the effect of the
policy on the consumption and cost of antibiotics as a group and
of speciﬁc classes, adjusted for the patient load, as well as on the
antimicrobial resistance of the isolated bacteria.
Results: An 18% and 16% reduction of the adjusted consump-
tion and cost, respectively, of the restricted antibiotics was
accomplished during the ﬁrst trimester after the implementation
of the new policy. However, this was accompanied by a 54% and
44% increase of the adjusted consumption and cost, respectively,
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of the non-restricted antibiotics. The logistic regression model
we performed showed that the new policy had an independent
positive effect on the in vitro antimicrobial susceptibility of
Pseudomonas aeruginosa (p = 0.051) but not of Acinetobacter
baumannii and Escherichia coli isolates.
Conclusion: Our data suggest that there are considerable
limitations of the programs aiming to reduce the consumption
of restricted antibiotics through the approval of their use by
specialists, at least in a proportion of settings. Education
programs that aim to involve the medical staff directly
responsible for the care of patients in voluntary decisions
regarding the appropriate use of antimicrobial agents may have
more profound and sustainable success, and thus, deserve to be
studied.
P1479
Estimating hospital versus ambulatory care
consumption of antibiotics in southwestern
Germany
K. de With, M. Steib-Bauert, H. Schro¨der, K. Nink,
W.V. Kern (Freiburg, Bonn, DE)
Objective: Preliminary data from the ESAC (European
Surveillance of Antibiotic Consumption, www.ua.ac.be/ESAC)
project indicated that the proportion of hospital care (HC)
antibiotic use on total antibiotic use in several European
countries ranges between 5 and 20%. Only few countries,
however, have so far been able to report representative
countrywide information on both HC and ambulatory care
(HC) antibiotic consumption. We estimated AC versus HC
consumption of antibiotics for one of the 16 German federal
states located in the Southwestern part of the country with a 10.5
million population.
Methods: Data on HC consumption (ATC class J01) were
obtained from a convenience sample of acute care general
hospitals (n = 42), extrapolated to state-wide consumption
(using ofﬁcial statistics for the total state-wide 152 general
plus 77 special non-psychiatric/non-paediatric/non-radiother-
apy hospitals), expressed in deﬁned daily doses per 1000
inhabitants and day (DID), and ﬁnally compared to ambulatory
care antibiotic use density in the same region and period of time
(years 2001 and 2002).
Findings: The estimated state-wide HC consumption of
antibiotics was 2.1 DID (95% conﬁdence interval, 1.9 to 2.2
DID) in both years. State-wide antibiotic consumption in the AC
setting during the same time was 12 DID (~85% of total
consumption). AC consumption of ﬂuoroquinolones (1.1–1.2
DID, 79%) and macrolides/clindamycin (1.8 DID, 95%) made up
a major proportion of total use of that drug classes.
Conclusions: Hospital antibiotic use in the Southwestern part
of Germany can be estimated to contribute ~15% to overall
antibiotic consumption in the general population.
P1480
Antibiotic use proﬁle and temporal trends during
a 5-year period at a Greek university hospital:
implications for antibiotic policy changes
E.I. Kritsotakis, P. Assithianakis, P. Kanellos, N. Tzagarakis,
M.C. Ioannides, A. Gikas (Heraklion, GR)
Objectives: To investigate the proﬁle and temporal trends of
inpatient antimicrobial use over a 5-year period at the
University Hospital of Heraklion Crete, Greece. Further, to
examine the way in which frequency of data collection and
stratiﬁcation by different patient-care areas provides guidance
to antibiotic policy changes.
Methods: Retrospective monitoring of antimicrobial
consumption was carried out according to the WHO anatomic
therapeutic chemical classiﬁcation (ATC) and deﬁned daily dose
(DDD) measurement methodology. Pharmacy records were
used to obtain aggregate data of drug deliveries to individual
wards. Results were expressed as usage density rates in DDDs
per 100 bed-days (DDD/100BD). Linear regression was used in
order to assess the statistical signiﬁcance of a temporal trend in
usage densities.
Results: During 1998–2002, hospital-wide antimicrobial use
(ATC group J01) signiﬁcantly increased by 22%, from 86.97 to
106.24 DDD/100BD. The annual average increase rate was 4.8
DDD/100BD. Stratiﬁcation by clinical service demonstrated
differences in the intensity and proﬁle of class use, as well as
varying temporal trends (ﬁgures 1, 2). Pooled usage rates in
DDD/100BD, overall percentage increases and annual average
increase rates were respectively 109.97, 35.6%, 8.1 for Medical
wards; 98.21, 48.7%, 9.1 for ICU’s; and 74.46, 34.3%, 5.7 for
Haemato-oncology wards. Surgical wards had a fairly constant
usage rate (98.36). A shift towards the newer broad-spectrum
antibiotics to the detriment of the older penicillins and
cephalosporins was noted in all hospital areas.
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Conclusion: Surveillance of aggregate data on the consumption
of antimicrobials using the ATC/DDD system provided a clear
picture of the proﬁle of hospital usage. Monthly data over a
sufﬁcient surveillance period allowed the assessment of
temporal trends. Stratiﬁcation of usage rates by clinical service
allowed areas of concern to be speciﬁed. Thus, surveillance of
monthly antimicrobial consumption rates stratiﬁed by patient-
care area can provide a simple, rapid and efﬁcient tool for
triggering antibiotic policy changes in the hospital and targeting
more detailed quality-of-use audits.
P1481
Appropriate use of aminoglycosides: the impact
of an antibiotic control team
C. Rioux, P. Lesprit, J.R. Zahar, A. Hulin, A. Bernier-Combes,
C. Brun-Buisson, E. Girou (Cre´teil, Paris, FR)
Objectives: Many factors are involved in the appropriate use of
aminoglycosides (AG), such as modalities of administration,
serum monitoring and duration of treatment. We assessed
prospectively the risk factors and the impact of an antibiotic
control team on the appropriateness of AG prescriptions.
Methods: In a setting of a restricted delivery system of AG in
our hospital, we ﬁrst performed an observational audit (OA) to
assess the appropriateness of prescriptions including
justiﬁcation of prescribing, adequacy of drug choice, adequacy
of administration modalities, modalities of serum monitoring
and duration of treatment. After implementation of speciﬁc
guidelines hospital wide, we then performed an interventional
audit (IA) where an antibiotic control team could interfere
when AG prescriptions were considered inappropriate.
Appropriateness of AG prescriptions between the 2 audits was
then compared.
Results: 200 prescriptions were analysed. During the IA, 32%
of prescriptions were modiﬁed by the control team. As
compared to the OA, prescriptions in the IA were signiﬁcantly
more appropriate with regard to treatment duration (73 vs
55%, p = 0.009) and serum monitoring (61 vs 40%, p = 0.05).
Median treatment duration was shorter in the IA (4 d) than in
the OA (6 d) (p < 0.0001). A logistic regression model showed
that risk factors for appropriate treatment duration were
(adjusted OR, 95% CI, p value): hospitalization in intensive
care unit (4.39, 1.57–12.2, 0.005), polymicrobial infection (4.08,
1.38–12.08, 0.01) and antibiotic control team intervention (2.41,
1.23–4.72, 0.01).
Table:
Conclusions: Despite a restricted delivery system, AG use was
frequently associated with excessive treatment duration and
errors in monitoring modalities. Reinforcing practice guidelines
through direct counselling improved appropriateness of
prescriptions.
P1482
Hospital antibiotic consumption in southern and
eastern mediterranean countries: preliminary
results from the ARMed project
P. Zarb, M.A. Borg, H. Goossens, M. Ferech for the ARMed
Participants
Introduction: ARMed is an international research project
investigating antimicrobial resistance and consumption in 7
southern and eastern Mediterranean countries through the
collection of comparable and validated antimicrobial resistance
data as well as information about antibiotic consumption
patterns and infection control initiatives.
Objectives: The consumption part of the study aims to collect
data on antimicrobial use within participating hospitals in the
region, which information is currently unavailable.
Methods: Data collection is planned over a 24-month period
using Anatomical Therapeutic Chemical (ATC) classiﬁcation, a
validated methodology adopted by the European Surveillance of
Antimicrobial Consumption (ESAC – www.ua.ac.be/esac). 23
hospitals are participating: Cyprus (5 hospitals); Egypt (7);
Jordan (1); Malta (1); Tunisia (3); Turkey (6). Results are
expressed in DDD/1000 bed-days.
Results: Data from 2004, the ﬁrst year of data collection,
indicates that Turkish hospitals seem to show the lowest
overall consumption [230–480 DDD/1000Bed Days], whilst the
Cypriot hospitals show highest values [2900–7500 DDD/
1000Bed Days]. The most common antibiotics used are the
beta-lactams, especially the penicillins although in Jordan and
Turkey cephalosporin consumption is very close to the peni-
cillins. Broad-spectrum penicillins [J01CA] are the mostly
utilised penicillins in Cyprus, Jordan and Tunisia whereas in
Malta and Turkey the combination penicillins [J01CR] are the
most widely used. There is more variability where cephalosp-
orin consumption is concerned. Cyprus utilises mainly ﬁrst
generation, Jordan and Malta the second generation. In Egypt,
Tunisia and Turkey there is signiﬁcant variability between
hospitals; nevertheless use of third generation cephalosporins
appears to be signiﬁcant.
Conclusion: A signiﬁcant variability was evident between
countries. This is likely to be multifactorial depending on the
antibiotics licensed in a country, the national and/or hospital
formulary, the type of hospital as well as any antibiotic
donations that are relevant in some of the study hospitals.
Nevertheless, the preliminary results suggest that trends within
hospitals of the same country tend to be similar. Furthermore,
the region as a whole seems to utilise a considerable quantity of
broad-spectrum antimicrobials. This can be a factor in the high
prevalence of resistance already documented in the study.
P1483
Russian pharmacoepidemiology study of the
antibiotic prescription during pregnancy
V. Rafalskiy, R. Tchilova, A. Ischenko, I. Toropova,
I. Nedorezenyuk, E. Maneeva, O. Suplotova, N. Antonovitch,
N. Shevchenko (Smolensk, Moscow, Yakutsk, Vladivostok, Barnaul,
Krasnodar, RU)
Objectives: To evaluate the current clinical practice of
prescription of antimicrobials in pregnancy women in Russia.
Methods: We carried out multicentre1 retrospective
pharmacoepidemiological study based in 7 centers (Moscow,
Smolensk, Vladivostok, Petropavlovsk-Kamchatski, Yakutsk,
Krasnodar, Barnaul). The data were taking from obstetrics and
gynecology clinics in 2003–04 years, 1464 cases of were analysed.
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Results: Mean age of the patients was 25.6 ± 6.0 (min – 14, max
– 52) years, mean gestational ages at admission to hospital was
27.0 ± 10.8 (3 to 42) weeks. Most often (77.5%) infection was
community acquired and 2.1% – nosocomial, in 20% patients
there was not to estimate origin of the infection. The most
prevalent infections during pregnancy in Russia was urinary
tract infections – 39.9%, STD – 19.3%, candidiasis – 17.4%, RTI –
6.6% Therefore the most interest was analysing the antibiotic
prescription for UTI in pregnancy (table). In 28% cases were
used topical (intravaginal) antimicrobial administration. Most
often of topically administrated antimicrobials (19.02% of all
prescriptions) were prescribed combined drugs included
antibacterials and amtimycotics. In 80.98% cases antimicrobials
were prescribed systemically. Mostly prescribed antimicrobials
were beta-lactams (16.2% for outpatients and 57.7% for
inpatients), ampicillin was prescribed more often (4.6% for
outpatients and 31.5% for inpatients). Amoxicillin + clavulanic
acid was prescribed in 6.4% of outpatients and 5.6% inpatients
pregnant women with UTI. Cephalosporins were prescribed in
5.2% and 20.6% for outpatient and inpatient UTI (mainly III- and
Ist generations). Mitroimidazoles – 1.8–7.4% (in general
metronidasole), nitro-furanes – 8.2–15.0%, aminolglycosides –
4.6–3.8% were prescribed quite often but unjustiﬁed. Other
antimicrobials (ﬂuoroquinolones, doxicicline, antiviral drugs,
antifungals) were prescribed relatively rarely. Despite the fact
that most prescribed drugs were class B by FDA, 5.8% all
antimicrobials prescribed to pregnancy were class C, 0.8% class
D and 9.1% were unclassiﬁed.
Conclusions: Most often prescribed antimicrobials for UTI (the
most prevalent infections during pregnancy in Russia) are beta-
lactams and combined topical antibacterials. In 15.7% cases were
prescribed antimicrobials of class C, D or unclassiﬁed by FDA.
In 25% outpatient and 53.6% inpatient were used antibiotics
with low in vitro activity for uropathogens.
P1484
Curbing pneumococcal resistance in orphanages:
interventions on the basis of prospective
surveillance of nasopharyngeal isolates
O.U. Stetsiouk, R.S. Kozlov, J.A. Poupard, L.S.
Stratchounski (Smolensk, RU; Philadelphia, US)
Objectives: To study the dynamics of the antibiotic usage in
children from orphanages located in different Russian cities as
the result of interventions with the increased use of the most
active antimicrobials and restrictions on use of the least active.
Methods: The study was performed in 12 orphanages (1–12)
from 5 cities of European Russia (Moscow, Saint-Petersburg,
Smolensk, Karachev, Bryansk). Use of antimicrobials during the
previous 12 months was analysed upon reviews of medical
records of 743 children <7 years in 2003. Appropriate
recommendations on predominant use of selected beta-lactams
(e.g. amoxicillin/clavulanate – AMC) with restriction of
antimicrobials of other classes (e.g. co-trimoxazole – SXT) were
made where applicable on the basis of the expert analysis of
antibiotic usage and pneumococcal nasopharyngeal resistance
rates. Repeated antibiotic usage analysis was performed
7 months later in 2004 upon reviews of medical records of 752
children <7 years.
Results: Total usage of antimicrobials increased 1.4 times in
2004 (1,065 courses per 752 children in 7 months equivalent to
2.44 courses per child per year) in comparison with 1,301
courses per 743 children in 2003 (1.75 courses per child per
year). Beta-lactams were the most frequently prescribed
antibiotics (70.6% and 72.1% of all prescriptions in 2003 and
2004 respectively). Among these the predominant ones in 2003
were: ampicillin/oxacillin – AM/OX (17.9%), AMC (16.1%),
cefazolin (14.1%), cefotaxime (13.0%) and ampicillin (11.2%); in
2004: AMC (18.4%), AM/OX (13.2%), cefazolin (10.4%),
penicillin (PEN) (8.8%) and cefotaxime (7.7%). Usage of AMC
increased from 19 to 45 courses/100 children/year,
cephalosporins from 42 to 67 courses/100 children/year.
Usage of macrolides decreased 2 times: from 20 to 10 courses/
100 children/year; at the same time usage of aminoglycosides
and SXT increased almost twice: from 10 to 19 and from 10 to 18
courses/100 children/year in 2004 vs 2003.
Conclusions: The recommended intervention resulted in 2.4
times increase of AMC usage in 2004 vs 2003 with no detectable
increase of resistance to PEN and aminopenicillins. Enhanced
use of cephalosporins led to increase of resistance to these drugs.
In spite of recommendations to restrict usage of AM/OX,
aminoglycosides and SXT, the analysis showed that these
antimicrobials still accounted for 13.2%, 7.8% and 7.5% of all
prescriptions, respectively, thus dictating the need for further
enforcement measures.
P1485
Antibiotic consumption in ambulatory care in
Latvia, 2004
S. Berzina, M. Ferech, G. Ozolins, H. Goosens (Riga, LV;
Antwerp, BE)
Objectives: To collect data on antibiotic consumption in
ambulatory care (AC) in Latvia according to the ESAC data
collection protocol. ESAC (European Surveillance of
Antimicrobial Consumption, granted by DG SANCO of the
EC) is an international network of national surveillance systems,
aiming to collect reliable and comparable data on antibiotic
consumption in Europe.
Methods: The data on AC antibiotic consumption for 2004 have
been collected using ATC/DDD classiﬁcation (WHO, version
2005) and expressed in Deﬁned Daily Doses per 1000 inhabitants
per day (DID). Data were obtained from the State Medicinal
Agencybased on the reports of the wholesalers for AC.
Results: The overall use of antibiotics in AC was 11.7 DID in
2004, which positions Latvia to countries with comparatively
low antibiotic consumption in Europe. The mostly used class of
antibiotics in AC were penicillins with extended spectrum
(mainly amoxicillin) – 3.97 DID (33.9%). Other frequently used
antibiotics were tetracyclines (mainly doxycycline), representing
2.41 DID (20.6%), combinations of penicillins/with beta-
lactamase inhibitors (essentially co-amoxiclav) – 1.18 DID
(10.1%), macrolides (mainly clarithromycin) 0.85 DID (7.26%),
ﬂuoroquinolones (essentially ciproﬂoxacin) – 0.84 DID (7.17%)
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and combinations of sulphonamides and trimethroprim,
incl.derivatives – 1.02 DID (8.71%). The most frequently used
antibiotics in AC in Latvia, in 2004, were amoxicillin (3.97 DID),
doxycycline (2.41 DID), and co-amoxiclav (1.18 DID).
Conclusions: Valid data on outpatient antibiotic use in Latvia
has been for the ﬁrst time collected and delivered to European
Surveillance of Antimicrobial Consumption. This allows
international comparison of the pattern of antibiotic
consumption in Latvia with other European countries.
P1486
Trends in glycopeptide antibiotics consumption
over a 6-year period in a general hospital, Athens,
Greece
C. Loupa, G. Kouppari, H. Papadaki, E. Divari-Katsiki, I. Koti,
K. Papaefstathiou, M. Tsimoraga, A. Karaitianou, M. Zoumberi,
M. Lelekis (Athens, GR)
Introduction: Glycopeptide use is under restriction in Hellenic
hospitals since late ‘80s. The aim of our study was to record
trends in their consumption over the last 6 years in our Hospital
(‘‘A. Fleming’’ General Hospital – 300 beds) and to correlate
these data with the numbers of important Gram (+) strains
isolated in our hospital during the same time period.
Methods: We measured glycopeptide use for the period 1999–
2004 by using data from the pharmacy computer. Consumption
was expressed as DDDs/1000 patient days (ABC calc 3.0).
Furthermore we correlated these data with data from the
microbiology department concerning numbers of MRSA,
MRSE and enterococci isolated during the same period.
Results: Glycopeptide consumption was 1.3, 6.1, 6.3, 7.9, 4.5
and 13 DDDs/1000 patient days for the years 1999, 2000, 2001,
2002, 2003, 2004 (900% increase). At the same time the
cumulative number of MRSA, MRSE and enterococci isolated
were 175, 224, 207, 415, 338, 479 respectively (170% increase).
When both types of data were put on the same graph,
glycopeptide consumption correlated well with the number of
important Gram(+) strains isolated (ﬁgure). Furthermore VRE
percentage among enterococci was 0, 0, 3.0, 0.6, 3.5, 1 for the
study years respectively. It is worth noting that 87% of our
MRSA strains were sensitive to rifampin, 83% to clindamycin,
74% to cotrimoxazole, 80% to clindamycin + rifampin and 74%
to cotrimoxazole + rifampin. Linezolid has not been introduced
in our hospital yet.
Conclusions: (A) Despite the restriction policy, a tremendous
increase in glycopeptide use was recorded in our hospital
during the study period and this correlated to the number of the
important Gram(+) strains isolated; (B) Nevertheless, VRE is not
a signiﬁcant problem for our hospital yet; and C. The huge
increase in glycopeptide use could be avoided at least in part,
since other, older and simpler antibiotics could substitute for
glycopeptides in many cases.
P1487
An audit of linezolid use in a university teaching
hospital, Galway, Ireland
S. Mcnicholas, A. Barber, G. Corbett-Feeney,
M. Cormican (Galway, IE)
Linezolid is the ﬁrst of a new class of antibacterial drugs, the
oxazolidinones. It has inhibitory activity against a broad range
of Gram positive organisms, including meticillin-resistant Sta-
phylococcus aureus (MRSA), glycopeptide-intermediate Staphylo-
coccus aureus (GISA), vancomycin-resistant enterococci (VRE)
and penicillin-resistant Streptococcus pneumoniae. Linezolid is
licensed for the treatment of pneumonia and skin and soft tissue
infections.
Objective: To audit linezolid use over a six-month period
among the in-patient population of a 504-bed teaching hospital
that includes most medical and surgical specialties with the
exception of nephrology, rheumatology and orthopaedics.
Methods: A prospective audit was carried out of the
prescribing of linezolid to in-patients from October 2004 to
April 2005. The ward pharmacist recorded the details of all
patients who were prescribed linezolid. A chart review was
performed to assess the proﬁle of patients prescribed linezolid,
clinical and microbiological indications for treatment, adherence
to treatment guidelines and documented adverse events.
Results: Over the 6-month period 53 courses of linezolid were
prescribed. Fifty two percent of the patients for whom linezolid
was prescribed were from surgical specialties; half of these
patients were under the care of one surgeon. Pneumonia was the
clinical indication for use in 32% of cases and soft tissue
infection in 36% of cases. The microbiological indication was
clear in 64% of cases where MRSA or VRE had been isolated. In
36% of cases therapy was either (1) empiric with no signiﬁcant
organisms isolated prior to prescription of linezolid or (2)
therapy was directed against an organism that could have been
treated with an alternative agent. Duration of treatment
exceeded 10 to 14 days in 40% of courses. An adverse event
was recorded in the case of only one course of linezolid.
Conclusion: In more than a third of cases linezolid use was
prescribed without clear justiﬁcation. Avoidable use of linezolid
is associated with increased costs and risks of acquired
resistance.
Professional and public health issues
P1488
The future of clinical microbiology in Belgium
W. Laffut, J. Van Eldere (Lier, Leuven, BE)
Objective: In winter/spring 2003–2004, the Belgian Society for
Infectiology and Clinical Microbiology (BVIKM/SBIMC)
conducted an inquiry on the future of infectiology and
clinical microbiology (CM). The aim was: to obtain data on
the current organisation of infectious diseases management in
Belgium in and outside the hospitals, to identify
shortcomings, opportunities for better organisation, to map
the aspirations and view of the future of clinical
microbiologists, to identify key issues in the formation of
future clinical microbiologists.
Methods: The inquiry was done by specialists in training in
clinical biology. An extended questionnaire was sent to all
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participants prior to on an oral interview during which the
interviewer ﬁlled in the answers.
Results: A total of 62 CM specialists completed the inquiry.
This represents approximately 25% of the national quorum.
Mean age was 48 years (32–63). 22 of the 62 interviewed CM
specialists worked full-time with more full-time employment in
hospital labs (HL). Next to routine microbiology, other
activities performed by CM specialists are mainly the other
domains of clinical biology, hospital hygiene and to a lesser
extent quality control and lab management. Almost two thirds
of the interviewed CM specialists believes that their training
hasn’t prepared them properly for the tasks they are
performing now. Most desired changes include more
emphasis on the clinical aspect of infectious diseases and on
antibiotic treatment counselling. CM does not exist as a
separate speciality in Belgium but is included in the ‘clinical
biology’ speciality training. The majority of the respondents
thinks that CM should become a sub-speciality (still part of
clinical biology) but with a speciﬁc minimal training that needs
to be deﬁned. The majority of the CM specialists also believes
that CM can share lab infrastructure with other disciplines and
that the essential aspect of CM lies predominantly in the
medical expertise.
Conclusion: CM training should put more emphasis on the
clinical aspect of infectious diseases and on antibiotic treatment
counselling. The majority of the respondents feels that CM
should become a sub-specialty (still part of clinical biology),
with a well deﬁned training curriculum.
P1489
Analysis of 6871 infectious disease consultations
Y. Wiener-Well, Y. Schlesinger, D. Raveh, A.M. Yinnon
(Jerusalem, IL)
Objectives: Since more than 10 years, all infectious disease
consultations have been recorded in a computerized database
(Epi Info 6.04d, CDC). Here we report on 1163 consultations of a
fellow, conducted during 1 year, compared with 5708
consultations conducted by two veteran board-certiﬁed
infectious disease consultants during the same period.
Methods: We analysed computerized consultation records,
including demographic details of patients; referring
department; initiative for, route and purpose of the
consultation; and recommendations; and compared between
the different consultants.
Results: A larger percentage of veterans’ compared to the
fellow’s consultations, were requested by attending physicians
(72% vs. 50%, p < 0.001), while follow-up (15% vs. 23%,
p < 0.001), laboratory results (11% vs. 23%, p < 0.001) or
prescription for a restricted antimicrobial agent (1.3% vs. 3.3%,
p < 0.001) were more prevalent in fellow consultations. The
fellow had a higher rate of additional consultations (in which
the patient was seen more than once) (40% vs. 30%, p < 0.001),
and performed more bedside consultations (68% vs. 47%,
p < 0.001) or consultation by curb side discussion (25% vs.
13.2%, p < 0.001), and less consultations by telephone (6.6% vs.
40.1%, p < 0.001). Diagnosis and prophylaxis were more often
the purposes of the veterans’ consultations (44.8% vs. 36.1%,
p < 0.001, 3.9% vs. 2.1%, p < 0.01, respectively), and they also
offered new diagnoses more frequently (p < 0.005). The veteran
consultants more often conducted consultation for community-
acquired infections (53% vs. 44%, p < 0.001), and more often
started antibiotic treatment (19% vs. 8.9%, p < 0.001).
Conclusions: Signiﬁcant differences were detected between
consultations conducted during the ﬁrst year of a fellow
compared to those of veteran infectious disease consultants.
These differences reﬂect the changing demands and activities in
the consultant’s work as experience and knowledge accumulate.
Periodic analysis of computerized data of consultations
facilitates supervision as well as direction of consultants’
work, addressing issues such as antibiotic use and patterns of
microbial resistance.
P1490
Bridging the gap between health care and public
health; capacity building in infectious disease
control
J. Doosje, M. Jambroes, A. Timen, J. van Steenbergen, V. van
Casteren (Utrecht, Bilthoven, NL; Brussels, BE)
Objectives: In recent years, the European Union (EU) has
developed and supported many activities in the ﬁeld of
communicable diseases. These activities not only concern
surveillance networks of speciﬁc infectious diseases (e.g.
Enter-net for Salmonella and Escherichia coli infections, EWGLI
for Legionella infections, EISS for Inﬂuenza infections), but also
EU training programmes like EPIET (European Programme for
Intervention Epidemiology Training) and a EU communicable
disease bulletin. Even more recent are the EU’s initiative
BICHAT to improve preparedness and response to
bioterrorism, and the development of a EU CDC. Moreover, a
major part of the new programme of Community action in the
ﬁeld of public health (PH) (2003–2008) concerns ID, with not
only a commitment to improve information and information
exchange, but particularly to strengthen the international rapid
response capacity.All this, to illustrate the importance of IDC on
the EU agenda.
Methods: The European Public Health Association (EUPHA) is
an umbrella organisation for PH associations in EU. In 2003
EUPHA has created an EUPHA section IDC bringing together
EUPHA members with expertise in this ﬁeld and
representatives of the various above mentioned EU initiatives
in order to: promote and strengthen research in the ﬁeld of IDC;
provide a platform for the exchange of information, experience
and research in IDC; bring together researchers, PH
practitioners and policymakers active in IDC; encourage joint
activities in IDC; and improve IDC training.
Results: By now the section has 307 members from 50 different
countries. As of 2005 the section is represented in the ECDC
advisory forum. Different section activities: Organising 8
workshops, a breakfast meeting and a pre-conference meeting
on timely IDC topics during EUPHA conference. Organising a
section workshop during ESCMID conference 2006.
Participation in different EU projects: SPHERE
(=Strengthening Public Health Research in Europe) project,
INPHECT (Intelligent Network for Public Health by using
Enhanced Communication Technologies) proposal. Editorial in
the EU journal of PH.
Conclusion: Since 2003 the EUPHA section on IDC has become
a mature multidisciplinary platform of IDC specialists in
Europe. For an adequate response on emerging infectious
diseases it is of utmost importance to closely collaborate with
different specialists in EU. Therefore we promote a strong
collaboration between the EUPHA section on IDC and the
ESCMID.
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EUREGIO MRSA-net Twente/Mu¨nsterland:
ﬁghting (CA-)MRSA international under
different cultural perspectives
F. Verhoeven, J.E.W.C. van Gemert-Pijnen, M.G.R. Hendrix,
A.W. Friedrich, M.F. Steehouder (Enschede, NL; Munster, DE)
Objectives: To establish a cross-border Dutch-German network
(www.mrsa-net.org) providing a user-friendly knowledge
centre for hospitals, public health authorities, GPs, nursing
homes and laboratories. Primary purpose is to aid in the
reduction of MRSA-rates and limit the cross-border
transmission of MRSA. Guidelines and their implementation
play a signiﬁcant role in reaching these aims. Cross-border (CA-)
MRSA guidelines will be redesigned according to international
standards and socio-cultural differences between the nations.
Methods: Based on quality standards for safety and healthcare
documentation used in high risk chemical organizations, a
framework for a systematic content analysis of national MRSA-
guidelines was developed. National guidelines were analysed
on the basis of this framework.
Results: A content analysis of the current national MRSA-
guidelines showed ﬁve dominating MRSA-perspectives: rule-,
expert-, risk-, demand- and community-driven. German
guidelines are mainly dominated by the rule- and expert-
driven perspectives (guidelines are literally derived from law
and follow the infection transmission route), in contrast to the
Dutch which focus on the demand of the user and the
community (addressed to public health and acceptability of
guidelines by users).
Conclusion: The analysis showed that the fact that there are
different guideline-perspectives results in an enormous,
confusing set of guidelines. The management and use of
guidelines becomes uncontrollable and leads to an illusory
organisation where healthcare workers don’t act in accordance
with the guidelines and start applying their own insights. This
might lead to cost-increasing and contrasting situations. To
implement guidelines successfully in a cross-border situation, a
cultural and technical synchronisation alongside an integrated
approach of the different perspectives of guidelines is necessary,
inline with the current disease management models. Further
research about the redesign and the evaluation of those
guidelines in practice will help achieving this.
P1492
Prevention of rabies in Georgia
R. Tsiklauri (Tbilisi, GE)
Background: Animal bites are a common but under recognized
public health problem. It has been estimated that there are 8–10
000 bites each year in Georgia, and based on an average visit and
post-exposure treatments cost at list $120 000 per year. Despite
the frequency and expense of these injuries, there is little
information about the incidence of animal bites because of a lack
systematic reporting and a lack of measurement of the quality
and completeness of reported data.
Objectives: To investigate animal bites and rabies reported
cases, revealed unreported cases, analyse and based on study
results ﬁnd more effective epidemiological measures of animal
bites and deaths (due to rabies) prevention in Georgia.
Methods: The capture-recapture method was used, along with
log-linear modelling. For sources were used to identify victims:
policlinic/ambulatory reports, hospital reports, animal control
reports and victim reports.
Results: In 1980–2001 years 150 700 dog and other animal bites
were reported. The capture-recapture method estimated that
there were 146 200 unreported bites. During these period 118
deaths due to rabies was registered in Georgia and 67 (57%)
cases among them have been registered during the last 6 years.
The reasons of fatal cases were untreated (47%), uncompleted
treated (34%) and late began post-exposure treated (19%) cases
of bites (mostly dog bites). About 56% of bitted persons did not
know about rabies and it’s prevention measures. About 32% had
incorrect information about prevention and only 12% of them
knew epidemiological and clinical aspects of disease. About 16%
of physicians who were responsible on quality post-exposure
treatment had not an adequate knowledge.
Conclusion: Dog and other animal bites are common but
preventable injuries. To improve surveillance and prevention
of rabies in Georgia, the focus should be on educating the
general public about the serious consequences of animal bite
injuries and developing the animal’s vaccination strategy.
Pharmacoeconomics and electronic resources
P1493
The expected economic burden of methicillin-
resistant Staphylococcus aureus in complicated
skin and skin structure infections: a modelling
approach
A. Kuznik, R. Mallick, D. Weber (Collegeville, Chapel Hill, US)
Objective: To model the expected rate of clinical failure of
initial empiric therapy and economic burden likely to be
associated with the increasing prevalence of methicillin-
resistant Staphylococcus aureus (MRSA) in patients hospitalised
with complicated skin and skin structure infections (cSSSI) in
the United States.
Methods: Using published data on (1) the prevalence of
MRSA and other bacterial pathogens causing cSSSI in the US,
(2) the in-vitro susceptibility rates of commonly used
regimens in cSSSI in the US in relation to the most
pervasive pathogens identiﬁed above, and (3) estimated
costs of failure of initial, empiric treatment from a recent
study of a large US multi-hospital database, we developed a
model to predict the expected clinical and economic impact of
increasing prevalence of MRSA. Speciﬁcally, clinical failure of
5 of the more commonly used initial regimens in cSSSI was
modeled in terms of their in-vitro susceptibility rates with
respect to MRSA, weighted by MRSA prevalence. Varying the
rate of MRSA further yielded projected clinical failure rates
and costs attributable to increasing levels of methicillin
resistance over time.
Results: Given current 55% prevalence of S. aureus pathogens in
cSSSI, half of them methicillin-resistant (base case
MRSA = 27%), the model projected an overall clinical failure
rate of 35.9% for 5 of the more commonly used initial regimens,
with an expected overall treatment cost (in US dollars) of $5,492
per patient (range, $4,566–5,633). If none of the S. aureus
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pathogens were resistant (MRSA = 0%), clinical failure rate was
projected to be 18.4% and treatment cost to be $4,869 per patient.
The differences in the two scenarios translated to an expected
clinical failure rate of 17.5%, an incremental cost of $623 per
patient, and for the 800,000 patients hospitalised for cSSSI
annually in the US, an expected health care system burden of
$498 million attributable to MRSA. Under a "worst-case"
scenario in which MRSA was the only causative pathogen
(MRSA = 100%) in cSSSI, clinical failure rate was projected to be
79.3%, and treatment cost per patient was expected to be $7,035.
Conclusions: Going beyond existing estimates, our model
generated a substantial expected clinical failure rate and
economic impact attributable to current MRSA levels, as well
as simulations of the expected impact of increasing MRSA
prevalence over time, varying levels of MRSA across regions
and choice of initial empiric regimens.
P1494
Treatment of complicated skin and skin
structure infections in the US: expected cost
differences between tigecycline and
vancomycin/aztreonam
R. Mallick, A. Kuznik, D. Weber (Collegeville, Chapel Hill, US)
Objective: To compare tigecycline and vancomycin/aztreonam
in terms of treatment-related costs for patients hospitalised in
the United States with complicated skin and skin structure
infections (cSSSI).
Methods: We conducted a retrospective analysis of pooled data
from US centres in two randomized, double-blind clinical
studies comparing tigecycline and vancomycin/aztreonam in
the treatment of cSSSI. Using regression analysis, we estimated
the effect of tigecycline treatment on hospital length of stay
(LOS), controlling for other signiﬁcant predictors. Using
published estimates of daily hospitalisation cost of cSSSI in the
US from a multi-hospital audit, we then translated the estimated
impact on LOS into economic terms. This analysis was repeated
for the subgroup of patients in which the primary pathogen was
methicillin-resistant Staphylococcus aureus (MRSA). Clinical
efﬁcacy (tigecycline 81%, vancomycin/aztreonam 83.1%;
p = 0.376) was similar across treatments and was not included
as a model parameter.
Results: Our retrospective analysis of the pooled clinical data
from US centres found that tigecycline was associated with a
shorter LOS [)1.85 days (p = 0.015)] compared with the
combination of vancomycin/aztreonam in the treatment of
patients with cSSSI. At a mean daily hospitalisation cost (in US
$) of $794, excluding antibiotic costs, this translated into
expected medical cost savings of $1,469 per patient for
tigecycline compared with vancomycin/aztreonam. In the
MRSA subgroup, comprising 26% of the clinical study sample,
tigecycline was associated with a greater reduction in LOS
[)2.82 days (p = 0.011)] compared with vancomycin/
aztreonam, translating to expected medical cost savings of
$2,239 per patient treated with tigecycline. These expected
medical cost savings more than offset the higher average daily
drug acquisition costs of tigecycline ($118/day) relative to the
vancomycin/aztreonam combination ($110/day).
Conclusion: In a retrospective analysis of pooled clinical data of
patients with cSSSI treated at US centres, tigecycline was
associated with a signiﬁcantly reduced length of hospital stay
relative to vancomycin/aztreonam; this translated into
substantial cost savings, especially in the subset of cSSSI
patients with MRSA.
P1495
The economic impact of linezolid in the treatment
of skin and soft tissue MRSA infections in Italy
M. Eandi, P. Dale, S. Sorensen, T. Baker, M. Procaccini,
S. Duttagupta (Turin, IT; London, UK; Bethesda, US; Rome, IT;
New York, US)
Objective: Linezolid has been shown to be highly effective
against infections caused by methicillin-resistant Staphylococcus
aureus (MRSA) in patients with complicated skin and soft tissue
infections (cSSTI). The objective of this study was to evaluate the
clinical and economic consequences of using linezolid for the
empiric treatment of cSSTI from the Italian hospital perspective.
Methods: A decision-analytic model was developed to calculate
the clinical and cost outcomes of empiric treatment of
hospitalized patients with cSSTI in Italy prescribed linezolid,
vancomycin or teicoplanin. Efﬁcacy data were derived from
clinical trials. Costs from published sources were applied to
tests, adverse events, and days of intravenous and oral (linezolid
only) treatment and hospitalization by ward type (general,
intensive-care). Resource use and utilization patterns were
obtained from a combination of clinical trial data and expert
opinion. Outcomes included total costs per patient, cost per cure
and cost per death avoided. Uncertainty surrounding the CE
ratio was tested using one-way sensitivity analysis.
Results: Starting empiric treatment with linezolid resulted in
98.4% of patients cured from MRSA compared to 98.0% with
vancomycin. The average cost per patient treated with linezolid
was €6,305 versus €6,228 for patients treated with vancomycin.
This resulted in a cost per cure of €22,404. In a separate analysis
more patients were cured using linezolid (97.6%) compared to
teicoplanin (94.7%). The average total cost per episode was
€6,401 for linezolid treated patients versus €5,897 for teicoplanin
treated patients, resulting in a cost per cure of €17,100. The most
sensitive parameters included hospital LOS and MRSA
resistance rate.
Conclusions: In the treatment of cSSTI due to suspected MRSA
in Italy, the empiric use of linezolid is cost-effective when
compared to vancomycin and teicoplanin
P1496
Outpatient and home parenteral antimicrobial
therapy for the treatment of cellulitis: evaluation
of efﬁcacy and cost
H. Ziglam, R. Tilley, C. Wootton, J. Morrison,
D. Nathwani (Dundee, UK)
Objective: Outpatient and home parenteral antibiotic therapy
(OHPAT) programmes are effective, well tolerated and
economically advantageous in carefully selected patient
populations. Skin and soft tissue infections represent a high
burden disease which in amenable to treatment by OPHAT
programmes. We retrospectively analysed our outcomes
registry to evaluate the clinical and health economic impact of
treating cellulitis in this setting.
Methods: We have reviewed 465 patients with cellulitis and
erysipelas who were treated with OHPAT. Each patient
treatment has a full integrated care pathway (ICP). The ICP
documents the microbiological outcome, drug and vascular
access complication rates, impact on drug costs and in-patient
bed days on the 465 number of patients treated from April 1998
to March 2005 are presented here. We also reviewed using the
SMR1O inpatient discharge diagnosis data from the Information
Statistics Division Scotland (ISD) and the Dundee Infectious
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Diseases Units (DIDU) Outcomes Registry Database. The key
diagnosis (ICD 10 codes) groups considered were cellulitis
(LO30, 31, 32, 33, 38, 39) and erysipelas (A46X) over eight
consecutive years (1997–2004).
Results: The patients received intravenous antibiotic therapy
for a mean duration of 5.64 days. The two primary agents
administered were once-daily ceftriaxone in 84%of patients and
teicoplanin in 9.8% of patients. Of the 465 patients, 431 (92.6%)
were cured or improved; 5 worsened and required surgery.
Tinea pedis was found in 31% of patients treated for cellulitis.
Economic beneﬁts were realized despite use of more expensive
agents. Data from the Dundee outcomes registry revealed a
mean reduction in length of hospitalization from 5.8 days (1996/
1997) to3.2 in 2003–2004- a reduction of 48% compared to
Scottish data from ISD which did not show any changes in
length of hospitalization between year 1996/1997 (5.33 days)
and year 2003–2004 (5.92 days).
Conclusions: We have found that OHPAT is clinically effective
and can be administered safely and successfully in an outpatient
setting. The majority of complications were minor, and 93% of
patients were cured. Tinea pedis and were found to be
signiﬁcant risk factors for acute cellulitis and indicate that
improved awareness and management of toe web intertrigo
might reduce the incidence of cellulitis. This analysis also
supports the premise that an adult OHPAT programme can
substantially reduce healthcare resource use in the European
healthcare setting.
P1497
Cost-effectiveness analysis of intravenous
moxiﬂoxacin compared to levoﬂoxacin in
hospitalised elderly patients with community-
acquired pneumonia
A. Lloyd, D. Battleman, S. Choudhri, A. John, M. Kubin (London,
UK; Arlington, West Haven, Kenilworth, US; Wuppertal, DE)
Objective: To evaluate the cost-effectiveness of moxiﬂoxacin
compared to levoﬂoxacin in hospitalised patients aged ‡65 with
community acquired pneumonia (CAP).
Methods: A randomised double-blind parallel group study was
conducted in 47 US hospitals. Patients had radiological evidence
of bacterial pneumonia conﬁrmed by at least 2 other signs, were
aged ‡65 years and were managed as inpatients on initiation of
treatment. Patients initially received moxiﬂoxacin 400 mg IV
O.D. or levoﬂoxacin 500 mg IV O.D., and once stabilised were
switched to oral therapy with the same agent. The effectiveness
endpoint for the economic analysis was the percentage of
patients successfully treated, deﬁned as patients with marked
improvement, resolution or clinical cure at test of cure visit after
7–14 days of therapy who did not experience a serious cardiac
adverse event. Total costs were estimated from the perspective
of the treating hospital and included antibiotic drugs, hospital
stay, hospital re-admission within 28 days and cost of managing
treatment failures.
Results: 394 patients were included in this analysis, 195
randomised to moxiﬂoxacin and 199 to levoﬂoxacin. 82% (95%
CI: 77–88%) of moxiﬂoxacin and 75% (69–81%) of levoﬂoxacin
treated patients were successfully treated (resolution, clinical
cure at TOC and no serious drug related AEs). In the
moxiﬂoxacin group patients reported a mean of 3.5 days of IV
antibiotic treatment and 5.7 days inpatient stay with 3.4 days IV
antibiotic treatment and 6.1 days inpatient stay in the
levoﬂoxacin group. Mean per patient drug cost was $257 in
the moxiﬂoxacin group, $222 in the levoﬂoxacin group. Mean
total cost was $8,339 in the moxiﬂoxacin group and $8,354 in the
levoﬂoxacin group. Findings were consistent across a range of
patient subgroups. Costs were sensitive to length of hospital
stay.
Conclusions: Patients in the moxiﬂoxacin group had higher
rates of successful treatment at slightly lower average costs than
the levoﬂoxacin group. This conﬁrms the results of the TARGET
study where moxiﬂoxacin showed superior clinical efﬁcacy in
comparison to co-amoxiclav with or without clarithromycin in
hospitalised CAP patients. Antibiotic costs were slightly higher
in the moxiﬂoxacin group than the levoﬂoxacin group but total
costs were slightly lower, due to reduced hospital stay.
P1498
Economic impact of invasive fungal infections in
ICU patients in a tertiary care hospital in
Switzerland
A. Imhof, W. Zingg, R. Laffer, C. Ruef (Zurich, CH)
Objectives: Invasive fungal infections (IFI) cause signiﬁcant
morbidity and mortality. The management of invasive fungal
infections is currently undergoing important changes due to the
availability of new therapeutic agents with improved safety
proﬁles but the acquisition costs of these new agents are high.
We evaluated the average overall cost of management
(microbiological diagnosis and treatment) of invasive fungal
infection in critically ill patients at a large university hospital.
Methods: A retrospective (2003–2004), pairwise-matched cohort
study was performed on 4 surgical ICUs and one medical ICU at
our university hospital. ICU patients with documented IFI
(n = 23) were matched with control subjects (n = 46) on the basis
of disease severity, sex and age (±5 years). Clinical outcome was
principally evaluated by in-hospital mortality. The economic
impact of microbiological studies and antibiotic treatment was
assessed. Calculations were based on the period between
admission and diagnosis of IFI in cases and the duration of
hospital stay in controls, respectively.
Results: The median length of hospital and ICU stay differed
signiﬁcantly between cases and controls (43 vs 14 days, 19 vs 3
days, P < 0.001, respectively). IFI occurred after a median
hospital stay of 22 (range 2–95) days. The mortality rate for
patients with IFI and matched control subjects were 30.4% and
10.9%, respectively (p = 0.04). There was no signiﬁcant
difference between cases and controls for Charlson index,
McCabe and SAPS II score. Median number of antibiotic
treatment courses was 3 for cases and 1 for controls
(p = 0.003), with a median duration of therapy of 6 days vs 1
day (p < 0.0001), respectively. Microbiological studies (MiS)
were conducted 78 times/100 patient-days (pd) in cases and 17
times/100 pd in the control group (p = 0.03). The most frequent
samples were bloodcultures in both groups. Swabs were
ordered signiﬁcantly more frequently in cases (median 25
(range: 1–150) vs. 2 (0–23); p = 0.04). The cost for MiS was
13’728 Euro/100 pd in cases vs. 3742 Euro/100 pd in controls,
and the costs for antifungal therapy 4’373 Euro/100 pd vs. 99
Euro/100 pd, respectively.
Conclusions: IFI is associated with excess length of ICU and
hospital stay, increased use of antibiotics and microbiological
diagnostics. The microbiological studies have a signiﬁcant
economic impact on the treatment of IFI.
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P1499
Cost-effectiveness of voriconazole to
amphotericin B deoxycholate in early and late
treatment of invasive aspergillosis
R. Greene, J. Mauskopf, C. Roberts, T. Zyczynski, H.
Schlamm (Boston, Research Triangle Park, New York, US)
Objective: We estimate the cost-effectiveness of alternative
initial drug treatments of invasive pulmonary aspergillosis
(IPA) in suspected earlier and later lung involvement, based
on the presence or absence of the halo sign on thoracic
computed tomography (CT).
Methods: We constructed a decision analysis model comparing
12-week treatment outcomes for a subset of patients enrolled in
a clinical trial of initial treatment of IPA with amphotericin B
dexoycholate (AmBd) vs voriconazole (VOR). Patients included
those with suspected lung involvement who underwent a
baseline thoracic CT. The subset was subdivided into two
groups based on the presence or absence of a characteristic CT
halo sign, a perimeter of ground glass CT opacity surrounding a
solid lung nodule ‡1 cm diameter, known as an early indicator
of IPA. Healthcare resource use and survival data were obtained
directly from the clinical trial. US unit costs for drugs and health
care services were applied from standard data sources. Cost and
survival at 12-weeks were estimated for those with and without
a halo sign at baseline. Incremental cost-effectiveness ratios
comparing VOR to AmBd were calculated for both patient
subgroups. Sensitivity of results to uncertainty in health care use
and cost estimates was tested.
Results: Patients in the halo subgroup had better survival than
those in the no-halo subgroup (70.6% vs 54.4%), with lower total
treatment cost ($44,352 vs $47,077). Survival was higher for VOR
than for AmBd in both patient subgroups (halo: 75.3% vs 65.2%;
no-halo: 68.3% vs 39.5%). In the halo subgroup, total costs were
lower for those treated with VOR than for those treated with
AmBd ($40,380 vs $48,985). In the no-halo subgroup, total cost
per patient was slightly higher for those treated with VOR
($48,133 vs $45,938). Accounting for the difference in survival,
the incremental cost-effectiveness ratio for VOR compared to
AmBd was $7,625 per additional 12-week survivor in this
subgroup.
Conclusions: Earlier identiﬁcation and treatment of IPA
appears to result in better survival and potentially lower costs
than later treatment. Initial treatment of IPA with VOR improves
survival in patients with early or late disease compared with
AmBd, is cost saving in the halo sub-group, and is cost-effective
in the no-halo subgroup, within the constraints of our analysis.
P1500
A multi-centre comparison of nursing staff time
required for the preparation and administration
of liposomal amphotericin B and amphotericin B
deoxycholate to voriconazole
E. Flynn, B.A. Oppenheim, P. Ribaud, G. Barbabietola, V.
De´marez, A. Marciniak, C. Roberts, K. Barker (Auburn, US;
Manchester, UK; Paris, FR; Foligno, IT; Creteil, FR; Sandwich, UK;
New York, US)
Objective: To describe and compare the nursing labor time
required for preparation and administration of liposomal
amphotericin B (L-AmB), amphotericin B deoxycholate
(AmBd), and voriconazole (VOR).
Methods: Activities associated with nurse preparation and
administration of the three study drugs were timed by trained
observers at ﬁve hospitals (one in Italy, three in France, and one
in the United Kingdom). Target tasks were classiﬁed as those
likely to be affected by the difference between the drugs and
excluded those tasks likely to differ because of site-speciﬁc
factors (e.g., travel time to a patient room in different hospitals).
Target tasks included: obtain supplies and medications; prepare
medications; educate patient; administer medications; monitor
for adverse events; and prepare follow-up medications. The
mean times for administration of a single day of study drug
were summarised and compared, accounting for a single daily
dose of L-AmB and AmBd and 2 daily doses of VOR IV or oral.
Results: Sixty-nine patients were observed receiving 256 doses
of study medications at the ﬁve hospitals. Time of
administration in minutes per day was 20, 16, 14, and 3 for L-
AmB, AmBd, VOR IV, and VOR oral, respectively.
Administration time was signiﬁcantly lower for VOR IV
compared with L-AmB (P < 0.05) and for VOR oral compared
to all IV regimens (P < 0.05). The task of preparation of
medications required the most time for IV formulations, and
was longer in the L-AmB group than the others (L-AmB:
12 mins vs AmBd: 7 mins; VOR IV: 9 mins). AmBd required
more time for patient monitoring and administration of follow-
up drugs than other formulations (AmBd: 7 mins vs L-AmB:
4 mins; VOR IV: 2 mins).
Conclusion: VOR IV required signiﬁcantly less time to prepare
and administer on a daily basis compared to L-AmB.
Measurements of IV antifungal versus oral VOR
administration suggest the opportunity to save 10–17 minutes
per day by switching to oral therapy when possible.
P1501
Need of cost-effectiveness investigation focused
on diagnosis, management and prevention of
osteopenia and osteoporosis in the setting of HIV
disease treated with HAART: when to act, how to
act, which patients are the ﬁrst target of
intervention
R. Manfredi, L. Calza, F. Chiodo (Bologna, IT)
Background: Osteopenia/osteoporosis are emerging untoward
effects of HIV infection/HAART. The pathogenesis is
multifactorial, involving all classes of anti-HIV drugs,
although protease inhibitor use, overall HAART duration, and
the male sex, seem related to a greater risk.Epidemiological-
clinical data. In an ongoing study at our Centre where >1000
HIV-infected patients (p) are followed, bone mineral density
was assessed in lumbar spine/femural head by a dual energy X-
ray absorptiometry (DEXA) exam to estimate the prevalence of
osteopenia/osteoporosis. In a screening of ~100 p, the frequency
of osteopenia and osteoporosis (based on lumbar T-score) was
~38% and ~10%, respectively. An increased risk was found in p
treated with protease inhibitors versus those receiving non-
nucleoside reverse transcriptase inhibitors or triple nucleoside/
nucleotide combinations.
Discussion and future insights: Prospective studies of
extensive p samples are needed, to elucidate the
epidemiology, pathogenesis, clinical issues and evolution of
HIV-associated bone metabolism anomalies. When planning
strategies for their early diagnosis, prevention and management
also cost-effectiveness issues should be considered, since no
pharmacoeconomic data still exist in this setting. Although
severe consequences (e.g. pathological fractures, prosthetic
implants) are expected to be infrequent their consequences in
terms of length and intensity of hospitalization, related costs,
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and especially severe consequences on the p’s quality of life,
play a notable role. Anyway, the most reliable diagnostic
procedure (DEXA) has affordable costs (around Eur 43.40 for a
total-body scan which also offers a body composition
assessment), as well as the ﬁrst-line drugs for osteopenia, e.g.
supplementation with calcium (Eur 5–6.5/month), and vitamin
D (Eur 7/month). These costs cannot be compared with the costs
of a standard care of an asymptomatic HAART-treated p (Eur
471 to 774/month) and the immunological, virologic, laboratory
and clinical controls made at least quarterly. Like
postmenopausal osteopenia/osteoporosis (burdened by a
greater risk of bone mass anomalies) also HIV disease should
be investigated from multiple cost-effectiveness points of view
to establish which p are the preferred candidates for a DEXA
screening when this examination is more useful during HIV
disease course and therapy, when the exam should be repeated
and when and how to intervene pharmacologically to prevent
serious and potentially invalidating complications.
P1502
A comparative study on the cost of new drugs in
different therapeutic categories
M. Falagas, K. Fragoulis, G. Zouglakis, I. Karydis (Athens, GR)
Objectives: Drug treatment is becoming more expensive due to
the increased cost for the introduction of new drugs and there
seems to be an uneven distribution of medication cost for
different therapeutic categories. We hypothesized that the cost
of new antimicrobial agents may differ from that of other
therapeutic categories and this may play a role in the stagnation
of development of new antibiotics.
Methods: We performed a pharmaco-economical comparative
analysis of the drug cost of treatment for new agents introduced
in the United States drug market in various therapeutic
categories. We calculated the drug cost [in US dollars (USD)]
of a 10-day treatment of all new drugs approved by the FDA
during the period between January 1997 and July 2003,
according to the 2004 Red Book Pharmacy’s Fundamental
Reference.
Results: New anti-neoplastic agents were found to be the most
expensive drugs in comparison to all other therapeutic
categories with a median 10-day drug-treatment cost of 848
USD compared to the median 10-day drug-treatment costs of all
other categories ranging from 29 to 301 USD (Table). On the
other hand, new antimicrobial drugs were found to be much less
expensive with a median 10-day drug-treatment cost of 137 and
85 USD for all anti-microbial agents and for anti-microbial
agents excluding anti-HIV medications, respectively.
Conclusion: The drug-treatment cost of new medications varies
considerably by different therapeutic categories. This fact may
inﬂuence industry decisions regarding the development of new
drugs and may play a role in the shortage of new anti-microbial
agents in the ﬁght against the serious problem of anti-microbial
resistance.
P1503
Usage and expenditure of 4f-quinolones in a
tertiary hospital in 2003 and 2004
T.A. Peppas, K. Malengou, N. Zachos, D. Voutsinas,
O. Kosmopoulou, N. Galanakis (Piraeus, Athens, GR)
Objective: Our aim was to assess 4-F-quinolone (4FQ) usage,
distribution and expenditure over 2 years.
Material and methods: All pharmacy 4FQ prescriptions
towards all departments of a 616 bed tertiary hospital for 2003
and 2004 were entered in PC databank. Analysis was performed,
by SPSS, by drug, deﬁned daily dose (DDD) and retail cost (in €).
Under the Greek legislation, as advanced agents 4F-quinolones
consist restricted antimicrobials.
Results: An overall of 16083 DDDs of 4FQ was dispensed in
2003 and 30378 during 2004, reﬂecting 0.097 and 0.19 4FQ
DDDs/patient-day, respectively. Expenditure for 4FQ was
434351 € for 2003 (20.4% of total hospital antimicrobial cost)
and 520052 € [21.1%] for 2004. In partial analysis most usage
involved ciproﬂoxacin, under 5 brand-names, which consisted
79% of all 4FQs dispensed. Most ordering forms were poorly
completed to justify choice. Huge discrepancies were observed
among similar departments. The signiﬁcant increase (+91%)
seen in 2004 was due to greater percentage of bid 4FQ choice
and poorer moxiﬂoxacin representation.
Conclusions: Close monitoring of antimicrobial usage,
particularly 4FQ, the most commonly used (and abused)
among restricted antimicrobials pinpoints the priorities of
Infection Control Team regarding urgent intervention
planning. Full data recording is of paramount importance for
both medical and administrative purposes.
P1504
Usage and expenditure of antimicrobials in a
tertiary hospital in 2003 and 2004
T.A. Peppas, N. Zachos, K. Malengou, O. Kosmopoulou,
I.F. Hager, M. Savvala, E. Dimitrakopoulou, N. Galanakis
(Athens, GR)
Objective: Our aim was to assess antimicrobial (A) consump-
tion, overall and regarding A under restriction (AUR), and also
their expenditure over 2 years.
Materials & methods: All pharmacy A prescriptions towards
all departments of a 616 bed tertiary hospital for 2004 and 2005
were entered in PC databank. Analysis was performed, by
SPSS, by drug category, deﬁned daily dose (DDD) and retail
cost (in €). Special analysis was performed for AUR [Under the
Greek legislation, advanced agents (3rd and 4th gen.cephalos-
porins, carbapenems, 4F-quinolones and glycopeptides-line-
zolid) consist restricted antimicrobials and non-restricted As
(NRA).
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Results: An overall of 103884 DDDs of As was dispensed in
2003 and 111376 during 2004, reﬂecting 0.63 and 0.71 DDDs/
patient-day, respectively. Expenditure for As was 2128223 €
for 2003 (20.3% of total hospital drug costs) and 2456465 €
[20.1%] for 2004. In partial analysis usage was higher, more
advanced and costlier in surgical compared to medical
departments, but huge discrepancies were observed among
departments in both sectors. Usage of AUR was quite high,
grossing 30766 DDDs and 1197473 € in 2003 and increasing to
32885 DDDs and 1487239 € respectively in 2004. A certain
department achieved expenditure of 23.9€/pt-day for AUR
alone in 2004, and a total of 256350 €, far exceeding the
respective ICU cost.
Conclusions: Close monitoring of antimicrobial usage and
selecting areas of urgent intervention planning are among the
primary duties and targets of Infection Control Team. Full data
recording is of paramount importance for both medical and
administrative purposes.
P1505
Antibiotic utilisation in Croatia, 2004
D. Sˇtimac, I. Vukusˇic, J. Culig, Z. Sˇostar, S. Tomic (Zagreb, HR)
Objective: To analyse antiobiotic utilization in Croatia using
Anatomical-Therapeutic-Chemical (ATC) drug classiﬁcation
system and number of deﬁned daily doses (DDD).
Methods: Data on the number of packages and purchase price
were collected for each individual drug. These data were used to
calculate the number of deﬁned daily doses (DDD) and DDD
per 1000 inhabitants per day (DDD/TID). Data obtained from
80% of pharmacies and 65% of hospitals were extrapolated to
the total number of pharmacies and hospitals in Croatia. Drug
utilization 90% (DU90%) segment was used as a prescribing
quality indicator.
Results: In 2004, the overall utilization of antibiotics in Croatia
amounted to 23.35DDD/TID. According to drug groups,
penicillins (J01C) showed highest utilization (12.24 DDD/TID),
predominated by the subgroup of penicillin combinations
(including beta-lactamase inhibitors, J01CR) with6.86 DDD/
TID, within which the combination of amoxicillin + clavulanic
acid accounted for99.9% with 6.85DDD/TID. Broad-spectrum
penicillins (J01CA) accounted for 43.2%(5.28 DDD/TID) of total
penicillin utilization, with a 97.7% predominance of amoxicillin
(5.16 DDD/TID). Cephalosporins (J01D) ranked second with
4.00DDD/TID, followed by macrolides and lincosamides (J01F)
with 2.41 DDD/TID, with an 86.84%predominance of
macrolides (J01FA) with 2.09DDD/TID. Among the latter,
azithromycin showed highest utilization with 1.44 DDD/TID,
accounting for 68.66% of total macrolide utilization.
Tetracyclines (J01A) ranked fourth with 2.02DDD/TID,
accounting for 8.65% of overall antibiotic utilization, followed
by quinolones with 1.65 DDD/TID, other antimicrobials with
0.91 DDD/TID, and aminoglycosides with 0.16DDD/TID.
Sulfonamides (J01E) accounted for a negligible proportion of
overall utilization. DU 90% segment included 9 of 43 antibiotics
registered in Croatia, with amoxicillin + clavulanic acid as the
leading one, followed by cephalexin with 1.83, cefuroxime with
1.53, azithromycin and norﬂoxacin with 1.3each, nitrofurantoin
with 0.56 and clarithromycin with 0.53DDD/TID. Hospital
utilization accounted for 7.1% of overall antibiotic utilization
expressed in DDD/TID and 22.7% of the respective ﬁnancial
cost, predominated by aminoglycosides (J01G) with 72% and
94.2%, and lowest proportion of tetracyclines (J01A) with 4.3%,
and 2.4%, respectively.
Conclusion: The utilization of antibiotics in Croatia is among
the highest in Europe, mostly due to overuse of amoxicillin +
clavulanic acid, which has no rational ground in professional
guidelines.
P1506
A comparative analysis of prescriptions for
antibiotics issued by outpatient doctors in urban
areas in 1999 and 2005
W. Drzastwa, E. Drzastwa, W. Lukas, E. Mizgala, G. Golczyk,
H. Trzeciak (Zabrze, PL)
Objective: The objective of the research was to analyse
antibiotics prescripsion behavior by Family doctors and
specialists treatments prior to and after the introduction of the
health care reform in Poland.
Materials and methods: Prescriptions from the ﬁrst six months
of 1999 and 2005 were compared. The data was collected from
two randomly chosen pharmacies in the city of Zabrze that
supply the citizens of the Silesian agglomeration from various
social backgrounds. Taking into account the value of a single
antibiotics package and the price a patient has to pay for it an
average price of medications prescribed by family and specialist
doctors was calculated.
Results: A total of 30793 prescriptions were analysed out of
which 24834 dated from 1999 and 5959 from 2005.In the ﬁrst
half-year of 1999 the percentage of prescriptions for antibiotics
reached 7.76% on average, and in the year 2005 – the average
was 11.6%. In the ﬁrst half-year of 1999 family doctors mostly
prescribed: penicyllins (43%), makrolids (26%), cephalosporins
(16%), tetracyclins (11%), chinolons (3%). In the same period
spcialist doctors prescribed: penicyllins (41%), cephalosporins
(17%), makrolids (15%), tetracyclins (13%), lincozamids (9%),
chinolons (4%). In the ﬁrst half-year of 2005 family doctors most
often prescribed penicyllins – (44.8%), makrolids – (27.1%),
cephalosporins – (12.5%), tetracyclins – (9.4%) and lincozamids–
based (3.1%) treatments Specialist doctors, on the other hand,
prescribed penicllins (41.7%), makrolids (17.9%), cephalosporins
(17.7%), tetracyclins (12.1%), lincozamids (5.2%) and chinolons
(3%). The average prices of the prescribed medications in the
years 1999 and 2005 were, respectively: for family doctors-EU
3.08 and 4.01, for specialist doctors EU 4.44 and 3.87.
Conclusions: There has been a considerable increase in the
percentage of prescriptions for antibiotics from 7.45% (in 1999)
to 11.3% (in 2005). The tendency towards prescribing antibiotics
in the speciﬁc groups of doctors has not changed signiﬁcantly. In
both years prescriptions for antibiotics were in line with the
recommendations. Also, prices of medications prescribed by
family doctors have risen.
P1507
Internet guide on antimicrobial resistance
A. Sosa, F. Traub, S. Valovic, P. Chea (Boston, US)
Objectives: (1) To organize the plethora of information
available, providing clinicians the tools to easily access
available online resources that include academic institutions,
professional societies as well as sites maintained by private
individuals; (2) to inform clinicians of new advances in the
epidemiology, diagnosis, treatment, and prevention of most
common infections; (3) to inform on subjects such as clinical
trials in antimicrobial resistance, information about speciﬁc
pathogens and their infections, genomic resources, culture
collections, electronic images of pathogens and antimicrobial
agents, antimicrobial resistance lecture and teaching materials,
environmental health and safety information, and a listing of
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websites of infectious disease and clinical microbiology
professional societies.
Methods: We deﬁned four inclusion criteria after extensive
consulting with APUA staff and scientiﬁc advisory members: (1)
Recognized/reputable source; (2) High quality of information
presented; (3) Potential usefulness to medical professionals and
the general public; and (4) Ease of navigation. Ideal parameters
were determined for the guide’s scope and the appropriate
sources identiﬁed online were subsequently reviewed. A set of
broad categories was established to organize the topics and the
online resources. Sites reviewed included those maintained by
the federal government, academic institutions, nonproﬁt
organizations, and commercial entities. Some personal
websites were included because of their quality and their
association with academic institutions. This review is intended
as an introduction to AMR websites.
Results: With use of popular search engines, such as Google,
Yahoo!, and AltaVista, we initially identiﬁed a great number of
websites. Using broad search terms, such as "antibiotic
resistance," we identiﬁed 1,310,000 web addresses. The term
"antimicrobial resistance" generated 578,000 hits, and the term
"drug resistance" generated 6,190,000 hits.
Conclusions: Websites found were classiﬁed following a
systematic topic structure. Each website listed describes: (1)
Full citation of the resource: author/editor and title of website;
(2) Date of publication or last revision; (3) Name of sponsor; (4)
Date of access (i.e.: 3 Sep 1999); (5) URL of resource with date; (6)
Description of resource; (7) Outstanding information related to
criteria.
P1508
An educational web portal on febrile
neutropenia: www.febrilnotropeni.net
H. Akan, M. Akova, T. C¸alikoglu, K.H. Gu¨lkesen on behalf of the
Turkish Febrile Neutropenia Study Group
Objectives: Countless health portals on the internet are
available for healthcare personnel. www.febrilnotropeni.net, a
Turkish health portal dedicated speciﬁcally to febrile
neutropenia related problems, has been run by the Turkish
Febrile Neutropenia Study Group (TFNSG) since May 2002. We
analysed an 11-month period (December 2004–October 2005) of
usage patterns of the Portal.
Methods and results: The portal is free to use but requires
registration and has more than 1850 registered users as of
November 2005. Of these, 20% are in-training positions, 28%
hold a faculty position in infectious diseases (ID), microbiology
or hemato-oncology, 24% are specialists in a non-university, but
a teaching setting. The remaining are a mixed group of primary
physicians, other speciality doctors and pharmaceutical
company workers. Running costs of the portal are partially
covered by educational grants from pharmaceutical sponsors
who have no role in organization of the site, but their names are
acknowledged. Articles chosen by the two faculty members, one
ID physician and one haematologist, are sent to registered users
by daily e-mail postings. These are selected from toc alerts of
various core clinical journals and well known educational web
sites (e.g. CDC, WHO, Medscape). A short Turkish summary is
provided and the reader is referred to the abstract and if
available, to the free full text of original article with a link. Other
materials included guidelines, free slide sets, study protocols
and updates from the Group, CME activities and meeting
announcements. Registrants may also use the site for expert
opinion. During the trial period, the site has been visited 30740
times with 282239 hits. Approximately 5.5 Gb material was
downloaded. The frequency of readings are related with the
time (highest between 9.00–11.00 am during weekdays and
lowest during weekends), the type of documents (i.e.
educational materials and guidelines), popularity of the news
(e.g. peaked during an epidemic of avian inﬂuenza when related
news and articles announced). The pages are most frequently
visited by ID specialists followed by clinical microbiology,
haematology and pharmaceutical company workers (33%, 19%,
9% and 8% respectively).
Conclusion: Timely published medical data have high
attraction rates among physicians. Our results also indicated
that, a web page gets ‘‘old’’ after about a month of publishing,
emphasizing the importance of well-timed announcements of
the Portal material.
P1509
NeLI and NRIC survey: information needs of
infectious disease professionals
P. Kostkova, S. D’Souza, G. Madle, J. Mani-Saada, S. Wiseman,
A. Roy, J. Weinberg (London, UK)
Healthcare professionals are increasingly facing the problem of
information overﬂow. It is getting impossible to keep up-to-date
with the latest research ﬁndings, care guidelines and pathways,
government strategies and national and local policies. Internet
enables an instant information dissemination enabling access to
the latest results at any time as well as informal knowledge
exchange by using chat rooms and discussion forums. However,
it is getting increasingly difﬁcult for busy professionals to ﬁnd
reliable quality-assured information on the Internet when they
need it. National Internet libraries in the UK are addressing this
problem: the umbrella portal National electronic Library of
Infection NeLI (http://www.neli.org.uk) providing a single
access portal to quality-assured information on treatment,
diagnosis, prevention and management of infection diseases,
and the National Resource for Infection Control NRIC (http://
www.nric.org.uk) - a single-stop shop for policies, guidelines
and research around infection control, hosted by NeLI. To better
meet the information needs of these Internet portals, accessed by
2000 unique users per month, we are conducting an information
needs study to explore clinical questions, user needs and disease
priorities of users seeking answers on NeLI and NRIC. A pilot
qualitative online questionnaire-based study revealed that our
users come from the variety of professionals: clinical scientist,
consultant, registrar, psychotherapist, lecturer, GP, medical
librarian, information scientist, health protection. These have
questions mainly around HIV, tinea, molluscum contagio,
meningitis, cold, MRSA, Lyme, Toxoplasma, chicken pox,
Inﬂuenza, diarrhoea and vomiting, rash, Staph. aureus, traveller
infections antibiotics resistance, malaria, MMR, meningitis, viral
myocarditis, anthrax, smallpox, and TB. This is in line with our
quantitative weblog-based evaluation of the most commonly
access topics on NeLI by NHS-based users: Antimicrobial
resistance and HAE (10.27%), TB (9.54%), meningitis (9.47%),
HIV (8.95%), chlamydia (6.31%), E. coli (5.54%), Staph. aureus
(5.26%), adenovirus (4.84%), blood borne infections (4.44%). The
results of the ongoing analysis of google search keywords that
brought users to NeLI and NRIC will be discussed. Further
results identifying the needs speciﬁc to the infection disease
professions will be discussed in relation to differences in the
national variations in information needs and priorities.
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P1510
Training in infection
S. D’Souza, P. Kostkova, F. Cooke, A. Holmes (London, UK)
Specialists today require prompt access to quality information in
order to work effectively. The diversity of specialist interests in
the ﬁeld of infection has led to the formation of a large number
of professional and scientiﬁc societies. These play an increas-
ingly important role in ensuring that the trainee is effectively
supported, not only during the period of training, but also in
longer-term personal development. Details of relevant societies,
conferences, grants etc are, on most society websites, conﬁned to
those for either that society or others in that specialty only, and
knowledge of the numerous places in which to look for this
information is necessary to ﬁnd out the latest information.
Training In Infection (TII – www.trainingininfection.org.uk) is
an online resource, primarily aimed at infection specialist
trainees but useful throughout the career path, which brings
together this information into one central access point, so that
users from all infection specialties can ﬁnd the appropriate
information for their specialty quickly and easily. It identiﬁes
and links to the key relevant resources covering a broad range of
infection related disciplines in a dynamic database structure.
Information on societies, conferences, grants, journals, textbooks
and more are available on the site, and have been put together to
create a one-stop infection training portal. Online discussion
forums to be implemented will allow trainees’ to share ideas and
make the most of their combined expertise, and users will be
able to receive alerts on new information in their specialty as
well as be reminded of conference deadlines, journal submission
deadlines etc. The ability to discuss regional issues online within
specialties also aims to promote greater local and international
collaboration. Training in Infection is endorsed by the National
electronic Library of Infection (NeLI – www.neli.org.uk), an
established digital library bringing together the best available
online evidence-based resources on the investigation, treatment,
prevention and control of infectious diseases.
P1511
Research designs and statistical methods in
medical abstracts
M. Kompoti, M. Matsagoura, A. Koutsovasilis, A. Koutsovasili,
S. Drimis (Athens, GR)
Statistical methods used in biomedical research articles are
being increasingly scrutinized in medical journals. However, no
such strict policy is generally applied in abstracts presented in
medical congresses.
Objective: This study aimed at assessing the frequency of
research designs and statistical methods reported in abstracts
presented in two successive years of the European Congress of
Clinical Microbiology and Infectious Diseases (ECCMID).
Material and methods: We reviewed all abstracts included in
the abstract book of the 14th ECCMID (Prague 2004) (PG) and
the 15th ECCMID (Copenhagen 2005) (CP). All abstracts of
original research studies but no abstracts of lectures were
included in our study. Two independent investigators read all
abstracts and extracted information concerning origin, type
(clinical, laboratory, animal model), research design, sample size
and statistical methods used in the study. Data analysis was
performed with logistic regression and Pearson’s chi-square test
for categorical variables and Student’s t-test for continuous
variables. Statistical signiﬁcance level was set at p < 0.05.
Results: A total of 4178 abstracts were included in the analysis
according to eligibility criteria (2110 from PG and 2068 from CP).
Laboratory studies prevailed (61%) followed by clinical studies
(35%) and experimental studies with animal models (4%).
The majority (79.3%) of the studies were observational
(retrospective, prospective, cross-sectional) of which 6.3%
concerned diagnostic accuracy testing of laboratory methods
and 2.3% were pharmacological studies, 3.8% were randomized
controlled trials. Statistical evaluation was clearly described in
26.5% of abstracts (26.1% in PG and 19.8% in CP, p < 0.001),
while the rest of abstracts included only descriptive statistics or
no statistics at all. The proportion of statistical methods
reporting varied according to the type of the study (animal
model studies 49.4%, clinical studies 38.9% and laboratory
studies 12.0%, p < 0.001). Multicentre research studies reported
statistics more frequently than single-center studies (26.5% vs.
21.5%, respectively, p = 0.005).
Conclusions: Statistical analysis is an inseparable part of
original research. Research design as well as the implemented
statistical methods should always be reported in an adequate
manner, thus improving the scientiﬁc quality of abstracts.
Antimicrobial PK/PD
P1512
NXL103-Oral Streptogramin: a phase I, double-
blind, single escalating oral dose study to
evaluate safety, tolerability and pharmacokinetics
in healthy adult male volunteers
M. Rangaraju, J. Rey, J. Hodgson (Romainville, Vitry sur Seine,
FR)
Background: NXL 103 (formerly XRP 2868) is a novel semi-
synthetic oral streptogramin that consists of a 30/70 (w/w ratio)
association of a pristinamycin IA (PI) derivative and a
pristinamycin IIB (PII) derivative. NXL 103 is being developed
for the treatment of respiratory tract and skin and skin structure
infections.
Methods: 60 healthy male subjects were enrolled in this study.
10 subjects in each of 6 cohorts (125 mg, 250 mg, 500 mg,
1000 mg, 1500 mg and 2000 mg) received either NXL103 (8) or
placebo (2). An additional cohort of 10 subjects received a single
dose of 500 mg NXL103 in fasting and fed conditions. Blood and
urine samples for PK analysis were collected at multiple time
points. Safety was assessed via adverse events, physical
examination, clinical laboratory data, ECG and cardiac
monitoring.
Results: NXL103 administered as 125 mg capsules at single
doses from 125 mg to 2000 mg was well tolerated and safe.
There was no serious or severe adverse event, no dose-
dependency in the number of AEs or their severity, no
signiﬁcant variation in blood pressure or heart rate, no
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abnormality on ECG recording, and no clinically signiﬁcant
changes compared to baseline for laboratory parameters. Both
components were rapidly absorbed; PI being slightly more
rapidly absorbed than PII. The Cmax and AUC (0-t) increased
approximately in proportion with dose. The proportion of PI
and PII components estimated on mean exposure values was
approximately comparable to that administered (30/70),
indicating that the relative bioavailabilities of PI and PII are
simila. Elimination half-life ranged from between 2 to 3 hours
for PI to 4 to 6 hours for PII. Food increased the bioavailability of
PI and PII by approximately 20%.
Conclusions: NXL103 is safe, well tolerated and exhibits
predictable PK properties in healthy volunteers in doses up to
2000 mg administered as a single dose.
P1513
Correlation of vancomycin and daptomycin
susceptibility in Staphylococcus aureus in
reference to accessory gene regulator
polymorphism and function
W. Rose, M. Rybak, B. Tsuji, G. Kaatz, G. Sakoulas (Detroit, New
York, US)
Objective: Polymorphism at the accessory gene regulator (agr)
locus in S. aureus (SA) deﬁnes 4 groups (I–IV). Agr group II SA
have been associated with glycopeptide treatment failure in
patients. SA with loss of agr function appear to have a higher
tendency to become vancomycin (V) resistant. It is unknown
whether this association only pertains to glycopeptides. We
examined the effect of varying V and Daptomycin (D) against
agr+ and agr null pairs in an in vitro pharmacodynamic model
(IVPM).
Methods: Agr group I and II wild-type prototype and knockout
(tetM::agr) pairs were evaluated. MIC values were determined
according to Clinical Laboratory Standards Institute. IVPM glass
and hollow ﬁbre models were used to simulate dosages and
AUC/MIC exposures for V ranging from 62.5 mg–1 g q 12 h
fAUC/MIC range 31–665 mg/L*h, and D 0.75 mg/kg–6 mg/
kg/day fAUC/MIC range 37.5–346. The dosage regimen and
AUC/MIC breakpoints that produced resistance was then
evaluated in the hollow ﬁbre IVPM. All IVPM simulations
were performed in duplicate over 72 h. Resistance was
evaluated using 3 and 6 x MIC screening plates at 0, 8, 24, 48,
56 and 72 h.
Results: Pre-exposure MIC values for agr I± and agr II± were
0.75/1 and 1 for V and 0.25 lg/ml for D respectively. V-
intermediate resistance (MIC = 8 mg/L) was detected in both
agr I and II null strains at a simulated V dosage of 62.5 mg q 12h
(AUC/MIC 31), representing an MIC increase of 8–10 fold. This
breakpoint for resistance was veriﬁed in the hollow ﬁbre model.
Although signiﬁcant regrowth was noted with suboptimal
dosing of D, no resistance was detected on D screening plates
for any daptomycin regimen evaluated.
Conclusions: Exposure of SA to V approximating 1/6 of
optimal serum concentrations resulted in the development of
heteroresistance in the agr null group I and II. Loss of agr
function did not correlate with the development of D
resistance despite suboptimal simulations of D exposures.
These results implicate loss of agr function important to the
development of glycopeptide resistance but not to loss of
susceptibility to D.
P1514
Teicoplanin efﬁciently penetrates into the rabbit
infected vitreous but may enhance expression of
virulence factors at sub-inhibitory concentrations
E. Forestier, F. Jehl, C. Gallion, R. Andres, S. Bronner,
L. Leininger, G. Pre´vost (Strasbourg, FR)
Objectives: Fluoroquinolones are the antibiotics that most
efﬁciently penetrate inside vitreous. However, alternative
treatments for endophtalmitis may be required in some cases
for example resistant bacteria. We used a rabbit experimental
model of endophtalmitis to evaluate the penetration of
teicoplanin in different conditions. The inﬂuence of sub-
inhibitory concentrations of teicoplanin was also evaluated on
the expression of S. aureus virulence factors.
Methods: New Zealand rabbits (>3 kgs) received one or
repeated doses of intra-venous (IV) teicoplanin (60 mg/kg)
every 12 hours for 3 days plus one dose a day for 2 more days.
Another group of rabbits was infected by 1000 CFU of a
methicillin resistant S. aureus IBS 3284 (CMI = 1.5 mg/L)
producing Enterotoxin A, Panton-Valentine leucocidin and
LukE-LukD. They were administrated 24–36 hours later with
60 mg/kg teicoplanin, as a single dose or as to reach the steady
state. Vitreous (200 lL) was sampled before new injections of
teicoplanin or at indicated time as well as blood before or 15 min
after teicoplanin injection. Teicoplanin concentrations were
measured by HPLC. Bacterial counts were recorded and
expression of virulence factors was semi-quantiﬁed by
dedicated competitive RT-PCR tests.
Results: In safe eyes, teicoplanin penetration remains moderate
reaching about 4 mg/L within about 6–8 h after one IV injection.
The half-life of teicoplanin in the rabbit vitreous is about
25 hours. After 5 days of repeated injections, intra-ocular
concentration stabilises around 4 mg/L while residual blood
concentrations were comprised between 30–40 mg/L. In
infected eyes, teicoplanin, when repeatedly administrated after
the beginning of clinical signs, i.e. 24 h post-
infection = 106 CFU/mL, reaches intra-vitreal concentrations
of 9.3 ± 2.3 mg/L 40 h post-infection, and increases to
14.3 ± 5.4 mg/L 84 h post-infection and 12 h after a fourth
injection. However, at sub-inhibitory concentrations (~2 mg/L),
it may be responsible for a signiﬁcant increase of agr, gamma-
hemolysin hlgA, lukED and Panton-Valentine leucocidin luk-PV
expressions with ratio ranging from 15 to 100 folds.
Conclusion: These preliminary results strongly suggest that
teicoplanin IV administration constitutes an interesting
alternative therapy for endophtalmitis provided high intra-
ocular concentrations are rapidly obtained. Investigations now
concern optimisation of teicoplanin dosage regimen.
P1515
Pharmacokinetics of temocillin in intensive care
patients and Monte Carlo simulations to evaluate
susceptible breakpoints
J.W. Mouton, R. DeJongh, V. Basma, P. Tulkens, S. Carryn
(Nijmegen, NL; Genk, Brussels, BE)
Background: Temocillin (TMO) is a narrow spectrum penicillin
with good activity against Gram negative micro-organisms
including ESBL and AmpC producers. Little pharmacokinetic
data are available however. We performed a pharmacokinetic
study in 6 ICU patients receiving TMO 2g q12h. Parameter
estimates were used to predict concentrations during
continuous infusion (CoInf) and compared with data obtained
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
from 6 other ICU patients receiving CoInf to validate the model.
The model was then used to perform Monte Carlo Simulations
(MCS) to determine Probabilities of Target Attainment (PTAs)
for pharmacodynamic indices (PDI) in order to evaluate and
suggest clinical breakpoints.
Methods: Blood samples were taken from ICU patients prior to
(t = 0) and after (t = 1, 2, 3, 6, 12 h) a 30 m infusion of 2 g TMO
(n = 6) or after 48 h during CoInf with 4 g/24 h (n = 6), and
then cooled, centrifuged and stored at )70C until analysis by
HPLC. Protein binding was determined using an ultraﬁltration
method. Results were used to estimate population
pharmacokinetic parameters by Winnonmix including the
covariance matrix. Miclab233 was used to perform simulations
for CoInf as well as to perform MCS (10000 cycles) and obtain
PTAs for the unbound fraction including 95% conﬁdence
intervals (CI) for the target concentrations. fT>MIC was
chosen as the PDI because of the pharmacodynamic properties
of TMO.
Results: Protein binding was 75%. A one-compartment model
best ﬁtted to the data, with estimates (se) of Vc = 14.3 (0.87) L
and k10 = 0.172 (0.059) 1/h corresponding to a mean half-life of
4.03 h. Using these estimates, the predicted unbound
concentration during CoInf was 16.9 mg/L, while the mean
concentration in the 6 other patients was 17.03 mg/L, a bias of
less then 1%. The breakpoint MIC for a mean fT>MIC of 50%
was 16 mg/L. However, MCS -taking the variation in the
population into account - indicated that 100% PTAs of a 2g q12h
dose were obtained at 4, 4, and 2 mg/L for 40, 50 and 60%
fT>MIC, respectively. The 95% CI at 50% fT>MIC indicated a
clinical breakpoint of 8 mg/L. The 95% CI was relatively large,
as expected from data obtained in patients rather than
volunteers.
Conclusion: The population pharmacokinetic estimates from 6
ICU patients were very well in agreement with the validation
study, with a bias of <1%. The MCS indicate a susceptible
breakpoint for temocillin of £8 mg/L provided an
administration of 2 g q12h is used.
P1516
Tissue penetration and pharmacokinetics of
moxiﬂoxacin in diabetic foot infections:an
interim analysis
J. Majcher-Peszynska, K. Karrasch, M. Saß, R. Mundkowski,
A. Gussmann, P. Kujath, B. Ruf, W. Schareck, H. Koch,
B. Drewelow (Rostock, Bad Saarow, Lubeck, Leipzig, Beeskow, DE)
Objectives: With its broad spectrum of activity against
grampositive, gramnegative and anaerobic organisms
moxiﬂoxacin covers the pathogens of the mainly polymicrobial
infections associated with the diabetic foot. Inﬂammatory and
ﬁbrotic processes in diabetic foot infections (DFI) contribute to
impaired tissue penetration of antibiotics. In addition, diabetic
patients represent a pharmacological risk population,
physiological changes in diabetic patients may alter the
pharmacokinetics of antibiotics. The study was designed to
investigate the penetration of moxiﬂoxacin into perinecrotic
tissue in 60 patients with DFI and the pharmacokinetic
properties of moxiﬂoxacin in diabetic patients.
Methods: The interim analysis of this open, multicentre study
included 30 adult, hospitalized male and female patients (mean
age: 69.8 years) with type 2 diabetes mellitus and DFI. The
pharmacokinetic parameters of moxiﬂoxacin and penetration
into DFI tissue at steady state (day 4 to 8) following once daily
administration of 400 mg IV or PO were evaluated. Correlations
between penetration of moxiﬂoxacin and clinical and laboratory
parameters were examinated.
Results: In all 30 patients the moxiﬂoxacin concentrations
measured in infected diabetic foot wounds 3 hours after
administration exceeded the in vitro MIC90 values of
susceptible Staphylococci (0.125 mg/l). The moxiﬂoxacin
concentrations achieved in DFI tissue correlated more strongly
with the AUC0-24 (r = 0.659; p < 0.01) than with the
corresponding plasma concentrations (r = 0.492, p < 0.01), but
not with the extent of the systemic inﬂammation and the blood
glucose level. Taking into account the predictive PK/PD
parameters for moxiﬂoxacin (based on an in vitro MIC90 value
of 0.125 mg/l for Staphylococcus aureus) a therapeutic success can
be expected (AUC24/MIC: 204.3; Cmax/MIC: 22.9). Signiﬁcant
differences between the routes of administration (IV vs PO)
were only observed for tmax (p < 0.01) and t1/2 (p < 0.05), but
not for other clinically relevant parameters (AUC0-24, Cmax,
moxiﬂoxacin tissue concentration). This allows sequential
therapy i.v./p.o. in this indication.
Conclusion: Based on adequate plasma concentrations in
diabetic patients, the sufﬁcient penetration into DFI tissue and
the possibility of a sequential therapy, moxiﬂoxacin represents -
from a pharmacological point of view - a valuable therapeutic
option in the treatment of diabetic foot infections caused by
susceptible organisms.
P1517
Fluoquinolones effects on patient lymphocytes
during prolonged treatments
E. Bertazzoni Minelli, A. Benini, D. Doria, P. Franceschetti,
M.E. Fracass (Verona, IT)
Fluoroquinolones (FQ), widely used in clinical practice, are
well tolerated. The most common adverse reactions are those
affecting gastrointestinal tract, phototoxicity and allergy. The
aim of the study is to evaluate the possible cellular damage in
lymphocytes of patients treated with different FQs according to
pharmacokinetic data. Blood samples obtained from thirty-six
patients treated with ciproﬂoxacin (CPX, 14 pts), levoﬂoxacin
(LVX, 15 pts.) and moxiﬂoxacin (MFX, 7 pts) at different doses
were analysed. Patients treated with CPX and LVX were in
therapy with other drugs (diuretics, cardiovascular drugs,
omeprazole, antiinﬂammatory drugs, etc.). MXF treated
patients were not in therapy with other drugs. Samples were
collected at time 0 (before FQs administration) and after 3 and
9 days of treatment. Serum levels of FQs were determined with
microbiological method and HPLC. Comet test was performed
on lymphocytes, to evaluate DNA damage. GSH levels were
determined as efﬁciency marker in metabolic process of
detoxiﬁcation. CPX showed good serum concentrations; its
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levels increases proportionally with administered doses (from
250 to 1000 mg). LVX concentrations resulted in good inhib-
itory levels after 3 treatments (500 mg) both per os and i.v.
Patients orally treated with 250 mg showed similar serum
levels (from 0.8 to 2.1 mg/l). MFX levels were between 3.6 and
1.6 mg/l after 3 and 9 days. Repeated CPX administration
induced a dose-dependent increase in all DNA damage
parameters, with statistical differences after 9 treatments.
MFX (400 mg) and LVX administration didn’t induce DNA
damage after 3 and 9 days. Intracellular levels of GSH were
similar in all treated groups, even if CPX treated patients
showed the lowest concentrations. No statistical correlations
were found between all parameters studied. These data
indicate that CPX induce DNA damage in lymphocytes in
combination with a reduced efﬁciency in detoxiﬁcation system.
This effect does not seems to depend on high intersubject
variability for FQs administered doses, co-administration of
other drugs, different ages of patients and low samples
numbers. Effects of single FQs molecules seems to be structure-
speciﬁc and selective.
P1518
Penetration of ertapenem in human pancreas.
Results of a prospective clinical trial
S. Motamedi, M.H. Schoenberg (Munich, DE)
Objectives: Ertapenem is a carbapenem commonly used to treat
intra-abdominal infections. The antibacterial spectrum includes
the major causative pathogens. Clinical trials proved excellent
clinical and microbiological efﬁcacy in peritonitis. On the other
hand in inﬂammatory pancreatic diseases sufﬁcient antibiotic
concentration in the inﬂammatory tissue is vital for the outcome
of the disease. We therefore investigated ertapenem
concentrations in pancreatic tissue and juice in comparison to
the plasma levels measured at the same time.
Methods: In a prospective clinical trial ertapenem was given in
a dosage of 1 g i.v. 30 minutes prior to operation in patients (18–
70 years) suffering from chronic pancreatitis or pancreas
carcinoma undergoing pancreas resection. Blood samples were
collected every 60 minutes during the operation. Moreover we
collected pancreatic tissue and pancreatic juice shortly before
resection and shortly before ﬁnalisation of the anastomosis. The
samples of ertapenem (blood, juice, tissue) were determined by
HPLC.
Results: In 13 patients (5 female, 8 male, mean age 54.8 ± 11.2
years) ertapenem blood concentrations were determined and
demonstrated intraoperatively high concentration (20 ± 8 mg/l)
above MIC90 values for major expected pathogens.
Concomitantly in 10 of these patients ertapenem concentration
was determined also in pancreas tissue and pancreas secretion
(in further 3 patients in pancreas secretion only). In 7/10
patients sufﬁciently high ertapenem levels were detected in
pancreatic tissue. In 3 patients with chronic pancreatitis no
accumulation was seen. Mean pancreas tissue concentration was
0.8 ± 0.4 lg/g tissue. 5 of 6 patients with pancreas carcinoma
had increased ertapenem levels in pancreas secretion but only 2
of 6 patients with chronic pancreatitis.
Conclusion: In patients with pancreas carcinoma, ertapenem
levels were measured in pancreatic tissue as well as in
pancreatic secretion and penetration seems to be similar to
imipenem. Due to chronic inﬂammation and possibly altered
microcirculation only in one half to one third of chronic
pancreatitis patients ertapenem levels were detected.
P1519
Bacterial strain-independent pharmacodynamics
of linezolid/doxycycline combinations with
Staphylococcus aureus: 5-day simulations using
an in vitro dynamic model
M. Smirnova, I. Alferova, I. Lubenko, Y. Portnoy, S. Zinner,
A. Firsov (Moscow, RU; Cambridge, US)
Objective: To delineate the possible advantages of linezolid
(L)/doxycycline (D) combinations over monotherapy, the
pharmacodynamics of L, D and L+D were studied with
S. aureus.
Methods: S. aureus ATCC 43300 and a clinical isolate S. aureus
479 were exposed to twice-daily L (half-life 6 h) and once-daily
D (half-life 15 h), alone and in combination (1:3 ratio based on
24-h AUC/MICs), for ﬁve consecutive days. To provide
simultaneous mono-exponential elimination of L and D with
different half-lives, a previously described dynamic model was
modiﬁed according to Blaser and Zinner. The MICs of L were
1.56 and 1.56 mg/L and MICs of D were 0.1 and 0.05 mg/L for
S. aureus ATCC 43300 and S. aureus 479, respectively. Nine
dosing regimens were simulated with each organism exposed to
different AUC/MICs (in hours): L30, L60 and L200; D90, D180
and D520; L30 + D90, L60 + D180 and L200 + D520. The
cumulative antimicrobial effect was expressed by its intensity
(IE) measured from the start of treatment to the time after the
last antibiotic dose when numbers of antibiotic-exposed bacteria
reached at least 108 CFU/ml. Emergence of resistance was
monitored daily by quantitating surviving organisms on agar
plates containing 2x and 4xMIC of L or D.
Results: With both S. aureus ATCC 43300 and S. aureus 479
exposed to L or D, IE increased with increasing simulated AUC/
MIC ratios, although signiﬁcantly higher IEs were produced
with L30, L60 and L200 treatments relative to D90, D180 and
D520 treatments. Each of the combined treatments, i.e.,
L30 + D90, L60 + D180 and L200 + D520, produced much
greater IEs than the sum of L and D IEs observed in the
respective mono-treatments with both S. aureus strains. Based on
population data, a pronounced selection of S. aureus resistant to
D occurred in all mono-treatments with D. It was also observed
with L30 + D90 and, to a lesser extent, with L60 + D180 but
not with L200 + D520. No resistance to L was observed with
L mono- or combination treatments.
Conclusions: These data predict a synergistic interaction of
L with D against S. aureus.
P1520
Anti-staphylococcal effects of telavancin in an
in vitro dynamic model: impact of different
half-lives and initial concentrations
I. Lubenko, M. Smirnova, E. Strukova, S. Vostrov, S. Zinner,
A. Firsov (Moscow, RU; Cambridge, US)
Objective: Telavancin is a lipoglycopeptide antibiotic with
excellent activity against gram-positive bacteria including
methicillin-susceptible and methicillin-resistant strains of
Staphylococcus aureus. Telavancin pharmacokinetics are linear
and dependent on renal function, with distinctly different half-
lives (T1/2 s) in healthy volunteers (8 h) and in patients with
severe renal insufﬁciency (18 h). To demonstrate the possible
impact of these pharmacokinetic features on the
pharmacodynamics of telavancin, its anti-staphylococcal effects
were studied in an in vitro one-compartment dynamic model
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that simulates normal (NEK) and impaired elimination kinetics
(IEK).
Materials and methods: A glycopeptide intermediately
susceptible strain of S. aureus (GISA) Mu-50 with a telavancin
MIC of 0.5 mg/L was selected for the study. With both NEK and
IEK simulations at a starting inoculum of 6 log cfu/mL, GISA
Mu-50 was exposed to different ratios of the peak concentration
(Cmax) to the MIC of telavancin (as a single dose), i.e., 2.6, 7.8
and 14. Based on time-kill data, the intensity of the antimicrobial
effect (IE - the area between control growth and time-kill curves)
was determined from time zero to the time when the effect no
longer could be detected, i.e. the time after the last dosing at
which the number of antibiotic-exposed bacteria reached 7
log cfu/mL.
Results: In each treatment, bacterial regrowth followed gradual
reduction in the starting inoculum during the ﬁrst 12 h (similar
in NEK and IEK simulations) that led to signiﬁcantly lower
minimal numbers of surviving organisms in IEK simulations
compared to NEK simulations. Despite similar rates of initial
killing, times to regrowth were much longer in IEK than NEK
simulations. At a given Cmax/MIC ratio, the IEs observed in
IEK were greater than in NEK simulations (ﬁgure).
Conclusions: These ﬁndings demonstrate pharmacokinetic-
dependent pharmacodynamics of telavancin with Staphylococci.
P1521
Pharmacokinetics of amoxicillin in pregnant
women with pre-term premature rupture of the
membranes
A.E. Muller, J. DeJongh, P.M. Oostvogel, R.A. Voskuyl, P.J. Do¨rr,
M. Danhof, J.W. Mouton (The Hague, Leiden, Nijmegen, NL)
Objectives: Amoxicillin is widely used during pregnancy, in
particular to treat group B Streptococcus. Insufﬁcient knowledge
on the pharmacokinetics just before and during delivery, could
pose patients with preterm premature rupture of the
membranes (PPROM) at serious risk for under dosing. We
investigated the pharmacokinetics in patients with PPROM in
this critical situation.
Methods: Seven healthy women at 34–37 weeks of gestation
were included. They received 1 g (ﬁrst dose 2 g) amoxicillin
for PPROM according to local guidelines. From each patient
14–28 blood samples were taken. Antibiotic serum concentra-
tions were determined by a validated HPLC method. Phar-
macokinetic parameters were estimated by population PK
modeling using NONMEM. To discriminate between various
models the minimum value of the objective function (MVOF)
was used. A reduction of >10 in MVOF was considered
signiﬁcant.
Results: A three-compartment pharmacokinetic model best
described the time course of amoxicillin. The clearance and
volume of distribution of the central compartment (Vc) were
estimated at respectively 23 ± 1.8 L/h and 6 ± 0.8 L
(mean ± SE). Estimates of the parameters and model
discrimination improved when we assumed the size of the
third compartment to be equal to the ﬁrst compartment. The
residual error was found to be proportional to the serum
concentrations. Most of the inter-individual variability could be
explained by variation of clearance. The mean volume of
distribution at steady state (Vss) and terminal half-life were
23.9 L and 1.34 h respectively. Estimated values of elimination
and distribution rate constants were: k10 = 3.9 h-1, k12 =
1.7 h-1, k21 = 0.8 h-1, k13 = 8.8 h-1 and k31 = 8.8 h-1. As was
to be expected due to the small population size, no signiﬁcant
relationship was observed between the individual posthoc
estimates for clearance and patient characteristics.
Conclusion: Here we describe the pharmacokinetics of
amoxicillin in pregnant women with PPROM. It was found
that the pharmacokinetics clearly differs from that in non-
pregnant individuals. Clearance and Vss were signiﬁcantly
higher and the terminal half-life was shorter. Furthermore, a
3-compartment model was found to describe the data better
than a 2-compartment model. It is an intriguing question
whether this 3rd compartment is a unique feature associated
with pregnancy. These data offer a theoretical basis to make
proper dose-adjustments in a particular patient group in a
critical condition.
P1522
Penetration of piperacillin and tazobactam in
severe acute pancreatitis
S. Foerster, E. Eckleben, U. Werner, E. Klar, B. Drewelow,
R. Wacke (Rostock, Wismar, DE)
Objectives: Acute necrotizing pancreatitis is still related to an
extremely high mortality rate, based on local infectious
complications, particularly in necrotizing areas. Limited
penetration of antimicrobial drugs in these areas is considered
to be a major cause for failure of therapy of severe infections.
Combinations of beta-lactamase inhibitors (BLI) and beta-lactam
antibiotics like broad-spectrum penicillines (BSP) have
antibacterial activity against most of the common pathogens in
severe necrotizing pancreatitis. Co-administration leads to an
increase of antibacterial activity due to an inhibition of beta-
lactamases. On that score, the penetration of co-administrated
PIP and BLI into inﬂamed or necrotic pancreatic tissue has not
been investigated yet.
Methods: Adressing the penetration capability of BSP and BLI a
clinical trial was designed to investigate the penetration of
piperacillin (PIP) and tazobactam (TAZ) in patients with severe
necrotizing pancreatitis undergoing pancreas surgery. Samples
(n = 21) were taken from plasma (Pl), necrotic areas of
pancreatic tissue (PN), peripancreatic fatty tissue (PFT) and
bursa secretion (BS) following intravenous administration of
4.0 g PIP and 0.5 g TAZ. Concentrations of PIP/ TAZ were
determined by HPLC/ UV.
Results: Mean plasma concentrations at 1.5 h after application
were 56.4 ± 29.5 mg/l (PIP) and 16.9 ± 15.9 mg/l (TAZ).
Corresponding mean concentrations were in PN 3.4 ± 4.9 mg/
kg (PIP) and 2.3 ± 1.8 mg/kg (TAZ), in PFT 2.1 ± 2.9 mg/kg
(PIP) and 1.4 ± 1.0 mg/kg (TAZ), in BS 44. 8 ± 28.2 mg/l (PIP)
and 15.1 ± 13.7 mg/kg (TAZ). The penetration rate into PN was
7.5% (PIP) and 13.4% (TAZ), into PFT 4.7% (PIP) and 8.5%
(TAZ), into BS 79.5% (PIP) and 89.5% (TAZ). The aimed
concentration for full enzymatic effect of TAZ (4 mg/l) was
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exceeded in Pl and BS, nearly reached in PN but not in PFT. The
concentration of PIP in combination with TAZ exceeded or
reached the MIC90 in Pl, PN and BS against E. coli, Klebs. spp.,
Enterobacter, Proteus spp. and Clostr. spp., in Pl and BS even
against Pseudomonas and Bacteroides.
Conclusion: Given in combination both - PIP and TAZ - have
been demonstrated to reach rapidly effective inhibitory
concentrations in inﬂamed and necrotic compartments of
pancreatic and peripancreatic tissue. Co-administration of
piperacillin and tazobactam may have a potential clinical
beneﬁt in prevention and treatment of local infectious
complications of severe necrotizing pancreatitis.
P1523
PK/PD challenges of in vitro time-kill curves – a
new modelling approach
S. Schmidt, O. Burkhardt, W. Treyaprasert, H. Derendorf
(Gainesville, US; Bangkok, TH)
Objective: In vitro PK/PD models, based on time-kill curve
data, have become a powerful tool to predict the in vivo
situation. Up to date, several modelling approaches have been
undertaken to develop suitable PK/PD models that ﬁt in vitro
data sufﬁciently well. Widely used simple sigmoid Emax
models meet these criteria only partly. A further approach
was undertaken to address the weak points of currently used
models and applied to model the effects of ceftriaxone against
Escherichia coli.
Methods: Constant concentration time-kill curves were
performed in Mueller-Hinton broth (MHB, DIFCO) with and
without bovine serum albumin (BSA) 40 g/L. Using
concentrations of ceftriaxone, ranging from 0.25 MIC to 16
MIC, the change in number of bacteria (CFU/ml) versus time
was linked to its effect. Escherichia coli ATCC 25922 was
employed as the test organism. Samples were taken at 0, 0.5,
1, 1.5, 2, 3, 4, 5 and 6 hours. The data were modelled
simultaneously, using a modiﬁed sigmoid Emax model and
the software Scientist for WindowsTM.
Results: A differential equation, characterized by growth rate
constant (k0) times the starting number (N) of bacteria rep-
resent the simplest case. Barging from log-growth phase to
stationary phase can be described by an additional Nmax term.
However, bacteria do not necessarily start growing in the log-
growth phase. This delay in onset of growth can be modeled by
an exponential term, characterized by a factor beta (b) and time
(t). To describe the overall change in number of bacteria not only
growth but also concentration (C) dependent kill has to be taken
into account. From certain drug speciﬁc concentrations on, a
maximum effect is reached, described by the maximum kill rate
constant kmax. However, it may be necessary to model a delay
in the onset of kill with an additional exponential term,
characterized by a factor alpha (a) and time (t). Finally, a Hill
factor/shape factor (h) is necessary to smooth the predicting
curves out. As shown in ﬁgure 1 this new model meets the in
vitro time-kill curve data sufﬁciently well. The ﬁnal equation
including all parameters described above is:
Conclusion: The proposed model was able to describe the
observed data much better than a simple Emax-model.
Incorporating two additional terms into the model, the in vitro
situation could be described much better, taking the delay in
onset of growth and kill into account.
P1524
Pharmacodynamic proﬁling of ceftobiprole for
the treatment of complicated skin and skin
structure infections and nosocomial pneumonia
T.P. Lodise, L. Ma, R. Pypstra, J. Kahn, G.L. Drusano,
G.L. Noel (Albany, US; Basel, CH; Raritan, US)
Background: Ceftobiprole (BPR), an investigational broad-
spectrum cephalosporin with robust activity against MRSA &
Gram-negatives (GNB), is in phase III trials for complicated skin
and soft tissue infection (cSSTI) & nosocomial pneumonia (NP).
Objectives of this study were (1) to describe the
pharmacodynamic (PD) proﬁles of BPR 500 mg IV Q8H as a 2-
hr infusion & 500 mg IV Q12H as a 1-hr infusion; (2) to
determine the overall probability of target attainment (PTA) by
weighting for the expected distributions (dis) of renal function
(Rfx) in the populations (pop) of interests; (3) to determine the
organism-speciﬁc PTA against the pathogens encountered in
phase II trials.
Methods: 150 subjects (total 2443 samples) were studied (Phase
I/II subjects). Samples were analysed using BigNPOD. To assess
the impact of differing degrees of RFx impairment on PTA,
CrCL (CrCL-Cockcroft & Gault method) was employed as a
covariate in the pop PK analysis. Monte Carlo Simulation (MCS)
(9999 subjects) was performed with ADAPT II. Overall PTA was
calculated for 30–60% fT>MIC. Weighting for the expected dis of
RFx in the pop of interests was accomplished by using the dis of
CrCL observed in 2 previous registration studies of the same
indications (cSSTI and NP). Dis of MICs for pathogens was
supplied by sponsor.
Results: In the pop PK analysis, the pop mean (SD) values for
volume, CLslope, CLintercept, Kcp and Kpc were:7.65 (3.89) L,
0.51 (0.32) L/hr, 2.35 (1.08), 3.05 (5.14) hr-1 and 1.10 (0.95) hr-1,
respectively. The obs-pred plot was obs = 1.003 x pred + 0.627;
r2 = 0.947 after the Bayesian step. In the MCS analysis of BPR
500 mg IV Q12 H, the PTA of achieving 30% fT>MIC & 50%
fT>MIC exceeded 90% for MICs values £2 mg/L & £0.5 mg/L,
respectively. For BPR 500 mg IV Q8H, the PTA of achieving
60% fT>MIC exceeded 90% for MICs values £2 mg/L. In the
organism-speciﬁc analysis, the PTA of a static effect (30%
fT>MIC) exceeded 90% for both MSSA & MRSA for BPR
500 mg IV Q12H. BPR 500 mg IV Q8H provided a >90% PTA
of a cidal effect (50% fT>MIC) for both MSSA & MRSA. For
GNB, the PTA of BPR 500 mg IV Q8H in achieving a cidal
effect (60% fT>MIC) exceeded 90% for non-AmpC-bearing
GNB. For AmpC-bearing GNB, the PTA of achieving a cidal
effect was 84.8%.
Conclusions: An extensive evaluation of the PD of BPR was
performed to estimate the overall activity of BPR against target
pathogens. These ﬁndings need to be validated in the clinical
trial arena.
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P1525
Investigation of different levoﬂoxacin regimens
in patients with acute complicated urinary tract
infections
P. Tenke, R. Benko (Budapest, Szeged, HU)
Objective: In the present study we aimed to ﬁnd out if a
continuous or an intermittent levoﬂoxacin (1 · 500 mg)
treatment is more advantageous for patients with acute
complicated urinary tract infection (UTI) caused by urinary
obstruction. We investigated if levoﬂoxacin adsorbs to the
surface of the foreign body, which was inserted with the aim of
temporary resolution of ureteral obstruction. Preventive effect of
levoﬂoxacin on bacterial bioﬁlm formation and incrustation was
also evaluated.
Methods: We enrolled and randomised 24 patients who had
acute UTI caused by urinary obstruction. Obstruction was
resolved with double J stent (DJS) insertion or percutaneous
nephrostomy (PCN) and meanwhile, antibiotic treatment was
started in all patients. 12 patients (group 1) were on antibiotics
till the day of deﬁnitive curative operation when all foreign
bodies were removed. In the other 50% of the patients (group
2) the antibiotic therapy was stopped 7 days after the DJS or
PCN insertion. Short term antibiotic course - which is advisable
for prevention of UTI before invasive endoscopic treatment -
was administered in both groups from the day of the operation
(after DJS or PCN removal) and it was continued until the
removal of all possible urinary foreign bodies used during the
operation. In both groups of patients we recorded and
evaluated early and late clinical and microbiological recovery.
Retrieved stents were sectioned for further laboratory
examinations. Adsorbed levoﬂoxacin in the conditioning ﬁlm
layer and on the stent surface was detected by HPLC.
Rasterelectron microscopy (REM) was used to examine
bioﬁlm formation and encrustation.
Results: We did not ﬁnd any signiﬁcant differences between the
two groups of patients, neither in clinical (presence of fever,
back pain, ﬂank pain, leukocyte count) nor in microbiological
recovery. Statistical analysis showed that signiﬁcantly greater
amount of levoﬂoxacin adsorbed to the conditioning ﬁlm than to
the stent surface in both groups of patients (0.72 ± 0.83 vs.
0.20 ± 0.34 in group 1 and 0.24 ± 0.28 vs. 0.1 ± 0.15 in group 2).
No viable, adherent bacteria were recovered by sonication and
culture in any of the patients, and no bioﬁlms or encrustation
were seen under REM either.
Conclusion: Our data prove the hypotheses that continuous
antibiotic treatment does not have any clinical or microbiological
advantages in patients with indwelling ureteral stents compared
to intermittent therapy.
P1526
Penetration of linezolid into sternal bone of
patients undergoing routine cardio-pulmonary
bypass surgery
S. Metallidis, N. Charokopos, E. Alexiadou, A. Tsona,
M. Chatzidimitriou, G. Lazaraki, O. Vasilaki, J. Nikolaidis,
G. Theodoridis, P. Nikolaidis (Thessaloniki, GR)
Objective: The prophylaxis of bacterial infections during
cardiac surgery is widely used in clinical practice.
Staphylococcus aureus, Staphylococcus epidermidis and
Enterococcus spp are the pathogens most frequently involved
in infective complications of cardio-pulmonary bypass (CPB)
surgery. It is generally agreed that the success of prophylaxis is
dependent on the ability to reach and maintain free antibiotic
concentration in tissues higher than the MICs for the most
common pathogens. So we estimated the tissue concentrations
of linezolid into sternal bone of patients undergoing CPB
surgery.
Methods: Six patients undergoing routine CPB surgery were
given 600 mg linezolid as a 30 min IV infusion along with
conventional prophylaxis of 1.5 g of cefuroxime immediately
before surgery. Two hours after the end of infusion blood
samples and sternal bone tissues were collected. The local
medical research ethics committee approved this study and all
patients gave written informed consent. Samples were assayed
for the presence of linezolid by a high-performance liquid
chromatography (HPLC) method.
Results: Following a 600 mg infusion of linezolid, mean serum
concentration for the six patients were 8.48 mg/L (range 7.3–
12.36 mg/L) 2 hours after the end of infusion. The concentration
of linezolid into sternal bone was 4.35 mg/L (range 3.9–5.2 mg/
L) 2 hours after the end of infusion. The penetration of linezolid
into sternal bone was 52.2%.
Conclusion: The penetration of linezolid into bone was 52.2% of
the simultaneous blood levels. In all bone samples the
concentration of linezolid exceeded the MIC for susceptible
pathogens (<4 mg/L). Although these data have been obtained
from healthy, well-perfused bone the values suggest that
linezolid may be a useful agent in the management of
multidrug-resistant Gram-positive bone infections.
P1527
The antibacterial effect of daptomycin,
teicoplanin and vancomycin against S. aureus
studied in an in vitro pharmacokinetic model of
infection
A. Noel, K. Bowker, A. MacGowan (Bristol, UK)
Objectives: Daptomycin (DAP) is the ﬁrst cyclic lipopeptide
antibiotic approved for parenteral use in Gram-positive
infection. As yet, no comparative pharmacodynamic studies
have been performed using DAP and the two most common iv
therapies teicoplanin (TEI) and vancomycin (VAN). We used a
pharmacokinetic (pK) model to study the antibacterial effect
(ABE) of these agents against two typical MRSA strains
(UKEMRSA15 & 16) and a hetero vancomycin intermediate
MRSA (hVISA).
Methods: An in vitro dilutional model was used to simulate the
free drug concentration over 48 h associated with doses of -
DAP 6 mg/kg 24 hrly (Cmax 6.4 mg/L, t 1/2 8 h); TEI 400 mg
24 hrly (Cmax 4.5 mg/L, t1/2 24 h); VAN 1 g 12 hrly (Cmax
13.5 mg/L, t1/2 6 h). An inoculum of 106 CFU/ml was used
and the experiments performed in triplicate. ABE was assessed
by area-under-the-bacterial-kill-curve 0–24 h (AUBKC24) and 0–
48 h (AUBKC48; logCFU/ml.h). Three strains of MRSA were
used; strain 15841 VAN MIC 0.38,TEI MIC 0.25, DAP MIC
0.12 mg/l; strain 33024 VAN MIC 0.38, TEI MIC 0.5, DAP MIC
0.12 mg/l; strain 19898 (hVISA) VAN MIC 2, TEIC MIC 8, DAP
MIC 1 mg/l.
Results: The AUBKC24 and AUBKC48 are shown in the table.
The smaller the value, the greater the ABE. Comparison of ABE
by ANOVA indicated that DAP had a superior ABE to TEI and
VAN, VAN a superior ABE to TEI. DAP or VAN MIC had no
effect on the ABE observed. TEI had poor ABE against the
hVISA (p < 0.05).
Conclusion: The ABE of DAP was superior to TEI and VAN at
simulated serum free drug concentrations using an in vitro pK
model.
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No effect of vitamin B6 co-administration for the
prevention of linezolid-induced
myelosuppression
D. Plachouras, E. Giannitsioti, F. Kontopidou, S. Athanasia,
S. Savanis, K. Pontikis, A. Antonopoulou, A. Papadopoulos,
H. Giamarellou (Haidari, GR)
Objectives: Linezolid, the ﬁrst oxazolidinone, is active against
methicillin resistant Staphylococcus aureus and has been effective
in a variety of acute infections. However long- term
administration, although desirable in bone infections caused
by resistant Gram-positive organisms, is hampered by the
occurrence of anaemia and thrombocytopenia. Administration
of vitamin B6 has been reported to prevent myelosuppression.
Methods: Patients attending the infectious disease clinic with
bone infections caused by resistant Gram-positive bacteria and
treated with linezolid (600 mg b.d. orally), received vitamin B6
(125 mg o.d. orally) for the period of administration of linezolid.
Full blood counts were followed-up weekly. Linezolid treatment
was discontinued if haemoglobin declined below 9 mg/dl or
platelets below 120000/ll. Data from sixteen patients with
osteomyelitis and 8 with prosthetic joint infections were
evaluated. Comparisons were performed with 20 matched
historical controls receiving linezolid without B6 by Kaplan-
Meyer curves with the log-rank test.
Results: The median follow-up of patients receiving B6 was
3.5 weeks and of controls 4 weeks. In the B6 group 63% of the
patientsdiscontinuedwhile in the control group44%of thepatients
discontinued treatment because of side effects (p NS). 47% of
patients receiving B6 discontinued due to thrombocytopenia and
20% due to anaemia. Respective percentages in the control group
were 21% and 38% (p NS for all comparisons). Mean time to the
occurrence of thrombocytopenia was 4 weeks in the patients who
receivedB6and3.25 weeks in the controlpatients. Respective times
to occurrence of anaemia were 3.4 and 3.85 weeks. All cases of
myelosuppression were reversible.
Conclusions: Administration of B6 failed to prevent or delay
both thrombocytopenia and anaemia in patients receiving
linezolid. Other methods should be investigated to facilitate
longer administration of linezolid in this group of patients.
P1529
Therapeutic drug monitoring of colistin – a
7-year review from a UK clinical antibiotic
assay service
K. Bowker, A. Noel, S. Tomaselli, A. MacGowan (Bristol, UK)
Objectives: Over the last 5 years there has been increased use
of colistin (Col). However, little clinical data is available on the
therapeutic levels of colistin. Monitoring of Col is useful in
terms of therapeutic levels and avoidance of toxicity for
patients with cystic ﬁbrosis and complicated Gram-negative
infections. Previous in vitro data has shown that Col is
bactericidal at Col concentration is ‡3 mg/L. Here we
assessed Col data collected from our antibiotic assay service
from the last seven years in order to establish if such levels
were obtained.
Methods: Col levels were determined by bioassay. Data was
retrospectively collected from the hospital information
management system. Data was assessed collectively and
stratiﬁed by known cystic ﬁbrosis patients, sex and age.
Results: From March 1998–April 2005, 220 serasets from 119
individual patients (59 male, 60 female) were received from 52
requester locations. 37 were denoted as cystic ﬁbrosis patients,
22 were aged £16 y and 90 ‡ 16 y. Of the 110 pre dose requests
received the mean Col concentration was 3.71 mg/L (95% CI
2.47–4.18), post dose (n = 123) 9.36 mg/L (CI 8.28–10.44). The
mean cystic pre dose Col (n = 32) 3.16 mg/L (CI 3.26–4.17), post
dose mean (n = 36) 9.36 mg/L (8.28–10.44). Mean female pre
dose 4.73 (3.11–6.34), post dose 10.05 (8.1–12.01); male pre dose
3.78 (3.18–4.39), post dose 9.00 (7.56–10.45) Mean £16 y pre dose
Col (n = 19) 3.3 mg/L (CI 2.17–4.49), post dose mean (n = 22)
9.09 mg/L (5.51–12.68). Mean ‡16 y pre dose Col (n = 83)
3.55 mg/L (CI 3.09–4.02), post dose mean (n = 90) 9.55 mg/L
(5.86 –10.78). No signiﬁcant differences were seen between the
pre and post dose concentrations for the different subsets
Student’s t-test p < 0.05.
Conclusions: These data show that the pre dose levels are
adequate for achieving clinical efﬁcacy for Pseudomonas spp
strains that have MICs below the NCCLS b.pt of £2 mg/L.
However for resistant strains increased serum concentrations
maybe required.
P1530
Antibacterial effect of moxiﬂoxacin and
ceftriaxone, ﬁrst doses, on Streptococcus
pneumoniae studied in an in vitro model
K. Bowker, A. Noel, A. MacGowan (Bristol, UK)
Objectives: ßlactams like ceftriaxone (cfx) and quinolones such
as moxiﬂoxacin (mox) are widely used to treat pneumococcal
infection. We studied the antibacterial effect of (ABE) after the
ﬁrst dose exposure to free drug serum concentrations of iv cfx
2 g and po mox 400 mg against S. pneumoniae strains with
typical MICs at low and high inocula.
Methods: A hollow ﬁbre in vitro model was used to simulate
free drug concentrations over 24 h of cfx (2 g 24 h iv, Cmax
26 mg/L, AUC 56 mg/LÆh, T1/2 6 h) and mox (400 mg, 24po,
Cmax2.0 mg/L, AUC20 mg/lÆh, T1/2 10.5 h). The cfx MIC was
0.06 mg/L (T>MIC cfx 100%) and mox MIC 0.06 mg/L (AUC/
MIC 334). Initial ABE was measured by the slope of the log
viable count 0–5 h and total ABE over the dose interval (24 h) by
log reduction in viable count at 24 h (d24) and the area-under-
the-bacterial-kill-curve (AUBKC24). Inocula of 106 cfu/mL and
108 cfu/mL were used.
Results: The initial and total ABE at low and high inocula
were: Given the pK/pD indices modelled both drugs showed
a maximal effect. Clearance from the model occurred at 12 h
(106 inoculum) and 24 h (108 inoculum). There were no
signiﬁcant differences in speed or extent of ABEs comparing
cfx and mox.
Conclusion: The ABEs of iv cfx and po mox against
S. pneumoniae is similar in the ﬁrst 24 hrs of drug exposure.
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P1531
Emergence of resistance in E. coli and Ent. cloacae
after exposure to ceftriaxone or ertapenem in an
in vitro model of infection
K. Bowker, A. Noel, A. MacGowan (Bristol, UK)
Objectives: Emergence of resistance (EoR) is an emergent factor
in therapeutic choice. We studied EoR to ceftriaxone (cfx) and
ertapenem (ert) in E. coli (Ec) and Ent. cloacae (Entclo), a more
challenging species within inducible Blactamases.
Methods: An in vitro dilutional model was used to simulate free
drug concentrations associated with 1 g 24 hrly cfx (Cmax
22 mg/L, t½ 8 h) and ert (Cmax 13 mg/L, t½ 5 h) over 72 h.
Two inocula 106 and 108 CFU/mlwere used andEoRassessedby
population-analysis-proﬁles (PAP). The area under the PAP
(AUC-PAP) was used to measure EoR. Ert MICs were
0.018 mg/L Ec and 0.25 mg/L Entclo, cfx MIC 0.14 mg/L Ec
and 0.5 mg/L Entclo. Experiments were performed in triplicate
and mean values presented.
Results: Observations at 72 h were similar to those at 48 h,
hence data to 48 h is given. At 106 and 108 CFU/ml, Ec viable
counts were reduced by 2 ﬁ 4 logs, there was no EoR. Against
Entclo inoculum 106 and 108, cfx resulted in an initial 0–2 log
drop, then regrowth, ert produced a >4 log reduction. EoR as
measured by the mean AUC-PAP (n = 3) with Entclo is shown
below: Dosing with cfx resulted in EoR to cfx and ert at high and
low inoculum. Dosing with ert resulted in no EoR at 106
inoculum, at 108 resistance emerged to both cfx and ert.
Conclusions: EoR depends on species (Entclo > Ec); duration of
exposure (long> short) and agent (cfx > ert). Ert appears to induce
less EoR both to itself and cfx than cfx does to itself and ert.
However, initial use of cfx may reduce the effectiveness of ert.
P1532
Comparative serum activity of telithromycin,
azithromycin, and amoxicillin/clavulanate against
aerobic and anaerobic respiratory pathogens
G. Stein, S. Schooley, E. Goldstein, K. Tyrrell, D.M. Citron (East
Lansing, Santa Monica, US)
Objectives: The purpose of this investigation was to study the
clinical potential of telithromycin, a new ketolide antibiotic, for
the treatment of mixed aerobic/anaerobic respiratory infections.
In this study, we compared the pharmacodynamics (duration of
inhibition/killing) of telithromycin (Tel) to azithromycin (Azi)
and amoxicillin/clavulanate (A/C) against aerobic and
anaerobic pathogens associated with mixed respiratory
infections.
Methods: Following written informed consent, ten healthy
adult subjects (ages, 20–47 yrs) received single doses of Tel
(800 mg), Azi (500 mg), and A/C (875 mg) one week apart
following a 12-h fast. Venous blood samples were obtained at 2,
6, 12, and 24 h after the dose and stored at )70C. Inhibitory
and bactericidal titre s were determined by microdilution
(S. pneumoniae & H. inﬂuenzae) and agar dilution (Peptostrep.
magnus, Peptostrep. micros, Prev. bivia, & Prev. melaninogenica)
procedures following Clinical & Laboratory Standards Institute
methodology. Bactericidal titres in serum endpoint was
determined as the highest dilution of serum yielding 99.9%
killing. The median titres at each time point were calculated and
the duration of activity was used for comparison of these agents.
Results: Against 2 Azi-resistant (MICs = 8 & 16 lg/ml) strains
of S. pneumoniae, both Tel (MICs = 0.25 & 0.5 lg/ml) and A/C
(MICs = 0.03 & 2.0 lg/ml) exhibited prolonged inhibitory
(6–12 h) as well as cidal (2–12 h) activity in our subjects. All
three antibiotics provided 12–24 h of inhibitory activity against a
beta-lactamase (BL) positive (Tel MIC = 4.0 lg/ml; A/C
MIC = 0.5 lg/ml; Azi MIC = 2.0 lg/ml) and negative (Tel
MIC = 4.0 lg/ml; A/C MIC = 4 lg/ml; Azi MIC = 2.0 lg/ml)
strain of H. inﬂuenzae. Both Tel and A/C exhibited prolonged
inhibitory (24 h for Tel; 6–12 h for A/C) activity against each of
the anaerobes studied (Tel MICs = 0.03–0.25 lg/ml).
Furthermore, both Tel and A/C provided prolonged (12–24 h)
cidal activity against the two Prevotella species.
Conclusions: In this ex-vivo study, we found that Tel can
provide prolonged (50% of the dosing interval) inhibitory
activity in serum against macrolide-resistant strains of
S. pneumoniae, BL pos. and neg. strains of H. inﬂuenzae, and
common respiratory anaerobic pathogens. These ﬁndings
suggest that Tel could have clinical utility in the treatment of
community-acquired mixed aerobic-anaerobic respiratory tract
infections, including sinusitis, bronchitis, and pneumonia.
P1533
Urinary bactericidal activity of levoﬂoxacin
(750 mg) against ﬂuoroquinolone-resistant
uropathogens
G. Stein, S. Schooley, D. Nicolau (East Lansing, Hartford, US)
Objectives: Increasing resistance in isolates of E. coli (12%) and
P. aeruginosa (40%) to ﬂuoroquinolones (FQ) is a concern since
these antibiotics are commonly used in the treatment of
complicated urinary tract infections (UTIs). Currently, no
interpretive standards exist for ‘‘susceptible’’ isolates in urine
for the newer FQ. The purpose of this investigation was to
evaluate the activity of high-dose levoﬂoxacin against FQ-
resistant urinary pathogens.
Methods: In this study, we determined the serum and urine
levels of high dose (750 mg) levoﬂoxacin (L) as well as its
bactericidal activity in urine (UBA) against L-resistant isolates of
E. coli (MICs = 8 to 64 lg/ml) and P. aeruginosa (MICs = 8 to
64 lg/ml). Following written informed consent, blood and urine
samples were collected from 10 healthy adult (ages, 20–47 y/o)
fasting subjects (5 M and 5 F) prior to and at 1.5, 4, 8, 12, and
24 hours after a single 750 mg dose of L. Serum and urine
concentrations were measured by a validated HPLC assay (0.9–
2.1% CV). The testing methodology for UBA was similar to the
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microdilution assay used for serum bactericidal testing (CLSI)
with the exception that antibiotic-free urine was used to dilute
these samples. The median titre (1:2–1:32) at each time point for
the 10 subjects was used to determine UBA.
Results: The mean serum pharmacokinetic parameters were
similar to previously published values: Cmax = 9.2 lg/ml,
AUC = 95 mgÆh/L, and T1/2 = 7.6 h. Mean urine
concentrations ranged from 475 lg/ml (4 h) to 186 lg/ml
(24 h). UBA (titres >1:2) was maintained for at least 12 hours
in all subjects for E. coli isolates with MICs = 8, 16, and 32 lg/
ml. For the E. coli strain with a MIC = 64 lg/ml, 8 subjects
exhibited UBA at 8 h but only 2 subjects exhibited UBA at 12 h.
Similar results were observed against the P. aeruginosa isolates.
Conclusions: The results from this ex-vivo pharmacodynamic
study in healthy volunteers found that 750 mg of L provides
prolonged (at least half the dosing interval) UBA against
L-resistant strains of E. coli and P. aeruginosa up to 32 lg/ml.
This suggests that a separate urinary susceptibility breakpoint is
indicated for urine isolates treated with 750 mg doses of L.
P1534
Meropenem and cloxacillin are active against
MRSA clinical isolates (including VISA) in acidic
broth and in THP-1 macrophages
S. Lemaire, F. Van Bambeke, P. Tulkens, M.P. Leclercq,
J. Coyette, Y. Glupczynski (Brussels, Lie`ge, Yvoir, BE)
Objectives: Exposure of Methicillin-resistant S. aureus (MRSA)
to acid pH restores its susceptibility to beta-lactams (Sabath and
al., AAC, 1972). In macrophages, S. aureus is mainly conﬁned
within phagolysosomes where the pH is acidic. We showed that
meropenem (MEM) displays similar intracellular activity
against MRSA ATCC 33591 and MSSA ATCC 25923 in
macrophages. In the present study, we have investigated the
intraphagocytic activity of MEM and cloxacillin (CLX) against 3
MRSA clinical isolates (including one VISA strain), in
comparison with the reference MRSA ATCC 33591 and MSSA
ATCC 25923 strains.
Methods: MIC’s were determined in MHB (plus NaCl 2%) by
micro-dilution method. mecA expression was examined at
neutral and acidic pH by a semi-quantitative RT-PCR (16 S
rRNA as housekeeping gene). Intracellular activity was assessed
in human THP-1 macrophages exposed to extracellular
concentrations equivalent to human Cmax (total drug; MEM:
50 mg/L; CLX: 8 mg/L) by examining the decrease in cell-
associated CFU after 24 h from the original, post-phagocytosis
inoculum (controls [no antibiotic]; approx. 1 log CFU increase).
Results: The table shows the MICs (in broth) at neutral and acid
pH and the intracellular activity for the 5 strains studied. In
ATCC 33591, mecA expression was similar for bacteria
maintained in broth at pH 7.4 or 5.5 (O.D. mecA/O.D. 16 S
rRNA: 0.20 ± 0.1 vs. 0.24 ± 0.1).
Conclusions: The intracellular environment markedly enhances
the activity of beta-lactams against MRSA, probably through
exposure to acid pH, although the latter does not affect mecA
expression.
P1535
Comparative activity of dalbavancin against
European Gram-positive isolates
I. Morrissey, C. Dencer, J.W.T. Dallow, J. Childers, A. Brook,
J. Cowan (London, UK)
Objectives: Dalbavancin (DAL) is a new semisynthetic
lipoglycopeptide with a half-life of 8.5 days, enabling once-
weekly dosing. This study compared the activity of DAL with
other agents against Gram-positive isolates from Europe.
Methods: Isolates from Belgium, the Czech Republic, Denmark,
Finland, France, Germany, Hungary, Italy, the Netherlands,
Poland, Spain, Sweden and the UK were included. The CLSI
broth microdilution method was used to determine MIC using
dried microtitre plates. The following antimicrobial agents were
evaluated: DAL, vancomycin (VAN), teicoplanin (TEI),
daptomycin (DAP), linezolid (LZD), dalfopristin/quinupristin
(SYN), erythromycin (ERY), levoﬂoxacin (LEV) and tetracycline
(TET).
Results: Selected data are shown in the Table (BHS, beta-
haemolytic streptococci; CNS, coagulase-negative staphylococci;
MR, methicillin-resistant; MS, methicillin-susceptible; SA, S
aureus; VS, ‘viridans’ streptococci). DAL was very active
against all isolates including MRSA (except for 25 of 204
enterococcal isolates that were VanA). Excluding the VanA,
DAL was the most active agent tested, including newer agents
such as DAP.
Conclusion: Dalbavancin demonstrates potent activity against
the majority of Gram-positive pathogens including MRSA and
represents a potential treatment option for serious Gram-
positive infections.
P1536
Population pharmacokinetics of dalbavancin and
pharmacodynamic simulations of a weekly
regimen
J.A. Dowell, B.P. Goldstein, M. Buckwalter, M. Stogniew,
B. Damle (New York, US)
Objectives: Dalbavancin (DAL) is a next generation
lipoglycopeptide antibiotic in development for the treatment
of complicated skin and skin structure infections (cSSSI). A
population pharmacokinetic (PK) analysis was performed to
estimate patient parameters and to determine signiﬁcant
covariates. Incorporating the PK model, pharmacodynamic
(PD) parameters were simulated to support the effectiveness
of a weekly dosage.
Methods: The PK analysis included 1668 DAL concentrations
from 532 patients across 3 clinical trials. Most patients received
1000 mg on Day 1 and 500 mg on Day 8. Possible covariates
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examined included demography and concomitant medications,
including medications that are considered inhibitors, inducers,
and substrates of cytochrome P450 enzymes. The PK-PD
analysis employed Monte Carlo simulations of time-dependent
and concentration-dependent parameters. Distributions of MICs
were obtained directly from clinical studies, and were also
simulated to explore the effect of higher MICs.
Results: DAL PK ﬁt a 2-compartment model with interpatient
variability (IPV) on all parameters. The typical value and IPV
(CV%) of clearance (CL) was 0.0571 L/h (18.0%), inﬂuenced by
body surface area (BSA) and creatinine clearance (CLCR).
Volume of distribution (V1) was 4.15 L (24.5%) and inﬂuenced
by BSA. The inter-compartmental clearance and peripheral
volume were 0.476 L/h and 11.4 L, respectively. Free drug
concentrations were simulated using a DAL protein binding of
93%. For a weekly 2-dose regimen, free DAL remained above
1 mg/L for the majority (>90%) of patients for more than
14 days. Using previously described area under the curve
(AUC)/MIC targets for Staphylococcus aureus, a proposed MIC
of at least 0.5 mg/L was associated with a greater than 90%
probability of target attainment.
Conclusions: DAL PK were predictable, demonstrating low
IPV. BSA and CLCR were the only sources of variability, but
described less than 25% of the IPV. PD simulations support the
use of dalbavancin in a weekly regimen.
P1537
Distribution of radioactivity in bone and related
structures following administration of [14C]-
dalbavancin to New Zealand White rabbits
E. Solon, J.W. Dowell, J. Lee, S.P. King, B. Damle (Newark, New
York, US)
Objectives: Methicillin-resistant Staphylococcus joint infection
due to peri-operative contamination is a complication after
arthroplasty. The objective of this study was to assess the
distribution of radioactivity in bone and related structures using
quantitative autoradiography after administration of [14C]-
dalbavancin in rabbits.
Methods: New Zealand White male rabbits were given a single
intravenous (IV) bolus dose of 20 mg/kg [14C]-dalbavancin
(n = 18) or control vehicle (n = 3). Plasma, cerebrospinal ﬂuid
(CSF), bone, bone marrow, and nucleus pulposus were collected
at 12, 24, 72, 120, 168 and 336 h post-dose by necropsy,
homogenized, combusted, and analysed for total drug-derived
radioactivity using liquid scintillation counting (LSC). In
addition, the left hindlimb from 1 rabbit/time point was
ﬂash-frozen and cryosectioned for quantitative
autoradioluminography.
Results: [14C]-dalbavancin-derived radioactivity was rapidly
and widely distributed into bone, bone marrow and, to a lesser
extent, in CSF and nucleus pulposus. Autoradioluminography
data indicated that concentration of radioactivity was highest in
bone marrow, whole blood, articulate cartilage, ligament,
epiphyseal plate, periostium, and meniscus. At 336 h post-
dose, [14C]-dalbavancin-derived radioactivity was measurable
in all tissues, and remained at relatively high concentrations in
bone marrow (30.27 lg equiv/g), epiphyseal plate (8.42 lg
equiv/g), periostium (5.18 lg equiv/g), and articular cartilage
(4.84 lg equiv/g). In homogenized bone using LSC, mean
concentration after 336 hours was 1.96 lg equiv/g.
Conclusion: [14C]-dalbavancin-derived radioactivity rapidly
penetrated knee joint tissues and persisted at relatively high
concentrations for at least 336 h after a single IV dose in
rabbits.
P1538
Telavancin transmembrane clearance during
in vitro continuous venovenous hemoﬁltration
J.H. Patel, M.C. Grio, M.D. Churchwell, J. Seroogy, S. Barriere,
B.A. Mueller (Ann Arbor, South San Francisco, US)
Objectives: Telavancin (TLV), a bactericidal lipoglycopeptide
with multiple mechanisms of action, is in Phase 3 trials for the
treatment of hospital-acquired pneumonia (HAP) with a focus
on infections due to methicillin-resistant S. aureus. TLV is
primarily eliminated by the kidneys and requires dosage
adjustment for renal dysfunction. TLV is highly protein bound
(93%) in healthy subjects which would suggest that it would not
be removed by dialysis, but its small volume of distribution
(0.15 L/kg) means that it may be removed by CVVH. CVVH is
widely used in the management of critically ill patients. The
objective of this study was to determine CVVH telavancin
transmembrane clearance (Cl) with 2 commonly used
hemoﬁlters (AN69, polysulfone) at conventional ultraﬁltrate
ﬂow rates.
Methods: TLV Cl was assessed in our in vitro CVVH model
using citrate anticoagulated bovine blood and B. Braun Diapact
machine. Experiments were run using AN69 (M100, Gambro)
and polysulfone (F160NR, Fresenius) hemoﬁlters. Ultraﬁltrate
(UF) ﬂows were 1, 2, 3 and 6 L/hr with sufﬁcient blood ﬂows
[(Qb) 200–350 mL/min] to maintain UF rates. Blood samples
were collected from the pre-ﬁlter line and UF samples from the
post-ﬁlter UF port. Concentrations of TLV in plasma and UF
samples were assayed using validated LC-MS/MS methods.
TLV Cl was determined using the following formula:Cl = (UF
ﬂow rate) [TLV]UF/[TLV]Arterial. Cl differences between the
ﬁlter types were compared using a two-tailed, unpaired t-test.
Results:
Conclusion: TLV is substantially cleared by CVVH and Cl
increases signiﬁcantly with increasing UF rate. Cl did not differ
by hemoﬁlter type. CVVH Cl at higher UF ﬂows exceeds the
total Cl reported in patients with normal renal function. TLV
likely will require dose adjustments in patients receiving CVVH.
P1539
Telavancin pharmacokinetics during in vitro
continuous venovenous haemodialysis
J.H. Patel, M.C. Grio, M.D. Churchwell, J. Seroogy, S. Barriere,
B.A. Mueller (Ann Arbor, South San Francisco, US)
Objectives: Telavancin (TLV), a bactericidal lipoglycopeptide
with multiple mechanisms of action, is in Phase 3 trials for the
treatment of hospital-acquired pneumonia (HAP) with a focus
on infections due to methicillin-resistant S. aureus. TLV is
primarily eliminated by the kidneys and requires dosage
adjustment for renal dysfunction. TLV is highly protein bound
(93%) in healthy subjects which would suggest that it would not
be removed by dialysis, but its small volume of distribution
(0.15 L/kg) means that it may be removed by CVVHD. CVVHD
is used in the management of critically ill patients. The objective
of this study was to determine CVVHD TLV transmembrane
clearance (Cl) with 2 commonly used hemodialyzers at
conventional CVVHD dialysate ﬂow rates.
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Methods: TLV Cl was assessed in our in vitro CVVHD model
using citrate anticoagulated bovine blood and B. Braun Diapact
machine. Experiments were run 5 times using AN69 (M100,
Gambro) and polysulfone (F160NR, Fresenius) hemodialyzers.
Dialysate ﬂows were 1, 2, 3 and 6 L/hr with sufﬁcient blood
ﬂows [(Qb) 200–350 mL/min] to maintain appropriate
transmembrane pressures. Blood samples were collected from
the pre-ﬁlter port (A) and post-ﬁlter port (V), and spent
dialysate samples (D) from the post-ﬁlter D port. Plasma TLV
concentrations (arterial and venous) and dialysate samples were
assayed using validated LC-MS/MS methods and TLV Cl was
determined using the following formula: Cl = (D ﬂow rate)
[TLV]D/(([TLV]Arterial+[TLV]Venous)/2). Dialytic Cl between
ﬁlter types was compared using a two-tailed, unpaired t-test.
Results:
Conclusion: TLV is effectively cleared by CVVHD. The higher
permeability polysulfone dialyzer was associated with
signiﬁcantly increased Cl vs. the AN69 dialyzer as dialysate
ﬂow increased. The degree of TLV Cl seen with CVVHD
suggests that dose adjustments will be necessary in patients
receiving CVVHD.
P1540
Carbapenems – differences in their antibacterial
activity due to their protein binding
S. Schmidt, O. Burkhardt, S. Schubert, A. Dalhoff, H.
Derendorf (Gainesville, US; Kiel, DE)
Objective: It is still a subject of controversy that only free,
unbound drug is responsible for antibacterial activity of
antibiotics. To provide further proof, that only free drug
contributes to antimicrobial efﬁcacy a comparative, dose-
ranging time-kill curve study was performed. To exclude
inﬂuence factors resulting from different mechanisms of action
this was done within the antibiotic class of carbapenems, using
compounds with different serum protein binding.
Methods: Constant concentration time-kill curves were
performed in 50% serum for the slightly serum protein bound
mer-openem (~2%) and imipenem (10%) as well as for the
highly serum protein bound ertapenem (95%) and faro-penem
(95–96%), ranging from 1 · MIC to 16 · MIC. The change in
number of bacteria (CFU/mL) versus time was linked to their
effect. Escherichia coli ATCC 25922, Klebsiella pneumoniae Bay 63,
Staphylococcus aureus Bay 133 and Streptococcus pneumoniae
ATCC 6303 were used as the test organisms. Samples were
taken at 0, 0.5, 1 2, 4, 6 and 8 hours. The data were modelled
simultaneously using the software Scientist for WindowsTM
and a modiﬁed sigmoid Emax model characterized by growth
rate constant (k0), maximum kill rate (kmax), and concentration
at half maximum effect (EC50).
Results: For all four bacterial strains investigated, there were
dramatic increases (400-700%) in EC50 for the highly se-rum
protein bound carbapenems (ertapenem, faropenem) in the
presence of serum proteins (Fig. 1). For both substances no
signiﬁcant differences in k0 and kmax were determined. In
contrast, imipenem and meropenem showed only minor
differences in EC50 in the presence and the absence of 50%
serum.
Conclusion: Only free, unbound drug is responsible for the
antimicrobial activity. Analysis of these time-kill curves clearly
showed that the antibacterial efﬁcacy was signiﬁcantly
decreased in the presence of 50% serum for the highly bound
ertapenem and faropenem while being unaltered for the slightly
bound meropenem and imipenem.
P1541
Experimental pitfalls in protein binding
measurements
S. Schmidt, O. Burkhardt, M. Sahre, H. Derendorf (Gainesville,
US)
Objective: Numerous in vitro experiments have shown that
Protein Binding (PB) is an important factor for antimicrobial
activity, especially for highly bound antibiotics. However, the
experimental conditions that simulate the in vivo situation best
are still subject of controversy. Therefore, an in vitro
microdialysis experiment was performed that evaluates
various inﬂuence factors on the PB of the highly bound beta-
lactams ceftriaxone (PB 95–98%).
Methods: A comparative, dose-ranging in vitro microdialysis
study was conducted to determine free, unbound ceftriaxone
concentrations in Lactated Ringer’s solution and Todd Hewitt
Broth (THB) both with and without bovine serum albumin
(BSA; Sigma, St. Louis) 40 g/L and human plasma at 37C.
Furthermore, in vitro constant concentration time-kill curves
were performed, using Escherichia coli ATCC 25922,
Streptococcus pneumoniae ATCC 6303 and Streptococcus
pneumoniae ATCC 49619 as the test organisms. The Data
was analysed using an appropriate PK/PD model,
characterized by growth rate constant (k0), maximum kill
rate (kmax), and concentration at half maximum effect (EC50)
and correlated to free ceftriaxone THB concentrations
determined by HPLC-UV.
Results: There were only minor differences in both unbound
drug concentrations and anti-infective activity when BSA 40 g/
L was added to either Lactated Ringer’s (PB 0% and 12.5±2.5%,
with and without BSA respectively) or THB (PB 27% and
25.5±2.5%, with and without BSA respectively). No signiﬁcant
changes in k0, kmax and EC50 were observed. However, using
human plasma, unbound concentrations (PB 60%)88%) were
altered dramati-cally.
Conclusion: Only free, unbound drug is responsible for the
antimicrobial activity. However, one cannot rely on that binding
to commercially purchased BSA is consistent with reported
protein binding values. Unbound concentrations should be
measured under the respective experimental conditions to be
able to correctly interpret the experimental results.
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P1542
In vitro postantibiotic effect of faropenem on
penicillin-resistant Streptococcus pneumoniae and
beta-lactamase-producing Haemophilus
inﬂuenzae
C.L. Young, I.A. Critchley, U.A. Ochsner, N. Janjic (Louisville,
US)
Objectives: Faropenem (FAR) is an oral penem with potent
activity against respiratory pathogens such as penicillin (PN)-
resistant Streptococcus pneumoniae (SP) and beta-lactamase
(BLA)-producing Haemophilus inﬂeunzae (HI). The
postantibiotic effect (PAE) is a pharmacodynamic (PD)
parameter that monitors suppression of bacterial growth
following short exposure and removal of the drug. PAEs are
clinically important for agents such as FAR with short half-lives
(1 h). The aim of the study was to determine the PAE of FAR on
resistant phenotypes of SP and HI.
Methods: Nine clinical isolates of SP, 3 PN-S, 3 PN-I, and 3 PN-
R and six clinical isolates of HI, 3 BLA-negative and 3 BLA-
positive were tested in PAE studies. PAEs were determined in
cation-adjusted Mueller-Hinton broth with 3-5% lysed horse
blood for SP and Haemophilus Test Medium for HI. Exponential
cultures (106 CFU/mL) were exposed to FAR at 1, 4 and 10 x
MIC. FAR was removed by serial washing (10,000-fold dilution)
prior to transfer to fresh media. Control cultures were treated in
the same way. Bacteria were incubated with shaking and viable
CFUs determined at 1, 4, 6, 8, 16 and 20 h. Counts of log10 CFU
were plotted against time and PAE deﬁned as the difference is
the time required for count in test culture and control (untreated
culture) to increase 1 log10 above the count observed
immediately after removal.
Results: Signiﬁcant PAEs of >0.5 h were observed for all strains
of SP at 4 and 10 x MIC. However, the PAE was more prolonged
on the PN-R strains with mean PAEs of 3.9 h at 4 and 10 x MIC.
Among HI, little or no PAE was observed on BLA-negative
strains but a signiﬁcant PAE was observed on the BLA-positive
isolates (mean PAEs of 5.9 h and 8.9 h at 4 and 10 x MIC
respectively).
Conclusions: FAR demonstrates a prolonged PAE on key
resistant phenotypes of SP (PN-R) and HI (BLA-positive)
compared with susceptible strains. The observation of PAE in
BLA-positive HI is unique in the class of beta-lactams. FAR
exhibits in vitro PD properties that may contribute to its clinical
efﬁcacy against PN-R SP and BLA-positive HI.
P1543
Telavancin is more efﬁcacious than vancomycin
in a murine model of bacteraemic peritonitis
induced by methicillin-resistant Staphylococcus
aureus
S. Hegde, N. Reyes, B. Benton, R. Skinner (South San Francisco,
US)
Objective: Telavancin (TLV) is a novel lipoglycopeptide that
operates through multiple mechanisms to produce potent and
rapid bactericidal activity against clinically relevant gram-
positive bacteria including methicillin-resistant Staphylococcus
aureus (MRSA). The present studies evaluated the in vivo
efﬁcacy of TLV vs vancomycin (VAN) in a model of MRSA
induced peritonitis in neutropenic mice.
Methods: Female NSA immunocompromised mice were
inoculated intraperitoneally with ATCC MRSA 33591 and
treated, beginning at 4 h post-infection, with 2 subcutaneous
doses (q 12h) of vehicle (VEH) or test compound. Mouse
pharmacokinetic data were generated and used to choose doses
of TLV (40 mg/kg) and VAN (110 mg/kg) in order to equate
clinical exposures (AUC’s (free drug) of 44 and 132 lg.hr/mL,
respectively). In survival studies, deaths were recorded for 14-
days post-infection and survival curves were compared using
log-rank test. In bacterial titer determination studies, designated
groups of control and drug-treated surviving animals were
humanely euthanized at various times post-treatment and their
blood and spleen were harvested to determine bacterial titers.
Results: MICs of TLV and VAN were 0.5 and 1.0 lg/mL,
respectively. Mortality was 100% in animals treated with VEH
or VAN. Mortality was 7% in TLV-treated animals (p < 0.05 vs
VEH and VAN). The pre-treatment bacterial titres were 4.3 log
CFU/mL and 8.7 log CFU/g in the blood and spleen,
respectively. Analysis of the time kill curves for both blood
and spleen revealed that TLV exhibited signiﬁcantly greater
killing activity than VAN (p < 0.05, two-way ANOVA). At 6 hrs
after the ﬁrst dose, the titers in the blood were reduced to a
greater extent by TLV ()2.5 log CFU/mL) compared to VAN
()1.2 log CFU/mL). At 6 hrs after the second dose, the splenic
titers were reduced to a greater extent by TLV ()3.8 log CFU/g)
when compared to VAN ()1.4 log CFU/g).
Conclusions: The data described here demonstrate that TLV’s
in vivo bactericidal activity is superior to that of VAN against
MRSA and results in successful infection resolution and,
consequently, improved survival in the murine peritonitis
model.
P1544
Proper use of carbapenems for blood-derived
clinical isolates of Pseudomonas aeruginosa
Y. Kobayashi (Tokyo, JP)
Methods: Regimens of carbapenems were given to 1500 healthy
adult subjects. Changes in their blood concentrations of
carbapenems were compared by using pharmacokinetic
parameters (two-compartment model analysis) of meropenem
(MEPM), imipenem (IPM), and panipenem (PAPM) and by
applying the lognormal distribution to the probability
distribution of distribution volume and plasma half-life with
Monte Carlo simulation (MCS). Based on the data on
distributions of the minimal inhibitory concentrations (MIC) of
various carbapenems for 77 blood-derived clinical isolates of
Pseudomonas aeruginosa isolated/identiﬁed at Keio University
Hospital between October 1997 and October 2004 (MIC90:
MEPM 8 mcg/mL, IPM 16 mcg/mL, PAPM 32 mcg/mL), the
MICs in the 1500 subjects were obtained with MCS. From the
changes in blood concentrations and MICs in the subjects, the
probability of achieving T>MIC was calculated for each
carbapenem regimen, using the formula reported by Kuti et
al.: %T>MIC = ln (Dose/Vd*MIC)*(T1/2/0.693)*(100/DI) <<ln:
natural logarithm, Dose: 1 dose (mg), Vd: distribution volume
(L), T1/2: plasma half-life (h), DI: dosing interval (h)>>. Based
on Craig’s data, the maximum bactericidal effect on Gram
negative bacilli is attained when %T>MIC is approximately 50%.
We focused on this information and analysed our data.
Results: The probability of achieving T>MIC50% was 43.2% for
MEPM 500 mg bid, followed by 4.2% for IPM 500 mg bid and
3.6% for PAPM 500 mg bid. When the dose was increased from
500 mg to 1000 mg, it was 60.7% for MEPM 1000 mg bid,
followed by 10.3% for IPM 1000 mg bid and 9.9% for PAPM
1000 mg bid. When the dose remained at 500 mg and the dosing
frequency was increased to three times daily, it was 76.5% for
MEPM 500 mg tid, followed by 43.0% for IPM 500 mg tid and
18.8% for PAPM 500 mg tid. Regarding MEPM, it was 85.9% for
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500 mg gid? and 86.7% for 1000 mg tid showing higher
probabilities.
Discussion: In severe sepsis caused by Pseudomonas aeruginosa,
remarkably higher T>MIC50% was achieved with carbapenems
at 500 mg tid, although the daily dose (1500 mg) was lower,
compared to 1000 mg bid. Carbapenems with a low MIC
distribution, i.e. a superior antibacterial activity, showed
higher probability of achieving T>MIC. Therefore, the optimal
treatment for such sepsis is MEPM 500 mg tid. MEPM 500 mg
qid appeared to provide comparable therapeutic effects with
those at 100 mg tid, the usual dose in foreign countries.
P1545
Penetration of moxiﬂoxacin into normal and
infected subcutaneous tissue in patients with
spinal cord injury measured by microdialysis
J. Barth, D. Ja¨ger, M. Mu¨ller, O. Burkhardt, H. Derendorf (Halle,
DE; Vienna, AT; Gainesville, US)
Background: Skin breakdowns, also termed decubitus ulcers or
pressure sores, are a major complication associated with spinal
cord injury, resulting in infection and tissue death. Moxiﬂoxacin
(MFX) is approved for the treatment of SSSI. Our objective was
to construct a population PK model for MFX disposition in
plasma, normal and infected subcutaneous tissue in spinal cord
injured patients with infected decubitus ulcer.
Methods: 4 patients receiving 400 mg MFX orally daily were
enrolled in this study. Blood, saliva and interstitial tissue ﬂuid
samples (microdialysis in normal and infected tissue) were
collected over a time period of 8 hrs. MFX concentrations were
measured by a validated HPLC. Concentration-time data
obtained in the present study were pooled with previously
published MFX data (n = 12). Population PK modelling was
performed with NONMEM.
Results: The concentrations of MFX achieved in plasma, saliva,
normal subcutaneous tissues and infected decubitus ulcers
showed parallel proﬁles versus time. The PK was best
described by a 2-compartment model with a link to interstitial
tissue ﬂuid. The population PK parameters were as follows
(given as estimate with percent interindividual variability in
parentheses): CL 10.2 L/h (3%); central VD 83.2 L (15%);
intercompartmental CL 31.9 L/h (16%); peripheral VD 92.2 L
(17%); and elimination rate constant for interstitial tissue ﬂuid
1.57 h)1 (17%). With a conservative MIC90 of 0.25 mg/L, the
Peak/MIC ratios were higher than 10 and the AUC24/MIC
ratios were higher than 100 for plasma, saliva and interstitial
tissue ﬂuids.
Conclusions: This study showed the good diffusion of MFX into
subcutaneous tissue in spinal cord injuredpatientswithdecubitus
ulcers. The interstitial tissue ﬂuids reached bactericidal levels for
common bacteria found in infected skin lesions.
P1546
Postantibiotic effect and postantibiotic
subminimum inhibitory concentration effects of
ciproﬂoxacin, levoﬂoxacin and moxiﬂoxacin on
Staphylococcus aureus and Pseudomonas
aeruginosa
I. Kaleli, M. Demir, N. Cevahir, E. Mete, U. Yildirim, S.
Tikvesli (Denizli, TR)
Objective: Investigations of pharmacodynamic parameters
such as postantibiotic effect and postantibiotic subminimum
inhibitory concentration effect have been employed for design of
dosing schedules of antimicrobial agents. In this study we
compared postantibiotic effect and postantibiotic subminimum
inhibitory concentration effect of ciproﬂoxacin, levoﬂoxacin, and
moxiﬂoxacin for clinical isolates of methicillin susceptible
Staphylococcus aureus, methicillin resistant Staphylococcus aureus
and Pseudomonas aureginosa.
Methods: The following strains were tested in this study:
methicilline-susceptible Staphylococcus aureus (n:4), methicilline
resistant - Staphylococcus aureus (n:2) and Pseudomonas aeruginosa
(n:2). The PAE was determined by viable plate count method
using Mueller Hinton broth. Tubes containing 5 ml of broth and
the antibiotic to be tested at 1, 2, 4 and 8x the MIC were
inoculated with approximately 5 · 106 CFU/ml. Growth
controls with an inoculum but not antibiotic were included
with each experiment.
Result: Postantibiotic effects of ciproﬂoxacin, levoﬂoxacin and
moxiﬂoxacin increased with increasing concentration of the
drug. The longest postantibiotic effect was observed for
moxiﬂoxacin. Moxiﬂoxacin showed no postantibiotic effect one
P. aureginosa at all concentration and had no post antibiotic effect
to another P. aureginosa at x2MIC and MIC. In our study the
longest postantibiotic subminimum inhibitory concentration
effect against MSSA was determined with moxiﬂoxacin.
Similarly the moxiﬂoxacin induced the longest effect against
MRSA. However, this time frame was shorter than that of
MSSA.
Conclusions: All three antibiotics, showed for longer
postantibiotic subminimum inhibitory concentration effect in
all subMIC concentrations, immeasurable within the study
period i.e. 24 hours.
P1547
Lack of horizontal transmission of
ﬂuoroquinolone resistance between S. mitis and
S. pneumoniae
S. Campbell, C. Howley, R.J. Davidson (Halifax, CA)
Objectives: Fluoroquinolone (FQ) resistance can arise in S.
pneumoniae through acquisition of DNA from S. mitis and
subsequent homologous recombination. The frequency at which
this occurs is unknown, and while likely a rare event, increases
in FQ resistance among S. mitis may increase the rate at which
horizontal transmission occurs. We sought to determine the
frequency at which FQ resistance could be transferred from S.
mitis to S. pneumoniae or from S. pneumoniae to S. mitis.
Methods: S. mitis (either FQ^R,Tetracycline[Tet^S], FQ^R,Peni-
cillin[Pen^S], or FQ^S,Pen^R) and S. pneumoniae (either
FQ^S,Tet^R, FQ^S,Pen^R or FQ^R,Pen^S) were grown in
co-culture using a pharmacodynamic model in the presence of
either moxiﬂoxacin (MXF) or levoﬂoxacin (LFX) at salivary drug
concentrations. After incubation, aliquots were plated onto
either Tet or Pen containing SBA plates to select for the recipient
strains. FQ susceptibility was performed using microbroth
dilution. The entire parC and gyrA genes were ampliﬁed and
sequenced to determine if horizontal transmission occurred.
Results: In initial experiments Tet was used as the selective
agent. However Tet resistance was transferred and therefore
Pen^R was used as a selective marker. An increase in the LFX
MIC in was observed in 3 S. pneumoniae and 1 S. mitis strain.
Sequencing of the parC gene revealed the selection of 2 Ser79Phe
and 1 Ser79Tyr mutations in S. pneumoniae and Ser79Phe in
S. mitis consistent with FQ resistance. Sequencing of the entire
gene failed to uncover evidence of horizontal transmission. No
mutations were detected in gyrA. Selection of 1st step parC
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mutations occurred only after exposure to LFX. MXF eradicated
both S. mitis and S. pneumoniae and failed to either select for
resistance or support horizontal transmission.
Conclusions: Although 1st step parC mutations were selected
in 4 strains (3 S. pneumoniae, 1 S. mitis), we failed to ﬁnd evidence
of horizontal transmission between S. pneumoniae and S. mitis
under our laboratory conditions. The phenomenon of horizontal
transfer resulting in FQ resistance has been described, however,
based on our results, we must speculate that it is an extremely
rare event and not likely to be a major driver of FQ resistance. Of
interest, the parC mutations were selected only under the
selective pressure of LFX. MXF completely eradicated both S.
pneumoniae and S. mitis and did not select for the development of
FQ^R mutations.
P1548
Activity of ertapenem and metronidazole against
Bacteroides fragilis and Escherichia coli in an
in vitro pharmacokinetic/pharmacodynamic
model employing pure and mixed cultures
R. Schaumann, C. Vorwerk, R. Habt, J. Forberg,
A. Rodloff (Leipzig, DE)
Objectives: The aim of the present study was to assess the
killing activity of ertapenem (ERT) and metronidazole (MTR)
against four selected Bacteroides fragilis strains with different
MIC values in an in vitro pharmacokinetic/pharmacodynamic
(PK/PD) model. Since anaerobes are often present in mixed
infections, kill kinetics were also established for mixed inocula
employing the B. fragilis strains together with four selected
Escherichia coli strains. The killing activity was analysed for
kinetic concentrations of the antimicrobial agents simulating
human serum kinetics.
Methods: A PK/PD in vitro model was established by adding
appropriate amounts of broth every half hour. At the same time
intervals samples were obtained and plated. After incubation
colony formingunitswere counted.Humanserumconcentrations
were simulated with Cmax = 100 mg/L and t1/2 of 5 hours for
ERT and Cmax = 14.0 mg/L and t1/2 of 7 hours for MTR. Mann
trend test was used for statistical analysis.
Results: As to be expected the E. coli strains were not killed by
MTR both in pure as well as in mixed cultures whereas the
susceptible E. coli strains were effectively killed by ERT. In pure
cultures the B. fragilis strains were effectively killed by MTR and
the growth of the susceptible B. fragilis strains was reduced by
ERT by about two to four logs. However, in some mixed
cultures the killing activity of MTR against the B. fragilis strains
was signiﬁcantly reduced.
Conclusion: The in part moderate in vitro activity of ERT
against the B. fragilis strains and the reduced activity of
metronidazole in mixed cultures against the B. fragilis strains
may explain some of the difﬁculties in treating mixed aerobic/
anaerobic infections.
P1549
Penetration of ciproﬂoxacin into human
cerebrospinal ﬂuid and brain tissue
A. Tsona, S. Metallidis, E. Koumentaki, J. Nikolaidis, P. Kollaras,
G. Lazaraki, P. Nikolaidis (Thessaloniki, GR)
Objectives: The aim of the present study was to determine the
penetration of ciproﬂoxacin into cerebrospinal ﬂuid (CSF) and
brain tissue of humans.
Methods: A total of 10 patients undergoing brain tumor
excision were evaluated. The patients received a single
intravenous dose of 400 mg ciproﬂoxacin. Samples of blood,
cerebrospinal ﬂuid and brain (brain-adjacent tumour tissue)
were collected during surgery 2 h after drug administration.
Ciproﬂoxacin concentrations in serum, cerebrospinal ﬂuid and
brain homogenate were analysed by means of a validated HPLC
method.
Results: Ciproﬂoxacin concentrations in plasma (mcg/ml),
cerebrospinal ﬂuid (mcg/ml) and tissue homogenate (mcg/g),
respectively, after 2 h ranged 0.87–2.67 mcg/ml, 0.07–0.37 mcg/
ml and 0.65–4.02 mcg/g. CSF-to-serum ratio ranged between
0.06 and 0.14. Tissue-to-serum ratio ranged between 0.41 and
4.25. Mean (±S.D.) CSF/serum concentration ratios and brain
tissue/serum concentration ratios were respectively 0.10 ± 0.03
and 1.70 ± 1.17.
Conclusion: These ﬁndings suggest that valuable informations
on brain tissue penetration can be obtained only from brain
material. Data from CSF penetration cannot be extrapolated to
the brain since the blood: SF barrier differs from the blood:brain
barrier. Concentrations of ciproﬂoxacin in cerebrospinal ﬂuid
were lower than those in serum, in contrast to the brain tissue
concentrations that exceeded serum concentrations. The
achieved concentrations in brain tissue were generally above
the MIC90 of common pathogens in central nervous system
infections (H. inﬂuenze, N. meningitidis, S. pneumoniae, L. mono-
cytogenes, Escherichia coli, aerobic gram-negative bacilli, Group B
Streptococci, MSSA). Cerebrospinal ﬂuid concentrations exceed
the MICs of Neisseria meningitidis and most gram-negative
aerobic bacilli. Our ﬁndings suggests that ciproﬂoxacin may be
an acceptable alternative for the treatment of meningitis due to
susceptible gram-negative aerobic organisms and for the treat-
ment of brain abscesses.
P1550
Pharmacodynamic comparison of three
carbapenems against extended-spectrum
beta-lactamase producing Escherichia coli and
Klebsiella spp. from the MYSTIC Program in
Brazil
C. Kiffer, C. Mendes, K.J. Eagye, J.L. Kuti, D. Nicolau (Sao Paulo,
BR; Hartford, US)
Objective: To model the performance of imipenem (IMI),
meropenem (MEM), and ertapenem (ETM) against ESBL
producing E. coli and Klebsiella spp in order to identify
possible PD differences among compounds.
Methods: Minimal inhibitory concentrations (MICs) were
generated for 133 randomly selected ESBL producing isolates
of EC (n = 29) and KL (n = 104) collected during 2004 from
Brazilian hospitals as part of the MYSTIC program. MIC testing
for IMI, MEM, ETM, ceftazidime (CTZ), and cefotaxime (CTX)
were done by E-test methodology. ESBLs were conﬁrmed via
CTZ/clavulanate and CTX/clavulanate E-Test. PD exposure,
measured as percent time above the MIC for free drug
(fT>MIC), was modelled via a 5000 subject Monte Carlo
simulation for the following 30-minute infusions:IMI 1 gram
every 8 hours, MEM 1 gram every 8 hours, and ETM 1 gram
every 24 hours, using pharmacokinetics from healthy
volunteers. The bactericidal cumulative fraction of response
(CFR) was calculated for each regimen against the populations
of EC, KL, and against all ESBL isolates together. Bactericidal
CFR was deﬁned as 40% fT>MIC for all agents. Results are
reported as CFR (95% Conﬁdence Interval).
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Results: Isolates were 100% susceptible (S) to IMI and MEM
(MIC range 0.125–1.5 and 0.023–4 mg/L, respectively), and 97%
S to ETM (MIC range 0.008–32 mg/L). Although all 3 agents
achieved high bactericidal CFR against all ESBL isolates, ETM
[97.06% (96.55–97.49)] was less likely than IMI [99.96% (99.85–
99.99)] and MEM [99.90% (99.77–99.96)] to attain this target
(p < 0.05). Similar results were observed when simulated
against only KL: ETM: 96.04% (95.46–96.55); IMI: 99.96%
(99.85–99.99); and MEM: 99.88% (99.74–99.94); p < 0.05.
Against EC, all compounds performed comparably, with CFRs
close to 100%.
Conclusions: These ﬁndings support other data that although
ETM is likely to be an effective empiric agent against most ESBL
producing EC and KL, its ability to achieve high bactericidal PD
exposure will be dependent on the presence of less susceptible
organisms in the population. IMI and MEM should remain ﬁrst
line for ESBL infections.
P1551
Activity of moxiﬂoxacin, levoﬂoxacin and
azithromycin physiological concentrations in
serum and epithelial lining ﬂuid against in vivo
selected Streptococcus pneumoniae mutants and
its parental strain
D. Sevillano, L. Aguilar, L. Alou, M.J. Gime´nez, F. Caﬁni, O.
Echeverrı´a, E. Pe´rez-Trallero, J. Prieto (Madrid, San Sebastia´n,
ES)
Objectives: This study analyses eradication and resistance
selection in Streptococcus pneumoniae with moxiﬂoxacin,
levoﬂoxacin and azithromycin, using a parental serotype 3
infecting strain (A) and subsequent resistant step-mutants
(isolates B, C and D) selected in vivo in a patient with
pneumonia.
Methods: Moxiﬂoxacin, levoﬂoxacin and azithromycin MICs
were 1, 2 and 0.5 lg/ml for the parental strain, 4, 16, and 4 lg/
ml for isolate B, and 4, 16 and >128 lg/ml for isolates C and D,
respectively. A pharmacokinetic computerized device was used
to simulate serum and epithelial lining ﬂuid (ELF)
concentrations. Initial inocula was approx. 108 cfu/ml.
Population analysis proﬁles were performed using plates with
increasing antimicrobial concentrations on a MIC basis.
Results: In serum, moxiﬂoxacin eradicated the parental isolate
(isolate A), with an AUC0-24 h/MIC value of 39.6. SerumAUC0-
24 h/MIC values of 26.5 and 5.5 for levoﬂoxacin and
azithromycin, respectively, were not able to eradicate isolate A.
In ELF, moxiﬂoxacin showed a bactericidal pattern against all
isolates with a minority (approx. 100 cfu/ml) of the survival
population (isolates B, C and D) growing in plates with
moxiﬂoxacin concentrations higher than those obtained in ELF.
Levoﬂoxacin and azithromycin showed a bactericidal pattern
only against isolate A, with the whole population of isolates B, C
and D growing in plates with levoﬂoxacin concentrations higher
(16–64 lg/ml) than those obtained in ELF, and in plates with
azithromycin concentrations as high as 2048 lg/ml (for isolates C
and D). In ELF, moxiﬂoxacin AUC0-24 h/MIC values were 201.0
for isolate A, and 50.3 for isolates B, C andD. Levoﬂoxacin AUC0-
24 h/MIC values were 94.0 for isolate A, and 11.8 for isolates B, C
andD. Azithromycin AUC0-24 h/MIC values were 8.0 for isolate
A; 10.0 for isolate B; and 0 for isolates C and D.
Conclusion: If prevention of resistance depends more on the
eradication of possible emerging mutants in pulmonary tissues
than of the parental susceptible strain, moxiﬂoxacin
concentrations in ELF may provide advantages over previous
quinolones and macrolides in preventing clinical failures.
P1552
Effects of levoﬂoxacin, ciproﬂoxacin and
azithromycin on the competitive growth of
Streptococcus pneumoniae, as a model approach to
selection of resistant populations
L. Alou, M.J. Gime´nez, D. Sevillano, L. Aguilar, O. Echeverrı´a, F.
Caﬁni, E. Valero, A. Fenoll, J. Prieto (Madrid, Majadahonda, ES)
Objectives: To explore how antimicrobial pressure inﬂuences
the evolution of Streptococcus pneumoniae populations sharing
the same ecological niche.
Methods: An in vitro computerized pharmacodynamic model
simulating physiological concentrations obtained over 24 h after
500 mg o.d levoﬂoxacin, 750 mg b.i.d ciproﬂoxacin, and 500 mg
o.d azithromycin was used to investigate its effect on a mixed
culture of ﬁve S. pneumoniae serotypes (S) as an approach to
ecology of population dynamics. Resistance patterns were: S12
was susceptible to study drugs, S31 was low-level macrolide-
resistant (efﬂux phenotype), S11 was high-level macrolide-
resistant (erm genotype), S9V was low-level quinolone-
resistant, and S3 was high-level quinolone-resistant. Initial
mixed inocula (time 0) included similar percentages of each
serotype.
Results: Mean colony counts in antibiotic-free plates (whole
pneumococcal population) increased (from 0 to 24 h) from log10
6.9 to 8.8 in drug-free simulations (control), from log10 6.8 to 7.9
in levoﬂoxacin simulations, from log10 6.8 to 8.6 in ciproﬂoxacin
simulations, and from log10 7.1 to 8.8 in azithromycin
simulations. At 24 h of control drug-free experiments,
dominant strains were S9V (57.4%) and S12 (41.8%) with
marginal populations of S31, S3 and S11. Azithromycin
selected in a much higher extent the strain with low-level
resistance to macrolides (S31) than the strain with high-level
resistance (S11) (accounting for 99.9% vs. 0.1% of total
population at 24 h). Ciproﬂoxacin selected in a higher extent
low-level (S9V) than high-level (S3) quinolone resistance (72.4%
vs. 27.6%). Levoﬂoxacin decreased the proportion of the
predominant S9V in controls to 22.2% (an intermediate-
resistant strain with MIC = 4 lg/ml), and unmasked the high-
level resistant strain (MIC = 32 lg/ml) up to 77.8%.
Conclusion: Strain distribution in antibiotic-free environment
depends on bacterial ﬁtness in mono- and multi-strain niches.
The selective pressure of antimicrobial regimens eradicate some
populations and unmask minor populations, thus redistributing
the whole population. Selective potential only for resistance
phenotypes with very low prevalence (as high-level quinolone
resistance) in the community should be preferred to that
selecting more prevalent resistance phenotypes.
P1553
Re-evaluation of the role of broad-spectrum
cephalosporins against staphylococci applying
contemporary in vitro results and
pharmacokinetic-pharmacodynamic principals
H. Sader, S.M. Bhavnani, P.G. Ambrose, R. Jones (North Liberty,
US)
Objectives: To re-evaluate the current in vitro activity and to
assess the PK-PD target attainment of cefepime (CPM),
ceftriaxone (CRO) and ceftazidime (CAZ) against Staphylococcus
spp.
Methods: The potency of CPM, CRO and CAZ against
staphylococci was accessed through the SENTRY
Antimicrobial Surveillance Program database, worldwide.
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
During the 1998–2004 period 41,883 S. aureus (SA; 63% oxacillin
[OXA]-susceptible [S]) and 14,349 coagulase-negative
staphylococci (CoNS; 22% OXA-S) were S tested against CPM,
CRO, CAZ and numerous comparators by CLSI broth
microdilution methods. Using volunteer PK data and a linear
intermittent intravenous infusion model, and an animal-derived
PK-PD target of 25% time above MIC, expected probabilities of
target attainment (PTA) for cephems were evaluated using
Monte Carlo simulation. PTA were determined for the following
dosing regimens: CPM 1gm q12 and q8 hours, CAZ 1 gm
q8 hours and CRO 1 gm q24 hours, each representing the most
common dosing patterns applied clinically. Cephem
susceptibility (%S) was calculated based on the current CLSI
(2006) breakpoints (BKPs) and also on BKPs derived from a PTA
>90%.
Results: Against OXA-S SA, MIC50/90 values were (in mg/L):
2/4 for CPM, 4/4 for CRO and 8/16 for CAZ, respectively; and
against OXA-S CoNS MIC50/90 values were (in mg/L) 0.5/2
for CPM, 2/4 for CRO, and 4/8 for CAZ, respectively. The
calculated %S of these cephems are summarized in the Table:
Twenty year-old CLSI BKPs would rank the tested agents
CPM ‡ CRO > CAZ and by PK-PD PTA CPM ‡ CAZ > CRO.
CPM has a potency advantage over CAZ (4- to 8-fold) and
superiority at the usual dosing over CRO (22.7–66.1%) for OXA-
S staphylococci. CAZ PK overcomes by-weight activity
disadvantages, while a low proportion (<5%) of active free-
drug penalizes CRO in the PTA calculations. PTA remained at
>90% to a BKP of 16 mg/L for CPM (1 gm q8) and CAZ and to a
BKP of 2 mg/L for CRO.
Conclusions: Regardless of applied BKP (CLSI or PK-PD), CPM
has the widest and more potent anti-staphylococcal activity
among commonly used ‘‘third- or fourth-generation’’ cephems.
When used at doses ‡ 3 gm/day, CPM assures maximal
coverage of OXA-S staphylococci whether using existing (CLSI)
or modiﬁed (PK/PD) BKPs. CRO should be used with caution.
P1554
Pharmacokinetic-pharmacodynamic modelling of
in vitro activity of azithromycin against four
different bacterial strains
W. Treyaprasert, U. Suvanakoot, H. Derendorf (Bangkok, TH;
Gainesville, US)
Objectives: To investigate the pharmacodynamic effect of
azithromycin by evaluation of in vitro kill curves against four
bacterial strains (Streptococcus pneumoniae/penicillin-
intermediate, Streptococcus pneumoniae /penicillin-sensitive,
Haemophilus inﬂuenzae and Moraxella catarrhalis), and to
establish a mathematical model to describe the PK-PD
relationship of azithromycin.
Methods: The MIC for all strains were determined by serial
two-fold macrodilutions. An in vitro kinetic model was used to
investigate the antibacterial efﬁcacy of constant drug
concentrations during 6 hours. The selection of the doses of
azithromycin tested in each bacterial strains was based on their
MIC values. Bacterial counts were determined on appropriate
agar plates using an adapted drop-plate method. Twelve
different PK/PD models were ﬁtted and compared to the
time-kill data by using non-linear regression.
Results: A simple PK-PD model was not sufﬁcient to describe
the pharmacodynamic effects for the four bacterial strains.
Appropriate models that gave good curve ﬁts included a
saturation term for the number of bacteria (Nmax), delay
terms (1-e-zt) for the initial bacterial growth phase and/or the
onset of anti-infective activity as well as a Hill factor (h) to
capture the steepness of the concentration-response relationship.
Azithromycin had high potency against S. pneumoniae strains
and M. catarrhalis while the potency of azithromycin against H.
inﬂuenzae was poor.
Conclusions: The developed PK/PD models are suitable for
describing the pharmacodynamics of azithromycin.
Applications of these PK-PD models will eventually provide a
tool for rational antibiotic dosing decisions.
P1555
Dose optimisation of enroﬂoxacin for use in
chickens against Salmonella enterica serovar
Typhimurium DT104 to improve efﬁcacy and
minimise selection of resistance
L.P. Randall, S.W. Cooles, K. Stapleton, N.G. Coldham,
L.J.V. Piddock, M.J. Woodward (New Haw, Birmingham, UK)
Objectives: Optimal antimicrobial dosage regimens aim to
achieve successful clinical outcomes without drug toxicity or
emergence of bacterial resistance. For concentration dependent
antibiotics, such as the ﬂuoroquinolones, in humans a
Cmax:MIC ratio of >10 is considered more important for
efﬁcacy and reduced selection of resistance than prolonged
antibiotic concentrations just above the MIC. Fluoroquinolone
resistance in zoonotic bacteria is a matter of public health
concern, and ﬂuoroquinolone treatment of poultry can rapidly
select for bacteria with reduced ﬂuoroquinolone susceptibility.
In this study we compared basic pharmacokinetic parameters
for the recommended dose of Baytril (enroﬂoxacin) 10% oral
solution in poultry to 2.5x this dose for birds dosed by
continuous water (standard) compared to pulsed water
treatments and dosing by gavage.Methods. For the pulsed
versus continuous water treatments, groups of chickens
received Baytril 10% oral solution at 50 (recommended) or
125 ppm continuously in the water or at 10 (recommended) or
25 mg/kg pulsed in the water. For each group, three birds were
killed at 0, 2, 4, 6, 8, 10 and 24 hours after start of antibiotic
treatment and caecal contents, liver, lung and sera were taken
and the concentration of ﬂuoroquinolone determined by
ﬂuorescence HPLC. For gavage treatment, dosing was at 10
and 25 mg/kg by crop intubation and four birds were killed in
each group at 2, 6 and 24 hours after gavage; caecal contents,
liver and sera were taken and analysed as above. Basic
pharmacokinetic parameters were determined using PK
solutions software.
Results: The mean ﬂuoroquinolone Cmax in caecal contents
(and sera) for gavage, pulsed water and continuous water
treatments respectively was 78.01 (1.81), 53.19 (1.17) and 24.73
(0.73) mg/ml after the recommended dose and 115.86 (3.86),
115.63 (2.74) and 68.02 (1.17) mg/ml after 2.5x the
recommended dose. Cmax of antibiotic in liver and lung was
increased by the modiﬁed regimens in similar proportions to
above. Both pulsed water and gavage treatment not only
resulted in higher Cmax values, but also a faster rate of
ﬂuoroquinolone clearance than continuous water treatment
(Figure 1).
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Conclusion: Dosing by gavage is not practical for thousands of
chickens. However, pulsed dosing at 2.5x the recommended
dose can increase Cmax values about fourfold and so could
improve efﬁcacy and reduce selection of resistance, compared to
the current recommended treatment regime.
P1556
Nephrotoxicity of intravenous colistin:
a prospective evaluation
M. Falagas, K. Fragoulis, S. Kasiakou, G. Sermaides,
A. Michalopoulos (Athens, GR)
Objectives: Nephrotoxicity is the major concern arising with
the use of intravenous colistimethate sodium.
Methods: A prospective cohort study was performed at ‘‘Henry
Dunant’’ Hospital, a 450-bed tertiary care center in Athens,
Greece. Patients who received intravenous colistin for at least
7 days for the treatment of multidrug resistant Gram-negative
bacterial infections were included in the study. The
development of nephrotoxicity through evaluations of serum
creatinine, blood urea, serum electrolytes, urinalysis, and
creatinine and sodium in 24-hour urine collection during
intravenous colistin therapy was the primary end point of the
study.
Results: Twenty-six patients were included in the study, 21 of
whom received colistimethate sodium (CMS) for at least 7 days
and were evaluated further. The mean (± SD)/median daily
dose, cumulative dose, and duration of treatment of intravenous
CMS was 5.5 (± 1.9)/6 million IU, 90.2 (±52.0)/72 million IU,
and 17.7 (±11.7)/15 days (range 7–54 days), respectively. Three
of the 21 evaluable patients (14.3%) developed nephrotoxicity
during the intravenous treatment with CMS. The cumulative
dose of the administered CMS was statistically correlated with
the difference between the end and start of CMS treatment
values of serum creatinine (r = 0.6, p = 0.004 by Spearman’s
test). A statistically but not clinically signiﬁcant decrease of the
mean baseline serum sodium concentration was observed
between start and end of treatment [mean 144.2 (±6.9) to 142.1
(±6.1) mmol/L, p = 0.04]. No other toxic events were noted
during the intravenous administration of colistimethate sodium.
Conclusion: Although this is an evaluation of a small number
of patients, our prospective study shows that nephrotoxicity was
not commonly observed in this group of patients who received
intravenous colistimethate sodium. However, caution should be
taken to avoid the prolonged administration of the antibiotic.
New and not so new antimicrobials
P1557
Molecular design of novel antimicrobial agents
on the base of 4-thiazolidone derivatives
A. Artemenko, E. Muratov, V. Kuz’min, A. Fedtchuk,
N. Mykhaylovska, R. Lesyk, B. Zimenkovsky (Odessa, L’viv, UA)
Objectives: The objective of the present work is Quantitative
Structure-Activity Relationship (QSAR) analysis of antimicrobial
activity of the 4-thiazolidone derivatives and consequent
computational design of new antimicrobials.
Methods: For the achievement of the formulated objectives the
QSAR investigation has been carried out using computational
chemistry approach based on Simplex Representation of Molecu-
lar Structure (SiRMS). On the framework of SiRMS it is possible to
develop the molecular design of the new effective antimicrobials.
Results: Systematic researches of relationship between antimi-
crobial activity (Staphylococcus aureus – methicillin-sensitive
(MSSA) strain, Pseudomonas aeruginosa – R and S strain, Klebsiella
pneumoniae, Candida albicans S and N˜itrobacter freundii) and a
structure of about one hundred ﬁfty compounds (4-thiazolidone
derivatives and analogs). The elucidation of structure-activity
relations allows predicting biological properties of such com-
pounds, to execute their direct synthesis and to receive the
indispensable information for research of mechanisms of their
biological effect. Completely adequate statistical partial least
squares models (R2 = 0.841–0.990, Q2 = 0.600–0.814) have been
obtained for all of the studied cultures.On the base of theﬁrst ones
themolecular fragmentsbothpromotingand interfering thegiven
antimicrobial activity have been determined. They give a possi-
bility to realize the computer high throughput screening and
molecular design of active compounds. The results of prognosis
are verifying by the experimental investigations. Also the inﬂu-
ence of heterocycle system evolution on antimicrobial activity has
been revealed.
Conclusion: QSAR analysis of antimicrobial activity of 4-thiaz-
olidone derivatives allows us to discover that the presence of
naphthalene-substituted fragment (independently on its location
in molecule) has distinctly negative inﬂuence on antimicrobial
action. The requirements to molecular design have been formu-
lated. For example, high active compounds must include 3-ind-
olyl fragment.
P1558
Computational design of the new antimicrobials
based on the substituted crown ethers
E. Muratov, A. Artemenko, V. Kuz’min, I. Konup, L. Konup,
S. Kotlyar, G. Kamalov, A. Fedtchuk, N. Mykhaylovska (Odessa,
UA)
Objectives: The objective of the present work is Quantitative
Structure-Activity Relationship (QSAR) analysis of antimicrobial
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activity of the row of substituted crown ethers and consequent
molecular design of new antimicrobials.
Methods: The well-known Hierarchic System of QSAR Models
based on simplex representation of molecular structure has been
used for the solution of the formulated problem, within the
framework of which one it is possible to develop the molecular
design of the new effective antimicrobial agents.
Results: We tried to conduct systematic researches of
relationship between antimicrobial activity (Planococcus citreus,
Streptococcus lactis, Micrococcus lysodeiktious, Staphylococcus
aureus, Streptococcus faecalis, Bacillus subtillum) about two
hundred ﬁfty crowns ethers including aromatic, cyclic and
heterocyclic etc. fragments and a structure of these molecules, in
particular – macro cycle size, it dentacy, lipophily, nature of the
substituents, and other factors. The elucidation of similar
relations allows predicting biological properties of crown
compounds, to execute their direct synthesis and to receive the
indispensable information for research of mechanisms of
biological effect of such kind of compounds. Completely
adequate QSAR models (R2 = 0.841–0.995, Q2 = 0.660–0.954)
have been obtained using partial least squares method for all of
the studied cultures. On the base of the ﬁrst ones the molecular
fragments with positive or negative inﬂuence on the explored
properties have been determined. They give a possibility to
realize the virtual screening and molecular design of
compounds with the high level of target activity. The results
of prognosis are verifying by the experimental investigations.
Conclusion: QSAR analysis of antimicrobial activity of crown
ethers allows us to suppose the presence of two different
mechanisms of their antimicrobial action. It is discovered that
the presence of diphenyloxide and tert-butyl fragments
promotes; diphenyl-sulphide and diamino-biphenyl – prevents
the antimicrobial action. It is shown that the hexadenthal crown
ethers containing aromatic fragments with a tert-butyl group are
the most perspective antimicrobials.
P1559
Enzymatic characterisation of methionyl tRNA
synthetase inhibition by REP8839
T. Jarvis, J. Bullard, L. Green, W. Ribble, J. Bertino,
U.A. Ochsner, I.A. Critchley, N. Janjic (Louisville, US)
Objectives: Methionyl tRNA synthetase (MRS) catalyses the
covalent attachment of methionine to its cognate tRNA.
REP8839 is a synthetic inhibitor of MRS with potent
antibacterial activity against Staphylococcus aureus including
clinically-relevant resistant strains (MIC90 equals 0.06 to
0.5 lg/mL). We determined the biochemical potency and
mechanism of action of REP8839 and related compounds with
respect to S. aureus MRS enzymatic activity. We also evaluated
the enzyme kinetic properties of mutated forms of S. aureus
MRS.
Methods: The metS gene from S. aureus was expressed in E. coli
and MRS was puriﬁed to near homogeneity by ammonium
sulfate fractionation and anion exchange chromatography.
Aminoacylation of tRNAmet was measured using scintillation
proximity assays (SPA). The kinetics of the ATP:PPi exchange
were determined using thin layer chromatography (TLC).
Mutants of S. aureus MRS were selected by serial passage and
spontaneous resistance in the presence of REP8839.
Results: REP8839 exhibited strong inhibition of S. aureus MRS
in the aminoacylation reaction, having an IC50 limited by the
enzyme concentration. In order to estimate the true inhibition
constant (Ki), we utilized an ATP:PPi exchange assay. REP8839
showed potent inhibition of S. aureus MRS, with a Ki of 10 pM.
Related inhibitors were analysed, and a correlation was
observed between the Ki for MRS and the MIC for S. aureus.
REP8839 was found to be competitive with methionine binding,
but uncompetitive with ATP binding (i.e., increasing the ATP
concentration resulted in tighter binding of REP8839). The
majority of analogs exhibited comparable mechanism of action;
altered mechanism of action was observed with a subset of
analogs. Mutated S. aureus MRS variants (derived from strains
with elevated MICs) showed substantially weaker binding by
REP8839. All of the mutated enzymes exhibited impaired tRNA
aminoacylation activity, with defects ranging from reduced
turnover rates to weaker afﬁnities for one or more substrates.
Conclusions: REP8839 is a potent inhibitor of S. aureus MRS.
Enzymatic potency of this class of inhibitors correlates with
microbiological potency. Mutations that confer resistance to
REP8839 result in functionally impaired MRS, encompassing a
wide variety of enzymatic phenotypes.
P1560
Antimicrobial activity of some new thioureides of
2-(4-chlorophenoxy)-benzoic acid
C. Limban, M.C. Balotescu, V. Missir, I. Chirita, G. Mihaescu,
A. Israil (Bucharest, RO)
We report here the antibacterial and antifungal activity of 8
newly synthesized and physico-chemically characterised
thioureides of 2-(4-chlorophenoxy)-benzoic acid. The new com-
pounds were prepared in three stage. Firstly, the 2-(4-chloro-
phenoxymethyl)-benzoic acid was prepared by treating the
phtalide with p-chlorophenol potassium salt in xylene. The
second stage was the synthesis of 2-(4-chlorophenoxymethyl)-
benzoyl chloride by treating the corresponding acid with
thionyl chloride using anhydrous 1,2-dichloroethane as sol-
vent, followed in the third stage, by the treatment of the
above-mentioned chloride with ammonium thiocyanate. The
2-(4-chlorophenoxymethyl)-benzoyl isothiocyanate resulted
after reﬂuxing the reaction mixture in dry acetone. The new
compounds were prepared by reﬂuxing the isothiocyanate with
primary aromatic amines in dry acetone. The obtained com-
pounds have been characterized by their physical properties
and their chemical structures were conﬁrmed using the spectral
analysis. The aim of this study was also to evaluate the in vitro
antimicrobial activity of the new compounds. The in vitro
antimicrobial testing was performed by binary microdilution
method, in 96 multi-well plates, in order to establish the
minimal inhibitory concentration (MIC), against Gram-positive
(Listeria (L.) monocytogenes, Staphylococcus (S.) aureus, Bacillus (B.)
subtilis), Gram-negative (Psedomonas (P.) aeruginosa, Escherichia
(E.) coli, Salmonella (S.) enteritidis), as well as Candida sp., using
both reference and clinical, multidrug resistant strains. Our
results showed that the tested compounds exhibited a speciﬁc
antimicrobial activity, depending on the nature of the substit-
uents and their position on the benzene ring, both concerning
the microbial spectrum and the MIC value. The MICs values
widely ranged between 1024 mcg/ml and 32 mcg/ml. The most
active proved to be N-[2-(4-chlorophenoxymethyl)-benzoyl]-N’-
(2,6-dichloro-phenyl)-thiourea and N-[2-(4-chlorophenoxymeth-
yl)-benzoyl]-N’-(4-bromo-phenyl)-thiourea, showing a large
spectrum of antimicrobial activity against enterobacterial strains
(E. coli and S. enteritidis), L. monocytogenes, S. aureus and Candida
sp. All the tested compounds were highly active against
S. aureus (MIC = 32 mcg/ml). Four of the tested compounds
exhibited antifungal activity (MIC = 256–32 mcg/ml), and
P. aeruginosa as well as B. subtilis were resistant to all tested
compounds.
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P1561
In vitro antimicrobial activities of novel
dianthraquinones produced by a marine
Streptomyces sp. against clinical Staphylococcus
aureus and Enterococcus faecium isolates
K.L. LaPlante, K. Lor, A. Socha, D.C. Rowley (Providence, North
Kingston, US)
Objectives: The escalation of antibiotic resistance among gram-
positive pathogens presents increasing treatment challenges and
requires the development of new therapeutic agents. Recentlywe
discovered a new class of dianthraquinone antibiotics produced
by a marine streptomycete. The inhibitory and bactericidal
activity of four dianthraquinone secondary metabolites and four
semi-synthetic derivatives were measured against clinical strains
of vancomycin resistant E. faecium (VRE), methicillin susceptible
and methicillin resistant S. aureus (MSSA and MRSA,
respectively). Two compounds, DAQ550a and DAQ552, were
tested against an expanded panel of pathogens.
Methods: Thirty-two clinical strains of VRE (n = 10), MSSA
(n = 12) and MRSA (n = 12) were obtained from patients at the
Veterans Affairs Medical Center in Providence, RI. MIC’s were
performedusingmethodologiesdescribedbyCLSI.Control isolates
wereATCC52923 andATCC29213. The bactericidal activity of each
antimicrobial agentwas evaluatedwith time-kill experiments using
6 randomly selectedMSSA (n = 2),MRSA (n = 2), and VRE (n = 2)
isolates tested at 4 times the respective MIC.
Results: Overall, DAQ550a and DAQ552 demonstrated
signiﬁcant in vitro activity. Over the 24 h time kill, DAQ552
demonstrated bactericidal activity (99.9%) against MSSA, MRSA
and VRE. DAQ550a demonstrated bactericidal activity against
MSSA and MRSA.
Conclusions: The potent activities and unusual structures of the
dianthraquinones tested here suggest that these may provide a
new molecular scaffold for the development of novel
antimicrobial agents. More biological testing is warranted to
more fully explore the clinical potential of these antibiotics.
P1562
Efﬁcacy of the novel antimicrobial peptide
plectasin to staphylococci
D. Sandvang, P.H. Mygind, S. Jenabian, D.R. Segura,
H. Kristensen (Bagsværd, DK)
Objective: The purpose of the investigation was to investigate
the in vitro efﬁcacy and kill kinetics of Plectasin against
Staphylococcus aureus. Plectasin is a newly discovered defensin-
type antimicrobial peptide found in the fungus Pseudoplectania
nigrella which showed activity against several Gram-positive
bacteria including drug resistant strains (Mygind PH. et al.
Plectasin is a peptide antibiotic with therapeutic potential from a
saprophytic fungus. Nature 2005; 437:975–980).
Methods: All experiments were determined according to CLSI/
NCCLS guidelines. Bactericidal activity was characterized by
time kill experiments at 2 and 10 times the MIC. Staphylococcus
aureus (S. aureus) ATCC29213 were used as the test organism
and vancomycin was used for comparison. The kill kinetics and
post antibiotic effect (PAE) were evaluated by CFU
determination. Inoculum sizes ranging from 10E4 to 10E7 cells
were used to test the inoculum effect. 10E10 cells were
employed for determination of mutant prevention
concentration (MPC) and the frequency of spontaneous
resistance.
Results: Plectasin is bactericidal as evidenced by kill kinetics
showing a 2.1 log reduction in CFU/ml after 1 hour of
incubation and a reduction of 3.1 log CFU/ml after 2 hours.
This is superior compared to the activity of vancomycin. No
inoculum effect was observed in the employed range of cells.
The observed PAE had a duration of 2 hours and 42 minutes.
No spontaneously resistance mutation was observed among
10E10 cells of staphylococci and the MPC were determined to be
8 times MIC.
Conclusions: Plectasin is a novel antimicrobial peptide that
shows potent antimicrobial activity against Gram-positive
bacteria including drug-resistant organisms. The potent,
excellent bactericidal activity in vitro, lack of cross-resistance to
clinical used antibiotics, low spontaneously resistance mutation
frequency and good PAE properties, suggest that Plectasin may
have potential as a therapeutic agent against staphylococci.
P1563
In vitro antimicrobial activity of the novel
polymeric guanidine Akacid plus
C. Kratzer, S. Tobudic, W. Graninger, A. Buxbaum,
A. Georgopoulos (Vienna, AT)
Objectives: Cationic antimicrobials are widely used for disin-
fection within clinical settings. In the present study the bacte-
ricidal and fungicidal activity of Akacid plus, a novel
polymeric compound of the cationic family of disinfectants,
was evaluated against quality control strains of Staphylococcus
aureus, Enterococcus hirae, Escherichia coli, Pseudomonas aeruginosa,
Candida albicans and Aspergillus niger in comparison to chlorh-
exidine digluconate.
Methods: The in vitro activity of Akacid plus and chlorhexidine
was determined by quantitative suspensions tests according to
the European Committee for Standardization at concentrations of
0.01–0.5% against bacterial strains and C. albicans and at
concentrations of 0.5–4% against A. niger after exposure for 5, 15
and 60 min in the presence and absence of 0.3% bovine albumin
and dilution in distilled and hard water.
Results: In the basic quantitative suspension test Akacid plus
destroyed all bacterial pathogens at a concentration of ‡0.1% in
£5 min contact time. Chlorhexidine was also highly active
against S. aureus, E. coli and P. aeruginosa, but failed to eliminate
E. hirae within 5 min. Under high organic burden, the
bactericidal activity of both disinfectants was slightly reduced.
Akacid plus showed fungicidal activity against C. albicans
within 15–60 min and eliminated A. niger at a concentration of
‡1% in 5 min contact time. Chlorhexidine was fungicidal against
C. albicans, but did not achieve biocidal activity against A. niger.
Conclusion: The novel polymeric guanidine Akacid plus
when compared to chlorhexidine digluconate showed similar
bactericidal activity against S. aureus, E. coli and P. aeruginosa
and superior biocidal activity against E. hirae and A. niger.
P1564
Investigation of emergence of bacterial resistance
to the novel antibacterial photodynamic agent
XF-42
L. Borsetto, E. Reddi, W. Rhys-Williams, W.G. Love (Padua, IT;
Brighton, UK)
Objectives: The emergence of bacterial resistance to antibiotic
therapies is a major threat to modern healthcare. The XF drugs
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are novel, light activated antibacterial agents (1) active against
Gram-positive bacteria, which have greater potency than
antibiotics. The emergence of resistance to XF-42 has been
investigated.
Methods: 0.382 mg/L of XF-42 was added to 108 cells/mL of
MRSA.After 5 minutes incubation in the dark the unboundXF-42
was removed and the culture illuminatedwith 13.7 J/cm2 of light
at 422 nm andCFUanalysis undertaken to determine the number
of viable cells remaining. 5 surviving clones of the treatmentwere
cultured and subjected to further treatment. 10 cycles were
undertaken to determine whether the number of surviving cells
increased, suggesting resistance build up to XF-42.
Results: The survival of methicillin-resistant Staphylococcus
aureus (MRSA) (ATCC BAA-44) is expressed as log N0/N,
where N0 and N are the CFU of untreated and treated
suspensions, respectively.
Conclusions: The results demonstrate that no detectable
resistance build up to the activity of XF-42 was seen after 10
successive treatments. A low propensity for emergence of
resistance is a valuable attribute for new anti-bacterial agents.
XF-42 might be effectively employed in the clinical setting for
prophylactic use to decolonise skin and nares and therapeutic
use to treat infected wounds/ulcers.
Reference
(1) Maisch T et al. Photodynamic effects of novel XF porphyrin
derivatives on prokaryotic and eukaryotic cells. Antimicrob
Agents Chemother 2005; 49: 1542–52.
P1565
Efﬁcacy testing of the topical antimicrobial XF-73
using a novel ex vivo porcine skin model
T. Maisch, R.M. Szeimies, N. Lehn, W. Rhys-Williams,
W.G. Love (Regensburg, DE; Brighton, UK)
Objectives: The XF drugs are novel, light activated antibacterial
agents (1) active against Gram-positive bacteria which have
superior potency to antibiotics but possess a low propensity to
induce resistant bacterial strain emergence. A novel ex-vivo
porcine skin model has been developed to test the antibacterial
activity of XF-73 on the surface of skin.
Methods: 10x7 cells of methicillin-resistant Staphylococcus aureus
(MRSA) were inoculated onto a 1.32 cm2 area of ex-vivo porcine
skin samples, immobilised in agar. After drying, solutions of XF-
73 were applied and after 60 minutes, the samples were
illuminated for 15 minutes with blue light (422 nm) with
various total light doses using a LumaCareTM LC-122M lamp.
CFU analysis were undertaken to determine the number of
viable cells remaining after treatment. Controls of drug alone
and light alone were included.
Results: Using 7.64 mg/L of XF-73, CFU analysis demonstrated
that at a total light dose of 5 J/cm2, there was ~90% kill of
bacteria. At 10 J/cm2, there was 99.9% kill of bacteria, and
99.99% at 20 J/cm2 and 40 J/cm2. At a total light dose of 20 J/
cm2, it was found that there was a <99% kill by XF-73 at
concentrations of 0.76, 1.53 and 3.8 mg/L. At a concentration of
7.64 mg/L, there was a >99.9% kill. This kill did not signiﬁcantly
increase at 22.93 and 76.4 mg/L.
Conclusions: The results demonstrate that XF-73 has
exceptional activity at low concentrations against MRSA on
the surface of porcine skin. XF-73 and light are non-toxic to skin
at therapeutic concentrations. Work is in progress to clinically
evaluate the effectiveness of this compound in eradicating
staphylococcal nasal carriage.
Reference
(1) Maisch T et al. Photodynamic effects of novel XF porphyrin
derivatives on prokaryotic and eukaryotic cells. Antimicrob
Agents Chemother 2005; 49: 1542–52.
P1566
Novel antimicrobial photodynamic agents active
against epidemic methicillin-resistant
Staphylococcus aureus
G. French, A. King, K. Shannon, W.G. Love, W. Rhys-Williams
(London, Brighton, UK)
Objectives: The rise of epidemic methicillin-resistant
Staphylococcus aureus (EMRSA) and the emergence of
mupirocin resistance means that it is essential to develop new
therapies that cannot be readily overcome by microorganisms.
The XF series of novel light activated antibacterial agents (1)
active against Gram-positive bacteria addresses this issue and
have superior levels of activity to antibiotics but with less
likelihood of resistance emergence. The antibacterial activity of
the XF Drugs against EMRSA has been investigated.
Methods: MIC and MBC assays were used to investigate the
antibacterial activity of XF-73, a novel antimicrobial
photodynamic agent against a range of Staphylococcus aureus
strains. A concentration range of 2–0.001 mg/L was
investigated. 15 minutes of 420 nm light activation (13 J/cm2)
was applied. Light alone had no effect.
Results:
Conclusions: The results demonstrate that XF-73 has
exceptionally low MIC and MBC values against all of the S.
aureus strains tested. The results also demonstrate that XF-73 is
equally effective against MRSA and methicillin-sensitive
Staphylococcus aureus (MSSA) indicating its mode of action is
independent of antibiotic resistance. XF-73 may therefore be
useful in prevention and treatment of EMRSA. XF-73 is non-
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toxic to skin at prophylactic/therapeutic concentrations and has
potential for the treatment of skin sepsis and the eradication of
nasal and skin MRSA carriage. Work is in progress to evaluate
the effectiveness of this compound in eradicating staphylococcal
nasal carriage.
Reference
(1) Maisch T et al. Photodynamic effects of novel XF porphyrin
derivatives on prokaryotic and eukaryotic cells. Antimicrob
Agents Chemother 2005; 49: 1542–52.
P1567
The in vitro bactericidal activity of NXL101, a
novel bacterial topisomerase inhibitor, against
Gram-positive cocci
M. Borgonovi, C. Delachaume, A.M. Girard, J. Lowther
(Romainville, FR)
Objective: NXL101 is a novel antibacterial currently in pre-
clinical development. The mechanism of action is directed
against topoisomerase, and the spectrum of activity is
exclusively against Gram positive organisms. The goal of
the study was to characterise the activity and time/kill
kinetics against common aerobic cocci in comparison to
currently marketed molecules: linezolid (LIN), vancomycin
(VAN), quinupristin/dalfopristin (Q/D) and moxiﬂoxacin
(MOX).
Methods: (i) In vitro susceptibility tests: The strains used were
from the culture collection of Novexel and were of clinical
origin. MICs were determined by an agar dilution technique.
Mueller Hinton agar medium was used, supplemented with 5%
horse blood for Group A streptococci (GAS), Group B
streptococci and S. pneumoniae. Overnight cultures were
diluted to obtain the ﬁnal inoculum of 104 CFU/spot. The
MIC was the lowest concentration which inhibited all visual
growth (3 or less colonies were ignored). (ii) Time/kill kinetics:
Experiments were performed against strains of S. aureus (n = 8)
and S. pneumoniae (n = 4) in 20 ml volumes of appropriate
growth medium with initial inoculum of around 106 CFU/ml of
logarithmically growing culture. Timed samples over a 24 hour
period were enumerated using a spiral plating method. NXL101
was compared to linezolid and vancomycin and the
concentrations tested were 4, 8 and 16-fold the MIC90 for both
species.
Results: (i) The MIC90s of NXL101 versus comparators are
shown in the table. (ii) Time kill experiments showed that
NXL101 was bactericidal against S. aureus, including methicillin
resistant strains (>3log10 reduction within 6–8 hours) compared
to a slowly bactericidal effect for vancomycin (24 hours).
NXL101 and vancomycin were both bactericidal against S.
pneumoniae within 6–8 hours. Linezolid was bacteriostatic
against all strains tested.
Conclusion: NXL101 exhibits bactericidal activity against
common Gram positive cocci, including strains which exhibit
resistance to methicillin, vancomycin and ﬂuoroquinolones.
NXL101 warrants further investigation.
P1568
Protein targets of N-chlorotaurine in bacteria
R. Arnitz, B. Moser, B. Sarg, H.W. Ott, H. Lindner,
M. Nagl (Innsbruck, AT)
Objectives: The aim of this study was to identify bacterial
proteins as targets of the endogenous antiseptic N-chlorotaurine
(NCT), which is a promising microbicidal agent for topical
treatment of infections. In addition, a combination of NCT with
ammonium chloride which enhances the microbicidal activity
signiﬁcantly was investigated.
Methods: Escherichia coli and Staphylococcus aureus were treated
with NCT and NCT plus ammonium chloride for different
incubation times between 1 and 30 min – a period where killing
takes place. To ﬁnd out protein changes, 2D-PAGE of bacterial
proteins followed by mass spectrometry was performed.
Results: Incubation in 1% NCT revealed a change of the charge
and a separation of numerous proteins into a series of spots with
a different isoelectric point. Moreover, in E. coli heat shock
protein 60 appeared, while ribosome releasing factor, D-ribose
periplasmic binding protein, and malonyl-CoA transacylase
spots decreased. In S. aureus, enolase and a translation
elongation factor decreased. These changes appeared more
rapidly in the presence of ammonium chloride, which can be
explained by formation of the more lipophilic and microbicidal
monochloramine. Molecular mechanisms of attack comprised
mainly oxidation of thio and amino groups as conﬁrmed with
model peptides.
Conclusion: These results ﬁt very well to previous preclinical
and clinical ﬁndings. They indicate both surface attack and
penetration of oxidation capacity into the bacteria and
destruction of essential proteins by NCT and NCT plus
ammonium chloride, respectively.
P1569
Anti-staphylococcal activity of ceftobiprole in
recent clinical trial isolates
K. Bush, R. Strauss, K. Amsler, M. Heep, S. Bajaksouzian,
A. Windau, M. Jacobs (Raritan, US; Basel, CH; Cleveland, US)
Objectives: Ceftobiprole is a new extended-spectrum
cephalosporin with activity against methicillin-susceptible and
methicillin-resistant Staphylococci, as well as against most
Enterobacteriaceae. In this study the anti-staphylococcal activity
of ceftobiprole is reported from a set of isolates from a recent
clinical trial.
Methods: Consecutive clinical isolates of Staphylococci from 340
patients enrolled in a multicentre clinical trial involving
complicated skin infections were examined for their
susceptibility to ceftobiprole and selected anti-Gram-positive
agents. MICs were determined using CLSI methodology.
Results: Among these isolates, 525 Staphylococcus aureus and 84
coagulase-negative Staphylococci (CoNS) were identiﬁed. The
percentages of methicillin-resistant strains were 43% for S.
aureus and 50% for CoNS. All strains (except one CoNS with a
linezolid MIC of 8 mg/L) were susceptible to vancomycin and
linezolid, with MICs <2 mg/L.Against methicillin-susceptible S.
aureus, ceftobiprole MIC50 and MIC90 values were 0.25 and
0.5 mg/L, respectively, and against methicillin-resistant S.
aureus, ceftobiprole MIC50 and MIC90 values were 0.5 and
2 mg/L, respectively. Ceftobiprole MICs ranged from £0.06 to
1 mg/L against methicillin-susceptible-CoNS (MS-CoNS) and
£0.06 to 4 mg/L against methicillin-resistant CoNS (MR-CoNS).
Ceftobiprole MIC50 and MIC90 values were 0.25 and 0.25 mg/
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L, respectively, against MS-CoNS and 0.5 and 2 mg/L,
respectively against MR-CoNS. Only one staphylococcal strain
(MR-CoNS) had a ceftobiprole MIC of 4 mg/L.
Conclusions: The potent anti-staphylococcal activity of
ceftobiprole was demonstrated in this collection of recent
clinical trial isolates, where >99% of the strains had MIC
values £2 mg/L.
P1570
Potency of garenoxacin tested against an
international collection of Staphylococcus aureus
isolates, including oxacillin- and ciproﬂoxacin-
resistant subsets (2004–2005)
T. Fritsche, H. Sader, M. Stillwell, R. Jones (North Liberty, US)
Objective: To characterize the antimicrobial activity of
garenoxacin (GRN), a novel des-F(6)-quinolone in late stage
clinical development, against a large international collection of
S. aureus (SA), including oxacillin (OXA)- and ciproﬂoxacin
(CIPRO)-susceptible (S) and resistant (R) subsets, collected in
2004–2005.
Methods: Consecutive, non-duplicate bacterial isolates (10,068
strains) acquired from patients with bloodstream, respiratory,
and skin and skin structure infections both nosocomial and
community acquired were submitted from >70 medical centres
in Europe, the Americas and the Asia-Paciﬁc region. All isolates
were tested using CLSI/NCCLS broth microdilution methods
against GRN, the currently marketed ﬂuoroquinolones (FQ)
including CIPRO, levoﬂoxacin (LEVO), gatiﬂoxacin (GATI) and
representative comparator agents. OXA- and CIPRO-S and -R
subsets were included. A GRN-S breakpoint of £0.12 mg/L was
applied for comparative purposes only and was based upon the
MIC population distributions of strains that included quinolone-
resistance determining region (QRDR) mutations.
Results: Potency for GRN and comparator FQs tested against
SA: (See Table). Key resistance patterns (%) among this SA
collection included OXA (40.3), CIPRO (36.4), erythromycin
(47.5), clindamycin (13.4), tetracycline (9.7), and trimethoprim/
sulfamethoxazole (4.8%); Gram-positive-targeted comparator
including vancomycin, linezolid, daptomycin and
quinupristin/dalfopristin all remained >99% S. Compared
with currently marketed FQs when tested against all SA, GRN
was 2- to 16-fold more active (MIC50, £0.03 vs. 0.06 or 0.5 mg/
L). Against both OXA-S and -R SA, GRN displayed markedly
enhanced potency compared with CIPRO and LEVO (‡4-fold),
and GATI (2- to 4-fold). Among CIPRO-R isolates, GRN also
maintained ‡4-fold greater potency (MIC50, 1 vs. ‡4 mg/L)
although overall S for all FQs was 0–1%.
Conclusions: Compared to the FQ agents tested against SA,
GRN was the most potent agent and maintained the broadest
coverage against OXA- and CIPRO-R strains even when
applying a very conservative epidemiologic breakpoint. When
a FQ is indicated for staphylococcal coverage, this des-F(6)
quinolone may represent a superior alternative among FQ class
agents, while minimizing selection of resistance.
P1571
Garenoxacin activity tested against S.
pneumoniae, H. inﬂuenzae andM. catarrhalis with
elevated or resistant ﬂuoroquinolone MIC values
R. Jones, H. Sader, T. Fritsche, P. Strabala, D. Biedenbach (North
Liberty, US)
Objective: To assess the garenoxacin (GRN) potency against a
vast number of international respiratory tract infection (RTI)
pathogens, especially versus phenotypic (high MIC) or
genotypic (sequence change) QRDR mutants. A total of 40,423
isolates from 6 continents were analysed (1999–2005).
Methods: S. pneumoniae (SPN; 18,887 strains), H. inﬂuenzae (HI;
15,555) and M. catarrhalis (MCAT; 5,981) were susceptibility (S)
tested by CLSI both microdilution methods against GRN and 25
comparison agents. Phenotypic QRDR mutants (PQMs) were
deﬁned by a ciproﬂoxacin (CIPRO) or levoﬂoxacin (LEVO) SPN
MIC at ‡4 mg/L; or CIPRO MIC of ‡0.25 mg/L for HI and
MCAT. 124 SPN strains in 3 S groups (1. CIPRO and LEVO MIC
‡4 mg/L; 2. CIPRO ‡ 4 mg/L and LEVO £2 mg/L; 3. CIPRO
and LEVO £2 mg/L) had QRDR sequences determined (gyr
A,B; par C,E).
Results: Penicillin, macrolides and ceftriaxone resistance (R)
rates for SPN were 18.1, 28.4 and 0.8%, respectively. CIPRO
(2.6% R) and LEVO (0.9% R) rates were low as were PQM
occurrences among HI (19 strains, 0.1%) and MCAT (15 strains,
0.2%). GRN remained the most active ﬂuoroquinolone (>90% S)
against all mutant isolates, but HI isolates were 78.9–84.2% S
(see table). QRDR sequencing demonstrated average numbers of
mutations at 2.7, 1.5 and 1.1 for S groups 1, 2, and 3, respectively;
GRN MIC 50/90 results are 0.5/2, 0.06/0.12 and 0.06/0.12 mg/
L. Highest GRN MIC results (‡1 mg/L) were associated with ‡3
QRDR mutations. (See Table)
Conclusions: GRN maintains clinically usable activity (MIC,
£1 mg/L) against important community-acquired RTI
pathogens having R to presently marketed ﬂuoroquinolones
and against those isolates with documented QRDR mutations.
Continued development of this novel des-F(6) quinolone agent
appears desirable.
P1572
Evaluation of garenoxacin activity tested against
all patterns of multiresistant S. pneumoniae:
multi-centre studies of nearly 15, 000 isolates
R. Jones, M. Stillwell, H. Sader, T. Fritsche, D. Johnson (North
Liberty, US)
Objective: To determine the possible co-resistance (R)
patterns among contemporary worldwide (1999–2005)
isolates of S. pneumoniae (SPN) and the effect on a new des-
F(6) quinolone, garenoxacin (GRN). Multi-resistant (MDR)
patterns were deﬁned by CLSI breakpoint criteria (2005) for
six agents (penicillin [PEN], cefuroxime axetil [CROX],
erythromycin [ER], clindamycin [CL], tetracycline [TC],
TMP/SMX [T/S]).
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Methods: A total of 14,665 SPN strains were susceptibility (S)
tested by CLSI broth microdilution methods, with isolates
originally cultured in laboratories in Europe, Asia, Australia,
Africa and the Americas. Comparison ﬂuoroquinolones (FQs, 4)
were ciproﬂoxacin, gatiﬂoxacin (GATI), levoﬂoxacin (LEVO)
and moxiﬂoxacin (MOXI). All S patterns were determined and
then the S rates calculated for non-pattern agents determined in
each group having ‡100 occurrences. See table for prevalence of
‡2%.
Results: Fifty-two distinct patterns were detected, of which 10
(81.8% of all strains) predominated. AmongMDR SPN strains (R
at ‡2 agents; 39.6% of isolates), GRN remained very active with
99.88% S at £1 mg/L (MIC90, 0.06 mg/L). SPN with R to only
one drug or a complete S pattern had 99.93% S to GRN
(p > 0.05). This potency for GRN was greater than GATI
(MIC90, 0.5 mg/L), LEVO (MIC90, 1 mg/L) and MOXI
(MIC25, 0.5 mg/L), all providing a 99.00% S rate. Patterns
with R to four agents had the lowest GRN-S rate at 99.55%.
Strains R to all agents were completely GRN-S (see table).
Conclusion: GRN was highly active (99.91% at £1 mg/L)
against all SPN R patterns including MDR phenotypes (5,811
strains). This activity was greater than comparison marketed
FQs (4), macrolides, and beta-lactams, but comparable (near
100% S) to glycopeptides, e.g. vancomycin (data not shown).
Continued development of GRN for serious MDR SPN
infections appears warranted.
P1573
Garenoxacin activity and potency against S.
pneumoniae and H. inﬂuenzae respiratory tract
isolates (2004–2005): report from a Worldwide
Surveillance Network
R. Jones, P. Strabala, T. Fritsche, H. Sader (North Liberty, US)
Objective: To evaluate the comparative activity of garenoxacin
(GRN), a novel des-F(6) quinolone, tested by reference methods
against recent community-acquired respiratory tract (CARTI)
and CA pneumonia (CAP) isolates. S. pneumoniae (SPN) and H.
inﬂuenzae (HI) strains from Latin America (10 sites), USA (23),
Europe (20), and the Far East (11) were sampled in 2004–2005.
Methods: Consecutive, non-duplicate cultures of SPN (3,042)
and HI (965) were tested by CLSI reference broth microdilution
methods with concurrent QC and interpretative criteria (M7-A7
and M100-S16, 2006). Comparison antimicrobials numbered >25,
including: penicillin (PEN), clarithromycin (CLAR), ceftriaxone
(CTRI), and 4 ﬂuoroquinolones (FQ), ciproﬂoxacin (CIPRO),
levoﬂoxacin (LEVO), gatiﬂoxacin (GATI), and moxiﬂoxacin
(MOXI). GRN susceptibility (S) was deﬁned as MIC at £1 mg/
L for comparison purposes only. CARTI isolates came from 23
nations and CAP strains from hospitalized patients (HCAP) in 9
countries.
Results: The following table lists key study results: (See table)
GRN activity remained unchanged compared to 1999–2003
results (2005 ECCMID abstract 1555 and 1565) with 99.9 and
100.0% inhibition at £1 mg/L for SPN and HI, respectively.
GRN was more potent than LEVO (16-fold), GATI (8-fold) and
MOXI (4-fold) against SPN, and HCAP isolates were slightly
more S than CARTI strains to nearly all agents. CTRI (96.0–
98.8% S), cefepime (92.8–96.4%) and amoxicillin/clavulanate
(90.5–91.8%) were the most active beta-lactams against SPN.
PEN- and macrolide (CLAR)-R was elevated (26.9–37.3%) in
SPN and nearly 24% of HI produced a beta-lactamase
(ampicillin-R). Possible QRDR mutations (CIPRO MIC, ‡4 mg/
L) in SPN were noted for 1.2–2.8% of isolates.
Conclusions: GRN continues to exhibit the greatest activity (4-
to 16-fold) compared to FQs tested against an updated (2004–
2005) collection of CARTI and CAP isolates of SPN and HI. As
FQ resistance evolves due to QRDR mutations, GRNMIC values
generally remain well below potentially R levels, minimizing
further selective pressure.
P1574
In vitro activity of garenoxacin tested against
ciproﬂoxacin-susceptible and -resistant
Enterobacteriaceae and Acinetobacter spp. strains
collected worldwide by the SENTRY
Antimicrobial Surveillance Program (2004–2005)
H. Sader, T. Fritsche, P. Strabala, R. Jones (North Liberty, US)
Objective: To evaluate the contemporary activity of
garenoxacin (GRN) against ciproﬂoxacin (CIPRO)-susceptible
(S) and CIPRO-resistant (R) Enterobacteriaceae (ENT) and
Acinetobacter spp. (ASP). Unlike recently marketed
ﬂuoroquinolones (FQ), GRN, a des-F(6) quinolone lacks the C-
6 ﬂuorine.
Methods: A total of 9,017 isolates (8,247 ENT and 770 ASP)
were consecutively collected from > 70 medical centres from
bloodstream, respiratory, urinary and skin and soft tissue
infections and tested by reference broth microdilution methods
according to CLSI/NCCLS methods and interpretative criteria.
A GRN S breakpoint of £1 mg/L was applied for comparison
purposes only.
Results: The results of the major organism groups tested: (See
table). GRN showed excellent activity against this large
collection of ENT (MIC50, 0.12 mg/L) and 82.7% of isolates
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were inhibited at £1 mg/L. The activity (MIC50/%S) of other
oral antimicrobials tested against ENT was: amoxicillin/
clavulanate 8/62.2%, cefuroxime 4/58.2%, gatiﬂoxacin £ 0.5/
85.9%, levoﬂoxacin £ 0.5/85.9%, moxiﬂoxacin 0.06/84.7%,
trimethoprim/sulfamethoxazole £ 0.5/74.4%. The in vitro
activity of GRN was most similar to that of CIPRO. Among
CIP-S ENT (6,985 isolates), 97.2% (86.3–100.0%) where S to GRN,
while among CIPRO-S ASP, 98.1% were S to GRN. 91.6% of CIP-
R ENT isolates were also R to GRN.
Conclusions: GRN in vitro activity was superior to other tested
orally administered agents representing several different drug
classes when tested against contemporary (2004–2005) ENT and
ASP isolates and was similar to that of the several commonly
used FQs.
P1575
Microbiologic efﬁcacy of garenoxacin vs.
comparators in complicated skin and skin
structure infections
D. Krievins, C. Le Devehat, G. Herrera (Riga, LV; Nevers, FR;
San Jose, CR)
Objectives: Garenoxacin (GRN) is a novel, broad-spectrum des-
F(6)-quinolone with activity against Gram-negative and Gram-
positive aerobes and anaerobes including quinolone-resistant
Staphylococcus aureus. The objective of this analysis was to
compare the microbiologic efﬁcacy of GRN to that of
comparators against common pathogens involved in
complicated skin and skin structure infections (cSSSI).
Methods: Two multinational, double-blind, randomized
studies were conducted. In the ﬁrst study, subjects received
GRN (600 mg IV to PO qd) or piperacillin/tazobactam (3.375 g
IV q6h) with transition to PO amoxicillin/clavulanate (500 mg
PO q8h). In the second study, subjects received GRN (600 mg
PO qd) or ciproﬂoxacin/metronidazole (500 mg q12h/500 mg
q8h). All antimicrobials were administered for 7 to 14 days.
Subjects were adults (‡18 y) newly hospitalized or ambulatory
outpatients with evidence of cSSSI who did not have underlying
osteomyelitis. Microbiologic efﬁcacy was determined 5
to18 days post-therapy.
Results: A total of 567 subjects were microbiologically evaluable
(GRN, n = 283; comparators, n = 284). The disease diagnosis was
similar between GRN and comparators and included infected
pressure sore (5% vs 3%), infected diabetic foot ulcer (18% vs
19%), major abscess (66% vs 67%), or postsurgical wound
infection (11% vs 12%). The majority of common skin
pathogens were eradicated by GRN and comparators.
Eradication rates for S. aureus were higher in the GRN group
[88% (120/137)] than in the comparator group [74% (108/146)].
Eradication of methicillin-resistant strains of S. aureus was 72%
(13/18) and 60% (12/20) for GRN and combined comparators,
respectively. GRN effectively eradicated quinolone-resistant S.
aureus [73% (8/11); comparators 50% (5/10)]. Eradication rates
for anaerobic pathogens were 86% (92/107) and 92% (100/109)
for GRN and comparators, respectively. GRN effectively
eradicated the Bacteroides fragilis group [82% (18/22)],
Peptostreptococcus species [86% (32/37)] and Prevotella species
[92% (23/25)]. Eradication rates were higher for GRN than
comparators against Gram-negative pathogens [88% (137/156)
vs 81% (143/176)]. This included activity against Escherichia coli
[82% (23/28)], Pseudomonas aeruginosa [83% (24/29)] and Proteus
mirabilis [82% (9/11)].
Conclusion: GRN demonstrated excellent, broad spectrum
activity against Gram-positive, Gram-negative, and anaerobic
pathogens including resistant organisms involved in cSSSI.
P1576
Dual action of gemiﬂoxacin in acute bacterial
sinusitis in patients with allergic rhinitis:
antibacterial and immunomodulatory effects?
H. Lode, J. Garau, T. File, P. Ball, G. Tillotson, I.
Morrissey (Berlin, DE; Barcelona, ES; Akron, US; St Andrews, UK;
Waltham, US; London, UK)
Background: Acute bacterial sinusitis (ABS) is a common
infection world-wide, with many patients having an associated
an allergic component/history. However the role of
antibacterials in these patients (pts) has not been examined. As
some ﬂuoroquinolones (FQ) have an in-vitro
immunomodulatory effect (IE) the clinical efﬁcacy of GEM
was compared other agents in ABS pts with or without allergic
rhinitis (AR).
Methods: 5 phase 3 clinical trials were pooled and pts where
allergic rhinitis was identiﬁed (584 pts) were compared with pts
not reporting AR (1834 pts). Clinical response (success or
failure) at end of therapy (EOT) & at follow-up (FU, approx. 1–
3 weeks after treatment) was studied. Comparators (CMP) were
cefuroxime (CEF) and trovaﬂoxacin (TRO).
Results: % Success based on clinical outcome at EOT and FU for
AR and non AR pts are shown in the table. For all treatments
EOT success was high for the non AR pts, but at FU this was
reduced, especially with both FQs. In contrast, GEM retained a
high clinical success rate in pts with AR unlike CEF or TRO.
Conclusion: GEM has been shown to be very efﬁcacious in a
sub group of problematic ABS pts. This advantage may be due
to the high antibacterial activity of GEM vs key ABS pathogens
and/or a stimulatory IE. Both being important with pts having
decreased local immune defences. These data also show that not
all ﬂuoroquinolones have immuno-stimulatory properties.
P1577
Garenoxacin efﬁcacy against multidrug-resistant
Streptococcus pneumoniae: retrospective analysis
of community-acquired pneumoniae isolates
obtained from nine phase II and III clinical
studies (1999–2003)
T. Black, H. Waskin, R. Hare (Kenilworth, US)
Objective: Garenoxacin (GRN) is a novel, des-F(6)-quinolone
with excellent activity against S. pneumoniae, one of the most
common pathogens causing community-acquired pneumoniae
(CAP). The incidence of infections caused by antibiotic-resistant
isolates of Streptococcus pneumoniae is on the increase, therefore
information regarding the activity of new anti-infective drugs
against populations of S. pneumoniae that are multi-drug
resistant (MDR) is critical. MDR S. pneumoniae (MDRSP)
includes isolates previously known as PRSP (penicillin-
resistant S. pneumoniae), as well as strains resistant to two or
more of the following antibiotics: second-generation
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cephalosporins, macrolides, tetracyclines, and trimethoprim/
sulfamethoxazole.
Methods: Pretreatment sputum and blood isolates collected
worldwide during GRN phase 2/3 clinical CAP trials (1999–
2003) were retrospectively analysed for the MDRSP phenotype.
Of the 352 S. pneumoniae isolates originally identiﬁed, 208 from
180 subjects were subjected to secondary MDR susceptibility
testing by central laboratories. Conﬁrmed MDRSP isolates were
matched to individual subjects to assess clinical and
microbiological outcomes for MDRSP-infections treated with
GRN.
Results: Expanded susceptibility testing identiﬁed 53/208
MDRSP isolates from 44 unique subjects. The lowest MIC50
and MIC90 values for MDRSP isolates tested against a panel of
representative drugs were observed for GRN (Table 1; 0.03 lg/
ml and 0.06 lg/ml, respectively). The incidence of resistance to
the ﬁve classes of drugs was 11%, 12%, 21%, 19% and 18% for
penicillin, 2nd Generation Cep., macrolides, tetracycline and
Tri/Sulf, respectively. No isolates were resistant to GRN using a
proposed susceptibility breakpoint value of £1 lg/ml. Thirty-
ﬁve percent, 28%, 15%, 9% and 13% of isolates were resistant to
1, 2, 3, 4 and 5 drug classes, respectively. The worldwide
incidence of MDRSP was 18% with an equivalent geographic
distribution of 19%, 21% and 16% among North America,
Europe and the Rest of World. Overall, GRN provided clinical
and bacteriological success for 32/35 (91%) CAP evaluable
subjects with MDR infection, which was similar to clinical
success for evaluable subjects with non-MDRSP CAP infections
151/165 (92%).
Conclusions: These data demonstrate the ability of GRN to
successfully eradicate MDRSP associated with CAP.
P1578
Clinical outcome of community-acquired
pneumonia infections treated with gemiﬂoxacin:
the effect of patient risk factors
J. Garau, T. File, P. Ball, H. Lode, G. Tillotson, I. Morrissey
(Madrid, ES; Akron, Waltham, US; St Andrews, London, UK; Berlin,
DE)
Background: Due to increased resistance to many traditional
therapies the respiratory ﬂuoroquinolones have become
important agents in the management of patients with
community-acquired pneumonia (CAP). Gemiﬂoxacin is a new
potent ﬂuoroquinolone with excellent activity against CAP
pathogens. Pooled data from 6 phase III CAP gemiﬂoxacin
clinical trials were evaluated.
Methods: Patients (1352 in total) were grouped based on risk
factors according to the IDSA guidelines [Mandell et al.2003
CID 37:1405]. Clinical response (success or failure) at end of
therapy (EOT) & at follow-up (FU, approx. 1–3 weeks after
treatment) was evaluated. The main comparators in the pooled
studies were cefuroxime & clarithromycin (171 patients),
trovaﬂoxacin (145 patients) & amoxicillin-clavulanate (98
patients). Per cent success is shown in the table (AB,
antibiotics, COPD, chronic bronchitis and obstructive lung
disease, HD, heart disease).
Results: Although gemiﬂoxacin showed lower % success than
comparator against CAP patients with no deﬁned risk factor,
gemiﬂoxacin was considerably more successful than comparator
against patients associated with risk factors, especially diabetic
patients where comparator success was low. This advantage
was often more prominent at FU than at EOT. Patients with
other comorbidities such as renal failure or malignancy were not
recruited in sufﬁcient number for analysis.
Conclusions: These data support the use of gemiﬂoxacin in the
treatment of CAP, especially where the patient has recognised
IDSA risk factors.
P1579
Microbiologic efﬁcacy of garenoxacin vs.
comparators against common pathogens
associated with community-acquired pneumonia
M. De Salvo, H. Vasconcelos Lopes, P. Kasemets, H.
Waskin (Buenos Aires, AR; Sao Paulo, BR; Tampere, FI; Kenilworth,
US)
Objectives: Garenoxacin (GRN) a novel, broad-spectrum des-
F(6)-quinolone is active against many clinically important
respiratory pathogens including penicillin-resistant strains of
Streptococcus pneumoniae. GRN has dual sites of inhibition (DNA
gyrase and topoisomerase IV) and may be less likely to promote
resistance. The objective of this analysis was to compare the
microbiologic efﬁcacy of GRN to that of comparators against
common pathogens involved in community-acquired
pneumonia (CAP).
Methods: Two multinational, double-blind, randomized
studies were conducted. In the ﬁrst study, subjects received
GRN (400 mg PO qd for 5 d) or amoxicillin/clavulanate (A/C;
500 mg PO q8h for 7–10 d). In the second study, subjects
received GRN (400 mg PO qd for 7–10 d) or levoﬂoxacin (LEV;
500 mg PO qd for 7–10 d). Adults (18 years of age or older)
were enrolled with clinical and radiologic evidence of CAP
[new inﬁltrate(s) on chest radiograph and fever, leukocytosis,
cough, chest pain, auscultatory ﬁndings, or sputum
production]. The majority of subjects were Fine class I/II in
both studies. Bacteriologic eradication was assessed 5
to18 days post therapy.
Results: A total of 377 treated subjects had pretreatment
pathogens (GRN, n = 179; comparators, n = 198). The overall
eradication rate in all treated subjects was 91% (129/142) for
GRN and 85% (123/145) for the comparators. Eradication rates
for S pneumoniaewere 92% (24/26) for garenoxacin and 96% (49/
51) for the comparators. Eradication of S pneumoniae was 100%
and 89% for A/C and LEV, respectively. In strains with reduced
susceptibility to penicillin eradication rates were 86% (6/7) vs
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67% (2/3) in favour of GRN. Eradication rates for H. inﬂuenzae
were 89% (40/45) and 75% (30/40) for GRN and comparators,
respectively. LEV eradicated 71% of H. inﬂuenzae isolates and
A/C eradicated 77% of the strains isolated. There were very few
isolates (4) of Moraxella catarrhalis in the 2 studies. In 1 study
GRN was 100% effective against 3 strains ofM. catarrhalis and in
the other A/C was 100% effective against the 1 strain isolated.
GRN eradicated 95% (19/20) of the Staphylococcus aureus isolates
vs 100% (11/11) for the comparators.
Conclusions: GRN was highly active against pathogens
commonly associated with CAP including drug-resistant
strains of S pneumoniae and represents an effective therapeutic
option for this patient population.
P1580
Efﬁcacy of garenoxacin in the treatment of
community-acquired pneumonia caused by
multidrug-resistant Streptococcus pneumoniae
G. Dien, J. Gaillat, L. Dunbar, L. Vives, H. Waskin (Hyeres,
Annecy, St Gaudens, FR; New Orleans, Kenilworth, US)
Objectives: Garenoxacin (GRN) a novel, broad-spectrum des-
F(6)-quinolone is active against many clinically important
respiratory pathogens including penicillin-resistant strains of
Streptococcus pneumoniae. There is a growing problem of
resistance in strains of S pneumoniae, with multi-drug-resistant
S pneumoniae (MDRSP) becoming increasingly more common.
The objective of this study was to evaluate the clinical and
microbiologic efﬁcacy of GRN in the treatment of community-
acquired pneumonia (CAP) caused by MDRSP.
Methods: This was a multinational, open-label, non-
comparative study. Subjects were adults (‡18 and <75 y) with
clinical (clinical signs, sputum production), radiologic (new
inﬁltrates on chest radiograph), or microbiologic (predominance
of Gram-positive cocci in pairs on sputum Gram-stain or a
positive blood culture for S. pneumoniae) evidence of CAP
caused by S. pneumoniae. Subjects received GRN 400 mg PO qd
or GRN 400 mg IV with transition to 400 mg PO qd for 7 to
14 days. Clinical and microbiologic responses were determined
at a test-of-cure visit 7 to 14 days posttherapy.
Results: A total of 121 subjects were enrolled. Of these, 47 (17
PO only, 30 IV to PO) were clinically and microbiologically
evaluable. Clinical and microbiologic success rates were 91%
(43/47) and 89% (42/47), respectively. Clinical success rates
were 94% (16/17) and 90% (27/30) for PO and IV to PO,
respectively. Documented S. pneumoniae bacteremia was present
in 28% (n = 13) of subjects with a clinical success rate of 92%.
Among evaluable subjects, resistance rates for S. pneumoniae
were penicillin 13%, second-generation cephalosporin 17%,
macrolides 21%, tetracyclines 21%, and trimethoprim/
sulfamethoxazole 17%. Twelve evaluable subjects had
pneumonia caused by MDRSP. Clinical success rate was 92%
(11/12) in subjects with MDRSP and 91% (32/35) in non-MDRSP
subjects. Clinical success of GRN for strains resistant to 2, 3, 4, or
5 antimicrobial drug classes, were 100% (5/5), 100% (1/1), 100%
(2/2), and 75% (3/4), respectively. Microbiologic success was
83% (10/12) and 91% (32/35) for MDRSP and non-MDRSP
(susceptible or resistant to 1 class) strains, respectively. GRN
was generally well tolerated with drug-related adverse events
(AE) reported in 14% (8/58; PO) and 21% (13/63; IV to PO) of
subjects.
Conclusions: GRN (PO or IV to PO) is an effective treatment
for CAP caused by MDRSP and non-MDRSP. GRN is well
tolerated.
P1581
In vitro bactericidal activity of daptomycin
against Staphylococcus aureus and Enterococcus
spp.: comparison with vancomycin, teicoplanin
and linezolid
H. Drugeon, M. Juvin (Nantes, FR)
Objectives: The aim of this study was to evaluate the
bactericidal activity (by killing kinetics) of daptomycin (DAP)
against Staphylococcus aureus (SA) clinical isolates with different
teicoplanin MICs and against Enterococcus faecalis (EFL) and E.
faecium (EFM) with different mechanisms of glycopeptide
resistance. DAP has been compared with teicoplanin (TEI),
vancomycin (VAN) and linezolid (LIN).
Methods: 6 SA strains (2 MSSA and 4 MRSA) with TEI MIC
distributed from 0.5 to 8 mg/L, 6 Enterococcus (3 EFL and 3
EFM) with glycopeptide phenotypes [S, R-vanA, R-vanB] were
studied using a killing curve method. 7 antibiotic concentrations
were used from 1 mg/l to 64 mg/l in two fold dilutions.
Surviving bacteria were counted at T0, T30’, T1, T3, T6, T12 and
T24 hours using agar plates with inhibitors to prevent antibiotic
carry-over. Antibiotics tested were daptomycin (DAP),
teicoplanin (TEI), vancomycin (VAN) and linezolid (LIN).
Results: All the SA isolates were susceptible to DAP
(MIC = 0.25–1 mg/l), to LIN (MIC = 1–2 mg/L), to VAN
(MIC = 1–2 mg/L) regardless of susceptibility to methicillin.
DAP showed the same strong concentration dependent
bactericidal activity with MSSA and MRSA: at T30’
bactericidal activity (BA) (decrease of 3 log10 cfu/mL) was
observed with 8–16 mg/L of DAP; at T3 hours, 1–4 mg/L of
DAP was sufﬁcient and at T6 hours, BA was obtained with
1 mg/L of DAP. The other antibiotics showed a time dependent
bactericidal activity but BA was observed only with long
exposure (‡12 hours) and with high concentrations. All the
Enterococcus isolates were susceptible to DAP (MIC = 1–2 mg/
L) and to LIN (MIC = 1–2 mg/L) regardless of the resistance to
glycopeptides. BA of DAP was also concentration dependent.
BA was obtained with 4–8 mg/L after 6 hours of contact and
with 1 mg/L after 12 hours of contact for EFL. BA was observed
with 8–16 mg/L after 6 hours of contact and with 1–2 mg/L
after 24 hours of contact for EFM. The other antibiotics had a
time dependant activity but didn’t show bactericidal activity
with concentrations 32 mg/L.
Conclusion: The bactericidal activity of daptomycin was very
strong, concentration dependent, and not inﬂuenced by the level
or mechanism of glycopeptide resistance The bactericidal
activity of linezolid was time dependent and observed only
with the highest concentration and the bactericidal activity of
vancomycin and teicoplanin was time dependent but was
inﬂuenced by the mechanism of glycopeptide resistance.
P1582
Comparative in vitro activities of telavancin and
other antibacterial agents against selected Gram-
positive bacteria
J. Brauers, M. Kresken, S. Bagel (Rheinbach, DE)
Objectives: Telavancin (TLV) is a bactericidal lipoglycopeptide
with multiple mechanisms of action that is in phase 3 clinical
trials for the treatment of complicated skin and skin structure
infections and hospital-acquired pneumonia with a focus on
infections due to methicillin-resistant Staphylococcus aureus
(MRSA). This study evaluated and compared the antibacterial
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activity of TLV with that of other antibacterial agents against
recent gram-positive clinical isolates from Germany.
Methods: A total of 363 aerobic gram-positive bacterial strains
recently collected were included. Antibiotics tested were TLV,
vancomycin (VAN), teicoplanin, penicillin, oxacillin, ampicillin,
cefuroxime, ceftriaxone, daptomycin (DAP), linezolid (LZD),
quinupristin-dalfopristin, clindamycin, ciproﬂoxacin,
levoﬂoxacin, gentamicin, streptomycin, erythromycin,
telithromycin, co-trimoxazole and tetracycline. MICs were
determined by the broth microdilution procedure according to
the guidelines of the CLSI.
Results: TLV exhibited potent activity against all gram-
positive bacteria including resistant isolates such as MRSA,
VAN-resistant enterococci, pneumococci (including multiple
resistant strains with various antibiotic resistance phenotypes)
and other streptococcal species. TLV showed excellent in vitro
activity against the species irrespective of the antibiotic
phenotype tested. For methicillin-susceptible S. aureus
(MSSA, n = 33) and MRSA (n = 42) MIC90 of TLV for both
phenotypes were 0.5 mg/L. For coagulase-negative
Staphylococci (n = 72, incl. MSSE, MRSE, MSSH, MRSH and
others) MIC90s were 0.5 or 1 mg/L. MIC90s of TLV for
Enterococcus faecalis (n = 30) and E. faecium (n = 32) were 1 and
2 mg/L, respectively. For VAN-resistant strains of E. faecalis
(n = 2) or E. faecium (n = 7) MICs for TLV ranged from 0.12 to
4 mg/L. Against Streptococcus pneumoniae (n = 60) TLV MICs
ranged from £0.001 to 0.03 mg/L. All Streptococcus pyogenes,
Streptococcus agalactiae and all viridans group streptococci
(n = 94) had MICs of £0.125 mg/L.
Conclusion: Based on MIC90, TLV was more potent than VAN,
DAP or LZD against Staphylococci, streptococci and E. faecalis. It
was superior to DAP and LZD against E. faecium and at least as
active as DAP or LZD against most VAN-resistant enterococci.
TLV appears to be a promising new antimicrobial agent for the
treatment of infections caused by gram-positive organisms
including multiply resistant isolates.
P1583
Evaluation of daptomycin, vancomycin,
teicoplanin and linezolid against Staphylococcus
aureus, Enterococcus faecalis and Enterococcus
faecium utilising in vitro time-kill methodology
J. Brauers, M. Kresken, A. Menke, A. Orland, I. Morrissey
(Rheinbach, DE; London, UK)
Objective: The cyclic lipopeptide daptomycin (DAP) exhibits
rapid, concentration-dependent bactericidal activity against
Gram positive bacteria (GPB). In this study we assessed the
bactericidal activity of DAP by time-kill methodology against
GPB in comparison with vancomycin (VAN), teicoplanin (TPL)
and linezolid (LZD) using drug peak serum concentrations
(PSC) and free serum concentrations (FSC).
Methods: The activity of DAP, VAN, TPL and LZD was
evaluated by the CLSI time-kill method. For our experiments
we used the following PSCs/FSCs (mg/l): VAN 40.0/18.0; TPL
45.0/4.5 and LZD 15.0/10.4. As PSC of DAP 60.0 mg/l was
chosen. The extent of protein binding (PB) of DAP is still under
investigation and data available so far indicate PB of either
92% or 63%. Therefore we tested two FSCs: 22.0
(corresponding to 63% PB) and 4.8 (corresponding to 92%
PB). The activity of DAP was determined in Mueller-Hinton
broth supplemented with 50 mg/l calcium. Viability counts
were performed at 0.25, 0.5, 1, 3, 6, 12 and 24 h. One
methicillin-susceptible Staphylococcus aureus (MSSA), two
methicillin-resistant S. aureus (MRSA), one vancomycin-
susceptible (VAN-S) and one VAN-resistant (VAN-R)
Enterococcus faecalis, one VAN-S and one VAN-R Enterococcus
faecium were tested. Bactericidal activity was deﬁned as >99.9%
killing during incubation.
Results: DAP was bactericidal at concentrations of 60.0 mg/l
and 22.0 mg/l in all seven strains. The concentration of
4.8 mg/l was bactericidal against the two MRSA and against
the VAN-S E. faecium. In the other four strains the maximum
reduction of initial inoculum ranged from 1.52 to 2.53
log10 CFU/ml. In six strains a bactericidal effect at 60.0 mg/l
and 22.0 mg/l of DAP, respectively, occurred between
15 minutes and 3 h and after 6 h in the VAN-S E. faecalis.
VAN at 40.0 mg/l or 18.0 mg/l was bactericidal in only two
strains after 24 h (1 MSSA, 1 MRSA). Against the other ﬁve
strains, VAN was bacteriostatic with maximum reduction of
initial inoculum between 1.91 and 2.78 log10 CFU/ml at
40 mg/l after 24 h, respectively. Both TPL and LZD were
consistently bacteriostatic against the test strains.
Conclusion: DAP at PSC of 60.0 mg/l as well as at FSC of
22.0 mg/l showed a pronounced bactericidal effect within 3 h in
6/7 strains. VAN was bactericidal in only 2/7 strains after 24 h.
Compared to VAN bacterial killing by DAP was very rapid. TPL
and LZD were bacteriostatic only.
P1584
The effect of human serum on the bactericidal
activity of daptomycin and comparators against
Staphylococcus aureus and Enterococcus spp.
I. Morrissey, A. Leakey, R. Maxﬁeld, T. Veltman, R. Woods,
M. Robbins (London, UK)
Background: Daptomycin is a new cyclic lipopeptide antibiotic
that shows rapid bactericidal activity and has high protein
binding when assessed by standard methodology. This study
investigated the bactericidal activity of daptomycin and the
effect of protein binding by the addition of 50% human serum
(HS).
Methods: Exponentially-growing methicillin-susceptible and –
resistant S. aureus (MSSA, MRSA) and vancomycin-susceptible
Enterococcus faecium (VSE) and -resistant Enterococcus faecium
(VRE) (ca. 106 CFU/mL) were exposed to daptomycin (DAP),
vancomycin (VAN), teicoplanin (TEI), piperacillin-tazobactam
(PTZ) or linezolid (LZD) at peak (P) and trough (T) serum
concentrations in Mueller Hinton broth supplemented with
Ca2+ to 50 mg/L with or without HS. Viable count was
determined at 0.25, 0.5, 3, 6 & 24 h. Plots were made of log
reduction in viable count over time and the area-under-the-
curve measured to calculate bactericidal indices (BIs) from these
plots (J Antimicrob Chemother 1997, 39: 713–717).
Results: Daptomycin reduced viable count of MSSA & MRSA
by approx. 5 logs or more within 0.25 h and VSE or VRE within
3 h at P. Other agents either did not achieve this or required 24 h
to do so (not shown). BI data are shown below (>represents kill
beyond the limit of detection). HS had little effect on DAP kill,
except against the VRE at T. Nevertheless, DAP at T against VRE
was more bactericidal than any other antibacterial except DAP
at P.
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Conclusions: DAP was the most bactericidal agent tested as
measured either by BI or rate of kill. Dap at P reduced MSSA
and MRSA to below detection within 15 min. The effect of HS
was minimal which suggests that protein binding is either weak
or highly reversible. These data support the use of DAP in the
treatment of infections caused by these organisms.
P1585
Daptomycin activity against multi-resistant
Staphylococcus haemolyticus bloodstream
isolates from severe infections
F. Campanile, M. Venditti, S. Borbone, D. Bongiorno, A. Penni,
S. Stefani (Catania, Rome, IT)
Objectives: Daptomycin, a new cyclic lipopeptide with activity
against multidrug-resistant Gram-positive pathogens including
MRSA, is approved for use in cSSST infections (US-FDA) and is
being reviewed by EMEA for approval in EU member countries.
The rapid bactericidal activity of daptomycin, due to its unique
mechanism of action, makes it an attractive antibiotic for serious
Gram-positive infections. The study was performed: (i) to
evaluate the activity of daptomycin and other drugs against 50
multi-resistant clinically relevant Staphylococcus haemolyticus
(MRSH), isolated from bloodstream infections in various
hospitals in Italy (ii) to determine epidemiologic and genetic
correlation among strains, and (iii) to characterize the SCCmec
DNA of these strains.
Methods: The MRSH strains were tested against a panel of
antimicrobial agents, by broth microdilution method performed
according to CLSI (Clinical Laboratory Standards Institute)
guidelines, including supplementation of 50 mg/L calcium for
daptomycin. Moreover, phenotypic tests and antibiotic
susceptibility proﬁling were carried out and the results
compared with molecular typing analysis by using SmaI-PFGE
ﬁngerprints and PCR to characterize the mec-complex.
Results: All isolates were resistant to erythromycin, gentamicin,
ciproﬂoxacin, 16 strains showed reduced susceptibility to
vancomycin (MICs 2 mg/L), 24 strains were resistant to
cotrimoxazole, 16 strains to clindamycin, 6 strains to
chloramphenicol and 3 strains to tetracycline. Almost all
isolates were inhibited by £1 mg/L of daptomycin, and only
four strains exhibited a MIC value of 2 mg/L. PFGE analyses
showed the existence of at least two multi-resistant S.
haemolyticus clones widespread in different hospitals.
Methicillin-resistance was correlated to the presence of the
mecA and preliminary results regarding the genetic element
carrying the gene, showed an organization of the mec-complex
of class A and class C.
Conclusions: Our results suggest that daptomycin has excellent
activity against multiresistant MR S. haemolyticus isolates, which
represent a serious threat in catheter-related bloodstream
infections. Furthermore, the emergence of S. haemolyticus
exhibiting reduced susceptibility to vancomycin is of
particular concern, probably due to the common use of
vancomycin as initial therapy for such infections. Moreover,
the use of additional molecular techniques to ﬁngerprint isolates
makes this study of clinically important CoNS more accurate.
Resistance, linezolid, glycopeptides and inhibitors of protein
synthesis
P1586
Mechanism of action of ceftobiprole: structural
basis for anti-MRSA activity
A. Lovering, F. Danel, M.G.P. Page, N.J. Strynadka (Vancouver,
CA; Basel, CH)
Objectives: Ceftobiprole is a new cephalosporin with a broad
spectrum of action including methicillin-resistant Staphylococci
(MRS) as well as many other Gram-positive and Gram-negative
pathogenic bacteria. This study investigates the structural basis
for the good activity against MRS.
Methods: The primary beta-lactam resistance determinant of
MRS, penicillin-binding protein PBP 2’ (or 2a) has been cloned
and expressed as a soluble form in which the amino-terminal
residues forming a membrane-anchor have been deleted. The
soluble form has been crystallized and the structure of the
complex formed after soaking crystals in a solution containing
ceftobiprole has been determined at 2.8 Angstrom resolution.
Additional data on the structure of the ceftobiprole-PBP2’
complex formed in solution has been obtained using
spectroscopic methods such as UV-circular dichroism.
Results: Ceftobiprole reacts rapidly with PBP2’ to form a stable
acyl-enzyme complex. The ceftobiprolemoiety is positioned deep
within the active site of the acyl-enzyme complex formed with
PBP2’, where it forms several hydrogen bonds and hydrophobic
interactions. In particular, the 7-aminothiadiazolylhyroxyi-
minoacetyl side chain of ceftobiprole sits more deeply within
the side-chain binding pocket of PBP 2’ than does the 7-acylamino
side chain of nitroceﬁn in the previously determined complex
structure. The additional interactions probably add to the
enhanced stability of the acyl-enzyme complex formed with
ceftobiprole, compared to complexes formed with other beta-
lactams that are inactive against MRS. Signiﬁcant structural
rearrangements between apo-enzyme and acyl-enzyme are
evident in the crystal structure and in solution.
Conclusion: Ceftobiprole readily forms a stable inhibitory acyl-
enzyme complex with the PBP 2’, the beta-lactam resistance
determinant of MRS. This, together with potent inhibition of the
normal complement of beta-lactam sensitive penicillin-binding
proteins, accounts for its excellent activity against Staphylococci
and probably accounts for the low rates of resistance
development observed in experimental conditions.
P1587
Incidence of Staphylococcus aureus with reduced
susceptibility to glycopeptides in a French
hospital (November 2004–April 2005)
C. Morate, A. Charron, C. Bebear, J. Maugein (Bordeaux, FR)
Staphylococcus aureus are a major cause of nosocomial infections
around the world. Glycopeptides remain the drug of choice for
severe infections caused by MRSA. However, after the emer-
gence of vancomycin resistance in Enterococcus and in the
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coagulase negative staphylococcus, strains of Staphylococcus
aureus with reduced susceptibility to glycopeptides (GISA)
have been reported in different countries like Japan, France,
Spain, the UK and the United States. The aim of our study was
to determine the proportion of vancomycin resistance in clinical
S. aureus isolates in a french university hospital, between
November 2004 and April 2005, then we wanted to deﬁne if
there was an epidemic clone and study the clinical impact of
these GISA strains. The protocol of detection was, ﬁrst, a
screening test on BHI agar containing 4 mg/L of teicoplanin,
then, the vancomycin and teicoplanin MICs were determined by
the method of Etest with an inoculum of 2.0 McF on the selected
strains. Finally, the isolates with MIC of the teicoplanin ‡8 mg/
L and MIC of the vancomycin ‡4 mg/L or MIC of the
teicoplanin ‡12 mg/L and MIC of the vancomycin £4 mg/L
were studied on population analysis. After that, pulsed-ﬁeld gel
electrophoresis (PFGE) was performed on the different isolates
and the pulsotypes were compared. From November 2004 to
April 2005, 468 S. aureus isolates were collected from 331
patients and screened for glycopeptide resistance on an initial
agar screening test containing 4 mg/L of teicoplanin. The
teicoplanin MIC was >4 mg/L for 65 isolates (13.9%) from 59
patients and these strains were selected for the determination of
the MICs by ‘‘macromethod’’ Etest. By this technique, 39 strains
were selected and studied by population analysis. All the
proﬁles were compared to the reference strain Mu3 proﬁle. This
procedure detected 5 isolates (from 5 patients) with heteroge-
neous reduced susceptibility to glycopeptides (hGISA). So the
incidence of Staphylococcus aureus with reduced susceptibility to
glycopeptides in our hospital was found to be 1.1%. Four strains
were resistant to methicillin and 3 were also resistant to
gentamicin. The diversity of the strains was conﬁrmed by
PFGE: there was not an epidemic clone in the hospital. The
clinical history showed that 4 patients had received a prior
treatment with vancomycin, and that 3 patients had a failure in
treatment: 2 of them had cystic ﬁbrosis.
P1588
Distribution of different aminoglycosides
resistance genes among the Iranian population of
enterococci
M.M. Feizabadi, S. Khatibi, A. Asgharzadeh, S. Gharavi (Tehran,
IR)
Objectives: Enterococcus faecalis was the most prevalent
organism (72.5%) involved in enterococcal infections at Tehran
Hospitals followed by E. faecium (22.5%). Due to widespread
expansion of aminoglycoside modiﬁying Enzymes (AGMEs)
genes, the rate of resistance to high level concentration of
aminoglycosides has increased in these years. The rate of high
level gentamicin resistant isolates of enterococci (HLGR) is high
in Iran (46%). The aim of this study was to determine the genes
encoding resistance to aminoglycosides among enterococci in
Iran.
Methods: Disks containing 120 lg gentamicin were used to
detect HLGR isolates. Primers speciﬁc for aac (6’) aph (2") and
aph (3’) IIIa genes were used in PCR to possibly detect
acetyltransferases and phosphotransferas, the common
AGMEs among 113 isolates of enetrococci. Theses isolates
were resistance to different concentration of gentamicin.
Results: A 222 bp region of the aac (6’)-aph (2") gene was
ampliﬁed by PCR in 95% HLGR isolates as well as in 40% of
low level getamicin resistant isolates (LLGR). Moreover the
gene aph (3’) IIIa was detected in 92.5% and 72% of isolates of
HLGR and LLGR respectively. Differences between isolates of
E. faecalis and E. faecium were found in term of prevalence of
aph (3’) IIIa gene.
Conclusion: The bifunctional enzyme AAC (6’)-APH (2") is the
main cause of resistance to high concentration of
aminoglycosides in our collection of enterococci. This enzyme
confers resistance to all clinically useful aminoglycosides with
the exception of streptomycin. In the absence of AAC (6’)-APH
(2"), gentamicin could be used in combination therapy.
P1589
Prevalence and genetic analysis of methicillin-
resistant Staphylococcus aureus expressing high-
level and low-level mupirocin resistance
M. Kural, T. Us, Y. Akgun (Eskisehir, TR)
Objectives: To investigate the genetic location of mupA gene
which encoded mupirocin resistance and characterize
mupirocin-resistant methicillin resistant Staphylococcus aureus
(MRSA) isolated from patients in a Turkish University hospital
by polymerase chain reaction (PCR) and plasmid analysis.
Methods: Methicillin and mupirocin resistance were detected
by disk diffusion (Oxoid, UK). The Etest (AB Biodisk, Sweden)
was performed to determine mupirocin minimum inhibitory
concentrations (MICs). The presence of mupA and mecA were
detected by PCR using speciﬁc primers. Plasmid analysis were
used to study the genetic location of mupA gene.
Results: A total of 595 (44.9%) MRSA strains were identiﬁed by
disk diffusion in 1324 S. aureus. Of the 595 clinical isolates 394
(66.2%) were from wound, 91 (15.3%) from blood, 41 (6.9%) from
catheter, 36 (6.1%) from lower respirator tract (bronchoalveolar
lavage, pleural ﬂuid and transtracheal aspirates), 13 (2.2%) from
sputum, 12 (2.0%) from urine and 8 (1.3%) from other
(serebrospinal ﬂuid, parasynthesis ﬂuid, peritoneal ﬂuid, and
bone marrow) clinical samples. Among the MRSA isolates,
mupirocin resistance was detected in 35 (5.9%) strains with disk
diffusion and Etest. Of the 35 mupirosin-resistant isolates 23
(3.9%) expressed high-level (MuH) and 12 (2%) expressed low-
level (MuL) mupirocin resistance. All isolates were vancomycin,
teicoplannin susceptible and chloramphenicol resistant with
disk diffusion. Isolates with high-level and low level mupirocin
resistance due to the mupA gene were also detected with PCR.
Plasmids were detected in all of the 35 isolates. However only
the MuH isolates contained a 38 kb plasmid that encoded high-
level resistance. All of the isolates contained a 4.4 kb plasmid
and resistant to chloramphenicol.
Conclusion: Our results indicated that the MRSA clones
detected in the hospital had acquired a high-level mupirocin
resistant plasmid. The past observations and recent studies
suggested that the numbers of such strians have increased
following extensive topical use of mupirocin. The usage of
mupirocin in our hospital has not yet been systematically
implemented. It is frequently prescribed for the treatment of
staphylococcal skin infections and less to eliminate nasal carriage
of MRSA. In our hospital we should be aware of the possible
emergence and increase of mupirocin highly resistant MRSA
strains in the future so that we should be considered when using
mupirocin to control the spread of MRSA in hospital.
P1590
Emergence and spread of acquired fusidic acid
resistance in Staphylococcus aureus
A. J O’Neill, F.B. McLaws, I. Chopra (Leeds, UK)
Objectives: A major route to fusidic acid resistance (fusR) in S.
aureus involves acquisition of fusB, a resistance determinant ﬁrst
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identiﬁed on plasmid pUB101. Here we show that (i) the two
currently-circulating major clones of fusR S. aureus identiﬁed to
date have acquired fusB from pUB101 (or from the same
ancestral source as pUB101), and (ii) that the pUB101-encoded
FusB is only one of at least three lineages of this protein that
appear to have evolved since recruitment of the original,
ancestral fusB to the Staphylococci.
Methods: Plasmid puriﬁcation, DNA sequencing, PCR
ampliﬁcation, and cloning in S. aureus RN4220 using shuttle-
vector pCU1, were all performed using established methods.
Antibiotic susceptibility testing was performed by agar dilution.
Results: The Epidemic European Fusidic acid-resistant
Impetigo Clone (EEFIC) and community-acquired MRSA
strain ST80 have been shown to carry chromosomal and
plasmid-encoded fusB, respectively. DNA sequencing of fusB
and its surrounding regions in these backgrounds revealed that
they are identical to sequences on pUB101. However, acquired
fusR does not always result from acquisition of the prototypical
fusB gene. A gene encoding a FusB homologue was recently
identiﬁed during sequencing of S. aureus strain MSSA476, and
we identiﬁed an additional homologue encoded in the genome
of S. saprophyticus strain ATCC15305. The products of these
genes exhibit ~40% homology to FusB and to each other.
Cloning of PCR amplicons corresponding to these genes and
their upstream expression signals into S. aureus established that
they both confer resistance to fus. Since these functional
homologues are more closely related to each other than to
those from other Gram-positive organisms, it is highly likely
that they evolved from an ancestral FusB after its recruitment to
the Staphylococci.
Conclusions: The three members of the staphylococcal family
of FusB proteins appear to have evolved from the same ancestral
protein, which, based on the low level of sequence homology
between fusB genes at the nucleotide level, clearly occurred well
before the introduction of fus into the clinic. Of the three, the
FusB protein encoded by pUB101 is by far the most successful,
and this gene/plasmid represents the source of (or shares a
source with) the major fusR strain lineages.
P1591
Telithromycin activity is reduced by efﬂux in
Streptococcus pneumoniae
C. Benvenuti, R. Koncan, G. Bahar, A. Mazzariol, G. Cornaglia
(Verona, IT; Ankara, TR)
Objectives: Telithromycin shows an excellent activity against
M-type erythromycin-resistant Streptococcus pneumoniae, thus is
commonly regarded as being capable of overcoming the efﬂux
resistance mechanism. Nevertheless, telithromycin MIC values
in those strains appear to be distinctly higher than in the
erythromycin-susceptible ones. The possibility of telithromycin
acting as an actual efﬂux substrate, as it was already
demonstrated in Streptococcus pyogenes, seemed worth
investigating.
Methods: Telithromycin MIC distribution was analysed in a
collection of 423 Italian S. pneumoniae strains originating from
multi-centre studies (2000–2003). The effect of an efﬂux
mechanism was investigated using [3H]-telithromycin.
Results: Telithromycin MIC ranges were £0.002–0.12 mg/l
(MIC50 0.008 mg/l and MIC90 0.03 mg/l) in erythromycin-
susceptible strains (lacking both mef and erm genes) and 0.016–
1 mg/l (MIC50 0.25 mg/l and MIC90 0.5 mg/l) in strains
endowed with the M phenotype. A distinct telithromycin
efﬂux was detected in the strains expressing the mef gene, but
not in those expressing the erm(B) gene, nor in the susceptible
strains lacking mef or erm genes. Efﬂux reversibility by addition
of an inhibiting compound (sodium arsenate) was
demonstrated. An msr-like sequence was also found in all
strains efﬂuxing telithromycin, but not in the others.
Conclusions: This is the ﬁrst time that telithromycin has been
shown to be efﬂuxed by S. pyogenes isolates. That the efﬂux is
related to the presence of both the mef and the msr-like genes is
clearly demonstrated, but – owing to the increasingly evident
complexity of S. pneumoniae efﬂux systems – other genes might
also contribute to the efﬂux.
P1592
An unusual phenotype of Enterococcus faecalis in
Greece expressing low-level resistance to
clindamycin and dalfopristin but susceptibility to
quinupristin-dalfopristin
M. Maniati, F. Kontos, P. Liakos, E. Petinaki, I. Spiliopoulou,
A. Maniatis (Larissa, Patras, GR)
Objectives: To investigate the resistance mechanism of a new
described phenotype among Enterococcus faecalis expressing low-
level resistance to clindamycin and dalfopristin but
susceptibility to quinupristin-dalfopristin (Q-D).
Methods: In Greece, during 2005, three Enterococcus faecalis
isolates, expressing this unusual phenotype, were recovered
from urine samples. The isolates were studied by PCR for the
lsa-gene and by PFGE. Nucleotide sequencing analysis of lsa
and 309 bp of the upstream region was performed. The isolates
were also tested by RT-PCR for the expression of the lsa-gene.
Results: The isolates belonged to three distinct clones and
carried the lsa-gene. No stop codons were found in any strain,
while some point mutations in the lsa-gene were detected.
Comparing the lsa mRNA production of these unusual strains
with that obtained from fully Q-D resistant ones no quantitative
differences were found.
Conclusions: The ﬁndings of the present study clearly show
that the resistance mechanism of quinupristin-dalfopristin is not
only correlated with the presence and the expression of the lsa-
gene. Some mutations detected in the lsa gene probably are
responsible for the production of an Lsa protein with decreased
activity, resulting to the Q-D susceptibility.
P1593
The presence of erm TR gene is responsible for
the macrolide-resistance of Streptococcus
agalactiae
A. Pratti, E. Akrivoussi, V. Karavassilis, E. Petinaki, A. Maniatis
(Larissa, GR)
Objectives: To investigate the mechanism of resistance to
macrolides in strains of Streptococcus agalactiae in the area of
Thessalia, Greece during the period 2000–2005.
Methods: The subject of this study were 147 strains of S.
agalactiae which were collected from clinical specimens (90%
vaginal swabs) from pregnant and non pregnant women. The
strains were identiﬁed by Gram stain, the Lanceﬁeld B antigen,
and by API Strep System (BioMerieux, France). Susceptibility to
macrolides, lincosamides and streptogrammines B was studied
by the disk diffusion method. The MICs were also measured by
the use of E-test. The differentiation between M and MLSB
inducible type was tested by the Double Disk Synergy Test
(DDST). The detection of the genes mef A, erm TR, and erm B
was performed by Polymerase Chain Reaction (PCR). The
clonality of the resistant strains was studied by pulse-ﬁeld gel
electrophoresis.
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Results: Of the 147 strains, 15 were resistant to erythromycin,
lincosamid and streptogrammines B. None was found to be
resistant to erythromycin only (M-phenopype). 60% of the
strains were MLSB constitutive phenotype, while 40% were
MLSB inducible. All strains were found to carry the erm TR
gene. Only one strain was found to carry both erm TR and erm B
genes. PFGE analysis revealed the emergence of multiple
resistant clones.
Conclusions: The resistance of S. agalactiae to MLSB antibiotics
is related with the presence of erm TR gene in Central Greece.
P1594
Emergence of novel clindamycin resistance
phenotype among invasive Streptococcus
pyogenes isolates in Sweden
A. Jasir, B. Luca, C. Schalen (Lund, SE)
Objectives: In some recent throat group A streptococci (GAS)
isolates from our diagnostic laboratory total resistance to clinda-
mycin but susceptibility to erythromycin and other 14- as well as
15-membered macrolides was found. The isolates were suscept-
ible to 16-membered macrolides and streptogramin B. These
atypical strains thus did not agree with previously known MLS
resistance phenotypes. The main objective was to characterize
theses resistance phenotype and genotypes.
Method and results: The isolates were examined for resistance
genes by PCR. Out of 14 strains one harboured an ermA gene.
The gene was sequenced and showed a mutation in regulatory
part and was localized on a transposons. All other strains were
negative for any erm genes and were also tested for 23s rRNA
mutations with negative outcome. Strains were T-and emm
typed and showed to belong to different types.
Conclusions: GAS account for common human infections such
as acute pharyngotonsillitis and impetigo, which untreated may
be followed by the nonsuppurative complications rheumatic
fever and acute poststreptococcal glomerulonephritis GAS may
also give rise to invasive, often life-threatening acute disease,
such as scarlatina, erysipelas, endometritis, necrotising fasciitis
and sepsis, often accompanied by toxic shock. Without known
exceptions, GAS are fully susceptible to betalactams, which are
ﬁrst-choice drugs for treatment. In cases of allergy or intolerance
to penicillins, macrolides are most used, and possibly as a
consequence, a signiﬁcant resistance development to these
agents has evolved in many parts of the world. Though the
role of clindamycin for treatment of streptococcal disease is
more limited this drug was shown to be particularly effective in
eradicating streptococci after penicillin treatment failure of
pharyngotonsillitis. Clindamycin, often as a supplement to
betalactams, also may have a life-saving effect in the treatment
of fulminant streptococcal infections. Due to its important role in
the treatment of invasive streptococcal disease, resistance
development to clindamycin in GAS is considered highly
undesirable. The alarming ﬁnding of a possibly new phenotype
of selective clindamycin resistance in GAS will motivate a
thorough analysis of the phenotype as well as identiﬁcation of
its resistance determinants.
P1595
Resistance mechanisms of telithromycin-resistant
clinical isolates of Streptococcus pneumoniae in
Europe
A. Al-Lahham, M. van der Linden, R.R. Reinert (Aachen, DE)
Objectives: Telithromycin is a novel ketolide antibiotic with
signiﬁcant in-vitro activity against Streptococcus pneumoniae. The
aim of this study is to characterize the resistance mechanisms of
clinical isolates of S. pneumoniae with reduced susceptibility to
telithromycin (>1 mg/l) and to perform the time-kill kinetics
with telithromycin.
Methods: Determination of MICs was performed by the
microbroth dilution method according to the CLSI and the
serotyping by the Neufeld Quellung reaction. Multilocus
sequence typing, sequencing of the 23S rRNA, sequencing of
genes encoding ribosomal proteins (L4 and L22), and ermB were
performed according to standard methods. Four isolates were
selected for time-kill, two of which with a telithromycin MIC
2 mg/l and two strains with a telithromycin MIC of 8 mg/l.
Results: In two nation-wide studies and one European
surveillance study (n = 6604) performed at the National
Reference Center for Streptococci (NRCS) in Germany,
reduced susceptibility to telithromycin (>1 mg/l) was detected
in 17 isolates (0.3%). MIC50/MIC90 (mg/L) of the strains to
other antibiotics were as follows: Telithromycin 2/8, penicillin G
2/2, cefuroxime 8/8, erythromycin A >32/>32, clindamycin
>32/>32, tetracycline 32/32, and gatiﬂoxacin 0.25/0.25. Two
major serotypes were observed, serotype 14 (58.8%) and
serotype 19A (29.4%). All isolates possess the cMLSB
phenotype (ermB positive). The isolates showed a wide range
of combinations of resistance determinants including multiple
alterations in the 23S rRNA (A138G, C150T, A260G, A1745T,
and C2216T), a S20N alteration in the ribosomal protein L4
(n = 9), and a N100S alteration in the erm(B) gene (n = 14). The
predominant clone was serotype 14 sequence type 143 (8 of 17
isolates), which was seen in France (n = 7) and Germany (n = 1).
Telithromycin-resistance has also spread to the Spain23F-1 clone
(ST 81; n = 1) and its serotype 19A variant. In vitro time-kill
showed a minimal kill from 0–8 hours and then regrowth.
Bactericidal activity was achieved only with 8 times the MIC in
all strains.
Conclusions: Although the incidence of telithromycin resist-
ance remains rare world-wide, the spread of telithromycin
resistance to multi-drug resistance clones with world-wide
distribution is worrisome.
P1596
Genotypes and serotypes correlation among
macrolide-resistant Streptococcus agalactiae
isolates in Zaragoza, Spain (2002–2004)
M.E. Llaneza, C. Seral, F.J. Castillo, E. Duran, C. Garcı´a,
I. Milla´n, J.A. Sa´ez-Nieto, M.C. Rubio, R. Go´mez-Lus (Zaragoza,
ES)
Objective: To analyze the phenotype-genotype as well as the
genotype-serotype correlation among macrolide-resistant
Streptococcus group B (GBS) isolated in Zaragoza, Spain, from
May 2002 to April 2004.
Methods: A total of 562 GBS were isolated from May 2002 to
April 2004 at the University Hospital of Zaragoza, Spain: 354
GBS obtained from vaginal swabs of pregnant women and 208
GBS obtained from non-pregnant women. The erythromycin
resistant-GBS were identiﬁed, phenotypically analysed,
screened by PCR for mre(A) gene and for erythromycin
resistance genes: erm(B), erm(TR), mef(A) and mef(E), and
serotyped with type speciﬁc antisera for serotypes Ia, Ib, II, III,
IV, and V.
Results: Among the total of GBS, 161 (28.65%) were erythro-
mycin-resistant: 86 (24.29%) erythromycin–resistant GBS were
isolated from vaginal swabs of pregnant women and 75
(36.06%) from non-pregnant women. The frequency of sero-
types in 151 erythromycin-resistant GBS tested, the distribu-
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tion of their resistance genes and the distribution of serotypes
among the different genotypes are illustrated in the table. NT,
nontypeable, The mre(A) gene was found in all the GBS
strains tested. MICs of erythromycin in erythromycin-resistant
GBS were: MIC50 and MIC90, >128 mg/L; range, 4 to
>128 mg/L for GBS harbouring erm(B) and erm(B)+erm(TR)
and MIC50 and MIC90, 8 mg/L and >128 mg/L, respectively;
range, 0.5 to >128 mg/L for GBS harbouring erm(TR).
Conclusion: Erm(B) was the erythromycin-resistant gene most
prevalent among the GBS isolates and these isolates showed the
highest MICs of erythromycin. The commonest serotypes among
erythromycin-resistant GBS isolated were III, II and I, and
showed genotypic variability harbouring either of the two most
prevalent genes, erm(B) or/and erm(TR).
P1597
Distribution of serotypes in tetracycline-resistant
Streptococcus group B isolated in Zaragoza, Spain
M.E. Llaneza, C. Seral, F.J. Castillo, S. Salvo, A. Martinez,
M. Pardos, M.C. Rubio, J.A. Sa´ez-Nieto, R. Go´mez-Lus
(Zaragoza, Madrid, ES)
Objectives: To analyse the tetracycline-resistant genotypes in
erythromycin-resistant Streptococcus group B (GBS) isolated in
Zaragoza, Spain collected from April 2002 to May 2004, and
their serotype distribution.
Methods: We studied the rates of resistance to tetracycline and
minocycline among 161 erythromycin-resistant GBS strains
isolated at the University Hospital Lozano Blesa of Zaragoza,
Spain. Isolates were subsequently phenotypically analysed by
means of the disk diffusion method and screened by PCR for
erythromycin and tetracycline resistance genes [erm(B),
erm(TR), mef(A/E), tet(M) and tet(O)]. The susceptibility to
erythromycin, josamycin, tetracycline and minocycline was
tested by the agar dilution method according to the NCCLS.
The strains were serotyped with type speciﬁc antisera for
serotypes Ia, Ib, II, III, IV, and V.
Results: Among the total of 161 isolates of macrolide-resistant
GBS collected from May 2002 to April 2004 in our hospital
(28.6% of the total SGB isolated), 124 (78.85%) were tetracycline-
resistant. The distribution of tet(M) and tet(O) among the
erythromycin-resistant GBS harbouring erm(B) was (66.1% and
54.2%, repectively) and harbouring erm(TR) was (63.8%
and 34.5%). The distribution of tetracycline resistance genes
and serotypes among the different genotypes in 121 GBS are
illustrated in the table.*NT: non typable Isolates carrying tet(M)
or tet(M)+tet(O) presented the following MICs: tetracycline
(MIC90 64, MIC50 32, range 16–128 mg/L); minocycline (MIC90
32, MIC50 16, range 4–32 mg/L). Isolates carrying tet(O)
presented the following MICs: tetracycline (MIC90 64, MIC50
32, range 32–64 mg/L); minocycline (MIC90 16, MIC50 16, range
4–32 mg/L).
Conclusion: The majority (61.1%) of tetracycline-resistant GBS
harboured tet(M) alone or in combination with tet(O). The most
prevalent serotypes among the total of tetracycline-resistant GBS
was the serotype III (38%) and the serotype II (28%). Serotype III
was more prevalent among the GBS harbouring the tet(M) gene
and serotype II was more prevalent among the GBS harbouring
the tet(O) gene.
P1598
Prevalence, type and genetic elements involved
in macrolide resistance in Viridans streptococci
M.S. Herna´ndez Iglesias, J.L. Mun˜oz-Bellido, J.A. Garcı´a-
Rodrı´guez (Salamanca, ES)
Objectives: To know the prevalence of resistance to macrolides
in viridans streptococci, its mechanism and the genetic elements
which are involved.
Methods: We studied 89 viridans Streptococcus pharyngeal
isolates from different patients. MICs for macrolides were
determined by the agar dilution method. The presence of mef
and ermA, ermB and ermTR genes, and the presence of MEGA
(Macrolide Efﬂux Genetic Assembly) or Tn1207 in resistant, mef
+ isolates was determined by PCR with speciﬁc primers. The
similarity to mef genes ﬁrst described in pneumococci (mefE)
and Streptococcus pyogenes (mefA) was determined by
sequencing.
Results: 48 viridans streptococci isolates were resistant to
macrolides (53.9%). 42 out of the 48 resistant isolates har-
boured mef genes (87.5%), one harboured ermB (2.1%), and 5
isolates harboured both mef and ermB genes (10.4%). No
isolates harboured ermA or ermTR genes. We studied genetics
elements which harbour mef genes in other streptococci, in 15
mef (+) isolates. We found MEGA insertion element in 14 of
15 isolates (93.3%), all of them harbouring mefE. The only
isolate in which we found mefA, did not harbour MEGA, but
Tn1207.
Conclusions: M phenotype is frequent in viridans streptococci,
and all of them harbour mef genes. Most MLSB phenotype
viridans streptococci do not harbour erm genes alone; most of
them combine erm and mef genes. Most isolates contained the
mef sequence corresponding to mefE, and the genetic element
(MEGA) usually described in pneumococci as harbouring this
gene. One isolate contained the sequence corresponding to
mefA, and the genetic element usually described in S. pyogenes
(Tn1207). The increasing presence of macrolide-resistant
pneumococci harbouring MEGA element might be related
with its wide presence in viridans streptococci. The acquisition
of MEGA by pneumococci from viridans streptococci through
transformation is being studied.
P1599
Characterisation of a Streptococcus pneumoniae
strain carrying erm(A) isolated in Italy
R. Camilli, M. Del Grosso, F. Iannelli, M. Monaco, A. Pantosti
(Rome, Siena, IT)
Objectives: The principal mechanism of macrolide resistance in
Streptococcus pneumoniae in Italy is target site modiﬁcation
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mediated by erm(B). The erm(A) gene is common in
Streptococcus pyogenes but rare in S. pneumoniae, even if recent
studies have demonstrated an increased detection of this
resistance determinant. Recently, a clinical S. pneumoniae
isolate carrying erm(A) has been obtained from a patient with
meningitis in Italy. The aim of this study is the molecular
characterization of this isolate.
Methods: Antimicrobial susceptibility tests were determined by
Etest. The presence of erythromycin resistance determinants was
detected by PCR assays. Genotyping was performed by PFGE
and MLST. The ﬂanking regions of erm(A) were analysed by
sequencing a fragment ampliﬁed by inverse PCR.
Transformation and conjugation experiments were carried out.
Transformants were analysed by PFGE and hybridization with
an erm(A) probe.
Results: The isolate belonging to serotype (st) 11A, was
resistant to erythromycin, inducibly resistant to clindamycin
and susceptible to penicillin and tetracycline. By PCR, the only
macrolide resistance determinant detected was erm(A). PFGE
analysis revealed the genetic correlation of this strain with other
st 11A S. pneumoniae Italian isolates. MLST conﬁrmed this data
since the isolate belonged to ST2003, which is a single-allele
variant of ST62, the most common ST among Italian st 11A
isolates. A 5200 bp DNA fragment, obtained by inverse PCR and
containing the erm(A) gene, was sequenced. This fragment
contains an orf upstream erm(A), the gene erm(A) identical to
that described in S. pyogenes and 3 ORFs, downstream erm(A),
one homologous to a hypothetical kinase and the other two to
transposases of other Gram-positive species. In transformation
experiments the gene erm(A) was transferred to an
erythromycin susceptible recipient. Hybridization analysis of
one transformant revealed that the size of the transferred DNA
fragment was approximately 50 kb. No transconjugant was
obtained in mating experiments.
Conclusions: This is the ﬁrst Italian report of an S. pneumoniae
isolate carrying erm(A). erm(A) appears to be contained in a
genetic element that includes two transposases, although the
gene is not transferable by conjugation.
P1600
Linezolid resistance in three clinical isolates of
coagulase negative staphylococci isolated from
bloodstream infections
A. Koutsoukou, S. Tsiplakou, A. Stylianakis, M. Tachtatzis,
A. Ntouroupi, A. Sideri, E. Tsakona (Athens, GR)
Objective: Treatment with the ﬁrst oxazolidinone antibiotic,
linezolid, of infections caused by staphylococci has proved
effective in most cases. In the present study we present the ﬁrst
three cases of linezolid resistant staphylococci in our hospital.
Methods: We examined three coagulase negative Staphylococcus
strains isolated from blood cultures (Bactec, Becton Dickinson).
Identiﬁcation and susceptibility testing were performed by the
Vitek II automated system (Biomerieux) and the results were
conﬁrmed by the API system (Biomerieux) and E-test (AB
Biodisk, Solna, Sweden), according to NCCLS guidelines.
Results: Three linezolid resistant staphylococci were isolated
from blood cultures. Identiﬁcation showed that all three isolates
were Staphylococcus cohnii subsp. urealitycum and the MIC
values were 12 lg/ml (n = 1) and 24 lg/ml (n = 2) which are
much higher than the value of 4 lg/ml that characterizes
sensitive strains. The isolates derived from three patients in
different wards of our hospital. The ﬁrst two isolates were
recovered from two ICU patients in April and August 2005 and
the last Staphylococcus cohnii was isolated from a patient in the
neurosurgery ward, who is still hospitalized. All patients
received prolonged treatment with linezolid.
Conclusions: Although six linezolid resistant clinical isolates of
S. aureus were previously reported in the literature, these three
isolates are the ﬁrst coagulase negative Staphylococcus isolates
resistant to linezolid. It is imperative to screen for resistance to
linezolid all Staphylococci and take the necessary precausions in
order to prevent the spread of a linezolid resistant strain in other
wards of our hospital.
P1601
Correlation between MIC and number of mutated
23S rRNA genes in oxazolidinone-resistant
Staphylococcus aureus
S.E. North, M.J. Ellington, A.P. Johnson, D.M. Livermore,
N. Woodford (London, UK)
Objectives: To determine the number of mutated 23S rDNA
alleles present in clinical and laboratory-generated linezolid-
resistant Staphylococcus aureus isolates.
Methods: 36 linezolid-resistant isolates were tested, 9 of them
clinical isolates (MICs 16–32 mg/L) and 27 mutants selected
in-vitro (MICs 8–64 mg/L). The mutants were raised by repeated
passage on increasing linezolid concentrations and their
parentage was veriﬁed by PFGE. MICs were determined by
agar dilution. Genomic DNA was digested with EcoRI and
hybridized with a 420 bp probe corresponding to domain V of
the genes encoding 23S rRNA, to determine gene copy number.
Pyrosequencing was used to quantify the proportions of wild-
type and mutated alleles present; assays were designed to detect
the presence of 7 mutations conferring oxazolidinone resistance.
Pyrosequencing and hybridization data were combined to
determine the number of mutated alleles present.
Results: Resistance selected in-vitro proved less stable than that
in the clinical isolates. Pyrosequencing showed that all 9 clinical
isolates had the G2576T mutation, 16 of the in-vitro selected
mutants had G2576T, 7 had T2504C, 2 had T2500A, 1 had
A2503G and 1 had G2505A. The 23S rDNA copy number in the
oxazolidinone-resistant clinical isolates varied from 4–6, and
from 5–9 in the laboratory-generated mutants; 14/27 laboratory-
selected mutants had changes in copy number, compared with
their parent strains, and 3 had changes in fragment size, but not
number. The number of mutated copies in lin-resistant isolates
ranged from 1–5 in laboratory-selected mutants and from 2–4 in
clinical isolates. An increasing number of mutated genes
correlated with increasing linezolid MIC.
Conclusions: In combination, pyrosequencing and hybridiza-
tion successfully determined the number of mutated 23S rDNA
alleles. Exposure to linezolid selected changes in 23S rRNA gene
copy number as well as sequence in 50% of in-vitro selected
mutants. There was a positive correlation between both the
number and proportion of mutated 23S rDNA copies and MIC,
previously unproven for Staphylococci.
P1602
Rapid emergence of resistance to linezolid during
linezolid therapy of an Enterococcus faecium
infection
J. Seedat, G. Zick, I. Klare, C. Konstabel, N. Weiler,
H. Sahly (Kiel, Wernigerode, DE)
Objectives: Linezolid (LZD) is an important antibiotic for the
treatment of enterococcal infections, especially when the
corresponding strain possesses multiresistance including
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resistance to vancomycin (VAN). We report the emergence LZD
resistance in clonally related VAN-susceptible and VAN-
resistant Enterococcus faecium isolates originated from an ICU
patient only 12 days after initiation of linezolid therapy.
Patient and Methods: VAN-resistant E. faecium was repeatedly
isolated from intraabdominal cultures of a 76-year-old female
ICU-patient with infected necrotizing pancreatitis after
pancreaticoduodenectomy (Whipple´s procedure). Antibiotic
susceptibility testing of the bacteria was performed by E-tests;
vanA gene were detected by PCR. The possible LZD resistance
mechanism (mutation in the 23S rDNA of one or more of the six
23S rRNA alleles of E. faecium) was examined by a PCR-based
method. Molecular typing of the strains was performed by SmaI
macrorestiction analysis.
Results: VAN-resistant but LZD-sensitive E. faecium (VRLSE)
were initially detected in intraabdominal cultures, however,
already twelve days after initation of LZD therapy, VAN- and
LZD-resistant E. faecium (VRLRE) strains were detected.
Resistance to LZD was conﬁrmed: MICs ranged from 16 to
32 mg/l. All E. faecium isolates showed identical or closely
related PFGE patterns. Throughout the ICU period, VAN- and
LZD-susceptible E. faecium (VSLSE) strains were repeatedly
detected in the same specimens from which the VRLSE and
VRLRE were isolated. Additionally, VAN-susceptible E. faecium
isolates with resistance to LZD (VSLRE) were detected.
Mutations in the 23S rDNA of three out of six alleles led to
LZD resistance in the E. faecium isolates examined. Two weeks
after termination of the LZD therapy, no LZD-resistant strain
could be detected in follow-up swabs.
Conclusions: Resistance to LZD in E. faecium can occur already
shortly after the initiation of LZD therapy. Assessment of
antibiotic susceptibilities of all isolates at the start of therapy and
regularly during the therapy is advisable, especially during
therapy of severe infections. The epidemiological and clinical
repercussions of resistance to LZD among enterococci cannot be
predicted at this time. Attention to proper dosing and prompt
removal of infected devices, when feasible, could limit
occurrence and spread of LZD-resistant E. faecium.
P1603
Different prevalence of the main tet determinants
among S. sonnei and S. ﬂexneri
L. Mensa, E. Pisos, S. Capilla, F. Marco, J. Vila, J. Gasco´n,
J. Ruiz (Barcelona, Las Palmas de Gran Canaria, Zaragoza, ES)
Objectives: To investigate the mechanisms of resistance to
tetracycline in Shigella spp.
Methods: One hundred and eleven tetracycline-resistant
Shigella spp strains (67 S. sonnei, 44 S. ﬂexneri), 6 were isolated
as a cause of enteritis in our geographical area and the
remaining recovered from patients with traveller’s diarrhoea.
Antimicrobial susceptibility to tetracycline was determined by
the Kirby-Bauer method. Presence of tetA, tetB and tetG genes
was established by PCR. Sequencing of ampliﬁed products were
used to corroborate the reliability of the PCR results. Maentel
Haenszel test was used to establish the statistical signiﬁcance.
Results: The statistical analysis showed that the tetA gene was
more frequent in S. sonnei (p < 0.05), while tetB was more usual
in S. ﬂexneri (p < 0.0005). Although without statistical
signiﬁcance (p:0.07), presence of non-determined mechanisms
of tetracycline-resistance seems to be more frequent among S.
sonnei.
Conclusions: Species-speciﬁc differences in the distribuition of
the tetA and tetB genes has been shown. Moreover 22.5% of the
analysed strains did not show any of the analysed determinants
of tetracycline-resistance. The concomitant presence of more
than one of the analysed genes is a rare event.
P1604
Distribution and genetic determinants of
tetracycline resistance in Laribacter
hongkongensis isolates from humans and ﬁsh
S.K.P. Lau, P.C.Y. Woo, M.W.S. Li, G.K.M. Wong, K.Y. Yuen
(Hong Kong, HK)
Objectives: To study the distribution of tetracycline resistance
and to clone and characterize a tetracycline resistance
determinant in Laribacter hongkongensis, a recently discovered
bacterial genus and species associated with community-
acquired gastroenteritis.
Methods: Twenty-four L. hongkongensis strains isolated from
patients with community-acquired gastroenteritis and 24
L. hongkongensis strains isolated from freshwater ﬁsh in Hong
Kong were used in this study. Genetic determinants for
tetracycline resistance were looked for by screening a genomic
DNA library of L. hongkongensis. The prevalence of tetA gene in
other strains of L. hongkongensis was studied by PCR using
laboratory-designed primers. The presence of the tetracycline
resistance determinants in plasmid was examined by Southern
blot analysis.
Results: Among 24 human and 24 ﬁsh isolates tested, 3 human
and 1 ﬁsh isolates were tetracycline-resistant. A 3566-bp gene
cluster, which consists of 2 putative transposases, a tetR and a
tetA gene, was cloned by inserting restriction fragments of
genomic DNA from a resistant strain, HLHK5, into pBK-CMV.
The 1266-bp tetA and 636-bp tetR genes shared signiﬁcant
nucleotide sequence homology with known tetA and tetR genes.
While the ﬂanking regions and 3’ end of the tetA were identical
to the corresponding regions of a tetC island in Chlamydia suis,
the tetA was almost identical to that of transposon Tn1721 and
plasmids found in many gram-negative bacteria, suggesting that
illegitimate recombination may have occurred to produce the
present tetracycline resistant determinant. Southern
hybridization suggested that the tetA gene of HLHK5 was
plasmid-encoded. The tetracycline resistance in L. hongkongensis
was associated with tetA. PCR ampliﬁcation of the tetA gene in
the 48 isolates of L. hongkongensis, including HLHK5, showed the
presence of tetA in all the four tetracycline resistant isolates but
none of the tetracycline susceptible ones. In contrast to strain
HLHK5, the tetA of two strains were identical to that of Tn1721,
while that of the other strain was more closely related to other
gram-negative bacteria plasmids.
Conclusion: Our results indicate that horizontal transfer of
genes, especially through Tn1721 and related plasmids, between
L. hongkongensis and other gram-negative bacteria is probably a
frequent event and is an important mechanism for acquisition
and dissemination of tetracycline resistance in L. hongkongensis.
Abstracts
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
P1605
Succesful treatment of infective endocarditis with
linezolid
T. Hryniewiecki, U. Lopaciuk, J. Stepinska (Warsaw, PL)
Objectives: There is an increasing proportion of resistant
strains causing infective endocarditis in recent years. It has
changed the approach to choice of antibiotic therapy. Linezolid
(Zyvoxid) is a new bacteriostatic antibiotic with a wide
spectrum of activity against Gram-positive organisms and
with good efﬁcacy in experimental animal models of
endocarditis. Unfortunately clinical experience with linezolid
in the treatment of endocarditis is limited. The aim of the study
was to observe efﬁcacy of linezolid in the treatment of infective
endocarditis.
Methods: The study group consisted of 8 patients hospitalised
in Institute of Cardiology in Warsaw (2003–2005) due to
clinically resistant infective endocarditis. The diagnosis of
endocarditis was established according to the Duke criteria by
clinical examination, echocardiography, laboratory
investigations and positive blood cultures with vancomycin
MIC estimation (in 5 pts). All patients were treated surgically
(valve replacement, artiﬁcial material removal) in conjunction
with different conventional antibiotics and afterwards with
600 mg of linezolid every 12 hours intravenously.
Results: Infective endocarditis was diagnosed as caused by
MRCNS in 2 pts, MSSA in 1 pt, Enterococcus faecalis in 1 pt and
Staphylococcus epidermidis MR in 1 pt. Vancomycin MIC vary
from 2 to 4 mg/l. In 3 pts culture-negative endocarditis was
diagnosed. All patients were treated with linezolid
intravenously 2 to 4 weeks (average 3,1). Clinical response and
eradication of bacteremia were achieved in all patients.
Leukopenia nad thrombocytopenia as an adverse reaction
occurred in 1 patient.
Conclusions 1. Linezolid is effective in patients with Gram-
positive endocarditis. 2. Linezolid could be also effective in
some patients with culture-negative endocarditis. 3. Linezolid
may provide an alternative in the treatment of infective
endocarditis due to multi-resistant bacteria, in patients with
resistant course or with adverse reaction to conventional
antibiotics.
P1606
Linezolid for the treatment of infections caused
by Gram-positive organisms in China
Y. Zhang, D. Lin, J. Wu, F. Wang, J. Zheng, J. Miao, L. Zheng,
R. Sheng, X. Zhou, H. Shen, M.M. Ijzerman, R. Croos-Dabrera,
W. Sheng (Shanghai, Hangzhou, Beijing, CN; Ann Arbor, US)
Objectives: To evaluate the safety and efﬁcacy of LZD in a
Chinese population.
Methods: This randomized, double-blind, multi-centre study
was conducted in China. After obtaining written informed
consent, patients from 18 to 75 years of age with pneumonia
(PNEU) or skin and soft tissue infection (SSTI) known or
suspected to be caused by a Gram-positive pathogen were
randomized 1:1 to receive either LZD, 600 mg, or vancomycin
(VAN), 1 g, each given IV q12h. Patients were to be treated for 7
to 21 days, and outcomes were assessed at end-of-treatment
(EOT) and follow-up (F-U) visits.
Results: One hundred forty-two patients were enrolled and
received study medication, 80 with PNEU and 62 with SSTI.
Clinical assessments (Effective = ‘‘cured’’ plus ‘‘marked
improvement’’) for patients in the fully evaluable population
are summarized in the table. The most frequently isolated
pathogen was Staphylococcus aureus: all isolates were susceptible
to both study drugs. The eradication rates for all pathogens in
evaluable patients at the F-U evaluation were 54/58 (93.1%) in
LZD-treated patients and 42/56 (75.0%) in VAN-treated patients
(p = 0.0072). All patients receiving study drug were evaluated
for safety. Drug-related adverse events (AEs) were reported in
18 (25.4%) LZD-treated and 12 (16.9%) VAN-treated patients.
The most commonly reported drug-related AEs in LZD-treated
patients were mild abnormalities in liver function tests and
leucopenia (4.2% each); rash (7.0%) was the most commonly
reported AE in VAN-treated patients. Seven (9.9%) LZD-treated
and 10 (14.1%) VAN-treated patients discontinued study drug
because of an AE.
Conclusions: Linezolid is an effective drug for the treatment of
infections caused by Gram-positive pathogens and is well-
tolerated.
P1607
Eradication in one patient, by rifamycin-
linezolid, of a methicillin-resistant
Staphylococcus aureus producing Panton-
Valentine leukocidin, responsible for 7 relapses
over 18 months, and decolonisation of her family
by mupirocin
L. Hocqueloux, M. Niang, L. Martin, J-F. Aumaitre, J.-L. Vaur,
J. Etienne, D-M. Poisson (Orle´ans, Lyon, FR)
Background: From October 2003 through March 2005, 9 strains
of methicillin-resistant Staphylococcus aureus producing Panton-
Valentine leukocidin (PVL-MRSA) were isolated in the hospital
of Orle´ans, among which 4 were isolated in an Ethiopian family
of 6.
Objective: We report the case of the mother who experienced 7
relapses over the period.
Methods: PVL-MRSA were isolated on routine and MRSA
agars (BioRad). Antibiotypes were studied by disk diffusion
method. Genetics and pulsotypes were studied by the French
Centre National de Re´fe´rence des Staphylocoques in Lyon
(CNR).
Results: Mrs KYM had her 4th child on October 8, 2003 in the
hospital of Orle´ans. She was healthy and presented no risk
factor for delivery. Three weeks later she was addressed for
surgical treatment of an abscess on buttocks. Cultures yielded
the special antibiotype: methicillin-R, kanamycin-R and
tobramycin-S, of the PVL-MRSA currently spreading across
Europe and Maghreb. The CNR found the lukS-PV and lukF-
PV-genes.Through March 2005, she relapsed 7 times and was
treated by pyostacin for a total of 32 weeks. Two of her children
were addressed for abscesses (1 buttocks, 1 thumb) yielding the
same bacteria. In March 2005, Mrs Kym was addressed to the
infectious diseases ward because of nasal furonculosis. Samples
yielded a PVL-MRSA with MLS-B phenotype. Treatment by
rifamycin-linezolid 14 d was initiated. The whole family was
screened. The father and the boy, 9, who had the infected thumb
17 months earlier, were carriers. The girl, 12, who had an
abscess on buttocks 8 months earlier was not. In April the whole
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
family accepted an attempt for decolonisation by 2% nasal
mupirocin 2 or 3/d for 5 d. Cure and decolonisation were
conﬁrmed by nares and cutaneous folds samples in May and
June. They missed an additional appointment in the beginning
of term, but a phone call to the social worker conﬁrmed none of
them relapsed. The CNR studied 7 strains (3 from Mrs KYM
2003, 2004, 2005, 2 from children abscesses in 2003 and 2004, 2
from boy’s and father’s nares 2005), and conﬁrmed that they
were all identical along the period and across the family.
Conclusion: Short treatment with linezolid-rifamycin in the
relapsing case associated with familial decolonisation by nasal
mupirocin was an effective strategy to stop a time-prolonged
familial outbreak of PVL-MRSA infection.
P1608
Multiple brain abscesses and purulent meningitis
by Listeria monocytogenes in an otherwise
healthy man. Favourable linezolid response,
hampered by a suspected early drug
myelotoxicity
R. Manfredi, S. Sabbatani, G. Marinacci, E. Salizzoni, F. Chiodo
(Bologna, IT)
Introduction: L. monocytogenes CNS infection in immunocom-
petent adults remains rare. Meningitis is the most common CNS
manifestation, with brain abscesses being <1% of overall
episodes. Anecdotal episodes of CNS L. monocytogenes infection
were reported from immunocompetent patients where both
diagnosis and treatment may be hampered by low clinical
suspicion and a frequent non-speciﬁc presentation. In a 15-year-
long survey conducted in Dallas (US), only 4 cases of non-
neonatal L. monocytogenes meningitis were found (estimated
incidence rate: 0.3%).
Case report: A 50-year-old male with a negligible history and
no obvious exposure to L. monocytogenes was hospitalized
owing to dizziness. A brain CT scan showed a small, late
ischemic lesion. A few days later hyperpyrexia, headache,
vomiting and altered mentation occurred. The CSF study
detected an elevated albumin content (217 mg/dL), low glu-
cose (4 mg/dL) and a WBC count of 256 cells/lL (60%
neutrophils) so that ceftriaxone-chloramphenicol were imme-
diately started. Clinical-neurological conditions deteriorated
while L. monocytogenes was cultured from the CSF so that
treatment was changed towards high-dose ampicillin-gentam-
icin. The persistence of severe clinical-neurological conditions
and altered CSF assay prompted the introduction of rifampi-
cin-cotrimoxazole after 10 days, but 8 days later other focal
neurological deﬁcits appeared and a MRI showed small,
hyperintense focal lesions involving the medulla oblongata,
interpreted as multiple abscesses. The introduction of linezolid-
meropenem, despite anemia (requiring 2 RBC transfusions
after 7–14 days) led to a progressive clinical-CSF improvement.
Our patient recovered completely and a control MRI carried
out 1 month after discharge conﬁmed the complete disappear-
ance of the multiple brain Listeria abscesses.
Discussion: The L. monocytogenes meningitis and multiple
subtentorial abscesses (including rare localizations at cerebel-
lum, bulb, and pons Varolii), had an evolving cumbersome
presentation. Despite the in vitro activity of a broad spectrum of
agents, multiple therapeutic changes became necessary, until the
last linezolid-meropenem combination, which was proved very
effective, although it was affected by relapsing anemia probably
attributable to linezolid. Linezolid, due to its elevated CSF-brain
penetration, and its activity against a broad spectrum of CNS
pathogens (including the intracellular L. monocytogenes), is
expected to become a key antimicrobial compound, waiting
for RCT.
P1609
Discrepancy between favourable in vitro
microbiological data and a severe clinical course
of a staphylococcal knee and soft tissue infection
responsive to oxazolidinone linezolid only after
failure of all other therapeutic attempts
R. Manfredi, S. Sabbatani, F. Chiodo (Bologna, IT)
Introduction: To offer therapeutic alternatives for the emerging,
multiresistant, serious Gram-positive infections, novel
molecules (quinupristin/dalfopristin, linezolid, daptomycin)
were introduced and are made available when multiresistant
Gram-positive cocci are documented as no more susceptible to
all available drugs including glycopeptides. However, inezolid
encompasses unique tissue penetration and diffusion features
(regarding soft tissues, lungs, joints and central nervous system)
which make this last drug extremely promising in all
circumstances where the penetration rate into infectious foci
becomes critical.
Clinical experience: A very intriguing case report of a severe,
staphylococcal knee arthtiris associated to an extensive local
cellulitis/fasciitis and haematogenous dissemination occurring
after a surgical curettage was characterized by a complete lack of
response to a prolonged vancomycin/teicoplanin plus rifampi-
cin therapy based on the apparently favourable in vitro sensi-
tivity assays of methicllin-resistant Staphylococci, but rapidly
responded to i.v. (followed by oral) linezolid administration.
The complete lack of clinical activity of a 2-week glycopeptide-
rifampicin administration cannot be explained by the in vitro
measured MIC90 values of isolated pathogens which showed
complete sensitivity of Staphylococcus aureus against vancomy-
cina/teicoplanin and rifampicin and susceptibility of a concur-
rent hematogenous S. epidermidis strain to glycopeptides-
rifampicin. Since an abscess formation and an underlying
osteomyelitis were carefully excluded by adequate instrumental
examinations, from a theoretical point of view the active
glycopeptide-rifampicin molecules should have been provided
appropriate cure. On the other hand, from a strictly clinical
issue, only a 2-week administration of i.v. linezolid followed by
one more week of oral linezolid allowed to obtain a complete
clinical-bacteriological cure and a complete function recovery
without any sequelae after a 1.5-year follow-up.
Conclusions: When the management of severe, multiresistant
Gram-positive infections is of concern, the in vitro activity of
single drugs and therapeutic classes should be carefully
evaluated in relation with the expected penetration and
diffusion rates of these drugs into the relevant organs and
tissues involved by the ongoing infectious localizations.
Otherwise, apparently unexplained failures may occur also
when in vitro studies point out a complete activity of the tested
compounds.
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Epidemiology of resistance to antibiotics – II
P1610
Contemporary prevalence of BRO beta-
lactamases in M. catarrhalis: report from the
SENTRY Antimicrobial Surveillance Program
(USA; 1997–2004)
L. Deshpande, H. Sader, R. Jones (North Liberty, US)
Objectives: To evaluate the prevalence of BRO-1 and BRO-2
among B-lactamase (Bl)-producing M. catarrhalis (MCAT) in the
USA. Although the Bl-mediated penicillin (PEN) resistance (R)
in MCAT has been stable at 95%, the BRO-1 and -2 occurrence
has not been determined in USA isolates since 1998. BRO-2 rates
have been reported at <15 (1980s), 4.8 (1984–94), 2.1 (1994–95)
and 3.1% (1997–98).
Methods: Community-acquired MCAT isolates (SENTRY
Program 1997–2004) were tested by CLSI broth microdilution
methods including: 7,860 worldwide and 3,671 in North
America (NA). BRO-1 and -2 was detected by PCR methods
(Levy and Walker; 2004), compared to epidemiologic tests, and
MIC values. 100 B-lactamase-positive (BL+) MCAT samples per
year from USA (39 sites) and Canada (CA; 7 sites) were tested
for the odd-numbered years.
Results: The BRO-2 rate was 4, 4, 3, and 3% for 1997, 1999, 2001
and 2003, respectively; rates in CA (8 isolates) > USA (6). Several
agents remained active: amoxicillin/clavulanate (MIC90,
£0.25 mg/L), ceftriaxone (CTRI; 0.5), cefuroxime (2),
erythromycin (£0.25–0.5), levoﬂoxacin (£0.03–0.06),
tetracyclines (2) and trimethoprim/sulfamethoxazole (TMP/
SMX; £0.5/9.5). PEN MIC distribution was tri-modal (£0.03, 1–2,
>4 mg/L) and CTRI bi-modal (0.016, 0.5), yet BRO-1 and -2
MIC/zone distributions overlap (best discriminated by
methicillin (mean zone, 10.6 vs. 19.4 mm) and PEN (13.9 vs.
24.1) disks). Possible BRO-2 epidemic clusters could not be
excluded due to a very common ribotype in 3 centres (CA, 2
sites; USA, 1).
Conclusions: This BRO-1 and -2 enzymes NA prevalence
update in MCAT isolates (1997–2003) shows stability at 96–
97% and 3–4%, respectively. Phenotypic tests (zones or MICs)
cannot easily distinguish between these B-lactamase types,
necessitating the use of molecular applications.
P1611
Penicillin susceptibility of beta haemolytic
streptococci: a 6-year surveillance
O. Karatuna, S. Karavelioglu, G. Soyletir (Istanbul, TR)
Objective: Although resistance to penicillin in beta haemolytic
streptococci has not been reported yet, increasing resistance
rates for alternative drugs, such as erythromycin, clindamycin
or tetracycline is an emerging concern which brings the
necessity to carefully monitor penicillin susceptibility.
Materials and Methods: In order to detect any changes in
penicillin MICs, we performed antimicrobial susceptibility
testing for all isolated beta haemolytic streptococci in our
hospital between January 2000 and November 2005.
Identiﬁcation to serogroup level was done using a commercial
latex agglutination kit (Avipath Strep, Omega Diagnostics Ltd.,
Scotland, United Kingdom).
Results: A total of 1890 isolates were identiﬁed, distribution of
groups for serogroup A, B, C and G were 75.6%, 18.9%, 2.8% and
2.7%, correspondingly. Penicillin susceptibility was determined
using Etest (AB BIODISK Solna, Sweden) strips according to
manufacturers’ instructions. When results are evaluated in 2-
year periods, MIC90 increased from 0.012 to 0.016 mg/ml for
group A, from 0.064 to 0.094 mg/ml for group B, from 0.012 to
0.064 mg/ml for group C and from 0.016 to 0.023 mg/ml for
group G (Table).
Conclusions: Even though highest MIC90 values were to be
found in group B (0.094 mg/ml), our results indicate the steady
increase in penicillin MIC for all serogroups. Three group A and
six group B isolates with penicillin MIC of 0.125 mg/ml,
reaching susceptibility breakpoint concentration according to
CLSI, and also highly elevated MIC90 concentrations for group
B streptococci may be messengers of possible forthcoming
resistant strains.
P1612
Trends in macrolide resistance among
pneumococcal carriage strains in French day-care
centres: 1999 to 2004
H. Carsenti-Dellamonica, M. Roussel-Delvallez, B. Dunais,
C. Pradier, P. Bruno, P. Touboul, C. Laurans, E. Bonnet,
P. Dellamonica (Nice, Lille, Paris, FR)
Objective: To study trends in macrolide resistance rates among
S. pneumoniae isolated from children aged 3 to 40 months
attending day-care centres in France following implementation
of prudent antibiotic use campaigns (Alpes Maritimes 2001,
2003, France 2003) and pneumococcal conjugate vaccine (PCV)
(2003).
Method: Nasopharyngeal aspirates were obtained from a
random 2-stage cluster sample of children attending day-care
centres in the Nord (N) and Alpes Maritimes (AM) areas during
3 consecutive surveys between January and March 1999, 2002
and 2004. Susceptibility to erythromycin and clindamycin and
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resistance phenotype were analysed by disk diffusion method.
Serotypes were determined using the quelling reaction.
Pneumococcal immunization status and antibiotic
prescriptions over the 3 previous months were recorded.
Results: SP was isolated from 278/548, 289/534 and 269/567
children in 1999, 2002 and 2004, respectively (p < 10)3).
Resistance to macrolides declined overall from 77.0% to 64.3%
of strains between 1999 and 2004 (p < 10)2). Among
erythromycin-resistant (E-R) isolates, percentage of erm-B
phenotype increased from 81.0% to 90.2% (p = 0.001). While
the proportion of penicillin non-susceptible strains declined
from 33.6% to 24.7% of SP isolates (p < 10)3), erythromycin
resistance remained stable among these strains at 92.0%. Overall
proportion of treated children fell from 64.3% to 48.7%
(p < 10)3) between 1999 and 2004; in AM this reduction was
observed in 2002 (16.0%; p < 10)3), while in N it occurred in
2004 (24%; p < 10)3) and the percentage of macrolides among
prescriptions fell from 13.0% to 9.0% (v2 for trend: p = 0.06).
Serotype distribution showed most E-R isolates were 6B, 14, 19F
and 23F. A 50% reduction in serotype 23F was observed in AM
in 2002 and in N in 2004. Immunisation with PCV concerned at
least 33.5% of children in 2004.
Conclusion: Macrolide resistance has followed a parallel
decline with penicillin resistance as a result of antibiotic-
prescription reducing campaigns and pneumococcal immuniza-
tion against the most prevalent macrolide-resistant serotypes.
P1613
Macrolide-resistant Streptococcus pneumoniae in
Slovenia 1999–2004: correlation with macrolide
use
M. Cizman, S. Zad-Pecar, M. Paragi for the Slovenian Meningitis
Study Group
Objective: To evaluate the prevalence of resistance of invasive
strains of S. pneumoniae to erythromycin after decline in
macrolide consumption.
Methods: The number of packages of antibiotics was obtained
from the Institute of Public Health of Slovenia. For the period
1999–2004 the data on outpatient antibiotic consumption were
collected using the ATC/DDD classiﬁcation (WHO version
2005) and the results were expressed in DDD/1000 inhabitants
per day (DID). All invasive strains of S. pneumoniae isolated from
sterile body ﬂuids in all Slovenian hospitals were included in the
study. Susceptibility testing was performed using NCCLS
approved disk diffusion test.
Results: During 1999–2004 the total use of antibacterials in
Slovenia decreased for 17.4% from 20.23 DID to 16.71 DID. The
consumption of macrolides which constituted 17.1–19.4% of
total use of antibacterials decreased for 21.3% (3.81 to 3.0 DID).
Short-acting (erythromycin, miocamycin), intermediate-acting
(midecamycin, roxithromycin, clarithromycin), and long-acting
(azithromycin) decreased for 33.4%, 25.8% and 13%
respectively. In all years the use of intermediate-acting
macrolides was the most prescribed subclass of macrolides
corresponding for 1.50–2.21 DID, followed by long-acting
(1.25–1.47 DID) and short-acting (0.07–0.12 DID). The
resistance of S. pneumoniae strains to erythromycin increased
from 5.4% (6/110) to 11.2% (19/170); in children from 2.9% (1/
34) to 18.1% (6/33) and in adults from 6.5% (5/76) to 9.5%
(13/137) respectively. Rates of the isolates resistant to
erythromycin and at least 2 of the following agents:
penicillin, tetracycline, TMP/SMX, chloramphenicol increased
from 0.9% (1/110) to 7.7% (13/169); in children from 0% (0/
34) to 15.1% (5/33) and in adults from 1.3% (1/76) to 5.8% (8/
137) respectively.
Conclusion: Despite a reduction of macrolide consumption in
outpatients the resistance of invasive strains of S. pneumoniae
was increasing during the observation period especially in
children.
P1614
Multiple drug resistance explains best the
changes in S. pneumoniae resistance in a ten-year
surveillance study in Belgium
J. Van Eldere, R.M. Mera, L.A. Miller, J. Verhaegen,
J.A. Poupard (Leuven, BE; New Orleans, Upper Providence, US;
Philadelphia, US)
Objective: Belgium is located between countries with very high
and very low antibiotic resistance rates. Modeling how
resistance changes over time and place in Belgium provides
insights into correlates of S. pneumoniae resistance at the
population level.
Methods: Surveillance data consists of 14,488 S. pneumoniae
invasive isolates from 1994–2004, identiﬁed by postal code as
well as clinical and demographic information. Antimicrobial
consumption (IMS Health Services) is expressed in deﬁned daily
doses (DDD) per 1000 inhabitants per day. Changes in resistance
by month and postal code were evaluated using mixed effects
models for repeated measures, using mathematical models of
transmission for the curve shape, and taking into account
seasonality. Resistance to penicillin, erythromycin, tetracycline,
and oﬂoxacin was considered in the analysis.
Results: Resistance to penicillins, macrolides and tetracyclines
peaked in the year 2000, and their levels in 2004 were 11.6%,
35.6% and 28.7% respectively. The shape of the curves is similar
for most of the antibiotics studied, with a steep rise from 1994 to
2000 and a plateau thereafter. Resistance to two or more
antibiotic classes corresponded to 72% of all resistant isolates
and in a multivariate model explains most of the variability
through time and place of the antibiotics studied. Resistance to
only one antibiotic (any) decreased from 16.3% in 1994 to 11.7%
in 2004, while resistance to two or more increased 2.5 times (95%
CI 1.95–3.12, p < 0.0001) from 14.1% in 1994 to 28.8% of all
isolates 10 years later. More than nine out of ten isolates that
were macrolide or tetracycline resistant were also multiply
resistant (MR). MR increases 0.57% for each DDD of overall
cumulative antimicrobial consumption, and out of all antibiotic
classes, macrolides and broad-spectrum penicillins are most
associated with resistance.
Conclusion: Resistance to two or more antibiotics is the most
important factor in understanding the changes over time for all
studied antibiotic classes in Belgium. The cumulative impact of
antimicrobial exposure of separate antibiotic classes at the
population level facilitates the survival and transmission of any
isolate that is resistant to two or more antibiotic classes.
P1615
Molecular mechanisms of antimicrobial
resistance in Salmonella typhimurium isolates,
causing bacteraemia in children under 5 years of
age in southern Mozambique
J. Ruiz, I. Mandomando, P. Esquivel, J. Vila, J. Gascon,
P.L. Alonso (Barcelona, ES; Manhic¸a, MZ; Resistencia, AR)
Objectives: To analyse the molecular mechanisms of resistance
to 7 antimicrobial agents in 85 Salmonella typhimurium causing
bacteremia in children under 5 years of age in Mozambique.
Abstracts
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
Methods: The isolates were identiﬁed by biochemical tests and
speciﬁc serotyping. Antimicrobial susceptibility to ampicilllin
(Amp), amoxicillin plus clavulanic acid (AUC), cloramphenicol
(Cm), gentamicin (Gm), cotrimoxazole (Sxt), nalidı´xic acid (Nal)
and tetracycline (Tc) were established by the method of Kirby
Bauer. The presence of beta-lactamases encoding genes (tem,
carb, oxa2-like) as well as the tetA, tetB, tetC, tetG, cmlA and
ﬂoR genes, and integrons type 1 was established by PCR, while
the presence of plasmid-mediated DHFR was determined by
PCR-RFLP and the CAT activity by a colorimetric assay.
Results: Seven different resistance patterns were identiﬁed: I.
Susceptible (38 strains); II. Amp, Sxt, Gm, A/C (37); III. Amp, Tc,
Cm (2); IV. Amp, Tc, Sxt, Cm (2); V. Amp, A/C (4); VI. Amp, Sxt,
A/C (1); VII (1). – Sxt. No isolate resistant to nalidixic acid was
detected. Resistance to beta-lactam agents was due to the
presence of beta-lactamases type TEM-like (pattern V), CARB-2
(III) and TEM-like plus OXA-30 (II, V, VI). Meanwhile resistance
to cloranphenicol and tetracycline was associated to CAT
activity (III, IV) and ﬂoR (III), and tetB (IV) and tetG (III)
respectively. No mechanism of cotrimoxazole resistance was
detected in the isolates of the patterns II, VI and VII, while dfrA1
was detected in the isolates of the group IV. Resistance to Gm
was associated to the presence of the gene aadB, detected in the
analysis of integrons type 1. Type 1 integrons were detected in
isolates belonging toi the pattern II (750 bp – aadB; 2000 bp –
oxa30, aadA1), III (900 bp – carb2, 1100 – aadA1), IV (1500 bp –
dfrA1, aadA1), V and VI (2000 bp – oxa30, aadA1).
Conclusions: A great diversity of resistance mechanisms has
been detected. Those mechanisms might spread among
microorganisms resulting in a serious health problem due to
the limited number of antibiotic treatments available in the area.
P1616
Small outbreaks of VEB-1 ESBL producing
Acinetobacter baumannii in Belgian nursing
homes and hospitals through cross-border
transfer of patients from northern France
B. Jans, C. Suetens, Y. De Gheldre, E. Leens, P. Bogaerts,
B. Coignard, Y. Glupczynski (Brussels, Yvoir, BE; Saint-Maurice,
FR)
Objectives: Following the national outbreak of multidrug-
resistant (MDR) Acinetobacter baumannii (Ab) producing a VEB-
1 extended-spectrum beta-lactamase (ESBL) which occurred in
France in 2003–2004, the French Institut de Veille Sanitaire
(InVS) alerted the Belgian sanitary authorities. A national
surveillance was set up by the Scientiﬁc Institute of Public
Health and by the reference laboratory to investigate the
possible spread of the French epidemic VEB-1 ESBL-producing
Ab in Belgian hospitals.
Methods: From 01/04 to 03/05, all Belgian acute hospitals were
invited to report cases of nosocomial infections/colonisations
due to MDR Ab isolates presenting a resistance proﬁle similar to
the French epidemic strain (resistance to all agents except
carbapenems and colistin) and to send such isolates to the
reference laboratory for phenotypic conﬁrmation and for
genotypic characterization (PCR of VEB-1 and class 1 Integron,
PFGE typing). Guidelines for detection of the epidemic strain,
screening for carriage in patients transferred from hospitals or
nursing homes (NH) close to the French border as well as
infection control measures were sent to all hospitals.
Results: Overall 73 Ab strains from 30 hospitals were sent to the
reference laboratory. Only, 26 of these fulﬁlled the phenotypic
resistance patterns and 6 were deﬁnitely conﬁrmed as VEB-1 Ab
and had a PFGE pattern identical to the French epidemic clone.
Two mini-outbreak clusters (each involving 3 cases) were
documented in hospitals from two cities (Tournai and
Chimay) closed to the French border. Two patients died from
their infection. In the ﬁrst outbreak, all 3 patients were residents
who lived in the same NH. Two of them were French citizens
who had been hospitalised in different acute care hospitals in
the North of France within the last year. In the second outbreak,
the index case had also been previously hospitalised in a French
hospital. Secondary transmission to two other hospitalised
patients occurred in this outbreak.
Conclusion: Despite the large extension of the VEB-1 Ab
outbreak in France no similar problem occurred in Belgium.
However, this national alert allowed to detect two small
outbreaks in Belgian institutions located close to the French
border. In both outbreaks the epidemic strain was imported
from France through patient circuits. This study illustrates that
transfers between acute care hospitals and NH may explain
cross-border spread of multi-resistant epidemic strains.
P1617
Types of extended-spectrum beta-lactamases in
Salmonella spp. and decreased susceptibility to
ﬂuoroquinolones
S. Ercis, Z. Gulay, D. Gur, B. Erdem, G. Hascelik, A. Tunger,
S. Gedikoglu, I. Tuncer, B. Sumerkan (Ankara, Izmir, Bursa,
Konya, Kayseri, TR)
Objectives: The aim of this study was to determine the rate of
ESBL production in clinical isolates of Salmonella spp. and to
detect decreased susceptibility to ﬂuoroquinolones in ESBL
positive isolates in Turkey.
Methods: A total of 620 Salmonella spp. isolated from clinical
samples from thirteen centres between 2000 and 2002 were
included in the study. In vitro susceptibility to ampicillin,
amoxicillin/clavulanic acid, cefotaxime, gentamicin,
chloramphenicol, tetracycline, trimethoprim/sulfamethoxazole
and ciproﬂoxacin were determined using the agar dilution
method on Mueller-Hinton agar following the Clinical and
Laboratory Standards Institute (CLSI) guidelines. Decreased
susceptibility to ciproﬂoxacin was deﬁned as an MIC of 0.125–
1 mg/L. Salmonella isolates were screened for ESBL production
by double disk synergy method using amoxicillin/clavulanic
acid, cefotaxime and ceftazidime disks. Types of ESBL enzymes
were analysed by PCR for TEM, CTX-M, SHV and PER-1 genes.
Results: In Salmonella spp. the highest level of resistance was
observed against ampicillin (41.3%) followed by
chloramphenicol (36.6%), tetracycline (34.2%) amoxicillin/
clavulanic acid (32.4%), trimethoprim/sulfamethoxazole
(2.3%), gentamicin (1.6%), and cefotaxime (0.8%). Ciproﬂoxacin
resistance was observed in one isolate (0.2%). Among 620
Salmonella isolates, 6 (0.97%) were shown to produce ESBL by
double disk synergy testing. These isolates were Salmonella
typhimurium (n = 2), serogroup C1 (n = 2) and Salmonella
enteritidis (n = 2). Three isolates were from fecal samples two
were from urine and one was from blood. One of the ESBL
producing isolates were susceptible to cefotaxime in vitro. Two
isolates showed decreased susceptibility to ciproﬂoxacin. All the
ESBL producers were resistant to ampicillin, amoxicillin/
clavulanic acid, chloramphenicol and harbored CTX-M type
enzymes. In three isolates a TEM-type enzyme was also present.
Conclusion: Albeit being rare, ESBL production is an important
resistance factor among Salmonella spp. In order to prevent
treatment failures, decreased susceptibility to ﬂuoroquinolones
should be investigated routinely in invasive isolates as well as
ESBL production.
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P1618
Incidence of faecal carriage of ESBL-producing
Enterobacteriaceae in hospital and community
patients during two non-outbreak periods of time
F.J. Castillo, M. Pardos, C. Seral, I. Millan, C. Pitart,
M.E. Llaneza, M.C. Rubio-Calvo (Zaragoza, ES)
Objectives: Determine the incidence of faecal carriage of ESBL-
producing Enterobacteriaceae in the stools of hospitalized
patients and in outpatients submitted to our laboratory for
stool culture between April 2002–February 2003 and August
2004–July 2005.
Methods: A total of 14748 faecal samples were analysed from
9384 patients (26.9% of whom were ambulatory) prospectively
collected between April 2002–February 2003 and August 2004–
July 2005. Sampling was carried out during two non-outbreak
periods from patients submitted to our laboratory for stool
culture. The stool samples were cultured by standard methods.
Enterobacteriaceae growing in modiﬁed CCDA (Oxoid)
containing cefoperazone 32 mg/L were identiﬁed and
screened for extended spectrum beta-lactamase (ESBL)
production by the double-disk sinergy test. Conﬁrmation was
performed by E-test with cefotaxime/cefotaxime-clavulanic
acid, ceftazidime/ceftazidime-clavulanic acid and cefepime/
cefepime-clavulanic acid.
Results: The cefoperazone-containing medium routinely used
in our laboratory for the isolation of Campylobacter occasionally
(16.9%) yielded strains of the family Enterobacteriaceae, some of
them ESBL-producing strains. The rates of patient´ faecal
carriage of ESBL-producing enterobacteria increased in
our area from 2.2% (103 of 4676 patients) in 2002 to 7.4% (349
of 4708 patients) in 2004 (p < 0.001). When hospitalized and
ambulatory patients were considered separately, the rates were
2.5% (29 of 1148) and 2.1% (74 of 3528), respectively, in 2002 and
8.1% (112 of 1375) and 7.2% (237 of 3296), respectively, in 2004.
The identities of the ESBL-producing isolates recovered during
2002 were: E. coli (n = 98), K. pneumoniae (n = 2), P. vulgaris
(n = 2) and E. cloacae (n = 1), and isolates recovered during 2004
were: E. coli (n = 340), K. pneumoniae (n = 3), K. oxytoca (n = 1),
P. vulgaris (n = 1), P. mirabilis (n = 2), E. cloacae (n = 1) and E.
aerogenes (n = 1).
Conclusions: A dramatic, signiﬁcant increase in the frequency
of faecal carriage of ESBL-producing isolates was demonstrated
in 2004 among hospitalized (8.1%) and ambulatory patients
(7.2%).The results revealed that the prevalence of faecal carriage
among ambulatory patients and hospitalized patients was not
signiﬁcantly different in both periods of time. Outpatients came
from the community carrying enterobacteria harbouring ESBL
in the intestinal tract, suggesting that the community could be a
reservoir for these microorganisms and enzymes.
P1619
ESBLs in Enterobacteriaceae from university
hospitals. APUA-Bulgaria Chapter study
E. Keuleyan, R. Markovska, I. Schneider, M. Sredkova,
P. Sotirova, D. Ivanova, A. Bauernfeind (Soﬁa, BG; Munich, DE;
Pleven, Stara Zagora, BG)
Objectives: To characterize the type of ESBLs and the
epidemiology of infections caused by ESBL producing
Enterobacteriaceae strains, isolated in 3-month period (end
1999/beginning 2000) during APUA Bulgaria Chapter
Antimicrobial Resistance Surveillance Study (ARSS).
Methods: A total of 71 K. pneumoniae, 3 K. oxytoca, 11 E. coli, 4 C.
freundii, 3 S. marcescens, and 3 E. cloacae from 6 university
hospitals, isolated from blood, wound, urine, sputum and other
clinically signiﬁcant specimens were proven to produce ESBLs.
Antimicrobial susceptibility was determined according to CLSI,
2002; conjugation on a solid medium was performed; isoelectric
focusing was followed by bioassay; PCR with beta-lactamase
group-speciﬁc oligonucleotides was applied, followed by
nucleotide sequencing; RAPD with ERIC-1A and ERIC 2
primers was performed.
Results: MIC of Ceftazidime varied from 4 to >512 mg/L, MIC
of Cefotaxime – 2–512 mg/L; the addition of sulbactam 1: 1
reducedMIC > 3-fold. Transconjugants exhibited resistance both
to extended-spectrum cephalosporins and aminoglycosides in
37 of 39 strains. According to their pI, two clusters of beta-
lactamase producers could be described: ﬁrst one – ESBLs
focussed at pI 8.2, and the second – pI at 6.3. Results from PCR
conﬁrmed the presence of two groups ESBLs: TEM and SHV.
Sequencing of representative strains showed the presence of
SHV-12 in two participating hospitals and of SHV-5 in only one
strain E. cloacae, while TEM-3 like enzyme was found in 2
centres and had a clonal dissemination.
Conclusions: The data from APUA ARSS revealed that during
1999–2000 ESBLs were emerging in Bulgaria: SHV-12, SHV-5
and TEM-3 like enzymes were identiﬁed; SHV-group
predominated. These results indicate the spread of ESBLs
producing Enterobacteriaceae in Bulgaria and the need for
stronger attention in microbiological diagnostics, antibiotic
therapy and infection control.
P1620
Emergence of multidrug-resistant Gram-negative
bacteria during selective decontamination of the
digestive tract on an intensive care unit
N. al Naiemi, E.R. Heddema, A. Bart, E. de Jonge,
C.M. Vandenbroucke-Grauls, P.H.M. Savelkoul, B. Duim
(Amsterdam,NL)
Objectives: During treatment with selective decontamination of
the digestive tract (SDD), four strains of multidrug-resistant
(MDR) Gram-negative bacteria (three Escherichia coli strains and
one Klebsiella pneumoniae) were isolated at the Intensive Care
Unit (ICU) in the Academic Medical Center (AMC) in
Amsterdam. These isolates were extended spectrum beta-
lactamase (ESBL) positive. We investigated whether this was
due to interspecies transfer of resistance genes.
Methods: The strains were typed by ampliﬁed fragment length
polymorphism analysis. The plasmids from these strains were
characterized by restriction fragment length polymorphism.
Resistance genes of the MDR-strains were characterized by PCR
and sequence analysis.
Results: AFLP analysis conﬁrmed that the three MDR E. coli
isolates represented three different strains. The MDR-strains
were shown to harbour the same plasmid with identical
extended-spectrum aˆ-lactamase (ESBL) genes; CTX-M-15 and
SHV-5.
Conclusions: Identiﬁcation of the emergence of such MDR
Gram-negative bacteria and recognition of resistance plasmid
transfer during SDD treatment is crucial for optimal application
of this regimen in ICUs. The use of the third generation
cephalosporins in SDD may associate with emergence and
increase in the prevalence of ESBLs. Therefore, for optimal
screening of resistance to cephalosporins in ICUs, the screening
for ESBLs should be included.
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P1621
Therapy-driven selection of carbapenem
resistance in CTX-M-producing Klebsiella
pneumoniae
D.G. Pillay, P. De, R. Merard, J.W.T. Dallow, M.E. Kaufmann,
R.L.R. Hill, D.M. Livermore, N. Woodford (Sutton Coldﬁeld,
London, UK)
Objective: Carbapenems are the drugs of choice for the
treatment of serious infections caused by ESBL-producing
Enterobacteriaceae and the emergence of carbapenem
resistance is rarely documented. We investigated pairs of
carbapenem-susceptible and resistant K. pneumoniae isolates
from three patients, collected before and after therapy with
carbapenems.
Methods: Pre- and post-therapy pairs of ESBL-producing K.
pneumoniae isolates were from three patients with urinary
catheter-associated infections who were treated with ertapenem
(ERP, 2 cases) ormeropenem (MEM, one case) in a district general
hospital with a low incidence of ESBL-producing organisms
(0.43/1000 bed days), and meropenem use of 1160 DDD/year.
Isolateswere compared by PFGE of XbaI-digested genomicDNA.
MICs were determined and interpreted by British Society for
Antimicrobial Chemotherapy methodology. blaCTX-M alleles
were sought bymultiplexPCR.Outermembraneproteins (OMPs)
were extracted, and analysed by SDS-PAGE.
Results: The three patients relapsed following ERP or MEM
therapy, and the post-therapy isolates from repeat urine samples
were resistant (table), with MICs ERP>MEM>IPM. All six
isolates from the three patients belonged to the same PFGE
strain, but transmission of the resistant variants is unlikely as
the patients were geographically and temporally unrelated and
separate selection of resistance in individual patients seems
more likely. All isolates had a group 1 CTX-M ESBL; the
resistant isolate in each pair had lost a major OMP, consistent
with a porin, compared with its susceptible ‘parent’. All three
patients were successfully treated with amikacin.
Conclusion: The emergence of carbapenem resistance in CTX-
M-producing K. pneumoniae following therapy severely limits
treatment options. Whilst unusual in general, such selection has
occurred repeatedly with this strain.
P1622
Wide geographic spread of diverse acquired
AmpC beta-lactamases in Escherichia coli and
Klebsiella spp. in the UK and Ireland
N. Woodford, E.J. Fagan, R. Hope, K.L. Hopkins,
M.E. Kaufmann, J.O. Kistler, M.F.I. Palepou, R. Pike, M.E. Ward,
D.M. Livermore (London, UK)
Objective: To determine the distribution of genes encoding
acquired AmpC beta-lactamases in cephalosporin-resistant
isolates of E. coli and Klebsiella spp. submitted to the UK
national reference laboratory.
Methods: MICs were determined by agar dilution and
interpreted according to breakpoints of the British Society for
Antimicrobial Chemotherapy. Isolates of E. coli or Klebsiella spp.
resistant to cefotaxime and ceftazidime, irrespective of addition
of clavulanic acid, were inferred to have possible AmpC-
mediated resistance. Genes encoding six phylogenetic groups
of acquired AmpC enzymes were sought with a multiplex PCR
assay (Perez-Perez & Hanson. J Clin Microbiol 2002;40:2153–62).
Selected isolates were compared by PFGE, and selected
blaAmpC amplicons were sequenced.
Results: 47 E. coli isolates and 8 Klebsiella spp. from separate
patients yielded PCR amplicons indicating the presence of genes
encoding acquired AmpC enzymes. Forty of these E. coli isolates
(from 20 hospitals) produced CIT-type enzymes, 6 (from 3 Irish
hospitals) produced ACC types, and 1 a DHA type. The
Klebsiella spp. produced ACC (5 isolates from 2 Irish
hospitals), FOX (2 isolates from 2 Welsh hospitals) or DHA (1
Irish isolate) enzymes. Genes encoding EBC-/ENT- and MOX-
type enzymes were not detected. Twelve E. coli isolates from one
hospital all produced a CIT-type enzyme; these 12 isolates
belonged to an epidemic UK strain, designated strain A; 8
isolates also contained blaCTX-M-15 linked to an upstream copy
of IS26, as is characteristic of strain A; 4 isolates lacked blaCTX-
M-15. Sequencing of a representative blaAmpC amplicon
indicated production of a novel CMY-2 variant in these isolates.
Conclusions: Diverse acquired AmpC enzymes are present in
E. coli and Klebsiella spp. in the UK and Ireland, with CIT-types
the most common, and ACC types linked to Ireland. The broad
resistance proﬁles of AmpC enzymes compromises patient
management. Hence, the acquisition of a CMY-2-like enzyme
by epidemic E. coli strain A suggests that acquired AmpC
enzymes are poised to become an important public health issue
in the UK.
P1623
Doripenem European surveillance: antimicrobial
activity against 6480 contemporary pathogens
(2004)
T. Fritsche, H. Sader, R. Jones (North Liberty, US)
Objective: To characterize the spectrum of activity and potency
of DOR (formerly S-4661) and comparator agents against
contemporary wild-type bacterial isolates from medical centres
in Europe and the Middle East in 2004. DOR is a novel
parenteral 1-B-methyl carbapenem in late stage clinical devel-
opment whose molecular structure confers stability to B-lacta-
mases and resistance (R) to renal dehydropeptidases.
Methods: The collection included 6480 non-duplicate,
consecutive clinical isolates from patients in 24 medical centres
in Europe (21), Turkey (2) and Israel (1) that were submitted to
the DOR surveillance program (2004) for identiﬁcation
conﬁrmation and susceptibility (S) testing. MIC values for >30
antimicrobials were determined using NCCLS broth
microdilution methods (2003). A tentative DOR susceptible (S)
breakpoint of £4 mg/L (£0.25 mg/L for S. pneumoniae) was used
for comparative purposes; CLSI (2005) criteria were used for
other tested agents.
Results: Antimicrobial activities of DOR and other
carbapenems vs. selected isolates. DOR consistently displayed
activity against staphylococci and streptococci (MIC90, 0.06 and
0.5 mg/L) most similar to that of imipenem, and against E. coli
and Klebsiella spp. (MIC90, 0.06 and 0.5 mg/L, respectively,
including 8.7 and 26.9% of strains that met ESBL screening
criteria), most similar to that of meropenem. Enterobacter spp.
isolates, including 35.8% that were ceftazidime-R (indicative of
AmpC production), were also highly S to DOR and other
carbapenems (0.5 to 1.4% R). DOR also provided slightly
enhanced coverage against P. aeruginosa (82.7% S) and
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Acinetobacter spp. (54.4% S) compared to other carbapenems.
Carbapenem R among these latter strains is, however, a
particularly worrisome development.
Conclusions: DOR is a new carbapenem with a competitive
proﬁle that incorporates both potent Gram-negative and Gram-
positive activity, with enhanced activity against the commonly
occurring non-fermentative Gram-negative bacilli.
Carbapenems are assuming a greater therapeutic role in many
nations as multi-drug resistance (including emergence of
Ambler class A, C and D B-lactamases) spreads, necessitating
their accelerated development.
P1624
Phenotypic and genetic characterisations of
enterococcal isolates in Tehran sewage, with
emphasis on detection of vanA and vanB genes
F. Rahimi, K. Borhani, M. Talebi, J. Vandyouseﬁ,
M.R. Pourshaﬁe (Tehran, IR)
Objectives: Enterococci are members of the normal gut ﬂora of
animals and humans and are thus released into the environment
directly or via sewage outlets, where they can survive for long
time periods. During the last decade the concern has been
focused on enterococci that are resistant to the glycopeptide
antibiotic vancomycin [vancomycin-resistant enterococci (VRE)].
The aim of the study was to detect and to analyse the
biochemical diversity of the Entrococci strains in Tehran
sewage and to determine the genetic characterization of VRE.
Methods: A total of 410 isolates of Enterococci were selected on
mE agar medium. All of the isolates were identiﬁed at the
species level by the common biochemical tests. Drug
susceptibility test of isolates was done by disk diffusion
method with 6 antibiotics vancomycin, erythromycin,
gentamicin, tetracycline, chloramphenicol and ciproﬂoxacin.
The MIC was also done by macrobroth dilution assay.
Analysis of the plasmid proﬁles and the PCR tests for vanA
and vanB genes were done.
Results: The results showed that 210, 111, 54, 20, 7, 3, 2, 2 and 1
isolates were E. faecium, E. hirae, E. faecalis, E. gallinarum, E.
mundtii, E. rafﬁnosus, E. dispar, E. casseliﬂavus and E. avium,
respectively. The antibiotic resistance to the isolates were as
follow: 4, 4, 18, 19, 30, 6% of the isolates were resistant to
vancomycin, gentamicin, tetracycline, ciproﬂoxacin,
erythromycin and chloramphenicol, respectively. MIC test
showed that 18 of the isolates were highly resistant to
vancomycin, 10 isolates were intermediate and 16 isolates
were sensitive to vancomycin. The plasmid proﬁles of the
isolates showed 4 strains lack plasmids, 14 strains having four
different proﬁles. PCR analysis showed that from 18 VRE, 83.3%
had vanA gene.
Conclusion: Enterococcal species, in general, was considered to
have a high distribution in Tehran sewage with E. faecium as the
most predominant strain. Overall, there was a 4% VRE in the
Tehran sewage treatment plant. The presence of VRE was
limited to E. faecium.
P1625
Antibiotic susceptibility of vancomycin-resistant
enterococci isolated in Greek hospitals
A. Christidou, A. Gikas, E. Scoulica, M. Roumpelaki,
A. Georgiladakis, E.I. Kritsotakis, G. Haliotis, S. Levidiotou,
J. Kioumis, A. Skoutelis, P. Nikolaidis, Y. Tselentis (Heraklion,
Halkis, Ioanina, Thessaloniki, Patra, GR)
Objective: To investigate the antibiotic susceptibility of
vancomycin resistant enterococci (VRE) isolated in 8 Greek
hospitals.
Material and methods: A total number of 373 VRE were
isolated from patients in 8 Greek hospitals Sixty-ﬁve isolates
were derived from VRE infected and 308 from VRE colonized
patients. Species identiﬁcation and vancomycin resistance
characterization were performed by convetional and molecular
methods. Susceptibility testing to 14 antibiotics was performed
by disk diffusion and E-test methods.
Results: Species and type distribution was as follows: E. faecium
vanA, 118 (31.6%); E. faecium vanB, 29 (7.7%); E. faecalis vanA, 14
(3.7%); E. faecalis vanB, 5(1.3%); E. avium vanA, 4(1.1%); E. hirae
vanA, 2 (0.6%); E. gallinarum vanC1, 173(46.4%); E. gallinarum
vanA, 1 (0.3%); E. casseliﬂavus/ﬂavescens vanC2/C3, 26(7%); E.
casseliﬂavus vanA, 1(0.3%) isolates. When all isolates (with
VanA, VanB, or VanC phenotype) were considered, antibiotic
resistance rates were: Penicillin, 39.1%; Ampicillin, 37.3%;
Streptomycin (HLR), 45.3%; Gentamicin (HLR), 23.3%;
Tetracycline, 28.7%; Rifampicin, 36.5%; Chloramphenicol, 5.6%;
Erythromycin, 75.9%, Norﬂoxacin, 84.5%; Ciproﬂoxacin, 70.3%;
Imipenem, 39.6%; Vancomycin, 100%; Teicoplanin, 37.5%; and
Linezolid 0%. When only the isolates with the VanA, or VanB
phenotype were considered as a group, different results were
obtained. The antibiotic resistance rates were: Penicillin, 82.2%;
Ampicillin, 79.9%; Streptomycin (HLR), 91.4%; Gentamicin
(HLR), 50%; Tetracycline, 42.5%; Rifampicin, 50.6%;
Chloramphenicol, 12.1%; Erythromycin, 100%, Norﬂoxacin,
91.4%; Ciproﬂoxacin, 92%; Imipenem, 83.9%; Vancomycin,
100%; Teicoplanin, 80.5%; and Linezolid, 0%. E. faecium
presented the highest resistance rates to all antibiotics tested,
except gentamicin (HLR) and tetracycline. Sixty-one out of 118
(57.6%) E. faecium vanA, 22/29 (75.9%) E. faecium vanB, and 1/14
(7.1%) E. faecalis vanA isolates exhibited multi-resistance (at least
to10 of the antibiotics).
Conclusion: VanA phenotype of VRE predominated over the
VanB in our hospitals. VRE presented high resistance rates to a
wide spectrum of antibiotics. Linezolid and Chloramphenicol
were the most active antibiotics against our VRE isolates. Multi-
drug resistance was determined in the majority of VanA, and
VanB E. faecium isolates.
P1626
Molecular characterisation of Tn1546 from
enterococci isolated from Portuguese human,
animal and environmental sources
C. Novais, T.M. Coque, J.C. Sousa, L. Peixe (Porto, PT; Madrid,
ES)
Objectives: To characterise the diversity of Tn1546 among
vancomycin resistant enterococcal (VRE) isolates recovered from
different sources in different Portuguese regions.
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Methods: We studied 153 VRE isolates collected in the North
and Center of Portugal (1996-2004) from: (i) 81 clinical isolates
from 3 hospitals in different cities, (ii) 4 faecal samples from
healthy volunteers, (iii) 2 river water samples, (iv) 6 samples
collected downstream of hospital sewage water, (v) 2 samples
from urban sewage water, (vi) 4 swine faeces (vii) 27 poultry
food samples for human consumption. Identiﬁcation and
characterization of vancomycin resistant genes vanA, vanB,
vanC1 and vanC2 were determined by a multiplex PCR. The
backbone structure of Tn1546 was characterized by a PCR
overlapping assay (10 overlapping fragments), and further
sequencing.
Results: Tn1546 was characterized in 153 vanA isolates that
were identiﬁed as E. faecium (n = 111), E. faecalis (n = 37), and
Enterococcus sp. (n = 5). All isolates were resistant to
vancomycin and 93% (142/153) to teicoplanin. Eighty-nine
PFGE proﬁles and 22 types of Tn1546 were detected among
the 153 enterococci studied. Some Tn1546 variants were
recovered only from speciﬁc sources (S, PP-1, PP-11, PP-2, PP-
4, PP-9, PP-10, PP-13, PP-23, PP-24, PP-25, PP-27, PP-6, PP-17)
while others were detected from isolates of different origins (A,
D, X, PP-3, PP-5, PP-15, PP-16, PP-20). Although no
polymorphism or size variation in the central regions of
Tn1546 (vanRSHA) was seen for most of the enterococci, the
remaining parts of the transposon, including the right and left
ends, were very heterogeneous involving mutations (in vanS
and vanX), deletions (vanY), duplications (vanX, vanZ) or the
presence of different insertion sequences (IS1216V, ISEf1,
ISEfm1). Tn1546 location was observed both in plasmids and/
or in chromosome.
Conclusions: A high diversity of Tn1546 was observed among
Portuguese VRE, suggesting a high recombination rate of this
structure. Variable distribution of Tn1546 variants suggests local
availability of speciﬁc types in local metagenomes and
dissemination of speciﬁc genetic elements among different
reservoirs.
P1627
Trends in prevalence rates and beta-lactamase
production of Haemophilus inﬂuenzae
nasopharyngeal carriage strains in children’s day-
care centres in south-eastern France
B. Dunais, H. Carsenti-Dellamonica, C. Pradier, P. Bruno,
P. Touboul, M. Sabah, G. Mancini, P. Dellamonica (Nice, FR)
Objective: To monitor prevalence rates and beta-lactam
susceptibility of Haemophilus inﬂuenzae (HI) nasopharyngeal
carriage strains among children aged 3 to 40 months attending
day-care centres in the Alpes Maritimes, France, in the context of
antibiotic prescription-reducing campaigns (Alpes Maritimes
2001, 2003, France 2003).
Method: Nasopharyngeal aspirates were obtained from a
random 2-stage cluster sample of children attending day-care
centres in the Alpes Maritimes (AM) areas during 3 consecutive
surveys conducted between January and March 1999, 2002 and
2004. HI isolates were characterized using the API-NHª test
(BioMe´rieux). Antibiotic prescriptions over the 3 previous
months were recorded.
Results: HI was isolated from 53.4%, 50.3% and 55.5% of 298,
294 and 337 children in 1999, 2002 and 2004, respectively. Beta-
lactamase-producing strains accounted for 53.1%, 43.9% and
37.9% of all HI isolates in 1999, 2002 and 2004, respectively (chi-
square for trend: p = 0.003). Types II, III, I and V made up at
least 80% of strains. The proportion of children with a recent
history of antibiotic intake declined from 62.7% in 1999 to 52.8%
in 2002 and 48.0% in 2004 (p = 0.001).
Conclusion: Beta-lactamase production among HI strains has
declined signiﬁcantly since 1999 among children attending day-
care centres as antibiotic prescriptions fell among this
population.
P1628
Susceptibility of Haemophilus inﬂuenzae in the
Netherlands
J.W. Mouton, D. Klomberg, S. Meijers, C. Klaassen (Nijmegen,
NL)
Background: Surveys of susceptibility of Haemophilus inﬂuenzae
(HI) by MIC testing are not common. MIC distributions are
necessary to determine wildtype cut-off values and clinical
breakpoints. We performed a nation wide survey to study
susceptibility of H. inﬂuenzae by E-test and compared these with
conventional surveillance results.
Methods: 34 laboratories equally distributed through The
Netherlands participated in a surveillance study. Each lab was
asked to collect 10 strains each of HI from consecutive sputum
samples. Strains were identiﬁed by participating laboratories
using their own standard identiﬁcation technique. MIC’s were
determined for ten antimicrobials (Moxiﬂoxacin,
Clarithromycin, Azithromycin, Cotrimoxazole (SxT),
Doxycyclin, Cefotaxime, Cefuroxim, Amoxicillin (Am),
Amoxicillin/Clavulanic acid (AmC)) using the Etest on site
following manufacturers instructions; control strain ATCC
49247 was included. Afterwards, strains were collected by the
central lab for further analysis if applicable. Results were
analysed using WhoNet version 5.3 and compared with the
surveillance results until 2002 as published in NETHMAP 2004.
Results: The MIC distribution of Am showed 4% of strains
(n = 332) with a MIC > 4 mg/L and 7% with a MIC of >2 mg/L,
indicating that resistance to Am is still relatively rare and does
increase as compared to NETHMAP2004. The lognormal
distribution of both Am and AmC (1 strain R) extended to
1 mg/L but showed tailing to 4 mg/L. This may indicate
hidden less susceptible strains but could equally well be
explained by testing circumstances, since the left part of the
MIC distribution showed comparable tailing. All strains were
susceptible to moxiﬂoxacin, levoﬂoxacin and cefotaxim. The
lognormal distribution of SxT extended to 0.25 mg/L with 10%
of strains showing higher values. Doxycyclin resistance was less
than 5%. Most of the strains were resistant to clarithromycin and
azithromycin with a MIC10 >0.5 mg/L for both.
Conclusions: Resistance of HI to common antimicrobials in The
Netherlands is still low and does not increase. The results of the
MIC distributions form an excellent basis for determining wild
type cut-off values and clinical breakpoints for H. inﬂuenzae.
P1629
A current perspective on Streptococcus
pneumoniae and Haemophilus inﬂuenzae
resistance trends in Europe: GLOBAL
Surveillance Study, 2005
M. Jones, D. Draghi, C. Thornsberry, D. Sahm (Plaisir, FR;
Herndon, US)
Objectives: S. pneumoniae (SP) and H. inﬂuenzae (HI) are the two
most common pathogens associated with community-acquired
pneumonia. Changes in the prevalence of resistance or
multidrug resistance (MDR) among these pathogens have
important therapeutic ramiﬁcations. The GLOBAL Surveillance
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initiative is a longitudinal study that benchmarks antibacterial
resistance among respiratory pathogens.
Methods: During 2005, 964 SP and 924 HI were isolated from
patient specimens collected at hospital laboratories in France
(Fr), Germany (Ger), Italy (It), Spain (Spa), and the United
Kingdom (UK). Isolates were centrally tested by broth
microdilution against LEV, penicillin (PEN; SP only),
azithromycin (AZI), erythromycin (ERY), clindamycin (CLI),
ceftriaxone (CTX), cefuroxime (CFX), and trimethoprim-
sulfamethoxazole (TMP-SMX) (NCCLS, 2005). Data were
analysed according to PEN resistance, MDR, and b-lactamase
status. MDR was deﬁned concurrent resistance to ‡2 of the
following agents: CTX, CFX, ERY, LEV, PEN, and TMP-SMX.
Results: For SP, PEN R was 1.8% in Ger, 2.6% in the UK, 8.5% in
It, 15.7% in Spa, and 27.1% in Fr. AZI R was 13.0% in the UK,
22.1% in Ger, 27.8% in Spa, 44.3% in It, and 46.3% in Fr. Overall,
LEV R was rare (£1%) and MIC90s = 1 mg/L in all countries.
62.9% of isolates were susceptible to all of the drugs tested, the
most common phenotype encountered. The prevalence (%) of
MDR among SP ranged from 4.7 in UK to 32.3 in Fr. Resistance
to PEN, ERY, CFX, and TMP-SMX was the most prevalent MDR
phenotype found in Europe. Overall 97.4% of MDR SP were
susceptible to LEV. For HI, b-lactamase rates varied by country
from 4.5% in It to 21.9% in Fr. Based on MIC90 LEV and CTX
were the most active agents tested against HI, regardless of
b-lactamase status.
Conclusions: LEV showed potent activity against SP and HI.
For SP, LEV activity was independent of resistance to PEN or
MDR phenotype. LEV maintained consistent activity against SP
based on MIC90, regardless of country studied. Antimicrobial
surveillance data from studies such as the GLOBAL offer
guidance to physicians for empiric prescribing.
P1630
Eight years of antimicrobial surveillance in
Haemophilus inﬂuenzae isolated in Portugal
(1997–2004)
M.P. Bajanca-Lavado, D. Louro, M.M. Canic¸a, and
GEMVSA (Multicentric Study Group on Antimicrobial
Susceptibility)
Objectives: Haemophilus inﬂuenzae (HI) is responsible for
respiratory tract infections as well as for severe invasive
infections such as meningitis, sepsis, epiglottitis and arthritis.
The aim of this work was to monitor antimicrobial susceptibility
of HI isolated in Portugal.
Methods: From January 1997 to December 2004, Antibiotic
Resistance Unit at the National Institute of Health, in Lisbon,
received 4865 HI strains isolated in 26 Hospital Laboratories
from different regions of Portugal. Beta-lactamase production
(nitroceﬁn) was determined for all strains. Minimum inhibitory
concentrations (MICs, mg/L) were determined, by an agar
dilution assay, to ampicillin (3344 strains) and co-amoxiclave
(3348 strains). For all beta-lactamase producers (489 strains) a
microdilution assay (Dade Behring) was used to perform MICs
to other antibiotics.
Results: From 1997 to 2004, beta-lactamase production
changed as follows: 8.3% (1997), 8.8% (1998), 12.1% (1999),
10.7% (2000), 9.9% (2001), 10.1% (2002), 10% (2003) and 9.3%
(2004). Since 1989, the mean value of 10%, in studies
performed in our laboratory, has been maintained.
Ampicillin resistance in non beta-lactamase producers
(ARNBLP) were from 1.5% in 1997 to 5.2% in 2004, with a
mean value of 3.5%. Between 2003 and 2004 a small increase
was observed in MIC90 to ampicillin (0.25 to 1 mg/L) and to
co-amoxiclave (1 to 2 mg/L). Resistance to other antibiotics
(considering intermediate and resistant strains) between 1997–
2000 (214 bla+) and 2001–2004 (279 bla+) decreased as follows:
cloramphenicol, 7.5% to 4.7%; tetracycline, 31.3% to 10%;
rifampicin, 2.8% to 0.4%. A high resistance rate of 26.5% to
SXT was obtained (2001–2004).
Conclusions: Our results suggest that beta-lactamase
production does not constitute a threat in HI therapy since
values were almost constant. Although with an unregulated
ﬂuctuation on ARNBLP percentages, it seems that this
mechanism is gaining importance in relation to beta-lactamase
production. Thus, we conclude the need to be aware of
ARNBLP, as these strains are difﬁcult to detect using the
NCCLS (2004) breakpoints. Further molecular studies of the
resistance genes responsible of this resistance mechanism are
needed. Resistance of beta-lactamase producer strains, to other
antibiotics decreased during the period of study, due to the
diminished use of these antibiotics. This study shows the
importance of monitoring antibiotic resistance in HI in order to
detect emerging mechanisms.
P1631
Antimicrobial susceptibility of respiratory
Haemophilus inﬂuenzae strains in northern
Greece
K. Koraki, P. Karapavlidou, D. Soﬁanou (Thessaloniki, GR)
Objectives: To investigate the antimicrobial susceptibility of
Haemophilus inﬂuenzae, one of the most frequent bacterial
pathogens of respiratory tract infections. Treatment of these
infections is most often empirical and considerable geographical
resistance variation has been reported.
Methods: Eighty H. inﬂuenzae strains were collected from
respiratory tract specimens (sputum, bronchoalveolar lavages,
endotracheal secretions) in a 4-year period (2000–2004).
Identiﬁcation was made by colonial morphology, Gram
staining characteristics, X- and V- factor requirements and API
NH (bioMerieux, France). Antibiotics were selected to reﬂect
representative current treatment options and susceptibility was
determined by Kirby-Bauer disc diffusion method on
Haemophilus test medium according to NCCLS guidelines.
Results: Out of the 80 H. inﬂuenzae strains 58 were isolated from
children and 22 from adults. 25% of isolates came from children
admitted to the intensive care units and 18.7% from cystic
ﬁbrosis patients. A seasonal trend was reported for infections
since 41.2% of isolates were collected during springtime and
25% during autumn months. Overall ampicillin resistance was
13.3% and resistant strains were isolated exclusively from
children. Ampicillin resistance was doubled among cystic
ﬁbrosis patients (27.3%). All isolates were susceptible to
amoxicillin/clavulanate, chloramphenicol, ciproﬂoxacin and
imipenem. The rank order of cephalosporin activity was
cefotaxime and ceftriaxone (100%) followed by cefuroxime and
cefaclor (95.8% and 88.9% respectively). Trimethoprim/
sulfomethoxazole was active against 95.2% of isolates while
erythromycin was the least potent antimicrobial agent with 75%
of isolates being susceptible to it. No multiresistant phenotypes
were detected.
Conclusion: Our results demonstrated that ampicillin
resistance among H. inﬂuenzae in our area is still relatively low
and overall antibacterial susceptibility rates are high.
Knowledge of antimicrobial resistance among these pathogens
is imperative for physicians to choose the most appropriate
therapeutic agent.
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Current state of Gram-negative hospital-acquired
urinary tract infections in Russian intensive care
units: pathogens and their resistance phenotypes
E. Khaykina, G. Reshedko, E. Ryabkova on behalf of the Rosnet
Group
Objectives: To reveal the most common gram-negative
pathogens of hospital-acquired urinary tract infections (UTIs)
and their antimicrobial resistance.
Methods: Gram-negative pathogens from ICUs patients with
hospital-acquired UTIs were collected in 2002–2004 throughout
Russia. Antimicrobial susceptibility testing was performed in
accordance with NCCLS. To interpret cefoperazone/sulbactam
susceptibility results breakpoints for cefoperazone were used.
SFM 2003 breakpoints were applied for polymyxin B.
Results: 396 nosocomial gram-negative uropathogens were
studied. Most common uropathogens were P. aeruginosa
(30.8%), E. coli (25.8%), K. pneumoniae (11.1%), followed by A.
baumannii (7.3%), Enterobacter spp. (5.8%), S. marcescens (4.5%),
Proteus spp. (3.8%) and other gram-negative rods (10.9%).
Resistance rates (I+R, %) among P. aeruginosa were: gentamicin
– 87%, levoﬂoxacin – 84%, ciproﬂoxacin – 81%, cefoperazone –
79%, cefoperazone/sulbactam–71%, cefepime– 62%, piperacillin
– 55%, amikacin – 48%, ceftazidime – 46%, imipenem – 45%,
meropenem–43%, piperacillin/tazobactam–43%, polymyxinB –
7%. Resistance rates (I+R, %) among E. coli were: piperacillin –
75%, ticarcillin/clavulanic acid – 69%, amoxicillin/clavulanic
acid – 62%, ciproﬂoxacin – 54%, gentamicin – 54%,moxiﬂoxacin –
54%, levoﬂoxacin – 53%, cefoperazone – 48%, ceftriaxone – 45%,
cefepime – 40%, ceftazidime – 32%, cefoperazone/sulbactam –
19%, piperacillin/tazobactam – 18%, amikacin – 17%, all strains
were susceptible to ertapenem, imipenem, meropenem.
Resistance rates (I+R, %) among K. pneumoniae were following:
piperacillin – 82%, cefoperazone – 75%, ceftriaxone – 71%,
gentamicin – 71%, amoxicillin/clavulanic acid – 66%, cefepime
– 64%, ceftazidime – 57%, ciproﬂoxacin – 53%, piperacillin/
tazobactam – 46%, moxiﬂoxacin – 43%, cefoperazone/sulbactam
– 43%, levoﬂoxacin – 41%, amikacin – 27%, ertapenem – 7%,
imipenem and meropenem were active against all isolates.
Conclusion: P. aeruginosa, E. coli and K. pneumoniae are the main
gram-negative uropathogens in Russian ICUs patients.
Imipenem, meropenem, ertapenem showed prominent activity
against E. coli and K. pneumoniae. Cefoperazone/sulbactam,
piperacillin/tazobactam, amikacin exhibited considerable
activity versus E. coli, while K. pneumoniae were more resistant
to them. P. aeruginosa were highly resistant to all tested
antimicrobials except polymyxin B, thus leaving virtually no
choices for therapy in terms of acceptable patient safety.
P1633
Antimicrobial susceptibility of Gram-negative
anaerobic bacteria from two hospitals in
Smolensk, Russia
D. Galkin, O. Kretchikova, M. Sukhorukova, R. Kozlov
(Smolensk, RU)
Objective: To analyse resistance patterns of gram-negative
anaerobic bacteria isolated during the ﬁrst half of the year
2005 in several hospitals in a Russian city.
Methods: Clinical anaerobic isolates from two hospitals in
Smolensk (Central region of Russia) were tested using agar
dilution method in accordance with CLSI 2005 (M11-A6)
guidelines.
Results: Overall 69 gram-negative anaerobic bacteria from 41
patients were studied. Isolation sites were represented by intra-
abdominal – 25 (60.9%), soft tissue – 7 (17.1%), prostate ﬂuid – 5
(12.2%), bone – 3 (7.4%), and dental – 1 (2.4%) infections.
Susceptibility of 31 (44.9%) Prevotella spp., 23 (33.3%) Bacteroides
spp. (predominantly B. fragilis group – 20 strains), 7 (10.2%)
Fusobacterium spp., 4 (5.8%) Porphyromonas spp., and 4 (5.8%)
Veillonella spp. to ampicillin, clindamycin, metronidazole,
imipenem, ertapenem, amoxicillin/clavulanic acid and
cefoperazone/sulbactam was determined. All species were
susceptible to carbapenems. In Prevotella spp. there were 64%
and 3% strains resistant to ampicillin and clindamycin and 4% of
strains with intermediate resistance to metronidazole. Among
Bacteroides spp. 92% of strains were resistant to ampicillin and
22% to clindamycin. No resistance to metronidazole was
detected in Bacteroides spp. MIC50/90 of 0.5/2.0 and 4.0/8.0
was achieved for amoxicillin/clavulanic acid and cefoperazone/
sulbactam, respectively in this group. All Fusobacterium spp.
were susceptible to clindamycin, 2/7 strains were resistant to
ampicillin and 1/7 strain demonstrated intermediate
susceptibility to metronidazole. Amoxicillin/clavulanic acid
and cefoperazone/sulbactam showed MIC50/90 of 0.125/2.0
and 1.0/4.0, respectively. Among Porphyromonas spp. strains, 1/
4 strain was resistant to ampicillin, clindamycin and
metronidazole. One Veillonella spp. strain was resistant to
ampicillin, with no resistance to metronidazole and
clindamycin. MIC50/90 of amoxicillin/clavulanic acid and
cefoperazone/sulbactam were, respectively 0.125/16.0 and
1.0/32.0 for Porphyromonas spp., 0.125/0.5 and 1.0/1.0 to
Prevotella spp., 0.06/0.5 and 1.0/4.0 to Veillonella spp.
Conclusion: Metronidazole, carbapenems, and inhibitor-
protected beta-lactams are preferred for the therapy of
anaerobic infections.
P1634
Bloodstream infections in an Estonian university
hospital
P. Mitt, K. Lo˜ivukene, V. Adamson, K. Kermes, T. Laeneste,
M. Maimets, P. Naaber (Tartu, EE)
Objectives: The objectives of this study were to: analyse our
current blood culture practice; describe the frequency of
occurrence and antimicrobial susceptibility of bloodstream
infections (BSI) isolates; determine the contamination rate.
Methods: We performed a prospective survey of all positive
blood cultures received in the Department of Microbiology of
Tartu University Hospital (938 beds) in 2004. Blood culture
system used was BACTEC 9120. Duplicates within one week
were excluded. Isolates were identiﬁed using conventional
microbiology methods and susceptibility tests were those
recommended by NCCLS. To determine extended spectrum
beta-lactamase (ESBL) producers an E-test with cefepime and
cefepime combined with clavulanic acid was used. Nosocomial
infections were deﬁned according to CDC criteria.
Results: During study period 7230 blood culture bottles were
received, comprising 2840 blood culture sets (10.4 sets per 1000
patient-days). These resulted in 427 (17.2%) positive blood
cultures, 127 (29.7%) were considered contaminants and
contamination rate was 5.1%. A total of 273 BSI episodes
involving 246 patients were identiﬁed and 161 (59%) of these
were nosocomial. The incidence of nosocomial BSI (N-BSI) and
community-acquired BSI (CA-BSI) was 0.6 and 0.4 per 1000
patient-days, respectively. Polymicrobial BSI was detected in 25
patients. Among N-BSI dominated coagulase-negative
staphylococci (49/30.4%), Staphylococcus aureus (19/11.8%),
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Klebsiella spp. (21/13%), and Escherichia coli (16/9.9%). The most
frequent pathogens of CA-BSI were E. coli (31/27.7%), S. aureus
(14/12.5%), Haemophilus inﬂuenzae (11/9.8%), and Streptococcus
pneumoniae (10/8.9%). Susceptibility to oxacillin of S. aureus and
CoNS was 100% and 21.4%, respectively. All S. pneumoniae
isolates were susceptible to penicillin. 97.8% of E. coli strains
were susceptible to ciproﬂoxacin, 67.4% to ampicillin, and 100%
to gentamicin. Susceptibility of Klebsiella spp. to both
ciproﬂoxacin and gentamicin was 96.7%, and to ampicillin
6.7%. 14.3% of Klebsiella spp. and none of E. coli isolates were
ESBL-producers. The susceptibility patterns of N-BSI and CA-
BSI pathogens were similar to each other.
Conclusion: Compared to West and North European countries
our number of blood culture sets per 1000 patient-days is low.
This may explain the relatively low incidence of BSI. The
interventions to reduce contamination rate need to be
implemented. The susceptibility among BSI isolates was high.
Clostridium difﬁcile revisited
P1635
Clinical features of Clostridium difﬁcile
associated diarrhoea and molecular
characterisation of the strains over a 5-year period
in a French university hospital
F. Barbut, B. Gariazzo, V. Lalande, R. Luiuz, B. Burghoffer,
J.C. Petit (Paris, FR)
Recent outbreaks of C. difﬁcile associated diarrhoea (CDAD)
reported in North America, United Kingdom and the Nether-
lands have emphasized the importance for an ongoing surveil-
lance of CDAD. The aims of the present study was to determine
the epidemiology of CDAD over the past 5 years and the rate of
nosocomial transmission in our acute care hospital (750-beds).
Materials and methods: All the cases of CDAD diagnosed
between January 1st 2000 and December 31st 2004 were
retrospectively reviewed. A CDAD case was deﬁned as
diarrhoea in hospitalised patients with a positive result for C.
difﬁcile cytotoxin or with a positive toxigenic culture. CDAD was
considered as severe if patient fulﬁlled at least 2 of the following
3 criteria: fever > 38.5˚C abdominal pain or leukocyte count
>10,000/mm3 or if the patient had an endoscopically proven
pseudomembranous colitis or complications (toxic megacolon,
perforation…). CDAD was considered as community acquired if
the diarrhoea occurred in patients within 72 h after admission
and if the patient had no history of hospitalisation in the
previous 2 months, otherwise CDAD was considered as
nosocomial. All the strains were serogrouped and
characterized by toxinotyping and PCR-ribotyping. Detection
of toxin A, toxin B and binary toxin was performed by PCR.
Results: 151 cases of CDAD were diagnosed: 147 clinical charts
could be reviewed and 131 strains were studied. Global
incidence of CDAD was 1.1 per thousand discharges with
higher rates in 2003 and 2004. Diarrhoea was community
acquired in 19% of patients. For patients with nosocomial
CDAD, transmission of the strain from patient to patient (i.e.
strain with the same serogroup and PCR-ribotype than the strain
from another patient hospitalised in the same ward in the
previous 2 months) was demonstrated in 10.1% of cases. Binary
toxin was positive in 11% of strains. Binary toxin was associated
to a more severe diarrhoea (p < 0.01) and to a higher case
fatality (p < 0.01). A speciﬁc clone accounted for 25% of all the
strains (serogroup H, PCR-ribotype ‘‘026’’) but this clone was
found both in nosocomial or community cases. Three strains
belonged to toxinotype III but further investigations are needed
to know whether these strains correspond to the hypervirulent
strains involved in recent outbreaks.
Conclusion: Incidence of CDAD is low in our hospital and
cross infection is limited. These results also suggest that strains
with binary toxin might be more virulent.
P1636
The development and application of a new exact
typing method for Clostridium difﬁcile: multi-
locus variable number of tandem repeat analysis
R.J. van den Berg, I. Schaap, K.E. Templeton, C.H.W. Klaassen,
E.J. Kuijper (Leiden, Nijmegen, NL)
Objectives: To study the epidemiology of Clostridium difﬁcile, a
typing method with a higher discriminatory power, typeability
and reproducibility than currently available methods is
required. Multi-Locus Variable Number of Tandem Repeat
Analysis (MLVA) is a new candidate technique, that has already
been tested successfully on a number of bacterial and fungal
species. Using the whole genomic sequence, we developed
MLVA for C. difﬁcile and compared the method to standardized
PCR-ribotyping. Additionally, MLVA was tested on a collection
of the new emerging hypervirulent PCR-ribotype 027 strains.
Methods: Short tandem repeat loci (3 to 9 bp) were identiﬁed
using Tandem Repeat Finder v3.21 on the genome of C. difﬁcile
strain 630. Ampliﬁcation of the repeats was performed using a
single PCR-protocol. PCR-fragments were analysed using multi-
coloured capillary electrophoresis on an ABI3100, with a
ROX500-marker as internal marker for each sample. The
number of repeats per fragment was subsequently
determined.The discriminatory power of the MLVA was
tested on 23 reference strains representing 11 serogroups and
12 toxinotypes. The ability to subtype speciﬁc PCR-ribotypes
was investigated with 7 subtypes of PCR-ribotype 001 (rep-PCR
types 1-7), 6 TcdA-/TcdB+ strains of PCR-ribotype 017, and 11
strains belonging to PCR-ribotype 027. Of these 11 type 027
strains, 9 were isolated from 3 outbreaks and 2 from endemic
cases.
Results: A total of 7 regions with short tandem repeats were
identiﬁed. MLVA discriminated all 23 reference strains and the 7
known reference strains of PCR-ribotype 001 (rep-PCR 1-7). Two
MLVA-types were recognized among 6 TcdA-/TcdB+ strains;
the differences were present in only one of the 7 repeat-regions.
Of 11 PCR-ribotype 027 strains, 9 outbreak-related strains were
identical to each other. Interestingly, two endemic type 027
strains differed from the other strains in 2 of the 7 regions.
Conclusion: MLVA is a highly discriminatory genotyping
method for C. difﬁcile and is capable to subtype various CR-
ribotypes. MLVA is also an important new tool to study the
epidemiology of the emerging PCR-ribotype 027 strains.
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Comparative study of Clostridium difﬁcile
diarrhoea in elderly patients treated with
moxiﬂoxacin versus amoxycillin for lower
respiratory tract infections
L. Mooney, M. Wilcox (Leeds, UK)
Fourth generation ﬂuoroquinolones such as moxiﬂoxacin have
improved anti-anaerobic activity. Consequently, these new
agents could induce C. difﬁcile infection (CDI) by inhibition of
‘protective’ anaerobic ﬂora. Recent reports have suggested such
an association. However, further studies are warranted to
determine the risk of CDI in elderly in-patients treated with
these agents, and notably where exposure to CD is measured/
controlled.
Methods: We prospectively investigated the propensity of
moxiﬂoxacin (MOX) or amoxycillin/macrolide (AML/MAC)
to induce CDI when used to treat lower respiratory tract
infections (LRTIs) in elderly in-patients, using a 4-ward,
crossover design (18 months total). Patients prescribed MOX
or AML/MAC were monitored for gastrointestinal symptoms.
Diarrhoea was assessed as due to CD, viral or other cause.
Relevant clinical data were collected. Concurrent
epidemiological surveillance was also performed to determine
environmental exposure to CD.
Results: 128 patients were studied, 24 receiving MOX and 104
had AML/MAC. Univariate analysis indicated that there was
no signiﬁcant difference between MOX and AML/MAC
patients in gender, age (83.6 vs 86.6 mean years,
respectively), or duration of hospitalisation (total, prior to
and post diarrhoea). Duration of antibiotic therapy did not
differ signiﬁcantly between MOX and comparator patients
(either total days or days before diarrhoea onset). There was a
signiﬁcant association between MOX and overall risk of
diarrhoea. However, there was no signiﬁcance between MOX
treatment and CD, viral or other cause of diarrhoea. Risk factor
analysis to inform on possible confounders was performed.
Initial epidemiological survey results indicate that there was no
change in environmental exposure levels to CD on each
hospital ward. Molecular typing of all clinical and
environmental isolates of CD is ongoing.
Conclusions: Although recent reports have highlighted a risk of
CDI associated with ﬂuoroquinolones (and increased age), none
have speciﬁcally studied hospitalised elderly populations
prospectively and controlled for exposure to CD. Diarrhoea
occurs relatively frequently after antibiotic therapy in the
elderly. MOX was associated with an increased rate of
diarrhoeal symptoms, but causes other than CDI explained
this association. MOX treatment was not signiﬁcantly associated
with CDI when compared with AMOX/MAC treatment for
LRTI in elderly in-patients.
P1638
Prevalence and association of macrolide-
lincosamide-streptogramin B resistance with
resistance to moxiﬂoxacin in Clostridium difﬁcile
strains isolated from symptomatic adults and
children hospitalised in two university hospitals
in Warsaw
H. Pituch, D. Wultanska, G. Nurzynska, P. Obuch-
Woszczatynski, F. Meisel-Mikolajczyk, M. Luczak (Warsaw, PL)
Objectives: Clostridium difﬁcile is the main aetiological agent of
nosocomialdiarhoea.Clindamycin, penicillins, andcephalosporins
have been associatedwithCDAD.However, several case reports of
ﬂuoroquinolone-associated C. difﬁcile diarrhea have been
published. C. difﬁcile strains usually exhibits susceptibility to
metronidazole, and vancomycin. We describe prevalence and
associationofmacrolide-lincosamide-streptograminB (MLSB) type
resistance with resistance to moxiﬂoxacin of C. difﬁcile strains
isolated from adults and children.
Methods: Eighty-three C. difﬁcile strains recovered from adults
and children hospitalised in two university hospitals were
investigated (hospital 1: adults n = 38, and children n = 30;
hospital 2: adults n = 15). Toxin types were determined by
commercial test for toxin A and cytotoxicity test for toxin B.
TcdA, tcdB were detected by PCR. MICs of erythromycin,
clindamycin, moxiﬂoxacin, vancomycin and metronidazole
were determined by E-test (AB Biodisk, Sweden). The ermB
gene was detected by PCR.
Results: Sixty-seven (81%) C. difﬁcile strains were toxigenic.
Among these, 44 were A+B+, and 23 were A-B+. All 83 strains
were susceptible to vancomycin and metronidazole. High level
resistance to erythromycin, clindamycin and moxiﬂoxacin was
found in 46%, 42%, 27% of the tested strains, respectively.
Twenty-one C. difﬁcile strains harboured high level resistance to
erythromycin, clindamycin and moxiﬂoxacin, simultaneously.
Among these, all were A-B+ and were isolated from adults,
only. Twenty-one of the macrolide-lincosamide-streptogramin B
(MLSB)-resistant A-B+ strains carried the erythromycin
resistance methylase gene (ermB).
Conclusion: Resistance against clindamycin, erythromycin and
moxiﬂoxacin among Polish A-B+ C. difﬁcile strains was very
frequent. Fluoroquinolone resistance is associated with
resistance to MLSB antimicrobials. We suggest that increasing
use of ﬂuoroquinolones is selective pressure for clonal
dissemination of A-B+ C. difﬁcile strains. Fluoroquinolones use
is a strong risk factor for CDAD in our hospitals.
Acknowledgement: This work was supported by the Ministry
of Scientiﬁc Research and Information Technology, Grant no. 2
P05D 074 27.
P1639
National surveillance to the incidence of
Clostridium difﬁcile-associated diarrhoea in the
Netherlands
S. Paltansing, R. Guseinova, R. van den Berg, C. Visser, E. van
der Vorm, E.J. Kuijper (Leiden, Amsterdam, NL)
Objectives: The recent outbreaks of Clostridium difﬁcile-
associated diarrhoea (CDAD) due to the new emerging PCR-
ribotype 027, toxinotype III strains has renewed the interest of
CDAD as an important nosocomial infection. To determine the
incidence of CDAD in the Netherlands, we conducted a
prospective surveillance study in 13 hospitals in the
Netherlands.
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Methods: From May 1st to July 1st of 2005, 13 participating
hospitals registered all patients diagnosed with CDAD. A
standardized questionnaire was devised to obtain patient
information. Faeces samples or isolated strains were sent to
the Reference Laboratory at the LUMC for culture and the
presence of genes for toxins A and B (TcdA and TcdB). PCR-
ribotyping was performed according to the method of Bidet and
toxinotyping as described by Rupnik et al.
Results: Routine methods to diagnose CDAD in 13 laboratories
included combinations of cytotoxicity tests (59%), enzyme-
immunoassays (56%) and culture of toxinogenic strains (31%). In
total, 91 patientswith CDADwere reported. The overall incidence
(median) of CDAD was 17 for 10,000 patient admissions and
varied from 1 to 75. Of 91 patients with CDAD, 41% was
community acquired. The median age of 54 patients with
nosocomial acquired CDAD was 59 years. Of 54 patients with
CDAD,7 (13.9%)diedduring the studyperiod.At least 41different
PCR-ribotypes could be recognized among 91 strains. Type 027
was identiﬁed in 9 patients from1 hospital. Toxinotyping revealed
the presence of at least 7 different types. Of 91 strains, 87% were
TcdA+/TcdB+, 10% TcdA-/TcdB- and 3% TcdA-/TcdB+.
Conclusions: The incidence of CDAD in the Netherlands is
lower than reported in USA and Canada, but varied
considerably per hospital. The new emerging type 027 was
found in 9 patients from 1 hospital with a high incidence of
CDAD (39 per 10,000 admissions).
P1640
Outbreak of Clostridium difﬁcile PCR-ribotype
027 toxinotype III in Harderwijk, the Netherlands
S.B. Debast, N. Vaessen, A. Choudry, R. van den Berg, E.
Kuijper (Harderwijk, Leiden, NL)
Objectives: Since 2002, several epidemics of Clostridium difﬁcile-
associated diarrhoea (CDAD) caused by C. difﬁcile PCR-ribotype
027 toxinotype III have occurred in USA, Canada, and the UK. In
April 2005, the ﬁrst outbreak encompassing 45 patients was
observed in a medium large hospital of 350 beds in the
Netherlands. The isolated 027 strain was completely resistant
to erythromycin and ciproﬂoxacin. The patient characteristics,
predisposing factors and outcome of CDAD were studied.
Methods: A case-control study was performed in 45 patients
and 90 at random selected controls without diarrhoea who
stayed at the same department as the patients when the
diagnosis of CDAD was made. Standardized questionnaires
were designed to collect data from the patient records and all
surviving patients were interviewed 3 months after the
diagnosis. Faeces samples were cultured for the presence of C.
difﬁcile and isolates were typed.
Results: The incidence of CDAD increased from 4 per 10,000
patient admissions in 2004 to 81.5 per 10,000 admissions in 2005.
Between April and September 2005, 45 patients with CDAD due
to type 027 were identiﬁed. Of 45 patients, 9 (20%) died of which
3 (7%) as a direct result of CDAD. Eleven (24%) patients
experienced one or more relapses. The average age of the cases
was 72 yrs, 42.2% of the patients was male. In a multivariate
analysis, antibiotic use (OR 15.3, p < 0.001), duration of hospital
stay (cases 31 days, controls 13 days; p < 0.001) and tube
feeding (OR 3.5, p = 0.03) were found to be signiﬁcantly
associated with CDAD. In particular, the use of ciproﬂoxacin
(OR 11.8, p < 0.001) and cephalosporins (OR 5.8, p < 0.001) were
associated. No association was found between the use of
protonpump inhibitors and the risk of CDAD. The use of
erytromycin was signiﬁcantly higher in cases (11.1%) than in
controls (2.2%) in a univariate analysis (p < 0.041), but this
relation was not signiﬁcant in a multivariate analysis.
Conclusion: Antibiotic use (especially ciproﬂoxacin and
cephalosporins), duration of hospital stay and tube feeding
were signiﬁcantly associated with CDAD caused by C. difﬁcile
type 027, toxinotype III in the Netherlands. We could not
conﬁrm the previously described relation between use of
protonpump inhibitors and risk of CDAD.
P1641
Clostridium difﬁcile PCR ribotype 027, toxinotype
III in the Netherlands
D.W. Notermans, T. van der Kooi, E.J. Kuijper, R.J. van den
Berg, D. Veenendaal, E. van Kregten, S.B. Debast, C.E. Visser,
A. Popma, S. van den Hof (Bilthoven, Leiden, Haarlem,
Amersfoort, Harderwijk, Amsterdam, NL)
Objectives & Methods: Shortly after the reports in June 2005 of
Clostridium difﬁcile PCR ribotype 027, toxinotype III in England,
this more virulent type was also detected in The Netherlands. In
response, the Dutch Centre for Infectious Disease Control has
undertaken measures to monitor and control the outbreak. C.
difﬁcile 027 guidelines for infection control and treatment were
formulated, separately for hospitals and nursing homes. The
Leiden University Medical Centre serves as a reference centre
for diagnostics and typing of C. difﬁcile. Laboratories are
encouraged to send in samples for typing in case of a clear
rise in the incidence in C. difﬁcile, rapid spread, or several
clinically suspect cases.Organisation-based surveillance was set
up: questionnaires are sent monthly to institutions with C.
difﬁcile associated diarrhoea (CDAD) outbreaks to obtain
information on incidence, C. difﬁcile testing strategies,
antibiotics use and control measures taken.Measures taken in
hospitals dealing with an outbreak of type 027 include:
treatment of CDAD with vancomycin in stead of
metronidazole, emphasis on frequent and thorough cleaning
and disinfection, isolation of all patients with diarrhoea until
tested negative for C. difﬁcile toxin, cohort isolation of CDAD-
cases if individual isolation capacity is exceeded and strong
restriction of certain antibiotics, including ﬂuorochinolones.
Results: Until November 1st, 2005, 224 samples from 23
institutions have been sent in for typing, resulting in 74 type
027 positives. Epidemic spread of type 027 has been detected in
7 hospitals and one nursing home. Furthermore, in retrospective
studies in four hospitals isolated cases of type 027 were detected.
It became clear that in one region with three hospitals, the
CDAD incidence had already risen in 2002, 2003 and 2004,
respectively. Unfortunately, no samples from that period were
available for typing. In the hospitals with epidemic spread of
type 027, a wide range in the monthly incidence of CDAD was
observed, from 50 to 114 per 10,000 admissions during the
outbreaks. The incidence in the pre-epidemic period varied from
3 to 7 (see ﬁgure).
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Conclusions: The outbreaks in hospitals are difﬁcult to control:
most hospitals continue to have new cases for a long period,
although the incidence is decreasing in several hospitals.
Fortunately, once a C. difﬁcile 027 outbreak in a hospital is
recognised, spread to other hospitals has not been observed.
P1642
Incidence of Clostridium difﬁcile infections in a
tertiary Greek hospital
M. Kanellopoulou, M. Martsoukou, N. Skarmoutsou,
A. Charalambopoulou, E. Liapi, G. Kaderakis, E. Papafrangas
(Athens, GR)
Objectives: C. difﬁcile is a major cause of antibiotic associated
diarrhoea (AAD) and colitis (C). The aim of this study was to
determine the incidence of these infections in our hospital (450
beds), during a period of 6 months (March–October 2005).
Methods: Anumberof 182 liquid stools fromequal adult patients
(mean age 61 y,M:110, F: 72) receiving broad spectrumantibiotics
(especially cephalosporins) were plated in CCFA (Oxoid) and
anaerobicBrucellaAgar (BA), after alcohol shockprocedure. If the
culture was positive, an immunochromatographic test was
performed for toxin A (ColorPACTM Toxin A, BD, USA). If the
last test was negative, a rapid enzyme immunoassay was
performed for toxins A+B (ImmunoCard, Meridian Bioscience
Inc. Cincinatti, Ohio).
Results: C. difﬁcile was isolated in 23/182 (12.6%) samples.
Seventeen men (pathological – P, pneumological – Pn, surgical –
S, urologic – U, outpatients – O, 7, 6, 2, 1, 1 respectivly) and 6
women (P:4, Pn:1, O:1) harbored C. difﬁcile in their intestin.
Twelve out of 23 strains (52%) produced toxin A, while the
remaining (48%) produced toxin B. Eleven patients had severe
diarrhoea (7–10 days). One patient got endoscopic examination,
which conﬁrmed colitis ﬁndings. The two outpatients received
oral cefuroxime in the preceding week of the positive culture.
Conlusions: (1) The incidence of C. difﬁcile infections in this
study is among these reported in international bibliography
(12.6%). (2) Since toxigenic B C. difﬁcile strains were
demonstrated in half cases, the use of the tests detecting both
toxins A and B by clinical laboratories is recommended.(3)
Molecular technics application (e.g. PFGE and ribotyping) will
offer a better knowledge of C. difﬁcile spread in our hospital.
P1643
Comparison of methods for detection of
Clostridium difﬁcile toxins
J. Leeming, R. Ferguson, D. Kulpoo, V. Kemp, J. Watts,
D. Carrington (Bristol, UK)
Assay of the cytotoxicity of stool samples to cells in tissue
culture is commonly considered the ‘gold standard’ for detec-
tion of C. difﬁcile toxin. However the method is slow and
therefore its use can result in delayed patient treatment and
implementation of infection control measures. We undertook a
comparison of two microtitre plate-based ELISA kits (TechLab
C. difﬁcile TOX A/B II and Meridian Premier Toxins A & B) and
three rapid immunoassay card kits (Remel Xpect Clostridium
difﬁcile toxin A/B, Meridian ImmunoCard Toxins A & B and
TechLab Tox A/B Quik Chek) with an in-house cytotoxin assay.
All samples tested had been referred for routine microbiological
examination. Toxin tests were done on unformed samples from
adult hospital in-patients and bone marrow transplant recipients
and on samples where C. difﬁcile toxin testing was requested by
the referring clinician. All kits were used according to
manufacturers’ instructions. Three hundred and thirty three
specimens were tested using all ﬁve kits and cytotoxin assay.
Sensitivities and speciﬁcities were calculated both (a) assuming
the cytotoxin assay to be the ‘gold standard’ (universally correct)
test and (b) taking a concensus view that any sample with at
least two tests positive is truly positive. Data are shown in the
table below. Overall, the microtitre plate-based ELISA kits were
more sensitive than the rapid immunoassay card kits. The
cytotoxin assay was negative for seven samples that were
positive by at least two other tests. Thus the plate-based ELISA
kits were also more sensitive (but less speciﬁc) than the
cytotoxin assay if consensus data was used to judge true
positivity. We conclude that some immunoassay kits offer an
acceptable alternative to cytotoxin assays for the detection of
C. difﬁcile toxin, allowing more rapid diagnosis.
P1644
Location of the enterotoxin gene in strains of
Clostridium perfringens associated with
gastroenteritis
K.A. Grant, S. Kenyon, R. Halford-Maw, E. Pettitt,
J. McLauchlin (London, Chesterﬁeld, UK)
Objectives: Clostridium perfringens type A is a common cause of
food poisoning and is also associated with non-food borne
gastroenteritis including antibiotic associated, infectious and
sporadic diarrhoea. The disease symptoms are due to an
enterotoxin produced when the organism sporulates in the
human small intestine. The C. perfringens entertoxin gene (cpe)
has been shown to be located either on the chromosome or on
one of two large plasmids and it is generally accepted that C.
perfringens strains associated with food poisoning have a
chromosomal cpe gene whilst strains isolated from non-food
borne diarrhoea have a plasmid encoded cpe gene. Spores from
strains possessing a chromosomal cpe gene have been found to
be far more heat resistant than spores from strains with a
plasmid encoded cpe gene. Heat resistant spores are more able
to survive the cooking process and go on to cause food
poisoning, thus explaining why most food poisoning strains
have been found to have chromosomally located cpe genes. The
purpose of this study was to determine the location of the cpe
gene in a range of C. perfringens strains from the UK, including
those from both food borne and non-food borne illness.
Method: A multiplex PCR assay described by Miyamoto et al.,
(2004) was used to determine the location of the cpe gene in 107
strains of C. perfringens isolates associated with food borne
illness and 16 strains associated with non-food borne illness.
Results: By multiplex PCR assay 35% of C. perfringens strains
associated with food borne outbreaks in the UK were found to
have a plasmid encoded cpe gene. These ﬁndings have not been
described before. All strains associated with non-food borne
illness had the cpe gene located on one of two plasmids, as
anticipated.
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Conclusions: A signiﬁcant number of food borne outbreaks of
C. perfringens food poisoning were found to be caused by strains
of C. perfringens carrying a plasmid encoded cpe gene. Since
strains of C. perfringens with a chromosomal cpe and plasmid
cpe genes have different physiological characteristics this may
have a profound impact on their mode of transmission.
References
Miyamoto, K., Wen, Q. and McClane, B. A. (2004) Multiplex
PCR genotyping assay that distinguishes between isolates of
Clostridium perfringens type A carrying a chromosomal entero-
toxin gene (cpe) locus, a plasmid cpe locus with an IS1470-like
sequence, or a plasmid cpe locus with an IS1151 sequence.
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P1645
Novel multiplex-PCR method for simultaneous
detection of Clostridium difﬁcile toxin A and
toxin B and the binary toxin (cdtA/cdtB) genes
applied on a Danish cohort
K.E.P. Olsen, S. Persson (Copenhagen, DK)
Objectives: A new multiplex PCR method was developed for
the detection of the Clostridium difﬁcile toxin genes: tcdA, tcdB,
cdtA and cdtB. This method was applied on 210 Clostridium
difﬁcile strains isolated from 175 Danish hospitalised patients
with diarrhoea in the period from April to October 2005, in
order to investigate the present toxin proﬁles and their
correlation to sex and age.
Method: A 5-gene multiplex PCR method was developed for
the simultaneous ampliﬁcation of the four Clostridium difﬁcile
toxin genes tcdA, tcdB, cdtA, cdtB and 16S rDNA as an internal
positive control. Template DNA was prepared from plate grown
bacterial colonies by a simple boiling procedure, and amplicons
were visualized by standard gel electrophoresis.
Results: Three different toxin proﬁles were detected in the
Danish cohort: 43 tcdA+, tcdB+, cdtA+/cdtB+; 107 tcdA+,
tcdB+, cdtA-/cdtB- and 24 non-toxigenic tcdA-, tcdB-, cdtA-/
cdtB-. The prevalence of the binary toxin genes in this study was
25%of the clinical isolates.More thanhalf of the strains (62%)were
isolated from the elderly part of the population (>59 years), and
74% of these strains displayed the tcdA+, tcdB+, cdtA+/cdtB+
proﬁle. Of the non-toxigenic strains, 83% of the patients were
females. One fourth of the strains isolated from children under
2 years of age were non-toxigenic. In four patients, two different
toxin proﬁles were obtained from independent faecal samples.
Conclusion: This method offers a one-step, rapid and speciﬁc
identiﬁcation ofClostridium difﬁcile toxin genes. This speciﬁc toxin
proﬁling allows an evaluation of the pathogenic potential of the
isolated Clostridium difﬁcile and surveillance of emerging toxin
proﬁles. Further studies of the isolated toxigenic Clostridium
difﬁcile strains will include gene deletion analyses of the tcdA and
the tcdC (toxin regulating gene) which independently have been
observed to cause enhanced pathogenicity.
P1646
Prevalence of Clostridium difﬁcile-associated
diarrhoea in hospitalised patients with
nosocomial diarrhoea in university of medical
sciences hospitals, Tehran, Iran
N. Sadeghifard, M.H. Salari, M.R. Ghasemi, F. Aminharati
(Ilam, Tehran, IR)
Objectives: This study was aimed at determining the
prevalence of Clostridium difﬁcile associated diarrhoea in
hospitalized patients with nosocomial diarrhoea at three
University hospitals in Tehran from December 2002 to August
2004.
Methods: During the study period, the stool samples of 1500
hospitalized patients with nosocomial diarrhoea were cultured
and tested by stool cytotoxin assay, toxigenic culture and also
650 of the samples were examined by enzyme immunoassay.
Results: In 159 (10.9%) of samples C. difﬁcile grew and 108 stool
samples (prevalence: 7.2%) were toxin positive by stool
cytotoxin assay, enzyme immunoassay or toxigenic culture.
There were no signiﬁcant relationships between C. difﬁcile-
associated diarrhoea and sex and age of patients.
Conclusion: The results of the present study showed that
among requested samples the highest percentage of C. difﬁcile-
associated diarrhoea was observed from the transplantation
department (13.9%), followed by ICU and Paediatric section.
P1647
Emergence of toxin A(-)/toxin B(+) variant
Clostridium difﬁcile
B-M. Shin, E-C. Kim, K. Lee, E-Y. Kwak (Seoul, KR)
Objectives: The prevalence of toxigenic Clostridium difﬁcile (C.
difﬁcile) has been reported about 70-80% in Korea. Toxin A(-)/
toxin B(+) variant C. difﬁcile strain is also important in
nosocomial C. difﬁcile infection. However, characterization of
clostridial toxin (toxin A, toxin B) had not been studied.
Methods: We used PCR for toxin A and toxin B genes in 260 C.
difﬁcile isolates from patients admitted in three tertiary hospitals
during January to December, 2004. Primers for toxin A genes
were NK1-NK2, NK2-NK3 and NK9-NK11 and toxin B gene
was NK104-NK105.
Results: Toxin A and toxin B positive rates using NK1-NK2,
NK3-NK2 and NK9-NK11 were concordant and ranged from
62.1% to 90.9% in 3 hospitals. The proportions of non-toxigenic
strains were 10-40%. However, we could differentiate toxin
A(-)/toxin B(+) variants using NK9-NK 11 primers. The
proportion of toxin A(-)/toxin B(+) C. difﬁcile variants were
43.0%, 9.7% and 36.4% in 3 hospitals respectively.
Conclusion: The prevalence of toxin A(-)/toxin B(+) variant C.
difﬁcile were 10–43%. This result revealed the highest prevalent
rates of C. difﬁcile variant strains in the world. The differences of
antibiotic usage pattern and problems of infection control
practices might contribute the high prevalence of variant
strains. More studies are needed to deﬁne the role of variant
strains in Korea.
P1648
Impact of antimicrobial treatment on dominant
faecal ﬂora: the emergence of Clostridium difﬁcile
M.F. De La Cochetiere, T. Durand, V. Lalande, P. Lepage,
J.C. Petit, J.P. Galmiche, L. Beaugerie on behalf of the Molecular
Bacteriology Group
Objective: Administration of antibiotic drugs has long been
known to cause alterations in the gut ecosystem. In some
patients, these alterations may create a niche that allows the
overgrowth of some pathogens such as Clostridium difﬁcile, the
main causative agent in nosocomial infectious diarrhoea. A
predictive tool to assess the risk of development of Clostridium
difﬁcile, would be of utmost clinical relevance. It remains to be
determined whether speciﬁc patterns in pre-existing gut
microbiota can predict the risk of onset of Clostridium difﬁcile,
upon initiation of antibiotic treatment. Using samples from 87
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subjects enrolled in a previously published clinical study on
antibiotic-associated diarrhoea (AAD), we investigated the
potential relationship between their dominant faecal
microbiota and the subsequent development of Clostridium
difﬁcile when subjects received antibiotics.
Methods: Temporal Temperature Gradient gel Electrophoresis
(TTGE) was used to assess dominant species distribution in gut
microbiota. Each electrophoregram was digitised from the
migration distances and a regression model [Partial Least
Square-discriminant analysis (PLS)] was built to investigate
the correlation between pre-treatment dominant faecal
microbiota and the acquisition of Clostridium difﬁcile during
antimicrobial chemotherapy.
Results: This PLS model could explain 46% of the subsequent
onset of Clostridium difﬁcile. This result supports the concept of
‘‘permissive’’ ﬂora with preliminary data focusing on
Clostridium coccoides-phylogenetic group.
Conclusion: To our knowledge it is the ﬁrst time that dominant
faecal microbiota is found to heighten susceptibility to the
subsequent onset of Clostridium difﬁcile upon initiation of
antibiotic treatment. These ﬁndings insinuate that strategies
reinforcing the control of dominant faecal microbiota at
homeostasis would be of clinical relevance. This study has
been partially ﬁnanced by Biocodex laboratories.
P1649
Quantitative C. difﬁcile and anaerobic ﬂora
cultures during treatment of C. difﬁcile-associated
diarrhoea with PAR-101
T.J. Louie, J. Emery, W. Krulicki, D. MacCannell, B. Byrne,
M. Mah (Calgary, CA)
Objectives: Selective therapy of C. difﬁcile diarrhea (CDD)
requires the reduction of pathogen counts in the colon, but
spare the normal ﬂora. To determine if PAR 101 is selective for
CDD, serial stool samples were collected at study entry, at day
10, and weekly x5 during the conduct of a phase 2a study of
CDD treatment.
Methods: Patients (n = 32) were randomized to receive 50, 100
or 200 mg twice daily of PAR 101 for 10 days. No prior therapy
was given to 24 patients; 8 receive 1 or 2 doses of standard
therapy. As treatment controls, 7 additional patients were
treated with vancomycin 125 mg qid for 10 days. Five well
persons donated stools as normal ﬂora controls. Fresh stool
samples were cultured 10-2, 4, 6, 8 for C. difﬁcile vegetative and
spore forms; faecal ﬁltrates were tested for cytotoxin B by cell
assay. Strains were characterized by tcdA/B, ermB, cdtA/B PCR
and by ribotyping. At study entry and day 10, aerobic and
anaerobic faecal ﬂora cultures, diluted 10-3, 5, 7, 9, were
examined for major ﬂoral shifts. Since Bacteroides group
organisms are ubiquitously present and cultivable, this genera
was selected as a indicator of the integrity of the microbial ﬂora.
Results: At study entry, mean log 10 CFU + SD vegetative
counts of C. difﬁcile (all PAR 101 patients) were 6.8 + 3.6, range
2–10.95; at day 10, with the exception of one patient receiving
50 mg, all other patients had C. difﬁcile quantitative counts
reduced < 2 log10/gm faeces. Vancomycin was similarly
effective. At study entry, Bacteroides group counts were < 3, 3–
8, & 8.5–10 log10 CFU/gm in ~1/3 each of patients. All normal
stools showed complex, multi-genera in high counts, with 4–5
Bacteroides group species > 11 log10 CFU/g. Mean + SD of
log10 CFU of Bacteroides group counts/g feces wet weight at
study entry and day 10 for 50 mg/day (n = 10) were 6.6 + 2.8/
8.2 + 2.6 (p = 0.11, wilcoxon matched pairs signed-ranks test, 2
tailed); for 100 mg/day (n = 8) were 6.6 + 2.8/6.3 + 2.5
(p = 0.44); for 200 mg/day (n = 11) were 7.0 + 2.9/7.3 + 3.1
(p = 0.56); and for vancomycin (n = 7) 7.4 + 2.7/3.6 + 1.9
(p = 0.03).
Conclusion: Patients with CDD have variably impaired normal
ﬂora. PAR 101 was effective in all dosages in eradicating C.
difﬁcile. A dose-dependent reduction in Bacteroides counts was
not observed. Vancomycin signiﬁcantly reduces Bacteroides
counts during CDD treatment. PAR 101 is effective against C.
difﬁcile in-vivo, and is relatively sparing of the normal ﬂora.
Virology – II
P1650
Improved detection of enterovirus in
cerebrospinal ﬂuid with a minor groove binder –
conjugated ﬂuorogenic TaqMan probe
B. Vincart, F. Brancart, P. Gilot, N. De Schrijver, S. Betermiez,
M. Delforge, C. Liesnard (Brussels, BE)
Objectives: To evaluate PCR primers and probes for the
detection of enterovirus (EV) in a real-time (RT) PCR assay
and determine their sensitivity and speciﬁcity in clinical strains
and in patient’s cerebrospinal ﬂuid (CSF).
Methods: A new set of forward primer and minor groove
binder probe (MGB) deduced from the highly conserved 5’ non-
coding region of the EV genome was evaluated and compared to
two previously published PCR primer-probe sets [Verstrepen et
al. (VER) and Rabeneau et al. (RAB)]. Dilutions of cell culture
supernatants of various enteroviruses infected MRC5 or Vero
cells were prepared to determine the accuracy and the analytical
sensitivity of the 3 assays. Sixty-eight CSF samples sent to the
laboratory for diagnosis of meningitis were prospectively
investigated by the three (RT) PCR assays and viral culture
(VC). RNA extraction was performed with Qiagen kit according
to the manufacturer’s recommendations.
Results: The three RT PCR assays were able to detect all
enterovirus strains in cell culture supernatants. However the
detection limit of the MGB RT PCR was 1 to 2 log10 more
sensitive in 14 out of 16 dilutions assays of VC supernatants
compared to the RAB and VER RT PCR. All VER and MGB
negative CSF were VC negative. Thirty-two CSF specimens from
68 patients suspected of viral meningitis were positive by all RT
PCR (47.1%), whereas only 8 were found positive by VC (11.8%).
The RAB RT PCR failed to detect 4 CSF conﬁrmed positive by
VC (1 Echo 6 and 3 non typable EV). Among samples positive by
RT PCR, sensitivity of VER, MGB and RAB was respectively
100%, 100% and 71.9%.
Conclusion: In our laboratory, MGB RT PCR has a good
correlation with VER RT PCR whereas RAB RT PCR is less
sensitive especially for the detection of Echovirus 6. The MGB
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RT PCR seems to be the most sensitive of the 3 RT PCR. Further
studies, including more EV strains should help to precise the
sensitivity of this assay.
P1651
Molecular typing of an uncommon enterovirus,
coxsackievirus A7, frequently associated with
certain diseases in Kuwait
A. Dalwai, S. Ahmad, E. Hussein, A. Pacsa, W. Al-Nakib
(Kuwait, KW)
Objectives: Enteroviruses generally share tissue tropism and
present with overlapping disease spectrum, however certain
enteroviruses may be over represented in certain diseases than
others. Coxsackievirus A7 though has been reported to cause
several diseases such as febrile illness, herpangina, aseptic
meningitis and acute ﬂaccid paralysis, the frequency was very
low. The study aimed to determine the prevalent enteroviruses
causing non-speciﬁc febrile illness, aseptic meningitis,
encephalitis, neonatal disease and myositis, in Kuwait. It also
aimed to study the association between a certain enterovirus
and a particular disease and its severity.
Methods: Diagnosis of enteroviral infection was based on
detection of enteroviral RNA by semi-nested RT-PCR of a
portion of the 5’UTR of the enteroviral genome followed by
Southern hybridization with an enterovirus speciﬁc probe to
conﬁrm the results. The enterovirus was genotyped by
sequencing of the 5’UTR, the VP4 and a portion of the VP2
encoding regions, and the sequence was analysed by BLAST
analysis, CLUSTALW alignment and PHYLIP phylogenetic
analysis package.
Results: Enteroviruses were the only etiological agents detected
in 24% (217) of 920 disease cases investigated. Coxsackievirus
A7 was identiﬁed to be the second most predominant
enterovirus (24%; 44 of 187 cases genotyped) associated with
disease, after only echovirus 9 (39%; 70/187). Although
identiﬁed in all the diseases investigated, coxsackievirus A7
occurred less frequently in CNS disease cases (17%; 25/147)
than in febrile illness cases (43%; 15/34). In a preliminary study,
it was also predominantly detected in 66% (4/6) of myositis
cases. The 5’UTR of this virus showed 96% homology with that
of coxsackievirus A7 prototype strain (Parker strain) whereas
the VP4 and the adjoining region showed greater homology to
human enterovirus B genotype sequence.
Conclusions: Coxsackievirus A7 was determined to be an
emerging enterovirus associated with different diseases in
Kuwait. It was frequently represented in mild febrile illness
and myositis cases than in CNS disease suggesting that the
isolate might be less neurovirulent. Molecular analysis suggests
that the isolate might have emerged due to recombination
between coding and non-coding segments of coxsackievirus A7
and human enterovirus B group genomes.
Acknowledgement: Supported by Research Administration
project grants MI 04/01, YM 03/02 and College of Graduate
Studies, Kuwait University.
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The new proposed enterovirus type 75 is causing
meningitis in Spain
A. Avellon, G. Trallero, G. Rubio, N. Rabella, I. Casas,
G. Palacios (Majadahonda, Bilbao, Barcelona, ES; New York, US)
Introduction: Several new proposed enteroviruses (EV) have
been recently described, including the named EV75 [1]. A total
of 8 isolates of this serotype were identiﬁed from 1974 to 2000 in
America, Africa or Asia Associated mainly with acute ﬂaccid
paralysis or unspeciﬁed disease.
Objective: To determine if this new serotype circulates in Spain
and what type of disease produces.
Methods: A total of 300 EV isolates coming in 2005 to the
Spanish Enterovirus Reference Laboratory were studied both by
micro neutralization assays and by Typing PCR [2]. In the
isolates in which EV75 was suspected by the mentioned
methods complete VP1 gene was ampliﬁed and sequenced
with speciﬁc designed primers.
Results: Four isolates from two different regions of Spain were
identiﬁed as EV75 (more than 80% of homology with the
published sequences). Three of them corresponded to aseptic
meningitis in children and were isolated from CSF.
Discussion: The present work demonstrates that this new
proposed virus circulates also by Europe and is associated to
aseptic meningitis. Till the moment it seems that is represented
in a minor proportion (4/300 studied), however the possibility
of spreading of this viral infection should be considered, as EVs
may behave in that way, as previously have been demonstrated
[3].
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P1653
Evolution of G1 rotavirus strains in Italian
children in an 18-year period
S. Arista, G.M. Giammanco, S. De Grazia, S. Ramirez,
C. Colomba, A. Cascio (Palermo, Messina, IT)
Objectives: Rotavirus is the most important cause of severe
gastroenteritis in infants and young children through the world
and is responsible of 500,000 deaths annually, mostly in
developing countries. Therefore, development of rotavirus
vaccine is a high priority. Rotavirus strains with G1 types
account for the majority of the diarrhoea episodes. Recently, a
monovalent G1 attenuated rotavirus vaccine was licensed in
Mexico. In view of a hypothetical introduction of such vaccine in
Europe, we investigated the variability over time of VP7
antigenic genes of G1 rotavirus strains in our area.
Methods: Fifty strains were selected from a total of 780 G1
strains obtained from children of less than 5 years of age
hospitalised with acute gastroenteritis at the ‘‘G. Di Cristina’’
Children’s Hospital of Palermo in the period 1986–2004. The
selected strains were genotyped by RT-PCR and 35 of them were
submitted to VP7 gene sequence analysis.
Results: All but one of the 50 strains were genotyped as G1P(8).
The VP7 sequences of 35 of them were distributed into lineages I
and II. Lineage I included 14 strains from 7 different years in the
range 1986–2004. Lineage II included 21 strains from 9 different
years in the range 1989–2004. The degree of similarity among the
nucleotide sequences of Italian strains in each lineage were
comprised between 94% and 100%. An alignment of the
deduced amino acid sequences showed major lineage speciﬁc
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amino acid changes in the variable antigenic regions with
respect to the reference Wa strain.
Conclusions: Sequence analysis indicated that in Palermo there
was co-circulation of G1 strains belonging to two different
lineages. Overall, the G1 strains showed a high degree of
similarity inside each lineage and shared speciﬁc amino acid
modiﬁcations. The antigenic differences between circulating
strains might permit them to escape neutralization and persist in
the infantile population. Our results suggest that rotavirus
strains belonging to the two G1 lineages should be both
included in a rotavirus vaccine preparation.
P1654
Epidemic spread of recombinant noroviruses
with four capsid types in Hungary
G. Reuter, H. Vennema, M. Koopmans, G. Szucs (Pe´cs, HU;
Bilthoven, NL)
Objectives: Noroviruses (‘‘winter vomiting diseases’’) are the
predominant etiological agent in Hungary and common
pathogen worldwide in outbreaks of gastro-enteritis in
humans. Noroviruses are genetically diverse group of viruses
with multiple genogroups (GG) and genotypes. More recently,
naturally occurring recombinant noroviruses were identiﬁed.
These viruses had a distinct polymerase gene sequence (ORF1,
designated GGIIb/Hilversum) and were disseminated through
waterborne and food-borne transmission in Europe. Our aim
was to characterize these emerging recombinant noroviruses
causing outbreaks of gastro-enteritis in Hungary.
Methods: Stool and RNA samples – from norovirus outbreaks
between January 2001 and May 2005 - containing ‘‘GGIIb/
Hilversum polymerase’’ (GGIIb-pol) were selected for analysis
of the viral capsid region (ORF2) by reverse transcription-
polymerase chain reaction (RT-PCR) followed by sequence- and
phylogenetic analysis.
Results: Forty (12.6%) of 318 conﬁrmed norovirus outbreaks
were caused by the new-variant lineage with the GGIIb-pol.
Viral capsid region was successfully characterized in 24 GGIIb-
pol outbreaks. Four different recombinants were detected with
capsids of Hu/NLV/GGII-3/Mexico/1989 (n = 10, 41.7%), Hu/
NLV/GGII-2/Snow Mountain/1976 (n = 9, 37.5%), Hu/NLV-
1/GGII/Hawaii/1971 (n = 4, 16.6%) and Hu/NLV/GGII-4/
Lordsdale/1993 (n = 1, 4.2%). Interestingly, outbreaks caused
by recombinant GGIIb-pol strains mostly associated with
outbreaks among children (47.5%) and had non-winter
seasonality.
Conclusions: Epidemic spread of emerging multiple
recombinant norovirus strain GGIIb-pol were detected in
Hungary that became the second most common norovirus
variants – next to the endemic GGII-4/Lordsdale virus – causing
epidemics of gastroenteritis in the last 4.5 years.
P1655
Human metapneumovirus infection in Cuba: ﬁrst
report
B. Acosta, I. Casas, P. Pe´rez Bren˜a, C. Savo´n, A. Goyenechea,
S. Oropeza, A. Pin˜o´n (Havana City, CU; Madrid, ES)
The respiratory infections are the most common diseases in the
world being the origin of a great morbidity and mortality
especially in infants and elderly. (1) Human Metapneumovirus
(hMPV) was ﬁrst described in Dutch children with acute
respiratory tract infections (ARTIs) in June 2001. (2) Very
limited studies data are available from tropical and developing
countries. We sought to determine the role of hMPV in upper
and lower respiratory tract infections in Cuban patients and
correlated the presence of virus with clinical characteristics of
the disease. Between 1 October 2002 to 30 September 2003, 93
clinical samples received from the National surveillance
program of ARTIs at the National Reference Laboratory of
Respiratory viruses, for virological study, were used to detect
hMPV by RT-nested PCR, amplifying a conserved fragment of
170 nucleotides in the polymerase gene. We found RNA hMPV
in 9.6% of samples from the patients with ARTIs. 44.4% of
individuals who tested positive for hMPV were under
12 months of age. Patients with evidence of hMPV had symp-
toms consistent with either upper or lower respiratory tract
disease or both. 66.6% of hMPV positive individuals were
detected during August-October (Table1). The results of this
preliminary study shows that hMPV is present among Cuban
patients with ARTI. Constitute the ﬁrst report of the frequency
of hMPV infection in a non-preselected group of Cuban patients
with ages ranged from 3 months to 60 years old. It should be
noted that this is the ﬁrst report of hMPV infection in Central
America and in the Caribbean region, further conﬁrming the
worldwide distribution of the virus (3–5).
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Detection of human metapneumovirus in
paediatric nasopharyngeal aspirates by a TaqMan
minor groove binder probe assay: a one-year
prospective study in Belgium
W. Verstrepen, P. Bruynseels, A. De Smet, A. Mertens (Antwerp,
BE)
Objective: Human metapneumovirus (hMPV) has a relative
high incidence in acute respiratory infections in children but is
difﬁcult to isolate in culture. The aim of the study was to
decrease the number of undiagnosed viral respiratory infections
in our hospital by means of a TaqMan minor groove binder
(MGB) probe assay.
Methods: From October 2004 to September 2005 a total of 1387
nasopharyngeal aspirates from children presenting at our
paediatric facility were analysed. RNA extracts from
specimens negative for RSV, parainﬂuenzavirus and
inﬂuenzavirus with an (in) direct immunoﬂuorescence assay
(IFA) were subjected to a TaqMan MGB probe assay in parallel
with a previously published TaqMan assay.
Results: Of the 1387 specimens, 371 (27%) were positive by IFA
for either RSV (226), parainﬂuenzavirus (47), inﬂuenzavirus A
(83) or inﬂuenzavirus B (15). HMPV was detected in 83 (8.4%) of
the remaining 988 specimens subjected to the newly developed
PCR. Of the patients with a positive hMPV assay, 46/52 (88.5%)
presented with respiratory symptoms. 72% of the positive
specimens were from children less than 2 year as compared to
only 6% from children older than 5 years. Viral load was highest
in children less than 1 year. A prominent seasonal variation was
noted since more than half of the positive specimens occurred
during the months March and April. There was no signiﬁcant
difference in the proportion nor viral load of positive specimens
from ambulatory patients, patients admitted to a general ward
or patients requiring intensive care. As compared to the
published Taqman assay, diagnostic sensitivity and speciﬁcity
were 97.6% and 99.9% respectively, whereas PPV and NPV were
98.8% and 99.8%. Method comparison (NCCLS guideline EP-
9A) failed to demonstrate a signiﬁcant difference between both
assays when the threshold cycle (Ct) was between 22 and 41.
Strongly positive specimens (Ct < 22) were associated with a
lower Ct using the published TaqMan assay. However, the new
TaqMan MGB probe assay appeared to be more sensitive for
weakly positive specimens (Ct > 41).
Conclusion: The number of viral respiratory infections
conﬁrmed in our hospital was substantially increased by
means of the hMPV TaqMan MGB probe assay. The new
assay is a reliable alternative to the previously published
TaqMan assay for detection of hMPV in nasopharyngeal
aspirates.
P1657
Nucleic acid sequence based ampliﬁcation and
molecular beacon detection for the real-time
identiﬁcation of respiratory syncytial virus in
paediatric respiratory specimens
R. Manji, F. Zhang, C. Ginocchio (Lake Success, US)
Background: Respiratory syncytial virus (RSV) is the leading
cause of lower respiratory tract infection in infants and young
children, with bronchiolitis and pneumonia being the major
clinical manifestations. The rapid diagnosis of RSV infections is
of central importance for individual patient management
(rational use of antibiotics and antiviral agents), hospital
infection control and monitoring epidemiological disease
patterns. This study included a technical validation and a
retrospective clinical evaluation of a real time NASBA assay for
the detection of RSV A and RSV B in paediatric respiratory
samples.
Methods: Samples tested included: dilution panels of in vitro
transcribed RNA, local RSV isolates, isolates of common
respiratory pathogens, and frozen respiratory specimens
(nasopharyngeal aspirates, washes or swabs) from 231
children (age range: 5 d to 2 yr) who were evaluated in the
paediatric emergency department for respiratory disease.
Nucleic acid (NA) isolation, ampliﬁcation and detection were
performed using the NucliSens EasyQ Basic Kit and NucliSens
EasyQ RSV A+B reagents (bioMe´rieux). Specimen NAs and a
RSV speciﬁc internal RNA control (IC) were co-extracted using
NucliSens Magnetic Extraction Reagents and the NucliSens
miniMAG instrument (bioMe´rieux) and co-ampliﬁed using a
single RSV speciﬁc primer pair. Included in the reaction were a
RSV speciﬁc molecular beacon (5’-FAM) and an IC speciﬁc
molecular beacon (5’-ROX). Target ampliﬁcation and continuous
monitoring of emitted ﬂuorescence were performed using a
NucliSens EasyQ analyzer (bioMe´rieux). Results were compared
to direct immunoﬂuorescence (DFA) and/or viral culture using
R-Mix cells (Diagnostic Hybrids, OH).
Results: The limit of detection for RSV was 2 RNA copies/rxn
and the 100% detection rate was 5 copies/rxn. The assay was
100% speciﬁc for RSV with no cross reactivity to other
respiratory pathogens. The NASBA assay detected 10% more
positive specimens than DFA and 44% more positive samples
than VC. The NPVs of the assays were: NASBA 94.6%, DFA
90.8% and VC 78.0%.
Conclusions: The NucliSens EasyQ RSV assay demonstrated
superior sensitivity to bothDFAandviral culture for the detection
of RSVAandB from respiratory specimens. The assaywas easy to
use, required minimal hands on time (1 hr) and a faster time to
results as compared to rapid culture (4 hr vs. 24–72 hr).
P1658
Genetic diversity and molecular epidemiology of
respiratory syncytial virus over six consecutive
seasons in Cuba
O. Valdes, C. Savon, A. Goyenechea, L. Palerm, Gr. Gonzalez,
Gu. Gonzalez, J. Melero, I. Martinez (Havana City, CU; Madrid,
ES)
Respiratory Syncytial Virus (RSV) is a major cause of acute
lower respiratory tract infection in infants and young children. It
has previously been shown that HRSV isolates can be divided
into two antigens groups A and B. The G protein is the most
divergent both between and within the two subgroups and
appears to accumulate amino acid changes with time, suggest-
ing evolution under selective pressure. Our knowledge of the
molecular epidemiology of RSV has so far been based mainly on
studies done in the developed world with e temperate climate.
Very limited epidemiological data are available from tropical
and developing countries, where RSV infections may follow a
different pattern. In this report we examine the molecular
epidemiology and evolutionary pattern of the G protein of both
subgroups A and B RSV through consecutive epidemics in
Cuba. Sixthly four nasopharyngeal swabs were collected from
children under 1 years of age with respiratory disease to
different hospitals in Cuba between 1994 and 2000, to examine
the molecular epidemiology and evolutionary pattern of the G
protein of RSV. All samples collected from 1994 to 1999 were
RSV subgroup A; however both subgroups co-circulate during
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2000. The Cuban isolated from 1994 to 1996 showed a great
homogeneity between them and were resemble to an ancient
strain (Long) with only ﬁve nucleotide differences, this also
occur in 1998 and 2000 with two strain. Furthermore was
detected different size of G protein (297 or 298 for RSV A and
295 for RSV B) due to change in stop codon used he genetic
homogeneity of the Cuban isolates (1994–1996) and their
resemble to an ancient strain such as Long was an unusual
ﬁnding in our country. In both subgroups was observed the
predominance of strains with almost similar sequences. Phylo-
genetic analysis for subgroup A strains showed that strains were
cluster in different genotypes with virus isolated in different
geographic regions. Both subgroups co-circulated during 2000
and clustered whit South African strains that circulate during at
the same time.
P1659
Point mutations in respiratory syncytial virus
detected by LightCycler PCR and melting curve
analysis
U. Germer, L. Nielsen, K. Boye, H. Westh (Copenhagen, DK)
Objective: The objective was to analyse RSV real-time PCR-
positive isolates from clinical samples, which appeared to
belong to three different groups according to melting
temperature (Tm) of the amplicons. The analysis was done
according to genotypic and phenotypic difference and related to
geographical distribution.
Materials and methods: 322 nasopharyngeal aspirates were
collected from children with respiratory distress in the city of
Copenhagen. Viral RNA extracted using the MagNAPure LC
automated extraction system was ampliﬁed in a real-time RT-
PCR previously described (1). Five samples from each of the
three groups with different Tm’s were selected for bidirectional
DNA sequencing using the RSV primers. Sequences were
analysed using Chromas Lite version 2.3.
Results: A total of 322 clinical samples were analysed. 170
(53%) of the 322 samples were positive and 152 (47%) were
negative for RSV. Three distinctive groups with different Tm’s
could be identiﬁed from the melting curve analysis. Group 1
(n = 91) had a Tm with a median of 60.9C, group 2 (n = 59) and
3 (n = 20) had lower Tm’s with a median Tm of 58.7C and
56.8C respectively. Sequence analysis of amplicons showed that
the difference in Tm was due to differences in genotype between
the three groups. Genotype 1 and 3 were closely related,
differing only in two nucleic acids in position 12525 (C to T) and
12564 (A to T). Both were silent mutations. Only position 12564
is targeted by the probe. Genotype 1 and 3 were both blasted to a
complete genome sequence of Respiratory Syncytial Virus
subgroup A (GenBank RSU39661) with the highest identity
score for genotype 1. Genotype 2 sequences were blasted to
Human Respiratory Syncytial Virus mutant cp52 subgroup B
(GenBank AF013255). Geographical analysis showed a higher
prevalence of the mutant strain (genotype 3) in the northern
areas of the greater Copenhagen area compared to central,
southern and western areas (p = 0.01).
Conclusion: We found three genotypes of RSV according to the
Tmof the PCRproduct. Twoof the genotypeswere closely related
with only two point mutations and the same phenotype.
Genotype 3 was mainly found in clinical isolates from the
northernpart ofCopenhagen, suggesting a local epidemic spread.
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Evaluation of a real-time NASBA assay for the
detection of inﬂuenza A and B virus
K. Brengel-Pesce, F. Jacobs, J. Telles, A. Lefeuvre, P. Van de
Wiel (Grenoble, FR; Boxtel, NL)
Objectives: bioMerieux is developing a real-time NASBA assay
to detect Inﬂuenza A and B RNA in different kind of respiratory
clinical samples, by using the NucliSens EasyQ basic kit in
combination with speciﬁc primers and molecular beacons.
Methods: 89 Nasal/throat swabs in transport medium from
hospitalised children (0–16 yrs from Edouard Herriot hospital,
Lyon, France) were used for this evaluation. Inﬂuenza RNA is
isolated using the NucliSens miniMag extraction. An internal
control is added to the sample prior to nucleic acid extraction. The
assay is designed to detect in a single tube, using a three-label
approach, the internal control and both InﬂuenzaAand Inﬂuenza
B RNA. Ampliﬁcation reactions were performed in a NucliSens
EasyQ Analyser allowing real-time detection. The results of the
clinical samples were compared to cell culture results.
Results: Among 89 swabs tested, real-time NASBA detected 10
(11.2%) samples for Inﬂuenza A and 2 (2.2%) samples for
Inﬂuenza B. Comparatively, by cell culture only 5 (5.6%)
samples were identiﬁed as Inﬂuenza A and non as Inﬂuenza
B. Interestingly, 1 Inﬂuenza A positive sample identiﬁed by cell
culture was found negative in real-time NASBA.
Conclusions: The data showed thatNucliSens EasyQ Inﬂuenza
A/B assay detected 50%more Inﬂuenza A virus than cell culture
method. Moreover, real-time NASBA detected 2 Inﬂuenza
positive samples, which were not detected by cell culture. With
this assay a qualitative detection of Inﬂuenza A and Inﬂuenza B
viruses in a single reaction can be donewithin 3 hours. It provides
a valuable alternative to cell culture method for the clinical
management of patients with Inﬂuenza infections.
P1661
Clinical manifestations and progression of
mumps meningitis in children in Romania
L. Raduta, S-A. Florescu, A.G. Tudor, M. Cotiga, C.P. Popescu,
R.F. Botgros, P.I. Calistru, E. Ceausu, L. Paun (Bucharest, RO)
Background: Mumps meningitis represents one of the major
and severe extra salivary manifestations of mumps virus
infection and; occasionally occurs mumps encephalitis.
Methods: Retrospective clinical study of 2372 mumps cases
diagnosed in the last 3 years in our department.
Results: 299 patients have developed mumps meningitis and 17
patients were diagnosed with mumps meningoencephalitis. Age
limits were from 3 to 17 years and sex ratio M/F was 7/
4.Clinical manifestations involved fever (95%), stiff neck (92%),
nausea and vomiting (89%), headaches (86%), photophobia
(73%) and neurological manifestations such as: equilibrium
disorders and drowsiness (6%), convulsions (0.17%), cerebellum
syndrome (0.12%). Meningeal symptoms have occurred shortly
after parotiditis in 94% of cases and before parotiditis in 3% of
cases; the other cases have evolved without parotid swelling.
Other localizations of the mumps infection were: parotiditis
(97%), pancreatitis (61%), submaxillitis (40%) and orchitis (4%).
Lumbar puncture yields CSF containing between 130 and
2830 WBC/mm3. The predominating cells were usually
lymphocytes, but 12% of the patients have polymorphonuclear
leukocyte predominance at the ﬁrst puncture. Protein levels are
normal to mildly elevated in all cases and hypoglycorrachia was
founded in 10% of the patients. Therapy for mumps meningitis
was symptom-based (analgesics and antipyretics) in 67% of
cases and glucocorticoid therapy in 33% of cases.
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Conclusions: (1) Neurological involvement in mumps occurred
in 13.32% of cases; (2) Men are afﬂicted two times more often as
women, but the age distribution is the same as for
uncomplicated mumps; (3) Mumps meningitis was the only
localization of the mumps infection in 3% of cases.
P1662
Rare manifestation of mumps: anterior uveitis
E. Turk Aribas, I. Erayman, A.C. Inkaya, B. Kandemir,
M. Bitirgen (Konya, TR)
Mumps is acute generalized infection occurs primarily in school-
aged children and adolescents. Most prominent manifestation of
mumps is swelling and tenderness of salivary glands especially
parotid gland. Uveitis is a rare manifestation of mumps. Here we
present a mumps case complicating with uveitis. 26 years old
paediatric nurse was admitted to our emergency department
because of headache and malaise. On physical examination
bilateral parotid enlargement was noticed. Opthalmology consul-
atation revealed anterior uveitis. Local prednisolon and cyclop-
entholate treatment were prescribed. Lumbar puncture revealed
lymphocytic pleocytosis without hypoglychorachea and elevated
protein levels. Mumps IgM was found positive. Differential
diagnosis made with other viral infections and sarcoidosis. Her
headache diminished day after the hospitalisation. Uveitis respon-
ded very well to local therapy and patient got well in 2 weeks.
P1663
Clinical and epidemiological aspects of a measles
epidemic, Bucharest, Romania
S-A. Florescu, M. Cotiga, C.P. Popescu, L. Raduta, G. Scurtu,
R.F. Botgros, G. Enache, P.I. Calistru, E. Ceausu (Bucharest, RO)
Objectives: We studied the clinical and epidemiological aspects
of the measels epidemic, still ongoing, in 2005.
Methods: Retrospective study of patients with measels
hospitalized in Clinical Hospital of Infectious and Tropical
Disease ‘‘Dr V. Babes’’ Bucharest between 01.04–31.10.2005.
Results: There were 108 cases; sex ratio M/F:58/50. The mainly
affected age group is under 13 months (38.9%) followed by
13 months–2 years (23.15%), 2–7 years (22.22%), > 16 years
(10.18%) and 7–16 years (5.55%). 70.37% cases were hospital-
acquired (mostly in paediatric clinics), 3.7% were community-
acquired; in 25.9% cases the source was unknown. The most
common clinical features were fever (100%), rash (100%),
conjunctival hiperemia (78.7%), cough (70.37%),
micropoliadenopatia (64.8%), diarrhoea (39.81%). Pulmonary
complications were described in 62.3% of cases; 22.38% of them
were bacterial pneumonia, 77.62% were viral pneumonia. In
20.37% of cases we diagnosed acute stomatitis, in 12.96%
bacterial conjunctivitis; in 14.81% of cases – otitis; in 1.85% of
cases – pharingitis, and in one case (0.92%) – urinary tract
infection. 7.4% of the patients were previously diagnosed and
treated for pulmonary TB. All cases were conﬁrmed
serologically through detection of speciﬁc IgM antibodies. 25
patients (23.15%) had severe clinical forms of measels. The
evolution was good in all cases.
Conclusion: 1. This year in the south-east part of the country,
evolves a measels epidemic with different features comparing to
the previous one (1997–1998).2. The ongoing epidemic is mostly
hospital-acquired and it affects mainly infants and small
children between 0–2 years old (62%), unvaccinated.3. The
severe forms were present in approximately ¼ of patients.4.
Clinical evolution was favourable in all cases.
P1664
Recombinant measles proteins, as the improved
analogue of whole virus based antigen in ELISA
to diagnostics reproach genotypes A and D6
M. Kulak, N. Netesova, P. Belavin, G.M. Ignatyev (Novosibirsk,
RU)
Objectives: Whole virus based ELISA test systems have
different sensitivity to various genotypes. Antigenic variability
between different genotypes of measles virus (MV) has existed.
We investigated the recombinant proteins NP and HN to
develop new antigen with useful properties for applied in
ELISA test systems.
Methods: Signiﬁcant antigenic epitopes of nucleoprotein (NP)
and haemagglutinin (HN) measles virus strain Edmonston were
generated by computer analysis. Using standard gene-
engineering techniques was evaluated two fusion peptides NP
and HN consist from only linear T-cell antigenic determinants.
The virus-neutralization activity of hyperimmune serum on
recombinant proteins was determined by plaque reduction
neutralization test (PRN). The level of speciﬁc IgG in serum to
genotypes A, D4, and D6 of measles virus was determined by
enzyme-linked immunosorbent assay (ELISA). We used
recombinant proteins NP and HN as antigens for ELISA.
Results: Hyperimmune serum was collected from mice after
immunization by NP and HN recombinant proteins. The level of
neutralize activity was measured in the PRN assay with strain
Edmonston. The titre reached up to 1:13.5 and 1:22.9 for NP and
HN recombinant proteins, respectively. Interestingly that,
hyperimmune serum on recombinant protein NP in ELISA
reacted both with NP (titre 1:6400) and with HN (titre 1:3200),
and in turn serum on recombinant protein HN reacted only with
HN (titre 1:12800). The estimation immunological properties of
proteins with use of the panel of serum (50 samples) collected
from patients. The diagnosis of measles infection was conﬁrmed
in laboratory (by RT-PCR). The nucleotide sequences of RT-PCR
products used for genotyping of MV. Selective interaction of
antibodies in ELISA with recombinant proteins in relation to
various genotypes is revealed. The interaction with genotypes A
and D6 was expressed with high level of correlation whereas
with genotype D4 any serum did not react authentically (as the
control was used recombinant protein N of SARS virus).
Conclusion: We have shown that neutralize antibodies formed
hot only on superﬁcial proteins such as HN, F and SH but also
on core proteins such as NP. Our data demonstrate that the
recombinant proteins NP and HN could be a cost-effective
alternative to current whole virus based ELISAs for surveillance
for immunity to measles and could more efﬁcient in detecting
susceptibility to measles in relation to genotypes A and D6.
P1665
Intrauterine infection of Crimean-Congo
haemorrhagic fever: the courses of two episodes
A. Celikbas, O. Ergonul, U. Yildirim, A. Zenciroglu, D. Erdogan,
I. Ziraman, N. Yilmaz, F. Saracoglu, N. Demirel, O. Cakmak,
B. Dokuzoguz (Ankara, TR)
Objective: The clinical courses of two pregnant patients with
Crimean-Congo hemorrhagic fever (CCHF) and their children
were presented.
Method: Two episodes were followed up in Obstetrics and
Gynecology and Infectious Diseases clinics of Ankara Numune
Education and Research Hospital, and Neonatology and
Pediatric Surgery clinics of Dr. Sami Ulus Children’s Hospital
in Ankara, Turkey.
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Episode 1: A pregnant woman with thirty-eight week of
gestation was hospitalized in obstetrics clinic with the
complaints of fever, malaise, and severe vaginal bleeding. On
admission, white blood cell count was 6700/mm3, haemoglobin
was 11.5 g/L, platelet count was 8 000/mm3. The level of AST
was 591 IU, ALT 163 IU, lactate dehydrogenase 1079 IU, and
creatinin phosphokinase 2132 IU. The baby was delivered by
cesarean section. In serum CCHF IgM was positive by ELISA,
and per oral ribavirin was administered after delivery. At the
ﬁrst day of delivery, the clinical and laboratory of ﬁndings of the
baby were found to be normal. However, on his 5th day, he died
because of massive bleeding. His CCHF IgM was found to be
negative.
Episode 2: A pregnant woman with 19 week of gestation was
admitted to the hospital. Her complaints were fever, malaise,
headache, myalgia, nausea, vomiting, diarrhoea, and
subconjuntival bleeding. In her laboratory investigation, white
blood cell count was 3400/mm3, haemoglobin level was 10.4 g/l
and platelet count was 53000/mm3. The level of AST was
813 IU, ALT 539 IU, and LDH 741 IU. In her serological analysis
CCHF IgM and CCHF virus -PCR was found to be positive. At
the twenty six week of gestation in obstetric ultrasound, fetal
intraabdominal ﬂuid was visualized and amniocentesis was
performed. In serological analysis of amniotic ﬂuid CCHFV-
PCR was found to be negative. Intraabdominal ﬂuid had
increased and scrotal edema was visualized at thirty eighth
weeks of the gestation. After her vaginal delivery, baby was
severely ill and was operated with the diagnosis of necrotizing
enterocolitis. His laboratory ﬁndings were normal except high
white blood cell count. On his ﬁfth day, thrombocytopenia
occurred and he died because of massive bleeding. His CCHF
IgM and PCR were negative.
Conclusion: To our knowledge, these are the ﬁrst episodes of
intrauterine CCHF infection. These episodes show that CCHFV
can transmit through placenta. Obstetricians in endemic
countries should consider CCHF infection among the patients
with massive bleeding and thrombocytopenia.
P1666
The attack and the infection rate of Crimean-
Congo haemorrhagic fever virus infection in an
endemic region
O. Ergonul, H. Zeller, S. Menekse, A. Celikbas, S. Eren,
N. Baykam, B. Dokuzoguz (Ankara, TR; Lyon, FR)
Objective: To detect the asymptomatic Crimean Congo
Hemorrhagic Fever Virus (CCHFV) infections in an endemic
area, and calculate the attack and the infection rate.
Methods: The study was performed in a CCHF endemic region.
The household members of the index cases were screened for
CCHFV IgG and IgM by ELISA. The data related to risk
exposure were obtained by a structured form.
Results: Eleven index cases were admitted to the clinic, 45
household members of these cases were screened. All the index
patients had positive IgM or PCR for CCHFV. Among the
household members, three individuals had IgG positivity (%),
and only one patient had IgM positivity. None of the screened
individuals had symptoms. The mean age was 28 (sd 17), and
52% of the subjects were female. Tick bite was detected a risk
factor (p = 0.040) for CCHV infection, whereas patient care and
contact with body ﬂuids of the patients were not (p > 0.05).
Eighteen patients had the history of tick bite, and 8 became
infected (44%), and ﬁve (27%) became ill. Among the infected
eight individuals, ﬁve became ill (63%).
Conclusion: Although we consider that some of the patients do
not notice tick bite, we can still suggest that the infection rate of
the virus is rather high compared to similar diseases. Tick bite is
the major risk factor, in comparison to exposure to blood and
body ﬂuids of the infected cases.
P1667
Dengue virus infections in children and
adolescents
B. Larru´ Martı´nez, E. Quiroz, M. Castrejo´n de Wong, E. Castan˜o
Guerra, J. Nieto, O. Saldana de Suman, D. Estripeaut Calderon,
X. Sa´ez-Llorens (Madrid, ES; Panama, PA)
Objectives: Study the prevalence of dengue virus infection on
children in Panama and describe their clinical features.
Methods: We reviewed all the reports of dengue virus infection
from January 2000 to August 2005. Epidemiological and clinical
dates were recorded. Diagnosis was made with positive IgM
antibody test or increase in serum IgG, 5 days after onset of
symptoms or culture of the virus in the ﬁrst ﬁfth days of illness.
Results: 457 children were included in our study. Distribution
according sex was: 57.6% female and 42.4% male. Median of age
was 13 years (IQR = 6). During the follow-up study we
recorded 2 years when the number of cases increased. The
distribution of cases among the study was: 8.4% in 2000, 33.9%
in 2001, 20.9% in 2002, 6.6% in 2003, 7.0% in 2004 and 23.1% in
2005. The proportion of paediatric patients also varied from;
11.9% in 2000, 9.6% in 2001, 12.4% in 2002, 9.7% in 003, 7.8% in
2004 and 4.4% in 2005. In Panama City we recorded 65.3% of the
infants. We detected an increase in the number of patients in the
rain season, fromMay till November. The mean of days between
the onset of symptoms and the ﬁrst blood sample was 6.3 days
(DS: 6.7) A second sample was obtained in 23.6% of our infants
with an average time of 10.1 days (DS: 7.4). The frequency of
classical symptoms related to dengue virus infection was: fever
(95.2%), severe headache (74.2%), chill (65.9%) rash (63.5%),
myalgia (51.9%), retro-orbital pain (51.6%), arthralgia (43.3%),
gastrointestinal symptoms (37.4%), inﬂamed pharynx (26.7%),
cough (26.5%), mild respiratory symptoms (18.6%) and
diarrhoea (10.7%). In our infants the symptoms which were
detected ﬁrst were; fever, severe headache, chill, myalgia, retro-
orbital pain, arthralgia, mild respiratory symptoms, cough and
inﬂamed pharynx. We did not observed differences on clinical
features between girls and boys. However, we detected detected
signiﬁcative differences among symptoms when we compared
infants who were £5 years old with those who were older
(p < 0.005). Four of our patients died because of dengue
hemorrhagic fever.
Conclusion: Dengue is endemic in Panama as in most tropical
countries and is one of the world´s major emerging infectious
disease. More data about this illness are needed to elaborate
sanitary programmes which contribute to control this infection.
P1668
Diagnosis of dengue infection by enzyme-linked
immunosorbent assay and reverse transcription-
polymerase chain reaction from oral specimens
J. Pupaibool, S. Krajiw, K. Arunyingmongkol, A. Nisalak,
C. Pancharoen, U. Thisyakorn, W. Kulwichit (Bangkok, TH)
Objectives: Dengue fever is among one of the major emerging
infectious diseases. Polymerase chain reaction (PCR) and
enzyme-linked immunosorbent assay (ELISA) using non-blood
samples are of diagnostic value for various infections including
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dengue. Salivary ELISA has been shown by various
investigators to be useful for dengue diagnosis. We sought to
perform a pilot evaluation of diagnostic value of ELISA and PCR
of oral brushes and saliva for dengue diagnosis in adults.
Methods: Adults with acute fever and suspected of dengue
infection admitted to our university hospital were enrolled.
Dengue diagnosis was made by standard ELISA using serum or
plasma. Patients with negative ELISA served as controls. Buccal
mucosal cells were collected for RT-PCR and saliva for both RT-
PCR and ELISA at least twice, 7–14 days apart. Our ELISA
criteria for saliva were single IgM > 20 units or single
IgG > 60 units or 2-fold increase in IgG titre with the second
titre >40 units for secondary dengue infection. Criteria for
primary dengue infection were the same as secondary infection
plus IgM:IgG ratio of over 1.8.
Results: 23 cases and 16 controls were enrolled. Our country is
endemic for dengue and thus there was no primary dengue
adult case in this study. As the study was performed in
hospitalized patients, most of the ﬁrst samples were collected
one day before or on the day of defervescence. The speciﬁcities
of either methods and the sensitivity of ELISA method for saliva
were 100%. Sensitivities were approximately 32–33% for RT-
PCR using buccal cells or saliva specimens. However, a
combination of RT-PCR results for both types of oral
specimens gave a sensitivity of 52%. The results are
summarised in the table.
Conclusions: Collection of oral specimens is less invasive and
may be more acceptable in certain situations. A single, acute
specimen is adequate for diagnosis by RT-PCR. Our specimens,
however, were collected late in the course of illness which
affected the sensitivity of RT-PCR’s. Earlier specimens may give
a better yield. A study in paediatric patients is needed to assess
the value of these methods for primary dengue infection.
P1669
Serologic evidence for Hantaviruses in the
northern and eastern Tyrol (Austria) and the
southern Tyrol (Italy)
G. Walder, A. Lanthaler, J. Simeoni, G. Morosetti, D. Scho¨nitzer,
O. Prinoth, M.P. Dierich, P. Kreidl (Innsbruck, AT; Meran, Bozen,
IT)
Objective: The aim of this study was to assess the proportion of
seropositives against Hantaviruses among healthy blood
donors.
Methods: 1607 volunteer donors were recruited by the institute
of transfusion medicine, representing the demographic situation
in the Tyrol regarding gender and residence. Sera were tested
for IgG with a commercially available ELISA. Positive samples
were conﬁrmed by a commercially available dot blot which was
also used for identiﬁcation of the serovar.
Setting: The study area comprises North Tyrol (Austria, north
of the main ridge of the Alps), South Tyrol (Italy) and East Tyrol
(Austria, both south of the main ridge of the Alps). South Tyrol
belongs to the catchment area of the Etsch river, which drains
into the Adriatic, while North- and East Tyrol are part of the
catchment area of the Danube, which drains to the black sea.
Results: None of 617 samples from the Italian part of the study
area yielded a positive result, wherein 7 of 988 donors of the
Austrian part turned out to be seropositive. Two patients were
positive for Hantaan, 3 patients were positive for Puumala, one
patient was positive for Dobrava and one patient had antibodies
against Hantaan and Dobrava. Only one of those patients
reported extensive travelling abroad.
Conclusions: Evidence was found for the occurrence of
Hantaviruses in the Austrian part of the region covering the
catchment area of the Danube, but not in the Italian part of the
study area covering the catchment area of the Etsch river.
Seropositivity to Hantaviruses differs by hydrogeographic
areas.
P1670
Molecular characterisation of a pantropic variant
of canine coronavirus
N. Decaro, V. Martella, G. Elia, M. Campolo, C. Desario,
M. Tempesta, C. Buonavoglia (Valenzano, IT)
Objectives: Canine coronavirus (CCoV) is an enveloped, single-
stranded RNA virus, belonging to group I coronaviruses within
the family Coronaviridae. Two different CCoV genotypes have
been recognised, that are designated CCoVs type I and type II
on the basis of their genetic relatedness to feline coronaviruses
(FCoVs) type I and type II, respectively. CCoV is usually
responsible for mild, self-limiting infections restricted to the
enteric tract. We report the molecular characterisation of a
pantropic variant of CCoV that caused fatal disease in pups.
Methods: CCoV type II strain CB/05 was isolated from an
outbreak of fatal disease affecting seven dogs housed in a pet
shop in Apulia region, Italy and characterised by fever, lethargy,
inappetance, vomiting, haemorrhagic diarrhoea, neurological
signs, and severe lesions in the parenchymatous organs. In all
tissues, CCoV antigen was detected by immunoistochemistry
and CCoV type II RNA was identiﬁed by genotype-speciﬁc real-
time RT-PCR. The 3’ end of the genome of strain CB/05 was
determined by ampliﬁcation of seven partially overlapping
fragments. The PCR-ampliﬁed products were subjected to direct
sequencing and the obtained nucleotide (nt) sequences were
assembled and analysed using the BioEdit software package and
the NCBI’s and EMBL’s analysis tools. GenBank accession
number DQ112226 was assigned to the sequenced 8.7-kb
fragment. The inferred amino acid sequences (aa) were
compared to the analogous proteins available in the online
databases.
Results: The structural proteins S, E, M, N of strain CB/05
displayed a high degree of aa identity to the cognate ORFs of
CCoV type II, although the S protein showed the highest
identity to type II FCoVs. While the nonstructural protein (nsp)
3a had the same length of known CCoVs, the nsp3b was 49-aa
shorter than expected due to the presence of a 38-nt deletion at
position 4704 and to a frame shift in the sequence downstream
the deletion that introduced an early stop codon.
Conclusions: Association of strain CB/05 to a severe, fatal
disease of dogs, together with virus isolation from organs with
remarkable lesions, strongly suggests that this virus has
changed the tropism, acquiring the ability to spread from the
enteric tract to the internal organs. By sequence analysis of the
viral genome, the only striking change was the truncated form of
nsp3b, but the role of the deletion in the ORF3b in determining
the patho-biological change deserves more in-depth
investigation.
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SARS coronavirus-like virus in Chinese
horseshoe bats in Hong Kong
S.K.P. Lau, P.C.Y. Woo, K.S.M. Li, Y. Huang, H.W. Tsoi, B.H.L.
Wong, S.S.Y. Wong, S.Y. Leung, K.H. Chan, K.Y. Yuen (Hong
Kong, HK)
Objectives: To perform a surveillance study for SARS
coronavirus (SARS-CoV)-like virus in non-caged wild animals
from the wild of Hong Kong Special Administrative Region
(HKSAR).
Methods: From summer 2004 to spring 2005, 127 bats, 60
rodents and 20 monkeys from 11 locations in HKSAR were
captured. Nasopharyngeal and anal swabs and blood samples
were collected and tested for SARS-CoV-like virus RNA by RT-
PCR using conserved primers targeted to a 440-bp fragment of
the RNA-dependent RNA polymerase (pol) gene. The complete
genome of the SARS-CoV-like virus from bats (bat-SARS-CoV)
was sequenced using RNA extracted from three anal swabs of
three bats as template. Phylogenetic tree construction was
performed using neighbor-joining method with GrowTree
using Jukes-Cantor correction. Prediction of signal peptides
and cleavage sites was performed using SignalP,
transmembrane domains using TMpred and TMHMM,
potential N-glycosylation sites using ScanProsite and protein
family analysis using PFAM and InterProScan. Antibodies were
detected using a recombinant bat-SARS-CoV nucleocapsid
protein enzyme immunoassay and neutralization assay for
human SARS-CoV.
Results: We identiﬁed a coronavirus closely related to SARS-
CoV (bat-SARS-CoV) from 23 (39%) of 59 anal swabs of wild
Chinese horseshoe bats by RT-PCR. Sequencing and analysis of
three bat-SARS-CoV genomes from samples collected at
different dates showed that bat-SARS-CoV is closely related to
SARS-CoV from humans and civets. Phylogenetic analysis
showed that bat-SARS-CoV formed a distinct cluster with
SARS-CoV as group 2b coronaviruses, distantly related to
known group 2 coronaviruses. Most differences between the
bat-SARS-CoV and SARS-CoV genomes were observed in the
spike gene, ORF 3 and ORF 8, which are the regions where most
variations were also observed between human and civet SARS-
CoV genomes. In addition, the presence of a 29-bp insertion in
ORF 8 of bat-SARS-CoV genome, not in most human SARS-CoV
genomes, suggests that it has a common ancestor with civet
SARS-CoV. Antibody against recombinant bat-SARS-CoV
nucleocapsid protein was detected in 84% of Chinese
horseshoe bats using an enzyme immunoassay. Neutralizing
antibody to human SARS-CoV was also detected in those with
lower viral loads.
Conclusion: Our data support the existence of SARS-CoV-like
virus in Chinese horseshoe bats in HKSAR.
P1672
Porcine caliciviruses in piglets in Italy
V. Martella, E. Lorusso, M. Camero, A. Lavazza, G. Pezzotti,
G. Elia, N. Decaro, C. Buonavoglia (Valenzano-Bari, Brescia,
Perugia, IT)
Objectives: Noroviruses (NoVs) (family Caliciviridae, genus
Norovirus) cause diarrhoea in humans and animals. The NoV
genome is 7.3–7.7 kb long with 3 open reading frames (ORFs).
Noroviruses are genetically heterogeneous and form at least 27
genotypes within 5 genogroups, GI, GII, GIII, GIV, and GV,
based on the capsid genes. Human NoVs cause an estimated 23
million cases of illness annually in the United States alone and
>90% of nonbacterial epidemic gastroenteritis worldwide.
Porcine calicivirus have been found to be genetically similar to
human GII NoVs or to sapoviruses but calicivirus RNA has been
detected at low frequency by RT-PCR in adults or fattening pigs.
The close genetic relationships between human and porcine
NoVs raise public health concerns regarding their potential for
zoonotic transmission and as a potential source of new epidemic
human strains.
Methods: A total of 46 faecal samples of nursing and weaning
piglets with enteritis were collected during 2003–2005 in porcine
herds in Italy. An additional 44 samples were include in the
analysis, that had been collected during a rotavirus (RV)
surveillance study in 2003–2005, all which tested positive to
RV by electron microscopy and by RT-PCR. Viral RNA was
extracted by the guanidine thiocyanate/glass milk method to
eliminate enzyme inhibitors. Primer pair Con2-Con3, targeted to
the VP4 outer capsid protein, was used for RV detection. A
degenerated version of primer pair 289/290 was used for NV
detection, that targets a conserved region in the RNA-
polymerase.
Results: NoV RNA was detected in 20/46 of the screened
samples, while RVs were detected in 24/46 samples. Mixed
infections NoV+RV were found in 10 samples. Screening of the
44 RV positive samples allowed detection of 15 mixed infections
with NoVs.
Conclusions: In previous investigations NoVs were detected in
4 of 1,017 normal slaughtered pigs in Japan, in 2 of 100 pooled
pig faecal samples of 3- to 9-month-old fattening pigs in the
Netherlands and in 6 out of 274 healthy adult and ﬁnisher pigs
in the United States. Interestingly, in this study a high rate of
positivity to NoVs (35/90) was found in nursing and weaning
piglets with diarrhoea, a ﬁnding that may suggest a higher
frequency of infection by NoV in young pigs or an association
between NoV infection and occurrence of enteric disease.
Altogether, these ﬁndings demonstrate that NoVs are common
in porcine herds in Italy and provide new insights into the
ecology of NoVs.
P1673
Detection of calicivirus genome in calves using
Ni/E3 primers
M. Mahzounieh, T. Zahraeisalehi, E. Moghtadaei
Khorasgani (Shahrekord, Tehran, IR)
Caliciviruses may cause a wide spectrum of disease in animals
and are important etiological agent of viral gastroenteritis in
humans. Members of the family caliciviridae are small nonen-
veloped viruses 27 to 35 nm in diameter. They possess a single
stranded poly adenylated RNA genome. Caliciviruses have
been isolated from mink, dog, cattle and non-human primates.
"Norwalk-like viruses" (NLVs) are the most common cause of
acute non-bacterial gastroenteritis in humans. Cattle may be a
reservoir of NLVs although never bovine NLVs have been
found in humans. In this study, we try to detect enteric
caliciviruses genome from 50 faecal samples of 6 dairy cattle
herds in Shahrekord area using Reverse transcriptase polym-
erase chain reaction (RT-PCR) assays speciﬁc for NLVs found
in humans. The primers used for PCR ampliﬁcation were Ni
and E3, which amplify a 113-bp product for the detection of
both genogroups I and II SRSV RNA in fecal material. Our
results showed that nine specimens (18%) were positive. These
ﬁndings suggest that calicivirus infection is endemic in dairy
herds in Shahrekord, Iran and may be have an important role
in calf diarrhea.
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P1674
Assessment of reovirus epidemiology in dogs
G. Elia, M.S. Lucente, A.L. Bellacicco, M. Camero, N. Cavaliere,
N. Decaro, V. Martella (Valenzano, Foggia, IT)
Objectives: Reoviruses are non-enveloped, 10-segmented
dsRNA viruses. In humans and mammalians three distinct
serotypes exist, whose prototypes are strains Lang (T1), Jones
(T2) and Dearing (T3). Although reoviruses have been isolated
both from the enteric and respiratory tract, no diseases has been
clearly associated to reovirus infection in humans. The potential
association with extra-hepatic biliary atresia, myocarditis, and,
above all, neurological and cutaneous diseases require further
investigations. Reoviruses are ubiquitous and scarcely species-
speciﬁc. Reovirus identiﬁcation is usually based on electronic
microscopy or gel electrophoresis and reovirus incidence seems
to be very low in humans and most mammalians. In this study,
we investigated the presence of reoviruses in dogs by means of
molecular methods.
Methods: One hundred ninety-two rectal samples from dogs
with diarrhoea, 12 ocular swabs, 19 nasal swabs and 27
oropharyngeal swabs from dogs with ocular/nasal discharge
were subjected to an RT-PCR assay targeting a conserved region
of viral genome segment L1 (primers L1-rv5/L1-rv6). Positive
samples were characterised by polyacrylamide gel
electrophoresis (PAGE), serotype-speciﬁc RT-PCR assays
targeting segment S1 and sequence analysis. To increase the
sensitivity, a nested PCR using primers L1-rv7/L1-rv8 was
performed on samples tested RT-PCR negative.
Results: Only 4 faecal swabs (2.1%) were found positive (RT-
PCR product of 416 bp). By using a serotype-speciﬁc RT-PCR
assay and/or sequence analysis, two strains was characterised
as type 3 and the other ones as type 1. PAGE of viral dsRNA
conﬁrmed the genetic characterisation. Unexpectedly, in second-
round PCR 50 faecal samples (26%), 9 ocular swabs and 10 nasal
swabs yielded a 344 bp product, while no oropharyngeal swab
was positive.
Conclusions: These data suggest a wider distribution of
reoviruses in dogs than previously thought, even if most
reovirus infections were detected only by nested PCR. The
ability of reoviruses to induce disease in dogs, alone or in
synergism with other pathogens, is still unclear, since attempts
to reproduce a speciﬁc disease in germ-free dogs have given
contradictory results. Due to their poor species-speciﬁcity,
reoviruses may be easily transmitted from animals to humans
(and vice-versa). Further studies are required to understand
reovirus ecology and their potential zoonotic impact.
P1675
Molecular epidemiology of parvovirus B19 in
Slovenia
T. Ursic, M. Petrovec (Ljubljana, SI)
Objectives: Parvovirus B19 is a member of a family Parvovir-
idae. On the basis of genetic distances and evolutionary
relationships, human parvoviruses are divided into three gen-
otypes: genotype I corresponding to B19-related isolates, geno-
type II to Lali-related isolates, and genotype III to V9-related
isolates. Parvovirus B19 causes a common exanthematous
disease in childhood or adult age, arthropathy, hydrops fetalis,
various haematological disorders and myocarditis. Up to now,
we have had no data of the prevalence of B19 virus in Slovenian
population. Consequently, we also lack information on the
genotypes of parvovirus B19 that are involved in the patients
who suffer from the infection.
Methods: To gather information of the genetic variants of B19
virus present in Slovenia, we extracted DNA from 48 serum
samples that were sent for serologic diagnostic of parvovirus
B19 infection and were positive for speciﬁc IgM in the period
from January 1997 to June 2005. Nearly half of all 48 patients
were children and young adults up to 25 years. The NS1 region
of parvovirus B19 was ampliﬁed by the nested PCR (primers
PB19F1, R1 and PB19F2, R2). All PCR products were directly
sequenced.
Results: The results of our study show that DNA of parvovirus
B19 was present in all 48 samples that tested positive for
speciﬁc IgM antibodies. After the ﬁrst round of PCR reaction, 17
samples were positive, and after the second reaction, all 48
samples were positive. Altogether 12 unique genotype variants
of parvovirus B19 were identiﬁed and all were clustered in the
genotype I group of B19-related isolates. Most of the distinct 12
genetic variants differed in 1% to 2% from the sequences
deposited in Gene Bank. The majority of sequences obtained
from the B19 virus epidemic in 1998 represents a single variant
of genotype I with the Gene Bank acc. no. AJ781038. We also
found that different genetic variants of parvovirus B19 were
circulating in 2002 and were 100% or 99% identical to the
genotype I variant with the Gene Bank acc. no. Z68146. In our
study, we were not able to identify any variants of other rare
genotypes (Lali or V9).
Conclusion: Parvovirus B19 DNA was successfully ampliﬁed
from all IgM positive serum samples of the patients. The
genotype I of parvovirus B19 is dominating in infections with
parvovirus B19 in Slovenia.
Bacterial pathogenesis – III
P1676
Characterisation of human brucellosis in Great
Britain by classical typing and VNTR molecular
typing
P. Groussaud, S.D. Brew, A.M. Whatmore, J.A. Stack (New Haw,
UK)
Objectives: Great Britain has been free of animal brucellosis
since 1985 (European Commission Decision 93/52). The main
source of infection for UK residents is through contact with
infected material in foreign countries. The objective of this study
is to type human samples received in the UK since 1999 using
Variable Number Tandem Repeats (VNTR) molecular typing to
conﬁrm results obtained by classical typing and relate these
results to the suspected source of infection.
Methods: Classical typing is traditionally used and is based on
the phenotypic attributes of each strain and biovar. VNTR
typing is a recently developed molecular method, which is
based on short repeats contained in the DNA that can be
ampliﬁed to give a banding pattern speciﬁc to each strain.
Results: Results found using both methods are consistent. The
results show geographical differences, consistent with
observations of strain genotype distribution found in animal
brucellosis.
Conclusion: Patient history has been gathered where possible
giving information on recent travels. Along with results found
Abstracts
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
by classical typing and conﬁrmed by VNTR typing we can draw
a picture of the sources of infection. These results illustrate the
potential of VNTR typing as a tool to aid conventional
approaches to epidemiological traceback that, in the presence
of a suitably comprehensive database of strain genotypes, could
help identify the source of an infection.
P1677
IS711-ﬁngerprinting of Brucella isolates from
humans
E.Stubberﬁeld (Surrey, UK)
Objective: Brucellosis is a zoonotic disease usually associated
with cattle, sheep, goats and pigs. Human infection has been
attributed to B. melitensis, B. abortus, B. suis, B. canis and B.
maris. Although the UK is ofﬁcially bucellosis free there are a
number of human cases due to travel and occupation that are
submitted to our laboratory for diagnosis. Deﬁnitive diagnosis
of Brucella is by bacteriological culture and microbial tests
(classical typing), however these require skilled personnel and
the results can be subjective. There are a number of molecular
tests that have been developed to assist with diagnosis more
rapidly and in some cases to strain level less subjectively.
IS711-ﬁngerpinting is a molecular technique that has proved
useful for the identiﬁcation of Brucella isolates to species and in
some cases stain level. IS711-ﬁngerprinting relies on the
variable number and location of the IS711 mobile genetic
element found in all Brucella isolates.
Method: 73 Brucella isolates from humans have been tested.
Genomic DNA was extracted, digested using restriction
endonuclease EcoR1, and electrophoresed. Southern blotting
was performed, hybridising with a DIG-labelled IS711 probe.
Results: The number of Brucella IS711 copies range from 5 to
more than 20. Brucella melitensis remains the most commonly
acquired Brucella species of travellers, while occupational
infections have included B. abortus isolated from cattle farmers
and B. suis associated with pig butchers. Two marine Brucella
strains have been isolated originating from an occupational
perspective (a laboratory worker) and a natural setting from an
unknown source. 7 unusual patterns have been observed, 5 of
which are unique. One of the new patterns has been observed
only in isolates originating in East African countries.
Conclusion: Although the diagnosis of Brucella to species and
strain level is not essential for the treatment of human
Brucellosis, it is useful for epidemiological studies. IS711-
ﬁngerprinting is able to identify the three biovars of B.
melitensis, many other techniques do not offer this capability,
because of this it may be a useful test in epidemiological studies.
This method remains an important diagnostic tool for Brucella
identiﬁcation.
P1678
Rapid diagnosis of brucellar epididymo-orchitis
by real-time PCR assay in urine samples
J.D. Colmenero, M.I. Queipo-Ortun˜o, J.M. Reguera, N.L. Mun˜oz,
A. Villalobos, A. Plata, P. Morata (Malaga, ES)
Objectives: To study the diagnostic yield of a real-time PCR
assay in urine samples for the rapid diagnosis of brucellar
epididymo-orchitis, in comparison with conventional
microbiological techniques.
Methods: Ten consecutive patients with brucellar epididymo-
orchitis were included in the study. The diagnosis of brucellosis
was established according to one of the following criteria: ﬁrst,
isolation of Brucella spp in blood or any other body ﬂuid or
tissue sample or, second, the presence of a compatible clinical
picture together with the demonstration of speciﬁc antibodies at
signiﬁcant titers or seroconversion. Epididymo-orchitis was
diagnosed in patients with scrotal enlargement, swelling and
pain not due to other causes.For DNA ampliﬁcation we used a
SYBR Green I LightCycler-based real-time PCR assay. The assay
ampliﬁes a 223 bp sequence of a gene that codes for the
synthesis of an immunogenetic membrane protein (BCSP31).
The pair of 21 nucleotide primers B4 (5’ TGG CTC GGT TGC
CAA TAT CAA 3’) and B5 (5’ CGC GCT TGC CTT TCA GGT
CTG 3´) were used in the ampliﬁcation process. After DNA
amplication, we performed melting curve analysis to verify the
speciﬁcity of the PCR products. In order to study the speciﬁcity
of the technique, all the samples from the patients with
brucellosis were paired with an equal number of samples from
controls with urinary tract infection. (E. coli four cases, K.
pneumoniae two cases, P mirabilis two cases, and C. freundii and P.
aeruginosa one of each).
Results: The mean age was 38.4 years (range 21–69). The
duration of the symptoms prior to diagnosis was
30.2 ± 16.2 days (range: 5–51). B. melitensis was isolated from
blood cultures in nine cases (90%). Wright’s seroagglutination
was negative or inconclusive in 30% of cases. Brucella was
isolated from urine in only one case whereas real-time PCR
assay in urine was positive in nine (90%) cases and the results
were available in four hours, whereas the mean time to
availability of the ﬁnal blood culture results was 5.8 days
(range 4.5–7 days). Real-time PCR was negative for all the
control samples from patients with urinary tract infections.
Conclusion: SYBR Green I LightCycler-based real-time PCR
assay in urine samples is highly sensitive and speciﬁc, easy to
perform and could provide the clinician with the results in
under ﬁve hours. The technique could be a practical and useful
tool for the rapid diagnosis of genitourinary complications of
human brucellosis.
P1679
Molecular diagnosis and characterisation of
human isolates
C.E. Dawson (Weybridge, UK)
Objectives: Although the United Kingdom remains Brucellosis-
free, there are more than 500,000 new cases of Human
brucellosis reported each year according to the World Health
Organisation. UK residents returning from worldwide travel
may have encountered exposure through contact with infected
animals and animal products such as dairy produce and meat.
Phenotypic characterisation or classical methods remain the
deﬁnitive diagnosis though require skilled personnel and have
their limitations. The increasing range of molecular techniques
can aid the rapid detection and characterisation of Brucella
species and their biovars and may have signiﬁcance in
Epidemiological studies.
Methods: A study of Brucella reference and ﬁeld strains of
mainly human isolates from different geographic locations were
analysed for diversity of their genes encoding the outer
membrane proteins (omps) 25, 2a and 2b. PCR products of the
three genes digested with seven restriction enzymes were
analysed for polymorphisms.
Results: A re-occurring unique pattern proﬁle seen only in
human isolates was observed originating in some European
countries and beyond. A growing database of strain types giving
a recent overview of Brucella infection of humans of many
countries.
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Conclusions: Molecular typing methods may have an
advantage over classical typing concerning Brucella melitensis,
the most common Brucella infection of humans. The
characterisation of human Brucella isolates may be useful in
Epidemiological studies for a variety of purposes.
P1680
Real-time detection of Campylobacter jejuni and
Campylobacter coli from environmental samples
and single nucleotide polymorphism proﬁling of
map A positive strains to determine their clonal
complexes
S. Lai, E. Best, S.B. Surman-Lee, R.J. Owen, J.V. Lee (London, UK)
Objectives: A study to demonstrate the rapid detection and
speciation of Campylobacter jejuni and of Campylobacter coli
isolates directly from enrichment broth using a Taqman
assay. Single nucleotide polymorphism analysis of mapA
positive strains was used for rapid identiﬁcation of C. jejuni
clonal complexes.
Methods: Thermotolerant Campylobacter species were initially
conﬁrmed by culture according to the modiﬁed draft ISO 17995
method, where water samples were ﬁltered through 0.2 mm
pore size nylon membrane. The ﬁlters were transferred to
selective enrichment in Preston broth to improve their recovery
and therefore detection of any campylobacter cells present. DNA
was extracted directly from the enrichment broth culture for
real-time detection of C. jejuni and C. coli using the Taqman.
Samples, which were map A positive were, further characterise
by single nucleotide polymorphism proﬁling for rapid
recognition of C. jejuni clonal complexes.
Results: Environmental samples, which were conﬁrmed by
culture were also map A positive by Taqman. SNP proﬁling of
mapA positive isolates identiﬁed clonal complexes, which are
predominantly contained in isolates of human disease and
chicken.
Conclusions: This study has demonstrated the feasibility of
rapid detection and identiﬁcation of C. jejuni and C. coli
following short enrichment incubation using a Taqman assay.
A rapid turnaround time of between 3–4 h per batch of 96
samples was achieved. SNP proﬁling offers important
epidemiological grouping at strain level, enabling accurate and
phylogenetically valid strain identiﬁcation for C. jejuni, which
may have important host associations for tracing sources of
infection and consequently improve public health responses.
P1681
Species identiﬁcation of human Campylobacter
strains
U-M. Nakari, A. Koivuma¨ki, A. Siitonen (Helsinki, FI)
Objectives: Campylobacter jejuni and C. coli are recognized as the
most common causes of acute bacterial gastroenteritis in
humans, C. jejuni being the predominant species in most
developed countries. The hippurate hydrolysis test is widely
used to differentiate C. jejuni from other Campylobacter species.
About 10% of C. jejuni isolates fail to hydrolyze hippurate under
laboratory conditions. Molecular methods represent an
alternative to the phenotype-based methods. We tested two
multiplex PCR assays for species identiﬁcation of human
campylobacter strains and compared the results with the
hippurate hydrolysis test.
Methods: Campylobacter strains isolated from patients were
tested for hippurate hydrolysis with Rosco diagnostic tablets. 50
hippurate-negative and 15 hippurate-positive strains were
selected for two multiplex PCR assays. One PCR-method was
based on distinctive ceuE-genes of C. jejuni and C. coli, the other
PCR-method detected genes from ﬁve major clinically relevant
Campylobacter species: hipO fromC. jejuni, glyA fromC. coli,C. lari
and C. upsaliensis, sapB2 from C. fetus subsp. fetus, and 23S rRNA
gene from Campylobacter spp. as an internal validation control.
Results: The C. jejuni hipO gene was detected in all of the 15
hippurate-positive strains and 10 of the 50 hippurate-negative
strains. The C. coli glyA was detected in 39 of the hippurate-
negative strains. In one hippurate-negative strain, sapB2 from C.
fetus subsp. fetus was detected. Species-speciﬁc genes were
detected in 53 of the 65 strains with the ceuE-based PCR assay.
C. jejuni ceuE was detected in 12 hippurate-positive and 5
hippurate-negative strains. C. coli ceuE was detected in 36
hippurate-negative strains.
Conclusion: All hippurate-positive strains were identiﬁed as C.
jejuni. Of the hippurate-negative strains, 78% were identiﬁed as
C. coli, whereas 20% were identiﬁed as C. jejuni and one strain as
C. fetus subsp. fetus. The results of the two PCR assays were
concordant, although some strains could not be identiﬁed with
the ceuE-based PCR assay. The results suggest that molecular
species identiﬁcation should be performed on hippurate-
negative strains after the hippurate hydrolysis test for accurate
species identiﬁcation. Multiplex-PCR is quick and easy to
perform. Using the PCR assay that simultaneously detects ﬁve
Campylobacter species also diminishes the need for further
phenotypic testing.
P1682
Phenotypic typing of Cryptosporidium species
isolated from children in Kuwait: a role in unique
transmission
J. Iqbal, P. Hira (Safat, KW)
Background: Cryptosporidiosis is recognized worldwide as a
signiﬁcant cause of diarrhoeal diseases in both adults and
children especially in children less than 2 years of age.
Objective: Cryptosporidium spp. isolated from young children in
Kuwait were characterized at the molecular level to understand
the transmission of infection. The study was approved by the
Ethical Committee, Faculty of Medicine, Kuwait.
Methodology: Over a period of 2 years, faecal specimens from
97 Kuwaiti children with persistent diarrhoea found to be
positive for Cryptosporidium spp. by microscopy were genotyped
and sub-typed with a small subunit rRNA-based PCR-restriction
fragment length polymorphism analysis. Informed consent was
taken from all individuals included in the study.
Results: The median age of infected children was 4.9 years, and
the majority of the infections (>70%) occurred during the cooler
months January–April, indicating a marked seasonal variation.
More than 85% of the children with cryptosporidiosis had only
Cryptosporidium infection. Socio-demographic information did
not reveal any particular mode of transmission of infection.
Genotyping of the organisms isolated showed that ninety-two
(95%) of the children had C. parvum, 4 (4%) had C. hominis, and 1
(1%) had both C. parvum and C. hominis. Altogether, 9 subtypes
of C. parvum and C. hominis were observed.
Conclusion: Our study revealed a very different distribution of
Cryptosporidium genotypes in Kuwaiti children as compared to
other tropical countries. The genotypes and subtypes isolated
are discussed with relation to the seasonality and possible mode
of transmission of this infection in Kuwait.
Acknowledgements: The ﬁnancial support for this study was
provided by Kuwait University Research Grant 03/03.
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P1683
Chlamydophila pneumoniae in patients
undergoing aortic valve replacement
M. Edvinsson, Y. Molin, E. Hjelm, S. Thelin, G. Friman,
C. Nystro¨m-Rosander (Uppsala, SE)
Objectives: The intracellular respiratory pathogen Chlamydo-
phila pneumoniae (Cp) might be involved in the pathogenesis of
atherosclerosis. Several studies have demonstrated a serological
association between Cp and cardiovascular disease and DNA
from the bacteria has been found in various atheromatous
vessels. After infection in the respiratory tract, Cp is believed to
be disseminated systemically within alveolar macrophages. The
prevalence of Cp within peripheral blood mononuclear cells
(PBMC) has in some studies been shown to be higher in
patients suffering from cardiovascular disease than in control
patients. We investigated the presence of Cp DNA in aortic
heart valves and PMBC in 55 patients (37 men; 18 women; mean
age 69 years) undergoing aortic valve replacement because of
aortic stenosis. Also, the presence of Cp mRNA was investi-
gated in the sclerotic aortic heart valves as a marker of viable
bacteria.
Methods: DNA was extracted from aortic valve biopsies and
PBMC using the QiaAmp DNA mini kit (Qiagen). mRNA and
DNA were extracted from another piece of the same biopsy
using Trizol (Invitrogen). Real-time PCR directed against the
chlamydia MOMP gene was used to detect Cp-speciﬁc DNA and
mRNA. Patient sera were tested for Cp-speciﬁc IgM, IgG and
IgA antibodies by the microimmunoﬂuorescence technique.
Results: Cp DNA was found in aortic heart valves from 20%
(11/55) of the patients and in PBMC from 5% (3/55) of the
patients. In one patient Cp DNA was found in both PBMC and
heart valve. No patient had Cp-speciﬁc IgM antibodies. In
patients that were PCR-positive for Cp DNA in the aortic heart
valves, 73% had IgG ‡1:64 and 45% had IgA ‡1:32. In patients
that were PCR-negative in the aortic heart valves, 59% had IgG
‡1:64 and 23% had IgA ‡1:32. Cp-speciﬁc mRNA in aortic heart
valves will be presented on the poster.
Conclusion: Cp-speciﬁc DNA was found in sclerotic aortic
heart valves from 20% of patients undergoing aortic valve
replacement. This conﬁrms previous investigations supporting a
role for Cp in the pathogenesis of aortic valve sclerosis. The
prevalence of Cp in PBMC was 5% which is comparable to that
reported in healthy blood donors and lower than that recorded
in patients suffering from other cardiovascular diseases. If the
bacteria are involved in the pathogenesis of aortic sclerosis they
have likely been spread to the aortic valve long before the
patient is in need of surgery because of the stenotic valve.
P1684
Molecular epidemiology of diarrheagenic E. coli
in children with acute diarrhoea in Tehran, Iran
and the antibiotic susceptibility of isolated
strains
F.Jafari, S.Salmanzadeh-Ahrabi, M.M.Aslani, F.Baghbani-Arani,
M. Azimi-Rad, M.R. Zali (Tehran, IR)
Introduction: Diarrhoea is one of the most common causes of
morbidity and mortality among young children in developing
countries. Diarrheagenic E. coli strains include several emerging
pathogens of worldwide public health. Six important categories
are Entero-aggrigative E. coli (EAEC), Entropathogenic E. coli
(EPEC), Enterotoxigenic E. coli (ETEC), Enterohemorrahgic
E. coli (EHEC), Entroinvasive (EIEC) and Shigatoxin-producing
E. coli (STEC). This study investigated the role of different
diarrheagenic E. coli in Iranian children with acute diarrhoea by
molecular methods and the antibiotic susceptibility of isolated
strains.
Methods: From April 2003 to January 2005, one thousand
eighty ﬁve children with acute diarrhoea in Tehran hospitals in
were enrolled in the study. The fecal samples were cultured on
MacConkey for conventional bacterial pathogen and Sorbitol
MacConkey agar for Non sorbitol fermenting phenotype, than
they were incubated in 37ordm;C. The primary stool cultures
were subjected to six different PCR reactions targeting stx1 and
stx2 gene, heat-labile enterotoxin (LT) producing gene, heat-
stable enterotoxin (ST) producing gene, eae gene and pCVD432
plasmid. The Kirby –Bauer disc diffusion method was used for
antibiogram of 110 isolated strains from different diarrheagenic
E. coli by 12 different antibiotics.
Results: Two hundred seventy one diarrheagenic E. coli strains
were detected. STEC was the most prevalence with 125 (46.1%).
The frequency of other strains was 28.7%, 16.3%and 8.8% for
ETEC, EAEC and EPEC, respectively. Out of 120 STEC isolated
86 strains (% 68.8) had stx1 or stx2 gene, and 4 strains had stx1
and stx2 gene. The eae gene was found in 13 (10.4) STEC strain.
Out of 110 tested strains, 102(92.5%) were resistance to ampicllin
and cefalotin, and 99 (90%) to streptomycin.
Conclusion: In this study STEC was the most frequent
associated with diarrhoea. The strong association between use
of antibiotics and colonization with antibiotic resistant E. coli,
suggest a major role for selection of resistant strains while using
antibiotics. The existence of other unknown intestinal adherence
factors has been suggested by the isolation of STEC strains that
lack the eae gene but are still associated with bloody diarrhoea
or hemolytic ureamic syndrome (HUS). Since there is no speciﬁc
treatment, there is an urgent need for effective preventive
measures based on detailed understanding of the epidemiology
of STEC infections.
P1685
Identiﬁcation of Shiga toxin-producing
Escherichia coli in raw beef using DNA
hybridization with digoxigenin-labelled probes
and multiplex PCRs
M. Weiner, J. Osek (Pulawy, PL)
Shiga toxin-producing Escherichia coli (STEC) is an important
cause of bloody diarrhoea, haemorrhagic colitis, haemolytic
uremic syndrome and thrombotic thrombocytopenic purpura.
Transmission of STEC occurs through consumption of contam-
inated food, especially meat, dairy products and water.
Objectives: To develop a three-steps procedure based on two
multiplex PCRs and DNA hybridization with digoxigenin-
labelled probes for identiﬁcation of STEC in raw beef.
Methods: Beef samples inoculated with different number of
E. coli O157:H7 cells were incubated in TSB medium at 37C for
6 h. The cultures were then transferred to TSB with mitomycin C
and incubated for another 18 h. The resulted cultures were used
as a source of DNA template. The mPCR-1 was established to
identify Shiga toxins genes (conserved sequence). The positive
culture samples were subjected to DNA hybridization with
DIG-labelled probes as follows: the culture was diluted and
inoculated onto agar plates supplemented with Tergitol and
incubated at 37C for 18 h. Then, the nylon membranes were put
on agar plates, carefully removed and incubated in denatura-
tion, neutralisation and equilibration solutions following incu-
bation with the stx-speciﬁc DIG-labelled probes, anti-DIG
conjugates and ﬁnally developed with enzyme substrates
(BCIP and NBT). Dark spots visible on the membranes were
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compared with the respective bacterial colonies on the original
agar plates. The corresponding bacterial colonies were isolated
and characterized using the mPCR-2 test which allows ampli-
ﬁcation of stx1 (Shiga toxin type 1), stx2 (Shiga toxin type 2),
rfbO157 (E. coli O157) and ﬂiCH7 gene (H7 antigen). An internal
control of ampliﬁcation (E. coli 16S rRNA gene) was also
included in both mPCR tests.
Results: The ﬁrst mPCR resulted in two ampliﬁcation products:
230 bp for stx and 401 bp for 16S rRNA genes. The positive meat
samples were further tested with DNA probes and positive
colonies were then characterized with the second test (mPCR-2),
generating the amplicons either of 348 bp (stx1), 584 bp (stx2),
420 bp (rfbO157), 247 bp (ﬂiCH7) or 798 bp (16S rRNA). The
speciﬁcity of this procedure was conﬁrmed by testing E. coli
O157:H7, O157:H-and non-STEC bacteria. The sensitivity of the
method was estimated as 4 CFU/g of meat.
Conclusion: The obtained results demonstrated the high
speciﬁcity of the procedure developed and the possibility of
using it for identiﬁcation of Shiga toxin-producing E. coli in raw
beef.
P1686
Correlation between virulence pattern,
phylogenetic group and extended spectrum
betalactamases genes in Escherichia coli strains
isolated from blood cultures
M. Damian, C. Usein, D. Tatu-Chitoiu, S. Ciontea, D. Jardan,
A. Palade (Bucharest, RO)
E. coli, heterogeneous species consisting of commensal and
pathogenic strains, is causing a broad spectrum of human
diseases, including extra intestinal and enteric infections.The
strains isolated from invasive infections were documented to be
carriers of a large number of genetic structures coding for
virulence, as well as for resistance to antimicrobial agents. The
aim of this study was to evaluate the virulence of strains in
comparison with the presence of ESBL genes and their distri-
bution among the different phylogenetic groups. A total of 51
E. coli strains, isolated from blood cultures, in hospitalised
patients, adults and children, were screened for virulence
factors-encoding genes (pap, sfa/foc, afa, hly, cnf, aer and
ﬁmH), for genes encoding resistance to extended spectrum
betalactam antibiotics (bla SHV and bla TEM genes) and the
appurtenance to one of the main four phylogenetic group based
on presence or absence of markers chuA, yjaA and TSPE4.C2
Three strains, negative for all virulence genes, were included in
the phylogenetic group A. Ten strains, which were positive for
ﬁve or six virulence genes, were identiﬁed as B2 group. No
matter the phylogenetic grouping, the remaining strains pos-
sessed at least one virulence gene. No strain was PCR positive
for all seven virulence genes targeted. Among the 16 strains
which were positive in the double disk test, 12 strains exhibited
both bla SHV and bla TEM genes and 4 strains only bla TEM
gene. Restriction with Pst I and Dde I and sequencing of the
amplicons were performed in order to identify the type of ESBL
gene expression product. Taking into account the link between
phylogenetic group and virulence, we obtained a good correla-
tion for the bacteremic E. coli strains analysed, but there was no
relationship with the production of ESBLs.
P1687
Isolation of shiga-toxin producing Escherichia
coli from meat samples, phenotypic and
genotypic characterisation of isolated strains
F. Baghbani-Arani, F. Jafari, M.R. Zali, S. Salmanzadeh-
Ahrabi (Tehran, IR)
Objective: Shiga-toxin producing Escherichia coli (STEC) is an
emerging foodborne pathogen of worldwide public health
importance. This bacterium has been reported as an etiological
agent of many outbreaks and sporadic cases. Deﬁnition of the
diversity and antimicrobial susceptibility of (STEC) may be
helpful in the management of sporadic cases and outbreaks.
Studies in different countries show that food items maybe
contaminated by this pathogen. The present study was carried
out to determine the frequency of contamination of meat
samples by STEC collected in Tehran as well as deﬁning
genotypes, serotypes, antibiogram susceptibility patterns and
molecular diversity of isolated bacteria.
Methods: From July 2004 to June 2005, 250 beef samples were
collected from different part of Tehran. A 25 grams of each
sampleswas enriched in EC broth and subculture onMac-Conkey
agar. DNA was extracted from a loop full of bacteria taken from
primaryﬁrst streakingareaofMac-Conkeyagar andwassubjected
to three different PCR reactions targeting stx1, stx2 and eae genes.
As much as colonies required were tested for ﬁnding the colony
responsible for positive results in the ﬁrst PCR. Antibiogram
susceptibility patterns of isolated strains were determined by
standard disk diffusingmethod. The 17 antimicrobial agentswere
used at this study. All isolates were serotyped by slide
agglutination test using standard antisera (MAST Groups)
Subtyping of strains was done with RAPD-PCR by 1283primer.
Results: Among 250 samples, 47 (19%) samples were positive
and their genotypes were as follow: 1(0.4%) stx1+, stx2-, eae-,
35(14%) stx1-, stx2+, eae-, 6(2.4%) stx1-, stx2+ and eae+.4 (1.6%)
stx1+, stx2+, eae-, 1(0.4%) stx1+, stx2+, eae+. Among these
positive samples 30 strains were isolated. According to the
antibiotic susceptibility tests, all isolates were resistance to
erythromycin (E) and oleandomycin (OL), and were sensitive to
imipenem (I); gentamicin (G) noroﬂoxazin (Nx) enteroﬂoxazin
(Ex) ciproﬂoxazin (Cf) and ceftazidim (ca). In Otyping and
Htyping the most frequency were O112ac and H2 serotypes.
Analysis of isolates by RAPD-PCR yielded 17different patterns.
Conclusion: Our results show that contamination of meat
samples by STEC is a life-threatening health problem.
Combinational analysis of Antibiogram susceptibility patterns
and serotypes with RAPD-PCR patterns can aid to survey the
characteristics of STEC strains.
P1688
Factors affecting the conjugative transfer of
plasmid pIP501 in Enterococcus faecalis
A.M. Al-qurashi (Dammam, SA)
Objectives: Factors which are known to inﬂuence plasmid
transfer were studies using the conjugative plasmid pI501,
which encodes erythromycin resistance, in Enterococcus faecalis.
Methods: The donors strains streptococcus a agalactiae V666
(group B) is resistant to in rifampicin and fusidic acid, non
hemolytic and b-lactamase-negative. It contains the broad host
range plasmid pI501, which confers resistance to erythromycin
and chloramphenicol. The recipient is Enterococcus faecalis strain
JH2-2 Group D.
Results: Transfer of pIP501 occured on a agar, on ﬁlters and in
broth cultures at relatively high densities (106–108 bacteria/ml).
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Transfer frequency was largely unaffected over a wide range of
temperatures (23–42C). The pH of the medium, in the range pH
5–9 had little effect on the transfer frequency. Log phase cultures
and donor: recipient ratios of 1:1000-100:1 were required for
optimal for plasmid transfer.
Conclusion: Factors which modiﬁed the transfer efﬁciency of the
conjugative plasmid pIP501 were mating media, solid or liquid
environment, mating time, mating temperature, selection
temperature, growth temperature of donor and recipient of prior
tomating, pH culture age, anddonor/recipient cells ratio, to obtain
a better understanding of this plasmid and its transfer process will
help understand what role they may have in the dissemination
resistance among streptococcal and enterococcal populations.
P1689
Presence of seven virulence genes in Swedish
Enterococcus faecium blood-culture isolates
collected during a ﬁve-year period
H. Billstro¨m, A˚. Sullivan, B. Lund (Stockholm, SE)
Background: Enterococcus faecalis and Enterococcus faecium have
during the last years become a signiﬁcant nosocomial problem.
This could be due to the enterococcus hardy nature combinedwith
intrinsic and acquired antibiotic resistance. Since most
individuals harbour enterococci in their normal intestinal
microﬂora there has been a discussion regarding the origin of
these isolates. During the last ten years the isolation ratio between
E. faecalis andE. faeciumhave shifted from10:1 to 3:1. This couldbe
because of increasing antibiotic resistance among infectious
E. faecium isolates compared to infectious E. faecalis ones. It is
possible that this increase also depends upon different virulence
genes such as enterococcal surface protein (esp), hyaluronidase
variant gene (hylEfm) and E. faecalis antigen A variant (efafm).
Objectives: The objectives in this study were to determine the
presence and frequencies of seven different enterococcal
virulence genes in infectious isolates. Further objectives were
to see if the number of virulence genes in these isolates vary or
increase over time.
Methods: A total of 257 strains isolated from bacteraemia
patients during year 2000–2005 at the Karolinska University
Hospital, Huddinge were used. All isolates were screened for
seven different virulence genes using a multiplex PCR. These
seven virulence genes were aggregation substance (asa),
cytolysin (cyt), collagen binding protein (ace), E. faecalis
antigen a variant (efafm), enterococcal surface protein (esp),
gelatinase (gel) and hyaluronidase (hyl).
Results: According to the results about half of all isolates were
esp-positive. The prevalence of the other virulence genes asa,
efafm, gel and hyl were detected, but in low frequencies (<5%).
Conclusion: It seems like the esp gene is the most dominant
virulence gene in E. faecium isolates. The occurrence of virulence
traits in these isolates further indicates that the potential to cause
infection is potentiated among this enterococcal population The
data from this investigation supports the hypotheses that
enterococci causing infection in hospitalized patients are
probably of nosocomial origin rather than endogenous.
P1690
Transcriptomic analysis of the alkaline-tolerance
response in Listeria monocytogenes 10403S
E. Giotis, A. Muthaiyan, D. McDowell, I. Blair, B. Wilkinson
(Newtonabbey, UK; Normal, US)
Objectives: The ability of L. monocytogenes to tolerate alkaline
stress is of particular importance, as this pathogen is often
exposed to such stress in food processing environments cleaned
with alkaline detergents or in the mildly alkaline pH values
which prevail within engulﬁng phagolysosomes. This study
aims to investigate the alkaline tolerance response (AlTR) in
Listeria monocytogenes 10403S using DNAmicroarray technology.
Knowledge of the alkaline-induced stress response will be
useful in understanding how this pathogen tolerates alkaline
stress.
Methods: Transcription proﬁling of L. monocytogenes 10403S
was carried out at 15, 30 and 60 min at high pH in order to
capture an early, an intermediate and a prolonged expression
response to alkaline stress using oligo arrays from the Pathogen
Functional Genomic Resource Centre. To verify the microarray
results the regulation of some pH stress response genes were
conﬁrmed by Real Time Quantitative Polymerase Chain
Reaction (RT-PCR).
Results: About 1584 genes were upregulated and 1754 genes (of
6347 Open Reading Frames represented on the arrays) were
down regulated at least 1.5 fold upon alkaline shock. Many of
the repressed genes encode enzymes that are involved in the
biosynthesis of amino acids, nucleotides and coenzymes,
indicating a metabolic adjustment of the cells to the high pH.
Notably, the strongest alkaline-inducible genes were involved in
the membrane transport systems.
Conclusion: The analysis of the data revealed that cells sense
and respond to alkaline stress with an extensive program of
changes in gene expression. Interestingly, there is a strong
correlation between the AlTR and virulence gene expression.
Comparison to various microarray data already in the literature
revealed similarity between the response to alkaline stress and
the transcriptional response to stresses such as osmotic shock.
P1691
Engineering improved listerial stress tolerance
"with a twist"!
R. Sleator, C. Hill (Cork, IE)
Objectives: To engineer Listeria monocytogenes strains with a
signiﬁcantly improved ability to tolerate stresses encountered in
the external environment and during gastrointestinal transit,
thus, improving Listeria’s efﬁcacy as a potential vaccine and
drug delivery platform.
Methods and results: Using a directed evolution approach,
based on a random mutagenesis strategy involving the E. coli
XL1-Red mutator strain, we generated a mutant variant of the
listerial betL gene (designated betL*), encoding a secondary
betaine uptake system. The mutant betL* promotes a dramatic
increase in resistance to a number of biologically relevant stresses
when expressed in a variety of different surrogate hosts. Using a
luciferase (Lux) reporter system in combination with the IVIS
Imager System (Xenogen Corporation, Alameda, CA), we
tracked betL* expression, in real time, both in vitro under various
environmental stresses and in vivo in animal models of infection.
In each case strains expressing betL* demonstrated a marked
improvement over those expressingwild type betL, both in terms
of gene expression and bacterial growth. Sequence analysis of the
mutated gene revealed a single nucleotide deletion in the spacer
region between the -10 and )35 promoter elements upstream of
the betL coding region. This deletion presumably introduces a
conformational ‘twist’ in the putative promoter, thereby increas-
ing its transcriptional output. Furthermore, the betL* mutation
appears to counter the heretofore unreported ‘twisted’ cell
morphology observed using scanning electron microscopy of
L. monocytogenes grown at elevated osmolarities.
Conclusions: It is possible to selectively improve genes
required for bacterial stress survival both inside and outside
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the host. Such mutated genes systems may ultimately be used
for the construction of more physiologically robust bacterial
based vaccine and drug delivery platforms.
P1693
Application of ﬂuorescent in situ hybridization
for detection of Helicobacter pylori
A.R. Samarbaf-Zadeh, S. Tajbakhsh, S.M. Moosavian (Ahwaz, IR)
Introduction: Peptic ulceration following infection of stomach
with H. pylori is a common disease. Accurate and rapid
detection of the bacteria can lead to implementation of
appropriate treatment and recovery. This research was
undertaken to evaluate the sensivity and speciﬁcity of
Fluorescent In-Situ Hybridization (FISH) in the detection of H.
pylori in patients who were suffering from dyspepsia.
Methods: For this purpose, one hundred gastric biopsy samples
taken from antrum and corpus of stomach by endoscopy were
tested by FISH and compared with conventional culture method
complemented with biochemical tests.
Results: FISH detected H. pylori in 48 clinical samples while
conventional method detected 42 samples. The sensivity and
speciﬁcity of FISH for detection of H. pylori were calculated as
98% and 100% respectively.
Conclusion: The ﬁndings of this study suggest that FISH is a
highly suitable and rapid method for diagnosis of H. pylori,
especially when the samples are taken from the antrum and the
corpus of the stomach this technique potentially can be applied
routinely for detection of this bacterium in clinical samples.
P1694
Prevalence of Helicobacter pylori oral carriage in a
children’s community
D. De Vito, M. Santantonio, M.F. Coscia, C. Rizzo, R.A. Monno,
G. Rizzo (Bari, IT)
Objective: Numerous studies have demonstrated that H. pylori
is ubiquitous; approximately 50% of the world’s population is
infected with the organism. Gastroduodenal diseases associated
with H. pylori infection are manifested principally in adults.
However, it’s usually during chilhood that the infection is
acquired, and it is possibile that mucosal and humoral responses
at this time may determine, at least in part, the course of the
natural infection. Our study will describe the prevalence of the
H. pylori oral carriage in children resident in Bari, south of Italy,
using the PCR method.
Methods: The evaluation was performed in 404 children, with
ages ranging from 6 to 11 years, from primary school district of
Local Health Unit of Bari, Italy (AUSL BA/4). The school and
the class have been selected using the cluster sampling method.
A standardized questionnaire was used to verify socio-economic
standard, hygiene and history of previous gastrointestinal
disorder. A standard full-mouth examination was made to
detect periodontal diseases, then dental plaque and saliva
collected from children were placed in PBS and transported in
laboratory. H. pylori infection status was checked by PCR
method. DNA was extracted from oral samples by the boiling
method and evaluated for the presence of H. pylori CagA and
UreA genes using commercial kit (AB Analitica, Padova).
Results: A total of 404 children (212 females and 192 males)
partecipated to the study. The presence of gene coding for CagA
was found in 57 children (14%), but gene UreA was detected
only in 22 (5%). The bacteria was detected in saliva,
supragingival and subgingival plaque, suggested that these
sites may be considered reservoirs for H. pylori in ureasi-positive
patients. There was statistically signiﬁcant relationship between
who didn’t wash their hands frequently and the presence of
UreA gene (O.R. 1.71).
Conclusions: Current knowledge implies that acquisition of H.
pylori seems to occur predominantly in childhood and that once
acquired the infection persists life-long in most infected subjects.
It has been reported at a worldwide level that H. pylori infection
prevalence in children varies between 10% and 80% and
increases with low socio-economic and educational levels and
age. The results of this study suggest that oral carriage of
H. pylorimay play a role in the transmission of infection and that
the hand may be instrumental in transmission.
P1695
The role of Helicobacter pylori in otitis media
with effusion
T. Yilmaz, M. Ceylan, Y. Akyon, O. Ozcakir, B. Gursel (Ankara,
TR)
Objectives: Otitis media with effusion (OME) is such a common
disease of childhood and its pathogenesis still remains
unsettled. Pepsinogen and pepsin has been shown in the
middle ear ﬂuid of patients with OME, indicating that gastric
juice could reach as far as middle ear. If gastric juice could enter
the middle ear, Helicobacter pylori, a common inhabitant of
gastric juice and mucosa, would also be expected to be found in
the middle ear of patients with OME. The objective of this study
was to evaluate possible role of Helicobacter pylori in
pathogenesis of otitis media with effusion.
Methods: The study group consisted of 22 children who are to
undergo bilateral ventilation tube insertion, adenoidectomy,
tonsillectomy with a diagnosis of OME, adenoid hypertrophy
and chronic tonsillitis. The control group consisted of 20
children who are to undergo adenoidectomy, tonsillectomy
with a diagnosis of adenoid hypertrophy and chronic tonsillitis.
For the study group, middle ear ﬂuid was aspirated and a small
biopsy was taken from the promontorium mucosa. For the
control group, myringotomy was done and a small biopsy was
taken from the promontorium mucosa. For both groups, 5 mm
deep tissue specimens were obtained from tonsil and adenoid.
For all the specimens taken from the patients, culture and a
Nested-PCR were performed to show Helicobacter pylori.
Results: Middle ear ﬂuid culture was positive for H. pylori in 2
patients and mucosa culture was positive in 1 patient only. In
the control group middle ear mucosa cultures were always
negative. When culture and PCR results were combined
together; the middle ear was positive for H. pylori in 10
patients in the study group and in 2 patients in the control
group. This difference was statistically signiﬁcant. H. pylori
presence in the tonsillar and adenoid tissues by culture and PCR
was also signiﬁcantly more frequent in the study group
compared to the control group.
Conclusion: This study is the ﬁrst to grow H. pylori in the
middle ear in OME. Signiﬁcantly increased colonization by H.
pylori of the middle ear, tonsillar and adenoid tissue in patients
with OME indicates that the bacteria reaching the middle ear
through gastroesophageal reﬂux might be involved in the
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pathogenesis of OME. For OME cases resistant to medical
treatment it may meaningful to evaluate the patient for
gastroesophageal reﬂux and H. pylori.
P1696
Distribution of the serine-aspartate repeat
protein-encoding sdr genes among nasal carriage
and invasive Staphylococcus aureus strains
A. Sabat, D. Melles, G. Martirosian, H. Grundmann,
A. van Belkum, W. Hryniewicz (Warsaw, PL; Rotterdam, NL;
Katowice, PL; Bilthoven, NL)
Objectives: This study was designed to examine the
distribution of the sdr genes among nasal carriage and
invasive Staphylococcus aureus strains as well as methicillin-
sensitive S. aureus (MSSA) and methicillin-resistant S aureus
(MRSA).
Methods: The presence or absence of the sdr genes using DNA
from 497 S. aureus strains was determined by a novel triplex
PCR procedure. The two-tailed Fisher’s exact test was used to
analyse the distribution of the sdr genes among S. aureus strains
originating from different hosts. P values less than 0.05 were
considered a statistically signiﬁcant difference.
Results: The sdr locus was found in all 497 investigated S.
aureus strains although in 29 strains it contained only the sdrC
gene (sdrD – sdrE–). The sdrC + sdrD – sdrE– gene proﬁle
was exclusive to MSSA strains (Fisher’s exact test; P = 0.0005)
and was not found in the strains collected from bone
infections (P = 0.0019). We also found a strong association
between the presence of the sdrD gene and MRSA strains
(P < 0.0001).
Conclusion: Our ﬁndings suggest that MSSA strains with the
newly uncovered sdrC + sdrD – sdrE– gene proﬁle have a
substantially decreased potential to establish bone infection.
P1697
Sequencing of lukS-PV and lukF-PV in
methicillin-sensitive and methicillin-resistant
Staphylococcus aureus of diverse genetic
backgrounds in a Swedish county
C. Berglund, B. So¨derquist (O¨rebro, SE)
Objectives: Community-aquired methicillin-resistant
Staphylococcus aureus (CA-MRSA) have been reported to carry
the loci for Panton-Valentine leukocidin (PVL) in high
frequency. The aim of this study was to describe variations
within the PVL genes (lukS-PV and lukF-PV) in methicillin-
sensitive and methicillin-resistant S. aureus of diverse genetic
backgrounds.
Methods: Twelve PVL-positive S. aureus were characterised by
multilocus sequence typing (MLST) and MRSA also by
staphylococcal cassette chromosome mec (SCCmec) typing.
Ten of these were isolated between 1990–2005 in O¨rebro
County, Sweden. Oligonucleotide primers were designed to
yield a product size of ~2500 bp including lukS-PV and lukF-PV
and ﬂanking regions by PCR ampliﬁcation. Cyclic sequencing
was performed with several sets of primers to overlap the
sequences on both strands and was separated on ABI PRISM
3100 Genetic Analyzer (Applied Biosystems). The nucleotide
sequences were analysed using ABI PRISM AutoAssemblerTM
DNA Sequence Assembly 1.4.0 software and compared using
BioEdit 7.0.1.
Results: Analysis with MLST differentiated the PVL-positive
CA-MRSA into six different sequence types (ST8, 36, 80, 152, 154
and 256) with either SCCmec type IV, IV c, V or unknown types.
Six additional STs (ST5, 22, 25, 30, 88 and new) were detected
among the PVL-positive methicillin-sensitive S. aureus. Sequen-
cing lukS-PV and lukF-PV revealed eight point mutations
among these isolates with twelve different origins. Five substi-
tutions had occurred in lukS-PV and three in lukF-PV. Only one
substitution was nonsynonymous (histidine ﬁ arginine).
Conclusion: The PVL-genes were well conserved despite the
different genetic origins of the isolates analysed. The PVL is an
extracellular product and the genes are not subject to any
selective forces and thereby diversify very slowly. Additional
nonsynonymous mutations might result in a non-functional
toxin.
P1698
The ﬁrst case of Staphylococcus
pseudintermedius in humans isolated from an
ICD lead
L. Van Hoovels, A. Vankeerberghen, K. Van Vaerenbergh,
A. Boel, H. De Beenhouwer (Aalst, BE)
Introduction: Staphylococcus pseudintermedius is recently
described as a new coagulase-positive species from animals
(Devriese et al., 2005). The pathogenic signiﬁcance of this novel
species remains unclear and to our knowledge no human
infection due to S. pseudintermedius has been reported to date.
Here, we present the ﬁrst isolation of S. pseudintermedius in
humans with important clinical signiﬁcance.
Patient and methods: A 60-year old male patient was referred
to our centre for an ischemic cardiomyopathy and ventricle
tachycardia for which he recieved an implantable cardioverter-
deﬁbrillator (ICD) in January 2004. In August 2005 he presented
with complaints of migration of the ICD device. Clinical
examination revealed perforation of the ICD pocket. Infection
was suspected and conﬁrmed by the presence of pus in the
pocket. The infected ICD was completely removed and several
samples (ventricular lead, pus and a tissue sample from the
pocket) were sent for culture.Bacteria obtained by routine
culture were further characterised by phenotypical
identiﬁcation, Pastorex Staph-Plus (BioRad), API Staph
(BioMe´rieux) and Phoenix (BD). For molecular analysis, PCRs
were performed targeting the nuclease (Nuc) and coagulase
(Coag) genes of S. aureus. Additionally, sequencing of the 16S
rRNA gene was performed and further analysed using BLAST.
Results: Staphylococci with identical phenotypical appearance
were isolated from 2 of the 3 ICD samples (lead and pus).
Colonies were beta-hemolytic on sheep blood agar, DNase and
coagulase positive but clumping factor, mannitol and Pastorex
negative. Biochemical identiﬁcation by API Staph and
Phoenix gave a presumptive identiﬁcation of S. aureus with a
conﬁdence value of respectively 88,5% and 97%.The PCRs for
the Nuc and Coag genes were both negative. 16S rRNA gene
sequencing resulted in the identiﬁcation of S. pseudintermedius
based on a 100% sequence similarity with a previous reported
sequence by Devriese et al.
Conclusion: This case report describes the ﬁrst identiﬁcation of
S. pseudintermedius as a signiﬁcant pathogen in human. Growth
characteristics and commercial identiﬁcation systems
misidentify the organism as S. aureus. When confronted with
an inconsistent phenotypical identiﬁcation pattern, clinical labs
should consider the use of 16S rRNA gene sequencing for ﬁnal
conﬁrmation.
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P1699
Characterisation of Staphylococcus aureus isolates
recovered from dairy sheep farms (agr group,
adherence, slime, resistance to antibiotics)
E. Vautor, M. Sabah, G. Mancini, M. Pepin, H. Carsenti-
Dellamonica (Sophia-Antipolis, Nice, FR)
Objectives: The purpose of this study was to investigate 46
Staphylococcus aureus natural isolates associated with dairy
sheep mastitis for epidemiological key features (agr group,
adherence, slime production and antibiotics resistance).
Methods: The S. aureus isolates (n = 46) were recovered from a
ﬁeld study in the southeast of France in 2001–2004 (28 from
subclinical mastitis, 10 from clinical mastitis, 8 from the
environment of the dairy sheep farm). A total of thirteen dairy
sheep farms, producing cheeses manufactured with raw ewe’s
milk, were involved. The agr group were determined by
multiplex and real-time PCR. The evaluation of adherence and
slime production were assessed with methods previously
described by Christensen et al. (1982). The susceptibility
patterns to 11 antibiotics were determined using the disc-
diffusion method on Mueller-Hinton agar plates. Oxacillin
susceptibility testing was performed on all the isolates. The 10
others antibiotics susceptibility was only studied on the 28
isolates recovered from subclinical mastitis as they represent the
major source of cheese contamination.
Results: 80% (37/46) of the isolates belonged to agr group 3,
regardless of clinical ﬁndings. 39% (18/46) were adherent,
strongly adherent or with maximal adherence (bioﬁlm
producers). 26% (12/46) were slime producers (moderate or
strong producers). All the isolates (n = 46), but seven, were
susceptible to all the antibiotics tested. Two isolates recovered
from subclinical mastitis were resistant to oxacillin and partly
resistant to ampicillin and penicillin-G. The ﬁve other isolates
were found: partly resistant to erythromycin (n = 1),
cefoperazone and penicillin-G (n = 1), erythromycin (n = 1),
neomycin (n = 1) or resistant to enroﬂoxaxin and partly resistant
to ampicillin and penicillin (n = 1).
Conclusions: S. aureus isolates recovered from sheep mastitis
in the southeast of France are mainly related to agr group 3
suggesting a role for agr-regulated proteins in the persistence
of this bacteria in the sheep udders. Bioﬁlm and slime
production may also be an important aspect for intracellular
survival of S. aureus which could promote the development of
persistent intramammary infections. Finally, ewe’s milk does
not appear to represent a source of resistant S. aureus and
specially methicillin (oxacillin)-resistant S. aureus (MRSA) for
human health.
P1700
Detection of virulence genes in Staphylococus
aureus isolates from dairy sheep, goats and cows
mastitis, using single-dye DNA microarray
E. Vautor, V. Magnone, G. Rios, M. Pepin, P. Barbry (Sophia-
Antipolis, FR)
Objectives: Staphylococcus aureus is a common cause of mastitis
in dairy farms animals. Although many putative virulence
factors have been identiﬁed in S. aureus genomes (Kuroda et al.,
2001), the differences in pathogenic potential between naturally
occurring isolates remain largely unaddressed. The relative
importance of host (tissue) factors versus bacterial virulence
determinants in disease pathogenesis is not well known, but it is
widely accepted that bacterial factors including toxins, cell wall-
associated adhesions, and secreted exoproteins are involved in
the process. In this study, we use a single-dye DNA microarray
assay to investigate the presence or absence of 196 putatives
virulence genes in 75 S. aureus isolates recovered from cases of
ovine, caprine and bovine mastitis.
Methods: Mastitis S. aureus isolates: sheep (n = 25), goats
(n= 22), cows (n = 20).DNA microarray: the arrays were
spotted with long oligonucleotides (65-mer) representing 192
known virulence genes and new candidates identiﬁed in Mu 50
genome (a human strain) and other S. aureus genomes. Each
gene were spotted four time. DNA extracted from the strains
were labelled with ﬂuorescent Cy5 using the BioPrime Array
CGH (Invitrogen). Control strains with known genetic and
phenotypic characteristics were used to normalize the data.
Results: (i) The majority of the virulence gene was detected in
all the isolates (e.g. coa, ica ADBC operon, htrA, hysA, nuc, sbi,
sdrE, ssp, feoB, fnb, sib, spa). (ii) genes were not detected in the
majority of the isolates (e.g. cna, edin, lukF-PV, SAV1999,…). (iii)
genes were not found in isolates, depending on the herd (e.g.
aur or SAV1038 absent in isolates from some dairy sheep farm),
on the isolates whatever the species (i.g. bsaP, capH, entK, eta,
fnbB, hsdS, lpl2, lukD, Map-ND2C,…). But we found gene
mainly related to species (e.g. agrIII, SAV2496,…)
Comprehensive results will be given in the poster.
Conclusions: The present study indicated that the prevalence
of virulence genes among S. aureus isolates recovered from
dairy farm species depends on the gene. These observations
suggest a common occurrence of host-adapted (or tissue-
adapted) S. aureus strains in which particular virulence genes
may play a signiﬁcant role. When taken with complementary
methods such as PCR or/and Southern hybridisation, single-
dye DNA microarrays may provide a powerful tool to type S.
aureus strains for epidemiological and possibly pathogenesis
studies.
P1701
Detection of DNA sequences distinguishing two
closely related genomes of Staphylococcus aureus
from subclinical versus gangrenous ewe mastitis
strains
N. Chevalier, C. Huard, R. Thiery, E. Vautor (Sophia-Antipolis,
FR)
Objectives: Staphylococcus aureus is a common cause of mastitis
in dairy sheep. The severity of mastitis ranges from subclinical
to gangrenous forms. Subclinical mastitis is an inﬂammation
that is not readily detected clinically whereas gangrenous form
is an acute necrotizing mastitis. With the ain to ﬁnd genetic
markers or virulence factors that are only present in gangrenous
strains a suppression substractive hybridisation (SSH) method
was used in the present study to compare two strains of S. aureus
respectively recovered from subclinical or gangrenous mastitis
in the same dairy sheep herd.
Methods: 42 ewes were held in the investigated farm. The
subclinical strain was recovered in January 2002 from the milk of
6 ewes. The gangrenous strain was recovered in December 2002
from an primipare dairy sheep that subsequently died from this
acute mastitis. DNA extracted from the strains were ﬁrst
compared by pulsed ﬁeld gel electrophoresis (PFGE). Then,
SSH was performed by using DNA from the subclinical strain
(driver), as described in a commercial kit (Clontech PCR-Select
Bacterial Genome Substraction Kit).
Results: Using PFGE, four band differences were found
between the two strains. Two DNA fragments, presumably
speciﬁc from the gangrenous strain were detected by SSH and
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sequenced: (i) a 262 bp (98% of homology with the sulﬁde
quinone reductase contained in Orf 11 pathogenicity island of
the MRSA 252 strain) (ii) 280 bp (98% homology with a gene
coding a bacteriophage holine contained in the S. aureus N315
genome). Control PCR tests using primers designed from these
speciﬁc gene candidates conﬁrmed that they were only present
in the S. aureus gangrenous strain.
Conclusions: According to Tenover et al. (1995), a 4 band
difference using PFGE indicates that the strains may possibly be
related genetically. Although genes classically involved in the
virulence of S. aureuswere not detected in the present study, two
putative virulence factors were detected. The sulﬁde quinone
reductase allows S. aureus to growth on sulﬁde (found in animal
manure). The holine protein breaks the internal membrane of S.
aureus to release daughter phages suggesting that a mechanism
of horizontal gene transfer could have been mediated by
bacteriophages and could explain the acquisition of virulence
factors.
Antimicrobial clinical trials
P1702
Outpatient treatment of acute pyelonephritis in
pregnancy after 24 weeks. A randomised
controlled trial
Z. Ahmadinejad, S. Hantooshzadeh (Tehran, IR)
Objectives: The purpose of this study was to compare the
safety and efﬁcacy of outpatient and inpatient treatment of acute
pyelonephritis in pregnancy.
Methods: This was a randomized controlled, clinical trial. One
hundred twenty eight gravidas past 24 weeks’ gestation
admitted in IMAM KHOMEINI hospital, Tehran & SAHID Dr
BAHONAR hospital, Kerman, divided by random blocks to
outpatient or inpatient therapy, received two 1-g doses of
intramuscular ceftriaxone at 24-hour intervals while
hospitalized, then were discharged and reevaluated within 48–
72 hours or remained hospitalized until afebrile for 48 hours.
All patients completed a 14-day course of oral cephalexin. We
performed urine cultures on admission and 10–14 days after
therapy.
Results: The two groups were similar with respect to age,
parity, temperature, estimated gestational age, initial white
blood cell count, and incidence of bacteremia. There were not
any signiﬁcant differences between two groups about the
clinical improvement after 48–72 hours, bacteriuria 10–14 days
after treatment, relapse of pyelonephritis, requirement to change
in antibiotic, date of pregnancy at delivery and preterm labor.
The relapse of bacteriuria and preterm labor in inpatients were
signiﬁcantly more than outpatients (PV = 0.0077 and 0.030
respectively). The birth weight of neonate in outpatients were
signiﬁcantly more than inpatients (PV = 0.013).
Conclusion: Outpatient antibiotic therapy is effective and safe
in selected pregnant women with pyelonephritis. However in
this study, the neonatal outcomes were better in outpatients and
the maternal outcomes in inpatients.
P1703
Experience with daptomycin in patients with
renal insufﬁciency
B.A. Mueller, S. Levy, K. Lamp, L. Friedrich, R. Russo (Ann
Arbor, Lexington, US)
Objectives: To assess the clinical efﬁcacy of daptomycin (DAP)
in patients (pts) with renal insufﬁciency.
Methods: The Cubicin Outcomes Registry and Experience
(CORE) is a retrospective observational chart review of pts
treated with daptomycin in 45 institutions in the United States.
Investigators collected demographic, disease state, clinical and
microbiological data; outcomes were deﬁned using standard
deﬁnitions. Patients nonevaluable for outcome were excluded.
CORE data were divided and data on cohorts of pts with a
creatinine clearance (CrCl) ‡30 or <30 ml/min were examined.
Results: Of the 1160 pts enrolled, 770 (66%) had evaluable pt
outcomes and either CrCl ‡30 ml/min (NML, n = 598) or CrCl
<30 ml/min not yet requiring renal replacement therapy (RI,
n = 172). The distribution of males and females was equal in
both groups. RI pts were older (45% ‡66 yrs vs 29%, p < 0.01).
The groups did not differ in the percent coming from the
community setting prior to starting DAP (NML 46%, RI 49%).
NML had more frequent history of fractures/orthopaedic
procedures (11 vs 4%, p < 0.01) and haematological cancers (6
vs 1%, p < 0.02) while RI had higher rates of any renal disease (4
vs 17%, p < 0.01), CHF (6 vs 12%, p < 0.05) and other
immunologic/ inﬂammatory disease (2 vs 11%, p < 0.01). RI
had higher rates of skin infections (60 vs 69%, p < 0.05) and
endocarditis (3 vs 6%, p < 0.05). Infections that were frequently
reported for NML and RI were bacteremia, non-catheter-related
(10 vs 10%), bacteremia, catheter-related (10 vs 4%),
osteomyelitis (14 vs 7%), and foreign body-orthopaedic (6 vs
5%), all p > 0.05. Methicillin-resistant Staphylococcus aureus
was the most common pathogen; NML 41%, RI 38%. RI had
higher rates of coagulase-negative staphylococci (9 vs 15%,
p < 0.02) and viridans streptococci (0.3 vs 1.7%, p < 0.05). There
was no difference in the percentage receiving antibiotics prior to
DAP; NML 75%, RI 68%. The mean DAP dose and duration
were similar; NML 4.7 mg/kg for 18 d, RI 4.6 mg/kg for 16 d.
The most frequent dose was 4 mg/kg; NML 58%, RI 39%. RI
initial DAP dosing was more frequent than recommended (q
48 h) in 76%. The mean time to clinical response was similar;
NML 5.2 d, RI 5.4 d. More pts in NML received concomitant
antibiotics with DAP; 53 vs 35%, p < 0.01). The clinical success
(cure and improved) rates were; NML 95%, RI 96%.
Conclusion: DAP shows favourable clinical success rates in pts
regardless of the presence of renal insufﬁciency.
P1704
In vitro activity of second line antibiotics against
Helicobacter pylori infection
A. Pe´rez de Ayala, T. Alarco´n, D. Monclu´s, E. Aznar,
J.L. Navarro, N. Arenal, M. Lo´pez-Brea (Madrid, ES)
Objective: The aim of our study was to determine the in vitro
activity of levoﬂoxacin, ciproﬂoxacin and rifampicin in clinical
strains of H. pylori.
Material and methods: 40 isolates of H. pylori from biopsies of
dyspeptic patients were obtained following standard
methodology. In vitro activity of metronidazole,
clarithromycin, levoﬂoxacin, ciproﬂoxacin and rifampicin was
determined by E- Test using 5% sheep blood agar and incubated
at 37ordm;C during 3–5 days in a CO2 atmosphere. MIC was
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determined as the point of complete inhibition of growth.
Breakpoint of the NCCLS for other microorganisms were
considered for ﬂuorquinolones: resistant if MIC > 4 mg/ l. For
rifampicin we considered the strain susceptible if MIC <32 mg/
l, as same studies reported.
Results: 42.5% of the strains were resistant to metronidazole
and 50% to clarithromycin. MIC50, MIC90 and range (mg/l)
was: 0.064, 0.125 and 0.012 ﬁ 32 for levoﬂoxacin, 0.064, 0.25 and
0.006 ﬁ 32 for ciproﬂoxacin and 0.75, 1.5, and <0.002–4 for
rifampicin. All the strains were susceptible to rifampicin and
only 2% of them were resistant to ﬂuorquinolones.
Conclusions: The ﬂuorquinolones tested and rifampicin
showed an excellent in vitro activity against H. pylori, despite
the high resistance rate to metronidazole and clarithromycin.
However, in vitro susceptibility test should be done before the
use in clinical practice.
P1705
Vibrio antibodies in serum and breast milk
samples of parturient women in Calabar, Nigeria
S. Utsalo (Calabar, NG)
Objectives: Serum and breast milk samples from 335 parturient
women and serum from non–parturient controls were analysed
for prevalence and titres of vibrio antibodies.
Methods: V. cholerae agglutinins and vibriocidal antibodies in
serum samples were analysed by direct agglutination and
immune bacteriolysis techniques respectively, using 96 well
microtitre plates. The protective value of breast milk was
evaluated by haemagglutination inhibition and rabbit
intestinal mucosal attachment of V. cholerae cells.
Results: Vibrio agglutinins were detected in serum samples of
191(57.0%) parturient and 78 (33.9%) non-parturient subjects
(p < 0.05). High prevalence rates of 68.9% and 39.1% occurred
among parturient and control subjects of 21–25 years of age
respectively. At 1:160 cut off titre to evaluate Vibrio cholerae
speciﬁc bacteriocidal antibodies, activity was detected in
samples of 31 (57.1%) and 9 (56.3%) parturients and controls
respectively aged 26–30 years. Breast milk from 67 (20.0%)
parturients contained vibrio agglutinins with titres ranging
between 1:20 and 1:320, while milk samples from 32 subjects
showed haemagglutination inhibition (HI) activity titres of
P 1:40. Of the 19 HI positive milk samples 17 (89.5%)
showed inhibition of V. cholerae adherence to rabbit intestinal
mucosa at titres P 1:80, and 53–92% reductions in cell
attachment.
Conclusion: Our study conﬁrms that parturient women in
Calabar may beneﬁt from signiﬁcant serum titres of V. cholerae
antibodies and provide immune protection for their babies
through breast milk secretions.
P1706
Moxiﬂoxacin vs clarithromycin for treatment of
community-acquired pneumonia associated with
common respiratory pathogens: a pooled analysis
R. Grossman, M. Niederman, R. Perroncel, S. Choudhri,
D. Haverstock (Mississauga, CA; Mineola, West Haven, US)
Objectives: Streptococcus pneumoniae and Haemophilus inﬂuenzae
are pathogens commonly associated with community-acquired
pneumonia (CAP). This study compared the clinical and
bacteriologic efﬁcacy of moxiﬂoxacin (MXF) to clarithromycin
(CLAR) in CAP patients with these pathogens.
Patients and methods: Data were pooled from three double-
blind, multicenter, Phase III trials comparing oral MXF 400 mg
QD to CLAR 500 mg BID for 10 days. All patients included had
mild-to-moderate CAP. Clinical and bacteriologic success rates
were identiﬁed for S. pneumoniae and H. inﬂuenzae isolated from
these studies. Data for the efﬁcacy-valid population was
recorded at the test-of-cure (TOC) visit (7–35 days post-therapy).
Results: 1437 patients were entered, of which 356 were
microbiologically evaluable. Infection with S. pneumoniae
and/or H. inﬂuenzae was documented in 149 (42%) of
patients (5 MXF and 2 CLAR patients had mixed infection).
Within this cohort, the two treatment groups were well
balanced based on demographic/baseline medical
characteristics (55% male, mean age 50 yrs, 41% smokers,
8% recent antimicrobial therapy). Clinical success and
bacteriologic eradication rates (one response per patient) at
TOC are presented in the Table.
Conclusions: In CAP associated with S. pneumoniae and H.
inﬂuenzae there was a trend towards greater bacterial eradication
for MXF vs CLAR. Clinical success rates were signiﬁcantly
higher for MXF monotherapy vs CLAR.
P1707
Variability of creatinine clearance measurements
in inpatients with community-acquired
pneumonia
R. Grossman, S. Choudhri, D. Haverstock (Mississauga, CA; West
Haven, US)
Objectives: Moxiﬂoxacin, levoﬂoxacin and gatiﬂoxacin have
been recommended as empiric therapies for patients with
community-acquired pneumonia (CAP). Levoﬂoxacin and
gatiﬂoxacin require dose-adjustment for renal insufﬁciency
while no dose adjustment is required for moxiﬂoxacin. This
study was designed to determine the frequency and underlying
variability of renal insufﬁciency in patients with CAP.
Methods: A pooled analysis of data from 2211 patients with
mild to moderate or severe CAP entered into one of six
randomized, controlled clinical trials was undertaken. Renal
function (calculated creatinine clearance; CrCl) was assessed in
each patient prior to treatment with MXF and then again during
and post-treatment.
Results: Baseline CrCl levels in this pooled population of
patients with CAP were: <25 mL/min in 47 (2.1%) of patients,
25–49.9 mL/min in 436 (19.7%) and ‡50 mL/min in 1728
(78.2%) patients. After the pre-treatment CrCl measurement 88
patients (4%) were lost to follow-up, so there was no during or
post treatment value. In patients with CAP the CrCl improved
from baseline in many patients during or post-treatment, while
some patients experienced a worsening of renal function (see
Table).
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Conclusions: Renal function (CrCl) is highly variable in CAP
patients with baseline evidence of renal insufﬁciency. Renal
function should be monitored closely to permit appropriate dose
adjustments if levoﬂoxacin or gatiﬂoxacin is used in this patient
population. Moxiﬂoxacin may be a better empiric choice in this
setting as it does not require dose adjustment in patients with
renal insufﬁciency or renal failure.
P1708
A prospective, controlled, randomised, non-
blind, comparative study of the efﬁcacy and
safety of high-dose single daily ceftriaxone plus
ciproﬂoxacin versus thrice-daily ceftazidime plus
amikacin in the empirical therapy of febrile
neutropenic patients
S. Metallidis, P. Kollaras, A. Tsona, T. Giannakakis, V. Seitanidis,
T. Kordosis, A. Hatzitolios, J. Nikolaidis, P. Nikolaidis
(Thessaloniki, Athens, GR)
Objective: Empirical antibiotic treatment for febrile
neutropenia is well established. The best regimen is still
controversial. The purpose of this study was to evaluate the
efﬁcacy, safety and cost of high-dose single daily ceftriaxone
plus ciproﬂoxacin versus thrice daily ceftazidime plus amikacin
in neutropenic febrile patients.
Patients and methods: Ninety-ﬁve patients with febrile
neutropenia were included in a prospective, controlled,
randomized, non-blind, comparative study. Patients were
randomly assigned to either treatment group (63 in the
Ceftriaxone/Ciproﬂoxacin group and 32 in the Ceftazidime/
Amikacin group) and evaluated as successes or failures
according to deﬁned criteria. Daily assessments were made on
all patients all adverse events were record.
Results: The overall incidence of documented infections was
45.9%: 24/47 (51.1%) in the Ceftriaxone/Ciproﬂoxacin group
and 10/27 (37%) in the Ceftazidime/Amikacin group. There
was signiﬁcant difference in clinical efﬁcacy between groups
(p = 0.011) at the end of therapy. Ceftriaxone/Ciproﬂoxacin
group had an overall incidence of resolution and improvement
of 95,7% in comparison to the 75% of the Ceftazidime/Amikacin
group. Thirty-nine organisms were isolated, 26 (66.67%) gram-
negative and 13 (33,33%) gram-positive. There was low
incidence of adverse events in both groups.
Conclusion: The combination of high dose single daily
ceftriaxone plus ciproﬂoxacin was more effective than the
standard combination of thrice daily ceftazidime plus amikacn
with no signiﬁcant adverse events in either group.
P1709
The ’Day 28 phenomenon’: single-dose
azithromycin microspheres (Zmax) reduce
respiratory symptoms in the post-treatment
period
D. Jorgensen, C. Roberts, D. Cardinale, J. Breen, M. Dunne,
F. Whaley (New London, New York, Ann Arbor, US)
Objective: In past studies of azithromycin in children, a post-
treatment (PT) beneﬁt was observed at Day 28. In 5 recent phase
3 trials in adults, single-dose Zmax was at least as effective as
standard comparators for treatment of respiratory tract
infections (RTIs), including CAP. Our objective is to
demonstrate a PT beneﬁt in this adult population.
Methods: Post-hoc analyses, including respiratory adverse
event burden (RAEB), were conducted on the All Treated
population (N = 2596; 1292 AZ-M, 1304 comparators) in the 5
phase 3 studies. The RAEB is the sum of duration, in days, of all
respiratory adverse events, divided by total number of
observation days of all patients, normalized to 1 year. The
overall and per study day RAEB were calculated for Zmax and
the pooled comparators for the 5 studies combined.
Results: RAEB, in days/patient year, was 15.5 for AZ-M
patients vs 20.2 for comparator patients (p = 0.08). The
difference in RAEB consistently and progressively favoured
Zmax, beginning at Day 11 and achieving statistical signiﬁcance
between Days 29 and 35, when the upper limits of the 95% CIs
around the differences were below zero (ﬁgure).
Conclusion: In 5 phase 3 studies, a single dose of Zmax was
safe and effective in the treatment of adult RTIs, and
demonstrated an additional beneﬁt in terms of reducing
respiratory symptoms in the 2–4 week PT period.
P1710
Integrated analysis of efﬁcacy of faropenem
medoxomil in the treatment of community-
acquired pneumonia
E.E.L. Wang, R. Echols, R. Tosiello (Louisville, US)
Faropenem medoxomil (FM) is an oral penem with potent
activity against Streptococcus pneumoniae and Haemophilus
inﬂuenzae. This integrated analysis was conducted to summar-
ize the efﬁcacy of 10 days of 300 mg BID of FM compared with
other beta lactams in the management of community acquired
pneumonia (CAP).
Methods: Efﬁcacy was determined in three multicenter
randomized double-blind controlled trials (RCT) and a single
uncontrolled study of faropenem medoxomil. Comparators
were 14 days of cefpodoxime (C), 10 days of amoxicillin-
clavulanate (AC), or 10 days of amoxicillin (A). The analysis
allowed examination of treatment effects by age, race, gender
and study site subgroups.
Results: A total of 2267 subjects were studied. Studies 1 and 4
were conducted in N. America, studies 2 and 3 in Europe,
Latin America, Israel, and S. Africa. N. American vs. other
studies included subjects at least 12 (vs. at least 18) years of
age and only out patient (vs. outpatient and hospitalized)
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subjects. The clinical responses for FM in both Per Protocol
and Intention-to-Treat populations were non-inferior to com-
parator for each study and for the three trials combined. No
differences were found in treatment effect by age, race,
gender, or country. Recovery of an etiologic agent from initial
respiratory or blood culture varied between 9.4 and 17.5% of
cases in the 4 studies for a total of 236 microbiologically
evaluable subjects. S. pneumoniae was eradicated or pre-
sumed eradicated in 82/90 (91.1%) and 49/52 (94.2%),
H. inﬂuenzae in 49/61 (80.3%) and 30/32 (93.8%), S. aureus
in 13/14 (93%) and 8/10 (80%), H. parainﬂuenzae in 6/8 (75%)
and 0/2 (0%), and M. catarrhalis in 6/7 (85.7%) and 4/4(100%)
FM and comparator recipients, respectively. Clinical response
for S. pneumoniae bacteremic patients was 18/21 (85.7%) for
FM.
Conclusions: FM efﬁcacy was consistent across studies, within
subgroups, and non-inferior to comparators. It is efﬁcacious
against the most common bacterial pathogens and in the most
severe form (bacteremic) disease. FM is a good option for the
treatment of CAP.
P1711
Propionibacterium acnes strains isolated from
acne vulgaris and severe infections
C. Oprica, C.E. Nord (Stockholm, SE)
Propionibacterium acnes is a member of the resident ﬂora of the
skin and is an important factor involved in inﬂammatory
reactions in acne patients. During the last years the prevalence
of different severe infections due to P. acnes has increased.
Objectives: 1) To detect the prevalence of resistant P. acnes
strains isolated from acne patients in Stockholm and different
severe infections in Europe; 2) To identify the mechanisms of
resistance and the genetic diversity among resistant strains.
Methods: P. acnes strains isolated from acne vulgaris and severe
infections were tested against clindamycin, erythromycin,
linezolid and tetracycline and pulsed-ﬁeld gel electrophoresis
was used for further characterization. PCR and sequencing of
the genes encoding domain V of 23S rRNA for clindamycin and
erythromycin resistant strains and 16S rRNA for tetracycline
resistant strains were performed.
Results: i) Antibiotic-resistant strains were more often isolated
from antibiotic treated patients with moderate to severe acne
area than from non-antibiotic treated acne patients. An
individual might harbor different pulsotypes of P. acnes with
various degrees of resistance. ii) Among the 304 clinical isolates
from 13 European countries were found resistant strains to
tetracycline, clindamycin, and erythromycin. Overall, in the
southern Europe a higher prevalence of erythromycin-resistant
strains was noticed and in southern and eastern Europe a higher
prevalence of resistance to clindamycin. It was noticed a high
genomic diversity and the geographical spread of some clones in
related areas but also in geographically distant countries. Most
clindamycin or erythromycin resistant P. acnes isolates, were
found to be members of a single clone that has spread in
different geographically countries. iii) P. acnes clindamycin and
erythromycin resistant strains carrying one of the described
mutations within the 23S rRNA were predominantly isolated
from Swedish acne patients compared to strains from other
infections. Forty-four per cent of tetracycline resistant strains
were found to carry a mutation in the 16S rRNA. These strains
were isolated from Swedish acne patients, were highly resistant
and were clustered in one pulsotype.
Conclusion: Surveillance of both the prevalence of resistant P.
acnes strains and associated resistance mechanisms is important
due to the rapid variation in resistance patterns, both in acne
patients and other severe infections.
P1712
Antimicrobial activity of Unisepta quick and
Deconex solarsept on the surface contamination
and dental instrument in dental clinics in Iran
F. Shahcheraghi (Tehran, IR)
Objectives: Quaternary ammonium compounds (QACs) are
amphoteric surfactants that are widely used for the control of
bacterial growth in clinical and industrial invironment.Unisepta
quick and deconex solarsept are new generation of QACs is
widely used as adjuncts in Iran to hygine in dental clinics.The
aim of present study was to investigate clinical efﬁciency of
these substances on the surface and instruments in dental
clinics.
Material and methods: The following bacteria and fungi on the
base of AOAC standard were used.Pseudomonas aeruginosa
(ATCC 27853), Staphylococcus aureus (ATCC 25923) Bacillus.
subtilis ATCC (6051), Mycobacterium bovis ATCC (35443) and
wild types of Trichophyton mentagraphit, P. aeruginosa and
Salmonella typhimorium (a common fungi in IRAN). A stock
solution of deconex solarsept (BORER chemie) and unisepta
quick (micro 10 unident) was prepared as recommended by the
manufacturer. The concentration of Bacterial suspention was 0.5
MacFarland and the results were reported on the base of
decreasing in (CFU) colony forming unit from 107 to 102.
Results: The results shows that Both of these disinfectants have
bactericidal and fungicidal activity on the standard P. aeruginosa,
S. aureus, S. typhimurium and Trichophyton mentagraphit, The
number of bacteria decreased signiﬁcantly (P < 0.05), but no
signiﬁcant difference was seen with B. subtilis, wild type of P.
aeruginosa and M. bovis.
Conclusion: The results conﬁrm that these QACs are not able to
sterilize or disinfect medical and dental instruments, and they
can not be used lonely, and it must be used with the other
methods for sterilization of surface and dental instruments.
P1713
Macrolide as long-term treatment in patients with
bronchiectasis colonised by P. aeruginosa
M. Schmidt-Ioanas, M. Allewelt, A. Polzin, T. Blum, H. Lode
(Berlin, DE)
Background: A certain efﬁcacy of macrolide against P. aeruginosa
has been described in vitro, mainly through mechanisms such
disruption of quorum sensing and suppression of inﬂammation.
Aim: To evaluate the efﬁcacy of macrolide in patients with
bronchiectasis colonised by P. aeruginosa.
Methods: The study prospectively included patients with
bronchiectasis and P. aeruginosa isolated in sputum in stable
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state. All subjects received either azithromycin
250 mg · 3 days/week or clarithromycin 500 mg daily on long
term and completed daily diary cards for symptoms and PEF
values until the end of therapy. Follow-up period was 1 year.
Results: 26 patients with bronchiectasis and P. aeruginosa evidence
in sputum were included (17 men, mean age 55.0 ± 12.1 yrs.). 12
patients received azithromycin and 14 patients clarithromycin, with
a mean duration of 4.5 ± 1.7 months. Five (19.2%) patients
discontinued treatment after less than 2 weeks because of adverse
events.At theendof therapy,12 (46.1%)patients showednoevidence
of P. aeruginosa in sputum while 9 (34.6%) patients still
had Ps. aeruginosa in sputum. An improvement in the
following parameters could be observed in all patients: sputum
volume (75.5 ml/day before therapy versus 31.6 ml/day after
therapy, p = 0.04); PEF (311.2±77.1 l/min before therapy versus
476.2 ± 30.2 l/min after therapy, p = 0.03); number of
exacerbations/year (2.8 in the previous year versus 1.7 in the
follow-up year, p = 0.01).
Conclusion: The study shows that macrolide may be an
effective therapy in patients with bronchiectasis colonised by
P. aeruginosa. Independently of the microbial eradication, an
improvement of the clinical symptoms and a reduction of
exacerbations were observed in all patients.
P1714
Fungal pathogens from haematoncology patients
and their susceptibility to new and old antifungal
drugs
M.A. Petrou (London, UK)
The expanding population of immunocompromised hosts has
been infected with many established and emerging opportun-
istic fungi. Most pathogens can be treated empirically whereas
for an increasing number of species proper treatment starts once
the MIC becomes available. Though invasive Aspergillosis
remains the principle life threatening complication in the
haematoncology patients (HOP) other pathogens cannot be
ignored as selection and resistance during prophylaxis increases
the risk of treatment failure.In order to understand the
frequency of rare fungal pathogens, selection and emergence
of resistance in our trust all fungi from HOP were identiﬁed
using standard mycological techniques and the MICs to amph-
otericin B (AMB), ﬂucytosine (5FC), ﬂuconazole (FCZ), itracon-
azole (ITZ), voriconazole (VCZ) and caspofungin (CFG) were
determined using the NCCLS method. 513 specimens were
processed, 53% respiratory, 17.5% blood, 12.8% oral, 8.4% other
sterile (bile, CSF, drains, lines and tissue biopsies) and 8.3% non-
sterile sites. Yeasts accounted for 85% and ﬁlamentous fungi
(FF) for 15%, representing 12 Candida sp, 7 other types of yeast, 6
Aspergillus sp and 8 other types of FF. C. albicans represented
35.7%, C. glabrata 29.3%, C. krusei 8.6%, A. fumigatus 10% and
other Aspergillus sp 2% of all isolates. The MIC 90s for all isolates
were AMB 0.5, 5FC 2, FCZ >64, ITZ 1, VCZ 1 and CFG 0.06 mg/
L. With the exception of Acremonium sp, A. versicolor, A. terreus
and Scedosporium apiospermum all isolates including the 15
isolates of C. lusitaniae were sensitive to AMB. Most but not all
FF and only one isolate of C. albicans from the yeasts were
resistant to 5FC. All FF, Rhodotorula sp, C. albicans 3%, C.
glabrata 53% and C. krusei 41% were resistant to FCZ. Only
Absidia corymbifera, Acremonium sp 25%, C. albicans 1%, C
glabrata 33% and Saccharomyces cerevisiae 4% were resistant to
ITZ. For VCZ A. corymbifera, Acremonium sp 25%, C. albicans 2%,
C. glabrata 31%, C. krusei 2%, C. tropicalis 10%, Rhodotorula
sp 66.6% and P. aecilomyces variotii 50% had an MIC ‡2 mg/L.
With CFG the effective concentration was ‡0.5 mg/L for
A. corymbifera, Fusarium solani, Geotrichum capitatum, Sporobolom-
yces salmonicolor, Acremonium sp 50% and C. parapsilosis 25%.The
data show that HOP are exposed to many different fungal
pathogens some of which are resistant to the old and the new
antifungals and that AMB is still the drug with the broader
spectrum and less developed resistance for both yeasts and FF.
P1715
Faropenem medoxomil in the treatment of acute
bacterial sinusitis: an integrated analysis
S. Kowalsky, R. Tosiello, R. Echols (Milford, US)
Background: Faropenem medoxomil (FM) is an orally
absorbed, synthetic, penem antibacterial agent with in vitro
activity against community-acquired respiratory pathogens.
Methods: The efﬁcacy of FM in subjects with acute bacterial
sinusitis (ABS) was evaluated in 3 Phase III trials; 100288,
10186, and 100287. Study 100288 was conducted in N. America,
Study 10186 was conducted in Europe and Israel and Study
100287 was conducted in the US and Argentina. 100288 and
10186 were prospective, randomized, double-blind, active
comparator trials and 100287 was an open-label ‘‘sinus tap’’
trial. The dose of FM was 300 mg BID in all 3 studies. The
comparator in 100288 and 10186 was cefuroxime axetil (CFX)
250 mg BID. The duration of FM treatment in 100288 was
7 days and 10 days vs CFX for 10 days. In 10186, FM or CFX
were given for 7 days. In 100287, FM was administered for
7 days. The primary efﬁcacy variable in all 3 studies was
clinical response at the Test-of-Cure (TOC). Microbiologic
response at the TOC was a secondary efﬁcacy variable in
10186 (sinus puncture and endoscopic collection) and 100287
(sinus puncture and aspiration). Non-inferiority was deﬁned as
the difference in cure rates (FM minus comparator) where the
lower boundary of the 95% CI was greater than -10%.
Results: The cure rates at the TOC are shown in the table for the
valid per protocol (vPP) and the Intent-to-Treat (ITT)
populations. The frequency of isolation of key pathogens and
the rate of eradication in samples obtained by endoscopically-
guided swab and in samples obtained by TAP were consistent
across studies. The eradication rates for S. pneumoniae,
H. inﬂuenzae, and M. catarrhalis were 94.8% vs. 96.3% (FM 7/
10 d vs. CFX 7/10 d), 82.4% vs. 90.5% (FM vs. CFX) and 96.2%
vs. 83.3% (FM vs. CFX), respectively.
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Conclusions: FM 300 mg BID x 7 days was shown to be non-
inferior to CFX in clinical efﬁcacy in two prospective, double-
blind, comparative trials. A third, open-label trial, demonstrated
similar efﬁcacy in microbiologically documented ABS caused by
key pathogens. Longer (10 d treatment) with FM provided no
additional efﬁcacy.
P1716
Faropenem medoxomil in the treatment of acute
exacerbation of chronic bronchitis: an integrated
analysis
S. Kowalsky, R. Tosiello, R. Echols (Milford, US)
Background: Faropenem medoxomil (FM) is an orally
absorbed, synthetic, penem antibacterial with in vitro activity
against community-acquired respiratory pathogens.
Methods: The efﬁcacy of FM in subjects with acute
exacerbation of chronic bronchitis (AECB) was evaluated in
2 Phase III trials. Study 10187 was conducted in Europe, Israel,
Mexico, and South Africa. Study 100291 was conducted in the
US and Argentina. Both were prospective, randomized,
double-blind, active comparator trials. The dose of FM was
300 mg BID for 5 days in both studies. The comparators were
clarithromycin (CLR) 500 mg BID for 7 days and azithromycin
(AZI) QD for 5 days (500 mg on Day 1 and 250 mg on Days
2–5). The primary efﬁcacy variable was clinical response at the
Test-of-Cure (TOC). Microbiologic response at the TOC, in
subjects with a baseline pathogen was a secondary variable.
Non-inferiority was deﬁned as the difference in cure rate (FM
minus comparator) where the lower boundary of the 95% CI
was greater than )10%.
Results: The cure rates are shown below for the valid per
protocol (vPP), Intent-to-Treat (ITT) and modiﬁed ITT
populations (all ITT subjects who met inclusion/exclusion
criteria). In both the individual studies and the pooled
analyses, for all populations, treatment with FM was not less
effective than either comparator. 20% of treated subjects in 10187
and 28% of subjects in 100291 were evaluable for microbiological
response. In 10187, the eradication rates for the
microbiologically evaluable population was higher in the CLR
group (77.1%) compared with the FM group (68.6%) (95% CI
)23.4, 6.3). In contrast, the eradication rate in 100291 was similar
in the FM (80.0%) and AZI (78.9%) groups (95% CI -9.7, 11.8).
When the data were pooled across studies, the response rates
were similar with FM (75.8%) and combined comparator (78.2%)
groups (95% CI -11.0, 6.3). The combined eradication/presumed
eradication rates in the pooled FM and comparator groups were
81.8% vs. 86.6%, respectively for S. pneumoniae and 76.0% vs.
77.6%, respectively, for H. inﬂuenzae.
Conclusions: FM was shown to be non-inferior to either AZI or
CLR in clinical efﬁcacy in two adequate and well-controlled
trials. Pooled analysis further strengthened the clinical non-
inferiority conclusion. The difference in eradication rates
observed in Study 10187 (CLR) was not supported by Study
100291 (AZI).
P1717
An integrated safety analysis of faropenem
medoxomil: results of 5,023 subjects from phase
II/III clinical trials
R. Echols, R. Tosiello (Milford, US)
Objective: To evaluate the safety proﬁle of faropenem
medoxomil (FM), a novel oral penem antibiotic.
Methods: 5,023 subjects from 3 phase II and 14 phase III clinical
trials received FM, 300 mg BID for 3–10 days for treatment of
acute bacterial infections. Randomized controlled trials (RCTs)
included 4,223 FM and 3795 comparator treated subjects.
Analyses were conducted to identify possible disparate
adverse event (AE) reporting based on type of infection,
subject age (12–17, 18-45, 4664, 65–75, >75) and gender,
duration of treatment (3/5 d v. 7/10 d), geography (NA, EU,
ROW), study design (open label v RCT), relationship to
treatment. Comparisons were made to control treatment based
on antibiotic class (b-lactam v. Other), and individual antibiotic
treatments.
Results: FM compared favourably to penicillins, cephalosporins
and macrolides. FM was better tolerated than TMP/SMX and
co-amoxiclav. Open labeled trials had higher AEs reported v.
RCTs. AEs reporting NA = ROW > EU except serious AEs and
deaths where ROW = EU>NA. AEs for FM 3/5 d = FM 7/10 d.
Underlying infection did inﬂuence AE reporting. Female gender
had higher AE reporting than male gender. FM was tolerated
equally well across age ranges, although deaths and SAEs were
more common in >75 age group. Common AEs (>1%/related
from RCTs) were diarrhoea, nausea, fungal vaginosis and
headache and were generally less frequent with FM than
control Rx. No evidence of neuro or cardio toxicity was
identiﬁed. Laboratory tests identiﬁed no hepatic, renal or
hematopoietic signals.
Conclusion: Faropenem medoxomil, a novel oral penem
antibiotic, has the safety proﬁle expected of a b-lactam but is
better tolerated than co-amoxiclav with approximately one-third
the GI side effects.
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P1718
The efﬁcacy of non-surgical and systemic
antibiotic treatment regimens in smoking and
non-smoking patients
E. Pa¨hkla, K. Lo˜ivukene, P. Naaber, M. Saag (Tartu, EE)
Periodontitis is a chronic infectious disease, which leads to the
destruction of periodontal ligament ﬁbres and alveolar bone
until tooth loss. The objective of this study was to compare the
longitudinal effect of combination of non-surgical periodontal
therapy with systemic antibiotics in smoking (S) and non-
smoking (NS) patients.
Methods: There were total of 28 patients with severe
generalized chronic periodontitis involved in this study (14 S,
14 NS), who did not respond well to previous mechanical
periodontal treatment. The clinical examination included
recordings of visible plaque index (VPI), modiﬁed gingival
index (MGI), bleeding on probing (BOP) and suppuration after
probing (SUP), probing pocket depths (PD) and clinical
attachment levels (CAL). The non-surgical periodontal therapy
was performed within 4 weeks. Clinical parameters were
recorded at baseline, 2-3 weeks after the ﬁrst mechanical
treatment and 14 months after combined treatment, during a
regular check-up visit. As the patients did not respond to the
conventional periodontal therapy, the microbiological analyses
were taken and a combination of systemic amoxicillin
500 mg · 3 and metronidazole 250 mg · 2 for 7 days, was
prescribed.
Results: The results suggested that the combined systemic
antibiotic therapy is effective in case of severe generalized
chronic periodontitis, as VPI, BOP, SUP, CAL, and MGI
improved signiﬁcantly after the treatment. In the NS group all
parameters, except CAL, improved signiﬁcantly after the
treatment. The S showed markedly smaller reduction in SUP,
MGI, and CAL.After instrumentation, no periodontal pathogens
were isolated in 11 (39%) patients, while 17 patients (61%) were
infected with one to three different pathogens. Among the
pathogens, Prevotella intermedia/nigrescens (10 patients) and
Actinobacillus actinomycetemcomitans (8 patients) were
dominating. The total level of microbial load (log10 CFU/ml)
as well as the spectrum of pathogens in S and NS patients
remained similar.
Conclusions: Despite of positive treatment effect in general,
there were insigniﬁcant improvements in any clinical
parameters in the smoking group. Smoking has adverse effect
on periodontal therapy; therefore the dentist should cooperate
with patients in counselling of smoking cessation to achieve
better results in the treatment of periodontitis.
Diagnostic and laboratory methods for bacteria-II
P1719
The usefulness of the measurement of laminin in
patients with bacterial infections
H. Lydatakis, I. Hager, T. Miha, V. Babali, N. Tsimberakis, H.
Tamvakos, S. Pappas, I. Diamantis (Piraeus, Athens, GR)
Objectives: Laminin (LN), which is a large multidomain
glycoprotein of the extra cellular matrix, has attracted much
attention because of its importance in many cellular functions,
including induction of cell adhesion, growth promotion and
mediation of cell communication. The target of this study was
to ﬁnd out whether there is any relation between the levels of
serum LN and the inﬂammatory activity of a microbial
infection.
Patients/Methods: From June to October 2005, 48 immunocom-
petent adults, with conﬁrmed bacterial infection were admitted
to our hospital (17 with pneumonia, 24 with pyelonephritis and
8 with cholecystitis) (Group 1). At the same time 50 hospitalised
patients for non-infectious causes (stroke, gastrointestinal bleed-
ing, anaemia) were also studied (Group 2). The levels of serum
LN and CRP were measured on the day of admission in both
groups. The levels of LN were measured using an enzyme
immunoassay kit (TaKaRa LAMININ EIA Kit) and 100 healthy
volunteers were used to determine its normal limits (130–
520 ng/ml). Plasma CRP concentration was assessed by immu-
noturbidometric method (using RANDOX, UK kits). Normal
values were considered those below 10.
Results: The mean serum LN levels of patients of Group 1 were
800.90 ± 249.29 (much higher that the normal limits), while the
mean CRP value was 117.53 ± 87.78. The mean corresponding
values in Group 2 were 475.79 ± 239.25 for LN (within normal
limits) and 24.15 ± 32.77 for CRP. There is a statistically
signiﬁcant difference between the mean LN levels of the two
groups (p < 0.001). Additionally, there is a statistically
signiﬁcant correlation between the levels of LN and CRP (a
well studied serum inﬂammatory marker) in patients with
bacterial infection (Group 1) (Pearson correlation coefﬁcient
r = 0.565, p = 0.01).
Conclusions: The deﬁnition of the LN levels could constitute a
new reliable, simple, direct serum marker for the conﬁrmation
of an active bacterial infection. Additionally, as the CRP levels
are above normal in Group 2 too (patients without infection)
while LN lies within normal limits, maybe LN is even more
speciﬁc than CRP. More studies are required in the future, with
more patients included, in order to conﬁrm the outcome of this
study.
P1720
Performance and clinical signiﬁcance of a direct
tube coagulase test using serum separator tubes
for rapid identiﬁcation of Staphylococcus aureus
from blood culture broth
D. Kwa, T. Schu¨lin-Casonato, P. Sturm (Nijmegen, NL)
Objective: Blood cultures are important in the diagnosis of
serious infections. Early administration of effective antibiotics is
associated with improved patient outcome. The performance of
the direct tube coagulase (DTC) using serum separator tubes
(SSTs) for rapid identiﬁcation of S. aureus from blood culture
broth (BCB) was investigated. The clinical signiﬁcance of rapid
identiﬁcation was assessed.
Methods: Consecutive blood cultures with gram-positive cocci
in clusters were tested. BCB was collected in SSTs using a
subculture-venting unit. After centrifugation, the supernatant
was discarded and 1 ml rabbit plasma was added to the
remaining pellet of bacteria. Coagulation was evaluated after 2
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
and 4 hours incubation at 37C, and after overnight incubation
at room temperature. In parallel, a direct tube coagulase test was
performed using a 1:10 saline dilution of BCB as described
previously. Isolates were identiﬁed by standard microbiology
procedures. Clinical signiﬁcance was measured by comparison
of antimicrobial prescription based on Gram stain results, direct
coagulase results, and culture results.
Results: Over a 6-week period, 90 BCBs from 46 patients were
tested. S. aureus was present in 22 BCBs. Using the serum
separator tube method and the saline dilution method, the
sensitivity of the DTC after 2 hours incubation was 91% and
41%, and after 4 hours 100% and 88%, respectively. The
speciﬁcity of both methods was 100%. Rapid identiﬁcation of
S. aureus resulted in initiation (n = 1) or streamlining (n = 4) of
antimicrobial therapy in 5 of 13 patients with S. aureus
bacteremia. Rapid identiﬁcation of coagulase-negative
staphylococci resulted in changes in antimicrobial therapy in 1
of 33 patients.
Conclusion: The DTC using SSTs for bacterial enrichment is a
very reliable, rapid, cheap and easy to perform method for
identiﬁcation of S. aureus from BCB. Implementation of this test
can improve antimicrobial therapy.
P1721
Evaluation of the results of the Spanish SEIMC
External Quality Control Program for the
diagnosis of Enterococcus faecalis and Klebsiella
pneumoniae infections
R. Guna, J.L. Pe´rez, N. Orta, C. Gimeno on behalf of SEIMC
Objectives: To evaluate the results obtained from four
shipments of two different strains by the participants in the
SEIMC External Quality Control Program (EQCP). These
controls were intended to analyse the percentages of correct
species identiﬁcation and the ability of the participants in
detecting some special features of the control strains: vanB
phenotype in the case of E. faecalis, and the production of
extended spectrum betalactamase (ESBL) in K. pneumoniae.
Methods: The same strain of each microorganism was sent in
two different shipments. The vanB E. faecalis strain was sent
both in a control of year 2002 as well as in other of 2004, while
the ESBL-producing K. pneumoniae was sent in 1999 and in 2005
to an average of 200 laboratories. The results obtained were
compared with those of a reference laboratory that certiﬁed both
the species identiﬁcation and the resistance features.
Results: In the 2002 control, 92.6% of participants identiﬁed
correctly E. faecalis, while 97.8% did it in 2004. As for the
glycopeptide resistance pattern of the enterococcal strain, 39.9%
and 53.3% of participants detected the vanB phenotype in 2002
and 2004, respectively. Overall, the K. pneumoniae strain was
correctly identiﬁed in both separate controls by most of the
participants (97.1% and 98.6%, respectively). Interestingly, the
percentage of laboratories that detected the presence of the ESBL
in the K. pneumoniae strain sharply increased from 55.0% in 1999
to 89.4% in 2005.
Conclusions: The overall percentages of correct species
identiﬁcation were high for the two microorganisms and for
both control points. Most important, the ability of the Spanish
clinical laboratories in detecting the special resistance features of
these strains clearly improved along the study period. These
data conﬁrm the importance of implement a continuous
surveillance of the diagnostic training in the clinical
laboratory, as well as the possible positive intervention of the
SEIMC External Quality Control Program in such improvement,
since the analysis of results is accompanied of updated reviews
on the subject of each control.
P1722
Evaluation of the RIDASCREEN Borrelia IgG
and IgM for the serological diagnosis of Lyme
borreliosis
A. Bonnet-Pierroz, A. Resenterra, O. Pe´ter (Sion, CH)
Objective: To evaluate 2 new ELISA RIDASCREEN Borrelia
IgG and IgM for antibody response in patients with conﬁrmed
Lyme borreliosis and to compare to the results of VIDAS Lyme
(IgG-IgM) and in-house immunoblots (B. garinii IgG and IgM
for early cases or B. burgdorferi sensu stricto, B. afzelii, B. garinii,
B. valaisiana IgG for late cases).
Methods: ELISA RIDASCREEN Borrelia IgG and IgM was
used to screen sera from patients with clinically conﬁrmed
Erythema migrans EM (N = 30). Patients with conﬁrmed
neuroborreliosis by intrathecal antibody synthesis (N = 45)
were evaluated for IgG antibodies to Borrelia. Sera from
patients with Acrodermatitis chronica atrophicans ACA
(N = 30) and sera and synovial ﬂuids from patients with Lyme
arthritis (N = 30) were also evaluated for IgG antibodies.
Patients with syphilis (N = 10) and infectious mononucleosis
(N = 10) were screened for IgG and IgM antibodies to Borrelia in
order to estimate the speciﬁcity.
Results:
Conclusion: The ELISA RIDASCREEN Borrelia IgG and IgM
have shown a good sensitivity for the serological diagnosis of
Lyme borreliosis. The short evaluation for the speciﬁcity of the
IgG test revealed a good assay with few false positive reactions,
whereas the IgM assay was, as expected more prompt to give
false positive results with sera from patients with infectious
mononucleosis. So far any equivocal or positive tests should be
conﬁrmed by immunoblots.
P1723
Is it necessary to incubate the BacT/Alert blood
culture bottles more than 3 days?
A. Vilas, D. Fontanals, I. Sanfeliu, I. Pons, D. Mariscal (Sabadell,
ES)
Objective: To assess the incubation time reduction of the
aerobic and anaerobic BacT/Alert system bottles from 5 to
3 days.
Methods: From 1996 to 2004 we processed 94.303 blood culture
sets and detected 9.432 (10%) positive blood cultures with
clinical signiﬁcance. We retrospectively examined the detection
time of positive bottles and assessed the clinical signiﬁcance of
the bottles that were positive between the fourth and ﬁfth day.
Results: Out of 9432 positive blood cultures with clinical
signiﬁcance, 9238 (97.9%) were detected within the ﬁrst 3 days
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of incubation. Out of the 194 positive blood cultures detected
between the fourth and ﬁfth incubation days, 105 were
recovered in concurrent cultures within the ﬁrst 3 days. Chart
reviews were conducted from 78 patients with the remaining 89
isolates. Only in 24 patients (0.3% positive blood cultures)
changes in antimicrobial therapy based upon the positive blood
culture results on day 4 to 5 were made, in the other patients the
empirical treatment was adequate. The isolated microorganisms
in those 24 patients were: 7 Gram-positive cocci (3 Staphylococcus
spp. not S. aureus, 1 Staphylococcus aureus, 2 Streptococcus viridans
and 1 Streptococcus pyogenes), 5 Anaerobes, 3 Enterobacteriaceae,
2 Pseudomonas aeruginosa, 2 Campylobacter spp., 2 Candida spp. 1
Cryptococcus neoformans, 1 Brucella spp. and 1 Haemophilus
inﬂuenzae.
Conclusions: Incubation of Bact/Alert blood cultures bottles
only for 3 days would have represented a detection loss of 0.3%
of the clinically signiﬁcant isolates, which led to antimicrobial
therapy changes. Although we keep employing a 5-day
incubation for routine blood cultures, we could reduce the
incubation time to 3 days depending on current instrument
capacity.
P1724
An enzyme immunoassay for anti-diphtheria
antibodies: a practical alternative to the Vero cell
assay
R. Budd, E. Harley, R. George, A. Efstratiou, K. Broughton,
A. Bradwell (Birmingham, London, UK)
Introduction: In this extended study, results from an anti-
Diphtheria toxoid enzyme immunoassay (EIA), speciﬁcally
designed to detect higher afﬁnity antibodies, were compared
with those from a Vero cell assay (VCA).
Methods and Results: 154 serum samples with antibody
concentrations ranging from 0.008–8.000 IU/mL on the VCA
from the Respiratory and Systemic Infectious laboratory (RSIL)
were assayed by EIA (The Binding Site Ltd, UK). A further 100
samples from RSIL selected on the basis of being close to the
protective level, were assayed to conﬁrm the performance of the
EIA. The EIA was calibrated, against the NIBSC reference
material 00/496 and the assay measuring range was 0.004–
3.0 IU/mL Results were compared using the WHO guidelines of
0.01–0.1 IU/mL as minimum protective level, and > 0.1 IU/mL
as protective. Relative agreement, sensitivity and speciﬁcity for
the ﬁrst 154 samples were: 91.6%, 98.8% and 83.3% respectively,
for the second set of 100 samples performance was: 90.0%, 84.5%
and 97.6%, and for the combined 254 samples results were:
91.3%, 92.9% and 89.4% respectively. ROC analysis of the total
254 samples conﬁrmed the highest sensitivity 92.9% and
speciﬁcity 89.4% occurred at a cut-off of precisely 0.1 IU/mL
for the ELISA assay.
Conclusion: Of the total 22 discrepant samples, 14 had VCA
and EIA values < 0.149 IU/ml, therefore we suggest the
possibility of establishing an equivocal zone for the
interpretation of the EIA results. If the test is part of a general
immune status assessment a grey zone is not required. If
undertaken to determine the requirement for immunization, the
use of the equivocal zone is recommended. By applying these
criteria in the EIA, only one sample would have suggested
inappropriate immunization, as indicated by a VCA result
> 0.149 IU/mL. Because of the > 90% agreement between the
two assays, signiﬁcant advantages of cost and speed, ease of use
and the potential for automation, the EIA could therefore be
considered as an alternative to the VCA.
P1725
Evaluation of accuracy limits of countable
colony-forming units on agar plates
J. Arbique, A. Rendell, K. Forward (Halifax, CA)
Objectives: Accurate colony counts are an essential component
of many microbiology research projects and clinical laboratory
processes. The suggested range of accuracy of colony-forming
units (CFU) extends from 30 to 300 (Standard Methods for the
Examination of Water and Wastewater). This recommendation
dates to 1907, and fails to adequately address the numerous
sources of inter- and intra-variability. Without more detailed
analysis it is difﬁcult to estimate the sample size and number of
replicates necessary to ensure accurate results. The purpose of
this study was to determine the validity of accuracy limits for
quantifying CFUs on agar plates.
Methods: Escherichia coli (ATCC 25922) and Staphylococcus
epidermidis (ATCC 12228) were used to prepare series of four
organism densities ranging from approximately 40–500 CFU, on
three different days. On each day, each of the 4 densities for both
organisms was plated on SBA and viable organisms were
counted following incubation. An average of the margins of
error obtained over the 3 days of testing was used to determine
the reproducibility of agar plate counts, and to estimate the
optimum number of replicate plates (sample size) required for
each organism at each concentration.
Results: Margins of error for both organisms were greatest
with suspensions yielding approximately 40 CFU, and lowest
for suspensions yielding 300 and 500 CFU. Nine replicate
plates were required for a suspension of S. epidermidis yielding
40 CFU to achieve the same margin of error as obtained with 3
replicate plates at concentrations yielding 100–300 CFU. Seven
replicates plates were required for a suspension of E. coli
yielding 40 and 100 CFU to achieve similar margins of error to
those obtained with 4 replicate plates at concentrations
yielding 300 CFU, and 3 replicate plates at concentrations
yielding 500 CFU.
Conclusion: We found that the greater the concentration (300
and 500 CFU), the fewer replicate plates necessary to reliably
estimate organism concentrations. The lower the organism
density (40 CFU), the more plates necessary to reliably
estimate CFUs. Contrary to the recommendations described in
Standard Methods for the Examination of Water and
Wastewater, CFU of 500 were reliably reproducible. For
greatest accuracy, experiments should be conducted so as to
assure that colony counts are in the range of 300–500.
P1726
Direct microscopy: a valuable instrument for
diagnosis and prognosis of periodontal disease
F.S. Alecu, C. Defta, M. Giurgiu, S. Dumitriu (Bucharest, RO)
Objective: To appreciate the composition of micro ﬂora from
periodontal pockets, using light microscopy and to compare it
with clinical status.
Introduction: It is generally accepted that periodontal disease
occurs when anaerobic Gram-negative ﬂora increase in number
with the subsequent decrease of facultative anaerobe Gram-
positive bacteria. In other words, the switch from Gram-positive
to Gram-negative of sub-gingival ﬂora has a pathologic
signiﬁcance and could be observed using direct microscopy.
Materials and methods: 30 specimens sampled with sterile
paper points from periodontal pockets and 10 samples from
clinical healthy persons were included in this study. Each
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sample was diluted in 0.5 ml saline solution and, with a
calibrated loop, was taken 10 lL aliquots in order to prepare a
smear for microscopic examination and for inoculation on solid
media (Columbia with 5% sheep blood). The smears were Gram
stained and the culture plates were incubated in anaerobic
conditions (72 h, 37 C) and in air (24 h, 37 C).
Results: In 95% of samples from patients with periodontal
disease, easily notable, high number of Gram-negative bacteria
at direct microscopy, associated with abundant growth in
anaerobic condition and poor growth in air. In 9 from 10
healthy patients, the Gram-negative ﬂora was almost absent and
Gram-positive bacteria were in high number, correlated with the
absence of bacterial growth in anaerobiosis and some growth in
air.The presence of Treponema spp. at direct microscopy was
associated with deep and bleeding periodontal pockets. After
few days of proper therapy, the good clinical status was well
correlated with an increasing number of gram-positive bacteria.
Conclusions: 1) Using a diluted sample for microscopic
examination, the value of the method increase, offering important
informationabout the compositionof sub-gingival ﬂora.2) Thegood
correlation between the clinical status and microscopic ﬁnding
recommend it as an easy to use diagnostic method in dentistry.
P1727
Identiﬁcation of species and glycopeptide
resistance among enterococcal isolates by BD
Phoenix
N. Siafakas, M. Pantelaki, E. Kalogeropoulou, S. Chaniotaki,
L. Galani, A. Antoniadou, L. Zerva (Athens, GR)
Objectives: Vancomycin resistant enterococci are emerging in
Europe necessitating their fast and accurate identiﬁcation by the
Laboratory. There was an attempt to evaluate the performance of
the BD Phoenix AutomatedMicrobiology System (BDDiagnostic
Systems, Sparks, Md.) for the correct identiﬁcation of species and
glycopeptide resistance in comparison to the gold standard of
diagnosis, PCR, using a large collection of clinical strains.
Methods: A total of 232 enterococcal isolates were tested by the
BD Phoenix sytem. These strains were isolated from 145 faecal,
55 urine, 18 pus, 5 blood and 9 samples from other body sites
cultures. A multiplex PCR was applied using 8 different pairs of
primers, speciﬁc for the identiﬁcation of E. faecium, E. faecalis and
the vanA, vanB, vanC, vanD, vanG, vanE glycopeptide resist-
ance genotypes. Susceptibility to the glycopeptides was also
conﬁrmed by the Etest (AB Biodisk, Solna, Sweden).
Results: According to the PCR, there were 101 E. faecium
(including 85 vanA-positive strains), 72 E. faecalis (including 1
vanA-positive and 1 vanB-positive strains) and 58 E. cass/gall
isolates. Two strains were not identiﬁed and were excluded from
the analysis. Discrepant results between the multiplex PCR and
the Phoenix system were obtained for 23/232 isolates (10%) with
similar rates amongst faecal (15/145, 10.4%) and the rest of the
isolates (8/87, 9.4%). The most common discrepancies were the
misidentiﬁcation of 11 E. faecium vanA strains and 7 E. faecalis
strains as E. cass/gall by Phoenix. Two E. faecalis strains were
incorrectly characterized as vancomycin resistant, two E. faecium
strains were misidentiﬁed as E. hirae and E.cass/gall, respectively,
and one E.cass/gall strain was reported as E. faecium resistant to
both glycopeptides. Thus, the sensitivity and speciﬁcity for the
identiﬁcation of E.cass/gall by Phoenix were 98.3% (57/58 strains)
and 88.4% (145/164 strains), respectively, while 12.8% of vanA
strains (11/86 strains) were not recognized by this system.
Conclusion: This study demonstrates that the new identiﬁca-
tion system, Phoenix, similarly to other automated or manual
systems, presents with problems regarding correct identiﬁca-
tion of enterococcal species and glycopeptide resistance. Specif-
ically, Laboratories should be aware that clinically signiﬁcant
isolates identiﬁed as E.cass/gall should be conﬁrmed by another
method.
P1728
An audit of sputum requisition practices
P. Lal, I. Balakrishnan (London, UK)
Objectives: To analyse the indications and rationale for the
processing of sputum specimens in a London teaching hospital.
Methods: Sputum samples received from 01/12/2004 - 28/02/
2005 were included in this study. Data were obtained from the
patient requisition forms and the Winpath systems and were
analysed further as per the objectives.
Results: A total of 1309 specimens were received during this
period. 1202 (92%) from hospital in-patients and 107 (8%) from
general practitioners. Out of the total of 1202 samples received
from hospital-in patients 167 (13.9%) had > 25 epithelial cells/
LPF. No clinical details were mentioned in 258 (21.4%) and 388
(32.2%) were from patients already on antibiotics. Repeat
specimens within one week were sent in 340 (28.2%) cases and
375 (33%) had atypical serology also sent. Out of the 1202
hospital-in patient samples 372 (30.9%) had a signiﬁcant isolate
and 488 (40.5%) had normal respiratory tract ﬂora isolated.
Others were reported as: ‘‘gross oral contamination’’ [168
(13.9%)], ‘‘no growth’’ [29 (2.4%)] and ‘‘no signiﬁcant growth’’
[37 (3.07%)]. There were a few specimens reported as
‘‘inappropriate specimen - two days old’’ [35 (2.9%)] and
‘‘leaking’’ or ‘‘Saliva only’’ [22 (1.8%)]. Out of a total of 107
samples received from GP patients 14 (13.1%) of samples had
> 25 epithelial cells/LPF, 25 (23.3%) had no clinical details
provided, 5 (4.6%) samples were sent while patients were on
antibiotics and 9 (8.4%) samples were repeated within one week.
Only 4 (3.9%) had atypical serology also sent.
Conclusions: - Less than one-third of specimens yielded a
signiﬁcant pathogen.- Adequate clinical details were lacking in
about one-ﬁfth of specimens.- Nearly one-third of specimens
were repeated within one week, without a clear indication.-
About 16% of specimens were of poor quality.- Atypical
serology was only performed in 3.9% of outpatients, as
compared with 33% of in-patients.This audit brings forth the
fact that the clinical indications for which sputa are being sent
for culture need to be clearly deﬁned and an educational
campaign instituted amongst relevant healthcare professionals.
Sputum collection techniques need to be rigorously applied if
good-quality specimens are to be obtained. Indications for
performing atypical serology need to be deﬁned and reinforced,
particularly in primary care.
P1729
A new approach to laboratory diagnostic of
infectious gastroenteritis – a follow-up
B. Olesen, D.S. Hansen, H. Tybring, A. Hansen, K.E.P. Olsen,
B.G. Bruun (Hillerød, Copenhagen, DK)
Objectives: In order to optimize use of laboratory facilities and
ensure ﬂexibility in relation to current epidemiology, a new
approach to laboratory diagnosis of infectious gastroenteritis
was applied: From an algorithm the decision of which
organisms to test for was deﬁned by the demographic, clinical
and epidemiological information submitted to the laboratory on
paper/electronic request forms.
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Methods: From April 1, 2004–June 30, 2005, hospitals and
general practitioners submitted a request form with the
following information together with the stool sample (s): (1)
acute or persistent diarrhoea (duration > 2 weeks); (2) bloody
stools; (3) recent history of foreign travel; (4) > 2 patients within
same epidemiological setting; and (5) nosocomial infection.
Provision of data is mandatory when submitting electronically.
Based on these data, analyses were performed according to an
algorithm. Examination for Salmonella, Shigella, Yersinia,
Campylobacter, and Clostridium difﬁcile was done by culturing.
Verotoxin producing E. coli (VTEC), enteropathogenic E. coli
(EPEC), enterotoxigenic E. coli (ETEC) and enteroinvasive E. coli
(EIEC) were identiﬁed by PCR for virulence genes and
serotyping. Rota and adenovirus were detected by antigen
tests and parasites by microscopy.
Results: In total we examined 8,628 samples from 4,088
patients. A pathogen was isolated in 19% of patients. In 673
cases (17%) clinical/epidemiological data were missing.
• 1,205 patients had diarrhoea < 2 weeks: 13% with Campylo-
bacter, 5% with Salmonella, 4% with ETEC, 3% with Giardia,
and 1% each with EIEC and VTEC
• 1,502 patients had diarrhoea > 2 weeks: 3% with Campylobac-
ter, 2% with Giardia, 1% each with EPEC and VTEC
• 740 patients had a history of foreign travel: 7% with Campy-
lobacter, 6% with ETEC, 4% with Salmonella, and 4% with
Giardia
• 214 patients had bloody stools: 18% with Campylobacter, 3%
with Salmonella, and 2% with VTEC
• 896 patients were < 7 years: 4% with Campylobacter, 3% with
EPEC, 2% each with Giardia, VTEC and Salmonella, and 1%
with ETEC
Conclusions: Campylobacter was the most common bacterial
pathogens in all groups and rotavirus was the most common
pathogen in children < 7 years. The new approach had a
number of advantages: more relevant microbiological analysis,
collection of data on deﬁned patient groups, and ﬂexibility
regarding adaptation to current epidemiological knowledge.
Increasing use of electronic submission of request forms will
optimize the approach used.
P1730
Recognition of Staphylococcus aureus isolates as
small colony variants applying Fourier-transform
infrared spectroscopy
K. Becker, N. Al Laham, W. Fegeler, R.A. Proctor, G. Peters,
C. von Eiff (Munster, DE; Madison, US)
Objectives: Small colony variants (SCVs) are an emerging
infectious disease problem, presenting as a naturally
occurring, slow-growing subpopulation of Staphylococcus
aureus that are characterized by tiny colonies on solid media.
Studies on SCVs recovered from patients with persistent
infections are hampered due to their frequent unstable
phenotype. In particular, SCVs are not easily distinguishable
from the normal phenotype in broth media and a reversion of
SCVs into the normal phenotype is not traceable.
Methods: A set of isogenic S. aureus isolates comprising the (i)
normal and the (ii) SCV phenotype (isogenic to the isolate with
normal phenotype) recovered from clinical specimens, as well as
(iii) corresponding mutants mimicking the SCV phenotype
(knock-out of hemB), and (iv) their complemented mutants
were used to investigate the feasibility of Fourier-transform
infrared (FTIR) spectroscopy to trace the expressed phenotype
in broth media. The respective isolates cultured on solid media
served as controls. In addition, all isolates were genotyped by
pulsed-ﬁeld gel electrophoresis and spa typing.
Results: Using ﬁrst-derivative infrared spectra to calculate
spectral distances, hierarchical clustering based on spectral
information in three different spectral ranges resulted in a
dendrogram that showed a clear discrimination between both
staphylococcal phenotypes. Distinct clusters comprising the
clinical and mutant SCV phenotype on one hand and the
normal phenotype (isolate with normal phenotype and
complemented mutant) on the other hand were found. Thus,
SCVs from different clonal lineages gave spectra that were more
similar to one another than to their normal growth parent. FTIR
was also shown to be able to trace the switch of the phenotypes
in broth when the medium was supplemented.
Conclusion: FTIR spectroscopy allows a rapid, reproducible
and clear discrimination of different phenotypes of S. aureus in
ﬂuid media for diagnostic and research purposes. In contrast to
genotyping approaches, FTIR staphylococcal ﬁngerprinting is
only reliable for typing purposes if the isolates exhibit the same
phenotype. In future studies, this technique may also provide an
approach for tracing the SCV phenotype in infected tissues.
P1731
Levels of sTREM-1 in cerebrospinal ﬂuid as a
marker for bacterial meningitis
M. Weisfelt, R. Determann, J. de Gans, A. van der Ende,
M.J. Schultz, D. van de Beek (Amsterdam, NL)
Objectives: Triggering receptor expressed on myeloid cells-1
(TREM-1) is a recently discovered cell surface molecule whose
expression on phagocytes is up regulated by exposure to
bacteria or fungi. A soluble form of TREM-1 (sTREM-1) can
be measured in various body ﬂuids. We studied whether
sTREM-1 in cerebrospinal ﬂuid (CSF) could serve as a
biomarker for the presence and outcome in patients with
bacterial meningitis.
Methods: In this retrospective study on diagnostic accuracy we
used an ELISA to determine levels of sTREM-1 in CSF from 46
adults with bacterial meningitis, conﬁrmed by CSF culture, who
participated in the prospective DutchMeningitis Cohort Study; 8
patients with viral meningitis, conﬁrmed by polymerase chain
reaction of CSF; and 9 healthy control subjects, who underwent
lumbar puncture to exclude the diagnosis of subarachnoid
haemorrhage. The Mann-Whitney U test and the Chi-square test
were used to identify differences between groups. A receiver-
operating-characteristic curve (ROC)was constructed to illustrate
various cut-off CSF levels of sTREM-1 in differentiating between
the presence and absence of bacterial meningitis and diagnostic
accuracy was quantiﬁed by 95% conﬁdence intervals (95% CI).
Results: Levels of sTREM-1 in CSF were higher in patients with
bacterial meningitis as compared to those with viral meningitis
[median, 159 pg/mL (range, 0 to 988 pg/mL) versus 0.5 pg/mL
(range, 0 to 48 pg/mL); P = 0.001] and controls [0 pg/mL
(range, 0 to 36 pg/mL); P < 0.001; Fig]. Patients with viral
meningitis and controls had similar CSF sTREM-1 levels. The
area under the ROC curve for discriminating between patients
with and without bacterial meningitis was 0.88 (95% CI, 0.80 to
0.96; P < 0.001). At a cut-off level of 40 pg/mL, sTREM-1
yielded a sensitivity of 0.80 (95% CI, 0.69 to 0.88) and a
speciﬁcity of 0.94 (95% CI, 0.77 to 0.99). In patients with bacterial
meningitis, CSF sTREM-1 levels were associated with mortality
[survivors versus nonsurvivors: median 99 pg/mL (range, 0 to
365 pg/mL) versus 214 pg/mL (range, 0 to 988 pg/mL);
P = 0.02].
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Conclusions: Measuring sTREM-1 in CSF may be a valuable
new approach to accurately diagnose bacterial meningitis and
identify patients at high risk for adverse outcome. Therefore, a
prospective study on sTREM-1 as biomarker in bacterial
meningitis is needed.
P1732
Systematic review of rapid diagnostic tests for
enterohaemorrhagic E. coli
I. Abubakar, L. Irvine, L. Shepstone, S. Schelenz, C. Aldus,
P. Hunter (Norwich, UK)
Objective: A variety of rapid tests for the detection of
Enterohaemorrhagic Escherichia coli (EHEC) have recently
emerged. Culture on Sorbitol MacConkey (SMAC) agar and
biochemical identiﬁcation, while easy to use and inexpensive, is
slow and lacks sensitivity in the detection of non O157:H7
serotypes. This study sought to determine the accuracy of rapid
serological or polymerase chain reaction (PCR) assays which
have been evaluated for the detection of all EHEC serotypes
compared to culture.
Methods: A systematic review and meta-analysis of 146
articles, identiﬁed via searches of electronic databases, hand
searching of selected journals, and through contact with
experts and commercial test manufacturers. The majority of
these needed to be excluded due to low quality or lack of
accuracy data. Sensitivity and speciﬁcity of each method was
calculated using full biochemical identiﬁcation as the
reference standard. Twenty-one studies met the inclusion
criteria, of which 7 used PCR methods and 10 used
serological assays and 4 were based on culture. A summary
receiver operator curve (SROC) was constructed from these
data and the area under the curve (AUC) calculated (using
the trapezium rule).
Results: Serological tests had individual sensitivities ranging
from 0.82 to 1.00 and speciﬁcities ranging from 0.67 to 1.00. PCR
tests had individual sensitivities ranging from 0.94 to 1.00 and
speciﬁcities ranging from 0.92 to 1.00. Additional analysis
comparing SMAC agar culture with toxin detection methods
showed poor sensitivity compared to PCR and serological tests
(ranging from 0.24 to 0.38) yet the speciﬁcity was very good (1.00
for all 4 studies considered).
Conclusions: Our results suggest that both molecular and
serological tests may have a potential role in detecting EHEC
infection. Whilst there is very little difference in the effectiveness
of these techniques, both are faster and have improved
sensitivity when compared to traditional culture methods.
Fast, reliable diagnosis could lead to more informed treatment
choices and improved outbreak control measures. However,
given the substantial extra cost of these assays, an assessment of
economic feasibility is necessary prior to use in everyday
practice.
P1733
Antibodies against Bordetella pertussis detected
by slow agglutination test and ELISA in two age-
related groups of vaccinated people suspected of
acute pertussis: a comparative study
Z. Medkova, O. Stepanikova (Brno, CZ)
Objective: The aim of presented study was to describe
differences between results of two tests used for detection of
antibodies against Bordetella pertussis (slow agglutination and
ELISA) in two age-related groups of patients suffering from
respiratory infection. Each of the people has undergone
vaccination against B. pertussis.
Methods: Paired sera obtained from two age-related groups
of patients [(1). age 0–6 years, n = 49; (2). age above 6 years,
n = 455] suffering from acute respiratory infection were tested.
The ﬁrst group comprised the children who were vaccinated
earlier than one year before testing; the second group was
determined by longer interval between the vaccination and
the testing. The criterion of positivity of the slow
agglutination was based on quadruple increase/decrease of
the titer of speciﬁc antibodies; the criterion of serodiagnosis of
the illness was the same. Each of the patients was tested by
ELISA IgA,IgG,IgM (Virotech) during the same period,
positive results of each of class of immunoglobulins were
evaluated as positive ELISA. The differences of results
obtained by the two tests were assessed inside and between
the groups.
Results: There were found 12.2% (respective 16.9%) concordant
positive and 36.7% (respective 19.6%) concordant negative
results between the tests in the ﬁrst (respective second) group.
There were found the following discrepancies in the frame of
non equal results: agglutination positive/ELISA negative sera
were present in 8.2% (respective 13.2%) persons and
agglutination negative/ELISA positive samples were present
in 42.9% (respective 62.2%) persons.
Conclusion: (1). The frequency of serologically conﬁrmed
infection based on results of slow agglutination is higher in
the group of people older six; the interpretation of the results in
the younger group is limited by the inﬂuence of actual
vaccination. (2). The ELISA evaluated as described above
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shows extremely high frequency of positivity in both groups,
thus, the usefulness for diagnostics of acute infection seems to
be low. (3). The study will be continued to asses relationships
between the positive results detected by slow agglutination and
the positive ones detected by ELISA in separate classes of
speciﬁc immunglobulins.
P1734
Accuracy of the MicroScan WalkAway system to
identify coagulase-negative staphylococci
A. Sa´ez, B. Ruiz, L. Martı´nez-Martı´nez (Santander, ES)
Objective: To determine the reliability of the identiﬁcation of
coagulase-negative staphylococci (CoNS) with the MicroScan
WalkAway 96 (WA, Dade Behring) system at species level when
a > = 90% probability is obtained, considering as a reference the
results of molecular identiﬁcation.
Methods: One hundred and sixty-eight isolates of CoNS from
clinical samples (October 2003-May 2005) for which the
identiﬁcation with the WA system was ‡ 90%, and 9 ATCC
type strains were evaluated. Bacteria were identiﬁed with the
WA system using Pos Combo 1S panels. Absence of coagulase
was determined with a latex assay (Pastorex staph-plus, Bio-
Rad). Reference identiﬁcation was established by sequencing of
the 16S rRNA; when identiﬁcation with WA and 16S rRNA
disagree, deﬁnitive identiﬁcation was deﬁned after sequencing
of the sodA and tuf genes, as previously described (Drancourt et
al. JCM 2000; 38: 3623–30 and Heikens el al. JCM 2005; 43: 2286–
90). For identiﬁcation, the sequences of 16S rRNA, sodA and tuf
were compared with those in GeneBank. Homologies values
above 97% were considered reliable.
Results: All 9 type strains were correctly identiﬁed by 16S
rRNA sequencing as named by the ATCC. Among the 168
clinical isolates, the molecular method identiﬁed the following
species (number): S. hominis (39), S. haemolyticus (35), S.
saprophyticus (30), S. epidermidis (27), S. lugdunensis (12), S.
schleiferi (7), S. capitis (7), S. simulans (4), S. pasteuri (2), S. warneri
(2), S. intermedius (2) and S. equorum (1). The WA system
correctly identiﬁed 8 out of the 9 ATCC strains. S. pasteuri is not
included in the WA database, and the corresponding ATCC
strain was misidentiﬁed as S. warneri. One hundred and ﬁfty-
seven out of the 168 (93.4%) clinical isolates were correctly
identiﬁed by the WA. Five S. haemolyticuswere identiﬁed by WA
as S. auricularis (2), S. simulans (2) and S. warneri (1). Other errors
corresponded to: two S. pasteuri misidentiﬁed as S. warneri, one
S. epidermidis as S. hominis, one S. lugdunensis as S. schleiferi, one
S. hominis as S. haemolyticus and one S. equorum as S. cohnii. All
isolates of S. saprophyticus, S. schleiferi, S. capitis, S. simulans, S.
warneri and S. intermedius were correctly identiﬁed by the WA
system.
Conclusions: The MicroScan WalkAway 96 is reliable to
identify CoNS at species level when a probability of > = 90%
is obtained. S. pasteuri should be incorporated to the WA
database in order to improve its performance.
P1735
The Polish National External Quality Assessment
Scheme (POLMICRO 2005) - detection of BLNAR
Haemophilus inﬂuenzae
E. Stefaniuk, B. Chmylak, J. Fiett, E. Zurek, W. Hryniewicz
(Warsaw, PL)
Objectives: The aim of this study was to analyse the results of
proﬁciency testing obtained by Polish microbiology laboratories
participating in POLMICRO. Haemophilus inﬂuenzae is an
important pathogen causing a variety of community-acquired
respiratory tract infections, acute otitis media and purulent
meningitis. Two mechanisms of ampicillin (AMP) resistance in
this organism are described. One is mediated by the production
of beta-lactamases TEM-1 and ROB-1; these AMP-resistant
strains are termed beta-lactamase-producing, AMP-resistant
(BLPAR). The second mechanism involves development of
altered penicillin-binding proteins (PBP) with decreased
afﬁnity to AMP and other beta-lectam agents. Strains with
resistance mechanisms mediated by PBP alterations are termed
beta-lactamase-nonproducing, AMP-resistant (BLNAR) H.
inﬂuenzae.
Methods: Four hundred seventy eight laboratories participated
in this part of the scheme. Each participating laboratory received
Haemophilus inﬂuenzae (PM-63)-beta-lactamase negative,
ampicillin-resistant strain (BLNAR). The laboratories were
asked to provide identiﬁcation to the species level and of the
susceptibility results and interpretation.
Results: Correct identiﬁcation to the species level of this strain
was reported by 454 laboratories (97.2%) of the 467 labs
involved. Thirteen laboratories reported the analysed strain as
Haemophilus parainﬂuenzae. Three hundred ninety eight
laboratories (88.1%) of 452 correctly detected the mechanism of
resistance to beta-lactams. Only three laboratories incorrectly
reported the organism as beta-lactamase producer. The greatest
dispersion of inhibition zone was observed in the susceptibility
of H. inﬂuenzae to ampicillin, amoxicillin-clavulanic acid and
clarithromycin.
Conclusions: Over 90% of the laboratories correctly identiﬁed
and interpreted beta-lactamase-nonproducing, AMP-resistant
(BLNAR) H. inﬂuenzae strain.
P1736
Serological diagnosis of syphilis by a completely
automated chemiluminescent immunoassay:
Architect syphilis TP
R. Vezzo, L. Vigore`, V. Giuffre` (Monza, IT)
Purpose and methods.The Architect Syphilis TP assay is a
chemiluminescent EIA that employs three recombinant antigens
of Treponema pallidum on the solid phase and an anti-human IgM
and IgG conjugate. We evaluated this assay in comparison with
a conventional EIA (Diesse Enzywell Syphilis Screen Recom-
binant) on unselected routine serum samples and on repository
specimens for whom the results for speciﬁc IgG and IgM and of
the rapid plasma reagin (RPR) assay were already known. In
both instances an immunoblot (IB: Inno-LIATM Syphilis Score,
Innogenetics) has been employed on discordant specimens as a
conﬁrmatory assay. The precision and robustness of the Archi-
tect assay were also evaluated.Results.On 1.165 routine samples
(975 from volunteer blood donors and 190 from in and
outpatients) the concordance between Architect and EIA was
high (1.155 samples, or 99.1%; 7 positives, 1,148 negatives). One
of the discordant, positive by Architect and negative by EIA,
was conﬁrmed by IB. The speciﬁcity of the Architect assay was
99.4% (95% conﬁdence limits: 98.9–99.8). The 177 repository
samples assayed belonged to three groups: 1) 9 biological false
positives from 6 subjects: all negative by Architect; 2) 134 true
positives, all positive by Architect, with a signiﬁcantly stronger
signal (average S/CO: 26.19 vs. 14.53) on the 23 IgM positive
samples, all of whom were also positive by RPR; 3) 34 samples
positive by RPR and negative by EIA IgG: 32 of them were
negative by Architect as well and for IgM, while two specimens
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were strongly positive by Architect and positive also for speciﬁc
IgM and with three speciﬁc bands by Inno-LIA, suggesting a
pattern of recent infection. The reproducibility of the Architect
assay was good, with CVs of 7.78%, 5.71% and 5.51% on 28
replicates over 4 weeks of the assay’s negative and positive
control and of an internal control; ﬁnally, the S/CO distribution
of negative specimens conﬁrmed the robustness of the assay,
with a mean of 0.09, a median of 0.06, 10 standard deviations
between the mean and the cut-off value and the 99th percentile
at a S/CO value of 0.53.Conclusion.The automated assay for
anti-Treponema pallidum antibodies on the Architect system has
an excellent sensitivity and a good speciﬁcity. The analytical
performances, coupled with the elevated throughput and
minimal samples handling, make this method a ﬁrst-choice
option for syphilis screening and diagnosis in medium and large
volume laboratories.
P1737
Usefulness of Sysmex UF-100 and Coral UTI
Screen in the diagnosis of urinary tract infection
M. Schinella, P. Rizzonelli, A. Frizzi, L. Collini, P. Gualdi
(Rovereto, IT)
Objective: Quantitative urine culture is the gold standard for
deﬁning the diagnosis of Urinary Tract Infection (UTI), because
it allows identiﬁcation of the uropathogenic species. However,
this method is time consuming and expensive. Approximately,
up to 70% of urine cultures are negative with high cost for
unnecessary testing. Thus, we have evaluated the usefulness of
two automated analysers for UTI screening to quickly identify
the negative samples that can be prompt reported to the
clinicians, improving in the quality of patient care and
allowing the laboratory to direct more effort into positive
samples.
Methods: 1.165 of midstream urine samples submitted for
microbiological examination were analysed by conventional
urine culture plates (McConkey agar + Trypticase Soy
agar + Bile Esculine Azide), Sysmex UF-100 (Sysmex, Japan)
and Coral UTI Screen (Coral Biotechnology, CA, USA)
automated analysers. UTI was deﬁned positive as follows: one
or two strains of bacteria with at least 105 UFC/ml for the culture
plates, more than 5.000 bacteria/ll and more than 15 WBC/ll
for the UF-100 and/or an RLU value grater than 2% of the
calibrator value for the Coral. When more than two strains of
bacteria were found, the culture was classiﬁed as contamined.
Results: The diagnostic performance of Sysmex UF-100 and
Coral UTI Screen are shown in table 1.
Conclusion: The Sensitivity (95.8%) and Negative Predictive
Value (96.4%) conﬁrm that Sysmex UF-100 and Coral UTI screen
are an excellent screening for UTI. After this evaluation, we
decide the use of the Sysmex UF-100 and Coral UTI Screen on
our routine workﬂow for UTI screening. The results of both the
analysers are sent to a software system (LabFinity Dasit, Italy)
connected to the LIS. If the results are lower than the cut-off
values, UTI can be excluded and directly reported to the
physician. Positive results are submitted to microbiological
culture and reported within 24 or 48 hours depending on
negative or positive bacterial growth. In our experience,
evaluated on further 2.955 samples, this means that 78% of
samples are immediately reported within very few hours. Of the
22% of positive samples, 222 (35%) were conﬁrmed by culture
and reported within 48 hours, 418 (65%) were not conﬁrmed
and reported within 24 hours.
P1738
Comparison of the blood and bone marrow
culture positivity rates for the diagnosis of
brucellosis
S. Iseri, C. Bulut, H. Irmak, M.A. Yetkin, S. Kinikli, N. Tulek,
A.P. Demiro¨z (Ankara, Samsun, TR)
Objectives: Brucellosis is a common disease, seen worldwide
as well as in our country. The diagnosis of brucellosis is made
with certainly when brucellae are recovered from blood, bone
marrow. In our study, we aimed to compare the blood and
bone marrow culture positivity rates in patient with
brucellosis.
Methods: This study was performed in the Infectious Diseases
and Clinical Microbiology Department of Ankara Research and
Training Hospital between 2002 and 2004. The diagnosis of
brucellosis was made on the history, physical ﬁndings,
serologic ﬁndings and the isolation of the organism. The
number of patients with brucellosis included to the study was
102. Blood and bone marrow samples were taken from all of
the patients on admission and cultured by using the BACTEC
9050 system.
Results: Blood culture positivity for brucellosis was 48% (49/
102), while bone marrow culture positivity was 34% (35/102).
The difference between those positivity rates was found to be
statistically signiﬁcant (p < 0.05). The isolation ratio from
blood cultures among acute cases was 66% (40/61) while it
was 31% (9/29) among subacute cases. Brucella isolation from
blood was not detected in 12 chronic cases. The isolation rates
of the microorganism from bone marrow of acute, subacute
and chronic cases were 45.9%, 20.7%, 0.9% respectively.
Among our patients, 32 had history of medical therapy for
brucellosis before admission and 27 of them was treated
inadequately. Of those 27 cases, the organism was isolated in
7 (25%) from blood and in 9 (33%) from bone marrow.In the
cases with high standard tube agglutination titers, the rate of
positivity was also high both in blood and bone marrow
cultures. However when compared with low standard tube
agglutination titers, that difference was not statistically
signiﬁcant.The mean growing time for the positivity of
cultures was 4.2 days for bone marrow and was 5.8 days for
blood cultures. The difference between the mean growing
times of two culture types was found statistically signiﬁcant
(t-test. p < 0.05).
Conclusion: Premedication, subacute and especially chronic
phases decrease the possibility of isolation of the microorganism
from blood culture. Therefore we suggest taking bone marrow
culture only for these kinds of patients as it. is a traumatic
process.
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P1739
Serological ﬁndings in blood sera of patients with
Yersinia-triggered arthritis
E. Golkocheva, R. Stoilov, H. Najdenski (Soﬁa, BG)
Objectives: Immunoblot analysis of IgA and IgG antibody
response of blood sera from patient with Yersinia triggered
reactive arthritis and with undifferentiated arthritis were made.
Patients and methods: Serum samples were obtained from
patients admitted to Clinic of Rheumatology at Medical
University, Soﬁa, Bulgaria with suspicion of Yersinia triggered
reactive arthritis, based on diagnostic criteria. A total of 20 blood
serum samples were analysed by immunoblot analysis with
speciﬁc antigens-Yops (yersinia outermembrane proteins).
When Y. enterocolitica is cultivated at 37oC under calcium
restriction (0.2 mM Ca2+), large amounts of Yops are secreted
into medium. These proteins were separated by 2D-SDS-
electrophoresis.
Results: Immunoblot analysis of IgA and IgG antibody response
against Yops in 20 blood sera from patients with arthralgias and
polyarthropathieswas carried out.Yersinia enterocolitica, serotype
O: 8, was used as source for Yop. Seven strong bands of the
molecular weights 26 kDa-YopE, 33 kDa-YopN, 36 kDa-YopD,
41 kDa -V-ag, 43 kDa-YopB, 46 kDa-YopM and 51 kDa-YopH
were visualized. For immunoblot assay the optimal concentration
of antigenwas established by analytical electrophoresis. Of the 10
blood sera from the patients with Yersinia triggered reactive
arthritis IgG antibodies were detected against YopH, YopM,
YopB, YopD, YopN and YopE. IgA antibodies were established
against YopM, YopB, YopD, YopN and YopE. All 5 sera from the
patients with other rheumatic diseases were negative for the
presence of anti-yersinia IgA antibodies and two of them were
positive for IgG against YopD. Antibodies from two classes were
not detected in 5 sera samples from healthy people.
Conclusions: Yops are borne by the virulence plasmid, which
mean that they are clearly associated with virulence properties
of pathogenic strains. Moreover, Yops is not restricted to single
serotype and this made them a speciﬁc antigen in diagnosis of
different Yersinia infections. Conventional techniques such as
culture and demonstration of serum agglutinins prove to be
insufﬁcient to demonstrate invasive or chronic yersiniosis in
contrast with the determination of speciﬁc serum IgA and IgG
antibodies by immunoblot analysis and antigen detection. The
detection of anti-Yops IgG and IgA antibodies by immunoblot
can be used for diagnosis of Yersinia triggered arthritis.
Acknowledgements: This work was sponsored by NATO-
reintegration grant 981256.
P1740
Identiﬁcation and susceptibility results by direct
inoculation of Vitek 2 cards from positive Bact/
Alert 3D system
M.A. Miguel, M. Cuervo, M. Lecuona, S. Campos,
M.I. Montesinos, A. Sierra (La Laguna Sta Cruz Tenerife, ES)
Objectives: To evaluate the identiﬁcation and susceptibility
results by using suspensions obtained directly from positive
blood cultures.
Methods: During the period between 1st August and 31st
October 2005 we selected all positive cultures grown in Bact/
Alert SA and SN bottles (bioMe´rieux) from gram-negative
bacilli. Only the ﬁrst culture positive from each patient was
included. We inoculated 5 mL ﬂuid from a positive bottle into a
serum separator tube (BD Vacutainer Systems, Plymouth,
United Kingdom) and centrifuged at 1500 x g for 10 minutes
and the supernatant was carefully aspirated. Using a cotton
swab the bacteria were removed from the top of the separator
layer to be suspended in 0.45% saline solution to get
0.6 McFarland. The suspension was processed according to
standard inoculation procedure for GN and AST-N020 Vitek2
cards. Positive Bact/Alert 3D bottles were also sub cultured and
after an overnight incubation several colonies were used to
make a 0.63 McFarland suspension in 0.45% saline. The
suspension was processed according to standard Vitek2
inoculation procedure for GN and AST-N020 cards.
Results:
Identiﬁcation: A total 56 gram-negative bacillus from positive
blood cultures were investigated. Fifty (89.2%) strains were
correctly identiﬁed to the species level, four (7.1%) strains were
not identiﬁed and two (3.6%) strains were misidentiﬁed.
Antimicrobial susceptibility testing: In all, 1040 MICs were
determined for 52 isolated by both methods. The unidentiﬁed
strains (4) were excluded. The overall MIC agreement between
direct and standard inoculation was 93.9%. All individual
antimicrobial agents scored > 90%. The overall minor error rate
was 2.8% (30 of 1040). The overall major error rate was 1.05% (11
of 1040). The overall very major error rate was 2.1% (22 of 1040).
The highest rate of MIC agreement was for amikacin, norﬂoxacin
(100%), meropenem (98%), gentamicin and oﬂoxacin (96.1%).
Conclusion: The direct method from positive Bact/
Alert&#61650; cultures cannot totally replace the approved
methods of identiﬁcation and susceptibility but in some cases
provides earlier information which allows a better patient
management and also reduce cost in patient care.
P1741
Investigation of Listeria monocytogenes "O"
antibodies in maternal and cord sera with the
agglutination test
E. Us, A.T. Cengiz, O. Gelisen (Ankara, TR)
Objectives: Listeria monocytogenes is a Gram-positive food borne
pathogen that is responsible for listeriosis, a human infection
with a mortality rate of 30%, which could cause severe mother-
to-child infections. This serious pathogen in pregnancy could be
treated if diagnosed, but there is no routine screening test for
susceptibility to listeriosis during pregnancy. Therefore, we
investigate different L monocytogenes serotype O antibodies for
diagnosis of listeriosis in 275 maternal sera with agglutination
test. 69 of them had spontaneous abortion, premature labour or
stillbirth (group I), while 206 had no obstetric patology (group
II) in their previous pregnancies. Cord bloods were also
obtained at the delivery and tested.
Methods: All sera were being tested against antigens with the O
formulation of serotype 1/2c, 3b, 4ab, 4c and 4d. The antigens
were prepared by the method of Osebold, and Larsen et all. The
bacterial suspensions were trypsinized for 15 min at 37C to
prevent cross-reactions and contaminations. Sera were diluted
by doubling serially in saline followed by addition of an equal
volume of antigen. A positive titre of greater than or equal to
1:320 was chosen as positive test result to maximize the
sensitivity and speciﬁcity.
Results: 4.36% of cases have ingested raw milk and diary
products, 1.81% ready-to-eat foods, and 5.81% developed non-
speciﬁc febrile illness (NFI) during their pregnancies. 20% of
group I were found positive (28.5% developed NFI) while at
group II 22% had positive (26.6% developed NFI) agglutination
titres to one ore more serotypes. All the cord blood sera of group
I were found negative, whereas two in group II (all 4ab) were
positive, with the positive maternal sera of the same serotype.
It’s evaluated as transmission of the antibody from mother to
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foetus. At group I the frequent serotypes were 1/2c = 4ab, at
group II 4ab, 1/2c, respectively. The newborns showed no
symptoms or signs of listerial foeto-maternal infection.
Conclusion: The women encountered the antigens of L mono-
cytogenes in any period of their life time (most 21–25 years of
age) and produce antibodies against this pathogen. There is a
relationship between NFI and positive titres. If the disease is
recognized, it is possible to treat the mother and allow the birth
of a healthy infant. We propose the less time consuming and
easy to perform agglutination test as a routine screening test for
susceptibility to listeriosis during pregnancy to prevent bad
pregnancy outcomes.
Molecular detection of microbial ribosomal genes
P1742
Prospective evaluation of a real-time PCR assay
for direct detection of methicillin-resistant
Staphylococcus aureus in clinical specimens from
hospitalized patients
N. de San, O. Denis, M-F. Gasasira, R. De Mendonc¸a,
C. Nonhoff, M.J. Struelens (Brussels, BE)
Objectives: To evaluate the performance of a real time PCR
assay (with a ﬂuorogenic target-speciﬁc probe), MRSA-IDI
(GeneOhm Sciences) for MRSA detection directly from muco-
cutaneous swabs in hospitalized patients.
Methods: Clinical swabs (1 to 14 samples with a median of 2.1
samples per patient) fromnares (n = 330) and skin (n = 326)were
prospectively collected for MRSA screening from 321 patients
admitted to a 858-bed teaching hospital. Swabs were inoculated
onto selectiveMRSAagar (MRSA-ID, Biome´rieux), into the buffer
extraction solution for IDI-MRSA PCR assay and into enrichment
broth (BHI with 7.5% NaCl). After 24h, BHI broths were
subcultured onto MRSA-ID agar. Selective agars were incubated
for 48 h at 35ordm;C and examinated daily. Suspected colonies
were identiﬁed by coagulase testing; oxacillin resistance was
tested by cefoxitin disk diffusion according to CLSI
recommendations. The PCR assay was performed according to
themanufacturer’s instructions. PCR resultswere comparedwith
phenotypic identiﬁcation test results. In case of discordant results,
the assay was repeated, but only results from ﬁrst testing were
considered for calculating test performance.
Results: MRSA was detected by culture in 74 specimen (11.3%)
from 38 patients. The sensitivity and speciﬁcity of the PCR
compared with culture was 82.4% and 96.9%, respectively.
Positive predictive value and negative predictive value were
77.2% and 97.7%, respectively. The sensitivity of PCR (92%) was
higher on nasal swabs than on swabs from other sites (77.5%,
p < 0.001). The PCR assay detected MRSA in 34 patients (89.5%).
The PCR assay provided results in 2 to 12 versus 48 to 72 hours
for conventional method.
Conclusion: In our hospital, the ID-MRSA PCR assay detected
89.5% MRSA carriers in less than 12 hours when performed on
multiple specimen. The assay appeared more sensitive in testing
nasal swabs than other clinical specimens. Prospective studies
are needed to evaluate the impact of this assay for rapid
implementation of infection control procedures and its global
costs and beneﬁts.
P1743
Rapid and sensitive detection of methicillin-
resistant Staphylococcus aureus from blood
culture bottle by real-time PCR
C. Eroglu, H. Yilmaz, U. Cakmak, D. Turan, H. Leblebicioglu
(Samsun, TR)
The purpose of this study was to establish a rapid and sensitive
real-time polymerase chain reaction (PCR) method for detection
of methicillin-resistant Staphylococcus aureus (MRSA) from blood
culture bottle. As a result of over use of broad-spectrum
antibiotics after the 1960s in whole the world, an outbreak of
MRSA infection has been seen. Severe nosocomial infections
with MRSA such as bacteraemia and sepsis may lead to multiple
organ failure and high mortality in the hospital. Although
standard method took at least 48 hours to identify MRSA by the
blood culture method, the presence of mecA and nuc genes
which is speciﬁc for methicillin resistance and S. aureus was
determined by real-time PCR method within only 2 hours after
blood culture signal positivity. Nineteen S. aureus and 33
coagulase negative staphylococci positive blood culture bottles
were studied retrospectively for detection of S. aureus and
methicillin resistance. Staphylococci were identiﬁed with clas-
sical methods and MICs of oxacillin were determined by Etest
(AB Biodisk) on Mueller-Hinton agar supplemented with 2%
NaCl. Real-time PCR was performed to all positive blood
culture samples for S. aureus and methicillin resistance deter-
mination. Nineteen (100%) S. aureus were determined correctly
by real-time PCR method. Forty-four methicillin resistant and 8
methicillin sensitive staphylococci were detected by Etest. Using
the real-time PCR method, the mecA gene was detected in 47
Staphylococci except 3. When compared with Etest and real-
time PCR method gave sensitivity, speciﬁcity, and positive and
negative predictive values of 100%, 63%, 94%, 100% for both
positive and negative tests, respectively. Agreements between
two methods were high (94%); there were 3 discrepant results
among the 52 strains were tested. Detection of MRSA bacterae-
mia and methicillin resistance with real-time PCR deﬁnitely is
useful for reducing mortality and morbidity of this type
infection. In conclusion, this method, as many as sensitive and
speciﬁc for detection of MRSA bacteraemia and clinically should
be beneﬁcial for prevention of unnecessary antibiotic use and
determination of appropriate antibiotic treatments of MRSA
infection.
P1744
PCR detection of Class B, C and D beta-
lactamases in environmental and clinical
Aeromonas strains
T. Fosse, C. Giraud-Morin, F. La Louze (Nice, FR)
Objectives: Aeromonas spp. strains are waterborne
opportunistic pathogens. They are able to produce different
types of beta-lactamases (class B, C and D). The determination of
beta-lactamase content is not easy by phenotypic methods. We
have developed a PCR tool to study diversity and distribution of
Class B, C and D beta-lactamases in a set of representative
clinical and environmental Aeromonas species.
Method: A total of 22 references, 20 environmental and 80
clinical strains were tested. Identiﬁcation was realized by
conventional tests and gyrB sequence analysis. Beta-lactam
antibiotic susceptibility was determined by diffusion agar and
micro broth dilution methods. Three sets of speciﬁc primers
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were deﬁned for the PCR ampliﬁcation of the internal region of
class B beta-lactamase (MEI1 and MEI2, 297 bp size), class C
beta-lactamase (AERCP1 and AERCP2, 840 bp) and class D beta-
lactamase (AERD1 and AERD2, 514 bp). All PCR products were
sequenced.
Results: Class D PCR was positive with most strains except A.
trota, a ticarcillin susceptible species (3 strains). Class C PCR was
positive with most cephalothin resistant strains (MIC >16 mg/l;
61/67 strains, 91%) including A. hydrophila and A. caviae
phenospecies. Class B PCR was positive with most strains of A.
hydrophila andA. veroniiphenospecies (33/38; 87%) including three
imipenem susceptible strains (MIC < 5 mg/l). beta-lactamase type
distribution was species related and was particularly useful to
better characterize environmental species such as A. bestiarum, A.
popofﬁi and A. allosaccharophila. Partial beta-lactamase gene
sequence analysis allowed phylogenic studies. Some
cephalosporinase gene from environmental species was probable
progenitor of ampC plasmidic beta-lactamase.
Conclusion: PCR with speciﬁc primers was a good method to
detect class B, C and D beta-lactamase in Aeromonas species.
Beta-lactamase type distribution and sequence analysis
phylogeny were largely species related and could be helpful
for molecular diagnostic and taxonomic purpose.
P1745
Detection of enterotoxine B producing
Staphylococcus aureus directly from milk
M. Popa, I. Codita, M. Surdeanu, M. Straut, S. Cretoiu,
M. Negut (Bucharest, RO)
Objectives: The aim of this study was to develop a convenient
DNA extraction method and to optimise a PCR reaction in order
to detect enterotoxin B producing S. aureus strains directly from
milk.
Methods: We applied a chemical extraction method of bacterial
DNA from milk samples artiﬁcially inoculated with S. aureus. A
PCR based method was used for the detection of seb gene
(coding for enterotoxin B) and nuc gene (coding for termonuc-
lease). A protocol for the multiplex PCR was developed and
optimized. The sensitivity of the reaction was checked by
determining the minimum number of organismsÆml-1, which can
be detected in the multiplex PCR and in each single PCR
reaction. Ampliﬁcation speciﬁcity of the seb gene was veriﬁed
by amplicon digestion with restriction endonucleases.
Results: The speciﬁc bands for both genes in the multiplex PCR
were detected in samples containing a DNA quantity
corresponding to 5000 organismsÆml)1. In the same reaction,
the amplicon for nuc gene was visible for as little as the DNA
concentration corresponding to 1000 organismsÆml)1. The
sensitivity of each single PCR reaction was similar with those
of multiplex PCR reaction.
Conclusion: The applied DNA extraction method allowed us to
obtain a good quality DNA and can be used for a direct milk
extraction. Multiplex PCR reaction is a simple, rapid and reliable
method for detecting enterotoxin B producing S. aureus strains
from milk.
P1746
Genotypic detection of resistance to
ﬂuoroquinolones by PCR-RFLP in Acinetobacter
baumannii clinical isolates
E. Garcı´a-pen˜uela, T. Alarco´n, A. Pe´rez de Ayala, N. Arenal,
J.L. Navarro, M. Lo´pez-Brea (Madrid, ES)
Objective: To detect the resistance to ﬂuoroquinolones in 30
Acinetobacter baumannii strains by a PCR-RFLP assay.
Methods: Thirty A. baumannii clinical isolates were obtained
from different specimens (bronchial aspirates, blood-cultures,
catheters, etc.). The MICs (Minimal Inhibitory Concentrations)
for oﬂoxacin were determined by agar dilution following
standard methodology.A PCR-RFLP method using one primer
pair for ampliﬁcation of a 344 bp fragment related to gyrA gene
(which codiﬁes subunity A of DNA-gyrase) and using one
restriction enzyme Hinf I was developed to study the resistance
to oﬂoxacin in the different A. baumannii strains. When an A.
baumannii strain is resistant to ﬂuoroquinolones, a mutation in
the position Ser 83 of the DNA-gyrase has been detected,
decreasing the afﬁnity for the antimicrobial. Agarosa gel was
used to determine the DNA pattern: 2 fragments of 289 bp and
55 bp when there is not mutation and 1 fragment of 344 bp
when the Ser 83 to Leu 83 mutation is present.
Results: The relationship between the PCR-RFLP pattern and
the MIC to oﬂoxacin is shown in the table 1. The results of PCR-
RFLP analysis of most strains were in agreement with the results
of MIC. One isolate was susceptible to oﬂoxacin by agar dilution
(MIC = 0.25 mg/l) whereas by PCR-RFLP this isolate seems to
be resistant because it presents the mutation in gyrA gene. Two
isolates with intermediate MIC (4 mg/l) showed mutation in
gyrA.
Conclusion: The genotypic study by PCR-RFLP proved that
oﬂoxacin resistant A. baumannii strains showed a punctual
mutation in gyrA gene, in the same position inside the sequence
of gene.
P1747
Evaluation of a rapid ampliﬁcation-detection
assay for the identiﬁcation of vancomycin-
resistant enterococci
J. Fuller, L. Turnbull, S. Shokoples, B. Lui, L. Rosmus,
R. Rennie (Edmonton, CA)
Objective: The routine identiﬁcation of vancomycin-resistant
enterococci (VRE) in clinical laboratories often yields a lengthy
turn-around-time that may impede infection control efforts,
particularly in an outbreak situation. In search of an improved
VRE test, we evaluated the GenoType Enterococcus assay
(Hain Lifescience, Germany), which provides both species and
van gene identiﬁcation for VRE, and compared the results to
conventional methods.
Methods: Forty clinical enterococcal strains isolated on VRE-
screen agar media were selected for study. Lactococcus and
Pediococcus were used as negative controls. Conventional
testing involved basic culture and identiﬁcation tests, E-test
susceptibility testing for vancomycin and teichoplanin, and PCR
for vanA, B, and C genes. The GenoType Enterococcus assay
involved multiplex DNA ampliﬁcation and reverse hybridiza-
tion of ampliﬁed product on an immobilized DNA strip-blot
containing probes for E. faecium, E. faecalis, E. casseliﬂavus,
E. gallinarum, vanA, vanB, vanC1, and vanC2/3.
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Results: The GenoType Enterococcus assay produced correct
species and van gene identiﬁcation for all 40 (100%) VRE
isolates, including 7 E. faecalis vanB, 12 E. faecium vanA, 12 E.
faecium vanB, 6 E. gallinarum vanC1, 1 E. gallinarum vanA-vanC1,
and 2 E. casseliﬂavus vanC2/3. The only minor discrepancy was
an E. casseliﬂavus that hybridized very weakly with the vanC1
probe in addition to the expected vanC2/C3 probe. The costs
per specimen were comparable for each test method. However,
the GenoType Enterococcus assay could be completed within a
normal working day in contrast to conventional testing, which
required a minimum of two days from the point of isolation on
the vancomycin-screen media.
Conclusion: From this preliminary evaluation, the GenoType
Enterococcus ampliﬁcation-detection assay provides VRE
species and van genotype identiﬁcation in a rapid and cost-
effective manner, superior to conventional culture methods.
Although further study is required, this kit may have clinical
utility during a VRE outbreak.
P1748
Application of minimal sequence quality values
prevents misidentiﬁcation of blashv type in
single bacterial isolates carrying different SHV
extended-spectrum beta-lactamase genes
N. Al Naiemi, B. Duim, K. Schipper, C.M. Vandenbroucke-
Grauls, A. Bart (Amsterdam, NL)
Background: Detection of extended spectrum beta-lactamase
(ESBL) genes by PCR and sequence analysis is the gold standard
for detection of SHV-type beta lactamases. Usually, quality
values of sequence analyses are not reported. During a study on
ESBL epidemiology, three strains for which the default sequence
assembly showed an SHV)2 or SHV-5 gene, showed low quality
values at certain positions in individual sequence traces. We
investigated the reason for these lower values.
Methods: SHV genes were ampliﬁed by PCR from three isolates
(Escherichia coli, Enterobacter cloacae and Pseudomonas aeruginosa).
Individual sequence traces were analysed with the computer
programs PHRED and Codon Code. PCR products were ligated
in vector pCR2.1 and transformed to E. coli. Sequence analysis
was performed on eight individual clones from each
transformation.
Results: Visual inspection of the low quality positions in the
sequence traces showed signals for two different nucleotides at
three positions in the SHV sequence: A or T at position 92, A or
G at position 402 and A or G at position 703. The
polymorphisms at positions 92 and 703 lead to aminoacid
substitutions, the four different combinations would give SHV
types 2, 2a, 5 or 12. The double signals suggested that two or
more blaSHV alleles were ampliﬁed. PCR amplicons were
cloned in E. coli, in the sequences of individual clones only two
combinations of the three polymorphisms were present:
A92G402A703 and T92A402G703. These two combinations
correspond to SHV-2 and SHV-12, respectively.
Conclusions: (i) In isolates of three different species, two
different SHV genes were present: SHV-2 and SHV-12. (ii)
Genotypic detection with default sequence assembly parameters
may lead to misidentiﬁcation of the number and type of SHV
genes carried by a single strain. (iii) Careful interpretation of
sequence data of SHV genes, including analysis of low quality
positions, may further improve our understanding of the
epidemiology and evolution of these ESBL genes.
P1749
Antimicrobial susceptibilities and
epidemiological analysis of Salmonella
typhimurium human isolates in Slovakia by
phage typing and pulsed-ﬁeld gel electrophoresis
V. Majta´n, L. Majta´nova, M. Szabo´ova´ (Bratislava, SK)
Objectives: Salmonella Typhimurium is a common cause of
salmonellosis among humans and animals in many countries.
In the last few decades the incidence of multidrug-resistant S.
Typhimurium infections appears to pose a particular health risk.
The objectives of this study were analysis by antibiotic
susceptibility, phage typing and pulsed-ﬁeld gel
electrophoresis (PFGE) of S. Typhimurium human isolates.
Methods: A total of 145 strains isolated during 1997–September
2005 were analysed. The susceptibility of isolates to ten
antibiotics was evaluated by a disk diffusion method. The
phage types were identiﬁed according to Anderson et al. (1977)
in the National Reference Center for phage typing of
Salmonellae. PFGE was used to resolve XbaI macro restriction
fragments from all strains.
Results: Of human isolates 88 (60.7%) were resistant to more
than two antibiotics. Sixty-three of isolates (43.4%) showed a
classic DT104 resistance proﬁle to ampicillin, chloramphenicol,
streptomycin, sulfonamides, tetracycline (ACSSuT). Among this
resistance type 37.2% were DT104, 7.6% were DT120 and one
strain was DT20a. Isolates encompassed 18 phage types. The
majority of isolates was found to be deﬁnitive phage type
DT104, representing 62.8% of all isolates. Other phage types
were mainly DT120, DT41 and DT20a. Nine pulsotypes and 18
subpulsotypes were obtained using XbaI restriction enzyme, but
pattern X1 with its subtypes predominated (86.9%). A major
pulsotype X1 was represented by 51.7% of DT104 isolates and
was also found among DT120 isolates.
Conclusion: Results indicated the spread of different clones of
the multidrug-resistant S. Typhimurium in the Slovakia, but with
predominance of one clone represented mainly by DT104
isolates. The phage typing as well as PFGE may offer an
improved level of discrimination for the epidemiological
investigation of S. Typhimurium human strains.
P1750
Novel reverse hybridisation assay to identify
CTX-M genotype in cephalosporin-resistant
isolates from UK and India
V.M. Ensor, M. Shahid, R. Hope, M. Warner, N. Woodford,
D.M. Livermore, P.M. Hawkey (Birmingham, UK; Aligarh, IN;
London, UK)
Objectives: a) To develop a novel reverse hybridisation assay
for identiﬁcation of CTX-M genotypes among large collections of
cephalosporin-resistant Enterobacteriaceae isolated during
surveillance studies in South-East England and North India. b)
To validate the assay results by DNA sequencing.
Methods: Isolate collection 1: 110 Enterobacteriaceae resistant
to extended-spectrum cephalosporins, isolated in London and
South-East England. These isolates were known to carry
phylogenetic group 1 blaCTX-M, but precise genotypes had
not been determined. Isolate collection 2: 130 Enterobacteriaceae
resistant to extended-spectrum cephalosporins, isolated in Ali-
garh, North India. Resistance determinants had not been
investigated previously. A novel multiplex PCR was used to
amplify blaCTX-M. Reverse hybridisation was carried out using
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biotinylated PCR amplicon and sequence-speciﬁc oligonucleo-
tides designed to identify members of CTX-M phylogenetic
group 1. Hybridisation results were validated by DNA sequen-
cing for 20 representative isolates from each collection.
Results: 109/110 London and SE England isolates known to
carry group 1 blaCTX-M gave a consistent proﬁle,
corresponding to that for CTX-M-15 and CTX-M-28; 1/110
gave a proﬁle corresponding to CTX-M-3 and CTX-M-22. 82/130
Indian isolates had blaCTX-M genes, all of which belonged to
group 1, and all these gave a hybridisation proﬁle
corresponding to CTX-M-15 or CTX-M-28. CTX-M-28 and
CTX-M-22 are rare variants, suggesting that the enzymes
present were more likely to be CTX-M-15 and CTX-M-3, and
this was conﬁrmed by DNA sequencing.
Conclusions: This is the ﬁrst reported application of this novel
reverse hybridisation assay to the analysis of large numbers of
cephalosporin-resistant Enterobacteriaceae. Results were
validated by DNA sequencing. The assay is cheap and
convenient, enables reasonable throughput, provides results
within one day and can be used in place of DNA sequencing.
We believe it will be valuable for monitoring the prevalence and
genotypes of blaCTX-M genes in Enterobacteriaceae.
P1751
Detection of mexA and mexX efﬂux genes in
P. aeruginosa: correlation between QC-RT-PCR
and real-time PCR
N. Mesaros, Y. Glupczynski, D. Pierard, A. Dediste,
Y. Van Laethem, P. Tulkens, M. Mingeot-Leclercq,
F. Van Bambeke (Brussels, Yvoir, BE)
Objectives: Efﬂux systems are rarely identiﬁed as such in
clinical microbiology laboratories. Yet, over expression of
transporters such as MexAB-OprM and MexXY-OprM are
likely to cause antibiotic multi- and cross-resistance in
Pseudomonas aeruginosa, leading to potential clinical treatment
failures because of their inducible character. We have previously
developed and validated with reference strains a QC-RT-PCR
method to quantify mexA and mexX expression levels (ECCMID
2005, P1731). In the present study, we have developed a Real-
Time-PCR assay and present here the correlation between both
methods using control strains and clinical isolates.
Methods: Expression levels of mexA and mexX were measured
by both techniques in (i) 4 reference strains expressing only one
of these efﬂux mechanisms [mexA (2) or mexX (2)]; and (ii) 8
clinical isolates, in comparison with the wild-type strain PAO1
(basal mexA and mexX expression levels).
Results: Real-Time PCR showed an inter-day reproducibility of
95 ± 5.3% (triplicates of 10 strains). Among the clinical strains, 5
over expressed mexA and 3 mexX. The Table shows (i) the mean
level of overexpression of mexA and mexX in comparison with
the wild type strain PAO1 (set at 1), as detected by Real-time
PCR for all strains; (ii) the ratio of these values to those observed
by QC-RT-PCR for the corresponding transporters.
Conclusions: Both QC-RT-PCR and Real-Time-PCR are poten-
tially useful in clinical laboratories as sensitive and rapid
diagnostic tools to quantify the expression level of mexA and
mexX in P. aeruginosa. Combined with phenotypic characteriza-
tion, this approach may help in a better understanding of the
resistance mechanisms and epidemiology of resistance in this
difﬁcult-to-treat nosocomial pathogen.
P1752
Molecular detection of penicillin resistance in
Streptococcus pneumomiae
N.G. Rizk, N.A. Abo Khadr, S.M. Abdel Salam, N.M. Gamil,
M. Hassan (Alexandria, EG)
Objectives: The aim of the study was to detect penicillin
resistant Streptococcus pneumoniae by using seminested polym-
erase chain reaction (PCR) and to compare it with minimum
inhibitory concentration (MIC) of penicillin G.
Methods: Fifty clinical isolates of Streptococcus pneumoniae
where isolated from patients admitted to Alexandria Main
University Hospital in Egypt and were recovered from sputum
(36 strains), throat swabs (11 strains), and pleural effusion (3
strains). Two species-speciﬁc primers 1A-1 and 1A-2, which
ampliﬁed 1043 bp region of the pbp1A penicillin-binding gene,
were used for pneumococcal detection. Two resistance primers,
1A-R1 and 1A-R2, were used to bind to altered areas of pbp1A
gene which, together with the down stream primer 1A-2,
amplify DNA sequences of 224 bp and 569 bp from isolates
with penicillin MIC > 0.1 and ‡ 1 lg/ml respectively. Results
compared with the MIC values obtained by E-test Penicillin G
strips.
Results: For 98% of the isolates tested, PCR results were in
agreement with MIC data. The sensitivity of PCR assay in
detection of penicillin resistance was 96.4%, and the speciﬁcity
was 100%. The positive and negative predictive values of the
assay were 100% and 95.6% respectively.
Conclusion: The seminested PCR is a rapid speciﬁc method in
diagnosis of Streptococcus pneumoniae, which can be applied
directly on clinical specimens. Meanwhile it can detect resistant
strains and differentiate between intermediate and high level
resistance.
P1753
Lipopolysaccharide-binding protein is a marker
of severity in patients with bacteraemia
S. Gaı¨ni, S.S. Pedersen, C. Pedersen, O.G. Koldkjær (Odense,
Sønderborg, DK)
Objective: Lipopolysaccharide-binding protein (LBP) is an
acute phase protein produced in the liver. The objective of our
study was to evaluate LBP as a marker of severity and prognosis
in patients with bacteraemia.
Methods: 42 adult patients with community-acquired bacterae-
mia were included in a prospective manner. Daily blood
sampling for LBP and Interleukin-6 (IL-6) was performed. The
patients were classiﬁed according to the Systemic Inﬂamma-
tory Response Syndrome (SIRS) criteria. Demographic data,
co-morbidity, microbiological aaetiology, routine biochemical
parameters, focus of infection, severity score and mortality on
day 28 were recorded. LBP and IL-6 levels were analysed on
plasma samples with a chemiluminescent immunometric assay
(Immulite-1000).
Results: The median age was 71 yrs. The mortality rate on day
28 was 16.6%. 5 patients had bacteraemia without SIRS, 17
patients had sepsis and 20 patients had severe sepsis. LBP
concentrations are presented as medians and range: 32.2 lg/ml
(28.2–34.1) in patients without SIRS, 45.4 lg/ml (20–85.6) in
patients with sepsis and 50.9 lg/ml (22.9–96.5) in patients with
severe sepsis (P < 0.05). LBP levels correlated to levels of IL-6 (rs
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0.52), C-reactive protein (rs 0.68), leukocytes (rs 0.44) and
neutrophils (rs 0.46) (P < 0.01). LBP did not predict the outcome
of the patients with bacteraemia.
Conclusion: LBP levels increased with the severity of sepsis in
patients with bacteraemia. LBP correlated to IL-6, C-reactive
protein, leukocytes and neutrophils. LBP did not predict the
outcome of the patients in this small cohort.
P1754
Pyrosequencing of the GRA6 gene to
discriminate type I, II and III Toxoplasma gondii
in clinical samples
B. Edvinsson, B. Evenga˚rd on behalf of the ESGT
Objectives: Infection with Toxoplasma gondii in immunocom-
promised transplant recipients is rare but often fatal. To increase
our knowledge about the signiﬁcance of the genotype of the
parasite during infection, methods suitable for routine use need
to be developed. Pyrosequencing is a rapid sequencing-by-
synthesis method performed in real-time. It is developed for
detection of short nucleotide polymorphisms (SNPs), and is
suitable for molecular genotyping of microorganisms. We here
present a pyrosequencing assay for rapid and reliable discrim-
ination of Toxoplasma gondii type I, II and III in clinical samples.
Methods: Twenty-two isolates of T. gondii were used for
pyrosequencing analysis of the GRA6 gene. Real-time PCR
was performed using a LightCycler 2.0 instrument to amplify a
176 bp fragment of the GRA6 gene. Pyrosequencing analysis of
two different SNPs contained within a 10 bp fragment of the
ampliﬁed product was preformed to identify T. gondii type I, by
detection of nucleotides G and A at these respective positions.
Type II was G and G, and type III was A and A. To test the assay
in a clinical context, blood samples and lung tissue from an
immunocompromised patient was analysed.
Results: The detection limit of the assay is 10 parasitic genomes
in a sample. Reproducibility (R) was calculated as R = Nr/N
(Nr = the number of isolates assigned the same type on repeat
testing and N = the number of isolates tested). R was
determined using three independent runs, and was 1,
suggesting clearly interpretable results with little variation.
Typeablility (T) of the assay was calculated as T = Nt/N
(Nt = the number of typeable strains and N = the number of
isolates tested). T was determined using three independent runs,
each including four atypical isolates. T was 0.82, suggesting that
the assay discriminates correctly between the three main
genotypes of T. gondii, but does not detect atypical strains.
Analysis of the clinical samples revealed type II T. gondii in
blood samples and lung tissue.
Conclusion: When preceded by real-time PCR, pyrosequencing
is a rapid process with a high reproducibility and throughput.
This makes it a good candidate for routine use. The method
does, however, not detect atypical or recombinant strains. More
than one gene may have to be analysed for that purpose.
Acknowledgement: In particular, we want to thank Marie-
Laure Darde´ and Herve´ Pelloux for provision of the T. gondii
isolates.
P1755
Virulence genes in Escherichia coli isolates from
calves in Shahrekord area, Iran
T. Zahraeisalehi, M. Mahzounieh, F. Asadian, M. Khosravi,
M. Boniadian (Tehran, Shahrekord, IR)
Shiga toxin-producing Escherichia coli (STEC) strains, also called
verotoxin-producing E. coli (VTEC) strains, represent the most
important recently emerged group of food-borne pathogens
around the world. Members of this group are a major cause of
gastroenteritis that may be complicated by hemorrhagic colitis
(HC) or the hemolytic uremic syndrome (HUS), which is the
main cause of acute renal failure in children. Domestic
ruminants, mainly cattle, sheep, and goats, have been implicated
as the principal reservoir. Transmission occurs through con-
sumption of undercooked meat, unpasteurized dairy products
and vegetables, or water contaminated by feces of carriers
because STEC strains are found as part of the normal intestinal
ﬂoras of the animals.We studied the prevalence of Shiga toxin-
producing Escherichia coli (STEC) in stool specimens of calves
with diarrhoea or other gastrointestinal alterations from 10 dairy
cattle farms of Shahrekord City (central of Iran). The virulence
genes, stx1, stx2, eae, Intimin Hly, enterohemolysin, ST, LT,
were detected by multiplex PCR method. STEC strains were
detected in 7 (11.5%) of 61 E. coli from 180 cases investigated.
STEC O157 was isolated in 7 cases (11.5%), whereas non-O157
STEC strains were isolated from 4 animals (6%). STEC strains
were the most frequently recovered enteropathogenic bacteria.
PCR showed that 5 (8.2%) isolates carried st gene. None of
isolates carried an ehxA, eae, and LT (labile toxin) genes. Our
results suggest that STEC strains are a signiﬁcant cause of calf
infections in this area and conﬁrm that, infections caused by
STEC non-O157 strains are more common than those caused by
O157:H7 isolates. The high prevalence of STEC strains (both
O157 and non-O157 strains) also found in human patients by
other investigators, and their association with serious compli-
cations, strongly supports the utilization of protocols for
detection of all serotypes of STEC in Spanish clinical microbio-
logy laboratories.
P1756
Periplasmic expression of active recombinant
shiga toxin (Stx) 1
M. Oloomi, S. Bouzari (Tehran, IR)
Objectives: Shiga toxins are A-B holotoxin including one
enzymatically active A subunit associated non-covalently to
ﬁve identical receptor binding B subunits. Each subunit can
cause different signalling pathways in different cells. To assess
the effect of each single subunit the speciﬁc clones for expressing
the single subunit was designed. Periplasmic expression yielded
native AB5 holotoxin or B5 pentamer.
Methods: O157 was used as bacterial strain for PCR
ampliﬁcation of shiga toxin gene. Each subunit was ampliﬁed
by speciﬁc primers and the ampliﬁed genes were cloned in
pBAD expression vector. The expression of the cloned genes
was induced and optimized by different concentration of
arabinose. The expressed proteins was assessed on SDS-PAGE
and detected by ELISA and western blotting. The expressed
recombinant AB5 holotoxin and B subunit were puriﬁed and
assessed for its biological activity on cells. Cell cytotoxicity was
shown by the expressed (AB5) holotoxin. Moreover inhibition
was observed by B subunit and antibody against it.
Results: E. coli clones expressing recombinant shiga toxin A and
recombinant shiga toxin B subunits were established to release
the toxin to periplasmic space. Expressed toxin was examined
by SDS-PAGE to visualize two subunits. The whole structure of
these expressed subunits was checked in native gel. Active AB5
structure expressed in periplasmic space was extracted by
polymyxine B. The biological activity of the constructed
recombinant shiga toxin showed both Vero cell Cytotoxicity
and inhibition of in vitro protein synthesis.
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Conclusion: In this study it was shown that for B subunit
assembly and secretion to periplasmic space as B5 pentamer
homologous leader sequence is not needed. Although for
biological active holotoxin (AB5) secretion to periplasmic
space the presence of homologous leader sequence of gene is
essential. These subunits can be used for studying on cell
cytotoxicity and also as a vector for antigen presentation in
immunotherapeutic approaches.
P1757
Characterisation of Gram-positive anaerobic cocci
by biochemical tests and partial 16S rRNA
sequencing
A. Bryk, A. Kanervo-Nordstrom, M. Hyvonen, E. Kononen
(Helsinki, FI)
Objective: Gram-positive anaerobic cocci, which are common
ﬁndings in various infections, are difﬁcult to identify in clinical
microbiology laboratories,where identiﬁcation isbasedonlyonfew
phenotypic tests. In recent years, this group of organisms
(traditionally known as peptostreptococci) has encountered
several taxonomic changes. The aim of the present study was to
compare the characterizationmadebya selectionof keyphenotypic
tests to that by partial sequencing of the 16S rRNA gene.
Methods: Fifty-nine clinical isolates sent to our laboratory as
gram-positive anaerobic cocci were examined for their colony and
cell morphologies and biochemically characterized using spot
catalase and indole reaction, 8 enzyme reactions by individual
diagnostic tablets (Rosco), sodium polyanethol sulphate
susceptibility, glucose fermentation, and determination of
metabolic end products. In addition, commercial identiﬁcation
test kit (Rapid ID 32A) patterns were performed. The sequencing
of the 16S rRNA gene of the 59 clinical isolates and 4 reference
strains comprised of about 470 bp, and the sequences obtained
were compared to those in GenBank database by using the
multisequence Advanced BLAST comparison software from the
National Center of Biotechnology Information.
Results: The biochemical characteristics of the isolates were
consistent with those of Peptostreptococcus anaerobius (n = 8),
Peptostreptococcus (Micromonas) micros (n = 6), Finegoldia
magna (n = 25), Peptoniphilus asaccharolyticus (n = 8),
Peptoniphilus sp. (n = 8) and Anaerococcus sp. (n = 2), whereas
2 isolates remained as unidentiﬁed gram-positive anaerobic
cocci. Biochemical identiﬁcation correlated with that obtained by
partial 16S rRNA sequencing in 56/59 (95%) isolates at genus
level and in 40/59 (68%) isolates at species level. The agreement
of the biochemical and sequence-based identiﬁcation was 100%
for P. micros and F. magna. Of 8 isolates biochemically identiﬁed
as P. asaccharolyticus, 2 isolates were identiﬁed as Peptoniphilus
harei and 6 remained as Peptoniphilus sp. by sequencing.
According to the sequence data, the 2 unidentiﬁed isolates
were Peptoniphilus ivorii.
Conclusion: Most isolates from human infections proved to be
F.magna.A relativelygoodagreementof identiﬁcationwasobtained
using biochemical testing and partial 16S rRNA sequencing.
P1758
23S PCR as a supplementary method for
diagnosis of infectious arthritis. A prospective
study
C. Moser, K. Andresen, A. Kjerulf, S. Salamon, M. Kemp,
J.J. Christensen (Copenhagen, DK)
Objectives: Molecular methods for identiﬁcation of infectious
agents in patients with clinical infectious disease are
increasingly being used. Especially in cases where antibiotics
have been given prior to sampling or when fastidious bacteria
difﬁcult to grow are the aaetiology of the infection. Infectious
arthritis is a serious disease where identiﬁcation of the
etiological agent is mandatory for optimal antibiotic treatment
as well as indication of the primary focus if not the joint it self.
Methods: In the present prospective study, 227 synovial ﬂuids
taken from patients in elucidation of affected joints and sent to a
Clinical Microbiological laboratory in the Copenhagen area,
Denmark, were examined by conventional (culture, phenotypic
tests) and molecular methods (PCR/sequencing of 23S
ribosomal genes). Conventional methods included Gram-
staining and microscopy, aerobic and anaerobic culture and
identiﬁcation. PCR/sequencing included DNA extraction, PCR
assay which produced a 700 bp fragment of 23S rDNA, and
sequencing of both DNA strands of the amplicons. Sequencing
data were edited and a BLAST search in the NCBI database was
done.
Results: Overall a microorganism was identiﬁed in 24 of the 227
synovial ﬂuids (10.6%). In 14 synovial ﬂuids from nine patients
bacteria were identiﬁed by either methods [Staphylococcus aureus
(n = 8), Streptococcus pneumoniae (n = 3), Streptococcus
dysgalactiae (n = 2), Citrobacter freundii (n = 1)]. Six synovial
ﬂuids were only culture positive; in four of those six specimens
coagulase negative staphylococci were isolated. In three of the
227 synovial ﬂuids a microorganism was identiﬁed by 23S PCR
only. In two synovial ﬂuids 23S PCR identiﬁed only one
microorganism, whereas culturing resulted in two isolates.
Conclusion: The present study indicates a signiﬁcant
contribution by molecular methods (PCR/sequencing of 23S
ribosomal genes) in recognizing and identiﬁcation of
microorganisms from foci normally considered sterile like
synovial ﬂuids. Continued suspicion of infected arthritis
despite of negative cultures should result in use of molecular
diagnostics.
P1759
Direct detection of Cardiobacterium hominis by
broad-range 16S rRNA PCR and sequencing in
the serum of a patient with infective endocarditis
E. Malli, D. Klapsa, A. Vasdeki, M. Morava, M. Pitsitaki,
E. Petinaki, A. Maniatis (Larissa, GR)
Objectives: To describe the detection of Cardiobacterium hominis
directly in the serum of a patient with infective endocarditis, by
employment of broad-range 16S rRNA PCR followed by
sequencing.
Methods: A series of blood cultures were taken from the patient
before starting empirical treatment. In addition, 10 ml whole
blood was collected in rubber sealed pyrogen-free tubes for
direct detection of bacterial DNA. Bacterial DNA was detected
by a broad range PCR reaction and sequencing process allowed
identiﬁcation of bacteria species.
Results: Cardiobacterium hominis was identiﬁed as the causative
agent of infective endocarditis, on two days after the serum
collection. Blood cultures, simultaneously obtained with the
serum sample, remained negative after 5 days of routine
incubation; however, after a prolonged incubation of twelve
days a gram negative bacterium was isolated from the aerobic
bottles, that was identiﬁed as C. hominis species, by the usual
phenotypic studies (catalase, oxidase reaction, indole, nitrate,
etc) which are time-consuming.
Conclusions: To our knowledge this is the ﬁrst report of direct
detection of C. hominis in the serum using molecular methods,
emphasizing the need for the establishment of such methods
especially for infections caused by fastidious organisms.
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P1760
Identiﬁcation of dangerous bacterial pathogens
by 16S ribosomal RNA gene sequence analysis
W. Ruppitsch, A. Stoeger, A. Indra, D. Schmid, K. Grif,
C. Schabereiter-Gurtner, A. Hirschl, F. Allerberger (Vienna, AT)
To assess the usefulness of partial 16S rRNA sequence analysis
for identiﬁcation of dangerous bacterial pathogens, a total of 28
isolates comprising Bacillus anthracis, Brucella melitensis, Biovars
melitensis, Suis, Abortus and Bovis, Burkholderia mallei, Burk-
holderia pseudomallei, Francisella tularensis, Yersinia pestis, and 9
genus-related and unrelated control strains were sequenced and
analysed using the GenBank database (Blast 2.2.10, National
Institute of Health, U.S.A), the MicroSeq500 database (version
1.4.1 and V1.0, Applied Biosystems, Foster City, U.S.A.), The
Ribosomal Database Project-II database (RDP-II, release 9,
update 26, Michigan State University, U.S.A), and the Ribosomal
Differentiation of Medical Microorganisms database (RIDOM,
University of Wuerzburg, Germany). On genus level all isolates
were identiﬁed using GenBank, RDP-II, and MicroSeq V1.0. The
older MicroSeq 1.4.1 database identiﬁed 92% of the tested
samples correctly on genus level. The RIDOM database did not
include sequence data of the tested species even on genus level,
the RIDOM database none (‘‘there seems to be, at least currently,
no close relative available’’). Genbank and RDP-II identiﬁed all
dangerous pathogens correctly. The MicroSeq V 1.0 database
identiﬁed four of the six species of dangerous pathogens. On
species level none of the dangerous pathogens was correctly
identiﬁed using MicroSeq 1.4.1 or RIDOM. As previously noted
by various other authors, the most important reason for failure
of databases in identifying a bacterium is a lack of the 16 S rRNA
gene sequence of the particular bacterium in the database rather
than misidentiﬁcation because of poor sequence quality. One
must also be aware that the following bacterial species or
subspecies have the same 16S rRNA gene sequence, which
makes differentiation by sequence analysis impossible: B. anthra-
cis and B. cereus, Y. pestis and Y. pseudotuberculosis, all Brucella
subspecies, and Francisella tularensis ssp. holarctica and mediasi-
atica. In addition to 16S rRNA gene analysis complementary
methods are essential to discriminate between these bacteria on
species or subspecies level.
P1761
Identiﬁcation of nontuberculous mycobacteria by
sequence analysis of the 16S ribosomal RNA, the
heat-shock protein 65 and the RNA polymerase
beta-subunit genes
S. Shin, J.H. Yoon, E.C. Kim (Seoul, KR)
Objectives: The diagnosis of diseases caused by
nontuberculous mycobacteria (NTM) is difﬁcult because NTM
are prevalent in the environment such as soil and water and
because they have fastidious properties. In this study, we
investigated the distribution pattern of NTM clinical isolates and
the identiﬁcation to the species level.
Methods: Among the presumptive NTM clinical isolates,
cultured in a third referral hospital from 21-Jan-2003 to 20-Jan-
2004 in Seoul, South Korea, which were negative by probe
hybridization method for Mycobacterium tuberculosis complex,
we selected those of more than 10 colonies or those cultured
more than twice in a same patient. A total of 120 isolates were
studied for the distribution of NTM including 97 isolates
recruited for species identiﬁcation by direct sequencing of 16S
rRNA, hsp65 and rpoB gene segments.
Results: Frequently identiﬁed NTM species were M. avium
30.8%, M. intracellulare 23.3% and M. abscessus 18.3%. Others
wereM. gordonae,M. senegalense,M. fortuitum,M. peregrinum,
M. kansasii, M. terrae complex, M. lentiﬂavum, M. chelonae, and
M. szulgai. Three M. tuberculosis complex (2.5%) were also
identiﬁed in thepresumptiveNTMisolates.The identiﬁcationrate
by sequencing of 16S rRNA, rpoB, and hsp65 were 65%, 82% and
87%, respectively. hsp65 or rpoB genewasmore efﬁcient than 16S
rRNA in identiﬁcation of NTM by sequencing.
Conclusions: Some NTM are considered to be the causative
organisms of clinical diseases even in the countries with
intermediate burden of tuberculosis, so accurate identiﬁcation
methodbydirect sequencingcanbeadapted to clinical laboratories.
P1762
Evaluation of the genotype MTBDR assay for the
simultaneous detection of resistance to
rifampicin and isoniazid of Mycobacterium
tuberculosis clinical strains
F. Brossier, C. Truffot-Pernot, N. Veziris, V. Jarlier,
W. Sougakoff (Paris, FR)
Objectives: The rapid determination of drug resistance in
Mycobacterium tuberculosis is an important challenge to ensure
a rapid effective chemotherapy. The Genotype MTBDR test is a
commercially available DNA strip assay enabling the molecular
genetic identiﬁcation of the M. tuberculosis complex and its
resistance to rifampicin (RIF-R) and isoniazid (INH-R) by
detecting the most commonly found mutations in the genes
rpoB (Asp516Val, His526Tyr, His526Asp, Ser531Leu) and katG
(Ser315Thr). Here, we report the evaluation of the Genotype
MTBDR assay from a set of 106 clinical isolates ofM. tuberculosis.
Methods: 106 clinical isolates were collected in France over a
2 years period (2003–2004) and were included in the study: 77
were RIF-R, 96 were INH-R (of which 73 were also RIF-R) and 6
were susceptible to both drugs. The susceptibility tests were
carried out by the standard proportion method. The mutations
involved in RIF-R and INH-R in rpoB, katG, inhA and his
promoter region, were characterized by DNA sequencing.
Results: The Genotype MTBDR assay identiﬁed 100% of the 77
RIF-R strains harbouring mutations in the rpoB gene, of which
37 (48%) showed a Ser531Leu mutation and 14 (18%) a
His526Asp or Tyr mutation. 61 of the 96 INH-R strains (63%)
harboured a Ser315Thr mutation in katG, all identiﬁed by the
Genotype MTBDR assay. 58 of this 61 strains displayed a high
level of INH-R. Among the other INH-R strains, 3 showed a
katG mutation at the level of the 315 regions, which was
different from Ser315Thr (2 of which showing a low level of
INH-R), and one harboured a deletion in katG (with a high level
of INH-R). These 4 mutations were also detected by the strip.
Finally, among the 31 remaining INH-R strains not detected by
the MTBDR assay, 13 were characterized by a mutation in
position -15 of the promoter region for the mabA-inhA regulon
(10 with a low level of INH-R), 7 by a Ser94Ala mutation in InhA
(all with a low level of resistance) and 11 by other mutations.
Conclusions: The MTBDR assay, which can readily be included
in a routine laboratory workﬂow, identiﬁed 100% and 68% of the
strains resistant to RIF and INH, respectively. Interestingly, 60 of
the 68 INH-R strains showing a high level of resistance (88%),
but only 5 of the 28 INH-R strains with a low level of resistance
(18%), were detected by the MTBDR assay, indicating that
complementary tests are necessary for detection of the
M. tuberculosis strains having a low level of resistance to INH.
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Variation in the streptococcal 16S rDNA detected
by pyrosequencing
M. Haanpera¨, P. Huovinen, J. Jalava (Turku, FI)
Originally the aim of this study was to identify alpha-haemolytic
streptococcal isolates to the species level by pyrosequencing the
v1 and v2 regions of the 16S rDNA and comparing the results to
the sequences of type strains that have been determined earlier.
However, the isolates could not be unambiguously identiﬁed
due to sequence variations detected in the alpha-haemolytic
isolates.
Materials and methods: Invasive S. pneumoniae isolates
(n = 17), alpha-haemolytic streptococcal blood culture isolates
(n = 16) and alpha-haemolytic streptococcal isolates from the
normal pharyngeal microbiota (n = 34) of six elderly persons
were analysed by pyrosequencing the v1 and v2 regions.
Results: Varying degree of genetic variation was found in
different types of streptococcal isolates. In the pneumococcal
isolates, no sequence variation was detected as all the isolates
contained the sequence speciﬁc for S. pneumoniae in both
regions. Also the sequences of the alpha-haemolytic blood
culture isolates were well in agreement with the sequences of
the streptococcal type strains. However, most of these isolates
could not be unambiguously identiﬁed, as they contained
sequences belonging to different species in the v1 and v2
region. Consequently, only ﬁve of the isolates could be
unequivocally identiﬁed as S. gallolyticus (n = 2), S. anginosus
(n = 1), S. mitis (n = 1) and S. sanguinis (n = 1). The commensal
streptococci contained numerous sequences to which an
identical type sequence could not be found. Also sequences
identical to type strains were found; but similarly to the blood
culture isolates, the results enabled the identiﬁcation of only
four isolates: S. mitis (n = 2), S. parasanguinis (n = 1), and S.
salivarius or S. vestibularis (n = 1). Moreover, the pyrograms of
three blood culture isolates and ten pharyngeal isolates
indicated heterogeneous 16S rDNA alleles. One such
pyrogram of the v1 region is presented in the ﬁgure.
Interestingly, four of the eight different nonheterogeneous v1
and v2 sequence combinations of the blood culture isolates were
also present among the pharyngeal isolates.
Conclusions: The results of this study indicate that the
variation in commensal streptococci is greater than that of
the streptococcal type strains and pathogenic isolates. The
presence of identical sequence combinations among the blood
culture and pharyngeal isolates supports the assumption that
potentially pathogenic isolates are present in the normal
microbiota.
P1764
Evaluation of partial 16S rRNA gene sequencing
for identiﬁcation of clinical isolates of Nocardia
species
M. Marı´n, M. Sa´nchez, M. del Rosal, E. Cercenado,
P. Martı´n-Rabada´n, E. Bouza (Madrid, ES)
New species of Nocardia are being described. Conventional
identiﬁcation based on biochemical characteristics and PCR-
restriction enzyme analysis is frequently unable to distinguish
them. Partial sequencing of 16S rRNA gene has proven useful in
the identiﬁcation of bacteria.
Objective: To evaluate the utility of 5’end 16S rRNA gene PCR
and sequencing in the identiﬁcation of clinical isolates of
Nocardia sp. compared with conventional methods and PCR-
RFLP of hsp65.
Methods: 48 clinical isolates of Nocardia sp. were characterized
by biochemical reactions and disk diffusion susceptibility
testing. Molecular identiﬁcation was performed by hsp65 PCR-
RFLP and PCR of 5’end of 16S rRNA gene followed by
sequencing. The sequences obtained were compared with
those included in Genebank. Only alignments with similarities
higher than 99% were considered. A comparison of sequences of
our Nocardia isolates with those deposited in Genebank and well
characterized phenotypically was performed using Clustal X 1.8
software.
Results: Distribution of species after PCR-RFLP of hsp65 wasN.
asteroides VI (22),N. farcinica (11),N. nova (6),N. asteroides I (4),N.
otitidiscaviarum (4) and N. asteroides IV (1). Partial sequence
analysis of 16S rRNA revealed a great heterogeneity between the
isolates of N. asteroides VI, as follows: N. cyriacigeorgica (15
isolates), N. abscessus (3 isolates) and N. carnea (1 isolate). For 3
isolates, no Genebank sequence was found with more than 99%
similarity. All N. farcinica isolates had the same sequence and
showed 100% similarity with those deposited in Genebank. N.
nova, N. asteroides I and N. otitidiscaviarum also showed sequence
heterogeneity. Three N. nova isolates matched with the recently
described N. veterana and 3 with N. nova. N. asteroides I isolates
were identiﬁed as N. abscessus (1) and N. beijingensis (3). All N.
otitidiscaviarum were identiﬁed properly. The isolate of N.
asteroides IV was identiﬁed as N. transvalensis.
Conclusions: Sequencing of 5’end 16S rRNA gene is a useful
and rapid molecular tool for the identiﬁcation of Nocardia
clinical isolates. This method could provide more accurate
results than the conventional ones used routinely in our
laboratory. Sequence analysis of the 5’end 16S rRNA has
enabled us to recognize great diversity and new species
among our Nocardia isolates. Several species would have gone
unnoticed using non-sequencing-based methods.
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Antibacterial susceptibility studies-III
P1765
Anaerobic bacteraemia due to Fusobacterium
necrophorum and Clostiridium cadaveris: a case
report
M. Panopoulou, E. Alepopoulou, E. Chrisaﬁdou, A. Tsaroucha,
C. Simopoulos, S. Kartali (Alexandroupolis, GR)
Introduction: Anaerobic bacteremia is uncommon accounting
0.5–9% of bacteremias and it is associated with a high mortality
rate, which is strongly and independently associated with
underlying liver disease.
Case report: A 62 year-old man presented to our hospital with a
2-day fever and rigor. He had a history of cancer of the
extrahepatic biliary tree, which was found incidentally during
an operation for the treatment of echinococcal cyst of the liver.
Physical examination reveals high fever (39 C) and tachycardia.
Blood tests showed the following results: Hb: 9.9 gr/dl, WBC:
22.500 /ul, PLT: 296.000 /ul, TPROT: 5.9 gr/dl, ALB: 2.4 gr/dl,
SGOT: 30 U/l, SGPT: 10 U/l, gGT: 137 U/l, ALP: 554 U/l, TBIL:
1.0 mg/dl, DBIL: 0.5 mg/dl, PT: 12/12.2, INR: 1.42, PTT: 30/34.
The ultrasound scan of the abdomen showed a large, cystic
lesion of the right lobe of the liver with heterogeneous content
and calciﬁed thick walls. The abdominal CT scan conﬁrmed the
presence of echinococcal cyst with the presence of intracystic air,
suggestive of cyst infection (abcess). Two sets from blood
sample cultures inoculated into aerobic and anaerobic bottles
and incubated in the BacT/Alert instrument (Bio Merieux-
France). Anaerobic bottles were positive after 48 hours of
incubation. The Gram stain revealed Gram negative bacilli and
Gram positive spore forming bacilli. Cultures on blood agar
plates yielded a heavy growth of two different types of colonies.
Each colony type subcultured to blood agar plates and
incubated aerobically and anaerobically (aerotolerance test).
After 24 hours of incubation the two organisms grew only in
anaerobic conditions. They identiﬁed by the Api 20A system
(Bio-Merieux-France) as Fusobacterium necrophorum and
Clostiridium cadaveris. The patient’s treatment started with
metronidazole, amikacin and ceftriaxone and followed by
metronidazole and imipenem. He was discharged after
3 weeks in a good condition.
Conclusions: Although anaerobic bacteremia is rare, there is
value in performing separate anaerobic blood cultures. The early
recognition of anaerobic bacteremia and administration of the
appropriate antimicrobial therapy play a major role in
preventing mortality especially in patients with underlying
disease.
P1766
Fluoroquinolone resistance among
Enterobacteriaceae strains isolated from urinary
tract infections
V. Skandami-Epitropaki, P. Fostira, A. Tsiringa, A. Xanthaki,
K. Zampitha, M. Toutouza (Athens, GR)
Objectives: To study the frequency and antibiotic susceptibility
of quinolone resistant bacterial stains isolated from patients with
community-aquired bacteriuria and compare it with urinary
pathogens from hospitalized patients.
Methods: During a 12-month period (October 2004–October
2005) a total of 772 bacterial strains were isolated out of 8369
urine samples submitted for culture in our hospital laboratory
from the community and from hospitalized patients with
urinary tract infection symptoms. Cultures and bacterial
identiﬁcation were obtained by conventional methods.
Antibiotic susceptibility testing was done by Kirby-Bauer disk
diffusion method according NCCLS criteria.
Results: Of the 772 bactrial strains studied (Escherichia coli 604,
Klebsiella pneumoniae 97, Proteus mirabilis 71), 14.6% of them were
found to be quinolone resistant. The percentage of quinolone
resistance was 19.9% for hospitalized patients (HP) and 5.7% for
community patients (CP). The quinolone resistance for E. coli
was 11.3% (16.5% for HP and 4.3% for CP), for K. pneumoniae
24.7% (28.0% for HP and 6.7% for CP) and for P. mirabilis 29.6%
(29.6% for HP, 29.4% for CP). Susceptibility pattern of the 113
quinolone resistant isolates to other antimicrobial agents was for
hospitalized patients and community patients respectively as
following: For E. coli ampicillin (AM) 7%–9.1%, amoxicillin-
clavulanate (AMC) 45.6%–54.5%, piperacillin-tazobactam (TZP)
69.4%–81.8%, cefuroxime (CXM) 64.9%–72.7%, trimethoprim-
sulfamethoxazole (SXT) 15.8%–18.2%, ceftazidime (CAZ)
66.7%–72.7%, cefepime (FEP) 66.7%–81.8%, gentamicin (GM)
80.7%–72.7%. For K. pneumoniaeAM 0%–0%, AMC 25%–0%, TZP
68.4%–100%, CXM 37.5%–100%, SXT 15.8%–100%, CAZ 37.5%–
100%, FEP 41.7%–100%, GM 79.2%–100%. For P. mirabilis AM
9.5%–20%, AMC 23.8%–40%, TZP 90.5%–100%, CXM 25%–40%,
SXT 4.8%–0%, CAZ 23.8%–40%, FEP 100%–100%, GM 56.3%–
60%. Seven strains of K. pneumoniae (29.2%) were carbapenem
resistant and metallo-beta lactamase producing.
Conclusions: High resistance rates to ﬂuoroquinolones were
observed in uropathogen bacteria isolated not only from
hospitalized patients but also from patients with community-
acquired urinary tract infections in Greece. Increasing resistance
rates to the rest antibiotic agents make the treatment of urinary
tract infections a very difﬁcult problem.
P1767
Susceptibility of Pseudomonas aeruginosa
isolated from the MYSTIC Programme to the
carbapenems: meropenem and imipenem
P.J. Turner (Macclesﬁeld, UK)
Objectives: The Meropenem Yearly Susceptibility Test
Information Collection Programme (MYSTIC) was initiated in
1997 in order to track the susceptibility of organisms in centres
that were prescribing meropenem. This poster seeks to examine
the susceptibility of Pseudomonas aeruginosa isolates over this
period to the carbapenems; meropenem and imipenem and, in
particular, records the susceptibility of imipenem-resistant
isolates to meropenem and vice versa.
Methods: Pseudomonas aeruginosa isolates were speciated by the
methods in current use at the participating centres. Minimum
Inhibitory Concentrations of meropenem and imipenem were
determined using reference methods described by CLSI.
Results: A total of 15709 isolates of Pseudomonas aeruginosa have
been tested globally, of these 78.2% were susceptible to
meropenem at the breakpoint of < 4 mg/L and 70.1% to
imipenem. Globally, susceptibility to the two carbapenems has
remained stable over the period 1997–2005, however when
imipenem-resistant isolates were examined (n = 4625) 32.7%
proved to be susceptible to meropenem, conversely of the 3359
meropenem-resistant isolates only 7.8% proved to be susceptible
to imipenem. A similar pattern was seen when isolates were
separated into global regions:USA 425 imipenem-resistant
isolates, 25.4% susceptible to meropenemUSA 346 meropenem-
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resistant isolates, 8.4% susceptible to imipenemN Europe 1448
imipenem-resistant isolates, 44.9% susceptible to meropenemN
Europe 898 meropenem-resistant isolates, 11.7% susceptible to
imipenemS. Europe 724 imipenem-resistant isolates, 41.3%
susceptible to meropenemS. Europe 465 meropenem-resistant
isolates, 9.0% susceptible to imipenemE. Europe 949 imipenem-
resistant isolates, 18.6% susceptible to meropenemE. Europe 812
meropenem-resistant isolates, 5.2% susceptible to meropenemS.
America 786 imipenem-resistant isolates, 17.4% susceptible to
meropenemS. America 668 meropenem-resistant isolates, 3.6%
susceptible to imipenem.
Conclusions: These results suggest that if a carbapenem is
required to be prescribed empirically in a situation where
Pseudomonas aeruginosa isolates are suspected then meropenem
is a logical choice because of its greater in vitro potency and
activity against some imipenem-resistant isolates.
P1768
Third Belgian multicentre survey of antibiotic
susceptibility of anaerobic bacteria
I. Wybo, D. Pie´rard, I. Verschraegen, M. Reynders,
K. Vandoorslaer, S Lauwers for the BVIKM-SBIMC/
GOSPIZ-GDEPIH working group
Objectives: To collect recent data on the susceptibility of
anaerobes and to compare with results from previous studies.
Methods: 450 anaerobic clinical isolates from various body
sites, collected from October 2003 to February 2005 in nine
Belgian university hospitals, were tested with E-tests against
penicillin (PEN), cefotetan (CTT), cefoxitin (FOX), amoxicillin-
clavulanic acid (AMC), piperacillin/tazobactam (TZP),
meropenem (MEM), clindamycin (CLI), metronidazole (MTZ),
chloramphenicol (CHL), moxiﬂoxacin (MXF) and linezolid
(LZD). Minimal inhibitory concentration for tigecyclin (TIG)
was determined by NCCLS agar dilution.
Results: Bacteroides fragilis group (BAFG) accounted for 53% of
the isolates, Fusobacterium spp. for 7%, other gram negative
bacilli (OGNB) for 11%, Clostridia (CLOS) for 14%,
nonsporeforming Gram-positive bacilli (NSFGPB) for 7% and
cocci for 8%. Beta-lactamases (BL) were detected in 61% of
isolates. Most BL + strains belonged to BAFG (98%) and OGNB
(70%). At NCCLS-recommended breakpoints, more than 95% of
isolates were susceptible to TZP, MTZ, CHL and MEM, 92% to
AMC but only 77%, 70%, 62% and 33% to FOX, CTT, CLI and
PEN respectively. No NCCLS-breakpoints for anaerobes are
available for MXF, LZD and TIG. MIC 50 and MIC 90 for MXF
were 1 and 64 mg/L, for LZD 2 and 4 mg/L and for TIG 0.5–
8 mg/L. In comparison with similar surveys conducted in 1987
and 1993–1994 susceptibility of BAFG to clindamycin decreased
from 83% in 1987, to 66% in 1993–1994 and 48% in 2004. In
BAFG 92% of B. fragilis and 78% of non-B. fragilis were
susceptible to AMC in this study; in 1993–1994 susceptibility
in these groups was 95% and 89% and in 1987–97% and 94%
respectively. All isolates, except 6 BAFG and 1 CLOS, were
susceptible to MEM. 98% of the isolates were susceptible to
CHL. Susceptibility to MTZ remains stable and is high in all
groups except NSFGPB where MTZ is active on merely 35% of
the isolates.
Conclusions: TZP, MEM and MTZ remain very potent
antimicrobial agents in the treatment of anaerobic infections.
Although still rare, resistant organisms were detected to each of
them. Therefore susceptibility testing of anaerobic isolates is
indicated in severe infections to conﬁrm appropriateness of
antimicrobial therapy. Further monitoring of background
susceptibility is necessary to guide empiric treatment.
P1769
Comparative in vitro activity of levoﬂoxacin
against Escherichia coli isolated from acute
pyelonephritis in france in 2005
C.J. Soussy, C. Lascols, C. Dib-Smahi and The Multicenter Group
Study.
Objectives: The objective of this study was to evaluate the in
vitro activity of levoﬂoxacin (LVX) comparatively to other
antibiotics against Escherichia coli strains isolated from acute
pyelonephritis in women consulting Emerging rooms by 23
French hospitals in 2005.
Methods: MICs of LVX, oﬂoxacin (OFX), ciproﬂoxacin (CIP),
nalidixic acid (NAL), amoxicillin-clavulanic acid (AMC),
ceftriaxone (CRO), ceﬁxime (CFM), amikacin (AN), gentamicin
(GM) and cotrimoxazole (SXT) were determined by agar
dilution according to the EUCAST breakpoints approved by
2005 recommendations of the Comite´ de l’Antibiogramme de la
Socie´te´ Franc¸aise de Microbiologie. Quality control was
performed with E. coli strain ATCC 25922.
Results: A total of 231 strains were collected. 46.3% of strains
were isolated from urinary samples, 10.8 % from blood culture
and 42.9% from the two specimens. MICs 50/90 (mg/L), the
range of MICs and the percentage of susceptibility (%) are
presented in the following table: Concerning the
ﬂuoroquinolones, MICs50/90 of LVX were one/two dilution
lower than those of OFX and two/one dilution higher than those
of CIP. For the other antibiotics, a higher percentage of
susceptibility was observed with CRO and AN, when a lower
percentage of susceptibility was observed with AMC and SXT.
Conclusions: Levoﬂoxacin exhibited good in vitro activity
against E. coli strains isolated from acute pyelonephritis with
93.1% of susceptible strains.
P1770
In vitro activity of double and triple
combinations of colistin, imipenem, rifampicin
and linezolid against epidemic strains of
multidrug-resistant Acinetobacter baumannii
producing OXA carbapenamases
D.W. Wareham, D.C. Bean (London, UK)
Objectives: A. baumannii has emerged as an important cause of
nosocomial infection in critically ill patients worldwide. In the
UK three strains in particular exhibiting multi-drug resistance
and producing OXA carbapenamases have been responsible for
ongoing outbreaks. Treatment options for infection with these
organisms are limited as only colistin and tigecycline retaining
signiﬁcant activity in vitro. Animal models and in vitro studies
using other multi-resistant strains suggest that drugs in
combination with colistin may be effective. We assessed the
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activity of colistin in combinations including imipenem,
rifampicin and linezolid against epidemic strains from a recent
UK outbreak.
Methods: Isolates of A. baumannii exhibiting resistance to
carbapenems were recovered from patients at Barts and The
London NHS. Isolates were referred to the Health Protection
Agency and conﬁrmed as belonging to clones producing OXA
carbapenemases. Activities of polymyxin, imipenem, rifampicin
and linezolid alone and in double and triple combinations were
determined using standard chequerboard assays with
increasing concentrations of drug 1 on the x axis, drug 2 on
the y axis and drug three in multiple replicate plates. After
incubation at 24 hours wells were examined for growth and
MIC’s determined for each combination. Synergy between
agents was deﬁned as a ﬁxed inhibitory concentration index
(FICI) of < 0.5.
Results: The isolates tested belonged to the OXA-23 clone 1,
OXA-23 clone 2 and the South East Clone, as conﬁred by the
HPA. Colistin was the most active agent alone with MICs from
1–2 mg/L. Imipenem MIC’s varied from 4–32 mg/L. The most
active combinations were colistin plus rifampicin (FICI = 0.38)
and colistin, rifampicin and imipenem (FICI = 0.39). Synergy
was not seen with colistin in combination with imipenem
alone. Linezolid in combination with colistin (FICI = 0.37), or
imipenem (FICI = 0.38) was synergistic but at therapeutically
unobtainable linezolid concentrations (64 mg/L).
Conclusion: Multidrug resistant strains of A. baumannii from
the UK producing OXA carbapenemases remain susceptible to
polymyxin in vitro. Polymyxin exerts its effect on the bacterial
cell wall; theoretically assisting other antibiotics to reach their
respective targets, and seems a logical choice for inclusion in
combination therapy. We have shown that rifampicin is
synergistic with polymyxin against these isolates in vitro and
may be effective in treating severe A. baumannii infections in
man.
P1771
A comparative in vitro evaluation of resistance
development after exposure to teicoplanin,
vancomycin, linezolid and quinupristin/
dalfopristin in Staphylococcus spp. and
Enterococcus spp.
E. De Vecchi, L. Nicola, M.R. Gismondo, L. Drago (Milan, IT)
Objectives: Glycopeptides, linezolid and quinupristin/dalfopr-
istin represent a valid therapeutic choice for treatment of severe
gram positive infections, but monitoring of development or
increase of resistance is continuously performed. This prelim-
inary study aimed to compare the ability to select for resistance
of teicoplanin, vancomycin, linezolid and quinupristin/dalfopr-
istin in clinical strains of staphylococci both susceptible and
resistant to methicillin and enterococci by performing one step
studies of resistance selection at antimicrobial concentrations
achievable in vivo.
Methods: Methicillin susceptible Staphylococcus aureus (MSSA),
methicillin resistant Staphylococcus aureus (MRSA), methicillin
susceptible Staphylococcus epidermidis (MSSE), methicillin resist-
ant Staphylococcus epidermidis (MRSE), Enterococcus faecalis and
Enterococcus faecium (20 strains for each species) were isolated
from different patients at L. Sacco Teaching Hospital of Milan,
Italy. Determination of MIC was performed by means of
microdilution broth method in accordance to Clinical and
Laboratory Standards Institute (CLSI). Frequency of sponta-
neous single-step mutations after exposure to teicoplanin,
vancomycin, linezolid and quinupristin-dalfopristin in MRSA,
MSSA, MRSE, MSSE, E. faecium and E. faecalis strains was
determined on agar plates containing each antibiotic at CLSI
resistance breakpoints and at peak blood concentrations. After
incubation at 37C for 48 h colonies were counted and compared
to the inoculum to calculate frequency of mutation. Colonies
grown in plates containing antibiotics were sampled for deter-
mination of MIC values.
Results: Frequency of mutation was less than 10–9 for all the
tested antibiotics at peak blood concentrations. Same results
were obtained when breakpoint concentrations for each drug
were used.
Conclusion: This one-step in vitro study demonstrated the
ability of teicoplanin, vancomycin, linezolid and quinupristin/
dalfopristin to prevent growth of resistant mutants of
staphylococci and enterococci, thus suggesting no occurrence
of mutational events leading to resistance when bacteria are
exposed to blood concentrations of these drugs. In order to
establish the development of resistance after in vitro serial
exposure to the same antibiotics simulating different in vivo
concentrations, further studies are needed and are now in
progress (multi step induction of resistance).
P1772
In vitro activity of antimicrobial agents against
Legionella obtained from hotel water systems in
Turkey
H. Erdogan, F. Can, M. Demirbilek, F. Ergin, H. Arslan (Antalya,
Ankara, TR)
Objective: To evaluate in vitro activity of antimicrobial agents
against Legionella obtained from enviromental sources in
Alanya in Turkey.
Material-Method: Fifty strains of Legionella obtained from hotel
water systems during August 2003–July 2005 years were tested:
Legionella pneumophila serogroup6n = 32,L. pneumophila serogroup
1n = 12,L. pneumophila serogroup3n = 2,Legionella spp.n = 4.The
antimicrobial agents tested were levoﬂoxacin, ciproﬂoxacin,
clarithromycin, azithromycin and rifampicin. The MIC of each
antimicrobial agent for Legionella was determined by the
microdilution method using buffered yeast extract supplemented
with alpha ketoglutarate broth. L. pneumophila ATCC 33152, S.
aureusATCC 29213 and E.coli ATCC 25922 were used as controls.
Results: MICs were in the following ranges: Claritromycin
0.007–4 mg/L, azithromycin 0.001–2 mg/L, rifampicin 0.001–
0.5 mg/L, levoﬂoxacin 0.001–2 mg/L, ciproﬂoxacin 0.001–
4 mg/L. According to MIC50 and MIC90 values of the agents,
affectivities were determined as follows: rifampicin >
ciproﬂoxacin > azithromycin > clarithromycin > levoﬂoxacin.
Conclusion: This is the ﬁrst result about in vitro activity of
antimicrobial agents against Legionella. Rifampicin was found
to be the most active agent.
P1773
In vitro activity of colistin against pan-resistant
Acinetobacter baumannii
S. Quinteira, H. Ramos, J.M. Amorim, L. Peixe (Porto, PT)
Objectives: The aim of this study was to evaluate the in vitro
activity of colistin against endemic pan-resistant Acinetobacter
baumannii (including resistance to imipenem) isolated during a
4 year period in a university hospital.
Methods: 150 imipenem-resistant Acinetobacter spp. isolates
were collected between January 2001 and October 2004, from a
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variety of clinical specimens of different patients attending
distinct wards in a university teaching hospital. Isolates were
identiﬁed by API32GN and by sequencing the 16S rRNA gene.
MICs of colistin were determined by agar dilution method,
according to NCCLS susceptible breakpoint (£ 2 mg/L). PFGE
(ApaI restriction enzyme) was performed.
Results: 141 of 150A. baumannii isolates (94%) were susceptible to
colistin. Colistin resistance (MIC ‡ 4 mg/L) was observed in 9
isolates (5 isolates with a MIC of ‡ 16 mg/L and 4 isolates with a
MICof 4 mg/L) recovered fromdifferentpatients indistinctwards.
Among these imipenem- and colistin-resistant isolates, 3 distinct
PFGE patterns were identiﬁed (clones A, B, and C). Resistance to
almost all beta-lactams (including carbapenems) and variable
susceptibility to aztreonam, amikacin and tobramycin was a
common feature of clone A. Isolates belonging to clone B showed
resistance to imipenem, amoxicillin and its association with
clavulanic acid (AMC), ureidopenicillins and their associations;
susceptibility to ceftazidime; and variable behaviour to
meropenem, cefepime, cefpirome and aztreonam. The
susceptibility proﬁle to aminoglycosides was variable, differing
from clone A in its susceptibility to netilmicin and minocycline.
Clone Cwas resistant to imipenem, amoxicillin, AMC, piperacillin,
piperacillin + tazobactam, ticarcillin and ticarcillin + clavulanic
acid, but remained susceptible to meropenem, aztreonam,
cefpirome, ceftazidime and cefepime.
Conclusion: Only colistin, one of the few effective drugs
available against multi-drug-resistant Acinetobacter infections,
showed in vitro activity against the majority of Acinetobacter spp.
strains isolated within the sampled hospital. The observed 6% A.
baumannii resistance to the recently re-introduced colistin seems
like the ﬁrst chapter of a novel repeatedly told for several
antibiotics.
P1774
Emergence of high-level gentamicin resistance in
clinical enterococcal isolates of companion
animals in Portugal
C. Pomba, M. Delgado, T. Ribeiro, T. Crespo, M.F. Silva Lopes,
J.H. Duarte Correia (Lisbon, Oeiras, PT)
Objectives: To characterize in vitro gentamicin susceptibility
among enterococci causing infections in cats and dogs, in order
to evaluate the impact of high-level gentamicin resistance in
small animal therapeutics.
Methods: The samples were collected at the Veterinary
Teaching Hospital of the Faculty of Veterinary Medicine and
at veterinary private practices in the Lisbon area. From January
1998 until November 2005, a total of 43 enterococci were isolated
from dogs and cats with urinary tract infection (UTI), otitis
externa (OE) and pioderma. BBL Crystal Gram Positive ID
System was used for identiﬁcation at the species level. Minimal
inhibitory concentrations (MIC) were determined by the
microdilution method according to NCCLS (1). The bifuntional
enzyme gene that confers high-level gentamicin resistance
(HLGR) was detected using PCR (2).
Results: Enterococcus faecaliswas the predominant isolate (n = 35),
followed in frequency by Enterococcus faecium (n = 6). MIC
cumulative data analysis showed that MIC50 values were 8 lg/
ml and MIC90 1024 lg/ml. Six (14%) HLGR clinical enterococcal
isolatesweredetected,withMICrangesbetween1024–2048 lg/ml.
Four of these enterococci were isolated from UTI and 2 from OE.
Four of the phenotypically high-level gentamicin resistant isolates
carried the aac(6’)-Ie-aph(2’’)-Ia gene.
Conclusions: The importance of enterococcal infection in small
animal clinical samples has increased over the last years. MIC
cumulative data points out low-level gentamicin resistance
among clinical enterococci isolates of veterinary origin and the
emergence of high-level isolates, as previously detected (2). This
fact compromises cell-wall active agents (such as ampicillin or
vancomicin) and aminoglicoside in vivo synergy. The aac (6’)-Ie-
aph(2’’)-Ia gene carriage is of concern because its expression
confers resistance also to tobramicin, netilmicin, amikacin and
kanamicin. Our ﬁndings are of critical importance, as they may
have a direct impact in therapeutic decision in the management
of companion animal’s infections by enterococci. Furthermore,
transfer of resistance genes and resistance strains between
animals and owners/caretakers by direct contact is a concerning
probability.
References: (1) NCCLS (2002) – M31 – A2.(2) Silva Lopes M. F.
et al. (2003) Gentamicin resistance in dairy and clinical
enterococcal isolates and in reference strains Journal of
Antimicrobial Chemotherapy 52, 214–9.
P1775
Study of antibiotic-resistant Streptococcus
pneumoniae strains, isolated in Romania, between
2004–2005
M. Pana, M. Ghita, R. Papagheorghe, N. Popescu, I. Nistor,
M. Nica, G. Bancescu, M. Andrei, S. Botea, D. Blana,
V. Ungureanu (Bucharest, RO)
Objective: To study the antibiotic resistance in pneumococci
isolated last years in Romania.
Methods: Four hundred ﬁfty ﬁve strains of Streptococcus pneu-
moniae coming from sputum or tracheal aspirate (TA):
N = 249,blood (N = 22), CSF (N = 59), others (sinus, eye ﬂuid,
middle ear ﬂuid): N = 125,were collected between 2004–2005 at
the National Reference Center for Streptococcus. The isolates
were tested for susceptibility (MICs) to the following antibiotics:
penicillin(Pc), erythromycin(Em), cefuroxim(Cxm), trimetho-
prim/sulfamethoxazole(Sxt), oﬂoxacin(Ofx), vancomycin(Va)
by standard dilution MIC testing.
Results: Interpretative criteria were used according to NCCLS
2002.During the study period penicillin resistant strains of S.
pneumoniae was noted as follows: 67% in sputum or TA,19% in
blood,12%in CSF,and 75% in others,against cefuroxim resistant
strains:15% in sputum or TA,10% in blood,4% in CSF.Regarding
the susceptibility to Ofx,penicillin resistant S. pneumoniae strains
from sputum or TA revealed 97.9%.The penicillin resistant
strains coming from sputum or TA showed resistance as
follows; 48% to Em and 78% to Sxt,against strains isolated
from others: 58% to Em and 49% to Sxt.No resistant strain to Va
was found.
Conclusion: The percentage of the penicillin resistant S.
pneumoniae isolates from the lower respiratory tract, middle
ear ﬂuid, eye ﬂuid and sinus was markedly higher than that of
the isolates from blood and CSF. The most efﬁcient drugs
against penicillin resistant pneumococci were cefuroxim and
oﬂoxacin. These results from Romania also underline the
previous observations regarding the higher emerging rates of
resistance in S. pneumoniae worldwide.
P1776
Penicillin resistance in Streptococcus agalactiae
F. Cavallini, S. Cagnacci, E. Maioli, R. Bandettini, E. Debbia,
A. Marchese (Genoa, IT)
Objectives: Streptococcus agalactiae has become recognized as a
cause of serious illness in newborns, pregnant women, and
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
adults with chronic medical conditions. Heavy colonization of
the genital tract with Streptococcus agalactiae also increases the
risk that a woman will deliver a preterm low-birthweight infant.
Early-onset infections (occurring at < 7 days of age) are
associated with much lower fatality than when they were ﬁrst
described, and their incidence is ﬁnally decreasing as the use of
preventive antibiotics during childbirth increases among
women at risk. Penicillin or ampicillin remains the drug of
choice for intrapartum antibiotic prophylaxis for Streptococcus
agalactiae colonization in pregnant women. Erythromycin and
clindamycin are the drugs of choice for women with serious
penicillin allergy who are colonized with Streptococcus agalactiae.
The objective of this study is to estimate the insorgence of
penicillin resistance among Streptococcus agalactiae.
Methods: All streptococcus agalactiae were tested against
penicillin by agar dilution method according to Clinical and
Laboratory Standards Institute 2005 (CLSI); breakpoints for
resistance were those recommended by the CLSI. Antimicrobial
agents were obtained from their manufacture as laboratory
grade powder.
Results and discussion: Four hundred seven (407) clinical
isolated were analysed during 2005. Streptococcus agalactiae
resulted resistant to Penicillin in 1 case; and about 2% resulted
borderlines.The present ﬁndings indicate a probable evolution
in S. agalactiae toward penicillin resistance this ﬁnding suggest
the need a continuous national and international surveillance
programs to provide timely data on the evolution of incidence of
penicillin resistance in this pathogen.
P1777
Ciproﬂoxacin susceptibility of the most common
isolates at bacterial conuctivitis
M. Dimitrova (Stip, MK)
Aim: Average of the susceptibility of the isolated strains to
ciproﬂoxacin.
Material and methods: 6.365 swabs from conuctivity saccus are
taken in a period from 01.01.2000 to 31.12.2004 at patients
diagnosed with chronic conuctivitis.
Results: Positive bacterial ﬁndings are 1.793 (28%). From them:
Staphylococcus aureus 1.471 (82%), Haemophilus inﬂuenzae 60
(3.3%), Staphylococcus epidermidis 110 (6.1%), Streptococcus
pneumoniae 66 (3.6%), Escherichia coli 30 (1.7%), Pseudomonas
spp. 37 (2.1%), Enterococcus faecalis 14 (0.8%). The susceptibility
to ciproﬂoxacin is high and it is: Staphylococcus aureus 92%,
Haemophilus inﬂuenzae 100%, Staphylococcus epidermidis 94%,
Streptococcus pneumoniae 88%, Escherichia coli 100%,
Pseudomonas spp. 80%, Enterococcus faecalis 100%.
Conclusion: According to the average numerals we concluded
that all the isolated strains are highly susceptible at
ciproﬂoxacin. Its application in the conuctivial saccus is
especially important in curing the conuctivial infections with
resistent strains like Pseudomonas aeruginosa. We successfully
cure the bacteria chronic conuctivitis with the adequately used
therapy according to antibiogram.
P1778
Antimicrobial resistance patterns of
Acinetobacter baumannii in clinical isolates
G.T. Tsilika, V.P. Pliatsika, M.T. Tsivitanidou, D.S. Soﬁanou
(Thessaloniki, GR)
Objectives: A. baumannii is a nosocomial pathogen, commonly
isolated from critically ill and immunocompromised patients.
The aim of the present study was to evaluate the antimicrobial
resistance of A. baumannii strains isolated in a tertiary care
hospital througout a three-year period.
Methods: A total of 1311 A. baumannii strains were selected
from January 2002 to December 2004.The specimens were
obtained from inpatients hospitalized in intensive care unit
(ICU) and pediatric intensive care unit (PICU) and other
departments of our hospital.The identiﬁcation and the
antimicrobial susceptibility testing were performed using the
Vitek 2 automated system(bioMerieux,France).
Results: The isolates included in the study originated from
haemocultures (28.5 %), central venous catheters (10.4 %), urine
(10.2 %), bronchial aspirates (25.4 %), wounds (25.5 %). Out of 1311
strains45.2%isolated fromICUandPICUand the remaining54.8%
from the other departments. We determined the occurrence of
resistance to 20 common used antimicrobial agents during a three-
year period. The majority of isolates were resistant to 17 or more
antibiotics tested.Some strains were deﬁned by resistance to all
antimicrobial agents exept colistin.The resistance to imipenem rose
dramatically from 18.4% in 2002 to 45.9% in 2004.Notable increase
detected also to: Trimethoprim/Sulfamethoxazole: from 80.9% in
2002 to 97% in 2004, Amikacin: from 80.5% in 2002 to 96.5% in 2004,
Netilmicin: from 79.8% in 2002 to 91% in 2004, Ticarcillin/
clavulanic acid: from 76.8% in 2002 to 97.4% in 2004, Piperacillin/
tazobactam: from30.3% in 2002 to 47.5% in 2004. Resistance rates to
other antibiotics testedwere as following:amikacin 71%, ampicillin
100%, cephalothin 100%, cefotaxime 97.7%, cefoxitin 100%,
ceftazidime 93.4%,ciproﬂoxacine 96.2%, nalidic acid 6.6%,
norﬂoxacin 96.4%,oﬂoxacin 95.1%, ticarcillin 97%, tobramycin
42.8%. Noteworthy is the decreasing of gentamycin resistance
from 38.8% 2002 to 17.2% in 2004.Colistin was the only
antimicrobial agent active to all clinical isolates.
Conclusions: The emergance and rapid spread of multidrug
resistant A. baumannii isolates are of a great concern
worldwide.Imipenem was one of the most potent agents for
treatment of those infections caused bymultiresistant strains.The
increasing prevalence of imipenem resistance limits therapeutic
options and leads to outbreaks of carbapenems resistant strains.
Tigecycline in vivo studies
P1779
Ecological impact of tigecycline on the normal
oropharyngeal and intestinal microﬂora
C.E. Nord, E. Sillerstro¨m, E. Wahlund, V. Parks, M.L. Odell,
J. Vouis (Stockholm, SE; Paris, FR; Solna, Uppsala, SE)
Objectives: Antibacterial agents disrupt the ecological balance
of the normal human microﬂora. Disturbances may lead to the
emergence of antibiotic resistance and/or to infections by
potentially pathogenic bacteria. Tigecycline, a member of a
new class of antibiotics (glycylcyclines), has been shown to have
a potent expanded broad-spectrum activity against most gram-
positive and gram-negative aerobic and anaerobic bacteria. The
aim of the study was to investigate the ecological effects of
tigecycline on the normal oropharyngeal and intestinal
microﬂora in healthy subjects.
Methods: Thirteen (13) white subjects (6 women, 7 men) aged
20 to 31 years, received 100 mg of tigecycline in the morning on
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day 1 as a 30-minute intravenous (IV) infusion, followed by 50-
mg doses of tigecycline given every 12 hours as a 30-minute
infusion for 10 days. One (1) subject was withdrawn on day 2
because of an adverse event. Serum, saliva, and faecal samples
were collected before, during, and after administration for
microbiologic cultivation and for assays of tigecycline. All new
colonizing bacteria were tested for susceptibility (resistance
>8 mg/L) during the investigation period.
Results: The serum concentrations on day 9, 12 hours after
dosing, were 0.2 to 2.1 mg/L (mean value 0.4 mg/L, median
value 0.2 mg/L, and SD 0.5 mg/L). The faecal concentrations on
day 8 were 3.0 to 14.1 mg/kg (mean value 6.0 mg/kg, median
value 5.6 mg/kg, and SD 2.9 mg/L). Saliva concentrations were
generally low, with highest mean value 0.18 mg/L, median
value 0.22 mg/L, on day 10, 3 hours after dosing. A minor effect
on the oropharyngeal microﬂora was observed. The numbers of
Enterococci and Escherichia coli in the intestinal microﬂora were
reduced at day 8, while other enterobacteria and yeasts
increased. There was a marked reduction of lactobacilli and
biﬁdobacteria but no impact on bacteroides. No Clostridium
difﬁcile strains were isolated. Two (2) Klebsiella strains and 5
Enterobacter strains resistant to tigecycline were found.
Conclusion: Tigecycline had a minor effect on the
oropharyngeal microﬂora. Tigecycline’s effect on the intestinal
microﬂora was due to its spectrum of antibacterial activity and
intestinal concentrations.
P1780
Single-centre experience of the use of tigecycline
in the treatment of deep-seated multidrug-
resistant Acinetobacter in patients with
multiorgan failure
E. Sizer, W. Bernal, G. Auzinger, I. Eltringham, S. Stoll,
L. Sawkeng, J. Wendon (London, UK)
Objectives: To examine and report the use of Tigecycline
(Wyeth) in the treatment of multidrug resistant acinetobacter
(MDRA) culture positive sepsis in 11 patients requiring
mutiorgan support.
Methods: All patients were managed within the Liver Intensive
Care Unit. Physiological data was collected prospectively and
entered onto a specialist database. Patients received standard
intensive care management; antibiotic and antifungal therapy
administered as indicated by microbiological cultures. Systemic
inﬂammatory response (SIRS) features initiated blood cultures
(vascular lines and peripheral), drain ﬂuid culture and
broncoalveolar lavage (BAL). Screening swabs were
undertaken weekly and samples sent for culture at
laparotomy. MDRA positive cultures from blood, BAL, drain
ﬂuid or samples taken at laparotomy in the context of SIRS
resulted in the initiation of tigecycline treatment.
Results: 11 patients received Tigecycline treatment for MDRA
infections. The underlying disease states were necrotizing
pancreatitis (1), post hepatectomy (1), polytrauma (1), all with
postive intra-abdominal cultures. Acute and acute on chronic
liver failure (4), MDRA +ive broncho-alveolar lavage ± blood
cultures and 4 post liver transplant patients (necrotising
pancreatitis in one, 2 with recurrent small bowel perforation
and 1 with retroperitoneal haemorrhage) all with positive blood
cultures and in 3 positive intra-abdominal tissue/clot. Mean
time from admission to treatment for MDRA was 25 days. Mean
duration of treatment was 10 days (range 4–15). Mean APACHE
II score at initiation of therapy was 18 (range 13–26); 4/11
patients survived to intensive care discharge and 3/11 to
hospital discharge. Microbiological clearance of MDRA was
observed in 8/11 cases. In those who did not achieve
microbiological clearance cause of death was intra-abdominal
haemorrhage, recalcitrant organ failure with recurrent small
bowel perforation and vasopressor resistant shock. In these
patients one remained culture positive for intraabdominal sepsis
despite full treatment (small bowel perforation x5). The drug
was well tolerated with the only side effect being that of
hypercalcaemia observed in 5/12 patients, mean corrected
calcium 2.59 mMol/l, range 2.32–2.81. In all cases this resolved
on drug discontinuation.
Conclusion: Tigecycline appears to be an efﬁcacious agent in
the treatment of deep seated MDRA infections.
P1781
Pharmacokinetic-pharmacodynamic model for
the safety of tigecycline in patients with
complicated intra-abdominal infections
A. Meagher, K. Liolios, J. Passarell, B. Cirincione, S. Van Wart,
J. Fiedler-Kelly, T. Babinchak, E. Ellis-Grosse (Buffalo,
Collegeville, US)
Objectives: Nausea (N) and vomiting (V) have been reported
with tigecycline, a new glycylcycline with expanded broad
spectrum activity. Exposure-response relationships and patient
covariates predictive of the ﬁrst N and V occurrence were
evaluated in patients with complicated intra-abdominal
infections (cIAI).
Methods: Data from patients from 3 cIAI trials (one phase 2 and
two phase 3), receiving 100 mg loading dose and 50 mg every
12 hours, were pooled for analysis. N and V (deﬁnitely,
possibly, or probably related to tigecycline) reported from the
start of infusion until 24 hours after the last dose were included.
Individual exposure measures [AUC0-12 and Cmax] were
calculated using a previously developed population PK model.
Logistic regression was used to evaluate predictors of ﬁrst N
and V occurrence. Covariates included age, weight, sex, region
of treatment, and baseline N and V.
Results: The dataset included 928 patients (218 with PK). Mean
(SD) age and weight were 46 (18) years and 73 (16) kg. 64% of
patients were men and 24%, 37%, and 18% were enrolled in
North America, Europe, and Latin America, respectively.
Baseline nausea or vomiting was reported in 47% and 35%.
Overall, N and V occurred in 18% and 13% of patients receiving
tigecycline, however most (62%; 67%) of ﬁrst N and V events
were mild in nature. Women had more N and V (23%; 17%) than
men (15%; 11%). N and V were lower in Europe (10%; 6%) than
in other regions. AUC0-12 and Cmax were not predictive. The
ﬁnal nausea model included weight, sex, region, baseline
nausea, and the interaction of weight/region as predictors of
the ﬁrst nausea occurrence (p = 0.671, 0.0006, 0.205, 0.033, &
0.023, respectively). The ﬁnal vomiting model included weight,
sex, region, & 4 interactions (weight/sex, weight/region, sex/
region, & weight/sex/region) as predictors of the ﬁrst vomiting
occurrence (p = 0.054, 0.819, 0.083, 0.815, 0.02, 0.005, & 0.01,
respectively).
Conclusion: AUC0-12 and Cmax were not predictors of nausea
and vomiting events for tigecycline. The ﬁnal nausea model
would predict: nausea to be less in men, Europeans, and in the
absence of baseline nausea. The ﬁnal vomiting model would
predict: heavier men, from all regions except Latin America, and
heavier women and to have less vomiting.
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P1782
Predictors of excess health resource utilisation in
treatment of hospitalised patients with
community-acquired pneumonia: retrospective
analysis of a clinical study comparing
intravenous tigecycline and levoﬂoxacin
R. Mallick, S. Sun (Collegeville, US)
Objective: Because hospitalisation for community-acquired
pneumonia (CAP) is associated with substantial morbidity and
health resource utilisation, we evaluated the predictors of
prolonged hospital length of stay (LOS) and treatment duration.
Methods: We conducted a retrospective analysis of data from a
double-blind, randomised, multicentre clinical study that
compared the efﬁcacy and safety of tigecycline with that of
levoﬂoxacin in the treatment of patients with CAP requiring
hospitalisation. Patients were stratiﬁed by the FINE Pneumonia
Severity Index and randomly assigned to receive tigecycline or
levoﬂoxacin via IV administration for at least 7 days. Treatment
duration and hospital discharge were based on physician
assessment of signs and symptoms of infection and patient
condition. We used Cox proportional hazards modelling with
stepwise selection to identify statistically signiﬁcant predictors
(p < 0.05) of treatment duration and hospital LOS.
Results: Among 426 patients with CAP in the clinical intent-to-
treat population with complete hospitalisation data, mean age
was 49.8 years (range 17–92) and 22.8% of patients were aged
‡65 years. Diabetes (11.5%), chronic obstructive pulmonary
disease (7.8%), and congestive heart failure (7.0%) were leading
co-morbidities. About 37.1% of patients were smokers and 5.6%
were characterised by alcohol abuse. Median FINE Pneumonia
Severity Index score was 3; 21.1% of patients had a score >4.
Among 294 patients with identiﬁed microbiology, Streptococcus
pneumoniae (41.2%) and Mycoplasma pneumoniae (26.2%) were
leading pathogens. Alcohol abuse [hazard ratio (HR) = 0.53
(p = 0.006)] and liver disease [HR = 0.60 (p = 0.037)] were
signiﬁcant independent risk factors for prolonged LOS.
Among patients with identiﬁed microbiology, age ‡65 years
[HR = 0.67 (p = 0.007)], and the presence of Haemophilus inﬂu-
enzae [HR = 0.59 (p = 0.01)] or H. parainﬂuenzae [HR = 0.60
(p = 0.007)] were additional independent risk factors for
longer LOS. Treatment in a European centre was associated
with longer treatment duration [HR = 0.30 (p < 0.0001)] as well
as longer LOS [HR = 0.26 (p < 0.0001)]. There were no signiﬁ-
cant differences between the 2 groups in treatment duration or
LOS.
Conclusions: Tigecycline, a ﬁrst-in-class glycylcycline, was
associated with treatment duration and LOS similar to that of
levoﬂoxacin, adjusting for several identiﬁed risk factors.
P1783
Tigecycline effective in treating patients with
intra-abdominal or skin/skin structure infections
who have bacteraemia
E.J. Ellis-Grosse, R. Maroko (Collegeville, US)
Objectives: The treatment of bacteraemia, which is a potentially
fatal complication of infections originating at other body sites, is
complicated by increasing resistance. Tigecycline, a ﬁrst-in-class
glycylcycline, has an expanded spectrum of activity against
Gram-positive, Gram-negative, anaerobic, and atypical bacteria
including resistant strains. Tigecycline is safe and effective in
treating complicated skin and skin structure (cSSSI) and intra-
abdominal infections (cIAI). This analysis examines tigecycline
clinical trial experience in patients with cIAI or cSSSI who had
bacteraemia (presence of bacteria in blood) at baseline.
Methods: Tigecycline and active comparator data were pooled
from 4 Phase 3 studies: cSSSI 300 and 305 studies [vs
vancomycin/aztreonam (V/A)] and cIAI 301 and 306 studies
[vs imipenem/cilastatin (IMI/CIL)]. A subgroup analysis
evaluated the presence of bacteraemia on the primary efﬁcacy
endpoint. A generalized linear model was used to examine the
interaction effects of treatment and whether or not the subject
experienced bacteraemia during the study.
Results: At test-of-cure visit in cSSSI subjects [clinically evalu-
able (CE) population] with bacteraemia, tigecycline cured 19/23
patients (82.6%; 95% CI 61.2, 95.0) and V/A cured 21/24 subjects
(87.5%; 95% CI 67.6, 97.3) with an adjusted difference of
tigecycline -V/A of )2.1% (95% CI -6.5, 2.4, interaction bacter-
aemia with treatment arm p-value = 0.780). In cIAI subjects who
had bacteraemia, tigecycline cured 33/40 subjects (82.5%; 95%
CI 67.2, 92.7) and IMI/CIL cured 40/50 subjects (80.0%; 95% CI
66.3, 90.0) at test-of-cure [microbiological efﬁcacy (ME) popula-
tion]. The adjusted difference of tigecycline-IMI/CIL was )0.2%
(95% CI -4.4, 4.0), interaction bacteraemia with treatment arm p-
value = 0.7368. These clinical response results are consistent
with overall tigecycline clinical and microbiological efﬁcacy
results seen in phase 3 trials that demonstrated the equivalence
of tigecycline to its comparators.
Conclusion: The baseline status of bacteraemia in patients with
cIAI or cSSSI does not appear to inﬂuence the efﬁcacy of
tigecycline.
P1784
Tigecycline vs imipenem/cilastatin for treatment
of complicated intra-abdominal infections:
European experience
R. Maroko, N. Dartois, Y. Brault, J. Goodrich, E.J. Ellis-Grosse on
behalf of the 301 and 306 cIAI Study Groups
Objectives: Treatment of complicated intra-abdominal infec-
tions (cIAI) is challenging due to diverse bacteriology and
bacterial resistance. The efﬁcacy and safety of Tigecycline (TGC),
a ﬁrst-in-class glycylcycline approved in Mexico, Brazil, Peru,
Colombia and USA for treating cIAI and complicated skin and
skin structure infections, was compared with Imipenem/Cilast-
atin (IMI/CIS) in adult hospitalised patients with cIAI in two
double-blind, Phase 3 multinational trials. This analysis evalu-
ated TGC efﬁcacy and safety in the European region of the
integrated results of these two trials.
Methods: One study was conducted in 96 centres (17 countries)
and the other study was conducted in 94 centres (27 countries).
Patients were stratiﬁed by disease severity (APACHE II score
£15 vs >15 but £30), and randomly assigned to IV TGC (100 mg
loading, then 500 mg q12h) or IV IMI/CIS (500/500 mg q6h) for
5–14 days. Clinical response at test-of-cure (TOC, 12–44 days
after therapy) for microbiological evaluable (ME) and microbio-
logical modiﬁed intent-to-treat (m-mITT) were co-primary
efﬁcacy endpoints where cure/failure responses were deter-
mined. Safety was assessed by physical examination, laboratory
results, and adverse event (AE) reporting.
Results: In the European analysis, 703 patients were mITT
(received ‡1 dose), 556 m-mITT (283 TGC, 273 IMI/CIS) and 460
ME (237 TGC, 223 IMI/CIS). Treatment groups were balanced
with respect to demographics. Patients were mostly white
(98.2%) men (58%) with a mean age of 50 years. For ME, clinical
cure rates at TOC were 92.4% (219/237) for TGC vs 88.8% (198/
223) for IMI/CIS (95% CI = )2.2, 9.4; test for non-inferiority
p < 0.0001). Clinical cure rates for m-mITT were 87.3% (247/283)
Abstracts
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
for TGC vs 83.5% (228/273) for IMI/CIS (95% CI = )2.5, 10.0;
test for non-inferiority p < 0.0001). Most commonly reported
treatment emergent AEs (TEAEs, mITT) for TGC and IMI/CIS
were nausea (14.7% and 11.8%, p = 0.267) and vomiting (10.7%
and 7.3%, p = 0.146). The IMI/CIS group had signiﬁcantly
higher TEAEs of fever (7.3% IMI/CIS vs 3.2% TGC, p = 0.017),
hyperglycaemia (1.7% IMI/CIS vs 0 TGC, p = 0.031) and
dyspnoea (2.8% IMI/CIS vs 0.3% TGC, p = 0.011) where TGC
had signiﬁcantly higher amylase increase (3.2% TGC vs 0.6%
IMI/CIS, p = 0.011) and BUN increase (2.3% TGC vs 0 IMI/CIS,
p = 0.003).
Conclusions: Similar to the overall integrated analysis of the
two Phase 3 trails, in the European analysis, TGC was safe and
effective in the treatment of hospitalised patients with cIAI in
comparison with IMI/CIS.
P1785
Tigecycline is safe and effective in the treatment
of complicated skin and skin structure infections:
European experience of two double-blind phase 3
comparison studies with vancomycin/aztreonam
R. Maroko, N. Dartois, D. Sarkozy, J. Goodrich, E.J. Ellis-Grosse
on behalf of the Tigecycline 300 and 305 Study Groups
Objectives: Tigecycline (TGC) a ﬁrst-in-class expanded
spectrum glycylcycline, has been approved in Mexico, Brazil,
Peru, Colombia and USA for treating complicated skin and skin
structure infections (cSSSI) and complicated intraabdominal
infections. Two phase 3, randomised, double-blind studies were
conducted in hospitalised men and women with cSSSI to
determine TGC safety and efﬁcacy compared with
vancomycin/aztreonam (V/A). The objective of this analysis
was to evaluate the efﬁcacy and safety seen in the European
population of the integrated analysis of these 2 Phase 3 trials.
Methods: One study was conducted in 53 centres in 8 countries
while the other study was conducted in 65 centres in 21
countries. Patients were randomly assigned (1:1) to receive
either TGC (100 mg, followed by 50 mg IV twice daily) or
vancomycin (1 g IV twice daily) plus aztreonam (2 g IV twice
daily) for up to 14 days. Clinical response at test-of-cure (TOC,
12–92 days after therapy) for clinically evaluable (CE) and
clinical modiﬁed intent-to-treat (c-mITT) populations were co-
primary efﬁcacy endpoints in which cure/failure responses
were determined. Secondary objectives included determination
of in vitro susceptibility to TGC of a range of bacteria that cause
cSSSI and microbiological efﬁcacy. Safety was assessed by
physical examination, laboratory results, and adverse event (AE)
reporting.
Results: In the European analysis, 385 patients comprise mITT
(received ‡1 dose of study drug), 326 comprised CE (167 TGC,
159 V/A/CIS) and 376 comprised c-mITT (189 TGC, 187 V/A/
CIS). Treatment groups were balanced with respect to demo-
graphics. Patients were mostly white (99.7%) men (63.6%) with a
mean age of 50 years. In the European region, clinical responses
to TGC andV/Aat test-of-curewere similar: c-mITT, 84.7% (160/
189) versus 86.6% (162/187), difference TGC-V/A was –2.0%
(95%CI –9.5, 5.6). Similar results were noted in the CE population
with TGC curing 89.8% (150/167) and V/A curing 95.0% (151/
159), difference TGC-V/A was –5.1% (95% CI –11.6, 1.2).Most
commonly reported treatment emergent AEs (TEAEs, mITT) for
TGC and V/A were nausea (17.3% and 3.2%, p < 0.001) and
vomiting (6.1% and 1.6%, p = 0.032). The V/A group had
signiﬁcantly higher TEAEs of SGPT increase (6.9% V/A vs
2.0% TGC, p = 0.025) and rash (2.6% V/A vs 0 TGC, p = 0.028).
Conclusion: In the European analysis of the integrated Phase 3
worldwide clinical studies, TGC monotherapy is as safe and
efﬁcacious as the combination of V/A in the treatment of
patients with cSSSI.
P1786
Safety and tolerability of tigecycline
R. Maroko, N. Dartois, G. Rose, E.J. Ellis-Grosse (Collegeville,
US; Paris, FR)
Objectives: Tigecycline (TGC), a glycylcycline, is a ﬁrst-in-class,
extended, broad-spectrum IV antibiotic that has demonstrated
clinical activity in patients with complicated intra-abdominal
infections (cIAI) and complicated skin and skin-structure
infections (cSSSI). The safety of tigecycline was evaluated in
four Phase III trials.
Methods: A total of 1415 hospitalized patients from these trials
were pooled and evaluable for safety analysis. In the cIAI trial,
patients received TGC 50 mg q 12 hrs (following a 100-mg
loading dose) or imipenem 500 mg and cilastin 500 mg q 6 hrs.
Those in the cSSSI study were treated with either TGC (same
dose/schedule) or vancomycin 1 gm with or without aztreonam
2 gm q 12 hrs.
Results: The most frequently reported adverse events (AEs) in
both TGC-treated groups were nausea (N) and vomiting (V).
The incidence of N was 29.5% while V was approximately
19.5%; these were generally mild to moderate in severity.
Infection-related serious AEs were slightly more frequent with
TGC versus comparators (6.7% vs 4.6%). Discontinuations due
to treatment-emergent AEs (including N/V) occurred at similar
rates with TGC and comparators (5.0% vs 4.7%). Six patients
(0.36%) treated with TGC presented with intestinal perforations
and developed sepsis/septic shock compared with 2 (0.12%) for
imipenem/cilastatin, with higher baseline Apache II scores in
the TGC group; the relationship to treatment could not be
determined. In the overall efﬁcacy analysis, subjects with
‘‘perforation of the intestines’’ were balanced between the two
groups, and overall efﬁcacy was not statistically different. No
clinically signiﬁcant renal, hepatic, cardiac (QTc), bone marrow,
or CNS toxicities were noted with TGC.
Conclusion: TGC appears to be safe and tolerable for patients
with cIAI and cSSSI. N/V were generally mild to moderate in
severity, self-limiting, and did not result in increased overall
drug discontinuation. There did not appear to be clinically
signiﬁcant renal, hepatic, cardiac, bone marrow, or neurological
toxicities related to TGC treatment. All-cause mortality rates did
not statistically differ between those treated with TGC and the
comparators. Its demonstrated efﬁcacy and favourable toxicity
proﬁle make TGC a good monotherapy option for selected
serious infections.
P1787
Tigecycline as effective as imipenem/cilastatin in
the treatment of complicated intra-abdominal
infections: experience in India
M.K. Ramesh, R.A. Sastry, A. Rekha, A.C. Ashok, P. Dhar,
E.J. Ellis-Grosse on behalf of Tigecycline 301 Study Group
Objective: Due to diverse bacteriology and bacterial resistance,
treatment of complicated intra-abdominal infections (cIAI) is a
challenge. In a double-blind, phase 3, multinational trial, the
efﬁcacy of tigecycline, a ﬁrst-in-class glycylcycline, was
compared with imipenem/cilastatin (IMI/CIS) in hospitalised
patients with cIAI. This subanalysis evaluated tigecycline safety
and efﬁcacy from 12 investigational sites in India.
Methods: Patients were stratiﬁed by disease severity (APACHE
II score £15 vs >15 but <31), and randomly assigned to IV
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tigecycline (100 mg loading, 50 mg q12h) or IV IMI/CIS
adjusted for body weight (500/500 mg q6h for ‡70 kg) for 5–
14 days. Clinical response at test-of-cure (TOC, 12–44 days after
therapy) for microbiological evaluable (ME) and microbiological
modiﬁed intent-to-treat (m-mITT) populations were co-primary
efﬁcacy endpoints where cure/failure responses were
determined. Safety evaluations included vital signs, laboratory
tests and record of adverse events (AEs).
Results: In India, 167 patients received at least 1 dose (mITT, 84
tigecycline, 83 IMI/CIS), 149 patients were clinically evaluable
(CE), 85 were ME, 120 were m-mITT. Treatment groups were
balanced with respect to demographic/baseline medical
characteristics. Primary diagnoses (mITT) were complicated
appendicitis (31%), gastric/duodenal perforation (26%),
perforation of intestine (18%), cholecystitis (12%), peritonitis
(6%), and intraabdominal abscess (5%). Cure rates at TOC in ME
in India were 36/41 (87.8%) tigecycline and 40/44 (90.9%) IMI/
CIS, which are consistent with overall ME results [80.6% (199/
247) tigecycline vs 82.4% (210/255) IMI/CIS (95% CI = )8.4, 5.1;
non-inferiority p < 0.001)]. In India m-mITT, cure rates at TOC
were 47/59 (79.7%) tigecycline and 54/61 (88.5%) IMI/CIS,
similar to the overall m-mITT results [73.5% (227/309)
tigecycline vs 78.2% (244/312) IMI/CIS (95% CI = )11.0, 2.5;
non-inferiority p < 0.001)]. Noninferiority of tigecycline among
India patients could not be statistically demonstrated because of
insufﬁcient sample sizes, however, magnitude of response to
study drugs in patients treated in India was comparable to that
in overall patients. In India, treatment AEs were similar with
signiﬁcantly higher incidence of dyspnoea in tigecycline (9.5%)
vs IMI/CIS (0.0%), p = 0.007.
Conclusions: Efﬁcacy results in India are consistent with
ﬁndings from the overall study and results at other centres,
suggesting tigecycline is noninferior to comparator in treating
cIAI.
Nosocomial infection: control of environment, viral infections
P1788
Bacterial ﬂora contamination of blood pressure
cuffs in use on hospital wards
N. Walker, R. Gupta, J. Cheesbrough (Preston, UK)
Bloodpressure cuffs are a plausbile vehicle for the transmission of
nosocomial infection between patients. Despite this, few studies
have examined the level of bacterial contamination and tested for
the presence of common nosocomial pathogens on their surface.
We swabbed 24 cuffs currently in use on hospital wards. Using
sterile gloves, a disposable template measuring 10 · 10 cms was
placedonto the cuff andamoistened sterile swabwas rubbedonto
the deﬁned area for 1 minute and then transported in 10 mls of
buffer medium. From each sample, 0.5 mls of the buffer was
plated onto 6 differentmediawhich included a non-selective agar
medium for total viable count (TVC) and selective media for S.
aureus, MRSA, C. difﬁcile, coliforms and Vancomycin resistant
enterococci (VRE.) Bacterial growth was recovered from all 24
cuffs. Pathogenic organisms were isolated from 14 cuffs (58%).
MSSA from 5, MRSA from 1 and C. difﬁcile from 5. The remaining
three cuffs grew more than one pathogenic organism; MSSA +
MRSA + C. difﬁcile from one and MSSA + C. difﬁcile from 2 cuffs.
Colifroms and VRE were not isolated from any of the cuffs. The
range of total viable counts recovered per 100 cm2 area of the cuff
varied from 1000 > 20000 cfu and the cuffs with the highest
counts tended to have more pathogens present. MSSA and C.
difﬁcile were isolated from 33% of the cuffs sampled and MRSA
from 8%. While the actual importance of this potential route of
transmission for nosocomial pathogens remainsunclear, it cannot
be dismissed. The impracticality of decontaminating blood
pressure cuffs between patients suggests that single patient use
cuffs or a barrier between cuff and skin would be a more viable
option on a busy general ward.
P1789
Needlestick and sharp injuries of health care
personnel in a newly founded tertiary hospital: a
prospective study
M. Falagas, I. Karydis, G. Georgoulias, P. Hatzopoulou,
D. Nikita, I. Kostogiannou (Athens, GR)
Objectives: Needlestick and sharp injuries of health care
workers are a major cause of anxiety and may expose
susceptible employees to the risk of infectious diseases.
However, the incidence of such injuries has not been
examined in a newly founded hospital while preventive
programmes are taking place.
Methods: We prospectively studied the needlestick and sharp
injuries of employees in a newly founded tertiary hospital in
Athens, Greece while a vaccination program against hepatitis B
virus as well as educational activities for avoidance of injuries
were taking place. Serologic studies for hepatitis B and C virus
as well as human immunodeﬁciency virus (HIV) were
performed in all injured employees and the source patients
(when known).
Results: Sixty-eight needlestick, 8 sharp injuries, and 3 splashes
were reported during the study period (01/10/2002 to 28/02/
2005) in 71 nurses, 2 housekeepers, 3 technicians, and 3
ambulance workers. The overall incidence (percutaneous
injuries and splashes) per 100full-time employment-years (100
FTEYs) was 2.4% whereas the incidence of percutaneous injuries
alone per 100 FTEYs was 2.3%. A higher incidence of injuries
was noted during the ﬁrst than the second half of the study
period (3.8% versus 1.8%, p = 0.003). No source patient was
found positive for hepatitis C or HIV. The use of high-titre
immunoglobulin after adjustment for the incidence of injuries
was higher in the ﬁrst than the second half of the study period
(22.6% vs 3.8%, p = 0.05).
Conclusion: Although we did not adjust for possible
confounders, our data show that educational and vaccination
preventive programs for needlestick and sharp injuries led to a
statistically signiﬁcant decrease in the incidence of such injuries
and use of high-titre immunoglobulin.
P1790
Epidemiology of occupational needlestick and
sharps injury among healthcare-workers in
Turkey
S. Hosoglu on behalf of the Occupational Infections study group,
Turkey
Background: Health care workers (HCWs) are frequently
exposed to the danger of infectious agents through needle
stick and sharps injury (NSSI) in their occupational efforts. In
Turkey, the hepatitis B and C viruses cause an essential threat to
the HCWs because of their prevalence rate (2%–4% and 0.5%–
1%, respectively).
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Method: A cross-sectional countrywide survey study was
performed on the epidemiology of NSSI among HCWs at 30
hospitals in 19 cities throughout the country. Data relating to the
epidemiology of NSSIs were collected using a standard
questionnaire in 2004.
Results: Totally 5048 HCWs completed the questionnaire
forms. Nurses are the leading group (2016 persons) that joined
into the study were followed by doctors (1452 persons)
andlaboratory technicians (475). Totally 2498 of them (49.5%)
declared an occupational exposure or NSSI in the last 12 months
related their job. Needle stick injury was reported in 1698 of
them (33.6%), splash into the eye in 1132 (22.4%), sharp injury in
737 (14.6%), and the other injuries in 419 (7.0%). The hepatitis
positivity was reported in 567 cases (2.27%) in source patients in
those exposures. The most frequent exposures were reported
among the nurses (58.2%) and doctors (53.4%). Only 1381 of the
HCWs (27.4) had speciﬁc education for prevention occupational
exposures and NSSIs.
Conclusion: This survey study showed risky practices and
demonstrated employees and locations frequently involved in
NSSIs. An education program is needed for all staff at risk of
exposure, targeting higher-risk employees.
P1791
Microbiological approach to reprocessing of
single-use devices for interventional cardiology
I. Caola, F. Tessarolo, M. Disertori, G.M. Guarrera, G. Nollo,
P. Caciagli (Trento, IT)
Objectives: To assess the microbiological status of reprocessed
single-use devices for interventional cardiology by testing
bioburden, sterility and pyrogenic load.
Methods: A total amount of 154 electrophysiology non-lumen
catheters (EP) were collected after the ﬁrst clinical use on
patient. 20 devices were contaminated with bacteria spiked
human blood and underwent four different pre-sterilization
protocols including chlorine, polyphenol, and enzymatic
agents. Treated samples were assayed by cultural quantitative
methods (CQM) for bactericidal properties and electron micr-
oscopy (EM) for biologic residuals. 73 EP were tested for
sterility. By the repetition of simulated-use (bacteria spiked
blood) and regeneration (enzymatic and chlorine treatment, gas
plasma sterilization) we obtained 54, 39, 26, 28, 36, 22 samples
respectively reprocessed 1, 2, 3, 4, 5, 6 times. Devices were
cultured for 28 days in trypticase soy broth. The pyrogenic
status of 61 EP was monitored after clinical use, after
decontamination-cleaning treatments and after complete
reprocessing by LAL test.
Results: High-resolution EM and CQM conﬁrmed the superior
properties of chlorine releasing agent added to enzymatic
detergent for devices treatment before sterilization.
Hypochlorous acid based protocols were more biocide (>3.1
log CFU reduction) than polyphenolic (3.2-1.9 log CFU
reduction). Sterility tests showed no positive sample to
inoculated strain until the fourth cycle of reprocessing.
Catheters showed the growth of the inoculated strain, Bacillus
subtilis in 1/35 and 1/22 samples after ﬁve cycles and six cycles
respectively. Every reprocessed device was non-pyrogenic (<20
EU/catheter). In addition, tests conducted on in-vitro spiked
catheters showed that pyrogenic loads of 200 EU/device were
reduced to less than 11 EU/device.
Conclusions: Reprocessing procedures following the adopted
regeneration protocol were able to satisfy the fundamental
microbiological requirements until ﬁve in-vitro reuses. Sterility
tests showed that devices’ sterility was not guaranteed after ﬁve
reuses. Pre-sterilization treatments including enzymatic
solutions and chlorine revealed high cleaning properties with
effective bioburden reduction. Storage intervals among
reprocessing steps longer than 24 hours should be avoided in
order to limit contamination and pyrogenic load. Technical
considerations suggest to consider the introduction of
reprocessing procedure only in hospitals with a considerable
workload.
P1792
Room disinfection in the hospital setting using
Akacid plus
C. Kratzer, S. Tobudic, W. Graninger, A. Buxbaum,
A. Georgopoulos (Vienna, AT)
Objectives: Akacid plus, a novel polymeric guanidine with
broad antimicrobial activity also against multi-resistant bacterial
strains, was used in the present study as room disinfectant.
Methods: Disinfection of closed rooms experimentally
contaminated with antibiotic-susceptible and multi-resistant
Staphylococcus aureus (MRSA), Pseudomonas aeruginosa and
Escherichia coli was performed using Akacid plus at
concentrations of 0.1%, 0.25% and 0.5% for 100 minutes.
Bacterial suspensions were distributed on stainless steel plates
and placed in a test and control room. Recovery of the test
bacteria was determinedbefore nebulizing, 60 and 100 minutes
after the beginning and 4 hours after the end of room
disinfection by a modiﬁed simple swab-rinse technique. For
the detection of MRSA in isolation units, surface samples were
collected by direct swab and enrichment culture.
Results: The swab-rinse method demonstrated a dose- and
time-dependent effectiveness of Akacid plus in eradicating S.
aureus, E. coli and P. aeruginosa on stainless steel plates.
Nebulizing of 0.5% Akacid plus was successful in eliminating
all hospital pathogens in 340 min contact time, while MRSA was
still detectable after use of 0.25% Akacid plus. 0.1% Akacid
plus achieved a reduction >100 CFU of S. aureus and P.
aeruginosa, but was only able to eradicate E. coli during the
observation time.
Conclusion: The results suggest that nebulized Akacid plus at
a concentration of 0.5% is a potent substance for eradication of
pathogenic organisms in the hospital setting.
P1793
Study on the antiviral efﬁcacy of Citrofresh, a
ﬂavonoid based organic acid complex sanitizer
Z. Nack (North-Geelong, AU)
Objective: Determine the antiviral efﬁcacy of this organic
sanitizer against enveloped and non-enveloped viruses using a
carrier based method. Seeking registration for Citrofresh in
Australia and in the EU as a Hospital Grade antiviral sanitizer.
Methods: The study was performed according to the American
Society of Testing and Materials (ASTM) Designation (E 1053–
85) recommended by the Australian Therapeutic Goods
Administration (TGA) to determine the efﬁcacy of a
disinfectant intended to use on inanimate, environmental
surfaces. We tested Citrofresh (diluted in standard hard
water) in three different concentrations: 1%, 2% and 4% on
adherent cell lines (PK-15, MRC-5, MDCK, A549, L929) in four
replicates against ﬁve different viruses including: Porcine
Parvovirus (non-enveloped, high resistant against sanitizer);
Human Rhinovirus-16 (non-enveloped, high resistant against
sanitizer); Human Adenovirus-4 (non-enveloped, moderate
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resistant against sanitizer); Human Inﬂuenza Type A (H3N2)
virus (enveloped, moderate resistant against sanitizer); Human
Herpes simplex virus Type 1 (enveloped, low resistant against
sanitizers). Prior to the viral testings, acute toxicity assay was
carried out to determine the adherent cells viability against
Citrofresh.
Results: Cell lines exhibited >80% viability after exposure to all
three concentration. Herpes simplex Type 1, Human Inﬂuenza
Type A and Human Adenovirus-4 exhibited the most signiﬁcant
viral log reduction of log10 4 to 5 at 4% concentration of
Citrofresh followed by the Human Rhinovirus-16 and Porcine
Parvovirus log10 4 reduction at 4% concentration. The reduction
of viable virus load was exhibited after 1 minute exposure time
to Citrofresh, which means no time-dependant activity.
Citrofresh clearly exhibited concentration and pH dependent
viral load reduction activity against Inﬂuenza Type A and the
Human Adenovirus -4 and Human Herpes simplex Type 1
virus. The reduction in viral titre for Porcine Parvovirus and
Human Rhinovirus-16 is probably pH dependent (the pH of 1%
Citrofresh is 6.5, 2% is 4.5 and 4% is 3.5).
Conclusion: Our investigation shows that Citrofresh is an
effective disinfectant on environmental surfaces, eliminating
enveloped and non-enveloped viruses and sufﬁcient to achieve
the minimum 4-log reduction with complete viral inactivation
which is prerequisite for registration.
P1794
Rapid environmental recontamination of an
intensive care unit after decontamination with
hydrogen peroxide vapour
K.J. Hardy, S. Gossain, P.M. Hawkey, B.A. Oppenheim,
N. Henderson, F. Gao (Birmingham, UK)
Objectives: To evaluate the effectiveness of hydrogen peroxide
vapour (HPV) to reduce the levels of total bacterial and
methicillin resistant Staphylococcus aureus (MRSA)
environmental contamination on an Intensive Care Unit (ICU),
and to establish the rate of environmental recontamination.
Methods: The study took place on a 9 bed open plan ICU. On
each environmental screen 3 sites in each bed space (under the
bed, the workstation and the monitor) were examined using
broth enrichment for the detection of MRSA. In addition total
bacterial counts were determined for under the bed and
workstation using RODAC plates. Environmental screening
was carried out monthly for the 3 months preceding the usage
of HPV, increasing to weekly for the 4 weeks prior to usage.
Additional sampling was carried out immediately before
patients were discharged from ICU, following the subsequent
terminal clean and then immediately after HPV use. After
readmission of patients sampling was carried out at 24 h, 48 h
and then weekly for a period of 8 weeks. Patients were screened
for MRSA on admission and then weekly.
Results: Sampling of the environment prior to the usage of HPV
revealed contamination of the environment with MRSA on 6/7
occasions, with MRSA colonised patients being present on only
3/7 occasions. After discharge of the patients and terminal
cleaning of the environment, MRSA was isolated from 5 (13%)
environmental sites. After the use of HPV, MRSA was not
isolated from any environmental sites upon immediate
sampling, but 24 h after patients were readmitted, including 2
patients known to be colonised with MRSA, MRSA was isolated
from 5 sites. These sites were not clustered around the colonised
patients but were widespread across the ICU. In the 8 weeks
post HPV usage MRSA has been isolated every week. The mean
total bacterial counts prior to the use of HPV were 22.0/10 cm2
underneath the beds and 3.8/10 cm2 on the workstations, this
was reduced after HPV to 0.1/10 cm2 and 0.2/10 cm2
respectively. After patients readmission the counts were 4.1/
10 cm2 underneath the beds and 1.2/10 cm2 on the workstations
after 48 h and returned to pre-HPV levels of 16.9/10 cm2 and
4.8/10 cm2 at each site respectively after 1 week.
Conclusion: Hydrogen peroxide vapour is effective in
eliminating bacteria from the environment. The rapid rate of
recontamination of the environment suggests that the use
of HPV is not an effective means of maintaining low levels of
environmental contamination on an open plan ICU.
P1795
Survival of some nosocomial infections agents on
the surface of different covering materials
H. Yazgi, M.H. Uyanik, M. Ertek, A.E. Aktas, H. Igan, A.
Ayyildiz (Erzurum, TR)
Objectives: The nosocomial infections are more serious and
dangerous than community acquired infections since they have
high rate of morbidity and mortality as well as they increase the
cost of therapy. Recently many precautions have been taken to
prevent these infections. One of these applications is that
covering of the ﬂoor of the wards, clinics, intensive care units
and operating rooms of the hospitals with vinyl ﬂooring
material, which is believed to be cleaned easily and effectively.
In this study it was aimed to determine the duration of survive
of the Staphylococcus aureus, Enterococcus feacalis, Escherichia coli
and Pseudomonas aeruginosa, which were most common
encountered as nosocomial infection agents, on the surface of
ﬂooring materials such as vinyl ﬂooring, ceramic laminated
wood and galvanized sheet at room temperature.
Methods: Four kinds of ﬂooring materials were prepared
approximately in 4–6 cm2 coupons and sterilized. Separate
bacterial suspensions equal to Mc Farland 1 turbidity were
swapped to the surface of each ﬂooring materials by sterile
cotton swabs. All contaminated test materials were put in sterile
petri dishes with cover and kept at room temperature without
subjecting to the direct sunlight. On the third day, culture
samples were taken from the surface of each material by sterile
cotton swaps soaked with sterile saline and streaked on the
blood agar surface. Culturing procedure was repeated every
other day until no growth detected. In case of three
consequently, negative culture results obtained culturing was
ended.
Results: Overall results of the study were presented on table 1.
Conclusions: Among the four ﬂooring materials, galvanised
sheet seemed to be the most unsuitable one for the bacteria to
survive long period. In other words this material should be
preferred as to laminated wood for covering benches and
laboratory tables. As for the ﬂooring of the ﬂoors the vinyl
ﬂooring material is better than ceramic.
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P1796
Evaluation of infection control practices in 31
haematopoietic stem-cell transplant facilities in
German-speaking countries: variation of
measures reﬂects lacking evidence
S. Wenzler-Ro¨ttele, A. Conrad, W.V. Kern, H. Bertz,
F.D. Daschner, M. Dettenkofer (Freiburg, DE)
Objective: Haematopoietic stem cell transplant (HSCT)
recipients are highly immunocompromised during pre- and
postengraftment. Thus, they are cared for in specialised facilities
and versatile precautions are practised in order to prevent
nosocomial infections. However, there is a lack of evidence
whether these interventions are effective. Furthermore, most of
the measures are cost-intensive and restrict the patients’
comfort. For evaluation of precautions, a survey was
performed to assess the spectrum of measures commonly
practised.
Methods: A questionnaire was compiled asking in detail for
infection control measures differing according to allogeneic and
autologous HSCT recipients. The questionnaire was sent to 61
HSCT facilities in Germany, Austria and Switzerland.
Results: 31 questionnaires (51%) were ﬁlled in and sent back.
Among the 31 centres, 24 were university hospitals, and 4
teaching hospitals. The overall number of transplantations that
were performed by the facilities varied considerably and ranged
from 3 to 120/y for auto HSCTs and from 3 to 110/y for allo
HSCTs. 80% of the institutions performing allo and auto HSCT
have implemented different precaution standards for each
group. Some measures regarding allo HSCT were routinely
adhered to in practically all institutions: accommodation in
single rooms (96%), interdiction of plants and opening of
windows (100% each) and protection from waterborne bacteria
by use of terminal tap water ﬁlters (92%). 83% of HSCT facilities
perform their allo transplantations in HEPA-ﬁltered rooms and
54% are providing laminar air-ﬂow for this population. There
was a broad spectrum of different measures regarding barrier
precautions: gowns when entering the room (required in 43% of
centres for allo and 24% for auto HSCT) and face masks (83%
allo and 66% auto HSCT). Precautions to be followed by the
patient varied among centres, e.g. speciﬁcation of the face
mask/respirator to be worn outside the isolation room (for allo
HSCT: 41% surgical mask, 5% FFP1, 36% FFP2 and 18% FFP3).
Conclusion: The broad variety of different preventive measures
performed by the different facilities reﬂects lacking evidence for
many infection control precautions that are commonly practised
in the care of HSCT recipients. This survey provides the basis for
further studies within the ONKO-KISS project (Hospital
Infection Surveillance System for Patients with Haematologic/
Oncologic Malignancies).
P1797
Microbiological analysis of saline solutions used
in wound cleansing
C. Nogueira, M. Alves, A. Magalha˜es-Sant’Ana, C. Migue´ns,
J. Gouveia (Coimbra, Pampilhosa da Serra, PT)
Objectives: In this study it was our aim to evaluate the
microbiological contamination of physiological serum ﬂasks in
use in medical day center for wound cleaning and to identify the
isolated microorganisms.
Methods: We have collected 44 saline solutions from 22 health
care centres localized in the health sub-region of Coimbra. From
each centre we have recovered 2 aleatory ﬂasks in current use.
The samples were transported at 4ordm;C and maintained at
this temperature until its processing. Saline solutions were
seeded by the pour-plate technique in plate count agar and
plates incubated at 28 and 37ordm;C for 48 h. The saline
solutions were evenly spread over the surface of Blood Agar and
Sabouraud Chloramphenicol Agar (SAB CHL-D). The transfers
of saline solutions ﬂasks were also tested for microbiological
contamination with a sterile cotton swab that was rubbed
vigorously, over the transfer surface and directly applied on
Blood agar media. Blood Agar plates were incubated at 37 C for
48 h and SAB CHL-D plates were incubated at 28 C and 35 C
and examined daily for a period of 30 days before declared as
culture negative. Microbial identiﬁcation was ﬁrstly accom-
plished by employing conventional morphological and bio-
chemical tests. When identiﬁcation was not possible by these
methods, 16S rRNA gene sequence determination and phylo-
genetic analysis were used for bacterial strains and in the case of
moulds we performed the ampliﬁcation and sequencing of
Internal Transcriber Spacers region of 5.8S gene.
Results: From the 44 saline solutions analysed, 54.5% were
contaminated. A total of 38 strains were isolated, 66% could be
identiﬁed to species level using morphological and biochemical
tests, the remaining 34% were identiﬁed by gene ampliﬁcation
and sequencing. About 69.6% of the identiﬁed strains were
Gram-positive cocci, the second dominant type of strain were
Gram-positive bacilli (13%), and the third dominant type of
strains were Gram-negative bacilli and moulds, both with 8.7%.
The most frequent contaminants belong to human normal ﬂora
(64%), supporting the idea that the source of contamination of
saline solutions analysed was human, in contrast with 36% of
contamination due to the environment.
Conclusions: The contamination of the saline solutions is due to
inadequate clinical practices. These results claim for more strict
hygienic measures and for the replacement of big ﬂasks by
single use ﬂasks with an incorporated overture used for wound
irrigation.
P1798
Frequencies of CMV-IE speciﬁc memory T cells
are inversely correlated with alloimmune
memory and serum creatinine in kidney
transplant patients
P. Nickel, G. Bold, F. Presber, C. Scho¨nemann, J. Pratschke,
D. Bitti, F. Kern, H.-D. Volk, P. Reinke (Berlin, DE)
Background/Aims: Cytomegalovirus infection is a signiﬁcant
cause of morbidity in transplant patients and has been
associated with allograft rejection. In this study frequencies of
IFNg-producing T cells following ex-vivo stimulation with
protein-spanning peptide pools for CMV proteins pp65 and
IE1 as well as donor-reactive T cell frequencies were serially
determined during the ﬁrst 6 months after renal transplantation
(Tx) to analyse the relation of CMV speciﬁc T cells, virus control
and alloimmunity.
Patients: 64 kidney transplant recipients were included.
Immunosuppression generally consisted of anti-IL-2R mAb,
calcineurin inhibitor, MMF and steroids. 2 presensitized patients
received an induction by 2x low dose OKT-3, anti-TNF mAb,
anti-CD20 mAb and 5x plasmapheresis. 8 Patients received FTY-
720, cyclosporine and steroids.
Methods: PBMCs from renal transplant recipients were
analysed in a computer-assisted ELISPOT assay before and at
multiple times (mean 5) post-transplantationfor IFN-y-
producing T cells following in-vitro stimulation for 24 hrs by
irradiated donor cells and pools of overlapping peptides
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covering the complete CMV IE-1 and pp65 proteins.Results:
CMV seropositive transplant recipients had signiﬁcantly
hightened IE-1 and pp65 speciﬁc T cell frequencies compared
to seronegative individuals. Patients withevidence of CMV
antigenemia or DNAemia could not be discriminated based on
CMV- and donor-reactive T cells or serum creatinine. However,
recipients of seropositive grafts with low IE1 response showed a
tendency towards more frequent CMV infection. CMV disease
was observed in only 3/64 individuals. 2 had no detectable IE1-
or pp65-T cell response, the third presented with a dominant
pp65 response. Interestingly, IE1-speciﬁc T cells correlated
inversely with early post-Tx donor-reactive T cell frequencies
during weeks 1–2 post-Tx. Most importantly, IE1-speciﬁc T cell
frequencies correlated inversely with serum creatinine at 6 and
12 months at several times post-Tx. In patients without acute
rejection, even pre-transplant IE-1 speciﬁc T cells correlated
inversely with 6 and 12 months creatinine.
Conclusion: These data suggest subclinical control of CMV
infection by IE-1 speciﬁc T cells and subsequently less graft
injury by (CMV-induced) alloimmunity.
P1799
Universal precautions: knowledge, attitude and
practice of healthcare workers regarding HIV,
hepatitis B and C
V. Gupta, S. Bhoi, A. Goel, P. Aggarwal (New Delhi, IN)
Objectives: Increasing incidence of HIV, Hepatitis B (HBV) and
Hepatitis C (HCV) in the patients expose the healthcare
professionals of acquiring these infections during occupational
exposure. We studied the knowledge, attitudes and practices of
healthcare workers regarding HIV, HBV, HCV and the risk of
occupational transmission of these diseases.
Methods: An interview survey was conducted among all the
health care workers (HCW) using a standardised questionnaire
comprising of 34 items in English and local language, as
suitable, by an expert in the Emergency Ward of a tertiary care
teaching hospital of a developing nation. Data analysis
(Bivariate and multivariate analysis) was done using SPSS
version 10.
Results: 170 (response rate: 80%) HCW participated in the
study. The mean age was 33 ± 6 years, 54 were females. The
study population comprised of 40% doctors, 23% nurses, 25%
lab technicians and 12% support staff. Respondents had
adequate knowledge about causative (65%) usual transmission
(63%), symptoms (69%) of AIDS but poor knowledge about HBV
and HCV (43%, 41% and 30% respectively). Inadequate
knowledge was also revealed about the infectious bodyﬂuids
(31%), disinfection of equipments (32%), pregnancy in HCW as a
susceptibility factor (22%), post exposure prophylaxis (34%) and
comparative infectivity of HIV and Hepatitis (38%). 70% of
HCW became anxious while treating these patients. Poor
compliance with Universal Precautions was noticed. High
compliance was reported for wearing masks (72%) and
wearing gloves (53%). Doctors were more likely to suffer
needlestick injury (p = 0.04) Occupational exposures was
found to be high (48%) with poor declaration rate (10%).
Guidelines adherence was inﬂuenced by profession (p < 0.001),
availability or adequacy of protective equipments but not by
work experience as HCW (p = 0.8). All of the respondents urged
for an interactive information session.
Conclusions: Results from this study reveal that there is a fair
level of knowledge about HIV/AIDS but Hepatitis B and C have
not generated adequate concern among the HCW. Incongruity
between perceived knowledge and reported practice suggests
that there is a need for an interactive awareness course about the
universal precautions. The educational programmes need to
consider attitudes in conjunction with empirical knowledge.
P1800
Molecular characterisation of acute hepatitis A
outbreaks in health care workers
H. Choi, S.Y. Jeong, S. Lee, M.A. Lee (Seoul, KR)
Objectives: The sero-prevalence of hepatitis A (HAV)
antibodies are known to be low in young adults in Korea.
Recently, seventeen cases of hepatitis A have been reported in
health-care workers (HCW) of ICU in a University hospital from
May 2005 to July 2005. We performed surveillance, and
determined molecular identiﬁcation of outbreaks.
Methods: 1. We checked the HAV IgM from all the patients of
SICU with elevated AST/ALT retrospectively and screened
AST/ALT level from all the nurses and the doctors in contact
with suspicious index case. 2. When we determined the
existence of outbreak, the molecular subtypes of HAV from a
blood of HCW were determined to provide the data for
epidemiologic study. We determined the index case, a
transmission route and the intervention for control an
outbreak were planned.
Results: 1. Seventeen HCW including 13 nurses and 4 doctors
who are 22 to 32 years old, suffered from acute HAV over
7 weeks period. 2. The possible transmission of HAV was fecal-
oral route from the bed-ridden patients with diarrhea to the
exposed HCW. 3. Seventeen HCW were identiﬁed with a
positive anti-HAV IgM. The eight HCW had a positive HAV
RNA. Analysis of the VP1-P2A region of each isolate showed
genotype 1A in ﬁve strains and co-circulation of 1A and 1B in
others.
Conclusions: The occurrence of HAV outbreak highlights the
importance of standard precaution in a hospital. The HAV
vaccination is considered in young aged-HCW. The genotype
identiﬁcation of blood would be useful for the epidemiologic
study of suspicious HAV outbreak in a hospital.
P1801
Management of a norovirus-associated
gastroenteritis outbreak on two psychiatric wards
A. Buehling, U. Arnold (Magdeburg, DE)
Objectives: We report a norovirus-associated outbreak of
gastroenteritis on a closed psychiatric and a gerontopsychiatric
wards from December 2004 to February 2005. During this time
46 patients and 25 healthcare workers (HCWs) were affected.
Introduction and results of hygiene measures based on
published guidelines on psychiatric wards are described.
Methods: Effective and adapted measures had to be
implemented to stop the outbreak and to prevent the spread
of disease to other areas of our hospital. Isolation or cohorting of
the psychiatric patients was excluded for therapeutic reasons.
Regular hand disinfection in patient rooms was impossible
because of the high risk of abuse. The following measures have
been introduced: use of gowns, masks and gloves by HCWs
during care of infected patients- frequent hand disinfections
with alcohol-based disinfectants by HCWs using ‘‘pocket
bottles’’; recommendation for all persons entering the station
to use gowns, gloves and masks and to disinfect their hands
frequently, distribution of handouts describing the measures;
hand disinfection by all patients after using toilet, before and
after taking meals (distribution of disinfectants by HCW);
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increased frequency of routine surface disinfection (3 times
daily) instead of routine cleaning once daily; routine disinfection
of door handles, handrails, wash-basins and –ﬁttings and light
switches 3–4 times a shift; avoidance of patient transfer via
hospital; visitor restriction during outbreak time; daily
evaluation of recommended measures and adaptation to the
current situation; exclusion of affected staff from the ward until
48 h symptom free.
Results: The hygienic measures have been explained to the
local HCWs in daily meetings. They have been fully accepted
only after a severe staff shortage in the ﬁfth week of outbreak
because of 3 new cases of gastroenteritis during HCWs and 14
newly infected patients. Because of the restrictive application of
the adapted guidelines for these special wards the outbreak has
been stopped within 4 further weeks.
Conclusion: In case of norovirus-based gastroenteritis
outbreaks on closed psychiatric wards hygienic measures
which are adapted to the concrete situation are necessary.
Especially in these cases the compliance with guidelines can be
increased by daily meetings and daily evaluation of
recommendations. Staff shortage during the outbreak forced
the strict compliance with the recommended measures.
Regional spread of antibiotic resistance
P1802
Nosocomial colonisation and infection of ICU
patients caused by persistent and multiresistant
clones of Acinetobacter baumannii
E. Vagiakou, A. Karabinis, D. Mylona-Petropoulou,
E. Paramythiotou, P. Tassios, L. Tzouvelekis, C. Mergioti,
G. Diamantopoulou, N. Legakis, H. Malamou-Lada (Athens, GR)
Objectives: To evaluate the nosocomial colonization and
infection of ICU patients caused byA. baumannii (Ab) and to
investigate the persistent clones over a 2 year period (May 2002-
April 2004).
Methods: We performed surveillance of patients, healthcare
stuff and ICU environment and we registered the infections of
Ab during 3 periods of 21 days each one. The interval between
1st–2nd period was 6 months and 2nd–3rd period was 1 year.
Rectal, oropharyngeal swabs tracheal aspirates from patients,
handswabs from stuff and samples from environment were
taken weekly. The identiﬁcation of Ab was performed using
Vitek II system the susceptibility was tested by Kirby-Bauer and
MIC methods and the <<DNA ﬁngerprints>>obtained by
pulsed ﬁeld gel electrophoresis (PFGE).
Results: During the 1st 2nd and 3rd period, 19 patients (14 men,
5 women), 13 patients (7 men, 6 women) and 12 patients (8 men,
4 women) were hospitalized in ICU respectively. Ab was
isolated in 74 from 250 samples (29.6%) at the 1st period, 59
from 336 (17.5%) at the 2nd and 62 from 260 (24%) at the 3rd
period. Totally Ab was isolated in 195 from 846 specimens (23%)
At the 1st 2nd and 3rd period among the patients carrying Ab,
7/14 (50%), 7/10 (70%) and 5/8 (62%) were infected
respectively. The infections observed during the study period
were: sepsis (8), urinary tract infection (1), pneumonia (11),
meningitis (1), thrombophlebitis (2). All the isolated Ab strains
were multiresistant to antimicrobial agents. Molecular analysis
of 169 isolated strains by PFGE distinguished the following
types: A (64, subtypes A1–A7), B (10) at the 1st period A(6), C(7),
D(22), E(2), F(1), G(1), H(2), I(1). J(1) at the 2nd period A(25), B
(16), D(1), H(3), K(2). L(5) at the 3rd period. Infections were
caused mainly by A and D types while the same types were
isolated from the environment and the hands of the ICU stuff.
Conclusion: There was a high rate of colonization and infection
of ICU patients by multiresistant clones of Ab. The persistence
of clone A of A. baumannii and the appearance of B type at the
3rd period after its disappearance at the 2nd period despite the
application hygiene measures, indicates the need for more strict
reinforced infection control in ICU. The transmission via the
hands of stuff to patients has become the most important
contributor factor in patient colonization and/or infection.
P1803
Decrease of antibiotic resistance of group A
streptococci in Korea
S. Kim, E.-H. Koh, I.-G. Bae, N.Y. Lee (Jinju, KR)
Objectives: The antibiotic resistance and its mechanism of
group A streptococci (GAS) varies according to nations or
study period. We have investigated antibiotic resistance and
mechanism of macrolide resistance for the strains isolated from
Korean children and compared to the previous (2002) results.
Methods: Throat cultures were taken from 2351 elementary
school children in Jinju, Korea from October to December, 2004
to isolate GAS. Antibiotic susceptibility test to erythromycin
(EM), clindamycin (CC), and tetracycline (TC) was performed
by disk diffusion method. Macrolide resistance phenotype and
genotype as well as emm genotype were studied.
Results: Isolation rate of GAS was 14.0% (328/2351). Resistance
rates of EM, CC, and TC were 9.8%, 8.8%, and 18.3%
respectively, which were dramatically decreased from 51%,
34%, and 30% in 2002 at the same area. Emm44/61 was
prevalent (29%), while emm12 was the most common type (34%)
in 2002. cMLSB, M, and iMLSB were observed in 87.5%, 9.4%,
and 3.1% respectively, compared to 64%, 34%, and 2% in 2002.
The strains with cMLSB and iMLSB had ermB gene and the ones
with M phenotype were positive with mefA gene.
Conclusion: The resistance rates to EM and CC were
dramatically decreased compared to the past (2002). Education
to the public and physicians, decreased consumption of
antibiotics, acquisition of immunity to the resistant strains, or
change of prevalent emm types could be considered to explain
the reason of decrease of antibiotic resistance. Although
antibiotic resistance rate was decreased, cMLSB type which
has high MIC was prevalent suggesting treatment failure for
those children carrying these resistant strains in Jinju, Korea.
P1804
Analysis of skin and soft tissue infections in
European medical centres: report from the
SENTRY Antimicrobial Surveillance Program
(1998–2005)
G. Moet, P. Strabala, H. Sader, T. Fritsche, R. Jones (North
Liberty, US)
Objective: To analyse the skin and soft tissue infections (SSTI)
or wound infections in hospitalized patients in the SENTRY
Program for pathogen prevalence and resistance (R) variations
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in European (EU) medical centres for the years 1998 to 2005
(8 years). This program also included North America (NA) and
Latin America (LA) for the same years, except 2003.
Methods: 50 consecutively isolated pathogens/site were
collected from each centre per year and varied in number of
sites each year in EU: 1998 (23), 1999 (6), 2000 (16), 2002 (3), 2003
(25), 2004 (23), and 2005 (21). Susceptibility testing was
determined by CLSI (formerly the NCCLS) broth
microdilution methods and interpreted by current (2005)
breakpoints.
Results: Table of all years total of SSTI pathogens. (See Table)
SA was the predominant pathogen in EU ranging from 35.7% of
SSTI isolates in 1998 to 47.5% in 2005. The top 5 most prevalent
organisms accounted for 80.0% of isolates in all years with PSA
and EC ranking second and third, respectively with 22.5%
combined, and ENC and ENT ranked fourth and ﬁfth with
10.7% of the total isolates. Compared to the Americas, MRSA
and VRE isolation was at a lower occurrence rate in the EU; but
between the rates of other monitored continents for CTZ-R PSA,
CIPRO-R EC and CTZ-R ENT (AmpC). VRE increased in EU
over the 8 year.
Conclusions: Pathogen prevalence in SSTI for EU has been
consistent over the 8 monitored years although SA (with MRSA)
appears to be increasing. EU is not a world leader in any key R
marker compared to the Americas. However, the R rates are
evolving which suggests continued need for surveillance
programs at regular intervals to detect mobile genetic R
elements.
P1805
Mechanisms of carbapenem resistance in
multiresistant Pseudomonas aeruginosa strains
from Germany
B. Henrichfreise, I. Wiegand, W. Pﬁster, B. Wiedemann (Bonn,
Jena, DE)
Objectives: Carbapenems play an important role in the therapy
of Pseudomonas aeruginosa infections. The aim of our study was
to characterize the molecular alteration responsible for changed
susceptibility towards carbapenems in multiresistant P.
aeruginosa strains from Germany.
Methods: 19 multiresistant P. aeruginosa strains from 9 cystic
ﬁbrosis and 9 non cystic ﬁbrosis patients were collected in 3
German hospitals in 2004. The strains showed reduced
susceptibility (intermediate or resistant; DIN guidelines) to
imipenem, piperacillin, ciproﬂoxacin and gentamicin. Clonality
was tested using PFGE. A PCR screening for VIM and IMP was
carried out. Efﬂuxpump overexpression was detected using an
efﬂuxpump inhibitor (EPI) test. OprD and for strains with
positive results in the EPI test the efﬂuxpump repressorgenes
mexR and nfxB were sequenced.
Results: PFGE patterns revealed no clonal relationship among
the multiresistant strains. Neither VIM nor IMP was detected.
The geno- and phenotypes found are depicted in table 1.
Defective oprD genes caused by premature stopcodons or
frameshifts were found in 17 strains. Among those 11 had no
mutations in mexR or nfxB and showed the highest MICs found
ranging from 8 to >32 and 4 to 32 mg/L of imipenem and
meropenem, respectively. 3 additionally had defective mexR
genes, but intact nfxB genes, 2 also had modiﬁcations in mexR
and nfxB, and 1 showed only in nfxB additional alterations. For
2 strains no alterations in oprD but in mexR were proven.
Conclusions: The predominating mechanism of carbapenem
resistance in multiresistant P. aeruginosa strains from Germany
was the loss of OprD. Accessory overexpression of
MexABOprM due to modiﬁcations in mexR did not result in
signiﬁcantly elevated MICs of meropenem. Moreover, the
additional overexpression of MexCDOprJ did not lower the
MIC of imipenem. In 2 strains with modiﬁcations only in mexR
only elevated MICs of imipenem indicate a reduced expression
of OprD accompanied by overexpression of MexEFOprN as
conferred by nfxC-type mutants.
P1806
Worldwide antimicrobial susceptibility patterns
of inducible Enterobacteriaceae isolated from
intraabdominal infections: results from SMART
2004
F. Baquero, P-R. Hsueh, D.L. Paterson, F. Rossi,
V. Satishchandran, T. Snyder, S. Rawlins, G. Gallagher,
M.A. Abramson, M.J. DiNubile, J.W. Chow (Madrid, ES; Taipei,
TW; Pittsburgh, PA, US; Sa˜o Paulo, BR; West Point, PA, US)
Objective: SMART (Study for Monitoring Antimicrobial
Resistance Trends) is an ongoing global antimicrobial
surveillance program focused on clinical isolates from
intraabdominal infections (IAI). The aim of this analysis was
to assess antimicrobial susceptibility patterns among inducible
Enterobacteriaceae from 5 different regions of the world during
2004.
Methods: 81 centres in North America (NA), Latin America
(LA), Europe (EU), Middle/East/Africa (ME/A), & Asia-Paciﬁc
(A/P) tested the in vitro activity of 12 antimicrobial agents
commonly used to treat IAI against consecutive unique aerobic
and facultative Gram-negative bacilli using microdilution
techniques according to CLSI guidelines. All Enterobacter,
Serratia, Citrobacter, Providencia spp., Morganella morganii,
Hafnia alvei, & Proteus vulgaris were considered to have
inducible beta-lactamases for the purposes of this study.
Results: Inducible Enterobacteriaceae were recovered from
1075 of the 5569 patients (19%) in the study worldwide,
constituting 1104/6156 (18%) of the total isolates. 359 (33%) of
the inducible Enterobacteriaceae isolates were recovered within
48 hours of hospitalization. Enterobacter spp. (49%), Citrobacter
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spp. (23%), M. morganii (10%) & Serratia spp. (10%), were the
most commonly isolated inducible Enterobacteriaceae. The %
susceptible isolates are reported below by region:
Conclusion: Among inducible Enterobacteriaceae causing IAI
in this study, carbapenems were the most reliably active drugs
in vitro across regions.
P1807
Worldwide antimicrobial susceptibility patterns
of Gram-negative bacilli isolated from
intraabdominal infections: results from SMART
2004
F. Rossi, F. Baquero, P-R. Hsueh, D.L. Paterson,
V. Satishchandran, T. Snyder, S. Rawlins, G. Gallagher,
M.A. Abramson, M.J. DiNubile, J.W. Chow (Sa˜o Paulo, BR;
Madrid, ES; Taipei, TW; Pittsburgh, West Point, US)
Objective: MART (Study for Monitoring Antimicrobial
Resistance Trends) is an ongoing global antimicrobial
surveillance program focused on clinical isolates from
intraabdominal infections (IAI). The aim of this sub-analysis
was to assess antimicrobial susceptibility patterns among Gram-
negative bacilli from 5 different regions of the world during
2004.
Methods: 6pA total of 81 major medical centres in North
America, Latin America, Europe, Middle East/Africa, & Asia/
Paciﬁc tested the in vitro activity of antimicrobial agents
commonly used to treat IAI against consecutive unique
aerobic and facultative Gram-negative bacilli from IAI using
microdilution techniques according to CLSI guidelines &
breakpoints.
Results: Enterobacteriaceae were recovered from 4905 (88%) &
non-Enterobacteriaceae were recovered from 826 (15%) of the
5596 patients in the study worldwide, constituting 5317 (86%) &
839 (14%) of the 6156 total isolates, respectively. E. coli (n = 2979;
56%) and Klebsiella spp. (n = 978; 18%) were the most commonly
isolated Enterobacteriaceae. Pseudomonas spp. (n = 605; 72%)
and Acinetobacter spp. (n = 110; 13%) were the most commonly
isolated non-Enterobacteriaceae. Isolates from Asia/Paciﬁc and
Latin America were generally more resistant. 2267 (43%) of the
Enterobacteriaceae & 272 (32%) of the non-Enterobacteriaceae were
recovered <48 hours after hospitalization. The % susceptible
isolates are reported below:
Conclusion: In this study, Enterobacteriaceae were the
predominant intraabdominal isolates recovered both <48 h
and >48 h after hospitalization. Carbapenems were overall the
most active agents against Enterobacteriaceae worldwide.
Resistance rates varied among geographic regions, with the
Asia/Paciﬁc and Latin America regions generally having the
most resistance.
P1808
Characterisation of streptogramin resistance
genes among Enterococcus faecium isolates from
Austrian animal husbandry
A. Eisner, G. Gorkiewicz, G. Feierl, F. Dieber, E. Marth,
J. Ko¨fer (Graz, AT)
Objectives: The streptogramin virginiamycin has been widely
used as a growth promoter in animal husbandry in the
European Union but was banned in 1998 because of concerns
about evolving cross-resistance to the streptogramin
quinupristin-dalfopristin used in human medicine. The aim of
the present study was to investigate the prevalence of
streptogramin resistance genes of Enterococcus faecium
recovered from animal faecal specimens collected in Southeast
Austria.
Methods: We analysed 300 E. faecium isolates of cattle (n = 100),
pig (n = 100), and poultry (n = 100) for the presence of
streptogramin resistance genes. We used selective enterococcal
broth for isolation. Species identiﬁcation was done on basis of
Gram stain, catalase and pyrrolidonyl arylamidase activity,
motility, Lanceﬁeld group D antigen typing, and by the 20 Strep
Apitest (bioMe´rieux). Detection of the resistance genes vat(E),
vat(D), and erm(B) was done by PCR.
Results: The erm(B) gene encoding macrolide, lincosamine, and
streptogramin B (MLSB) resistance was found in each 2 E.
faecium isolates recovered from pig and cattle, none of the
isolates from these animals carried genes coding for
streptogramin A resistance. On the contrary, 14 E. faecium
isolates from broiler specimens contained the vat(E) gene and
one isolate contained the vat(D) gene. All of these isolates also
contained the erm(B) gene.
Conclusion: Our data indicate that the use of the meanwhile
banned antimicrobial feed additive virginiamycin has created a
reservoir of streptogramin-resistant E. faecium in Southeast
Austrian poultry.
P1809
Characterisation of macrolide-resistant
Streptococcus pneumoniae isolates from Russia
S.A. Grudinina, O.Y. Filimonova, E.N. Ilina, A. Al-Lahham,
M.V. Malakhova, L.G. Stolyarova, S.V. Sidorenko, R.R. Reinert
(Moscow, RU; Aachen, DE)
Objectives: Streptococcus pneumoniae (Spn) resistance to
macrolide antibiotics continues to be of major concern. The
aim of present study was to analyse phenotypic and genotypic
characteristics of macrolide resistant Spn isolates.
Methods: Eighty one macrolide resistant Spn isolates were
collected in Moscow, 2003–2005. The susceptibility testing was
performed according to the CLSI guidelines. Macrolide resist-
ance phenotypes were characterized by triple-disk diffusion test,
using erythromycin, clindamycin and rokitamycin disks. Detec-
tion of genes, coding resistance to macrolides, was done by
RT-PCR. Sequencing for QRDR mutations was performed on
levoﬂoxacin resistant Spn isolates. Selected isolates were
analysed by MLST.
Results: By the triple-disk test, 21 isolates were assigned to the
M phenotype, 20 of them were carrying mefA gene, and one was
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negative. Twenty eight isolates were cMLSB-phenotype, 25 of
them were carrying both ermB and mefA genes, in two isolates
only ermB was detected, and one isolate was negative for both
genes. iMcLSB phenotype was demonstrated by 29 isolates, both
ermB and mefA genes were detected in 6 of them, and only
ermB in 23. Three isolates didn’t demonstrated blunting of zone
of inhibition around rokitamycin disk. Associated resistance to
penicillin G, tetracycline, chloramphenicol and co-trimoxazole
was observed in 67.9%, 86.4%, 42.0% and 75.3% of Spn isolates
respectively. Nine multidrug resistant isolates, harbouring both
mefA and ermB genes, were subjected to MLST. Among them
one isolate was found to share the allelic proﬁle ST 81 (Spain23F-
1 clone), and four isolates were single-allele variants of ST 81. In
four isolates new allelic proﬁles were detected. Three isolates
were resistant to levoﬂoxacin (MIC ‡4 mg/L), in two of them
with levoﬂoxacin MIC > 32 mg/L (ST81 single-allele variants)
E85K, S79F and I460V substitutions were detected in GyrA, ParC
and ParE, respectively. D83N and I460V substitutions were
detected in ParC and ParE of one isolate with new allelic proﬁle.
Conclusion: High prevalence of macrolide resistant Spn,
harboring both ermB and mefA genes is observed in Moscow,
macrolide resistance is associated with resistance to other
groups of antibacterials. Some multidrug resistant isolates are
highly related to internationally disseminated multiresistant
clone Spain23F-1. Strains with ﬂuoroquinolone resistance in
Moscow were all single locus variants of the Spain23F-1 clone.
P1810
Occurrence of tet(W) gene in a Clostridium
difﬁcile clinical isolate
P. Mastrantonio, F. Barbanti, P. Spigaglia (Rome, IT)
Objectives: To investigate the presence of tet(W), a tetracycline
resistance gene recently identiﬁed in anaerobic commensal
bacteria from animals and humans, in C. difﬁcile clinical isolates.
Methods: Several C. difﬁcile clinical isolates from different
Italian hospitals were analysed for the presence of a tet(W)
gene by PCR assays. The primers used were designed on the
tet(W) sequences available in GenBank. PCR fragments obtained
by these ampliﬁcations were sequenced. tet(W) DNA ﬂanking
regions were also examined with a set of PCRs constructed on
the sequence of the conjugative transposon TnB1230 of
Butyrivibrio ﬁbrisolvens 1.230, that is the only element
carrying a tet(W) partially characterized so far. tet(W) positive
isolates were also examined for the tet(M) gene and for the
presence of int and tndX, markers for the Tn916 and the Tn5397-
like elements, respectively. The Tn916-like elements were
further characterized by PCRs designed on Enteroccus faecalis
Tn916 sequence. Tetracycline MIC values were determined by
the E-test method. Tetracycline resistance gene transfer was
evaluated by ﬁlter mating experiments, using C. difﬁcile p881R
strain as recipient.
Results: A tet(W) gene was found in only one isolate, C. difﬁcile
cd5, also positive for the tet(M) gene. This isolate was resistant
to tetracycline with a MIC of 8 mg/L. Sequence analysis of the
tet(W) PCR fragment (about 1860 bp) showed that this gene had
an identity of 99% with the genes found in Clostridium spp strain
K10, Mitsuokella multacida and Butyrivibrio ﬁbrisolvens. No
ampliﬁcations were obtained with the primers designed on
TnB1230, indicating the presence of a different genetic support
for tet(W) in C. difﬁcile. tet(M) gene of C. difﬁcile cd5 was carried
by a Tn916-like element that showed nucleotide sequence
mutations in the region containing orf 17–20 compared to the
element of E. faecalis. Conjugative transfer of tet(W) was not
observed, whereas the tet(M) gene was transferred to the
recipient strain. C. difﬁcile transconjugants were resistant to
tetracycline with a MIC of 8 mg/L.
Conclusion: The results obtained in this study demonstrate for
the ﬁrst time the presence of a tet(W) gene in a clinical isolate of
C. difﬁcile, providing further evidence of the spread of this
resistance determinant among gastrointestinal bacteria.
P1811
Macrolide resistance determinants are prevalent
and readily selected for in viridans group
streptococci among healthy Norwegian adults
P. Littauer, B. Haldorsen, M. Kra¨mer, B. Aasnæs, G.S. Simonsen,
A. Sundsfjord (Tromsø, NO)
Background: Norway has a low prevalence of antimicrobial-
resistant bacteria including macrolide resistant (MR) respiratory
tract pathogens. We have observed an increase in macrolide
consumption in Norway and there is a lack of knowledge on the
reservoir of macrolide resistance determinants among viridans
group of streptococci (VGS) in the pharyngeal ﬂora.
Objectives: Examine the occurrence, selection and persistence
of macrolide resistance determinants in VGS pharyngeal ﬂora in
healthy Norwegian adults before and after treatment with
azithromycin.
Methods: Throat samples were collected before (day 1), after
treatment (day 7) and after 3 months (day 90) from 20 healthy
volunteers. The samples were plated directly as a lawn on
PDMII agar plates with 5% deﬁbrinated blood with an
erythromycin Etest strip. Photos were used as quantitative
comparisons. Up to 10 morphological different colonies with
erythromycin Etest MIC ‡1lg/ml from each specimen were
collected; day1 (n = 59), day 7 (n = 157) and day 90 (n = 76). In
total 86 representatives MR, VGS-isolates were selected for
further studies: (i) MICs of erythromycin, tetracycline and
penicillin were determined by Etest. (ii) PCR’s for erm(B),
erm(TR), and mef(A/E), and subsequent sequence-typing of
mef. Species identiﬁcation was performed by sodA sequencing.
Results: A total of 17/20 persons carried a low number (<5) of
MR VGS in day1 specimens, while 20/20 had a signiﬁcant
higher number (>100) of MR strains in day2 specimens. In day90
specimens, 20/20 carried a low number of MR, resembling day1.
Reduced susceptibility to penicillin was observed in 32/86 (34%)
isolates. Tetracycline resistance was found in 43/86 (57%), and
mainly in erm(B)-positive strains. mef(A/E)-positive dominated
day1 (53%) and erm(B) day2 specimens 52%. Sequence typing
revealed mef(E) (n = 41) and mef(A) (n = 3). SodA sequence;
S. mitis (n = 42), S. oralis (n = 9), S. parasanguinis (n = 12),
S. salivarius (n = 22), and S. sanguinis (n = 1).
Conclusion: There is a pool of VGS carrying macrolide
resistance determinants in the normal pharyngeal ﬂora of
healthy adults that are readily selected for during
azithromycin exposure. The mef(E) and erm(B) were the most
prevalent resistance genes and co-resistance to tetracycline was
frequently observed, resembling the ﬁndings in Norwegian
clinical isolates of S. pneumoniae. These VGS may provide a
pool of resistant bacteria that may transfer resistance
determinants to more pathogenic organisms.
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P1812
Relationships in genotype, phenotype, T type and
PFGE type among macrolide-resistant
Streptococcus pyogenes strains isolated in the
Czech Republic
V. Jakubu`, P. Urba´sˇkova´, L. Strakova´ (Prague, CZ)
Objectives: To determine relationships between phenotypic
and genotypic methods among erythromycin-resistant S. pyo-
genes strains.
Methods: A total of 1331 clinical isolates of S. pyogenes resistant
to erythromycin were collected in 39 microbiology laboratories
during 2001–2003. Erythromycin susceptibility was tested by the
disk diffusion method. Strains with an inhibition zone <21 mm
around the erythromycin disk (15 lg) were sent to the National
Reference Laboratory for Antibiotics (NRL). Presences of MLSB
resistance genes (ermTR, ermB and mefA) were tested by PCR. T
serotypes were determined in randomly selected representatives
of each phenotype (n = 370). PFGE type were determined in
strains from year 2003 only (n = 68).
Results: The rate of the most prevalent phenotype (constitutive
MLSB resistance) was 63%, 55% in the year 2001 and 2003,
respectively. The major prevalent T types among the analysed
strains were serotype T 28 (58%), T 12 (10%), T 4 (8%) and T
B3264 (8%). Gene ermB was the most frequent (54%). The results
of PCR method was highly congruent with observed phenotype
of resistance. PFGE patterns of strains with constitutive MLSB
resistance were highly identical.
Conclusion: M phenotypes, constitutive and inducible
resistance to MLSB antibiotics were found and ermTR, ermB
and mefA genes were detected among the analysed strains. The
T serotype 28 was identiﬁed the mainly prevalent in our
collection. The majority of strains harbouring T serotype 28 were
constitutively resistant to macrolides. The study showed close
relationships among genotypes, T types, speciﬁc resistotypes
(phenotype) and PFGE types.
P1813
Analysis of trends for susceptibility of the
B. fragilis group from 1997–2004, a US survey
D.R. Snydman, N.V. Jacobus, L.A. McDermott, R. Ruthazer,
Y. Golan, D.W. Hecht, S.M. Finegold, E.J.C. Goldstein, L. Harrell,
S. Jenkins, C.L. Pierson, J. Rihs, R. Venezia, V.L. Yu,
S.L. Gorbach (Boston, Chicago, Los Angeles, Santa Monica,
Durham, Charlottte, Ann Arbor, Pittsburgh, Baltimore, US)
Objectives: Since recognition of transferable clindamycin and
tetracycline resistance in Bacteroides, we have undertaken a US
national survey on the susceptibility of B. fragilis group to
analyse emergence of resistance and trends, since these species
are not routinely tested for susceptibility in hospital clinical
laboratories.
Methods: Agar dilution MICs were determined for 5225 isolates
from 1997–2004 for B. fragilis and related species from 9
geographically diverse centers in the US. Antibiotics included
3 carbapenems, 3 B-lactam/B-lactamase inhibitors, 2 quinolones,
a tetracycline, clindamycin, metronidazole, chloramphenicol, a
glycylcycline and linezolid. Isolate identity was conﬁrmed by
API 20A.
Results: Analysis of resistance trends from 1997–2004 showed a
decrease in geometric mean MIC’s (geoMIC) for imipenem
(0.80 mcg/ml to 0.32 mcg/ml, p < 0.001) and meropenem
(0.52 mcg/ml–0.42 mcg/ml, p = 0.003) for the Bacteroides
species. Ertapenem geoMIC remained unchanged (0.99 mcg/
ml). For the B-lactamase inhibitors, piperacillin-tazobactam
geoMIC declined from 2.56 mcg/ml to 2.22 mcg/ml
(p < 0.001). Ampicillin-sulbactam geoMIC did not change. Few
isolates were resistant to any carbapenem or B-lactamase
inhibitor combination. Clindamycin resistance increased,
especially for B. fragilis, B. ovatus and B. thetaiotaomicron (all
p < 0.001). Among quinolones, resistance of Bacteroides to
moxiﬂoxacin increased (geoMIC went from 2 mcg/ml to
3.5 mcg/ml, p < 0.001). B. fragilis remains the most sensitive
Bacteroides species to moxiﬂoxacin, although approximately
45% of stains have MIC’s ‡to 4 mcg/ml in 2004. Tigecycline
susceptibility, tested over 5 years, did not change. The ﬁrst
conﬁrmed metronidazole-resistant isolate (MIC = 64 mcg/ml)
obtained in the US was noted in 2002 but none were noted in
2003 or 2004.
Conclusion: Improved susceptibility of Bacteroides species to
some carbapenems and the B-lactamase inhibitor combinations
is unexplained but signiﬁcant. Clindamycin resistance continues
to increase, especially for B. fragilis. Moxiﬂoxacin susceptibility
for the non fragilis species shows that the majority of strains are
resistant. The ﬁrst metronidazole resistant isolate has been
reported from the US. Since resistance trends are associated with
species, the differentiation within the species is of extreme
importance, since it may impact the choice of antimicrobial
agent for the treatment of infections caused by this group of
anaerobes.
P1814
Observed duration of nasopharyngeal carriage of
penicillin-resistant pneumococci: relations to age
and serogroup
P. Geli, L. Ho¨gberg, H. Ringberg, E. Melander, M. Lipsitch,
K. Ekdahl (Solna, Malmo¨, Lund, Stockholm, SE; Boston, US)
Background and objectives: Knowledge of how the duration of
pneumococcal carriage varies with age and serogroup is
essential to understanding how immunity to carriage arises
throughout the course of life, and designing appropriate models
for the effects of vaccination or other public health initiatives
aiming to reduce the pneumococcal transmission in the
community. Using data from an ongoing Swedish intervention
project, the duration of nasopharyngeal carriage of penicillin-
resistant pneumococci (MIC PcG >0.5 mg/L) stratiﬁed by both
serogroup and age of the carrier were estimated.
Methods: The mean duration and corresponding 95%
conﬁdence interval was estimated by ﬁtting a gamma
distribution to the observed duration of carriage for each
serogroup and age stratum.
Results: The mean duration of carriage for all cases was 37 days
(95% CI 35–38). Children below the age of 5 years carried PRP
for signiﬁcantly longer periods (43 days, 95% CI 41–45)
compared with older individuals (25 days, 95% CI 24–27).
There were also differences within the group of cases below the
age of 5 years, as the duration of carriage became signiﬁcantly
shorter for each year older the cases were. Serogroup 9 and 14
were carried for signiﬁcantly shorter periods compared with
serogroup 6. Serogroup 9 also had signiﬁcantly shorter carriage
duration compared with serogroups 19 and 23 for cases 0–
4 years. For cases 5 years or older, no signiﬁcant difference in
carriage duration for different ages or serogroups could be
noted.
Conclusions: Even though the estimate does not cover any
correction for the censored carriage duration and therefore not
yield an estimate of the total length of carriage, the results
highlight the importance to take both serogroup and age of the
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carriers into account when studying the dynamics of
pneumococcal transmission and modelling the effect of
pneumococcal vaccination in young children.
P1815
Erythromycin-resistant Streptococcus pneumoniae
isolated in Spain: serotypes, clones and
mechanisms of resistance
L. Calatayud, J. Linares, C. Ardanuy, E. Cercenado, A. Fenoll,
E. Bouza, R. Pallares, R. Martin for the Spanish Pneumococcal
Infection Study Network
Objective: The aims of this study were to characterize the
mechanisms of resistance to Erythromycin (Ery) and tetracycline
(Tet) in pneumococcal strains collected in a recent Spanish point
prevalence study, and to determine the frequency of the
International Clones among EryR pneumococcal strains.
Methods: ermB, ermA, mefE, mefA, tetM and int genes were
detected by PCR in all EryR strains. Serotyping and PFGE
(SmaI) were performed in all strains.
Results: 15 (35%) of 360 Pneumococci isolated during one week
(Feb–2004) in 147 Spanish hospitals were EryR. The rate of EryR
was higher in children than in adults (39% vs 33% p = 0.09) and
in Penicillin-resistant than in Penicillin-susceptible strains (63%
vs 15%, p < 0.001). The most frequent serotypes found among
EryR strains were: 19F (25%), 19A (17%), 6B (12%), 14 (10%) and
23F (10%) that accounted for 73% of EryR strains. Among EryR
strains 109 (87%) had MLSB phenotype (73% constitutive and
14% inducible) and 16 (13%) had M phenotype. The genes
detected in MLSB isolates were: ermB in 102 isolates, and ermB
and mefE genes in 7 isolates. All 96 (88%) MLSB isolates with
resistance to Tet had tetM gene and 79 of them had int gene
(related to Tn916-like). Seven positive ermB strains susceptible
to Tet had int gene. No ermA gene was detected among EryR
strains. Of the 16 M phenotype strains, 14 had mefE gene (6 of
them belonged to Spain9V-3–14 clone, and 8 were unrelated)
and 2 had mefA gene and belonged to England14-9 clone.
Although MLSB strains belonged to 67 PFGE patterns, 4 clones
(Spain23F-1, Spain6B-2, Sweden 15A-25 and ST89-19F)
accounted for 44% of these strains. Capsular switching was
observed in two clones, Spain23F-1 (serotypes 19F and 19A) and
Sweden15A-25 (serotypes 23A, 23F, 19A and 19F).
Conclusions: The majority of macrolide-resistant pneumococci
isolated in Spain had ermB, tetM and int genes, suggesting the
spread of Tn916-like elements. The ermB positive strains, related
to Spain23F-1, Spain6B-2, Sweden 15A-25 and ST89-19F clones,
were more frequently isolated in adults, whereas mefA/E
positive strains related to Spain9V-3-14 and England14–9
clones were more frequently isolated in children.
P1816
Changing patterns of antimicrobial resistances
among bacterial isolates recovered from European
patients hospitalised with pneumonia: report
from the SENTRY Antimicrobial Surveillance
Programme (1998–2004)
T. Fritsche, H. Sader, D. Biedenbach, J. Streit, R. Jones (North
Liberty, US)
Objective: To characterize changes in the frequency of
occurrence of bacterial pathogens responsible for pneumonia
in hospitalized patients in Europe for the years 1998–2004 and
examine select antimicrobial susceptibilities (S) for predominant
pathogens. The emergence of resistance (R) among pathogens
responsible for pneumonia has resulted in changes to empiric
therapy, with increasing reliance upon third- and fourth-
generation cephalosporins, beta-lactam/beta-lactamase
inhibitor combinations, carbapenems and ﬂuoroquinolones.
Methods: Participating European medical centres (10–31/year)
referred 50 consecutive, non-duplicate pathogens (8419 isolates)
from lower respiratory tract sites determined to be signiﬁcant by
local criteria as the probable cause of pneumonia. All identiﬁed
isolates were tested for S by the broth microdilution method
[NCCLS M7-A6, 2003] and results interpreted using CLSI
[M100-S15; 2005] breakpoint criteria.
Results: Rank order of principle pathogens and changes in
select S are in the Table. The composition of the six top-ranked
pathogens did not change over the study interval; the rank order
did, however, with PA, SA, ESP, KSP and EC being
predominant in 1998 and SA, PA, KSP, EC and ESP in 2004.
Decreasing S were apparent with most key organism/
antimicrobial combinations, including OX and CIP among SA;
CRO, CAZ and CIP among Enterobacteriaceae; and CAZ, IMI
and CIP among PA. PEN and ERY S among SPN decreased until
2000 (66.7 and 49.0%, respectively), increased signiﬁcantly in
2001 (84.9% S), and returned to near-1998 levels in 2004. ESBL-
phenotypes (CRO or CAZ or aztreonam MIC ‡2 mg/L)
remained essentially unchanged among EC between 1998 and
2004 (8.2% and 8.3%, respectively), whereas among KSP
increases were more substantial (16.7% and 26.9%). Metallo-
beta-lactamase-producing PA were identiﬁed during the study
from Italy (2000–2001; 10 isolates, clonally-related; VIM-1),
Germany (2002; one isolate; GIM-1) and Greece (2004; two
isolates; VIM).
Conclusions: Although temporary R declines were seen among
some European pneumonia pathogens, all showed increasing R
to most class agents during the study period. The increase in
ESBL among Enterobacteriaceae, and R among PA to most agents
except polymyxin B, are especially worrisome. Continued
longitudinal comparisons of emerging pathogens and changing
susceptibility proﬁles are critical elements in guiding empiric
therapies and epidemiologic interventions.
P1817
Distribution of capsular and surface
polysaccharide serotypes of methicillin-resistant
Staphylococcus aureus in Germany
C. von Eiff, K.L. Taylor, A.I. Fattom, G. Peters, K. Becker
(Munster, DE; Rockville, US)
Objectives: Staphylococcus aureus is still one of the most feared
pathogens because of his ability to cause serious infections,
including overwhelming sepsis. Since 1961, the emergence and
spread of methicillin-resistant Staphylococcus aureus (MRSA) has
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been documented in almost every continent and it is associated
both with hospital and community-acquired infections.
Although S. aureus has been found to express 13 capsular
types, only two capsular polysaccharides (CPs), type 5 and type
8, comprise ca. 80% of infectious isolates. A renewed interest
emerged following the observation that CPs are both essential
virulence factors and putative protective antigens.
Methods: Four-hundred consecutive MRSA isolates were
collected at 10 centres (max. 40 isolates per centre) as part of a
multicentre study conducted throughout Germany in 2004.
Isolates were collected from various sources, including
colonization sites as well as infectious foci. Only one isolate
per patient was included and all isolates were spa-genotyped.
CPs were determined by slide agglutination with CP-speciﬁc
antibodies (anti-T5-DT, anti-T8-conjugate, anti-336-rEPA). The
serotypes were conﬁrmed by immunodiffusion using
lysostaphin-digested cell lysates.
Results: In the present study, we serotyped MRSA isolates
collected most recently in a German multicentre study. All 400
MRSA isolates evaluated were one of the serotypes tested, with
290 isolates being type 5 (72.5%), 44 isolates being type 8 (11%),
and 66 isolates being type 336 (16.5%). The prevalence of
capsular and surface polysaccharide serotypes varied greatly
from centre to centre, with type 5 ranging from 50–90% (type 8,
2.5–22.5% type 336, 7.5– 35%). While serotype 336 was often
associated with spa types 008 and 032 (as observed in different
centres), high prevalence of this surface polysaccharide serotype
was not due to a major outbreak in a single centre. Altogether,
serotype 336 was detected in strains exhibiting 20 different spa
types. Sorting by culture specimen source, type 336 was more
common in airway-related specimens (e.g. swabs from anterior
nares, throat and bronchial secretions).
Conclusion: CP serotyping of MRSA isolates from Germany
show that the majority of isolates are comprised of serotypes 5.
Of interest, type 336 strains are more common than type 8
strains, with one of six strains positive for type 336. The
unexpected high prevalence of type 336 positive strains was not
due to clonal spread.
P1818
Molecular epidemiology of methicillin-resistant
Staphylococcus aureus isolates collected in a
national screening study in hospitals in
Luxembourg in 2003
J. Mossong, P. Marques, M. Sertznig, D. Hansen-Koenig,
D. Meunier, R. Hemmer, A. Hakim, F. Schneider on behalf of the
National Group on Preventing Nosocomial Infections GNPIN
Objectives: The molecular epidemiology of methicillin-
resistant Staphylococcus aureus (MRSA) among inpatients in
Luxembourg hospitals in 2003 was studied using pulsed-ﬁeld
gel electrophoresis (PFGE).
Methods: A national MRSA carriage screening study was
carried out in 2003 in 14 hospitals in Luxembourg. During one
week, all participating hospital inpatients were swabbed on
three anatomical sites: throat, nose and groin. We investigated
the molecular epidemiology of the 46 MRSA isolates collected
from 34 patients in 5 hospitals using the PFGE method with the
SmaI restriction enzyme. Cluster analysis was carried out using
Bionumerics software. Band-based similarity Dice coefﬁcients
were used for dendrogram construction, which provides a
quantitative assessment of strain similarity. Samples were
deﬁned to belong to a cluster using a similarity coefﬁcient of
75% or higher. PFGE proﬁles were compared with the most
similar strains from the Harmony IUMS Global MRSA Database.
Results: 21 different restriction proﬁles were observed among
the 46 MRSA isolates and 34 patients. Isolates from the same
patient but from different anatomical sites had similar PFGE
proﬁles. 7 clusters of MRSA strains could be identiﬁed with the
two largest clusters containing 15 (44%) and 10 (29%) patients,
respectively. Strains from these 2 major clonal clusters occurred
in 5 and 4 out of the 5 hospitals, respectively. Isolates from the
cluster with 15 patients were most similar to the well-known
Iberian clone: France A (10 strains), Belgium E1 (2 strains),
France B, France C and Northern Germany I (1 strain each).
Isolates from the next largest cluster of patients correlated with a
group of strains previously found in Finland and Belgium:
Belgium E3 (2 strains), Finland E1 (7 strains) and Finland E7 (1
strain). The remaining strains were most closely related to
Belgium EC2 (3 strains), Berlin IV (1 strain), Southern Germany
II (2 strains) and UK E15 (3 strains).
Conclusion: Two major clonal clusters of MRSA strains were
found to be dominant among hospitals inpatients in Luxem-
bourg. The molecular diversity of circulating strains was fairly
diverse and proﬁles were very similar to previously described
patterns in neighbouring countries and Europe. Further
sequence-based genotyping is warranted to gain a better
understanding of the clonal structure and elucidate transmission
patterns.
P1819
First detection of vancomycin-resistant
enterococci in Russia: genetic background
A. Mironova, E. Cherkashin, G. Kliasova, V. Tishkov,
A. Brilliantova, S. Rezvan, S. Sidorenko (Moscow, RU)
Background: In June 2002 the ﬁrst vancomycin-resistant
Enterococcus gallinarum, harbouring vanB gene, was isolated
from the patient of haematological centre. The purpose of this
study was to determine VRE prevalence and to detect resistance
genes.
Methods: Screening for VRE was performed among patients of
haematological centre from April 2003 to March 2005. Enterococci
were identiﬁed by basic tests and by PCR ampliﬁcation of ddl
genes. Susceptibility testing was performed using the ICLS broth
microdilution method. Resistance genes were detected by PCR,
selected vanA, vanB and vanC1 amplicons were sequenced.
Macrorestriction analysis (SmaI) resolved by pulsed-ﬁeld gel
electrophoresis (PFGE) was performed.
Results: During the study 31 VRE isolates with different
phenotypes of resistance to glycopeptides were obtained from
3578 specimens. The prevalence of VRE in the gastrointestinal
tract was 3.5%. One E. faecalis (isolated from patient arrived from
US) and 23 E. faecium isolates, harbouring vanA genes,
demonstrated MIC’s of vancomycin (Van) and teicoplanin
(Tec) 256–1024 and 16–128 mg/L respectively. Three E. faecium
and four E. gallinarum isolates were vanB-positive, with Van and
Tec MIC’s >32 and 0.25–1 mg/L respectively. All stains were
susceptible to linezolide. Among E. faecium isolates with vanA
genes one predominant PEGF type was observed, differentiated
in nine PEGF sub-types. Each of three other PEGF types detected
seemed to be unique. Among six vanA genes sequenced, four
demonstrated similarity to vanA gene from E. faecium
(GeneBank AF516335) and two to - vanA gene from E. faecalis
(GeneBank AY697425). In two sequenced vanB genes from in E.
gallinarum nucleotide substitutions, resulting in seven new
amino acid substitutions, were detected.
Conclusions: Heterogeneity of glycopeptide-resistance genes,
circulating in haematological centre, leads to the conclusion that
their spread is not a local phenomenon. Spread of VRE is an
emerging and, possibly, underestimated problem for Russia.
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P1820
Study of resistance and clonal relatedness of
clinical isolates of Stenotrophomonas maltophilia
from a hospital in northern Spain
C. Valderrey, E. Sevillano, F. Calvo, L. Gallego (Bilbao, ES)
Objectives: The aim of this work was to study the antibiotic
resistance and genetic relatedness among clinical isolates of S.
maltophilia isolated frompatientswith tract respiratory infections.
Methods: The study included 36 S. maltophilia isolates obtained
in a Hospital from Bilbao (Northern Spain) during 2005 (from
January to October). Susceptibility to antimicrobial agents was
determined by the disk diffusion method following the NCCLS
recommendations. The antibiotics tested were imipenem, me-
ropenem, cefotaxime, ceftazidime, cefepime, aztreonam, amika-
cin, tobramicin, ciproﬂoxacin, oﬂoxacin and trimethroprim/
sulfamethoxazole. Total DNA was used as target for PCR-
ﬁngerprinting experiments with primers RD1, ERIC2, AP3, M13
and RNAr 1 and 2. To detect class 1 integrons, primers 3´CS and
5´CS were used in ampliﬁcation experiments.
Results: Resistance to antibiotics tested was the following:
imipenem (100%), meropenem (67%), cefotaxime (92%), ceftaz-
idime (28%), cefepime (64%), aztreonam (86%), amikacin (8%),
tobramicin (14%), ciproﬂoxacin (25%), oﬂoxacin (25%) and
trimethroprim/sulfamethoxazole (0%). PCR-ﬁngerprinting tech-
nique was only useful when ERIC2 primer was used identifying
28 distinct genotypes. The other primers were not able to
produce reliable band patterns. Patients with several isolates
maintained the same clone along time, although there are two
patients from which two different genotypes have been isolated,
and two clones that have been isolated from more than one
patient. Class 1 integrons were detected in 56% of isolates
ranging in size from of 1500 to 300 bp (8 isolates bored
combinations of two structures).
Conclusions: Trimethroprim/sulfamethoxazole and amikacin
showed the best activity against the isolates tested. For PCR-
ﬁngerprinting experiments the best primer was ERIC2 which
produced reliable and reproducible band patterns. There was a
high clonal diversity since 28 different genotypes were identiﬁed
among the 27 patients included in the study. Many isolates bored
class 1 integrons with sizes similar to those detected in other non-
fermenters bacilli from the same environment.
P1821
Invasive pneumococcal disease in adults in
North-Rhine Westphalia, Germany, 2001–2004
M. van der Linden, A. Al-Lahham, R. Reinert (Aachen, DE)
Objectives: Elderly adults are at increased risk for invasive
pneumococcal disease (IPD). We conducted a population-based
survey of IPD among adults inNorth-RhineWestphalia, Germany.
Methods: Surveillance for our current study focused on North-
Rhine Westphalia, the largest federal state in Germany (18
million inhabitants). 202 (52.2%) acute care hospitals27 micro-
biological laboratories serving these hospitals agreed to partici-
pate. We studied hospitalized patients older than 15 years of
age. A case of IPDwas identiﬁed by the isolation of S. pneumoniae
from an otherwise normally sterile site. Isolates were veriﬁed for
species diagnosis by optochin testing and bile solubility, and for
serotyping by the Neufeld Quellung reaction. MICs of penicillin
G, amoxicillin, cefotaxime, cefpodoxime, cefuroxime, clarithro-
mycin, clindamycin, gatiﬂoxacin, levoﬂoxacin, telithromycin,
tetracycline, and trimethoprim/sulfamethoxazole were deter-
mined using the microdilution method according to the latest
CLSI guidelines.
Results: We found that 95.4% of IPD isolates were susceptible
to penicillin G and 15.2% were clarithromycin resistant.
Serotypes 14 (14.8%), 3 (8.8%), 7F (7.4%), 4 (6.9%) and 1 (5.6%)
were the most common serotypes. The serotype coverage of the
of the 7-valent pneumococcal conjugate vaccine was 40.1%, the
coverage of the 23-valent pneumococcal polysaccharide vaccine
was 80.2%. 774 isolates (77%) were obtained from blood, 61
isolates (6%) from CSF. Among the CSF isolates no cefotaxime
intermediate or resistant strains were found. Between 2001 and
2004 penicillin resistance increased from 0.7% to 1.5%.
Clarithromycin resistance increased from 12.1% to 14.8%.
Conclusions: The percentage of isolates from IPD in adults that
are resistant to penicillin remains low but is increasing. The level
of resistance to clarithromycin is now 14.8%. The coverage of
both the the 7-valent pneumococcal conjugate vaccine and the
23-valent pneumococcal polysaccharide vaccine remains high.
P1822
Surveillance of carbapenem resistance among
Enterobacteriaceae: species and geographic
distribution
C.A. Wood, J.W. Chow, T.A. Snyder, M.A. Abramson,
G. Gallagher, M.J. DiNubile, R.M. Gesser (West Point, US)
Objectives: Carbapenems are the most reliably active beta-
lactam antibiotics against Enterobacteriaceae and are often the
treatment of choice for infections caused by multi-drug resistant
isolates. While carbapenem resistance has occasionally been
reported in Enterobacteriaceae, there are limited data on its
frequency and distribution.
Methods: Two large ongoing surveillance databases were
searched for imipenem (IMP) and ertapenem (ETP) resistance
in Enterobacteriaceae: SMART (Study for Monitoring Antimicro-
bial Resistance Trends), a worldwide program focusing on
community- and hospital-acquired intra-abdominal pathogens,
and ISS (ICU Surveillance Survey), a US program focusing on
ICU isolates from any sterile body site.
Results: The overall frequencies of carbapenem-resistant
Enterobacteriaceae remained <2% in SMART and <4% in ISS
throughout the periods of observation (see table). For 2004,
resistance (%) in SMART was most common in E. aerogenes (7.8),
E cloacae (2.3), K. pneumoniae (2.1), S. marcescens (2.0), and E. coli
(1.2) and for ISS in K. pneumoniae (6.5), E. cloacae (5.4), E. aerogenes
(2.9), S. marcescens (2.0), and E. coli (1.2). Carbapenem resistance
(%) varied by geographic region: Latin America (4.0), Asia (1.6),
Middle East/Africa (1.2), North America (1.2), and Europe (0.8).
Overall, 5.8% of ESBL producing K. pneumoniae and E. coli were
resistant to ETP or IMP and rates varied by geographic region.
All isolates studied to date have exhibited multiple resistance
mechanisms.
Conclusion: Carbapenem resistance was uncommon among
clinical isolates of Enterobacteriaceae in these surveillance
studies. Its observed frequency varied by species and
geographic region.
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P1823
Exploring the molecular basis for differences in
phenotype of Salmonella enteritidis typing phage
N. DeLappe, D. Morris, M. Cormican (Galway, IE)
Objectives: The Salmonella enteritidis phage tying scheme of the
Laboratory of Enteric Pathogens, Health Protection Agency, UK,
is a widely used method for subtyping this important pathogen.
The method is rapid and highly discriminatory. Interpretation of
results can be subjective and the typing phage which are central
to the method have not been well characterised. Complete
sequence data is available for the Salmonella typhimurium
podovirus phage P22.
Methods: The 16 typing phage were propagated on S. enteritidis
PT1b (PB406). Phage were visualised by electron microscopy.
Phage DNA was extracted and digested with HindIII.
Consensus PCR primers were designed based on sequences of
P22 and other S. typhimurium phage. Additional primers were
designed based on the sequence of the S. enterititidis typing
phage 3 (a siphovirus). Ampliﬁcation, sequencing and DNA
probe hybridisation of various phage genes were performed
using standard techniques.
Results: On EM the 16 typing phage comprise 6 podoviridae
(phage 1, 8, 10, 14, 15 and 16), 6 siphoviridae (phage 3, 5, 7, 11, 12
and 13) and 4 myoviridae (phage 2, 4, 6 and 9). Digestion with
HindIII subdivided each morphotype into 3 groups. The
podoviridae contained genes homologous to P22 while the
siphoviridae contained genes homologous to the sequenced S.
enteritidis typing phage 3. Some sequence variation was detected
in podovirus and siphovirus genes however in some cases
phage, which differ in their phenotype had no difference
detected in HindIII digestion pattern or partial sequence.
Conclusions: The S. enteritidis typing phage set comprise 3
distinct phage morphotypes. In some instances distinct phage
that contribute to differentiation between S. enteritidis phage
types had no DNA sequence variation detected. Variations in
phage typing reactions may in part be due to epigenetic
difference in typing phage, e.g. due to methylation of phage
DNA. Salmonella enteritidis typing phage biology could provide a
model for developing approaches to phage therapy.
Interesting case reports
P1824
Sporadic orofaringeal tularaemia in 2 cases
Y. Tezer, C. Kader, O. Memikoglu, H. Kurt (Ankara, TR)
Tularemia is a zoonotic bacterial disease. The causative agent,
Francisella tularensis, is spread to humans by direct contact with
infected rodents, inhalation, ingestion of contaminated water or
by arthropod bites. In some endemic regions, outbreaks occur
frequently, whereas nearby rural parts may be completely free.
We presented two cases of tularemia in non endemic region of
the Turkey.
Case 1: A 46 year old female patient referred to tertiary hospital
due to swollen on the neck for 2 months. Before admission beta
lactam antibiotics had been prescribed to her for tonsilophar-
yngitidis. But her complaints had been continued. So she
admitted to our hospital. She had been suffered fever sore
throat and neck pain. She had a palpable and painfull cervical
lymphadenopathy which was not suppurated. Leukocytosis and
elevated C reactive protein were predominant. At screening
there were not any lymphadenopathy detected elsewhere. She
had been examined about Cytomegalovirus Epstein Barr virus
and brucellosis. They were negative. Fine needle aspiration from
neck was negative considered as malignancy. Cultures were
negative for routine bacteriologic examination. Microagglutina-
tion test for tularemia was 1/320 positive. Then we decided to
treat her with gentamycin for 10 days. After treatment cervical
lymphadenopathy became small. Leukocyte count and C react-
ive protein levels were reach normal range.
Case 2: A 29 year old female patient referred to university
hospital due to cervical lymphadenopathy and fever and sore
throat. Before admission beta lactam antibiotics were prescribed
to her for 2 weeks. But no apparent beneﬁts had been detected.
There was a palpable and ﬁstulated cervical lymphdenopathy.
Drainage was examined microscopically and cultured for
bacteria, mycobacteria and fungi. On routine cultures no
microorganisms were grown. Fine needle aspiration was done.
It was reported that suppurative granulamatous lympadenitis.
So we were examined for tularemia, cat scratch disease.
Microaggltunation test for tularemia was 1/320 positive. Then
streptomycin had been given for 10 days and excision of
lymphadenopathy had been done. No complications or
recurrence occur.
Results: Both patients were applied to us from non endemic
and different regions of the Turkey. They had no known insect
bite history. Both of them were diagnosed by serological tests.
Conclusions: In the differential diagnosis of tonsillopharyngit-
idis, tularemia also must be considered in the non endemic
regions.
P1825
Tularaemia presenting with tonsillopharyngitis
and cervical lymphadenitis: two case reports
B. Kandemir, I. Erayman, M. Bitirgen, E. Turk Aribas,
A.C. Inkaya, S. Guler (Konya, TR)
Tularemia is a zoonotic disease caused by Francisella tularensis.
Francisella tularensis is transmitted to humans by direct contact
or ingestion of infected animal tissues, through the bite of
infected arthropods, by consumption of contaminated food or
water, or from inhalation of aerosolized bacteria. In this report
we describe two cases of oropharyngeal tularemia who presen-
ted with tonsillopharyngitis and cervical lymphadenitis.
Case I: A 43 years old woman with multiple cervical lymph-
adenitis has been admitted to our clinic. Her complaints started
2 months ago with signs and symptoms of tonsillopharyngitis.
She had received non speciﬁc treatment (ampicillin+sulbactam)
and ten days later cervical lymph nodes appeared. The diagno-
sis was made serologically. The antimicrobial therapy (strepto-
mycin 1 · 1 g im) was given for fourteen days. The patient
recovered completely.
Case II: A 16 years old girl with multiple cervical
lymphadenitis was admitted to hospital. Her complaints
started 3 months ago with throat ache after which multiple
cervical lymphadenitis appeared. She was admitted to our out
patient clinics and diagnosed to have tularemia. Anti-microbial
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therapy (streptomycin 1 · 1 g im+doxycyciline 2 · 100 mg) was
given for four weeks but no clinical response was achieved.
Patient was admitted to the hospital and surgical drainage was
performed. Treatment against tularemia was prolonged. Patient
was ﬁnally recovered at the end of nine weeks of therapy. It can
be concluded that early diagnosis and treatment of tularemia are
important. Some patients may beneﬁt from surgical drainage
and prolonged therapy.
P1826
A case of nonclostridial crepitant cellulitis which
is due to Escherichia coli
C. Ayaz, M. Ulug, M.K. Celen, M.F. Geyik, S. Hosoglu
(Diyarbakir, TR)
Objectives: This condition is caused by gas forming bacteria
that involve the skin, either or as an extension from deeper
structures. The origin of infection is an abdominal wound,
perianal disease, or operative incisions that have become
secondarily infected. Tracking of gas-forming organisms from
deeper sites of infection may also present as crepitant cellulitis
without a break in the skin. Diabetics are more likely to acquire
such infections, especially in the lower extremites. Among the
bacteria isolated are anaerobic organisms such as Bacteriodes or
anaerobic streptococci, or coliform bacteria, especially
Escherichia coli and Klebsiella. Because of this reason we
reported a case of a nonclostridial crepitant cellulitis which is
due to Escherichia coli.
Case: A 40 year old man who was previously healthy, has come
with fever, pain, oedema, erythema, crepitant and limitation of
movement at the right lower extremity. In his history he had no
complaint until 2 weeks ago. Perianal abscess has developed at
this time and it has drainged spontaneously 3 days later. Than
his complaints has comprised 3 day duration. On physical
examination, the temperature was 38.9C, pulse rate 116/
minute, respiratory rate 42/minute and blood pressure was
90/50 mmHg. Laboratory evaluation showed a haemoglobin
8.1 g/dl, leucocyte count of 32700/mm3 (neutrophils 92%).
Serum electrolytes, renal and liver function tests were within
normal limits. C reactive protein was elevated up to 354 mg/dl,
ESR was 77 mm/h. Escherichia coliwas isolated from wound and
blood cultures. He was treated initially with ampicilin-
sulbactam (6 g/day) and required attempt. Even with optimal
surgical and medical therapy, he dies at the third day of the
treatment from septic shock.
Conclusion: The onset is generally gradual, and there is usually
mild local pain and systemic toxicity, allowing clinical
differentiation from the more fulminant clostridial
myonecrosis. The surgical approach should be aggressive, but
tailored speciﬁcally to the underlying cause of infection.
Antibiotic therapy is directed at a mixed aerobic-anaerobic
ﬂora, until culture reports are available.
P1827
A case of iliopsoas abscess which is due to
Pseudomonas aeruginosa
C. Ayaz, M. Ulug, M.K. Celen, M.F. Geyik, S. Hosoglu
(Diyarbakir, TR)
Objectives: Pyogenic psoas abscess, a rare but life-threatening
infection, results from primary suppuration or is secondary to
the spread of infection from an adjacent structure. Primary
iliopsoas abscess occurs probably as a result of hematogenous
spread of an infectious process from an occult source in the
body. Primary iliopsoas abscess can occur in diabetus mellitus,
intravenous drug abuse, AIDS, renal failure and
immunosupression. Ultrasound is diagnostic in only 60% of
the cases. Computed tomography should be done for deﬁnitive
diagnosis and is considered the gold standard. Stapylococcus
aureus is the causative organism in patients with primary
iliopsoas abscess, but pyogenic psoas abscess caused by
Pseudomonas aeruginosa is uncommon. Because of this reason
we reported this case.
Case: A previously well 67 year old woman presented with a
month history of right loin to groin pain, limping or limitation of
hip movement, fever and nausea. She was a diabetus mellitus
patient for 7 years. On her physical examination, the
temperature was 38.1C, pulse rate 104/minute, respiratory
rate 28/minute and blood pressure was 140/90 mmHg.
Examination of the respiratory system, cardiovascular system
and abdomen were found to be normal. Laboratory
investigations revealed total leucocyte count of 17800/mm3
(polymorphs 88%), C reactive protein was elevated up to
168 mg/dl, ESR was 77 mm/h. Serum electrolytes, renal and
liver function tests were within normal limits, but serum glucose
level was elevated to 351 mg/dl. Her blood cultures were
sterile, but abscess culture yielded Pseudomonas aeruginosawhich
was taken during the surgery. She was treated imipenem (2 g/
day) + amicasin (1.5 g/day) and required surgical drainage. She
was treated and followed up 21 days, and discharged at the end
of the treatment.
Conclusion: In these patients treatment involves the use of
appropriate antibiotics along with drainage of the abscess. An
adequate knowledge of the causative organisms should guide
the initial choice of antibiotics. Depending on the results of the
abscess ﬂuid culture and sensitivity, adjustments should be
made. Percutaneous drainage or surgical drainage may be done
in them. In conclusion early recognition, empiric antimicrobial
coverage and aggressive drainage or debriment are indicated in
these patients.
P1828
Cervical lymphadenitis in a diabetic woman
F. C¸okc¸a, A. Azap, S. Go¨c¸men, H. Erdi Sanli, S. Gu¨l (Ankara,
Kirikkale, TR)
Objective: Rhodococcus equi infections are commonly seen in
immunocompromised patients. Exposure to domestic animals,
such as horses and pigs may play a role in some cases. Two
thirds of the R. equi infections in immunocompromised were
reported in HIV infected patients, and the rest divided between
transplant recipients, immunosupressive medications and other
kinds of immunosupression. The clinical picture presents with
pulmonary infection in 80% of patients. Here, we report a rare
case of cervical lymphadenitis in a diabetic women due to
R. equi.
Case: A sixty-year-old diabetic woman was admitted with the
complaints of fever, right cervical erythematous swelling with
tenderness and warmth. On physical examination; inﬂammation
beginning from the right submandibular region and descending
to the upper chest was detected. A tender mass of 8 · 5 · cm.
was palpated on the right cervical region. Ampicillin/sulbactam
4 g/day was given emprically for a week with no improvement.
The CT scan of the neck showed conglomerated lymphadenop-
athy extending from the submandibular area to the supracla-
viculary region with 10.5 · 3 cm in size. The mass began to
ﬂuctuate and 500 cc abscess material was drained surgically.
Gram’s stain of the purulent material showed polymorphonu-
clear leukocytes with pleomorphic gram positive coccobacilli.
The cultures of the material grew R. equi. Therapy was changed
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to teicoplanin and ciproﬂoxacin combination and surgical care
of the wound with antiseptics was performed. After a month,
intrevenous medical therapy was changed to oral route with
roxythromycin and ciproﬂoxacin and was continued to
2 months with complete resolution.
Conclusion: Increased awareness and improved laboratory
techniques help for the early diagnosis of rhodococcal infections.
Timely diagnosis is important because the microorganism is
usually resistant to penicillin G, oxacillin, ampicillin, carbeni-
cillin and cefazolin. The use of at least one antibiotic with
intracellular activity is necessary in the treatment of R. equi
infections. Empirical two drug regimens with erythromycin,
rifampin and/or ciproﬂoxacin are recommended.
P1829
Bacterial spondylodiscitis: an evaluation of 67
patients
I. Villa Blanco, O. Garcı´a Regata, J.D. Garcı´a Palomo, J.L. Pen˜a,
J.P. Horcajada, M.C. Farin˜as (Santander, ES)
Objectives: To analysed the features of spondylodiscitis (SD),
their clinical presentation, the commonest diagnostic methods
and the kind of treatment applied according to the different
groups of the study.
Methods: A retrospective and descriptive study taking place
amongst the patients diagnosed as having SD from 1998 till
2003. In each case we studied the presence of underlying
disease, primary infectious sources in the prior 6 months, the
way symptoms started, location, diagnostic methods, treatment
and evolution, comparing between different aetiologies.
Results: 67 patients with SD were studied.53 of them had
pyogenic SD,(35 had spontaneous SD and 18 had an SD after
spinal surgery) and 14 patients had tuberculous SD. 45 were
men (16 to 84 years; mean 51.8). Patients with postoperative SD
were the youngest (mean 42.17 y, p = 0.001). Underlying dis-
eases were found in 75% of patients, mainly in postoperative SD
(50% of cases) (p = 0.009). An episode of previous bacteremia or
infectious source was found in 40% and 63% respectively of
patients with spontaneous pyogenic SD, signiﬁcantly higher
than in surgical SD (6% had bacteremia and 11% other infectious
source, p < 0.01). The most common presenting symptoms were
back pain (98.5%) and neurological deﬁcits (54%). Frank fever
occurred in 29% of cases, being more frequent in spontaneous
SD (49%) than in postoperative SD (6%) or tuberculous SD (7%),
p £ 0.002. Leukocytosis was found only in 28% of patients.
Postoperative SD presented the lowest levels of ESR (p = 0.008).
S. aureus was the most frequent bacteria isolated (31%) in
pyogenic spontaneous SD, as coagulase negative staphylococci
was in surgical SD. Lumbosacral localization was detected in
45% of spontaneous pyogenic SD and in 95% of postoperative
SD. Tuberculous SD predominate in dorsolumbar region.
Paravertebral abscess formation was observed in 39% of pyo-
genic SD and in 93% of tuberculous SD (p = 0.001). Surgical
treatment was required in 46.2% of tuberculous SD and in 9% of
pyogenic SD (p = 0.005). Outcome of patients with spontaneous
SD was worse (sequelae in 62%), than in patients with surgical
SD (38.2%) or tuberculous SD (14%) (p = 0.015).
Conclusions: 1) Spontaneous SD was the most frequent and it
occurred mainly in patients suffering from underlying diseases;
2) Nearly all patients had pain but only in 1/3 of them was
accompanied by fever; 3) The lumbar zone was the most
frequent location; 4) The majority of patients had a complete
resolution of their symptoms only with medical treatment.
Meningitis and endocarditis
P1830
Fastidious Gram-negative micro-organisms as
causative agents of cerebral abscess.
Consequences on medical and surgical treatment
R. Manfredi, S. Sabbatani, F. Chiodo (Bologna, IT)
Background: The ethiopathogenesis of CNS abscess includes a
broad spectrum of pathogens and predisposing conditions, so
that a polymicrobial ﬂora is a quite frequent event.
Capnocytophaga spp. includes fastidious Gram-negative
organisms, usually underestimated in the common clinical
practice, and poorly tested in vitro for antimicrobial
susceptibility. Surprisingly, also agents usually active on
Gram-positive pathogens demonstrated some efﬁcacy against
Capnocytophaga spp. (i.e. erythromycin, rifampin, tetracyclines,
cotrimoxazole, chloramphenicol, and glycopeptides), which is
usually responsible of anecdotal episodes of CNS infection
(meningitis, brain abscess, and subdural empyema).
Methods and results: The fourth case report of Capnocytophaga
spp. brain abscess is herewith reported. A probable origin from
a recent cat bite and a mandibular granuloma is suspected. Due
to the lack of clinical and neuroradiological response to
neurosurgical debridement and an association therapy
including imipenem, amikacin, clindamycin and ﬂuconazole,
empiric administration of linezolid (1200 mg/day) was
attempted, and a rapidly favorable clinical, microbiological,
and neuroradiological response was achieved.
Conclusions: Notwithstanding the identiﬁcation of
Capnocytophaga spp. as the sole microorganism yielded by
purulent drainage of a CNS abscess, patients with multiple
risk factors and recent surgery are expected to suffer from a
polymicrobial CNS infection. Due to its favourable CNS
penetration and its dual mode of administration (both i.v. and
oral), linezolid may represent an alternative option in the event
of CNS diseases borne by numerous risk factors and a suspected
polymicrobial origin, especially when a lack of response to ﬁrst
therapeutic attempts is of concern. In the management of a CNS
abscess where the role of microorganisms with an unpredictable
sensitivity proﬁle remains of concern, chemotherapy should be
directed also against potentially multiresistant organisms.
Considering also the relevant limitations given by the often
poor CNS penetration, the activity of glycopeptide agents is
limited, compared with that of linezolid.
P1831
Aetiologies and antimicrobial resistance proﬁles
of purulent meningitis study carried out in a
hospital of infectious diseases, Algiers
D. Mohammedi, M. Ouar-korichi, N. Kerrad, D. Ouerdane,
F. Mechouet, S. Khaled (Algiers, DZ)
Objectives: The purpose of our study is to determine the main
etiologies of purulent meningitis from the community and their
resistance proﬁles to antibiotics.
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Methods: -Identiﬁcation: the strains were identiﬁed by colonial
morphology, haemolysis on blood agar plates, biochemistral
and antigenic identiﬁcation; antibiotic susceptibility testing: all
the strains were tested by disk diffusion according to the
National Committee for Clinical Laboratory Standard methods.
MICs were determinated by screening test or MIC evaluation in
solid media.
Results: Our study concerns 252 bacterial strains isolated from
January 2000 to June 2005. Among the strains isolated, Neisseria
meningitidis represented the most number of cases with 43.7
%.These were distributed among all different age groups.
Serogroup A was the most predominant and represented
54.5% of total strains while groups B and C represented 15.5%
and 14.5% respectively. Streptococcus. pneumoniae represents the
second causes of purulent meningitis with 32.5% while
Haemophilus. inﬂuenzae b is the third causative bacterial agent
with 23.8%.This last agent is most predominant among infants
less than 2 years of age in 80% of cases. Neisseria. meningitis is
susceptible to all types of antibiotics tested. However,
Haemophilus. inﬂuenzae b produced an inactivating enzyme
(penicillinase) in 26.7% of cases. The resistance was associated
to cotrimoxazole in 68.7% of cases. The results of MIC done on
Streptococcus. pneumoniae show that 35.4% of strains has an
intermediate resistance to penicillin and high level of resistance
in 4.9%. The amoxycillin is active in 98.8% of the strains,in the
opposite cefotaxim has an intermediate resistance in 6.1% and a
high level of resistance in 2.4% of the strains. The resistance to
penicillin was associated with resistance to erythromycin,
cotrimoxazole or to both in some cases.
Conclusion: Streptococcus. pneumoniae represents the second
causative bacterial agent responsible of purulent meningitis
and showed an increasing prevalence of resistance proﬁles to
penicillin and cefotaxim in our hospital. This implicates an
effective microbiological and epidemiological control.
P1832
Management of meningitis and knowledge of
meningitis guidelines amongst medical staff in a
large teaching hospital in England
V. Price, M. Pareek, M.J. Wiselka (Leicester, UK)
Objectives: Bacterial meningitis is a serious clinical and
medicolegal consequences if management is incorrect.
Meningitis protocols have recently been published by the
British Infection Society/Meningitis Research Foundation and
are widely disseminated in our institution. Local Guidelines are
also available on the hospital intranet and in the Emergency
Department and acute Medical Admissions wards. This study
investigated the level of understanding about meningitis and
knowledge of the guidelines in medical staff of different grades
working in the emergency Department and the Acute Medical
Admissions Unit in a large teaching and emergency hospital.
Methods: 90 medical staff were interviewed faced to face and
asked a series of questions on the management of meningitis.
Results were stored on a database and responses were analysed.
Results: General knowledge about meningitis was variable.
Although 96% knew that bacterial meningitis was a notiﬁable
disease only 40% knew the procedure for informing the Health
Protection Agency and only 43% would notify viral meningitis.
Only 30% of responders were aware that guidelines could be
viewed on the hospital intranet. Only 41% correctly identiﬁed
the indications and cautions for lumbar puncture. Although the
majority recognised the need for urgent administration of
antibiotics 18% would omit antibiotics until further assessment
and lumbar puncture results. Only 30% were aware of the need
to consider adding ampicillin to cover listeria in patients over
55 years of age and there was uncertainty about the
management of patients with penicillin resistance.
Conclusions: Although protocols and guidelines for meningitis
have been produced and are easily accessible the majority of
medical staff were uncertain how to access and utilise this
information. The level of knowledge and expertise in managing
meningitis amongst medical staff working in A and E and the
Acute Medical Unit was poor and there is a need for further
education to improve patient management. Guidelines are of no
value if they are not disseminated to front-line medical staff.
P1833
Prevalence of penicillin-resistant pneumococci in
Streptococcus pneumoniae meningitis
D. Dimitriu, L. Cochior, A. Vata, O. Filip, V. Luca, C. Luca,
D. Mihalache, C. Dorobat, M. Negoita (Iasi, RO)
Objectives: The aim of this study was to evaluate the
prevalence of penicillin resistant and multi-drug resistant
pneumococci isolates in Streptococcus pneumoniae meningitis.
Methods: A retrospective study was carried out on 46 clinical
records between January 2001 and October 2005. Among the 46
CSF samples the pneumococcal ethiology was conﬁrmed by 55%
positive cultures and 70% Latex agglutination. Antibiotic sus-
ceptibility testing was performed by disk diffusion method
according to NCCLS standards. Isolates of pneumococci with
oxacillin zone sides of >20 mm are susceptible (MIC < 0.06 mi-
crog/ml) to penicillin, while at those of <19 mm the MIC has to
be determined (by E – test).
Results: Isolates from 12 patients (26%) were found with
penicillin-resistance (PRP) – of which 67% were multi-drug
resistant-and 34 (84%) with penicillin susceptibility – of which
35% were resistant to other drugs. An abrupt onset of disease
was found in 58% PRP patients and 79% from non-PRP ones.
Chest X ray pulmonary determinations were found in 50% PRP
patients and 35% non-PRP ones. Sixty-six per cent of PRP
patients and 29% of non-PRP ones had a prior hospitalization.
Only 8% of non PRP patients had a positive blood culture.
Antibiotic switch was made in 41% cases with PRP isolates and
29% cases with non PRP ones. The overall rate of mortality was
8%, with 16% for PRP patients and 6% for non-PRP ones.
Conclusions: Non-PRP isolates were the prevalent ethiology of
S. pneumoniae meningitis. 35% of non -PRP strains developed
other drug resistance, and 67% PRP strains were multi -drug
resistant. PRP meningites evolved more as a hospital-related
pathology, with an abrupt onset, frequently associated with
pulmonary determinations and higher mortality rate.
P1834
Community-acquired bacterial meningitis in the
elderly
M. Weisfelt, D. van de Beek, L. Spanjaard, J.B. Reitsma,
J. de Gans (Amsterdam, NL)
Background: Although vaccination strategies have shifted the
age distribution of meningitis to older age groups, few studies
have speciﬁcally examined bacterial meningitis in the older
adult.
Methods: From October 1998 to April 2002, we prospectively
included 696 episodes of community-acquired bacterial
meningitis, conﬁrmed by culture of cerebrospinal ﬂuid, which
occurred in patients aged >16 years. We dichotomized the
cohort with respect to age: patients aged ‡60 years were deﬁned
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as older adults and patients aged 17–59 years as younger adults.
Predictors for an unfavourable outcome (deﬁned as score 1–4 on
the Glasgow Outcome Scale) were determined by logistic
regression. We tested for statistical interaction between age
group and potential prognostic factors by adding multiplicative
interaction terms to the model. The Mann–Whitney U test and
the Chi-square test were used to identify differences between
groups.
Results: 257 of 696 episodes (27%) occurred in older adults and
439 episodes in younger adults (69%). Streptococcus pneumoniae
was themost commonpathogen in older adults (69%).Meningitis
in younger adults was caused by Neisseria meningitidis and S.
pneumoniae in 50% and 40% of the episodes, respectively. Older
adultsweremore likely topresentwith the classic triadof bacterial
meningitis (fever, neck stiffness and altered mental status) than
younger adults (58%versus 36%; P < 0.001). Theprognostic value
of independent risk factors for unfavourable outcomewas similar
in both age groups. Older adults had more complications during
clinical course, resulting in ahighermortality rate than in younger
adults (34% versus 13%; P < 0.001). Sepsis was the most common
cause of death in both age groups (30% in older adults versus 32%
in younger adults; Fig). Whereas older adults tended to die more
often due to cardiorespiratory failure (25% versus 11%; P = 0.06),
younger adults more often died due to brain herniation (23%
versus 2%; P = 0.004).
Conclusions: Bacterial meningitis in older adults is associated
with high morbidity and mortality rates. Elderly patients often
present with classic symptoms and S. pneumoniae is the most
common pathogen within this age group. Whereas older adults
often die due to cardiorespiratory failure, younger adults more
often die due to brain herniation.
P1835
Incidence of serogroups and penicillin
susceptibility in Neisseria meningitidis isolates
(1996–2004)
F. Pardo, P.A. Romero, M.L. Pe´rez del Molino, A. Go´mez,
L. Moldes, M. Trevin˜o, V. Tu´n˜ez (Santiago de Compostela, ES)
Objective: The aim of this study was to analyse the serogroup
incidence and penicillin susceptibility in N. meningitidis before
and after Spanish epidemic outbreak in 1997. In this year the
Public Health Service decided a massive vaccination in our
sanitary area (Galicia, north-west of Spain, 459.180 inhabitants)
and in autum of 2000 the inclusion of vaccine against
N. meningitidis serogroup C in vaccination programme.
Methods: Retrospective study of all cases of meningococcal
disease conﬁrmed by culture and/or PCR in the Health Care
Area of Santiago de Compostela (Galicia) from 1996 to 2004.
Results: In the period 1996–2004 we identiﬁed 151
meningococcal disease episodes by microbiologic diagnosis
(56.3%, 41.7% and 2.0% to B, C and W135 respectively). In
1996, serogroup C were the 80% of the isolates. In 1997 and 1998
the serogroup incidence was almost the same (B = 45.7%,
C = 48.6%). From 1999 an increase in B serogroup cases were
detected, in 1999 (66.6%), in 2000 (88.9%) and in 2003 (76.9%).
The most frecuent phenotype has been 2b P1:2.5 in C serogroup.
During this period an increase in penicillin susceptibility was
observed (in B serogroup 0% in 1996 and 44% in 2004 of the
isolates were susceptible and in C serogroup 0% in 1996 and
50% in 2004).
Conclusions: The B serogroup is the most frecuent isolate
during this period except in the years 1996 and 1997. The strain
that cause the epidemic outbreak in 1997 (C:2b P1:2.5) was not
isolated since 2000. In our Health Care Area, C:2a serotype, was
isolated for ﬁrst time in 2000, and since then, is the unique
serotype isolated in C serogroup. Incidence rate in C serogroup
has changed from 3.34/100.000 in 1997 to 1.09/100.000 in 2004.
This decrease was caused by the drop of incidence rate on the
youngest groups (<2 years and 2–4 years). The incidence rate in
B serogroup during these years was modiﬁed from 1.48/100.000
in 1997 to 2.17/100.000 in 2004.
P1836
A four-year retrospective analysis of infective
endocarditis in a Belgian university hospital
N. de Visscher, B. Delaere, B. Krug, Y. Glupczynski (Yvoir, BE)
Objectives: To establish the epidemiology of infective
endocarditis (IE) and determine the prognostic factors for
adverse outcome in patients admitted to a university hospital
with a cardiovascular surgery department.
Methods: Between 01/00 and 12/04, the clinical and laboratory
features of all consecutive adult patients with a deﬁnite
diagnosis of IE (Duke criteria) were evaluated retrospectively
by two infectious diseases physicians on the basis of clinical data
charts and microbiological laboratory.
Results: 45 patients (24 men, 21 women) presented with a
deﬁnite diagnosis of IE. Mean age was 64, 6 yrs; 34 cases (76%)
were native valve endocarditis (NVE) and 11 (24%) were
prosthetic valve endocarditis (PVE); 30% of patients with NVE
had underlying valvular abnormalities (3 bicuspidies, 4 mitral
prolapsus or regurgitation, 3 others). Ten out of 11 cases of PVE
were late-onset episodes (>1 year after surgery). Global
mortality was 42% (18/45 pts), including 15 patients (33%) still
under antibiotic therapy. A higher mortality rate was observed
in PVE [7/11; (64%)] than in NVE [11/34; (32%)]. Overall, 18 pts
(42%) underwent surgery (mean: 18 days following admission).
Valvular replacement was contra-indicated in 11 pts because of
critical status and/or major co-morbidities. The distribution of
isolated pathogens was: streptococci: 20 cases (44%) including 4
cases of S. bovis, S. aureus: 14 cases (31%, including 2 MRSA),
Enterococci: 3 cases (7%), miscellaneous: 8 cases. The affected
valves were: only aortic: 19 (43%), only mitral: 15 (33%), only
tricuspidal: 1, aortic and mitral: 4, mitral and tricuspidal: 2,
aortic, mitral and tricuspidal: 2. A high mortality rate was
observed in S. aureus IE (9/14 [64%]), especially in the subgroup
of patients with a PVE (4/5 pts [80%]). The mortality rate in
patients with IE episodes caused by Streptococci amounted 21%
(5/24 pts).
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Conclusion: As expected in a referral hospital with a cardiac
surgery department, the prevalence of S. aureus IE was elevated
as well as the attributable mortality rate. The high global
mortality rate may be explained by the high frequency of severe
co-morbidities and by the late referral of patients to hospital.
Our data suggest that there is room for improvement in the
diagnosis and management of IE in a multidisciplinary
collaborative approach.
P1837
Prosthetic valve endocarditis in southern Spain.
Study of 111 cases
A. Plata, A. Villalobos, J.M. Reguera, A. Alarcon, J. Galvez,
J. Ruiz, J.M. Lomas, J. De la Torre, F. Miralles on behalf of the
Andalusian Group for the Study of Cardiovascular Infections
Objective: To determine the clinical, epidemiological,
diagnostic, and therapeutic characteristics of a series of 111
cases of prosthetic valve endocarditis.
Methods: Weundertook a retrospective, descriptive study of 111
cases of prosthetic valve endocarditis obtained from a series of
deﬁnite or probable 626 left sided infectious endocarditis from six
second- or third-level Andalusian hospitals from 1985 to 2005.
Results: Of the 111 cases of prosthetic valve endocarditis, 96
(86.5%) were deﬁnite and 15 (13.5%) possible. The mean age was
58 ± 13 years, and they were more common in men (61%). Late
infection was more common than early involvement (74 vs. 37
cases). The aortic valve was involved in 54 cases (48%) and the
mitral valve in 48 cases (43%. Most (66%) of the valves were
made of metal and prior handling had taken place in 26 cases
(23%). Clinical characteristics were fever 88%, constitutional
syndrome 36%, murmur 41%, vascular events 37%, and immune
phenomena 17%. Complications included left ventricular failure
54%, kidney failure 22%, peripheral embolism 20%, CNS
embolisms 18% and heart block 9%. The etiology was as
follows: in early prosthetic valve endocarditis the three most
common pathogens were S. Coagulase-negative (40%), S. aureus
(22%) and Enterococcus (11%). Late prosthetic valve endocarditis
involved S. viridans (30%), S. Coagulase-negative (17%) and S.
aureus (13%). Transesophageal echocardiography alone in 14
cases (12%), and transthoracic followed by transesophageal
echocardiography in 53 cases (48%). Medical therapy was
applied in 54 cases (48.6%) and surgery in 57 (51.3%). A cure
was achieved in 71 cases (64%), the other 40 (36%) dying. Of
those who underwent surgery, 38.5% died and 31.4% of those
who were treated medically died. The death rate from early
prosthetic valve endocarditis was greater than that for late
prosthetic valve endocarditis (54% vs. 29%).
Conclusions: 1) Prosthetic valve endocarditis is a very serious
infection which is still associated with an excessively high
mortality, despite advances in diagnosis and treatment. 2) Early
prosthetic valve endocarditis has a worse prognosis than late
prosthetic valve endocarditis, due to its distinguishing
pathophysiological features. 3) The greater mortality seen in
patients who underwent surgery is probably associated with the
fact that they had more complications, such as perivalvular
abscesses or persistent infection.
P1838
Outcome of infective endocarditis
E.E. Hill, S. Vanderschueren, P. Herijgers, M-C. Herregods,
P. Claus, W.E. Peetermans (Leuven, BE)
Objectives: Despite progress in diagnosis and therapy, almost
half of patients with infective endocarditis (IE) has at least one
complication and overall mortality remains high. The aim of the
present 5-year prospective observational study was to deﬁne
predictors of outcome in patients with IE.
Methods: From June 2000 through December 2004, all ﬁrst
episodes of deﬁnite IE by the modiﬁed Duke criteria,
encountered in a single tertiary-care medical center, were
registered and followed-up for 6 months.
Results: Overall, 193 patients suffered 203 IE episodes. Sixty-
one percentage were males. The median age was 62 years (range
54–73). Fifty-ﬁve percentage of episodes were referred from
another hospital. At least one complication occurred in 79%.
Surgical intervention was performed in 63% and was mainly
indicated because of congestive heart failure. The median time
from diagnosis to surgery was 6 days (range 0–92). Six-months
mortality was 22% (n = 42). In bivariable analyses, factors
associated with 6-months mortality were: age, female gender,
causative microorganism, nidus of infection and therapeutic
policy. Six-months mortality was 18% for native valve IE and
31% for prosthetic valve IE; Twenty-ﬁve% for nosocomial IE and
19% for community-acquired IE. Six-months mortality rates for
microorganisms were: Staphylococci 33% (n = 26) [S. aureus 32%
(n = 19) and CoNS 35% (n = 7)], Enterococci 24% (n = 8),
Streptococci 8% (n = 4) and other microorganisms 14% (n = 4).
The 6-months mortality for patients with a contraindication to
surgery was 74% (n = 20), for patients conservatively treated
without a contraindication 7% (n = 3) and for combined
surgical-medical treatment 16% (n = 19). In multivariable
logistic regression predictors of 6-months mortality were age
(OR, 1.05; 95% CI, 1.01–1.1; P = 0.03), causative microorganism
(OR, 0.74; 95% CI, 0.55–1; P = 0.049) and a contraindication to
surgery (OR, 32.26; 95% CI, 7.2–145; P < 0.001).
Conclusion: In the present prospective single centre study of
193 patients with deﬁnite IE, 6-months mortality rate was 0.22,
and was especially high in patients with preestablished
contraindications to surgery, in the elderly and in patients
with staphylococcal IE. Six-months mortality in patients with
combined surgical-medical treatment versus exclusively
medical therapy in patients without a contraindication to
surgery was not statistically signiﬁcant. Staphylococcal and
enterococcal IE had a worse prognosis compared to
streptococcal IE.
P1839
Epidemiology and aetiology of infective
endocarditis
E.E. Hill, P. Claus, M-C. Herregods, P. Herijgers,
S. Vanderschueren, W.E. Peetermans (Leuven, BE)
Objectives: The epidemiological features of infective
endocarditis (IE) have changed. We report the results of a
5-year prospective observational study investigating trends in
the epidemiology and etiology of IE.
Methods: From June 2000 through December 2004, we
registered 203 deﬁnite IE episodes according to the modiﬁed
Duke criteria in 193 patients older than 16 years, hospitalized in
a single tertiary-care center.
Results: Sixty-one% of episodes involved males. The median
age was 62 years (range 54–73).Fifty-ﬁve percentage (n = 112)
were referred from another hospital. Forty-four percentage
(n = 90) were nosocomial. Thirty-four percentage (n = 70)
involved prosthetic valves and 17% (n = 12) thereof were of
early postoperative onset. The mitral valve was most frequently
involved. Exposure to IE risk factors during the previous
6 months was recorded in 67% (n = 136) of the episodes.
Twenty-four percentage (n = 49) were intravascular catheter-
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related, 20% (n = 40) had previous surgery and 9% (n = 19)
were related to urinary or digestive tract procedures. Only 2
patients had illegal substance abuse. The most frequent
predisposing acquired cardiac condition for native valve
endocarditis was degenerative valvular disease in 55% (71/
129). Twelve percentage (n = 24) had prior IE. The most
frequent predisposing congenital cardiac condition was a
bicuspid aortic valve in 5% (n = 11). In 16% (n = 32), no
predisposing heart disease was discernible.
Causative microorganisms included: Staphylococci in 43%
(n = 87) with S. aureus in 31% (n = 62), CoNS in 12% (n = 25),
Streptococci in 26% (n = 52) with S. viridans in 12% (n = 25), S.
bovis in 8% (n = 16), Enterococci in 17% (n = 34) and other
pathogens in 3% (n = 7). Culture negative IE was reported in
11% (n = 23). Both in community-acquired and nosocomial IE, S.
aureus was the most frequent causative agent. Twenty-three
percentage (14/62) were methicillin-resistant S. aureus. S.
viridans IE was mainly community-acquired while enterococcal
IE was nearly equally distributed between community and
nosocomial origin.
Conclusion: Compared to older series, we observed a high
proportion of nosocomial IE and of prosthetic valve IE. S. aureus
and E. faecalis were the most prevalent causative
microorganisms. Enterococci were nearly equally distributed
between community and nosocomial origin, suggesting that
nosocomial enterococcemia should be added as a major
criterion, as proposed before for S. aureus.
P1840
The role of aminoglycosides in combination with
a beta-lactam for the treatment of bacterial
endocarditis: a meta-analysis of comparative
trials
M. Falagas, D. Matthaiou, P. Papastamataki, I. Bliziotis (Athens,
GR)
Objectives: The addition of an aminoglycoside to a beta-lactam
for the treatment of patients with infective endocarditis has been
supported mainly from data from laboratory and animal
studies. We sought to review the evidence from the available
comparative clinical trials regarding the role of aminoglycosides
in combination with a beta-lactam for the treatment of bacterial
endocarditis due to Gram-positive cocci.
Methods: The studies for our meta-analysis were retrieved
from searches of the PubMed database and from references of
relevant articles. Included studies were trials that provided
comparative data regarding the effectiveness of the treatment
and/or mortality in patients receiving monotherapy with a beta-
lactam or beta-lactam/aminoglycoside combination therapy.
Two independent reviewers performed the literature search,
study selection, and extraction of data from relevant studies
published in English during the period 01/1975–08/2005.
Results: No clinical trial comparing beta-lactam monotherapy
to beta-lactam/aminoglycoside combination therapy for the
treatment of enterococcal endocarditis was found. We
performed a meta-analysis of 5 available comparative trials (4
randomized controlled trials and 1 comparative prospective
trial) that included 261 patients with bacterial endocarditis in
native valves due to Staphylococcus. aureus (4 studies) or
Streptococcus viridans (1 study). There was no statistically
signiﬁcant difference between the compared arms regarding
mortality (OR 0.59, CI 95% 0.21–1.66), treatment success
(OR = 1.25, CI 95% 0.49–3.05), treatment success without
surgery (OR = 1.66, CI 95% 0.64–4.30), and relapse of
endocarditis (OR = 0.79, CI 95% 0.15–4.29). Nephrotoxicity was
less common in the beta-lactam monotherapy arm compared to
the beta-lactam/aminoglycoside combination therapy
(OR = 0.38, CI 95% 0.16–0.88, p = 0.024).
Conclusion: The limited evidence from the available
prospective comparative studies does not offer support for the
addition of an aminoglycoside to beta-lactam treatment of
patients with endocarditis due to Gram-positive cocci. A large
multicenter randomized controlled trial may be necessary to
reach a deﬁnitive conclusion on this issue.
P1841
Outpatient antimicrobial therapy for infective
endocarditis. Single-centre experience
C. Cervera, A. Del Rı´o, L. Garcı´a, M. Sala, A. Olivera, M. Almela,
A. Moreno, C. Mestres, F. Marco, J.M. Miro´ (Barcelona, ES)
Objectives: To evaluate the characteristics and outcome of
infective endocarditis (IE) patients included in a Outpatient
antimicrobial therapy (OPAT) program.
Methods: From January 1997 to May 2005 all patients who
received OPAT therapy for an IE were prospectively evaluated.
Inclusion in OPAT program require clinical stability and
agreement of patients. Active drug addiction was
contraindicated for inclusion. Antibiotic treatment was
administered in bolus for once-daily antibiotics regimens. We
used CADD-LegacyTM PLUS (Deltec, Inc. St Paul. USA) portable
infusion system for either continuous or intermittent-
programmed bolus infusion.
Results: We included 65 patients, 51 male (78%), mean age
60 years old (SD: 19.3 years). The diagnostic of IE was deﬁnite
in 45 cases (13 with pathologic diagnosis), 15 probable and 5
possible. Mostly of the cases were community-acquired IE
(83%). Mitral valve IE was the most frequent anatomical site
involved (46%), followed by aortic (32%). Native-valve IE
represent the majority of cases (55%), but 32% were prosthetic-
valve and 12% were pacemaker lead IE. Viridans group
streptococci was the most frequent isolate (31 patients, 48%)
with 4 cases of S. bovis IE. Eleven patients had S. aureus IE
(17%). At the time of the diagnosis, 10 patients had valve
rupture and 4 patients had periannular abscess. A total of 15
patients required some surgical intervention for the IE [9
valvular replacement (2 of them associated with aortic graft), 5
pacemaker extraction and 1 aortic graft]. The majority of the
patients received outpatient monotherapy (65%). The most
frequent antibiotic used was Ceftriaxone (55% of the cases),
followed by cloxacillin 20%, gentamycin 20%, vancomycin 14%,
teicoplanin 14%, ampicillin 8% and other antibiotics in 14%. In
60% of the patients the vascular access was a periferically-
inserted venous central catheter and in 26% we used a portable
infusion system. Twelve patients (18%) had some complication
during OPAT that require hospital readmission, of which 5
could return to OPAT program. Three patients had a fatal
outcome (deaths) during admission, not related to IE
complications. The mean duration of OPAT was 18.9 days
per patient, and globally supposed 1.230 days of hospital
admission savings.
Conclusion: OPAT for IE can be a good therapeutic option for
IE stable patients. This procedure can represent a considerable
amount of hospital admissions savings, improving also patients’
well-being, and must be take into account for the treatment of
this disease.
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Epidemiology and outbreaks
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Outbreak of botulism type E associated with
eating traditional soup in a family group in Iran
P. Vahdani, D. Yadegarynia, M. Keshtkar Jahromi, O. Eilami,
M. Zare Dehabadi (Tehran, IR)
Objectives: Botulism, a neuroparalytic illness, is caused by
toxin produced by clostridium botulinum. Food born botulism,
a potentially lethal neuroparalytic disease, is caused by
ingestion of preformed toxin. Clinical illness is characterised
by cranial nerve paralysis, followed by descending ﬂaccid
muscle paralysis. In this article we report a case series including
a family group of type E botulism after ingestion of an Iranian
traditional soup.
Methods: In January 2005, 11 patients of a family group
developed clinical manifestations of botulism 1–2 hours
following ingestion of a traditional soup. Their main clinical
presentations were severe weakness (90.9%–10 case) and
lethargy (72.8%–8 case). Other signs and symptoms were
blurred vision, ﬁxed and dilated pupils, diplopia, dry mouth
and decreased gag reﬂex. Based on clinical ﬁnding, all patients
received 3 monovalent antitoxins (A, B, C). Stool, gastric ﬂuid
and serum samples were sent for toxicological evaluation using
the standard mouse bioassay.
Results: Type E toxin was detected in the stool and serum
sample of only one patient. All patients recovered and
discharged one week after admission.
Conclusion: This study conﬁrmed that prompt administration
of antitoxin can prevent progression of disease based on clinical
judgment and also may be life saving. In this case series study,
we observed a short incubation period of 1–2 hours only in type
E botulism.
P1843
An outbreak of group G streptococcal pharyngitis
among hospital personnel considered to be food-
borne
N. Karabiber, A. Gurbuz Ertas, M. Karahan, E. Aykut Arca,
Z.C. Karahan, A. Tekeli (Ankara, TR)
Introduction: Food-born outbreaks of streptococcal pharyngitis
are relatively rarely reported,and while Group A streptococci are
the main causative agents, only a few epidemics caused by
Group G streptococci have been published. We describe here an
outbreak of Group G streptococcal pharyngitis occurred among
the staff of a teaching hospital in Ankara.The outbreak: An
explosive outbreak of pharyngitis occured mainly among the
staff working in certain departments (i.e. Intensive Care Units,
Operation Rooms) of Tu¨rkiye Yu¨ksek Ihtisas Teaching Hospital,
in 29 January 2004.
Methods: A total of 377 (111 and 266; 3 and 47 from catering
ﬁrm personel) throat cultures were evaluated in 2 days,and 124
BHS strains were isolated, 65 and 59 on the ﬁrst and the second
days, respectively. Presumptive identiﬁcation by nbacitracin
and trimethoprim/sulfametoxazole disk diffusion test showed
that 121 strains were non-Group A, 3 strains were Group A
streptococci. In deﬁnite grouping by Streptococcus Grouping Kit
(Avipath-Strep,OMEGA),121 strains were found to be
Lanceﬁeld Group G,3 strains were found to be Group A
streptococci (GAS). One of the GAS strains was isolated from
a catering staff on the ﬁrst day, the other two were isolated from
two health care personnels on the second day. During the
outbreak, 16 of 50 catering ﬁrm personel (32%) were found to
positive for Group G streptococci. All the BHS tested were
found sensitive to penicillin G and erythromycin by agar disc
diffusion method.
Conclusions: The conﬁguration of the epidemic curve
suggested a common source of exposure. Since respiratory
spread of streptococci in such a rapid fashion would be highly
unlikely and that 16 of 121 positive throat culture were from the
staff of the catering ﬁrm that provide all the food services for the
hospital, and that most of them were working at the
departments in which the outbreak occurred, we considered
that the outbreak might be food-borne. Prompt treatment with
penicillin all the ill personnel and 9-day holiday coming
consequently 30 January, terminated the outbreak. All the
strains were cryopreserved for further typing studies.We are
now typing these strains by Pulsed Field Gel Electophoresis
(PFGE) after digestion with SmaI restriction endonuclease. Our
initial results show that these strains are of the same origin.
P1844
Outbreak of acute gastroenteritis in an air force
base in Western Greece
E. Jelastopulu, T. Constantinidis, T. Kolokotronis, D. Venieri, G.
Komninou, C. Bantias (Patras, Andravida, GR)
Objectives: On 20 September 2005, an operative training day at
the Air Force base in Western Greece, soldiers and staff
experienced an outbreak of acute gastroenteritis. The purpose
of this study was to determine the causes of the outbreak and
develop control measures.
Methods: Following the assessment of descriptive
epidemiology, a case-control analytic approach was utilized
with 100 randomly selected cases and 66 controls. Patients
completed a questionnaire pertaining to the presence and
severity of gastrointestinal disturbances, date and time of
symptoms onset and consumption of food items served in the
base on the implied training day. Adequate questionnaire was
administered to the controls. Odds ratios were calculated and
statistical signiﬁcance was determined using x2 test. Samples of
food items were collected for bacteriological examination.
Results: The overall attack rate was at least 50% among the
approximately 1050 attendees. The outbreak started abruptly in
the late afternoon on 20 September, peaked at midnight and
ended about 25 hours later. From the interviews and the
analysis it was established that the lunch (beef, macaroni,
tomato sauce and grated cheese) consumed several hours prior
to onset of symptoms by affected military personnel was the
likely source of the outbreak with a strong statistical association.
There was only one subject who did not eat lunch. Among the
symptoms the most prominent were watery diarrhoea (96%)
and abdominal pain (73%). Relatively few indicated vomiting
(8%) and nausea (7%). The mean incubation period was 9 h. In
the bacteriological examination, Staphylococcus aureus was
detected in a sample of raw beef and in two samples of grated
cheese (rest-cheese from lunch and an unopened package).
Conclusion: The short incubation period with abrupt onset, the
symptomatology and the short, self-limiting nature of the
illness, are suggestive of gastroenteritis caused by an
enterotoxin-producing bacterium. S. aureus is considered to be
the most likely cause. Although mortality and longer-term
morbidity are uncommon with food poisoning caused by
enterotoxin-producing bacteria, this outbreak highlights its
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capacity to cause short term, moderately-severe illness in a
young and healthy population. It underscores the need for
proper food handling practices and reinforces the importance of
appropriate microbiological specimen collection from cases, as
well as the public health importance of timely notiﬁcation of
such outbreaks.
P1845
Occurrence, characterisation and antimicrobial
resistance pattern of Staphylococcus aureus
strains isolated from dairy products in southern
Italy
G. La Salandra, E. Goffredo, C. Pedarra, M.C. Nardella,
A. Parisi, A. Dambrosio, N.C. Quaglia, G.V. Celano,
G. Normanno (Foggia, Valenzano, IT)
Objectives: The ingestion of food contaminated by enterotoxins
(SEs) synthesized by Staphylococcus aureus is responsible of one of
the most common foodborne diseases (Staphylococcal Food
Poisoning- SFP). Since S. aureus is often involved in cases of
subclinical mastitis of ruminants, milkmay results contaminated.
Infact, the dairy products are frequently related to cases of SFP,
expecially in areas characterized by a high level of consumption
of these products. Consequently an active microbiological
surveillance is needed in order to control the risk of SFP and to
allow the improvement of the public health standards. S. aureus
also show a large antimicrobial resistance pattern. In this work
are reported the results of a survey conducted on the occurrence
of S. aureus in dairy products fromApulia region (Southern Italy).
Furthermore, the isolated strains were characterized in order to
determine their ability in synthesizing SEs and to evaluate their
antimicrobial resistance pattern.
Methods: 250 samples of dairy products (milk, cheese,
mozzarella cheese, ricotta cheeses) were analysed for the
detection of S. aureus. The isolated strains were tested for the
detection of SEs, using the reverse passive latex agglutination
test (SEA to SED) and submitted to PCR to detect entA, entB,
entC, entD and entE genes. Furthermore, the strains were tested
for susceptibility to ampicillin, tetracycline, gentamicin,
eritromycin, enroﬂoxacin, co-trimoxazole, teicoplanin and
vancomycin, by the agar diffusion method.
Results: Out of 250 samples analysed, 36 (14.4%) resulted
contaminated with S. aureus and, among these, 19 (52.7%) have
been recognized as enterotoxigenic strains (10 samples of milk, 5
samples of mozzarella cheese, 3 samples of cheese from ovine
milk and 1 sample of cheese). All the strains tested (one per each
positive sample) showed antimicrobial resistance properties but
none of these was resistant to teicoplanin and vancomicin.
Conclusions: The results obtained from this survey show that
milk and dairy products from Southern Italy are frequently
contaminated by enterotoxigenic strains of S. aureus and
highlighted the need to implement strict hygienic control
measures along the food chain in order to decrease the risk of
SPF. Furthermore, the presence of antimicrobial-resistant strains
of S. aureus in food may be considered a source of community-
acquired infections, with the direct risk of transfer of the
antimicrobial-resistance to intestinal human microﬂora.
P1846
Eco-epidemiology of cryptosporidiosis 1999–2003,
in HSE West, Ireland
D. McKeown, R. Cloughley Galway City, IE
Objective: To determine the eco-epidemiology of
Cryptosporidiosis in the Health Services Executive – Western
Area (formerly the Western Health Board).Concerns about the
incidence of Cryptosporidiosis in the Western Area prompted
the Department of Public Health to undertake further
investigation of potential links between Cryptosporidiosis and
environment by focusing on farming activity and water supplies
in the ﬁrst instance.
Background: Cryptosporidiosis was not notiﬁable in the
Republic of Ireland prior to 2004, unless cited as a cause of
gastroenteritis in a child less than two years old. As a result the
incidence of Cryptosporidiosis in the Republic of Ireland at the
time was unknown. Nationally it was estimated that up to 8% of
cases of gastroenteritis in children less than two years old could
be attributed to Cryptosporidium. In the Western Area from 1999
to 2003 the proportion of cases of gastroenteritis in children less
than two years old attributable to Cryptosporidium ranged from
10.8% to 24.5%. This was cause for concern.Many rural locations
in the Western Area are served by voluntarily-operated water
schemes. Water quality from these schemes is often microbio-
logically unsatisfactory. The Department of Public Health
Methods: Initial research involved analysis of notiﬁcation
records for cases of Cryptosporidiosis received from 1999 to
2003 inclusive. Crude incidence rates for Cryptosporidiosis in
the Western Area were compared with crude incidence rates in
England & Wales, Northern Ireland, and Scotland for the same
time period. Cases of Cryptosporidiosis from the Western Area
were geo-coded and mapped to visualize the geographic spread
of cases, and are being contrasted with geographic data for
farming activity, and also with available data on water supplies.
Results & conclusions: The results of the initial phase of this
research indicated the incidence of Cryptosporidiosis in the
Western Area may be cause for concern. The geographic spread
of cases and potential links to farming practices and water
supplies will be presented.
P1847
Bacterial ﬂora in pharyngeal swabs of family
practitioners’ patients from Silesian province,
Poland
J. Jo´zwiak, I. Szymczyk, W. Lukas, B. Boruta, J. Skorupka
(Zabrze, PL)
Objective: The evaluation of epidemiology and seasonal
ﬂuctactions of bacterial ﬂora in pharyngeal swabs taken from
family doctors’ patients.
Material and methods: A total of 7807 of positive pharyngeal
swabs ordered by primary care physicians from Silesia were
examined during the 2000–2005 period. The microbiological
analysis was performed in Silesian Analytic Laboratories. The
intake of material, its transport and ﬁnal identiﬁcation complied
with laboratory standards.
Results: The most common pathogens were, in order of
prevalence: Streptococcus viridans (57.4%), Moraxella catarrhalis
(45.2%), Staphylococcus aureus along with MRSA (31.6%) and
MRSA alone (1.6%), E. coli (18.8%), Klebsiella pneumoniae (6.6%),
Streptococcus B. haemoliticus (4.7%). Candida albicans was
identiﬁed in 14.2% of positive specimens. Considering
seasonal ﬂuctuation, the number of positive swabs in each
month tended to gradually increase in spring with its
culmination in May (10.4%). As for the most common
pathogens Streptococcus viridans and Moraxella catarrhalis
mirrored the general tendency and dominating in spring
season (up to 11.7 and 12.1%, respectively) and having less
stronger impact in automn (up to 9.3 and 9.4%). The frequency
of isolation of the other pathogens revealed seasonal ﬂuctuations
conﬁned to either spring, as in the case of Klebsiella pneumoniae,
Escherichia coli and Staphylococcus aureus strains (up to 17.7, 12.3
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and 11.6%, respectively) or automn season, as stated for Candida
albicans (up to 11.9% of isolates). No signiﬁcant seasonal
variability in the prevalence of emergence of Streptococcus
B-haemolyticus strains in swabs was observed.
Conclusions: 1. Seasonal ﬂuctuations of pharyngeal, bacterial
ﬂora were observed. 2. There was a signiﬁcant predominance of
Streptococus viridans and Moraxella catarrhalis in analysed
samples. 3. Our data suggest low reliability and very strict
indications for ordering pharyngeal swabs in everyday
management of family practise.
P1848
Micro-organisms isolated from corneal and
conjunctival samples in a Spanish teaching
hospital
N. Arenal, D. Domingo, J.L. Navarro, J.M. Azcona, E. Garcia-
Pen˜uela, M. Lopez-Brea (Madrid, ES)
Aim: The aim of this study was to identify the microorganisms
isolated from corneal and conjuntival samples, isolated from
patients attending the ophtalmology department of a Spanish
hospital.
Material and methods: A total of 69 corneal scrapes and 544
conjunctival swabs were obtained since October of 2002 to
October of 2005 in an university hospital of Madrid. Samples
were cultured into blood and chocolate agar plates and
incubated at 35ordm;C in O2 and CO2 atmospheres,
respectively, for two days (conjunctival swabs) and ﬁfteen
days (corneal scrapes). Identiﬁcation and susceptibility tests
were performed following standard methodology.
Results: Thirty four (49.3%) out of 69 corneal samples and 96
(17.6%) out of 544 conjunctival swabs yielded positive cultures,
respectively.
Results are summarized in the following table:
Conclusions : Corneal scrapes yielded a higher number of
positive cultures than conjunctival swabs. Gram-positive
microorganisms were more prevalent both from corneal
scrapes and conjuntival swabs although the difference was
more evident in corneal scrapes. S. aureus was the specie most
prevalent in conjunctival samples meanwhile CNS were the
most prevalent in corneal scrapes.
P1849
Spectrum and susceptibilities of bacteria isolated
from the vitreous ﬂuid of patients undergoing
vitrectomy
D. Mylona-Petropoulou, N. Markomichelakis, K. Ziva, N.
Ikonomopoulos, M. Theodoropoulos, C. Koutsandrea, H.
Malamou-Lada (Athens, GR)
Objectives: To determine the spectrum and susceptibility of
bacteria in vitreous ﬂuid from patients undergoing vitrectomy
for endophthalmitis.
Methods: Vitreous ﬂuid samples (n = 177) were obtained from
150 patients (94 male, 56 female) undergoing vitrectomy for
endophthalmitis between January 2001 and October 2005.
Specimens of undiluted aqueous and vitreous ﬂuid were
cultured for aerobic, anaerobic bacteria and fungi by
conventional methods. Identiﬁcation and antibiotic
susceptibility were performed by the API system, Vitek II
system (BioMerieux) and the agar disk diffusion methods
according to CLSI recommendations.
Results: Ninety one isolates were recovered from the samples.
Gram stain was positive in 133/177 (75.1%), while cultures were
positive in 94/177 (53.2%) samples. Gram-positive bacteria were
the most common isolates (71/91, 78%), followed by Gram-
negative bacteria (11/91, 12%) and fungi (9/91, 10%).
Staphylococci coagulase-negative were isolated in 41/91 (45%).
The next most common species isolated among Gram-positive
bacteria were S. aureus (6.6%), Streptococcus spp (9.9%),
Propionibacterium acnes (9.9%), Bacillus spp (3.3%), Streptococcus.
pneumoniae (1%) and Enterococcus faecalis (1%). Among Gram-
negative bacteria eight isolates were Enterobacteriaceae, two
were non fermenters and one was Haemophilus inlfuenzae. Two
of the fungal isolates were Candida albicans, one Acremonium spp
and six Aspergillus fumigatus. Polymicrobial growth was
observed in six patients with two at least isolates. Of
staphylococci coagulase-negative 10/41 (24%) were resistant to
methicillin. Only one strain of Staphylococcus aureus was
methicillin resistant. All Gram positive isolates were
susceptible to vancomycin. All isolates were sensitive to
amikacine and ceftazidime while resistance was observed in
9/177 (5%) isolates to ﬂuoroquinolones.
Conclusion: A variety of microorganisms was isolated from the
vitreous ﬂuid of patients. The predominant isolates were Gram-
positive bacteria, especially staphylococci coagulase-negative
with low resistance rate to methicillin. So, therapy should be
based on the isolation and identiﬁcation of the infecting agent
and the in vitro antibiotic susceptibility to the appropriate
antibiotics.
P1850
The prevalence of intestinal parasitic infection in
the students of primary schools in Nazloo region
in Urmia during 2004–2005
K. Hazrati Tappeh (Urmia, IR)
Background: Intestinal parasitic infections are of the most
important hygienic and economical problems of millions of
people in all over the world, mostly from developing countries.
Understanding their epidemiological situation and relation to
environmental and social factors is necessary for struggling with
them in every society. This investigation was designed to study
the prevalence of parasitic intestinal infections among primary
school attending students in Nazloo region of Urmia district in
2004.
Materials and methods: 271 students were chosen randomly
from 7 schools upon their population. Having their
questionnaires ﬁlled, two faecal samples were taken from each
student and examined with direct wet mount and formalin-
ether sedimentation technique. Scotch tape was also applied in
order to detect the enterobiasis and taeniasis. 271 students
completed the test. All infected persons by E. vemicularis,H. nana
were treated by Mebandazole and Giardia lamblia were treated
by metronidazole.
Results: Overall prevalence of parasitic protozoan infections
was 29.5%. Giardia lamblia was found in 28 cases (10.3%),
Entamoeba coli in 27 cases (10%) and Blastocystis hominis in 2 cases
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(0.7%). 28.4% of students had Enterobius vermicularis and just one
case (0.4%) showed Hymenolepis nana infection. Concomitant
infections were found in 17 cases (6.3%) for Giardia and E. coli, 2
cases (0.7%) for Giardia and B. hominis, one case (0.4%) for E. coli
and B. hominis, one case (0.4%) for Giardia and E. vermicularis and
one case (0.4%) for E. coli and E. vermicularis.
Discussion: With regard to high prevalences of giardiasis and
enterobiasis it increase the prevalence that intestinal parasitic
infections. It is suggested to decrease the rate of these parasitic
infections in the region by strict programes that help to increase
the knowledge of students, their parents and teachers about
hygen.
P1851
Legionella pneumophila as an occupational risk
factor for inter-city bus drivers
Y. Polat, C¸. Ergin, I. Kaleli, A. Pinar (Denizli, Ankara, TR)
Objectives: Legionellaceae are ubiquitous aquatic
microorganisms that usually isolated from evaporative
condensers. Various man-made sources such as cooling
towers, whirlpools and spas are sources for Legionella
pneumophila. In hot climate, bus air-conditioning and air-
circulating systems are possible sources for the organism. In
this study, serologic status of bus drivers and their assistants for
Legionella infections as well as bus air-conditoner moisture exit
samples for Legionella species were investigated.
Methods: Serum samples were collected from bus drivers
(n = 63) and their assistants (n = 19). Samples were tested for
anti-legionella antibodies by indirect immunoﬂuorescence
technique. 1/320 dilution was accepted as a positive result for
anti-Legionella pneumophila antibodies. Results were analysed
according to risk factors based on hot/cold climate route
(Aegean and Mediterranean parts of the Turkey were accepted
as hot climate region), immundeﬁciency, chronic diseases and
work hours. According to serologic test results, air-conditioners
of buses which has been driven by 1/10 dilution seropositive
persons, were investigated. Air-conditioner moisture exit
samples were cultured on BCYE-alpha agar supplied with
BMPA. Same samples were tested by PCR targeting a 108-bp
fragment of the 5S rRNA gene of Legionella.
Results: Anti-Legionella pneumophila antibodies were positive
in 12 (15.2%) bus-persons. Bus drivers’ seropositivity was higher
than assistants (p < 0.05). In hot climate route, seropositivity
was higher than cold climate route (p < 0.05). No positive PCR
result was detected.
Coclusion: In conclusion, higher seropositivity rates in bus
drivers were pointed out a newer occupational risk factor for
legionellosis. Although PCR positivity was not detected for bus
air-conditioners, high seropositivity rates show that bus drivers
have been somehow exposed to legionella. Further legionellosis
surveillance studies for bus drivers may help to understand
legionella exposure during travel.
Urinary tract infection
P1852
The frequency of and risk factors for
asymptomatic bacteriuria in type 2 diabetes
mellitus
H. Turan, K. Serefhanoglu, A.N. Torun, S. Kulaksizoglu,
M. Kulaksizoglu, B. Pamuk, H. Arslan (Konya, Ankara, TR)
Objective: Asymptomatic bacteriuria is an important risk factor
contributing to pyelonephritis and renal disfunction in diabetic
patients. In this study, the relationship between
microalbuminuria and age, body mass index, duration of the
disease, the level of glycohemoglobin, glycosuria and
glomerular ﬁltration rate is studied prospectively in diabetic
patients who have asymptomatic bacteriuria.
Methods: A hundred and twenty-three type 2 diabetic
outpatients who were admitted to Baskent University Konya
Medical and Research Center between January–October 2005
were included in the study. Ages of the patients were within the
range of 26–80 years. The diagnosis of asymptomatic bacteriuria
was established according to the CDC criteria. Concurrent
samples for urinary culture, glomerular ﬁltration rate,
microalbuminuria and glycohemoglobin were obtained.
Results: Twenty-two of 123(17.8%) patients had signiﬁcant
bacteriuria. Of these patients 74% were female. Although age,
body mass index, creatinine clearence and presence of
microalbuminuria were similar, there was a signiﬁcant
difference in glycohemoglobin levels, duration of diabetes and
glycosuria between the two groups (p < 0.05). E. coli was the
most common microorganism obtained from urinary samples.
Risk factors for asymptomatic bacteriuria were shown in the
Table.
Conclusion: The frequency of asymtomatic bacteriuria was
found to be similar with the previous studies. High
glycohemoglobin levels and long duration of diabetes were
found to be the risk factors contributing to asymptomatic
bacteriuria in type 2 diabetic patients.
P1853
Descriptive study of complicated pyelonephritis
A. Villalobos, A. Plata, I. Portales, N. Macı´as, A. Federico, S.
Santamarı´a, D. Lo´pez, G. Uribarri, J.D. Colmenero (Malaga, ES)
Objective: To determine the clinical and epidemiological
characteristics, etiological agents, and diagnosis of complicated
or severe pyelonephritis.
Methods: A retrospective, descriptive study of a series of 634
patients with complicated or severe pyelonephritis that fulﬁlled
the IDSA criteria and required hospital admission to the
Intensive Care Unit or the Internal Medicine Ward of Carlos
Haya Hospital, Malaga, from January 1996 to December 2004.
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
Results: The study included 634 patients, with a mean age of
57.58 ± 19.2. 456 (71.9%) were women. The predisposing factors
were: renal lithiasis patients (26.7%), prostatic adenoma (8.2%),
vesical structure disease (4.3%), vesical functional disorder
(6.6%), chronic kidney failure (4.3%). The underlying diseases
included: diabetes mellitus (30.3%), immunosuppression (6.8%),
previous urinary tract instrumentation (4.3%), permanent
catheter (3.6%). The mean hospital stay was 10.93 ± 8.7 days.
The mean duration of symptoms was 5.9 ± 8.2 days, among
which were fever (89.1%), chills (79.3%), lumbar pain (77.3%),
mictional syndrome (70.5%), ﬂank tenderness (76.8%).
Laboratory data included leukocytosis, leukocyturia (90.1%),
bacteriuria (23.3%). Blood cultures were positive in 204 patients
(41.2% of the blood cultures performed). Urine cultures were
positive in 352 patients (59.6% of the urine cultures performed).
The most frequent pathogens were: E. coli (72.9%), Proteus
(7.1%), Klebsiella, Enterobacter, Serratia (5.4%) and Enterococcus
(4.3%). Abdominal ultrasound was undertaken in 90.9% of the
cases, with 46% showing disease. Of note among the
complications were sepsis (25.7%), septic shock (8.4%), acute
kidney failure (16.1%), and perinephritic abscess (1.6%). 29
patients (4.6%) died; attributable mortality (3.5%).
Conclusions: 1) Complicated or severe upper urinary tract
infection is a common cause of hospital admission in our setting.
2) The absence of leukocyturia or mictional syndrome does not
exclude the presence of complicated upper UTI. 3) The high
percentage of bacteriemia necessitates blood cultures, with E.
coli being the most common pathogen. 4) The associated
morbidity and mortality are important in association with
sepsis or septic shock.
P1854
Urinary tract infections in women suffering from
urinary incontinence in individual family
practice
E. Mizgala, W. Lukas, H. Trzeciak, W. Drzastwa (Zabrze, PL)
Objective: The evaluation of prevalence and contributory
factors associated with the development of urinary tract
diseases among women with urinary incontinence.
Material and methods: 124 women aged from 35 to 65 years
had their urine culture examination performed. The material
was taken from the central stream of ﬁrst catch urine and
transported on Uromedium. Antibiogram was carried out with
the use of Becton-Dicinson’s discs.
Results: In 14 cases the urine culture tested positively which
accounted for 11.3% of subject women. The most common
pathogens of urinary tract were, in order of prevalence:E. coli-
64.3%, Staphylococcus aureus -14.3%,Citrobacter diversus-7.13%
and Klebsiella pneumoniae-7.13%. Candida albicans strains were
isolated in one patient. E. coli had the highest sensitivity to
Norﬂoxacin - 100% and Cefuroxim - 100%, Amoxicillin with
clavulonian acid -88.8%, Ampicillin Nitrofurantoin and
Trimethiprim – sulfamethoxazole – 77.7% in each case,
Cefalothin –66.6%, Tetracycline - 55.5%, and Amikacin - 33.3%
but only in 11.1% to Amoxacillin. Staphylococcus aureus proved
sensitivity only to Gentamicin (100%) andNitrofurantoin (100%).
In the case of Citrobacter diversus 100% sensivity to Norﬂoxacin,
Nitrofurantoin, Tetracycline, Trimethoprim / Sulfamethoxazole,
Ceftazidim and Cefotaksym was conﬁrmed.Klebsiella pneumoniae
also proved sensitivity to Amoxicillin with clavulonian acid,
Cefuroksime, Nitrofurantoin, Norﬂoxacine, Tetracyclin and
Trimethoprim / Sulfamethoxazole. When considering the
sensitivity of pathogens to antibiotics in the family practise
setting of higher reliabilty are Nitrofurantoina,
Norﬂoksacyna.After the administration of guided therapy
complete release from symptoms was observed in 10 women (71
%).
Conclusions: Women with urinary incontinence relatively
seldom suffer from urinary tract infections. The most common
pathogen among women with urinary incontinence was E. coli
sensitive to Floxacins and Cephalosporins but with impaired
reaction to Amoxycillin.
P1855
Incidence and in vitro antibiotic resistance of
streptococci in community-acquired urinary tract
infections
E. Ikonomopoulou, C. Verra, H. Pavlidou, K. Papadopoulos,
N. Baikoussis, E. Stavrianou, I. Katsarou, A. Christopoulos,
A. Gioka, A. Regli (Patras, GR)
Objectives: To estimate the incidence of streptococci in
community acquired urinary tract infections (UTI) and also to
carry out the in vitro antibiotic resistance of streptococci in
urinary tract infections.
Methods: During almost a three years period (01/01/2003 –
30/10/ 2005), 301 (10.5%) streptococci strains were isolated from
3010 community acquired urinary tract infections. The
identiﬁcation and the susceptibility test were performed by the
Vitek system (Biomerieux). All enterococcal isolates were tested
for Vancomycin and Linezolid susceptibility using the E- test
(AB Biodisk).
Results: The distribution by sex was 69.4% women and 30.6%
men. 207 (68.8%) of streptococci strains were Enterococcus faecalis,
43 (14.3%) were Enterococcus faecium, 7 (2.3%) were Enterococcus
avium, 6 (2.0%) were Enterococcus gallinarum and 38 (12.6%) were
streptococci group B. The in vitro antibiotic resistance of
Enterococcus faecalis was: Penicillin G 38.9%, Ampicillin 2.4%,
Gentamicin500 29%, Streptomycin2000 52.7%, Nitrofurantoin
0%, Ciproﬂoxacin 44.4%, Tetracyclines 54.6%, Vancomycin 4.3%,
Linezolid 0%. The in vitro antibiotic resistance of Enterococcus
faecium was: Penicillin G 79%, Ampicillin 69.8%, Gentamicin500
23.3%, Streptomycin2000 53.5%, Nitrofurantoin 0%,
Ciproﬂoxacin 74.4%, Tetracyclines 23.3%, Vancomycin 27.9%,
Linezolid 0%. The in vitro antibiotic resistance of group B
streptococciwas: Penicillin G 5.3%, Ampicillin 0%, Cefazolin 2.6%,
Clindamycin 5.3%, Erythromycin 13.2%, Nitrofurantoin 0%,
Oﬂoxacin 2.6%, Tetracyclines 76%, Vancomycin 0%. 3 strains of
Enterococcus gallinarum and 1 of Enterococcus avium were
resistant to Vancomycin.
Conclusions: Streptococci are responsible for the 10.5% of
community acquired urinary tract infections. Enterococcus
faecalis was the most frequent pathogen (68.8%) and was high
resistant to Ciproﬂoxacin, Tetracyclines, Gentamycin and
Ampicillin. Enterococcus faecium showed high resistance to the
majority of antibiotics including Vancomycin and Ciproﬂoxacin.
Linezolid remains a promising treatment to VRE.
P1856
Virulence and resistance of Escherichia coli
isolates from pregnant and non-pregnant women
with community-acquired urinary tract infections
in a Kuwait hospital
E. Draghijeva, P. Egbase, S. Mathai (Kuwait, KW)
Objective: To compare the availability of virulence factors and
the resistance of E. coli isolates from pregnant women with
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uncomplicated community-acquired urinary tract infections
(CA-UTIs) and non-pregnant women in London hospital in
Kuwait over a period of two years.
Methods: Eighty-six pregnant and 90 non-pregnant women
with signs of CA-UTIs were enrolled in the study. The strains
isolated from the patients who had signiﬁcant bacteriuria were
included in the microbiological analyses. The identiﬁcation of
the strains was performed using the API 20E system
(BioMerieux), while their susceptibility was determined by
disk diffusion method. The interpretation of the results was
realized according to NCCLS guidelines. Quality control was
performed using reference strain E. coli ATCC 25922. O-
serotyping was carried out with polyvalent and monovalent
antisera. Hemolysin production was tested on human blood
agar plates. Possession of K1 antigen by E. coli was tested with
agglutination by murine monoclonal antibodies to the group B
meningococcal capsule.
Results: We found O serogroups O1, O2, O4, O6, O7, O18 and
O75 among strains isolated from pregnant and non-pregnant
women. Hemolysin was presented in 35% and 40% respective.
K1 antigen was presented in 40% of strains in studied groups.
There are some statistically signiﬁcant differences in
antimicrobial resistance between both groups. Amoxicillin-
clavulanate (AMX-CLV) resistance was higher among UTI
haemolytic isolates of E. coli in pregnant women (54%) then in
non-pregnant women (38%). Similar distinction in Cefuroxime
resistance was found – 15% and 0. Amikacin resistance was
higher among UTI isolates of E. coli in non-pregnant women
(47%) then in pregnant women (23%).
Conclusions: There are no signiﬁcant differences in expression
of virulence factors of E. coli from pregnant and non-pregnant
women with CA-UTIs in London hospital, Kuwait. The
resistance rates of E. coli from pregnant women to AMX-CLV
and Cefuroxime are signiﬁcantly higher than in non-pregnant
women.
P1857
The penetration of telithromycin in
gynaecological tissues and activity in cervicitis
patients
H. Mikamo (Gifu, JP)
Objectives: Chlamydia trachomatis and Neisseria gonorrhoeae are
major causative organisms for sexual transmitted infections in
Japan. Although several oral antimicrobial agents are active
against C. trachomatis, few effective oral antimicrobial agents
against N. gonorrhoeae exist in Japan. Two studies were
conducted: a clinical pharmacology study examining
penetration of telithromycin (TEL), an oral ketolide antibiotic,
in female genital organ tissues and a clinical study examining
TEL 600 mg once daily (qd) in cervicitis patients (pts).
Methods: Eleven hysterectomy pts were assessed in the phase II
clinical pharmacology study investigating the distribution of
TEL in female genital organ tissues by bioassay. Pts took one
600 mg dose of TEL prior to the operation. A Phase III clinical
study was also conducted examining the efﬁcacy and safety of
TEL 600 mg qd for 5 days in pts with cervicitis caused by C.
trachomatis or N. gonorrhoeae. Clinical efﬁcacy was evaluated on
Days 14 and 28.
Results: In the pharmacology study (n = 11), mean tissue
concentration in female genital organs at 180–435 minutes after
one dose of TEL 600 mg was 1.22 lg/g in portio vaginalis,
1.97 lg/g in cervix uteri, 2.37 lg/g in the endometrium, and
2.61 lg/g in myometrium. Distribution ratios (tissue
concentration/plasma concentration) ranged from 2.29 to 4.90.
In the clinical study of 58 pts, efﬁcacy on Days 14 and 28 was
81.1% (43/53 pts) and 96.0% (48/50 pts). Bacteriological efﬁcacy
on Days 14 and 28 was 81.1% (43/53 pts) and 96.0% (48/50 pts).
Eradication of C. trachomatis was 80.4% (37/46) on Day 14 and
95.3% (41/43) on Day 28, and of N. gonorrhoeaewas 90.0% (9/10)
on Day 14 and 100.0% (9/9) on Day 28. Safety was evaluated in
58 pts; the incidence of possibly related adverse events in 56,
excluding 2 for whom incidence could not be determined, was
26.8% (15/56). Possibly related treatment emergent adverse
events were mainly gastorointestinal and of mild or moderate
intensity.
Conclusions: TEL 600 mg administered once daily for 5 days
was clinically active for the treatment of cervicitis caused by C.
trachomatis or N. gonorrhoeae. This activity appears to be
supported by the distribution of TEL in female genital organ
tissues. Further clinical studies are required to conﬁrm these
preliminary results and to study the potential interaction with
imidazole derivatives and/or oral contraceptives.
P1858
Acute uncomplicated pyelonephritis may be
safely treated with 7 days of an oral
ﬂuoroquinolone. Analysis of two prospective
multicentre studies in the emergency department
D. Elkharrat, P. Veyssier, H. Botto, E. Vicaut, G. Pottel, H.
Drugeon, F. Tremolieres for the French AUP Study Group
Background: Short-course therapy for acute uncomplicated
pyelonephritis (AUP) is the newly suggested standard. Talan
et al. have demonstrated that oral ciproﬂoxacin (Cip) for 7 days,
was associated with greater cure rates than a 14-day
trimethoprim-sulfamethxazole regimen. We assessed efﬁcacy
and tolerance of a 7-d. regimen of Cip (Study I), then of
levoﬂoxacin (Lvx) in Study II, in patients presenting with AUP
to the emergency department (ED).
Methods: Methodology and end points were identical in
these 2 uncontrolled studies, conducted in 35 (I) and 12 (II)
EDs, respectively. Consecutive non-pregnant females with
presumed AUP (fever ‡38.5ordm;C, ﬂank pain, positive
urine dipstick) were recruited after signing consent. Blood
and urine samples were taken for culture before Cip 500 mg
bid (I) or Lvx 500 mg once daily (II), was started. AUP was
subsequently conﬁrmed if bacteriuria was ‡10 to the 5th
CFU/ml of 1 uropathogen and abdomen/pelvis ultrasound
was normal. The main end point was bacterial eradication
(BE) at 5–9 d. post-treatment (visit 4); others were global cure
(GC) [clinical cure + BE] at V4 and at end of study, 28–42 d.
post-treatment (V5). Study efﬁcacy was based on Infectious
Diseases Society of America (IDSA) guidelines (GC = 80% at
V4 and =60% at V5, with <50% of lost to follow up between
V4/V5).
Results: Of 171 (I) and 82 (II) enrolled pts. 139 aged
31.7 ± 12.9 y., and 69, aged 3.58 ± 15.0 y. were retained for
ITT analysis; 16.5% and 16.0% had positive blood cultures.
Escherichia coli was the uropathogen in 99.2% and 100% of
cases. Finally 122 (I) and 60 (II) were retained for per protocol
(PP) analysis. At V4 bacterial eradication rates were 93.4% and
98.3 %. Global cure rates were 89.0 and 92.8% at V4 and
77.3% and 75.0% at V5 with only less than 7% of lost to
follow-up between V4 and V5 in both cases. Side effects were
observed in 12.8% and 27.6% of pts. who received 1 or more
FQ doses.
Conclusions: AUP treatment with Lvx 500 mg. once daily or
Cip 500 mg bid for 7 days is efﬁcacious and well tolerated.
*We thank our colleagues for contribution to these studies.
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P1859
Coryneform bacteria in prostatitis patients:
species composition and antibiotic susceptibility
S. Tu¨rk, P. Korrovits, K. Ausmees, M. Punab, R. Ma¨ndar (Tartu,
EE)
Chronic prostatitis (CP) is believed to be an infectious disease in
most cases. Both aerobic and anaerobic bacteria are involved in
the polymicrobial microbiocenosis found in prostate speciﬁc
specimens. Coryneform bacteria form a remarkable part of this
community, yet scarce knowledge exists about their clinical
signiﬁcance, species composition and antibiotic susceptibil-
ity.Our aim was to compare the corynebacteria of the seminal
ﬂuid of CP patients and controls and to evaluate their antibiotic
susceptibility.
Material and methods: Semen samples from 66 controls and 49
CP patients (NIH IIIa or IV category) were analysed.
Corynebacterium seminale was identiﬁed by beta-glucuronidase
activity, the rest of coryneforms using API Coryne (BioMerieux).
E-test method was used for susceptibility testing.
Results: Coryneforms were found from 78% CP patients and
84% controls (p > 0.05). Twelve species and genera were found
among 120 strains identiﬁed, the most frequent being C. seminale
(in 60% CP patients and 58% controls). CP patients harboured
signiﬁcantly more Arthrobacter sp. (17% vs 2%, p = 0.03) and
Corynebacterium group G (14% vs 2%, p = 0.01), the latter
association was especially eminent in case of patients with
serious inﬂammation (>1 WBC/ml): 33% vs 2%, p = 0.0003. All
tested 65 strains were susceptible to ampicillin-sulbactam, single
strains were resistant to doxycycline (5%) and TMP/SMX (5%),
however, moderate resistance was common to doxycycline
(29%). Resistance to clindamycin (38%), benzylpenicillin (28%),
nitrofurantoin (17%), erythromycin (16%) and norﬂoxacin (11%)
was observed as well. Half of CP-related Corynebacterium
group G strains showed resistance to nitrofurantoin and
benzylpenicillin. In addition, they were often moderately
resistant to clindamycin, erythromycin and, ﬁnally, norﬂoxacin
frequently used to treat CP.
Conclusions: Most of men have coryneforms in their semen,
more than half harbour C. seminale. Corynebacterium group G and
Arthrobacter sp are more frequently found in CP patients than
the controls. In the treatment of CP of unknown etiology it is
useful to take into consideration the susceptibility proﬁle of
Corynebacterium group G.
P1860
Serologic evaluation of cytomegalovirus and
Listeria monocytogenes in women with abortion
M. Jamshidi Makiani, M. Amirian, A. Sotode, M. Zangane
(Bandar Abbas, IR)
Objective: To evaluate the role of CMV and listeria
monocytogenes in abortion.
Methods: This descriptive prospective study was done on 450
women, 250 women with spontaneous abortion before 20th
weeks of pregnancy as a case group and 200 healthy woman
with full term delivery as a control group. Serum samples were
taken from all patients. ELISA test was done for evaluation of
CMV (IgG and IgM) and Listeria antibodies in both groups.
Prevalence of seropositivity was determined. Data were
analysed by x2 and chi-square test.
Results: 450 seologic tests were done on samples. Average age
in case group was 25.6 ± 7.6 and in control group was
25.3 ± 6.5 years. In cases with abortion 89 (35.6%) and in
control group 35 (17.5%) were seropositive for Listeria
monocytogenes. Difference in seropositivity between 2 groups is
statistically signiﬁcant (p = 0.0001). CMV IgG antibodies were
positive in 235 (94%) of case group and in 150 (75%) of control
group; the difference is signiﬁcant statistically (p = 0.0001).
CMV IgM antibody was positive in 13 (5.2%) of case group and
none in control group. Difference is signiﬁcant (p < 0.0001) there
was no correlation number of previous abortion and
seropositivity for Listeria and CMV.
Conclusion: The present study showed an important role of
Listeria monocytogenes and CMV infection in abortion.
P1861
Serum and prostatic tissue concentrations of
moxiﬂoxacin (400 mg) after a single intravenous
infusion in patients with benign prostatic
hyperplasia undergoing transurethral resection of
the prostate
F.M.E. Wagenlehner, C. Lunz, F. Kees, W.F. Wieland,
K.G. Naber (Straubing, Regensburg, DE)
Background: The spectrum of bacterial prostatitis comprises
Gram-negative, Gram-positive and atypical pathogens. Because
of its broad spectrum of activity, moxiﬂoxacin might be a
suitable antibiotic for the treatment of bacterial prostatitis.
Aim: In this study the penetration of moxiﬂoxacin into prostatic
tissue after intravenous application of 400 mg as single dose was
investigated.
Methods: In a prospective, multicentric study patients with
benign prostatic hyperplasia received a single dose of
moxiﬂoxacin 400 mg in an 1 hour lasting infusion (250 ml) for
perioperative prophylaxis before undergoing transurethral
resection of the prostate (TUR-P). Serum concentrations were
determined in all patients before infusion, at the end of infusion
(time point 0), 0.5, 1 and 2 h after the end of infusion. Patients
were randomized for tissue sampling either 0, 0.5, 1 or 2 h after
the end of infusion. At the beginning of TUR-P approximately
1 g of tissue was sampled for analysis. Concentrations of
moxiﬂoxacin in serum and tissue were determined by HPLC.
Results: 39 patients were evaluated in the study. The
concentrations (mean, SD, median, 25/75% quantile) are
shown in the table. The prostatic tissue concentrations of
moxiﬂoxacin were approximately twice as high as in serum.
At the end of infusion the tissue and serum concentrations were
already equilibrated, because the tissue-serum ratios did not
differ signiﬁcantly from the end of infusion until 2 h after the
end of infusion.
Conclusion: After an intravenous infusion of 400 mg the serum
and prostatic tissue concentrations of moxiﬂoxacin were well
above the MIC values of the most important prostatic pathogens
until 2 h after the end of infusion. Therefore, moxiﬂoxacin might
be a good alternative for the treatment of bacterial prostatitis
and/ or perioperative prophylaxis for TUR-P.
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FUO, soft tissue and miscellaneous infections
P1862
A prospective multi-centre study of the value of
F-18-ﬂuorodeoxyglucose positron emission
tomography as part of a structured diagnostic
protocol in patients with fever of unknown origin
C.P. Bleeker-Rovers, F.J. Vos, A.H. Mudde, A.S.M. Dofferhoff,
L.F. de Geus-Oei, A.J. Rijnders, P.F.M. Krabbe, F.H.M. Corstens,
W.J.G. Oyen, J.W.M. van der Meer\ (Nijmegen, Doetinchem,
Arnhem, NL)
Objectives: Infection accounts for about one-third of cases of
fever of unknown origin (FUO), which remains a major
diagnostic challenge. Recently, F-18-ﬂuorodeoxyglucose (FDG)
positron emission tomography (PET) has entered the ﬁeld of
clinical infectious diseases. FDG accumulates in tissues with a
high rate of glycolysis, which is present in malignant cells and in
all activated leukocytes. The aim of this prospective multi-centre
study was to validate the use of FDG-PET as part of a structured
diagnostic protocol in the general patient population with FUO.
Methods: From December 2003 to July 2005, 70 patients with
FUO, deﬁned according to the revised Petersdorf criteria, were
recruited from one university hospital and ﬁve community
hospitals. A structured diagnostic protocol was used. FDG-PET
was performed after certain obligatory laboratory tests, chest X-
ray and abdominal ultrasound. The ﬁnal clinical diagnosis was
used for comparison with the FDG-PET results.
Results: A ﬁnal diagnosis was established in 35 patients (50%):
12 infections, 5 malignancies, 16 non-infectious inﬂammatory
disorders and 2 miscellaneous causes. Of the total number of
FDG-PET-scans, 33% were helpful. Positive predictive value of
FDG-PET was 70% and negative predictive value was 95%.
FDG-PET was helpful in all patients diagnosed with an infection
except for one case of pyelonephritis. Contribution of FDG-PET
to the ﬁnal diagnosis did not differ signiﬁcantly between the
university hospital and the community hospitals. FDG-PET was
not helpful in any of the patients with normal erythrocyte
sedimentation rate (ESR) and C-reactive protein (CRP).
Conclusion: In addition to the apparent value of FDG-PET in
diagnosing different infectious diseases as described in several
case series, FDG-PET is a valuable imaging technique as part of
a diagnostic protocol in the general patient population with
FUO and a raised ESR or CRP. Based on previous studies
comparing Gallium-67-citrate or labelled leukocyte scintigraphy
and FDG-PET in patients with FUO and resulting from
favourable characteristics of FDG-PET, conventional
scintigraphic techniques may be replaced by FDG-PET in
institutions where PET is available.
P1863
Emergence of clindamycin-resistant Streptococcus
pyogenes causing cellulitis
C. Gudiol, J. Carratala, N. Fernandez-Sabe, R. Alfonso, L.
Calatayud, F. Tubau, C. Ardanuy, F. Gudiol (Barcelona, ES)
Objective: Clindamycin is recomended in combination with
penicillin for invasive infections due Streptococcus pyogenes such
as streptococcal toxic shock syndrome (STSS). The aim of our
study was to assess antimicrobial susceptibilities of S. pyogenes
isolated from patients with cellulitis.
Methods: Review of medical records of consecutive adults
hospitalized for community-acquired cellulitis from January
1995 to December 2004. HIV-infected patients and drug addicts
were excluded. Antimicrobial susceptibilities of all S. pyogenes
isolates were studied by microdilution method, and macrolide
resistance phenotype by double disc test. Macrolide resistance
genes were detected by PCR.
Results: Over the 10-year study period, there were 523 episodes
of cellulitis. The infection was microbiologically documented in
191 cases of whom 39 (7.5%) were caused by S. pyogenes (blood
cultures 21, needle aspiration culture 18, surgical sample culture
4). Antimicrobial susceptibilities of S. pyogenes isolates were:
penicillin 100%, erythromycin 85%, clindamycin 90%, and
ciproﬂoxacin 95%. Six (15%) S. pyogenes strains were
erythromycin-resistant; 2 had M phenotype (mefA+), 3 had
constitutive MLSB phenotype (ermB+) and 1 had inducible
MLSB phenotype (ermA+). Rates of S. pyogenes cellulitis due to
erythromycin-resistant strains increased signiﬁcantly, from 0 of
19 episodes from 1995 to 1999 to 6 of 20 (30%) episodes from
2000 to 2004 (p = 0.020). Of note, all 4 cases of cellulitis due to
clindamycin-resistant strains occurred during the last 3 years of
the study. Five (13%) patients presented with STSS and died (1
due to an erythromycin-resistant strain). Overall mortality
(<30 days) was 33% in patients with infections due to
erythromycin-resistant strains and 12% in the remaining
patients (p = 0.224).
Conclusion: Our study suggests that clindamycin-resistance
among S. pyogenes causing cellulitis may be increasing. This
resistance might become a problem when treating S. pyogenes
infections, especially STSS cases.
P1864
Risk factors for community-acquired bacteraemic
Gram-negative cellulitis
G. Peralta, E. Padro´n, M.P. Roiz, M.J. Rodriguez-Lera, I. De
Benito, L. Garcı´a-Maurin˜o, J.C. Garrido, L. Ansorena, M.J.
Grande, M.B. Sa´nchez (Torrelavega, Santander, ES)
Objectives: Empirical therapy in patients with cellulitis
frequently doesn’t cover Gram-negative bacteria so the
detection of these microorganisms in the blood cultures has
special therapeutic implications. However risk factors of
community adquired bacteremic Gram-negative cellulitis
(BGNC) are not well deﬁned in the literature. We explore risk
factors for BGNC.
Methods: To identify all cases of limb cellulitis attended at our
hospital emergency service between January 1997 and December
2004, an administrative database was used. Then we selected the
patients with blood cultures obtained at the time of the cellulitis
episode using the microbiology laboratory database.
Nosocomial cellulitis were excluded. A standardized data
collection form was used to review the hospital records. In
statistical analyses, Student‘s t test was used for the comparison
of mean values and chi square test and Fisher‘s exact test for the
comparison of categorical data (two tailed).
Results: Of the 2251 patients with limb cellulitis identiﬁed in
the study period, 301 patients had blood cultures and were
selected for the analysis. Bacteremia was detected in 59 of the
301 patients (19.6%), 15 of them due to Gram-negative
microorganisms. These microorganisms were: P. aeruginosa
(n = 3) (one of them mixed with S. aureus), P. multocida (n = 2),
Moraxella spp (n = 2), H. inﬂuenzae (n = 2), A. xylososidans
(n = 1), Acinetobacter spp (n = 1), E. coli (n = 1), K. pneumoniae
(n=1), E. aerogenes (n = 1), Leclercia adecarboxylata (n = 1).
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Statistical signiﬁcant differences were detected between patients
with and without BGNC in the proportion of patients older than
65 years (81.3% vs 42.5%), the antecedent of recent animal bite
(18.8% vs 0.7%), the presence of immunosuppression (12.5% vs
1.8%), the presence of haematological illness (12.5% vs 0.7%),
and the degree of leukocytosis at admission (8989 ± 3736 vs
12690 ± 6028 cel/lL).
Conclusions: BGNC is frequently detected in our patients. Age
older than 65 years, the existence of immunosuppression, the
existence of haematological illness, and the antecedent of animal
bite are more frequent among patients with BGNC. Patients
with BGNC had a lower degree of leukocytosis at admission.
These factors should be borne in mind to select empiric therapy
for patients with cellulitis.
P1865
Is erysipelas-associated Tinea pedis a site of
streptococcal colonisation?
L. Hocqueloux, L. Bret, M. Niang, D.M. Poisson (Orleans, FR)
Objectives: Tinea pedis is considered the most frequent portal of
entry of erysipelas of legs (SEL) but whether it is the site of
streptococcal colonisation is unknown.
Methods: From June to October 2005 we prospectively searched
for clinical Tinea pedis in patients hospitalised in our infectious
diseases ward for SEL (acute and unilateral feature with fever
were only retained). All patients had bacteriological samples on
inter-digital spaces of both feet (SEL side and contra lateral
side).
Results: Fifteen patients were included. All but one were
treated by intra-venous Penicillin-G followed by oral
amoxicillin. On SEL side: Tinea pedis was found in 10/15 (67%)
and, when present, streptococcal colonisation (C or G
streptococcal groups) was found in 7/10 (70%), although
streptococcal colonisation was never found (0/5) in its
absence. On contra lateral sides : no streptococcal colonisation
was found without Tinea pedis, which was observed in 7/15,
with streptococcal colonisation in 6/7. Then there is a strength
statistical association between streptococcal colonisation and
Tinea pedis, on SEL side (p = 0.025) as well as on contra lateral
side (p = 0.003). In one patient blood-cultures yielded with the
same Streptococcus than found in foot samples.
Discussion: Streptococcal colonisation of Tinea pedis is a
common ﬁnding on both feet of patients hospitalised for SEL.
Whether inter-digital colonisation is a primary stage of invasive
disease remains unproved. In our experience, a strain of
Streptococcus that colonised inter-digital space was isolated in
patient’s blood, suggesting this hypothesis may be true in some
cases. If conﬁrmed, this concept could lead to a new strategy for
secondary prophylaxis of recurrent SEL by decontaminating
streptococcal colonisation of Tinea pedis.
Conclusion: Patients hospitalised for SEL with Tinea pedis often
exhibit streptococcal colonisation of feet’s inter-digital spaces.
Curiously C and G groups, but no A group, are over-
represented in this setting.
P1866
Bacteriology of acute erysipelas
T. Siljander, S. Va¨ha¨kuopus, M. Karppelin, J. Syrja¨nen, M.
Toropainen, J. Kere, J. Vuopio-Varkila (Helsinki, Tampere, FI;
Huddinge, SE)
Objectives: This study aims at identifying individuals and
families suffering from acute erysipelas and streptococcal
infections and focuses on the molecular properties of
streptococci involved in infections and carriage.
Methods: From March 2004 to March 2005, 90 patients with 98
disease episodes presenting with acute erysipelas and 89 age
and sex matched control subjects were recruited, interviewed
and clinically examined at Tampere University Hospital. In
addition, 48 family members and other relatives were recruited.
Bacterial swabs were taken from throat and from the affected
skin of index patients (blisters, wounds or abrasions). From the
samples, betahemolytic streptococci and S. aureus were isolated
and identiﬁed. The streptococci were classiﬁed for their group
antigens (A, C, F and G), the species was determined and the
isolates were emm sequenced and T-serotyped when possible.
Results: From the 235 throat samples, betahemolytic streptococci
or S. aureus grew in 19% (19/98) of index patients, 31% (12/39)
of their household members, 11% (1/9) of other relatives and
16% (14/89) of control subjects. Streptococcus group G (GGS, 6/
19), A (GAS, 2/19) and F (2/19) were more frequently found in
the throat samples of index patients. Similarly, in the household
members’ samples GGS (5/12) was found more commonly. In
contrast, in controls’ samples GGS was missing. Of the 73 skin
samples from index patients, 48% were culture positive and of
these groups G (18/35, 51%), A (5/35, 14%) and G + A (1/35,
3%) were found either alone or in combination with S. aureus.
Among GGS, 11 different emm types were found; stG6, stG480
and stG643 predominated. Among GAS, 8 types were found,
emm81 predominated. One patient had the same GGS isolate in
throat and skin. Six patients had recurrent infections during the
study; two of them with 3 disease episodes. Of the 35 culture
positive skin samples, 12 were taken from the erysipelas
infection focus (42% positive for GGS) and 23 from another
site (61% positive for GGS), e.g. wound, intertrigo, between toes
or an unknown site.
Conclusion: A predominance of GGS was seen in the throat of
erysipelas patients and their families whereas GGS was not
present in control subjects. GGS, instead of GAS, also seems to
predominate in erysipelas skin lesions. Several emm types were
present in both groups and there was no clear predominance of
a distinct type. The recurrent nature of erysipelas became
evident also during this study.
P1867
The evaluation of Fournier’s gangrene severity
index score in 11 patients
M. Ulug, M.K. Celen, M.F. Geyik, C. Ayaz, S. Girgin (Diyarbakir,
TR)
Objectives: Fournier’s gangrene is synergistic necrotizing
fasciitis of the perineum and abdominal wall along with the
scrotum and penis in men and the vulva in women. It is rare but
life-threatening process. In this study we identify effective
factors in the survival of patients with fournier’s gangrene and
to determine the accuracy of the fournier’s gangrene severity
index score (FGSIS).
Methods: We evaluate 11 patients with fournier’s gangrene
who were threated and follewed up from us between January
2005 and September 2005 in the department of General Surgery
prospectively.
Results: The results were evaluated in two groups: those who
died (n: 3) and those who survived (n: 8). No statiscally
signiﬁcant difference was found between the age of the
survivors and those who died. The admission and ﬁnal
laboratory parameters that correlated statiscally signiniﬁcant
with outcome includes leucocyte count, hematocrit, urea,
creatinine, lactate dehydrogenase, bicarbonate and albumin.
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The mean FGSIS for survivors was 2.1 ± 1.3 compared with
14.3 ± 4.6 for nonsurvivors. There was a strong correlation
between the FGSIS and the death rate (p¡U¨ 0.0001). Pseudomonas
aeruginosa was isolated from wound cultures in nonsurvivors.
Conclusion: Fournier’s gangrene is an infectious disease
affecting on ever aging population of patients. Patients
metabolic status and the extent of disease at presentation ia an
important factor in the prognosis of Fournier’s gangrene.
Because of this reason the FGSIS be used clinically to evaluate
the therapeutic options and asses the results.
P1868
Clinical outcomes of Staphylococcus aureus
infections in the community
S. Davis, M. Perri, A. Singh, K. Spiers, M. Hayden, R. Muder, M.
Zervos (Detroit, Royal Oak, Chicago, Pittsburgh, US)
Background: The purpose of this study is to gain a better
understanding of the clinical outcomes of community associated
MRSA (CA-MRSA).
Methods: Over a 2 year period (October, 2003 – 2005) patients
with S. aureus infections originating in the community were
identiﬁed. Data was extracted from medical records and patient
interviews. Outcomes of patients with CA-MRSA, health care
associated MRSA (HA-MRSA) and community associated
MSSA (CA-MSSA) were compared.
Results: Patients with CA-MRSA (n = 102), HA-MRSA
(n = 102) and CA-MSSA (n = 102) had a median age of 46, 62
and 52 respectively (p < 0.001). Sites of culture were skin/soft
tissue (75, 74 and 92%), respiratory tract (3, 4, and 3%), blood (4,
7 and 1%), urine (3, 11 and 0%), and other (3, 2 and 2%). 30-day
mortality was 0% in this population. 50% of patients received
antibiotic therapy alone, 5% surgery alone, 30%
antibiotics + surgery, 3% other therapy, and 12% no treatment.
The most common antimicrobial classes received were
vancomycin (27%), beta-lactams (23), ﬂuoroquinolones (11),
and cotrimoxazole (10) with 14% of patients receiving multiple
agents. Median duration of antibiotic therapy was 12, 15, and
10 days, in the CA-MRSA, HA-MRSA and CA-MSSA groups
respectively. 47, 82, and 57% received adequate antimicrobial
therapy (p < 0.001). Hospital admission was required in 46, 57,
and 17% of patients (p < 0.001). Clinical success rates of initial
therapy were 61, 63, and 84% (p < 001), and recurrences were
more common in the CA-MRSA group, (18, 0, and 6%, p < 001).
Characteristics associated with outcome are listed in Table 1. In
multivariate analysis, presence of MRSA and diabetes were
predictive of clinical failure.
Conclusion: In the community setting, MRSA infections are
associated with an adverse impact on outcome compared to
MSSA infections and patients with CA-MRSA are signiﬁcantly
less likely to receive adequate antibiotic therapy.
P1869
Microbiological analysis of root canals associated
with periapical abscesses and the antimicrobial
susceptibility of isolated bacteria
S. Ozbek, A. Ozbek, M. Koseoglu, S. Evcil, A. Erdogan,
A. Ayyildiz (Erzurum, TR)
Objective: The periapical abscess is a collection of pus in the
pulp or around the root of teeth. Many odontogenic infections
can be managed without antimicrobial therapy or bacteriologic
investigation. However, when an acute bacterial infection has
progressed or antimicrobial therapy might be of beneﬁt to
patients, antibiotics are prescribed. We aimed to identify
microorganisms in root canals with periapical abscess and the
antimicrobial susceptibility proﬁle of them and to revise
antimicrobial treatment protocols when antimicrobials is used
empirically.
Methods: 30 patients with odontogenic infections included in
this study. The microbiologic investigation was performed
under strict aseptic conditions. A standardize routine of root
canal therapy was instituted, and in each case a single root canal
was sampled. In multirooted teeth only the largest canal was
sampled to preserve the identity of a single endodontic/
microbiologic ecosystem. For microbial sampling, two
sequential paper points were introduced into the full length of
the canal, and kept in place for 1 min. One of the paper points
was used for aerobic culture and the other one for anaerobic
culture. To identify isolated bacteria, whole bacterial fatty acid
proﬁles were evaluated by using Microbial Identiﬁcation
System. Antimicrobial susceptibility results were obtained by
disc diffusion test for aerobics, and E-test for anaerobics.
Results: Totally 156 bacterial strains were isolated. 86 of them
were aerobic and 70 of them were anaerobic. 18 or 60% of
cultured specimens yielded mixed (aerobic and anaerobic)
species. The most prevalent bacteria were Staphylococcus spp.
as aerobic, Peptostreptococcus prevotii and Streptococcus
morbillorum as anaerobic.
Conclusion: Beta-lactam antibiotics combined with beta-lactam
inhibitor (amoxicillin-clavulanic acid) had a quite effect on
Gram (+) and (–) aerobics. When we take into consideration that
beta-lactam antibiotics stimulate production of beta-lactamase,
amoxicillin-clavulanic acid combination appears a good ﬁrst
step antimicrobial. Clindamycin may be second alternative for
that purpose. For anaerobics, cefoxitin and metronidazol had
well effect. Although imipenem and piperasilin-tazobactam are
perfect, they should not be ﬁrst step of therapy. Due to the
frequency of mixed infections, a combination of amoxicillin-
clavulanic acid and metronidazol or a combination of
clindamycin and metronidazol considered to have well effect
for mixed infections.
P1870
Human infections due to Pasteurella multocida in
a tertiary care hospital: a 12-year review
A. Christidou, S. Maraki, Z. Gitti, K. Magurean-Zervaki, Y.
Tselentis (Heraklion, GR)
Objective: P. multocida infections in humans are well known as
animal derived infections. The purpose of this retrospective
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study is to review the spectrum of P. multocida infections in our
centre.
Methods: We studied the medical records of all patients who
had positive cultures for P. multocida between 1993 and 2004.
Demographic, epidemiological, clinical and microbiological data
including age, sex, animal exposure, site of infection, underlying
diseases, type of therapy and outcome were evaluated. All
isolates were identiﬁed by standard conventional
microbiological methods. Antibiotic susceptibility testing was
performed by the disk diffusion method onto Muller-Hinton
agar supplemented with 5% sheep blood and the MICs of the
antibiotics tested were determined by the E-test method.
Results: Thirteen cases of P. multocida infections were
diagnosed during this period. The male to female ratio was
10:3 and most patients (62%) were >70 years of age. Respiratory
tract infections were most commonly encountered (61.5%),
followed by soft-tissue infections (30.8%) and septicemia
(7.7%). Underlying disease was present in 8 (61.5%) patients.
Among them, 4 presented a kind of malignancy. Bullous
pemphigoid, mitral valve stenosis, coronary disease, chronic
obstructive pulmonary disease, and intracranial haemorrhage
served also as predisponding factors. A traumatic animal
exposure was reported in only 3 patients and non-traumatic in
2 cases. All isolates were susceptible to beta-lactams (penicillin,
amoxicillin, amoxicillin/clavulanic acid, cefepime, cefuroxime,
ceftriaxone, imipenem, and meropenem), quinolones
(ciproﬂoxacin, norﬂoxacin, levoﬂoxacin, and sparﬂoxacin),
chloramphenicol, tetracycline, trimethoprim/sulfamethoxazole
and 54% were intermediately resistant to aminoglycosides
(gentamicin). Appropriate antibiotic therapy was administered
to all patients and a clinical response was observed in 10 (77%)
of them. Mortality rate was 23%.
Conclusions: Pasteurella multocida must be considered as a
possible etiology for a variety of infections, even without an
obvious animal exposure. Although this organism is susceptible
to a large spectrum of antibiotics, a failure to treatment may be
recorded especially in severe infections and in compromised
patients.
P1871
Infections caused by Nocardia cyriacigeorgici in
Zaragoza, Spain: identiﬁcation and antibiotic
susceptibility
C. Villuendas, B. Moles, V. Rodriguez-Nava, A. Couble, F.
Laurent, M. Revillo, P. Boiron (Zaragoza, ES; Lyon, FR)
Objectives: Nocardia species known to date differ in their
clinical presentation, antibiotic resistance patterns and
geographic distribution. Nocardia cyriacigeorgici is a recently
described species.The aim of this study is to analyse the
identiﬁcation results, antimicrobial susceptibility together with
the clinical data, of 13 N. cyriacigeorgici clinical isolates,
recovered from 1998 to 2004 in our laboratory.
Methods: Identiﬁcation ofNocardia spp. isolates was achieved in
our laboratory on the basis of the following: visualization of the
colony, Gram stain and parcial acid-fast positivity by modiﬁed
acid-fast staining, casein, xanthine and tyrosine hydrolysis,
opaciﬁcation of Middlebrook 7H10 agar, production of
arylsulphatase after 14 days incubation and antimicrobial
susceptibility pattern.Identiﬁcation at species level was
achieved by 16S rDNA gene sequencing (Laboratoire de
Mycologie. Faculte´ de Pharmacie. Lyon. France)Antimicrobial
susceptibility tests included commercial broth microdilution
(EMIZA 9 EF Sensititre) and gradient strip agar dilution (E-test
AB Biodisk). Interpretation of results was done according to
NCCLS standard guidelines.
Results: In the six years of study, 129 isolates of Nocardia spp.
were recovered, 13 of them belonging to N. cyriacigeorgici species
(10%). N. cyriacigeorgici represents the third species in frecuency
in our serie, after N. abscessus and N. farcinica. The 13 strains
were recovered from 13 patients, 12 from respiratory specimens
and one from blood-culture.Pneumonia was the most frequent
clinical manifestation, being COPD and previous corticosteroid
therapy the most common predisposing conditions. All N.
cyriacigeorgici isolates showed susceptibility to: amikacin,
tobramycin, cefotaxime, imipenem, trimethoprim-
sulfamethoxazole and linezolid, and resistance to: amoxicillin-
clavulanic acid and ciproﬂoxacine.
Conclusion: N. cyriacigeorgici is not an infrequent cause of
nocardiosis in our geographical area. The uniformity showed in
the antimicrobial proﬁle can be useful for it´s identiﬁcation. In
our hospital, patients with COPD and receiving corticoid
therapy is the most important group of risk for adquiring N.
cyriacigeorgici infection. Whit the technics available in our
laboratory the isolates were identiﬁed as Nocardia spp. and
identiﬁcation at species level was only possible by phylogenetic
analysis using 16 rDNA sequencing.
P1872
High frequency of single-step resistance
mutations in Nocardia farcinica exposed to
quinolones
U.S. Jensen, J.D. Knudsen, K. Schønning (Hvidovre, DK)
Objectives: Nocardia farcinica infections often require prolonged
antibiotic therapy and perorally administered agents are
desirable. Isolates commonly display in vitro susceptibility to
quinolones when tested by disc diffusion methodology. In the
present study, we investigated the activity of three different
quinolones (ciproﬂoxacin, levoﬂoxacin and moxiﬂoxacin)
against N. farcinica and assessed the robustness of their
activity by determining the frequency of single step resistant
mutants when exposed to inhibitory concentrations of
quinolones.
Methods: 10 isolates of N. farcinica were used in the study;
correct identiﬁcation to the species level was veriﬁed by 16S
rDNA sequencing. MICs of ciproﬂoxacin, levoﬂoxacin and
moxiﬂoxacin against N. farcinica as well as S. aureus ATCC
25923 and E. coli CCUG 17620 were determined by the agar
dilution method using inocula of approximately 10.000 CFU and
48 h of incubation. Single step mutation frequencies were
determined by heavily inoculating selective agar plates
containing quinolone at a concentration of 4x MIC and
counting resistant colonies after 5 days incubation. Inoculum
was quantiﬁed by seeding a dilution series of the inoculum
employed on unselective plates and counting colonies after 48 h
of incubation and frequencies were calculated by dividing the
number of resistant colonies by the number of CFU present in
inoculum.
Results: When MICs were determined by agar dilution method
all quinolones displayed roughly the same potency against N.
farcinica isolates (MICs between 0.25 and 4). As expected
moxiﬂoxacin were the most potent quinolone against S. aureus.
However, all three quinolones selected for single step resistant
mutants, the frequency of which was higher for ciproﬂoxacin
(~10)6) than for levoﬂoxacin (10)7–10)8), which again was
higher than for moxiﬂoxacin (10)8–10)9). However, even for
moxiﬂoxacin the frequency against N. farcinica was comparable
to the single step mutation frequency of ciproﬂoxacin against S.
aureus (10–9).
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Conclusions: Although quinolones may exhibit activity against
N. farcinica, N. farcinica is capable of rapid development of
resistance. Therefore, quinolones should probably be avoided, at
least as single agents, in the treatment of Nocardia infections.
P1873
Correlation between clinico-laboratory ﬁndings
and a positive IgM ELISA test for leptospira: a
retrospective study
E. Mendrinou, P. Goudas, A. Regli (Patra, GR)
Objective: To correlate a positive Elisa test for IgM antibodies
against Leptospira with the clinical and laboratory ﬁndings in
patients with suspected Leptospirosis.
Method: We retrospectively analysed the history, clinical
course and laboratory ﬁndings in a total of 420 patients, with
suspected Leptospirosis. All patients fulﬁlled the criteria for
clinical diagnosis of Leptospirosis. From the 420 patients, 21 had
to be transferred to the dialysis unit for haemodialysis and 6
patients had to be admitted to the Intensive Care Unit (ICU) due
to severe pulmonary haemorrhage. Serum samples from all
patients were tested for IgM antibodies against Leptospira.
Results: From the total of 420 patients death occurred to only
four, due to respiratory failure from severe pulmonary
haemorrhage. The rest of the patients recovered completely.
From the total of 420 patients 25 had a positive Elisa IgM test for
Leptospirosis (5.95%). However, from the 21 patients that were
transferred to the dialysis unit, 8 had a positive Leptospirosis
test (25%) and from the six patients admitted to the ICU, three
had a positive test (50%). Among other laboratory ﬁndings there
was a stronger correlation between very low platelet levels
(<30.000 mm3) and very high blood bilirubin levels (>20 mg/dl)
with a positive test for Leptospirosis. All 25 patients with a
positive test had less than 30.000 platelets per mm3 and 18 had
blood bilirubin over 20 mg/dl. The differential diagnosis of
icterohemorrhagic fevers includes a vast number of pathogens,
some of which are untraceable with the common laboratory
methods. In our study, from the total of 420 patients, only 5.95%
had a positive test for Leptospirosis. In 92 of the rest 395
patients, many different pathogens were traced, most of them
being several kinds of viruses (CMV, EBV), Brucella and Coxiella.
In 303 of the patients no pathogen was traced.
Conclusions: Taking into consideration the high sensitivity of
the Elisa test we conclude that: 1. Icterohemorrhagic
Leptospirosis comprises only a small subtotal of
icterohemorrhagic fevers; 2. There is a correlation between
higher levels of bilirubin and/or very low platelet levels with
Leptospira infection; 3. There seems to be a correlation between
Leptospira infection and severity of icterohemorrhagic fevers.
P1874
Evaluation of continuous ambulatory peritoneal
dialysis-related peritonitis attacks in Ankara
S. Tekin Koruk, M.A. Yetkin, I. Koruk, F.S. Erdinc, S. Sahan, N.
Tulek, M. Duranay, A.P. Demiro¨z (Ankara, Konya, Samsun, TR)
Objectives: Peritonitis is a common clinical problem that occurs
in patients with end stage renal disease treated by peritoneal
dialysis. The aims of this study were to assess demographic
aspects, rates of peritonitis, causative organisms, clinical
outcomes and treatment approach for continuous ambulatory
peritoneal dialysis (CAPD) -related peritonitis cases.
Methods: Seventy cases of peritonitis occurred in 55 patients
treated in Infectious Diseases and Clinical Microbiology
Department between May 2003 and April 2004 were enrolled
into this study. The mean age of the patients was 48.4 years
(range 16–77 years). Cloudiness of the peritoneal dialysis ﬂuid
and/or abdominal pain were considered suggestive of
peritonitis and were conﬁrmed by cell count and culture.
Baseline cell count, Gram stain, and cultures were obtained, and
repeated with periodic follow-up.
Results: The overall incidence of peritonitis was 2.5 ± 2.5
episodes/patient-year. In 52.7% of patients there were only
one peritonitis attack, where as in 47.3% of them had two or
more attacks. Age, gender, education and profession of the
patients have not been found as a risk factor in peritonitis
attacks.The most common presenting symptoms of the patients
were abdominal pain, cloudiness of the peritoneal dialysis ﬂuid,
nausea and vomiting. Peritoneal dialysate ﬂuid white blood cell
count was 1773 ± 1224/mm3 in 70 episodes. Cultures were
positive in 51 (72.9%) peritonitis episodes; coagulase-negative
staphylococci was the most common organism (%22.8), followed
by Staphylococcus aureus (%21.4), 19 episodes (%27.2) had
negative culture results. There was a statistically signiﬁcant
decrease in serum CRP and ESR levels and at the end of the
treatment when compared with the levels on admission.At the
end of the study, 61 episodes of 70 peritonitis cases were treated
with IP cefazolin and gentamicin protocol. Seven of the patients
did not respond initiate therapy and the therapy was converted
to IV protocol. Seven episodes were treated with IV antibiotics
on admission for medical reasons (systemic infection and/or
concurrent exit-side or tunnel infection). There were two deaths.
Two catheters were removed and the patients were transferred
to haemodialysis programme.
Conclusion: Despite all technical improvements during recent
decades peritonitis is still the major complication of CAPD. For
the accurate treatment of complications, causative organisms
and their antimicrobial susceptibilities must be known.
Paediatric viral infections
P1875
Particularities of measles outbreak in Constanta,
Romania
C.S. Cambrea, S. Rugina, M. Ilie, C. Marcas, D. Tanase, I. Cretu,
C.N. Rugina (Constanta, RO)
Background: In Romania Measles vaccination is included in
National Program of Vaccination, but in nomad collectivities
(gipsy) the program of vaccination it’s very difﬁcult to apply. In
the last 6 years in Constanta County we didn’t noticed any case
of measles, but starting June 2005 appeared an increasing
number of children with measles.
Objective: To present some particular aspects of measles
outbreak which starts 6 months ago.
Material and method: We performed a prospective and
retrospective study about children hospitalised in Children
Infectious Diseases Department of Constanta Infectious Diseases
Clinical Hospital.
Results: Over a period of 5th and half months we hospitalised
in our department 628 cases of children with measles. The
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evolution on months was: 26 cases in June, 85 cases in July, 123
cases on September, 209 cases on October and 146 cases in the
ﬁrst 15 days of November. The age of children was between
2 months and 11 years, but the majority (91.56%) was less than
2 years old. The majority (95.38%) were gipsy children. Children
from family foci were also majority (82.48%). Clinical diagnosis
was conﬁrmed by serological diagnosis in all cases. The most
frequent complication was: pneumonia and bronchopneumonia
(96.97%), hepatic injury (62.73%), and laryngitis (34.23%).
Hemorrhagic rash was present in 4.14% cases. Koplick spot
was found in 74.56% cases. Measles was associated with
Streptococcal tonsillitis in 47.92% cases, with oral candidiasis
in 20.22% cases and with pulmonary tuberculosis in 8.12% cases.
Severe forms of evolution were observed in complicated cases
with: encephalitis (0.79%) or bronchopneumonia (5.89%), which
required intensive care unit survey. We registered only one
deceased, in a case of measles encephalitis; this child presented
also pulmonary tuberculosis.
Conclusions: The majority of cases were among gipsy children
and presented slight and medium forms of evolution (93.31%).
In gipsy collectivities even it’s very difﬁcult, it’s necessary to
perform a better epidemiological survey for correct
implementation of vaccination program.
P1877
Human metapneumovirus infection in children
presenting to hospital in Belfast
E. McHenry, P.V. Coyle, P. Jackson, M. Shields (Belfast, UK)
Objectives: Acute respiratory tract infections are a major cause
of morbidity and mortality worldwide, however 15–35% of cases
of bronchiolitis and pneumonia in children are of uncertain
aetiology. hMPV is a recently described respiratory pathogen
belonging to the same Paramyxoviridae family as respiratory
syncytial virus (RSV). We aimed to describe the local
epidemiology of paediatric hMPV infections and assess the
impact of the routine use of a multiplexed reverse-transcriptase
polymerase chain reaction method for virus detection from
respiratory samples, which was introduced in July 2003.
Methods: A retrospective computer and chart audit of all
children attending the Royal Belfast Hospital for Sick Children
who tested positive for hMPV from July 2003 to July 2004 was
performed. Respiratory samples were tested routinely for
twelve common respiratory pathogens.
Results: Over the study period, of 587 samples processed, 40
patients tested positive for hMPV with 39 case notes available
for inspection. Median age was 6 months (range 3 weeks to 13
years). Thirty-six cases were community-acquired and 23 (60%)
patients had signiﬁcant co-morbidities. Cough was the
predominant reported symptom. Chest X-Ray was performed
in 31 cases, of which 28 showed abnormalities. Bronchiolitis (22/
39) was the commonest initial clinical diagnosis. The majority
(69%) of patients received antibiotic therapy, but a convincing
bacterial pathogen was isolated in less than half of these cases.
Thirty patients were admitted for management. More than one
virus was identiﬁed from 14 patients, with rhinovirus being the
predominant co-infection. Overall, the average length of stay
was 6.6 days. However, where hMPV was the sole pathogen
identiﬁed, average length of stay was 3.1 days.
Conclusion: Our data suggests that hMPV infections are more
common in children with underlying co-morbidities. The rate of
radiological imaging was higher than expected and perhaps is a
reﬂection of the patient population or the degree of severity of
illness. Nosocomial acquisition occurred in 3 cases, which has
implications for patient cohorting. Effective diagnosis of viral
respiratory pathogens is necessary to elucidate their
epidemiology and assess clinical impact. Moreover, such data
is crucial for effective infection control in hospitals and may
ultimately allow more rational prescribing of antibiotics.
P1878
Prevalence of parainﬂuenza and inﬂuenza viruses
amongst children with upper respiratory tract
infection
U. Arslan, D. Findik, I. Tuncer (Konya, TR)
Objective: Viruses are a frequent cause of upper respiratory
tract infections in children. Among the respiratory viruses,
inﬂuenza viruses are known to cause outbreaks globally. The
present study was carried out to identify the inﬂuenza virus
serotypes causing acute respiratory infection in children
attending univesity hospital in Konya in Turkey.
Methods: Thorat swabs were collected from 117 acute viral
upper respiratory infection suspected children attending the
out patient clinic of Meram Medical Faculty Hospital. Two
swabs were taken fron each chidren and one of the swabs was
used for bacteriological cultures and if these were negative the
other one was used for viral diagnosis. Totally 100
bacteriological cultures negative swabs were investigated by
Real-time PCR for the presence of Parainﬂuenza 1, 2 and 3,
Inﬂuenza A and B.
Results: One or more viral pathogens were detected in 24
children, with Parainﬂuenza 1 9% being the most commonly
identiﬁed virus. Parainﬂuenza 2 in 7% and Parainﬂuenza 3 in
5%, Inﬂuenza A were identiﬁed in 5% and Inﬂuenza B in 1%.
From the specimens of 3 children more than one virus detected.
Conclusion: The inﬂuenza viruses cause morbidity and
mortality among children and elderly. This study analysed the
occurrence of inﬂuenza and paranﬂuenza respiratory ifections
due to inﬂuenza and paranﬂuenza viruses. Molecular methods
used directly on clinical material have an important role in the
rapid diagnosis and surveillance of inﬂuenza viruses and can be
applied in clinical practice for correct diagnosis and
administration of effective treatment.
P1879
Clinical features of children with adenovirus
serotype 3 infection
C-H. Lin, Y-C. Huang, C-G. Huang, T-Y. Lin, T-Y. Lin
(Kweishan, Taoyuan, TW)
Purpose: To deﬁne clinical manifestations and laboratory
ﬁndings of children with adenovirus serotype 3 infection.
Materials and Methods: A total of 499 children with a
diagnosis of adenovirus infection based on throat virus culture
were treated in Chang Gung Children’s Hospital from January
2004 to May 2005. Serotypes were determined in 197 strains. One
hundred and forty-seven of them were serotype 3. The other
serotypes included serotypes 1, 2, 5, 6, 7, 8 and 35. The
demographics, clinical presentations and laboratory ﬁndings of
the 147 patients with serotype 3 were presented.
Results: The mean age was 4 y7 m, ranging from 5 months to
12 y2 m. Seventy percents of children with serotype 3 infection
clustered between October 2004 and January 2005. The mean
duration of a positive culture result was 8.5 days. The mean
duration of fever was 6.0 days, with 4 days before admission.
Forty (27%) childrenwere treated as outpatients. Themean length
of hospital staywas 5.4 days. The 3most commondiagnoseswere
exudative tonsillitis (25%), pneumonia or bronchopneumonia
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(24%) andpharyngoconjunctival fever (12%). The 3most common
symptoms and signs were fever (100%), cough (88%) and coryza
(74%). Neurologic complications were noted in 2 children.
Eighteen children had documented coinfection (including virus,
bacteria and Mycoplasma pneumoniae). Leukopenia
(WBC < 5000/microliter) was noted in two of 111 cases while
leukocytosis (WBC > 15000/microliter) in 32 (29%). Six (5.5%) of
110 cases had a normal serum C-reactive protein (CRP) level
(<10 mg/L), while 80% of 110 children had a serum CRP greater
than 40 mg/L. Seventy (47.6%) of 147 children ever received
antibiotics therapy. The outcomes were excellent in these cases.
Conclusion: Recognizing that children with adenoviral
serotype 3 infection may present with prolonged high fever,
leukocytosis and elevated CRP, which mimics bacterial
infection, the clinician may not prescribe unnecessary
antibiotics for these children.
P1880
Infectious mononucleosis-like syndrome in a
children’s hospital in Greece
I. Varzakakos, K. Papavsileiou, H. Papavasileiou, A. Makri,
D. Sbokou, Z. Karakatsani, A. Voyatzi (Athens, GR)
The Infectious Mononucleosis like syndrome (IM) is an acute
febrile disease of older children and young adults, and is
characterized by lymphadenopathy, tonsillitis, splenomegaly,
liver dysfunction and by the presence of peripheral lymphocy-
tosis with >10% atypical lymphocytes. Epstein –Barr virus (EBV)
is responsible for over 90% of the cases, Cytomegalovirus (CMV)
for 5%–7% and Toxoplasma gondii <1%.Herpes simplex, rubella
and adenovirus are rare. The infection is usually characterized
by mild symptoms. However in some cases the clinical
manifestations may be rather atypical and severe.
Objective: To determine the prevalence of IM like syndrome
among patients in a children’s hospital and its possible
association with etiologic factors, age, major symptoms and
atypical manifestations.
Material and methods: During a one-year period (January to
December 2004) a total of 700 samples were examined in our
laboratory. The study population was children between 1–
15 years old, which either examined in the outpatient’s clinic or
hospitalized. All serum specimens were examined by1. Indirect
Immunoﬂuorescence for the presence of IgG and IgM antibodies
against the viral capsid antigen (VCA) EBV, 2.Immuno
Chemistry luminescence for the detection of IgG and IgM
antibodies to CMV and 3.EIA for the detection of IgG,IgM abs of
Herpes simplex I and II and Toxoplasma gondii.
Results: Of the 700 children examined 43 (6.1%) were found
positive for IgG and IgM VCA antibodies and 28(4%) showed
positive speciﬁc IgG and IgM antibodies for CMV. These
patients had one or more of the primary following symptoms:
fever (87%), lymphadenopathy (80%), pharyngalgia (50%),
cough (15%), skin eruption (9%). Atypical manifestations as
meningoencephalitis were found in two children one aged
20 months (caused by EBV) and the other of 7 years old (caused
by HSV I) conﬁrmed by PCR. The laboratory data showed
positive serology for EBV and CMV infection, the existence of
atypical lymphocyte (76%), LDH, ASAT and ALAT were
moderately elevated (44 %) and CRP increased (18%).
Conclusion: The frequency of IM like syndrome in Greece,
though it’s relatively low, it’s not rare. The above results
suggested that EBV, CMV, HSV should be considered in any
young patient with IM and acute neurological illness of
uncertain etiology.
P1881
Detection of enterovirus, parvovirus B19 and
human herpes virus type 6 by real-time PCR in
blood samples of infants with febrile syndrome
M. Garcı´a-A´lvarez, M.D. Folgueira, C. Prieto, M.J. Babiano,
P. Rojo, J.R. Otero (Madrid, ES)
Objectives: Enterovirus, parvovirus B19 and human herpes
virus type 6 (HHV-6) are a common cause of infection in young
infants. The objective of this study was to determine what
portion of the infants who received a clinical diagnosis of febrile
syndrome have a viral etiology by these three genera of viruses.
Methods: Ninety-six patients were included in the study, all of
them were admitted to the pediatric casualty of a tertiary care
hospital, and all of them presented a febrile syndrome without a
clear focus of infection (urinary tract, lung and meningeal
infections were discarded). The assay was carried out in 96
blood samples by real-time PCR. DNA was isolated from 200 ll
of blood by semi-automated system MagNA Pure LC Total
Nucleic Acid Isolation kit (Roche Diagnostics, Nederland BV).
PCR was performed in a LightCycler instrument (Roche
Molecular Biochemicals) by a uniform cycling parameters:
10 min at 95C for polymerase activation, and 50 cycles of 15 s
at 95C and 60 s at 60C for ampliﬁcation of the speciﬁc target
sequence (5 UTR gene for enterovirus, VP2 gene for parvovirus
B19 and DNA polymerase gene for HHV-6). PCR product
formation was detected continuously by the use of TaqMan
probes.
Results: A viral ampliﬁcation was detected in 52 (54%) of the 96
patients included in this study. Enterovirus was detected in 12
(12.5%) of the patients, parvovirus B19 in 10 (10.4%) and HHV-6
in 35 (36.4%). In ﬁve cases two viral ampliﬁcations were
detected at the same time: 3 parvovirus B19/HHV-6 and 2
enterovirus/HHV-6. The mean age of the patients was 2 years
old (range from 24 days to 14 years). In group of infants
<6 months old (n = 27) there were 7 enterovirus and 6 HHV-6.
In the infants from 7 months to 3 years old (n = 53) there were 3
enterovirus, 3 parvovirus and 24 HHV-6. In the last group of
infants >3 years old (n = 16) there were 2 enterovirus and 7
parvovirus B19.
Conclusions: Viral infections are an important cause of sepsis
in infants admitted to hospital. Enterovirus was the most
frequent virus detected in infants <6 months, parvovirus B19
the most frequent in children >3 years old, and the HHV-6 was
detected in all age groups. Qualitative real-time PCR in blood is
a rapid and sensitive method for diagnosis of enterovirus and
parvovirus. However, is not the better method for diagnosis of
HHV-6, a latent virus, in which this technique is not capable of
distinguish between recent and acute infection.
P1882
Molecular epidemiology and clinical features of
rotavirus infection in Iranian children
M. Taremi, F. Farahtaj, L. Gachkar, E. Mazaheri Tehrani,
H. Edalatkhah, A. Fayaz, M. Zali (Tehran, IR)
Objectives: Group A rotaviruses are a major cause of acute
gastroenteritis in infant and young children worldwide. In this
study, the molecular epidemiology and clinical features of
rotavirus infection in Iranian children was investigated.
Methods: Between February 2004 to January 2005, thirty
hundred and seventy two diarrhoea stools from children
under 5-years-old with acute diarrhoea that attended the
biggest paediatric hospital in Tehran (Iran), were analysed
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using ELISA, electropherotyping and reverse transcription-
polymerase chain reaction (RT-PCR).
Results: Ninety-four samples (25.3%) were positive for the
presence of rotavirus either by PAGE, ELISA, or both.
According to PAGE, the predominant electrophoretic pattern
detected was the long proﬁle 62 of 67 (92.5%) followed by the
short electropherotype ﬁve of 67 (7.5%). Out of the positive
samples, 49 were further characterized by RT-PCR typing assay
for identiﬁcation of G types, resulting in 29 strains of G1
genotype while 20 samples could not be assigned a G type. All
of G1 genotypes had a long RNA electropherotype. Among the
patients with rotavirus infection, 23 (24.5%) required
hospitalization. Watery diarrhoea (92.6%), vomiting (73.4%)
and fever (64.9%) were signiﬁcantly more frequent in children
suffering from rotavirus gastroenteritis. Seven out of 94
rotavirus-positive patients had severe dehydration
(P < 0.0001). Rotavirus infection mostly affected children
under 2 years of age with a peak incidence of 40% in children
1–2 years of age and it occurs year round with a seasonal
pattern: more frequently during winter (46.2%).
Conclusion: This study revealed that rotavirus is an important
etiological agent of acute gastroenteritis in Tehran. We found
that a major proportion of the specimens were untypeable.
Improved detection and characterization of incompletely typed
strains will help to develop comprehensive strain informa-
tion that may be required for tailoring effective rotavirus
vaccines.
P1883
Serological study of prevalent rotaviruses in
Tehran
E. Habibi, S. Ghorbani, A. Jarollahei, Z. Habibi (Tehran, Zanjan,
IR)
Objectives: Rotaviruses are icosohedral and non-enveloped
viruses that belong to reoviridae family which consist of three
layers of protein surrounding 11 segments of dsRNA. Rotavirus
is one of the most important agents of acute gastroenteritis in
children. In this survey, the most prevalent serotypes in Tehran
and seasonal distribution in a year were detected.
Methods: In this study, a total number of 180 specimens of
faecal samples of children and infants with acute gastroenteritis
were collected from two children hospitals in Tehran. The
samples were tested by ELISA procedure. Serotyping
investigation of Iranian rotavirus isolates, using 7 serotypes
monoclonal antibodies (G1-G2-G3-G4-G6-G8-G9) in ELISA tests
and Immunosorbent Electron microscopical studies using
trapping and decoration techniques were performed.
Results: Rotavirus type A infection was identiﬁed in 66 samples
(37%). Serotyping investigation in ELISA tests proved that
serotypes G1 and G4 were the most common serotypes
circulating among infected children and infants in Tehran. By
electron microscopic studies the characteristic of rotavirus
particles were observed in the faecal samples of infected
children. The maximum incidence of infection was determined
to occur among the cold months of the year.
Conclusion: It was approved that G1 and G4 serotypes are the
main rotavirus serotypes present among children in Tehran. It
was detected that rotavirus diarrhoea was most prevalent
among children of under 3 years of age.
P1884
Neurological manifestations in varicella
C.P. Popescu, S-A. Florescu, M. Cotiga, G. Enache, R.F. Botgros,
L. Raduta, P.I. Calistru, E. Ceausu (Bucharest, RO)
Objectives: Clinical,paraclinical and terapeutical evaluation of
neurological manifestations in varicella.
Methods: We analysed patients with varicella and neurological
manifestations admitted in Clinical Hospital of Infectious and
Tropical Disease ‘‘Dr.V.Babes’’ Bucharest from January 2001 to
October 2005.
Results: From 447 patients with varicella 19 presented
neurological manifestations (sex ratio M/F:10/9). 18 had acut
cerebellar ataxia and one had encephalitis. We estabilished the
diagnosis on the basis of clinical aspects (including neurological
examination), cerebrospinal ﬂuid examination and
electroencephalogram. The age interval was between 7 months
and 30 years. Most cases were diagnosed in children and
teenager (17); one case toddlers, and 2 cases in adults.
Neurological manifestations appeared in most cases among 7
and 10 days after the onset of rash (15 cases). In the order of
frequency: gait disorders (15), cerebellar ataxia (11), fever (7),
vomiting (5), nistagmus (3), seizures and coma (1). CSF showed
limphocytic pleiocytosis and elevated levels of protein (10
cases); in 9 cases CSF had normal aspects. Electroencephalogram
had dominant theta wave with totally or partially suppression of
alpha activity in all patients. All cases showed clinical and EEG
improvement at the end of the treatment.
Conclusions: The most frequent neurological manifestation
was cerebellar. The evolution was good under treatment, with
no sequelae at 1 month of follow up.
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